Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,muscle contraction (GO:0006936),0.9031429448469318,2.6165780695655845,0.0,0.0,0.0,54/126,2.90%,MYH11;MYOM1;ACTA2;LMOD1;MYL1;TPM2;MYBPC1;MYLK2;DMD;MYLK;TRDN;RYR1;TPM1;MYOT;NEB;TTN;MYL9;MYH2;TCAP;TNNI2;SMTN;CACNA1S;SCN4A;TNNC2;ACTG2;EDNRA;MYOM2;CALD1;LMOD2;ACTA1;TNNT3;MYL2;VCL;MYOM3;ROCK1;HRC;LMOD3;SGCA;MYL6;CKMT2;SNTB1;KCNJ12;GJC1;CACNA1H;ITGA1;DTNA;DYSF;DES;MYL3;MYBPC2;VIM;SLC8A1;ASPH;SNTA1
prerank,actin-myosin filament sliding (GO:0033275),0.9471843676629204,2.397388902856506,0.0,0.0,0.0,19/38,2.61%,MYL1;TPM2;MYBPC1;DMD;TPM1;NEB;TTN;MYH2;TCAP;TNNI2;TNNC2;ACTA1;TNNT3;MYL2;MYL6;DES;MYL3;MYBPC2;VIM
prerank,muscle filament sliding (GO:0030049),0.9471843676629204,2.397388902856506,0.0,0.0,0.0,19/38,2.61%,MYL1;TPM2;MYBPC1;DMD;TPM1;NEB;TTN;MYH2;TCAP;TNNI2;TNNC2;ACTA1;TNNT3;MYL2;MYL6;DES;MYL3;MYBPC2;VIM
prerank,myofibril assembly (GO:0030239),0.9083712998446591,2.342974839703546,0.0,0.0,0.0,17/42,2.55%,LMOD1;TPM1;OBSCN;TTN;MYOZ2;TCAP;MYPN;MYOM2;LMOD2;TNNT3;MYL2;CASQ1;CSRP1;SYNPO2L;LMOD3;CSRP3;WDR1
prerank,sarcomere organization (GO:0045214),0.9437207999052247,2.272710185336544,0.0,0.0,0.0,14/27,2.55%,TPM1;OBSCN;TTN;MYOZ2;TCAP;MYPN;MYOM2;LMOD2;TNNT3;CASQ1;CSRP1;SYNPO2L;CSRP3;WDR1
prerank,striated muscle contraction (GO:0006941),0.8201510898826547,2.1649301711515703,0.0,0.0006112401015158391,0.004,15/53,2.70%,MYLK2;DMD;TPM1;TTN;TCAP;RYR2;TNNI2;TNNC2;TNNT3;STAC;LMOD3;CSRP3;DTNA;MYL3;SLC8A1
prerank,heart contraction (GO:0060047),0.8288187491672002,2.1363516812686374,0.0,0.0007858801305203644,0.006,13/41,2.70%,MYLK2;DMD;TRDN;TPM1;TTN;TCAP;RYR2;TNNI2;SGCG;MYL2;CSRP3;MYL3;SLC8A1
prerank,actomyosin structure organization (GO:0031032),0.7778882443194541,2.121193453143375,0.0,0.0011460751903421983,0.009,24/75,6.29%,LMOD1;TPM1;OBSCN;TTN;MYOZ2;TCAP;PDLIM1;MYPN;MYOM2;LMOD2;TNNT3;ROCK1;CASQ1;CSRP1;SYNPO2L;LMOD3;CSRP3;MYH9;WDR1;ITGB1;TNFAIP1;MYO18A;ITGB5;SORBS1
prerank,cardiac muscle cell development (GO:0055013),0.9158118603272327,2.0729856653418546,0.0,0.005093667512631991,0.036,11/20,2.70%,MYH11;SORBS2;TTN;TCAP;PDLIM5;HEY2;MYL2;ALPK3;CSRP3;ALPK2;SLC8A1
prerank,cardiac muscle contraction (GO:0060048),0.8321361682460473,2.0591836268338177,0.0,0.006693079111598437,0.054,11/34,3.16%,MYLK2;DMD;TPM1;TTN;TCAP;RYR2;TNNI2;CSRP3;MYL3;SLC8A1;CAMK2D
prerank,muscle cell differentiation (GO:0042692),0.8214395139509183,2.0519532263656357,0.0,0.0075849339869920014,0.067,11/32,3.40%,MYOCD;DMD;NEB;MEF2C;NRAP;HEY2;SPEG;SYNE1;FBXO40;RORA;MRTFA
prerank,skeletal muscle tissue development (GO:0007519),0.8546950627780313,2.0396580052790503,0.0,0.009015791497358627,0.083,9/32,1.72%,MYLK2;RYR1;MYOZ2;MEF2C;KLHL40;ACTA1;LMOD3;CSRP3;MYL6
prerank,cardiac muscle cell differentiation (GO:0055007),0.9034262887689699,2.036628637703076,0.0,0.009168601522737586,0.092,8/21,2.70%,MYH11;MYOCD;TTN;TCAP;MEF2C;ALPK3;ALPK2;SLC8A1
prerank,smooth muscle contraction (GO:0006939),0.94780653744372,2.036228112832156,0.0,0.008710171446600705,0.094,7/14,2.70%,MYH11;ACTA2;MYLK;SMTN;EDNRA;ROCK1;SLC8A1
prerank,regulation of heart contraction (GO:0008016),0.7213040537903578,2.010421202262055,0.0,0.014853134466834887,0.165,23/90,3.42%,PLN;TRDN;RYR1;TPM1;ATP2A1;RYR2;ATP2B4;HSPB7;TNNI3K;TBX2;TMIGD3;CASQ1;HRC;ATP2A2;ITPR1;KCNJ12;CACNA1H;DES;SLC8A2;SLC8A1;ASPH;CAMK2D;STIM1
prerank,muscle organ development (GO:0007517),0.7584381784698959,2.0067918367016215,0.0,0.015300103791068343,0.174,19/54,6.21%,SOX6;TAGLN;DMD;NEB;SMTN;MEF2C;SGCG;SGCA;ITGA7;CACNA1H;SPEG;LARGE1;FHL3;FHL1;ITGB1BP2;ANKRD2;UTRN;MEF2A;CHD2
prerank,calcium ion transport into cytosol (GO:0060402),0.8790573278018091,2.005012623851771,0.0,0.014885494236915138,0.181,7/21,2.87%,JPH2;RYR2;CACNA1C;ATP2B4;CACNA2D1;SLC8A1;GRIN2C
prerank,mesonephric tubule development (GO:0072164),-0.7577688468048712,-1.9966206754022358,0.0,0.1789671740191953,0.129,8/15,10.88%,BMP7;BMP4;SLIT2;PKD2;OSR1;SALL1;FGFR2;SIX1
prerank,regulation of cation channel activity (GO:2001257),0.7050700874307501,1.9880044978482194,0.0,0.021087783502296446,0.25,15/89,5.72%,JPH2;KCNAB1;CACNB2;DMD;FGF13;MEF2C;STAC;HRC;FGF14;CAMK2D;SHISA9;ITGB1;CACNB4;JPH1;CNIH2
prerank,regulation of muscle contraction (GO:0006937),0.8340501062149465,1.9696095371845694,0.0,0.032283128519533924,0.354,10/26,2.58%,MYLK2;TPM1;CNN1;MYL9;TNNC2;PPP1R12B;TNNT3;MYL2;PLCE1;MYL3
prerank,cellular response to alkaloid (GO:0071312),0.8889254876277949,1.9626721902261581,0.0,0.035620016915835516,0.389,5/17,2.70%,RYR1;RYR2;CACNA1S;HTR1B;SLC8A1
prerank,muscle cell development (GO:0055001),0.8139908714519535,1.9613800069699883,0.0,0.034666045757398296,0.394,12/30,2.70%,MYH11;DMD;NEB;TTN;TCAP;NRAP;HEY2;ALPK3;FER1L5;ALPK2;DYSF;SLC8A1
prerank,actin filament organization (GO:0007015),0.6623566488972545,1.9601663906920712,0.0,0.034215553864397986,0.407,26/151,5.53%,LMOD1;TPM2;FLNA;TPM1;NEB;TTN;TCAP;ACTN1;ENAH;PLS3;NRAP;XIRP1;DSTN;LMOD2;ACTA1;MYO1E;MYO1D;LMOD3;HIP1;FAT1;LCP1;RHOBTB3;MYO1B;ERMN;ARHGEF2;MYO5C
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.8482739803635971,1.9500682879766857,0.0016233766233766235,0.041896522610422614,0.479,7/22,1.44%,JPH2;TRDN;ATP2A1;RYR2;AKAP6;STAC;CASQ1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.8255570111690428,1.9421525722638975,0.0015151515151515152,0.048020550475338104,0.536,6/24,3.16%,JPH2;DMD;TRDN;AKAP6;HRC;CAMK2D
prerank,regulation of blood circulation (GO:1903522),0.785547230347536,1.9415787442335004,0.00423728813559322,0.046649844547688835,0.543,10/34,3.16%,PLN;TPM1;AGTR1;HSPB7;TBX2;TMIGD3;KCNJ12;CACNA1H;DES;CAMK2D
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.811875419360682,1.937791555686556,0.0014367816091954023,0.04852306036648814,0.568,8/27,3.16%,PLN;CTNNA3;ATP2A1;FGF13;RYR2;CACNA1C;ATP2A2;CAMK2D
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.8193744743994354,1.9347860528614116,0.0014684287812041115,0.049510448222782964,0.591,8/27,5.30%,JPH2;PLN;CACNB2;DMD;HRC;CAMK2D;CACNB4;JPH1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.8006972054024083,1.9321473855694116,0.0030211480362537764,0.05019809333698828,0.604,4/25,2.99%,JPH2;CNNM2;SLC8A1;FAM20A
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.6576190904318688,1.9283563269977897,0.0,0.051850022404447034,0.624,19/140,7.66%,JPH2;AGTR1;RYR2;CACNA1C;GPR20;EDNRA;PTGER3;CACNA2D1;ADCY5;CD36;S1PR3;PLCE1;SLC8A1;ADRA1D;JPH1;CXCR6;CAV1;GPR17;C1QTNF1
prerank,cytosolic calcium ion transport (GO:0060401),0.8005142727163627,1.9279232874014882,0.0,0.05067180441566305,0.628,10/28,7.87%,JPH2;RYR2;CACNA1C;CACNA2D1;ATP2A2;SLC8A2;SLC8A1;JPH1;AFG3L2;ATP2B1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.8035072812472738,1.9277238244014192,0.0014347202295552368,0.04930341528517276,0.63,6/29,2.58%,MYLK2;TPM1;TTN;TCAP;MYL2;MYL3
prerank,skeletal muscle contraction (GO:0003009),0.8616153989234988,1.927542036366654,0.0,0.04787729107654533,0.633,5/19,1.37%,TCAP;TNNI2;TNNC2;TNNT3;STAC
prerank,regulation of calcium ion transport (GO:0051924),0.7335671866015598,1.924360511886041,0.0,0.04923261181300303,0.65,12/54,4.50%,PLN;CACNB2;MYLK;TRPC6;CAMK2G;CASQ1;CACNA2D1;HRC;PACSIN3;STIM1;CCL5;BCL2
prerank,vasoconstriction (GO:0042310),0.9283685759079989,1.9149766384241833,0.0,0.05727679304204303,0.72,4/11,2.70%,ACTA2;EDNRA;EDNRB;SLC8A1
prerank,calcium ion import (GO:0070509),0.7974101873785864,1.912443148669147,0.0014492753623188406,0.05881002976727394,0.736,7/28,2.70%,CACNB2;ATP2A1;CACNA1S;CACNA1C;ATP2A2;CACNA1H;SLC8A1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.701615863033232,1.9070956577735552,0.0,0.06364537557033674,0.768,10/76,4.00%,LMOD1;SYNPO2;NTF3;NTRK3;LMOD2;SYNPO2L;CDC42EP3;SEMA5A;WDR1;NUP62
prerank,striated muscle cell development (GO:0055002),0.890954578216055,1.9021838005324843,0.005076142131979695,0.06873973141641639,0.799,3/14,1.60%,LMOD1;LMOD2;LMOD3
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.7281384353871717,1.8953077912257952,0.0,0.07653369481611479,0.832,11/54,7.03%,KCNAB1;FLNA;KCNMA1;AKAP6;KCNJ12;KCNMB1;FHL1;KCNN2;KCNIP3;CAV1;NEDD4
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.7807987331172914,1.8928690326130584,0.002898550724637681,0.07783907600457474,0.839,4/32,1.44%,JPH2;TRDN;AKAP6;CASQ1
prerank,muscle tissue morphogenesis (GO:0060415),0.8750357643289866,1.8893253512203843,0.0016051364365971107,0.081233809491455,0.856,5/16,1.06%,MYLK2;MYLK;TTN;TCAP;HEY2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.8187293072517088,-1.8874358166819807,0.0,0.5033451769289867,0.516,3/10,0.84%,PRKCB;PID1;APPL2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.6368810643817934,1.882718077304878,0.0,0.08889070988507781,0.88,26/142,8.89%,PLN;RYR1;AGTR1;RYR2;CACNA1C;EDNRA;HCRTR1;ATP2B4;TRPC6;PTGER3;HRC;ADCY5;CD36;S1PR3;PLCE1;SLC8A2;SLC8A1;ADRA1D;CXCR6;CAV1;CALB1;FZD9;C1QTNF1;ATP2B1;TRPM4;TRPC5
prerank,cardiac cell development (GO:0055006),0.9321022790585061,1.8812231761554563,0.0,0.0891755648104358,0.882,7/11,3.14%,MYH11;TTN;TCAP;ALPK3;ALPK2;SLC8A1;JAG1
prerank,cellular response to copper ion (GO:0071280),-0.6956732370803295,-1.8773456086851912,0.0,0.3889396259934705,0.573,11/16,18.89%,SNCA;MT2A;MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1F;MT1B;HSF1
prerank,epithelial cell development (GO:0002064),0.8087700612110945,1.8699017383930516,0.003257328990228013,0.10552420682797281,0.921,2/20,3.53%,ACTA2;TMEM79
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.7200705267187018,1.8670814836949556,0.0026702269692923898,0.10762687923849915,0.928,7/48,3.16%,JPH2;DMD;TRDN;AKAP6;CASQ1;HRC;CAMK2D
prerank,positive regulation of heart rate (GO:0010460),0.8303525873731534,1.8669959964596046,0.003257328990228013,0.10531666949117907,0.928,5/17,2.89%,TPM1;RYR2;HRC;ATP2A2;ADRA1D
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.8604146873249988,1.8589753871507453,0.0017543859649122807,0.11592301403530825,0.945,3/17,4.10%,KCNAB1;AKAP6;KCNE4
prerank,cardiac muscle tissue development (GO:0048738),0.7052885336373886,1.8586973141593492,0.0012755102040816326,0.11386622784727506,0.946,8/50,1.66%,MYOCD;MYLK2;TTN;TCAP;HEY2;SGCG;TBX2;CSRP3
prerank,response to muscle stretch (GO:0035994),0.8574021786352237,1.853602446779695,0.003401360544217687,0.1207963250620677,0.954,6/15,2.70%,DMD;TTN;TCAP;RYR2;CSRP3;SLC8A1
prerank,protein kinase A signaling (GO:0010737),0.8910698096868951,1.8518254641615983,0.0017605633802816902,0.12156817161882877,0.956,3/12,3.35%,MYOM1;TTN;LCP1
prerank,positive regulation of cation channel activity (GO:2001259),0.735241714601281,1.8473661418993579,0.008275862068965517,0.1278286424300074,0.959,5/40,1.44%,JPH2;TRDN;AKAP6;STAC;CASQ1
prerank,skeletal muscle organ development (GO:0060538),0.7779202594289659,1.8472574914067226,0.004651162790697674,0.12548399731119284,0.959,6/26,6.08%,MYOZ2;MEF2C;CSRP3;MYL6;LARGE1;CAV1
prerank,actin nucleation (GO:0045010),0.7987645526584392,1.845323309298823,0.00322061191626409,0.12654433293978393,0.963,7/21,8.93%,LMOD1;LMOD2;LMOD3;ACTR3;WHAMM;SPIRE1;WASHC1
prerank,blood circulation (GO:0008015),0.6913708630400497,1.8373566836846889,0.0012970168612191958,0.14026230404972895,0.977,8/49,1.43%,PLN;GUCY1A1;TRDN;AGTR1;ELN;SGCG;MYL2;ROCK1
prerank,extracellular matrix assembly (GO:0085029),0.8081712326287157,1.835721411342496,0.007530120481927711,0.1407380333740219,0.978,6/23,6.92%,MYH11;NTN4;HAS2;EMILIN1;PXDN;LAMB2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.8020798878147603,1.8348505809131217,0.0015479876160990713,0.1397628275756944,0.978,6/23,1.60%,MYOCD;MEF2C;RBM24;AKAP6;SMYD1;LMOD3
prerank,heart development (GO:0007507),0.6229914896345602,1.8322416793522307,0.0,0.14262087118672698,0.98,21/150,2.23%,MYOCD;PDLIM3;LDB3;TCAP;CACNA1C;PDLIM1;MEF2C;NTRK3;PDLIM5;CRIP1;DLC1;SGCG;MYL2;TBX2;MICAL2;ALPK3;SYNPO2L;CSRP3;PLCE1;PDGFB;ALPK2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.9115697222755221,1.8273191529492838,0.0,0.14970556907389246,0.986,3/11,0.71%,MYOCD;SOX6;MEF2C
prerank,regulation of cardiac conduction (GO:1903779),0.6922656962109377,1.8253547970432706,0.0025940337224383916,0.1512186933905306,0.986,13/54,3.42%,TRDN;RYR1;ATP2A1;RYR2;ATP2B4;TNNI3K;CASQ1;ATP2A2;ITPR1;SLC8A2;SLC8A1;ASPH;STIM1
prerank,activation of adenylate cyclase activity (GO:0007190),0.7319183949889586,1.8182878291976363,0.004207573632538569,0.16369838718731816,0.989,8/35,4.27%,CAP2;LHCGR;EDNRA;TMIGD3;ADCY5;ADCY2;ADCY9;TSHR
prerank,ureteric bud development (GO:0001657),-0.6641846730302191,-1.817935197934369,0.0026041666666666665,0.6411028042990252,0.839,8/17,10.88%,BMP7;BMP4;SLIT2;PKD2;OSR1;SALL1;FGFR2;SIX1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.8424257318428856,1.8179145294071537,0.001639344262295082,0.16184109787885625,0.989,5/17,3.63%,TPM1;CNN1;MEF2C;PRKG1;TGFB3
prerank,embryonic skeletal system development (GO:0048706),-0.5593883568865884,-1.8174467827812886,0.0,0.5152370746763149,0.842,15/35,10.88%,PDGFRA;HOXB3;SULF1;COL1A1;PCSK5;HOXA3;KIAA1217;WNT5A;DSCAML1;RBP4;HOXB4;MEGF8;WNT9A;OSR1;SIX1
prerank,calcium ion homeostasis (GO:0055074),0.6350767575039079,1.8140693376482255,0.002288329519450801,0.1674847979801064,0.993,12/95,3.64%,JPH2;TRDN;ATP2A1;RYR2;ATP2B4;ATP2A2;CSRP3;SLC8A2;SLC8A1;FAM20A;STIM1;CCL5
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.801256428956342,1.8070401046015259,0.008156606851549755,0.17989683471629472,0.999,9/21,3.16%,DMD;TRDN;RYR2;CACNA1C;AKAP6;CASQ1;HRC;SLC8A1;CAMK2D
prerank,negative regulation of cell development (GO:0010721),-0.5989020853823828,-1.8051537394334083,0.0030864197530864196,0.4998129300733447,0.879,5/25,4.17%,IGF1;FBN1;APPL2;B2M;PCM1
prerank,smooth muscle cell differentiation (GO:0051145),0.8656151066308707,1.8040646450627784,0.0035087719298245615,0.18353211714800585,0.999,6/12,5.24%,MYOCD;MEF2C;HEY2;EDNRB;MRTFA;TBX18
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.7104387601798376,1.8039380000717928,0.00554016620498615,0.18087931691575743,0.999,7/41,4.09%,FLNA;KCNMA1;AKAP6;STAC;KCNJ12;KCNMB1;KCNN2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.8928815842924008,1.8007956467632988,0.0037313432835820895,0.18489542886160654,0.999,3/10,6.08%,KCNAB1;KCNE4;CAV1
prerank,regulation of smooth muscle contraction (GO:0006940),0.8043714684173403,1.795928704937057,0.011182108626198083,0.19311019661753812,0.999,7/20,8.18%,MYOCD;CNN1;PLCE1;CAV1;ATP2B1;SETD3;DAPK3
prerank,modified amino acid transport (GO:0072337),-0.6853101390791306,-1.7948890058061218,0.0,0.48896388615958714,0.904,5/15,7.67%,SLC6A13;SLC16A12;PDPN;SLC25A32;CTNS
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.8439600367114091,1.79476969879071,0.008532423208191127,0.19318380253206938,0.999,2/13,1.06%,RYR2;HEY2
prerank,calcium ion transport (GO:0006816),0.619524871441578,1.7923467342665027,0.0,0.19580357546058116,0.999,17/113,3.64%,CACNB2;RYR1;ATP2A1;RYR2;CACNA1S;CACNA1C;ATP2B4;TRPC6;CACNA2D1;ATP2A2;ITPR1;CACNA1H;ANO6;SLC8A2;SLC8A1;STIM1;CCL5
prerank,cardiac myofibril assembly (GO:0055003),0.8188596385573453,1.789329125660877,0.0034602076124567475,0.20018113324643727,0.999,6/15,1.66%,NEB;TTN;TCAP;NRAP;MYL2;CSRP3
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.6281879408365492,-1.786926929391566,0.007594936708860759,0.4719964860851639,0.926,9/19,11.87%,ROBO1;JCAD;DCN;SEMA6A;CCBE1;XDH;PIK3CB;CD63;SPRY2
prerank,negative regulation of reproductive process (GO:2000242),-0.6538076446447683,-1.786547333343304,0.0,0.4219072633127959,0.926,6/17,15.51%,IGF1;SULF1;GJA1;ARHGDIB;CALR;DUSP1
prerank,chordate embryonic development (GO:0043009),-0.4920740250044132,-1.7851603927733124,0.0,0.385603615074253,0.929,18/55,11.77%,ALDH1A2;CHD7;SULF1;COL1A1;BMP7;PCSK5;KIAA1217;PTCH1;WNT5A;RBP4;PKD2;ARNT2;ADAM10;FUT8;IGF2;TGFB1;FGFR2;TGFBR1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.7158304165416232,1.7792936486045752,0.010884353741496598,0.22177537283284685,0.999,8/38,6.08%,CACNB2;CTNNA3;CACNA1C;CACNA2D1;CAMK2D;KCNA5;KCNE4;CAV1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.7100390026006801,1.7764182983712111,0.00846262341325811,0.2258446084945882,1.0,11/35,7.68%,PDE3A;CAP2;AKAP6;CD36;IRAG1;ADCY2;GUCY1B1;NUDT4;KSR1;CAP1;SOX9
prerank,metal ion homeostasis (GO:0055065),0.6968454585655508,1.7747487871292154,0.01510989010989011,0.22688468518141047,1.0,4/40,2.99%,JPH2;CNNM2;SLC8A1;FAM20A
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.8372293040380576,1.7742601365861093,0.006944444444444444,0.22504520833481104,1.0,8/13,11.18%,TRDN;HRC;SLC8A1;CAMK2D;CAV1;CALM1;SRI;PDE4D
prerank,cellular response to purine-containing compound (GO:0071415),0.8938858761298066,1.7692155444360265,0.0057361376673040155,0.23479053899442873,1.0,4/10,2.70%,RYR1;RYR2;CACNA1S;SLC8A1
prerank,calcium ion import across plasma membrane (GO:0098703),0.8130321544292597,1.766707244454735,0.0065252854812398045,0.238298065976965,1.0,5/14,6.55%,ATP2B4;CACNA2D1;SLC8A2;SLC8A1;TRPV2
prerank,anion transport (GO:0006820),-0.5518766767851158,-1.7665895056651517,0.0037735849056603774,0.4267596428316577,0.957,8/33,8.18%,SLC13A4;SLC13A3;ABCG2;SLCO2B1;LRRC8B;SLC26A7;SLC22A6;SLC4A2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.7384253537333421,1.7651486849939966,0.019174041297935103,0.23942113923717123,1.0,10/25,8.74%,CTNNA3;FGF13;RYR2;CACNA1C;ATP2A2;CAMK2D;TBX18;CAV1;CALM1;TRPM4
prerank,heart morphogenesis (GO:0003007),0.6820880135957261,1.7649080997382047,0.01045751633986928,0.2369904884507093,1.0,14/50,7.86%,MYLK2;TTN;TCAP;RYR2;DLC1;HEY2;TBX2;SYNPO2L;ALPK2;HEYL;BMPR1A;VEGFA;SOX9;TGFB2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.8489244358065092,1.7594211219325462,0.005119453924914676,0.24792838886869376,1.0,8/12,11.18%,TRDN;HRC;GJD3;CAMK2D;CAV1;CALM1;SRI;PDE4D
prerank,calcium ion import into cytosol (GO:1902656),0.8048380031180077,1.757422025572161,0.004807692307692308,0.2501403400247635,1.0,5/15,6.55%,ATP2B4;CACNA2D1;SLC8A2;SLC8A1;TRPV2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.5878082012573752,-1.7564055299847507,0.002793296089385475,0.4408440311777656,0.968,13/24,24.18%,ITCH;NOD1;IRAK1;CASP8;IKBKG;TAB2;IRAK2;UBC;RNF34;TAB1;AAMP;UBB;CYLD
prerank,response to purine-containing compound (GO:0014074),0.7920780123054647,1.752016823414362,0.018032786885245903,0.2610186246004357,1.0,2/17,0.51%,RYR1;RYR2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.7555195728100661,1.7451365332133535,0.016717325227963525,0.2763710799742727,1.0,5/22,6.29%,CACNB2;DMD;STAC;CACNB4;STAC3
prerank,dendrite self-avoidance (GO:0070593),0.8113204203155845,1.7442356298488797,0.003179650238473768,0.27551647575826443,1.0,4/16,1.61%,NEXN;PALLD;MYPN;ROBO3
prerank,positive regulation of potassium ion transport (GO:0043268),0.6822689813536363,1.7428203615473457,0.012482662968099861,0.2761406034522821,1.0,7/38,4.09%,FLNA;KCNMA1;AKAP6;KCNJ12;KCNMB1;FHL1;KCNN2
prerank,positive regulation of ATPase activity (GO:0032781),0.6736935312751149,1.7413122963775594,0.006802721088435374,0.2771318960265563,1.0,6/41,2.58%,TPM1;ATP2A1;RYR2;DYNLL1;TNNT3;MYL3
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.7195190330934241,1.7402467016282317,0.008633093525179856,0.2767946866764343,1.0,7/33,5.98%,TPM1;CNN1;MEF2C;PRKG1;IGFBP5;TGFB3;OGN
prerank,cellular calcium ion homeostasis (GO:0006874),0.5915621223310056,1.7382433699430078,0.0010905125408942203,0.2793118503420953,1.0,33/133,12.68%,PLN;TRDN;RYR1;ATP2A1;RYR2;HCRTR1;ATP2B4;TRPC6;HRC;ATP2A2;CSRP3;SLC8A2;SLC8A1;CAMK2D;STIM1;CCL5;BCL2;ATP1B1;CAV1;AFG3L2;CALB1;RMDN3;FZD9;ATP2B1;TRPC5;PTH1R;ATP2A3;CCL14;GPER1;HTR2B;DMPK;CHRNA7;CALB2
prerank,platelet aggregation (GO:0070527),0.7282922531681675,1.7376545605925242,0.011095700416088766,0.27804047583262725,1.0,11/33,7.51%,FLNA;MYL9;ACTN1;VCL;CSRP1;MYH9;ACTG1;ACTB;TLN1;ITGB3;PLEK
prerank,cellular response to cadmium ion (GO:0071276),-0.5619633041885789,-1.734559707746939,0.009433962264150943,0.527572767541403,0.988,14/24,18.89%,EGFR;CHUK;MAPK9;AKT1;MT2A;MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1F;MT1B;HSF1
prerank,focal adhesion assembly (GO:0048041),0.7476063107747467,1.7333761538255228,0.016819571865443424,0.286497959854816,1.0,8/21,9.97%,ARHGEF7;ACTN1;DLC1;FERMT2;PEAK1;SORBS1;WHAMM;ACTN2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.8529065243688444,1.7309126866799487,0.017605633802816902,0.28991324050885514,1.0,1/10,0.03%,MYOCD
prerank,zinc ion homeostasis (GO:0055069),-0.5669663154207939,-1.730216746580783,0.003194888178913738,0.5131850074554181,0.991,15/28,17.80%,SLC39A10;SLC30A10;SLC39A8;PRKN;SLC30A1;SLC39A6;MT2A;MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1F;MT1B
prerank,amino acid import (GO:0043090),-0.6018192048664397,-1.7280660314046903,0.002717391304347826,0.4894909198174131,0.992,8/21,9.92%,SLC6A13;SLC1A3;SLC47A1;SLC6A1;SLC6A6;SLC7A5;SLC22A4;SFXN2
prerank,cGMP-mediated signaling (GO:0019934),0.8096707513472811,1.7256409270610278,0.01763668430335097,0.3015756787528897,1.0,4/13,3.85%,PDE3A;CD36;IRAG1;GUCY1B1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.8507666935437387,1.723215786060736,0.013816925734024179,0.30520360145798564,1.0,2/11,0.71%,MYOCD;MEF2C
prerank,regulation of glucose import (GO:0046324),-0.5463418435061022,-1.7221078530831422,0.0,0.4909823129342397,0.994,14/30,16.75%,IGF1;OSBPL8;PID1;PRKAG2;APPL2;PTPN11;OCLN;CREBL2;ENPP1;APPL1;RHOQ;INSR;AKT1;CAPN10
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.8322064256819525,1.7210143427782516,0.007142857142857143,0.30495951709982977,1.0,3/12,1.59%,MYOZ2;ATP2B4;DYRK2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.8322064256819525,1.7210143427782516,0.007142857142857143,0.30495951709982977,1.0,3/12,1.59%,MYOZ2;ATP2B4;DYRK2
prerank,positive regulation of calcium ion transport (GO:0051928),0.6873934589462249,1.719244842586319,0.01566951566951567,0.30670922859838656,1.0,7/36,7.87%,CACNB2;MYLK;TRPC6;PDGFB;CCL5;CAV1;ATP2B1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.7558592034720005,1.717842921505226,0.01658374792703151,0.3072060579686948,1.0,9/20,7.02%,DMD;RYR2;CACNA1C;HRC;ATP2A2;SLC8A1;CAMK2D;ATP1B1;CALM1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.8462071045010404,1.7172857691525294,0.019891500904159132,0.30560094950474714,1.0,5/10,9.21%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.6936542258958391,1.7154603592828503,0.013623978201634877,0.30781925483450745,1.0,9/37,5.14%,TPM1;CNN1;MEF2C;PRKG1;HTR1B;PDGFB;IGFBP5;TGFB3;BMPR1A
prerank,striated muscle tissue development (GO:0014706),0.7071340068351902,1.7113708774983973,0.010736196319018405,0.3166067797254721,1.0,6/29,1.72%,MYOZ2;MEF2C;SGCG;TBX2;CSRP3;MYL6
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.683291587589092,1.7098790009868903,0.011984021304926764,0.31732622482331374,1.0,8/41,2.87%,RYR1;RYR2;ATP2B4;CACNA2D1;ITPR1;SLC8A2;SLC8A1;GRIN2C
prerank,cellular polysaccharide catabolic process (GO:0044247),0.7967144634120539,1.7080204671324406,0.02254428341384863,0.3195165944658821,1.0,9/16,12.40%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1;AOAH;PHKA1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.8173883051057057,1.7068864883134756,0.011904761904761904,0.32003866008328075,1.0,3/12,0.63%,CTNNA3;RYR2;CACNA1C
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.6197754184434743,-1.7065070693953477,0.002631578947368421,0.5483293795317218,0.995,6/18,11.67%,PTN;SLIT2;CAMK1D;PTK2B;IL6R;LYN
prerank,negative regulation of cation channel activity (GO:2001258),0.7305386655947242,1.7064770507165752,0.019490254872563718,0.3180605845887713,1.0,2/26,0.28%,KCNAB1;TRDN
prerank,sensory perception of taste (GO:0050909),0.8683876379779295,1.7045455782122163,0.012867647058823529,0.3206251050946457,1.0,3/10,5.34%,ASIC3;CD36;PKD1L3
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.8325832015367766,1.700739904898603,0.01834862385321101,0.3294172735563583,1.0,3/11,3.16%,CACNB2;CACNA2D1;CAMK2D
prerank,glycerolipid metabolic process (GO:0046486),0.8285051865623574,1.7000445731581704,0.016245487364620937,0.3284280385459105,1.0,2/11,0.44%,DGKB;DGKG
prerank,metal ion transport (GO:0030001),0.6069302815086497,1.6997938048960404,0.00954653937947494,0.32604757962225783,1.0,20/86,12.48%,RYR1;ATP2A1;RYR2;CACNA1S;CACNA1C;CACNA2D1;ITPR1;SLC8A2;SLC8A1;CCL5;CAV1;RAMP1;TRPC5;SLC30A5;MRS2;ATP2A3;PANX1;CACNA1B;CHRNA7;TRPM2
prerank,negative regulation of neurogenesis (GO:0050768),-0.5384616178098626,-1.699312573645673,0.003436426116838488,0.5578333552762051,0.996,6/34,5.75%,PTN;NF1;APPL2;B2M;PCM1;RUFY3
prerank,positive regulation of ion transport (GO:0043270),0.651327083750901,1.6987093543493315,0.019230769230769232,0.3259994812453752,1.0,15/48,11.09%,CACNB2;MYLK;TRPC6;PLA2G3;ANO6;CCL5;FHL1;GDNF;PRSS8;KIF5B;ATP2B1;CNKSR3;AHCYL1;ACTN2;GPD1L
prerank,regulation of cation transmembrane transport (GO:1904062),0.7089913292844018,1.6979161623348387,0.013254786450662739,0.3250439028727562,1.0,6/29,5.31%,KCNAB1;ATP2B4;HRC;SNTA1;KCNN2;KCNIP3
prerank,glucan catabolic process (GO:0009251),0.7958796816653267,1.695900885059083,0.022328548644338118,0.328345284807396,1.0,7/15,8.25%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1
prerank,response to cadmium ion (GO:0046686),-0.549542592074846,-1.6954027082653234,0.013468013468013467,0.5529515560156786,0.997,14/26,18.89%,EGFR;CHUK;MAPK9;AKT1;MT2A;MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1F;MT1B;HSF1
prerank,homotypic cell-cell adhesion (GO:0034109),0.684536018762185,1.692809618768522,0.013020833333333334,0.33423720096525195,1.0,11/39,7.51%,FLNA;MYL9;ACTN1;VCL;CSRP1;MYH9;ACTG1;ACTB;TLN1;ITGB3;PLEK
prerank,striated muscle cell differentiation (GO:0051146),0.786348231058879,1.6917535640936525,0.018032786885245903,0.3345135355566006,1.0,3/16,3.56%,MYOCD;MEF2C;SORT1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.7169298607419259,1.6879070851956128,0.02564102564102564,0.3426437369068789,1.0,5/26,1.59%,MYOZ2;ATP2B4;AKAP6;LMCD1;DYRK2
prerank,peptidyl-arginine modification (GO:0018195),0.7872240773589565,1.68755011612564,0.01697792869269949,0.34080422102614755,1.0,6/15,10.66%,ART1;PADI3;PADI2;ART4;PRMT7;KRTCAP2
prerank,positive regulation of calcium ion import (GO:0090280),0.8174746707292752,1.6872022317847641,0.02072538860103627,0.3388843804930446,1.0,2/12,2.09%,ATP2A1;PDGFB
prerank,circulatory system development (GO:0072359),0.5829289192153313,1.6867656263104034,0.005567928730512249,0.337101573551644,1.0,21/118,7.86%,PDLIM3;LDB3;CACNA1C;PDLIM1;MEF2C;NTRK3;PDLIM5;CRIP1;HEY2;MYL2;MICAL2;ALPK3;PLCE1;PDGFB;HDAC9;PDLIM7;MEF2A;FBXW7;SMYD4;SOX9;TGFB2
prerank,regulation of amyloid-beta clearance (GO:1900221),0.7838251159023442,1.6865952668118749,0.02413793103448276,0.3346776674804117,1.0,2/16,1.43%,MYOCD;ROCK1
prerank,sulfur compound transport (GO:0072348),-0.5537558185166856,-1.6861863624040379,0.006024096385542169,0.5782876810495248,0.997,16/27,30.54%,SLC6A13;SLC13A4;ABCG2;SLC6A6;SLC26A7;SLC25A14;SLC35F3;SLC25A30;SLC25A11;LRRC8D;SLC36A1;SLC26A6;SLC25A19;SLC5A6;SLC35B2;RACGAP1
prerank,ether lipid metabolic process (GO:0046485),-0.6356728066969417,-1.6848698068451224,0.009925558312655087,0.5588238795267292,0.998,7/14,16.25%,AGMO;GNPAT;PAFAH1B1;PLA2G6;PLAAT3;PLA2G7;LIPE
prerank,cellular zinc ion homeostasis (GO:0006882),-0.5613104074024236,-1.6816866144479494,0.0032258064516129032,0.5496925371863501,0.998,14/26,17.80%,SLC39A10;SLC30A10;SLC39A8;SLC30A1;SLC39A6;MT2A;MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1F;MT1B
prerank,diacylglycerol metabolic process (GO:0046339),0.7082738427396468,1.680170248202426,0.02674591381872214,0.3504208156344074,1.0,3/23,1.83%,DGKB;DGKG;PLCE1
prerank,response to calcium ion (GO:0051592),0.5938200256337753,1.6798818054069082,0.006880733944954129,0.3482048378304764,1.0,17/102,7.03%,KCNMA1;RYR1;TTN;RYR2;MEF2C;PPP3CA;RASGRP2;KCNMB1;CAMK2D;STIM1;D2HGDH;SYT10;MEF2A;KCNH1;CAV1;CALM1;NEDD4
prerank,cAMP-mediated signaling (GO:0019933),0.7168901851990499,1.6791228310932043,0.0197869101978691,0.34738213181148697,1.0,7/24,7.68%,PDE3A;CAP2;AKAP6;ADCY2;KSR1;CAP1;SOX9
prerank,hepaticobiliary system development (GO:0061008),-0.6028609984515779,-1.676031382454537,0.0,0.5590676508763249,0.998,6/20,6.56%,TGFBR3;NF1;COBL;WNT4;PKD2;LSR
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.7465100635417498,1.6754315387316432,0.024806201550387597,0.3561925286570863,1.0,3/20,6.71%,MYOCD;NR2F2;HEXIM1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.7858964051241203,1.6748248815119604,0.011904761904761904,0.35509766376863755,1.0,6/16,7.86%,SOX6;SOX5;RBM24;SP7;SOX9;TGFB2
prerank,cardiac ventricle morphogenesis (GO:0003208),0.6604191399942456,1.6730362102585155,0.018970189701897018,0.3578234625427087,1.0,8/41,5.14%,TPM1;MEF2C;HEY2;MYL2;MYL3;HEYL;JAG1;BMPR1A
prerank,nerve growth factor signaling pathway (GO:0038180),0.8368747930881217,1.6710606414841815,0.022058823529411766,0.3609447340926824,1.0,2/10,0.72%,NTF3;RAP1A
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.6001003818810191,1.6708658386704798,0.0035714285714285713,0.3585884419743586,1.0,7/86,2.55%,LMOD1;SYNPO2;LMOD2;SYNPO2L;CDC42EP3;SEMA5A;WDR1
prerank,carbohydrate biosynthetic process (GO:0016051),-0.5693957337863379,-1.6707708601378908,0.011204481792717087,0.5656010277596771,0.998,8/21,22.31%,ST3GAL4;B4GALT1;ST3GAL6;FUT8;ST3GAL3;MPDU1;ST6GALNAC5;B3GALT2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.7500371963718158,1.6673049907561521,0.02,0.3666707120973215,1.0,3/18,1.89%,FLNA;POLR2L;RASL11A
prerank,regulation of cell communication (GO:0010646),0.6636309489573505,1.6670372277723178,0.03281027104136947,0.3646483805614491,1.0,12/35,10.88%,TRDN;RYR2;IGFBP7;SLC8A1;ANXA1;CAMK2D;NUP62;TBX18;PTPN1;MGLL;SRI;CDC42SE2
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.7268578192351707,1.6662647434224953,0.02723146747352496,0.36410899039312605,1.0,3/22,6.71%,MYOCD;NR2F2;HEXIM1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7694551886054997,1.6660191345284636,0.02671118530884808,0.36202366371928146,1.0,4/15,6.50%,NTF3;NTRK3;CDH13;VEGFA
prerank,positive regulation of reproductive process (GO:2000243),0.6801664749955656,1.664186028316292,0.02812939521800281,0.3646544726554842,1.0,7/31,11.73%,PDE3A;CACNA1H;TACR3;VEGFA;PLCB1;SIRT2;ACVR1B
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.5139654439859166,-1.6610700914386718,0.00684931506849315,0.5958664962344365,1.0,9/36,13.46%,AFDN;SPTBN1;VAMP5;GOLGA4;OPTN;GCC2;GOLPH3;BLZF1;RILPL2
prerank,osteoclast differentiation (GO:0030316),-0.5596340987295878,-1.6606806321028298,0.01680672268907563,0.5748958183637864,1.0,5/22,2.87%,GAB2;FOXP1;MAPK14;ANXA2;SBNO2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5958533280979554,-1.6598095119170293,0.01078167115902965,0.5580077872196937,1.0,9/18,16.07%,PUM1;UFD1;BIRC2;SEC14L1;DDX60;RNF125;BIRC3;ANKRD17;NOP53
prerank,regulation of histone modification (GO:0031056),0.7883480251706836,1.657141629306817,0.01718213058419244,0.3832757547320395,1.0,1/13,0.03%,MYOCD
prerank,cell-matrix adhesion (GO:0007160),0.58936282557366,1.657029329388761,0.007963594994311717,0.38072792796479327,1.0,20/95,8.29%,ITGA8;ARHGEF7;ACTN1;ITGB6;DLC1;VCL;BCAM;ITGA7;ITGA1;FERMT2;ITGA3;ITGB1;PEAK1;EMILIN1;ITGB5;SORBS1;SGCE;ITGB3;ITGA4;WHAMM
prerank,supramolecular fiber organization (GO:0097435),0.5422420435830708,1.6568856287005007,0.0,0.37830900146659285,1.0,53/333,8.56%,MYH11;LMOD1;TPM2;TRDN;TPM1;TTR;FGF13;ACTN1;MFGE8;COL18A1;XIRP1;COL4A2;COL4A1;LMOD2;MYO1E;MYO1D;LMOD3;ADAMTS14;CD36;HIP1;P3H2;FAT1;DES;VIM;LOXL2;HOOK2;KIF2A;CRTAP;COL4A6;RHOBTB3;MYO1B;ERMN;DST;MAP7D3;ARHGEF2;EMILIN1;MYO5C;TUBGCP6;PXDN;MAPT;TPPP;CALB1;PIN1;HDGFL3;CORO1C;NAT8;TGFB2;ARHGAP17;WHAMM;COL27A1;RHOF;COL4A5;TPM4
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.6039064297512946,-1.6554911697893722,0.0025906735751295338,0.5606600872175589,1.0,9/18,17.36%,TSHZ3;NLGN1;PTK2B;SHANK3;CACNG4;NRXN1;NLGN2;NLGN3;CACNG8
prerank,negative regulation of catalytic activity (GO:0043086),0.7150667333943541,1.6550789201075329,0.029921259842519685,0.38065551795678493,1.0,2/24,0.41%,PLN;PPP1R12A
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.4974858793847185,-1.6532585389013685,0.003424657534246575,0.5522891261758425,1.0,10/37,11.20%,ALCAM;HMCN1;CADM1;CXADR;NLGN1;VCAM1;NECTIN1;TENM3;PTPRD;CADM3
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.8085665264913064,1.6529253270972033,0.03482587064676617,0.38413703484293543,1.0,2/11,2.32%,AGTR1;PLA2G3
prerank,second-messenger-mediated signaling (GO:0019932),0.5947990082095923,1.6518897762219853,0.012269938650306749,0.3845718972037154,1.0,12/82,5.56%,GUCY1A1;AGTR1;RYR2;RCAN2;CD36;PLCE1;EDNRB;GUCY1B1;INPP5A;NUDT4;CAMKK2;CXCR6
prerank,renal system development (GO:0072001),0.6327945637976209,1.6504036708431586,0.023106546854942234,0.38587003335068465,1.0,8/52,7.86%,MYOCD;ITGA8;AGTR1;CEP290;TBX18;HAS2;VEGFA;TGFB2
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.573138033281533,-1.6503673358533093,0.0223463687150838,0.5479299816846459,1.0,8/20,14.62%,NUPR1;CASP8;BIRC2;PELI1;SDCBP;OGT;STUB1;BIRC3
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.7095982399348165,1.6490601991395033,0.0202808112324493,0.38674098160289017,1.0,3/22,0.77%,NTF3;RAP1A;NTRK3
prerank,negative regulation of cell junction assembly (GO:1901889),0.7074000416104327,1.6473106762657075,0.033973412112259974,0.3893533007514426,1.0,7/25,6.96%,SLIT1;DLC1;ROCK1;PHLDB2;CLASP2;ARHGAP6;CORO1C
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.569861498395259,-1.6469960532581809,0.011019283746556474,0.5483338479021906,1.0,8/20,22.31%,ST3GAL4;B4GALT1;ST3GAL6;FUT8;ST3GAL3;MPDU1;ST6GALNAC5;B3GALT2
prerank,mesenchyme development (GO:0060485),-0.6301343990900568,-1.646914974958601,0.01015228426395939,0.53186071144068,1.0,8/15,21.93%,BMP7;BMP4;PKD2;BMPR2;FGFR2;TGFBR1;HMGA2;CRELD1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.8358378473434939,1.644881818552172,0.025878003696857672,0.39370238783283323,1.0,3/10,2.95%,SOX6;SOX5;LOXL2
prerank,cellular response to zinc ion (GO:0071294),-0.6288304110085294,-1.6446636497843663,0.010443864229765013,0.5263404607518279,1.0,11/15,20.84%,GLRA2;MT2A;MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1F;MT1B;GLRA1
prerank,cellular response to organonitrogen compound (GO:0071417),0.5779467367941775,1.6436942859186545,0.01366742596810934,0.3945249235233983,1.0,26/99,13.20%,PDE3A;MEF2C;RAP1A;AKAP6;NR1H4;HTR1B;P2RY2;IGFBP5;TSHR;ACTB;LARS1;TAF1;CPEB1;SOX9;RELA;IMPACT;GABRB2;CAPN2;RRAGB;SH3BP4;GABRB3;TRPM2;CPEB3;HCN2;DMTN;ZFP36L1
prerank,response to metal ion (GO:0010038),0.6149058178524998,1.64246988021411,0.01680672268907563,0.3953032792696903,1.0,17/67,9.57%,KCNMA1;TTN;CRIP1;PPP3CA;LOXL2;D2HGDH;FXN;BCL2;CAV1;MAPT;NDRG1;CALM1;NEDD4;PPP1CA;AHCYL1;SLC30A5;HIF1A
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7555614684789358,1.6408936497133468,0.03633217993079585,0.39736202458613834,1.0,6/16,3.16%,DMD;RYR2;CACNA1C;HRC;SLC8A1;CAMK2D
prerank,negative regulation of macroautophagy (GO:0016242),-0.5399589406867077,-1.6373316861482399,0.008902077151335312,0.5476021522379131,1.0,13/26,23.99%,PIK3CA;NUPR1;SMG1;NRBP2;AKT1;SCFD1;QSOX1;FEZ1;LZTS1;CHMP4B;CHMP4A;SMCR8;PHF23
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5987654607730978,1.6363240947018713,0.02155688622754491,0.4088298653817059,1.0,7/76,2.89%,AGTR1;LHCGR;GPR20;PTGER3;ANO1;PLCE1;ADRA1D
prerank,actin filament-based transport (GO:0099515),0.7150485710787146,1.6362407398121757,0.04032258064516129,0.4062645537231369,1.0,7/21,7.99%,ACTN4;MYO1E;MYO1D;MYO1B;MYO5C;SYNE2;SUN2
prerank,action potential (GO:0001508),0.6431565157943124,1.6358059057455647,0.027932960893854747,0.40484750420330806,1.0,15/44,16.59%,DMD;SCN4A;AKAP6;CACNA1H;KCNE4;KCNB1;SLC4A3;SRI;GPER1;KCNA2;GNAQ;CHRNA4;YWHAH;CACNA1I;KCNH2
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.7206162248676454,1.6341112410790122,0.025477707006369428,0.4073433820358723,1.0,8/21,9.99%,GUCY1A1;ADCY5;ADCY2;ADCY9;GUCY1B1;AMPD2;ADCY6;NPR2
prerank,lipid phosphorylation (GO:0046834),0.814178067283966,1.6340814910389052,0.031135531135531136,0.40466589577905754,1.0,2/10,0.44%,DGKB;DGKG
prerank,actin filament depolymerization (GO:0030042),0.7944823247709221,1.6337640551004846,0.040780141843971635,0.40287330690991263,1.0,5/11,12.33%,DSTN;MICAL2;WDR1;CFL2;MICAL3
prerank,regulation of striated muscle contraction (GO:0006942),0.6903718592615992,1.632642532512857,0.022091310751104567,0.4037076779209696,1.0,6/27,2.58%,DMD;RYR2;TNNI3K;TNNT3;MYL2;MYL3
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.7700307342859758,1.631991502021264,0.03527336860670194,0.40298448652837754,1.0,5/13,4.09%,CACNB2;CACNA1C;GJC1;KCNA5;KCNN2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.6690294514049092,1.6306035629439906,0.02556390977443609,0.40438997444657165,1.0,7/30,4.10%,RYR2;CACNA1C;CACNA2D1;GJC1;SNTA1;KCNA5;KCNE4
prerank,regulation of cardiac muscle contraction (GO:0055117),0.6557646824462471,1.6303375432340619,0.029045643153526972,0.4025257347469241,1.0,7/34,7.02%,PLN;RYR2;TNNI3K;ATP2A2;SLC8A1;ATP1B1;CALM1
prerank,sympathetic nervous system development (GO:0048485),-0.6144175188340859,-1.6290629900716216,0.014563106796116505,0.5728295186464017,1.0,6/15,12.08%,NF1;NRP2;NRP1;CTNNB1;SEMA3A;SOX4
prerank,regulation of cartilage development (GO:0061035),0.738540990352573,1.6290268127540208,0.036741214057507986,0.40387390080158325,1.0,4/18,7.68%,SOX6;SOX5;TAPT1;SOX9
prerank,vesicle transport along actin filament (GO:0030050),0.7168023627575846,1.6288267355797006,0.043548387096774194,0.4017931240032412,1.0,5/19,5.53%,ACTN4;MYO1E;MYO1D;MYO1B;MYO5C
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5556549598318145,-1.6273401350623522,0.0158311345646438,0.566206088563653,1.0,12/20,31.51%,SULF1;SPRY2;DSTYK;CREB3L1;FGF2;GPC1;SULF2;PRKD2;SPRY4;SPRY1;FGFBP3;SMOC2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.754922369897311,1.6233326192331825,0.032148900169204735,0.41640830502879683,1.0,4/15,3.34%,AGTR1;CD36;PLA2G3;LPL
prerank,regulation of metal ion transport (GO:0010959),0.7345748763255725,1.6220328410807356,0.050933786078098474,0.4178296278554233,1.0,5/16,4.50%,PLN;CAMK2G;CACNA2D1;STIM1;BCL2
prerank,cell-substrate junction assembly (GO:0007044),0.656125516786316,1.6202303413321295,0.02482758620689655,0.42112496369914193,1.0,10/33,9.97%,ARHGEF7;ACTN1;DLC1;FERMT2;PEAK1;DST;SORBS1;LAMC1;WHAMM;ACTN2
prerank,negative regulation of viral life cycle (GO:1903901),-0.6168934449862528,-1.6195478448919516,0.014527845036319613,0.5928446749604567,1.0,10/15,30.45%,LY6E;TRIM5;BST2;IFITM1;MID2;SNX3;IFITM3;IFITM2;GSN;PPIA
prerank,regulation of receptor recycling (GO:0001919),-0.6067443692155646,-1.6195154595933658,0.019704433497536946,0.5773364531682247,1.0,9/16,24.73%,ANXA2;TBC1D16;LAMTOR1;ECE1;OPTN;SNCA;RAB29;SCRIB;INPP5F
prerank,neurotrophin signaling pathway (GO:0038179),0.7048677377649023,1.6182628778476362,0.039538714991762765,0.42483701650705147,1.0,3/21,3.56%,NTF3;RAP1A;SORT1
prerank,B cell proliferation (GO:0042100),0.7533170950524101,1.6174942460311559,0.028145695364238412,0.42455814824721855,1.0,5/17,11.11%,MEF2C;CD79A;BCL2;RASGRP1;CD180
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.6147955183398455,-1.6169548403497904,0.030612244897959183,0.5748505331476884,1.0,4/14,8.32%,IL18;LGALS9;CD55;PTPN22
prerank,microtubule polymerization (GO:0046785),0.6795035011373557,1.616650963764022,0.037257824143070044,0.4247068136610601,1.0,9/28,7.13%,FGF13;CLASP2;MAP7D3;TUBGCP6;MAPT;TPPP;PIN1;HDGFL3;TPX2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.6321825991254728,1.6158277697234722,0.02316076294277929,0.42481376881469296,1.0,4/44,1.71%,LMOD1;LMOD2;LMOD3;CDC42EP3
prerank,neurotransmitter uptake (GO:0001504),-0.6659519189003329,-1.6146915183926196,0.023310023310023312,0.5719002013189055,1.0,3/12,1.14%,ATP1A2;SLC1A3;GLUL
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6902094714435693,1.6129079283531098,0.029239766081871343,0.4316883216955613,1.0,6/24,7.71%,SOX6;SOX5;CHADL;LOXL2;SOX9;SNAI2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.6170224865534754,1.611951719201106,0.030913978494623656,0.4320492533505975,1.0,8/44,5.82%,FLNA;KCNMA1;AKAP6;KCNJ12;KCNMB1;ANO6;KCNN2;ATP1B1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.7898301886444534,1.6115518700494156,0.05008635578583765,0.4306671034771751,1.0,5/10,9.97%,SEMA5A;WDR1;PLEK;CFL2;ACTN2
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6862843595760465,1.6092776924034593,0.028358208955223882,0.435152941725517,1.0,9/25,9.69%,CTNNA3;ITGA7;ITGB1;JAM3;CD200R1;CD200;ITGB3;ITGA4;PARVA
prerank,metanephros development (GO:0001656),-0.5264547281159924,-1.6089097054220745,0.015384615384615385,0.5874442412927887,1.0,10/26,14.31%,NF1;FOXD1;BMP7;BMP4;PTCH1;PKD2;CTSH;OSR1;SIX1;SOX17
prerank,filopodium assembly (GO:0046847),-0.6077979931371101,-1.6085668936564588,0.023017902813299233,0.575812304880055,1.0,5/16,4.56%,DNM3;FGD6;FGD5;FGD4;SRGAP2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.6870135200326108,1.6084565469602203,0.03313253012048193,0.43521031661784987,1.0,4/26,3.59%,SYNPO2;ROCK1;SYNPO2L;ACTG1
prerank,heart process (GO:0003015),0.7505740093168879,1.6079514735304947,0.0297723292469352,0.4340372039419553,1.0,3/14,1.34%,TRDN;SGCG;MYL2
prerank,positive regulation of cartilage development (GO:0061036),0.753326003781817,1.6038039226053,0.030201342281879196,0.44447524631923635,1.0,5/17,7.68%,SOX6;SOX5;LOXL2;TAPT1;SOX9
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5993596275236018,1.6034820171040174,0.023076923076923078,0.44294110729225455,1.0,12/59,6.20%,NEXN;PALLD;MYOT;MYPN;IGFN1;ROBO3;CDH13;ITGB1;CDH4;KIRREL3;IGSF21;DSCAM
prerank,morphogenesis of an epithelium (GO:0002009),0.6775998839684846,1.602308929140477,0.026986506746626688,0.44386817960076663,1.0,8/25,10.07%,VCL;LAMA5;ACTG1;ACTB;TBX18;SOX9;LIN7C;ARHGAP12
prerank,connective tissue development (GO:0061448),0.6427970391439354,1.602211338265695,0.034818941504178275,0.44158880281353496,1.0,6/35,7.68%,SOX6;SOX5;SNORC;ARID5B;DYRK1B;SOX9
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.6964809261296406,1.6006027762879247,0.03650793650793651,0.4442240743589167,1.0,5/21,4.10%,FLNA;CACNA2D1;SNTA1;KCNA5;KCNE4
prerank,heart trabecula morphogenesis (GO:0061384),-0.5799316151250531,-1.600461691710389,0.01020408163265306,0.601741526353402,1.0,8/18,11.77%,TGFBR3;BMP7;TEK;ENG;ADGRG6;RBP4;FKBP1A;TGFBR1
prerank,regulation of microtubule depolymerization (GO:0031114),0.6852624908626893,1.6002949677088916,0.04185351270553064,0.4426791606885694,1.0,7/25,7.13%,FGF13;TRIM54;CLASP2;MAP1B;ARHGEF2;HDGFL3;TPX2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.5624205658610235,-1.5990668864252906,0.03282828282828283,0.5954244301885638,1.0,3/19,0.54%,AFDN;BMP6;TJP1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6137339853230303,-1.5972759998438923,0.020689655172413793,0.5921877265462642,1.0,6/15,13.81%,ADGRV1;KIT;COL11A1;WHRN;PIEZO2;TMEM120A
prerank,platelet degranulation (GO:0002576),0.5467858459205787,1.5953725579568854,0.008978675645342313,0.4560272702205756,1.0,22/118,7.86%,FLNA;TTN;STXBP2;ACTN1;ACTN4;VCL;ITIH4;CD36;PDGFB;ENDOD1;WDR1;LGALS3BP;TGFB3;TAGLN2;RARRES2;VEGFA;PCDH7;CALM1;TLN1;ITGB3;PLEK;TGFB2
prerank,relaxation of muscle (GO:0090075),0.7589871397761487,1.5947470186186368,0.02304964539007092,0.45551184125221367,1.0,5/13,5.82%,PLN;ATP2A1;SLC8A1;CAMK2D;ATP1B1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.7373980972243769,1.5937269819305222,0.031096563011456628,0.456153554054245,1.0,4/17,1.77%,PPP1R12A;VCL;ROCK1;S1PR3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.7571215464623712,1.593441589615054,0.051194539249146756,0.4544621954778865,1.0,1/14,0.09%,CCDC3
prerank,superoxide anion generation (GO:0042554),0.7536694461997908,1.592908521443221,0.04406779661016949,0.4536242866870398,1.0,1/13,0.36%,NCF2
prerank,regulation of multicellular organism growth (GO:0040014),-0.6054325582012994,-1.590576627930154,0.03317535545023697,0.6118977777607097,1.0,4/15,3.58%,IGF1;GHR;APP;PTCH1
prerank,response to cholesterol (GO:0070723),-0.5860306560084242,-1.5905142168381945,0.01282051282051282,0.5992293956521768,1.0,10/17,26.84%,PTCH1;GRAMD1C;TGFB1;TGFBR1;GRAMD1A;SMAD2;PMVK;ABCA2;SMO;OSBPL7
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.6312283462796667,-1.5896882691858873,0.020833333333333332,0.590939993050498,1.0,4/14,6.44%,KIT;WNT5A;SEMA7A;PLCG2
prerank,mesoderm formation (GO:0001707),0.7282119991789048,1.5881686266763138,0.048859934853420196,0.4666869396310988,1.0,4/17,7.48%,ITGA8;ITGA3;ITGB1;ITGB3
prerank,bicellular tight junction assembly (GO:0070830),-0.46182850296616096,-1.587467613787006,0.01652892561983471,0.5896449359904717,1.0,8/46,6.83%,AFDN;DLG1;CDH5;PECAM1;PARD6G;OCLN;CLDN5;CLDN11
prerank,protein autoubiquitination (GO:0051865),-0.4247822637409241,-1.5856049134924912,0.0,0.5870358790953315,1.0,20/61,15.22%,RNF220;SH3RF1;RNF146;ITCH;CUL3;RNF185;UBE2D3;RNF13;RNF213;MDM2;SH3RF3;PRKN;UBE3A;RNF181;STUB1;DTX3L;SH3RF2;RNF115;RNF10;OBI1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.760989203032502,1.5854780226953153,0.03885135135135135,0.47287571720270355,1.0,4/14,6.45%,FLNA;LIMS1;LIMS2;SLC2A10
prerank,ganglioside biosynthetic process (GO:0001574),-0.6075178105350991,-1.5844951773021854,0.024875621890547265,0.5808121986551749,1.0,6/15,11.00%,ST8SIA4;ST3GAL1;ST3GAL5;ST6GALNAC3;B4GALT6;ST8SIA2
prerank,myotube cell development (GO:0014904),0.8048119142679482,1.5842382509236406,0.05555555555555555,0.4743003681649106,1.0,4/10,1.60%,RYR1;KLHL40;ACTA1;LMOD3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.7732315257501287,1.583659855920137,0.04568527918781726,0.4737194748300158,1.0,5/12,3.49%,TPM1;MEF2C;PRKG1;PDGFB;IGFBP5
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7233054675192996,1.5810923799212862,0.03980099502487562,0.4792924022246821,1.0,6/17,5.82%,RYR2;CACNA1C;GJD3;GJC1;SLC8A1;ATP1B1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.695591128304154,1.5801087030422678,0.037267080745341616,0.4798018869689561,1.0,6/21,7.13%,FGF13;TRIM54;CLASP2;ARHGEF2;HDGFL3;TPX2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.6131668879601025,1.5787962413584768,0.031725888324873094,0.48182240002191784,1.0,6/51,3.74%,SYNPO2;TPM1;SYNPO2L;FERMT2;TGFB3;PPM1E
prerank,detection of calcium ion (GO:0005513),0.7395894648216007,1.5785971209744545,0.051194539249146756,0.47982347968993355,1.0,4/13,7.02%,RYR2;KCNMB1;STIM1;CALM1
prerank,cell differentiation in spinal cord (GO:0021515),0.7747721154385688,1.5784182738901495,0.04181818181818182,0.47782632620316257,1.0,1/10,0.10%,SOX6
prerank,regulation of sequestering of calcium ion (GO:0051282),0.7608465292189488,1.5764488223181357,0.04945054945054945,0.4816978409586776,1.0,3/12,1.44%,TRDN;RYR2;CASQ1
prerank,N-glycan processing (GO:0006491),-0.5635678136382751,-1.5763953011639686,0.017766497461928935,0.6084068782762876,1.0,9/18,12.19%,MAN1C1;ST8SIA4;ST8SIA1;FUT8;MGAT4B;GANAB;MAN2A1;ST8SIA2;GNPTAB
prerank,lipid modification (GO:0030258),0.6411044219174048,1.57488011237798,0.039889958734525444,0.48430590710104976,1.0,6/37,9.50%,DGKB;DGKG;ALOX5;PLPPR1;LPCAT3;DGKD
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.6406064893230621,1.572269054347909,0.04148783977110158,0.49027407689927155,1.0,4/34,2.33%,FLNA;ARHGEF7;LIMS1;FERMT2
prerank,endothelial tube morphogenesis (GO:0061154),-0.6899336133052416,-1.571980530708006,0.016018306636155607,0.6201203693609505,1.0,4/10,7.11%,STARD13;BMP4;ACVRL1;CTNNB1
prerank,epiboly involved in wound healing (GO:0090505),0.7206104204908824,1.571853015287503,0.04047217537942664,0.4892048951747173,1.0,4/16,3.40%,FLNA;CCN1;LCP1;MRTFA
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.7321972268398435,1.5716024823670323,0.034013605442176874,0.4874496550190024,1.0,5/14,8.12%,DMD;ACTN4;TESC;ATP1B1;WNK2
prerank,aorta morphogenesis (GO:0035909),0.7142116482946911,1.5714588773673352,0.04942339373970346,0.4853230570799972,1.0,5/17,5.14%,MYLK;HEY2;TBX2;JAG1;BMPR1A
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5777224576807068,1.570842021161956,0.030712530712530713,0.48485833372200743,1.0,11/67,6.36%,FLNA;ARHGEF7;CD36;LIMS1;PDGFB;CDK6;FERMT2;CDH13;RSU1;UTRN;LIMS2
prerank,negative regulation of ATPase activity (GO:0032780),0.7342363845606742,1.5699937149201861,0.03471074380165289,0.4851976907363383,1.0,2/16,6.42%,PLN;TP53
prerank,embryonic hemopoiesis (GO:0035162),-0.6448331885408574,-1.5692312552478103,0.028037383177570093,0.6233543540490709,1.0,8/12,27.64%,KIT;FLT3LG;THOC5;KDR;ATF4;TAL1;ZFPM1;KMT2A
prerank,regulation of epithelial cell migration (GO:0010632),-0.44644320356221373,-1.5683855793673784,0.00881057268722467,0.6157883685002574,1.0,18/51,13.52%,PTN;MCC;SASH1;DOCK5;GLUL;PTPRG;PTK2;RAB11A;BMPR2;CTSH;PLCG2;ENPP2;PRKCE;BMPER;RTN4;PPM1F;PFN2;PFN1
prerank,endodermal cell fate commitment (GO:0001711),-0.6829794935437364,-1.5682415215651517,0.015184381778741865,0.6053808554434551,1.0,4/10,14.31%,CTR9;RTF1;LEO1;SOX17
prerank,embryonic heart tube morphogenesis (GO:0003143),0.6100445753825079,1.5673127811738259,0.028727770177838577,0.4915305987771299,1.0,4/43,1.52%,RYR2;MEF2C;TBX2;MICAL2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.7124582972449603,1.5665609912722886,0.03877221324717286,0.4911857195465377,1.0,1/18,0.10%,SOX6
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.674803678017206,1.5644605228809576,0.057722308892355696,0.49558606533811483,1.0,5/23,3.16%,TRDN;CASQ1;CACNA2D1;HRC;CAMK2D
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5931638298912407,-1.5643526048001897,0.028132992327365727,0.6143630759093843,1.0,6/15,13.94%,GRM3;GRM7;HOMER3;DAGLA;GRIK3;GRM5
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.6311782056472461,-1.5638090789805352,0.02771362586605081,0.606389343821164,1.0,4/12,17.85%,NUPR1;IL18;IL33;TTBK1
prerank,cGMP biosynthetic process (GO:0006182),0.7829178239656385,1.5631085239158655,0.054945054945054944,0.497841240672305,1.0,2/10,3.85%,GUCY1A1;GUCY1B1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.4985066427404031,-1.5626221386971362,0.02147239263803681,0.6017392058653875,1.0,12/29,13.52%,TJP1;PIK3CA;PLEKHH2;SLIT2;KANK3;SHANK3;CYRIB;PRKN;SSH2;PFN2;PFN1;SSH1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.5559922814178334,-1.5611987161371728,0.022792022792022793,0.598794336405891,1.0,9/20,18.20%,DAB2;PID1;BCL2L1;TGFB1;RHOQ;TMEM59;PKDCC;NUMB;TMBIM1
prerank,UV protection (GO:0009650),-0.67201315994414,-1.5611899615447928,0.018907563025210083,0.5890166395998451,1.0,7/10,22.60%,SCARA3;ERCC5;CAT;XPA;GPX1;MFAP4;ERCC2
prerank,primary alcohol metabolic process (GO:0034308),-0.5177378771435934,-1.5610045168329498,0.022284122562674095,0.5803329659223885,1.0,12/25,24.50%,IGF1;GPD2;RBP4;ALDH3A2;NAAA;NAPEPLD;CYP1B1;GDPD1;GDE1;PECR;ADH1A;RDH10
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5455395724485421,-1.5604981327662555,0.014204545454545454,0.5735322301901697,1.0,11/23,17.38%,TGFBR3;SMAD3;DKK3;ENG;LTBP4;LATS2;SMURF2;TGFB1;TRIM33;SMAD2;SMAD4
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.6708139042165896,1.5594523572224064,0.0528,0.5076746349155029,1.0,4/20,4.50%,ATP2A1;ATP2A2;CAMK2D;BCL2
prerank,negative regulation of vascular permeability (GO:0043116),0.7553673188954706,1.559061471777802,0.06282722513089005,0.5063668091729238,1.0,3/12,2.33%,PDE3A;ANGPT1;FERMT2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6974425112706881,1.5581027209145288,0.05705229793977813,0.5071189813519318,1.0,5/19,7.86%,SLIT3;HEY2;HEYL;BMPR1A;TGFB2
prerank,artery development (GO:0060840),-0.5403577771202145,-1.557975267551521,0.02203856749311295,0.57557226627925,1.0,9/23,11.77%,ROBO1;NF1;NRP1;ENG;ACVRL1;PKD2;BMPR2;HES1;TGFBR1
prerank,atrioventricular valve development (GO:0003171),0.7401067809420815,1.5568858204753615,0.04391891891891892,0.5084870272090471,1.0,4/14,7.86%,SLIT3;HEYL;BMPR1A;TGFB2
prerank,cardiocyte differentiation (GO:0035051),0.7836924451849703,1.5567491656848151,0.044964028776978415,0.5064798402935399,1.0,1/10,0.03%,MYOCD
prerank,aortic valve morphogenesis (GO:0003180),0.6326530454731988,1.5561986340107097,0.04956268221574344,0.5058295097651587,1.0,9/30,7.71%,SLIT3;HEY2;ELN;ROCK1;HEYL;JAG1;EMILIN1;SOX9;SNAI2
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.6450591399341101,-1.5560899552443306,0.03571428571428571,0.5757924656425264,1.0,6/11,23.13%,CRY1;SIK1;EP300;C1QTNF3;CLK2;PGP
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.506623783532738,-1.5533995858654865,0.04105571847507331,0.5801269469627405,1.0,13/26,24.33%,ITCH;NOD1;IRAK1;CASP8;IKBKG;TAB2;IRAK2;UBC;TAB1;AAMP;UBB;CYLD;ALPK1
prerank,cation transport (GO:0006812),0.5188719583018452,1.5533973988508498,0.00857449088960343,0.512662799221616,1.0,27/167,11.35%,KCNAB1;KCNMA1;FGF13;SCN4A;TRPC6;ANO1;KCNJ12;SLC6A17;KCNMB1;ANO6;SLC8A2;SLC8A1;KCNA5;KCNQ4;KCNN2;PKD1L3;KCNH1;ATP1B1;SLC25A29;SLC23A1;ANO10;TRPM4;ABCC8;SLC7A8;PANX1;KCNK3;KCNA2
prerank,regulation of muscle cell differentiation (GO:0051147),0.6518672700771587,1.5531705141484917,0.047345767575322814,0.5109391442779682,1.0,4/31,5.32%,MYOCD;MEF2C;HDAC9;MEF2A
prerank,regulation of calcium-mediated signaling (GO:0050848),0.6569892333767613,1.552507057285496,0.04160246533127889,0.5103825461113913,1.0,5/25,7.51%,ITPR1;CDH13;SLC8A2;MAPT;PLEK
prerank,Notch signaling pathway (GO:0007219),0.5787910643672998,1.5522582243936733,0.04475703324808184,0.5087828073703635,1.0,12/59,8.65%,SUSD5;SORBS2;NOTCH3;HEY2;PLXND1;HEYL;JAG1;MAML2;NLE1;SNAI2;MAML3;ADAM17
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.6517911515341611,1.5504076314596313,0.05555555555555555,0.5125772171297324,1.0,3/25,1.44%,CACNB2;AKAP6;CASQ1
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6834075024742372,1.550193830708012,0.05413533834586466,0.5108909890202967,1.0,2/24,0.71%,MYOCD;MEF2C
prerank,calcium-mediated signaling (GO:0019722),0.5470841429822637,1.549717947980643,0.02937720329024677,0.5100467078226685,1.0,24/93,14.87%,AGTR1;RYR2;CACNA1C;RCAN2;ATP2A2;PLCE1;PPP3CA;EDNRB;SLC8A1;NUDT4;CAMKK2;CXCR6;ATP1B1;RCAN3;TRPM4;SAMD14;HTR2B;DMPK;TRPM2;DMTN;PPP3CB;LRRK2;PPP1R9A;PRKACA
prerank,actin filament network formation (GO:0051639),0.7465427164039935,1.5486790762695886,0.06329113924050633,0.5112463863171564,1.0,3/11,3.35%,ACTN1;PLS3;LCP1
prerank,mitochondrion localization (GO:0051646),0.7039150100025152,1.5484519368667435,0.051118210862619806,0.5096585660468668,1.0,9/19,14.40%,ATP2A1;MARK1;MEF2A;TRAK1;ATCAY;MFN2;NECTIN2;MUL1;LRRK2
prerank,spinal cord development (GO:0021510),-0.6433972586899745,-1.5480330003703986,0.036057692307692304,0.5961589170686549,1.0,9/12,29.13%,NF1;VIT;GLI2;PKD2;SOX4;LOXL3;SOX11;RELN;SOX12
prerank,dopamine metabolic process (GO:0042417),-0.5615189876207756,-1.5469157158550237,0.04292929292929293,0.5922573710648776,1.0,6/18,14.69%,SNCAIP;MOXD1;MAOA;PRKN;SNCA;GCH1
prerank,positive regulation of protein transport (GO:0051222),0.5692647205113349,1.5463051300855326,0.044226044226044224,0.5143457520281048,1.0,9/67,8.36%,MYOM1;TTN;OAZ2;TGFB3;CEP290;MYO18A;CNST;TGFB2;FRMD4A
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.744202412511494,1.5457013669084367,0.0391156462585034,0.5138746470118785,1.0,5/14,5.14%,TPM1;MEF2C;PRKG1;IGFBP5;BMPR1A
prerank,glycogen catabolic process (GO:0005980),0.7281025471266128,1.544588206433065,0.0672,0.5150894984502022,1.0,7/15,8.25%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5841258770183593,1.5436982210500005,0.029754204398447608,0.5155403697502984,1.0,6/57,3.81%,FLNA;ADCY5;HTR1B;NPY1R;ADCY2;ADCY9
prerank,neuron remodeling (GO:0016322),-0.6679348923891175,-1.54234721741808,0.024390243902439025,0.6055840998061806,1.0,6/10,13.30%,APP;ADGRB3;ANKS1A;SCARF1;CX3CL1;EPHA8
prerank,cellular response to catecholamine stimulus (GO:0071870),0.6599097581273626,1.542198690813852,0.05100463678516229,0.518189262500147,1.0,8/23,14.87%,RYR2;ATP2B4;GABPA;ADCY6;SIRT2;MAPK1;LRRK2;PRKACA
prerank,ceramide biosynthetic process (GO:0046513),-0.45848221060013117,-1.5412953686083697,0.011320754716981131,0.6021976282175967,1.0,12/40,11.00%,SGMS1;SGMS2;CERS5;ST8SIA4;ST3GAL5;SPTLC2;ST6GALNAC3;SPTSSA;B4GALT6;CERS6;ASAH2;ST8SIA2
prerank,regulation of adenylate cyclase activity (GO:0045761),0.6674778512925379,1.5408858170228823,0.07371794871794872,0.5205848593687467,1.0,4/22,3.42%,CAP2;CACNA1C;EDNRB;STIM1
prerank,histone lysine demethylation (GO:0070076),-0.5219104154459834,-1.5403484533241203,0.03571428571428571,0.598226634133474,1.0,9/25,21.49%,KDM7A;KDM5C;KDM5B;KDM2A;KDM3B;RIOX2;KDM4D;KDM1A;KDM6A
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.4960664534777847,-1.5401500959321701,0.04242424242424243,0.5907519336114245,1.0,11/28,17.15%,ITCH;NOD1;IRAK1;CASP8;IKBKG;TAB2;IRAK2;UBC;IRGM;TAB1;AAMP
prerank,lymphocyte proliferation (GO:0046651),0.6714076330317502,1.5386701253516517,0.057926829268292686,0.5258794533118419,1.0,6/22,13.12%,MEF2C;CD79A;BCL2;RASGRP1;LMBR1L;PPP3CB
prerank,protein localization to cilium (GO:0061512),-0.4714882720019603,-1.538059172992544,0.019672131147540985,0.591675541791651,1.0,18/32,37.15%,BBS9;ZNF423;RABEP1;IFT122;TULP3;RAB29;EHD1;TCTN2;BBS1;TCTN1;BBS4;ARL6;TULP1;CSNK1D;ATP6V1D;IFT20;TMEM107;INVS
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.5498241511853699,-1.5377532164903176,0.02368421052631579,0.5852232954836435,1.0,9/20,32.40%,WNT4;CRY1;SIK1;EP300;C1QTNF3;CLK2;PGP;NCOR1;CDA
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5896020876830079,-1.5345818288135689,0.0488997555012225,0.5924598403781063,1.0,8/14,29.19%,SULF1;SPRY2;CREB3L1;FGF2;GPC1;SULF2;SPRY4;SPRY1
prerank,regulation of actin filament-based movement (GO:1903115),0.7675817890432972,1.5335894425964094,0.06338028169014084,0.5404518897592073,1.0,2/10,0.21%,PLN;MYLK2
prerank,regulation of protein secretion (GO:0050708),0.5364821991372769,1.5332276163849932,0.021229050279329607,0.5392206680300602,1.0,15/119,8.37%,MYOM1;TTN;CACNA1C;RAP1A;ITPR1;KCNA5;TGFB3;CCL5;ALOX5;KCNB1;MYO18A;ENSA;TGFB2;FRMD4A;DPH3
prerank,regulation of DNA binding (GO:0051101),-0.44397760155841665,-1.5326135822918314,0.020242914979757085,0.594145610354065,1.0,22/44,27.56%,IGF1;LEF1;HMGB1;HJURP;NFKBIA;ILRUN;PRKN;TGFB1;HES1;SP100;PPARG;KDM1A;MDFI;BCL3;SUMO3;HMGA2;NME1;SMO;TFAP4;MAPK8;HMGB2;EGF
prerank,regulation of histone acetylation (GO:0035065),0.6112453109139535,1.5306916961804429,0.05386740331491713,0.5455113249744873,1.0,5/33,9.41%,MYOCD;SET;PPARGC1A;CHEK1;PAXIP1
prerank,skeletal system morphogenesis (GO:0048705),-0.4399146204649177,-1.529202263295549,0.029288702928870293,0.6020722410997774,1.0,13/42,11.77%,PDGFRA;HOXB3;FBN2;HOXA3;CYP26B1;DSCAML1;WWOX;HOXB4;MEGF8;SFRP4;FGFR2;SIX1;TGFBR1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.59336567649517,1.5281094190367466,0.050340136054421766,0.552120958897227,1.0,8/47,6.96%,FLNA;ARHGEF7;ACTN4;LIMS1;FERMT2;KANK1;LIMS2;CORO1C
prerank,positive regulation of heart contraction (GO:0045823),0.6626284199756527,1.5276697455140782,0.08091603053435115,0.5510126669998856,1.0,5/19,8.74%,RYR2;HRC;ATP2A2;TGFB2;TRPM4
prerank,tight junction assembly (GO:0120192),-0.4349310380972409,-1.5267102428354395,0.020080321285140562,0.6054180540138213,1.0,9/49,6.83%,AFDN;DLG1;CDH5;PECAM1;PARD6G;OCLN;CLDN5;LSR;CLDN11
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.5083481759388332,-1.5264753252694687,0.031073446327683617,0.5987083900337353,1.0,15/23,29.52%,PTCH1;IFT122;MEGF8;TULP3;HERC4;MGRN1;ENPP1;GLIS2;GPR161;BTRC;GPC3;RFX4;RACK1;ULK3;PTCH2
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6466787873793013,-1.5263783525336763,0.04128440366972477,0.5918279606628192,1.0,6/10,20.22%,LRP1;APOD;SNCA;HGS;NDRG4;PTPN2
prerank,regulation of calcium ion import (GO:0090279),0.6588404046276715,1.5256922834727646,0.07589285714285714,0.5553304810408428,1.0,2/21,2.09%,PLN;PDGFB
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.7522988894863442,1.5255191982907939,0.06343283582089553,0.5535744235175684,1.0,4/10,10.24%,CACNB2;CACNA2D1;CALM1;SRI
prerank,detection of mechanical stimulus (GO:0050982),0.6968564548171592,1.525506464493316,0.05555555555555555,0.5511971055175909,1.0,4/19,5.34%,TTN;TCAP;CSRP3;PKD1L3
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.6626314640951755,1.5233655597586708,0.07465007776049767,0.5562112182026314,1.0,9/21,13.00%,VCL;ROCK1;ACTG1;PEAK1;DUSP3;CORO1C;DAPK3;ROCK2;CLASP1
prerank,negative regulation of defense response to virus (GO:0050687),-0.648852645571429,-1.5232833684047211,0.03205128205128205,0.5977782703350705,1.0,4/10,7.42%,ITCH;PPM1B;ILRUN;PCBP2
prerank,granulocyte differentiation (GO:0030851),-0.5413919567644668,-1.521988864767522,0.03598971722365039,0.5965620329730028,1.0,11/18,30.45%,LEF1;LBR;PML;EP300;RARA;CBFA2T3;CDK2;TAL1;CDKN1A;RXRA;E2F1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.6228330184532181,-1.5209823039272987,0.03669724770642202,0.5940983868043673,1.0,8/12,28.40%,LY6E;TRIM5;IFITM1;MID2;SNX3;IFITM3;IFITM2;GSN
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6192079087822896,1.518945310412478,0.05299860529986053,0.5689970599545854,1.0,6/31,7.86%,TPM1;RYR2;MYL2;MYL3;BMPR1A;TGFB2
prerank,sensory perception of sound (GO:0007605),-0.38007834811211744,-1.5187484480544091,0.0,0.5965011793202439,1.0,17/88,9.94%,EYA1;COL1A1;CEMIP;ADGRV1;KIT;COL11A1;USP53;GRM7;GSDME;COL4A3;DCDC2;ATP6V0A4;ALDH7A1;EML2;WHRN;RIPOR2;CLIC5
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.6857000649661262,1.5173727988220194,0.08116883116883117,0.5722353425378596,1.0,5/17,8.51%,NOTCH3;PLXND1;HEYL;MAML2;MAML3
prerank,regulated exocytosis (GO:0045055),0.5031604854195094,1.517293751797432,0.019088016967126194,0.5699840180115952,1.0,28/173,7.97%,FLNA;TTN;STXBP2;ACTN1;ACTN4;VCL;ITIH4;CD36;PDGFB;ENDOD1;MYH9;WDR1;LGALS3BP;TMEM79;TGFB3;TAGLN2;RIMS3;SYT10;RARRES2;VEGFA;PCDH7;CALM1;TLN1;RAB3A;ITGB3;PLEK;TGFB2;ARHGAP17
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.6879224265513317,1.5166146372725706,0.08090614886731391,0.5701655503351304,1.0,4/17,2.70%,CACNB2;CACNA1C;CACNA2D1;SLC8A1
prerank,dicarboxylic acid transport (GO:0006835),-0.48321729849410255,-1.514769310893996,0.034375,0.6076711267065077,1.0,7/28,7.83%,SLC1A3;SLC13A3;PDPN;GJA1;SLC26A7;SLC25A32;SLC22A6
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.3936686064043621,-1.5142298293702996,0.011627906976744186,0.6032338321955144,1.0,20/67,14.92%,FLT1;PDGFRA;EFEMP1;IL15;KIT;GHR;EPHA4;TEK;EGFR;PTK2;ABI1;EPHA3;PTK2B;ABL2;FGFR2;LYN;PRLR;KDR;INSR;PKDCC
prerank,microtubule polymerization or depolymerization (GO:0031109),0.6526655865162994,1.5140978802262475,0.07446808510638298,0.5765528760102423,1.0,7/24,6.89%,FGF13;KIF2A;MAP7D3;MAPT;TPPP;PIN1;HDGFL3
prerank,positive regulation of glucose import (GO:0046326),-0.529529580488243,-1.5137025501148622,0.021621621621621623,0.5989391449934595,1.0,10/21,16.75%,IGF1;OSBPL8;PTPN11;OCLN;CREBL2;APPL1;RHOQ;INSR;AKT1;CAPN10
prerank,positive regulation of secretion by cell (GO:1903532),0.5543524771422007,1.5132474853762032,0.03990326481257558,0.5771984308621381,1.0,10/70,8.36%,MYOM1;TTN;CLASP2;TGFB3;UNC13D;KCNB1;MYO18A;RAB3A;TGFB2;FRMD4A
prerank,cytoskeleton organization (GO:0007010),0.5236872752715264,1.5128128020371923,0.025056947608200455,0.5764535762447605,1.0,15/114,4.93%,PALLD;TPM1;WTIP;MAST4;MICAL2;PLCE1;LIMD1;CNN2;DES;PACSIN3;PACSIN2;RHOBTB3;ARHGAP10;DST;MARK1
prerank,cellular metal ion homeostasis (GO:0006875),0.5237166034274049,1.5119048346048816,0.030542986425339366,0.5772790364637604,1.0,15/102,7.87%,TRDN;KCNMA1;ATP2A1;RYR2;ATP2B4;ATP2A2;CSRP3;SLC8A2;SLC8A1;STIM1;CCL5;ATP1B1;CAV1;RMDN3;ATP2B1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6250705489011021,1.5112233352633995,0.059375,0.5771922376184316,1.0,5/26,7.03%,KCNAB1;ITGB1;FHL1;ATP1B1;NEDD4
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.747605258297353,1.5107317362800936,0.09505703422053231,0.5766515522713115,1.0,4/10,11.23%,PFKP;HK2;GFPT1;PFKM
prerank,cGMP metabolic process (GO:0046068),0.7318008487752719,1.5099659088147914,0.05975395430579965,0.5769409085164637,1.0,2/12,3.85%,GUCY1A1;GUCY1B1
prerank,RNA stabilization (GO:0043489),0.612344508536375,1.5095091696121103,0.06801736613603473,0.576030651040092,1.0,9/33,10.29%,RBM24;TENT5B;TRDMT1;PARN;CIRBP;GDNF;NAF1;FUS;HNRNPU
prerank,cartilage development (GO:0051216),0.5770723141684421,1.5091792863303959,0.06870229007633588,0.5747543497772084,1.0,5/49,4.91%,SOX6;SOX5;MEF2C;SNORC;OSR2
prerank,aortic valve development (GO:0003176),0.6022860720011369,1.5087196873142619,0.05865921787709497,0.5740070620534213,1.0,9/34,7.71%,SLIT3;HEY2;ELN;ROCK1;HEYL;JAG1;EMILIN1;SOX9;SNAI2
prerank,membrane lipid metabolic process (GO:0006643),-0.5170637717834614,-1.5081355651656723,0.04057971014492753,0.616350316863655,1.0,7/22,13.96%,AGMO;ST3GAL6;CERK;SERINC1;CYP1B1;ARV1;B4GALT4
prerank,regulation of potassium ion transport (GO:0043266),0.6168394372113071,1.5068524854916217,0.061946902654867256,0.5777341645225422,1.0,6/31,7.78%,KCNAB1;KCNA5;FHL1;KCNN2;KCNIP3;KIF5B
prerank,epithelial cell-cell adhesion (GO:0090136),0.7444536294850361,1.5056154451306492,0.06984667802385008,0.579682967738189,1.0,3/11,6.24%,SERPINB8;VCL;ITGB5
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6888518971744311,1.504019609719323,0.0722495894909688,0.5829077617496251,1.0,2/17,0.77%,NTF3;NTRK3
prerank,positive regulation of phospholipase activity (GO:0010518),0.6535025142701623,1.503723544870847,0.06844741235392321,0.5816220680484364,1.0,4/22,3.64%,NTF3;AGTR1;NTRK3;CCL5
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.7730370791930034,1.5026994910021945,0.05989110707803993,0.5828579406575012,1.0,1/10,0.08%,PDE3A
prerank,peptidyl-tyrosine modification (GO:0018212),-0.40479063198487564,-1.5019569327206421,0.014285714285714285,0.6366511149097985,1.0,23/56,22.01%,FLT1;PDGFRA;EFEMP1;KIT;EPHA4;TEK;EGFR;PTK2;ABI1;EPHA3;PTK2B;TPST1;ABL2;FGFR2;LYN;KDR;INSR;PKDCC;TTBK1;ABI2;FGFR4;FLT4;EPHB2
prerank,myotube differentiation (GO:0014902),0.6850222419435403,1.5019241539340593,0.08143322475570032,0.5832000730989014,1.0,6/17,5.58%,MEF2C;KLHL40;CACNA1H;ADAMTS5;SORT1;KCNH1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.6740712777217823,1.5018423597782484,0.08818635607321132,0.5811760988335132,1.0,6/17,7.05%,CACNA1H;SLC4A8;UNC13D;SYT10;KCNB1;RAB3A
prerank,glucose transmembrane transport (GO:1904659),0.6639036551813482,1.5015522118983307,0.08360128617363344,0.579943152984653,1.0,4/18,6.45%,SLC2A4;SLC5A3;SORT1;SLC2A10
prerank,positive regulation of ruffle assembly (GO:1900029),-0.6009799506760498,-1.5000984432828275,0.04794520547945205,0.638080770878087,1.0,11/13,37.25%,EPS8;NLGN1;PLEKHM1;PFN1;EPS8L2;EPS8L1;NDEL1;DEF8;HRAS;FAM98A;P2RY12
prerank,negative regulation of biomineral tissue development (GO:0070168),0.6674398850197822,1.4999264292782797,0.064,0.5833078784578336,1.0,6/21,10.88%,ASPN;HEY2;ROCK1;SOX9;TRPM4;ROCK2
prerank,branched-chain amino acid catabolic process (GO:0009083),0.6745998718285924,1.4993629960569634,0.06069802731411229,0.5806924785600827,1.0,5/20,6.00%,BCAT2;MCCC2;HSD17B10;HIBADH;DLD
prerank,branched-chain amino acid metabolic process (GO:0009081),0.6745998718285924,1.4993629960569634,0.06069802731411229,0.5806924785600827,1.0,5/20,6.00%,BCAT2;MCCC2;HSD17B10;HIBADH;DLD
prerank,protein autoprocessing (GO:0016540),0.6829715183463971,1.4993332169389955,0.06397306397306397,0.5785280116298321,1.0,3/17,6.32%,HJV;FXN;AFG3L2
prerank,negative regulation of lipid metabolic process (GO:0045833),0.6491414582648694,1.498798284987281,0.0748502994011976,0.5780749746847588,1.0,1/22,0.09%,CCDC3
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.45497610203139494,-1.4986168660357408,0.03484320557491289,0.6383921606497323,1.0,10/33,13.20%,MCC;DCN;PTPRG;SLIT2;APOE;ACVRL1;PTPRM;ADAMTS9;SP100;PFN2
prerank,macrophage chemotaxis (GO:0048246),0.7323234123021021,1.4978928791416801,0.09191176470588236,0.5787981777557338,1.0,2/10,3.64%,EDNRB;CCL5
prerank,positive regulation of phosphatase activity (GO:0010922),0.6566882104495071,1.4978711333585448,0.07244094488188976,0.5766413157696114,1.0,6/21,10.07%,MEF2C;ITGA1;CALM1;PLEK;CD300A;PDGFRB
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.6802575012538453,1.4975514424637224,0.08873720136518772,0.5754778537302276,1.0,5/17,10.07%,PPP1R12A;ITGA1;CALM1;CD300A;PDGFRB
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.517164003446753,-1.4973934496322279,0.02857142857142857,0.6370714356050861,1.0,8/21,12.97%,PRKCB;FOXP1;ELF1;PRKCH;SLC39A10;PTPN22;LYN;ELF2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.5342492100596107,-1.4968940452415227,0.0440771349862259,0.6321962248619494,1.0,8/20,18.20%,DAB2;PID1;BCL2L1;TGFB1;RHOQ;TMEM59;NUMB;TMBIM1
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3793379312940484,-1.4944769400270757,0.0,0.6362177820518607,1.0,17/85,9.94%,EYA1;COL1A1;CEMIP;ADGRV1;COL11A1;USP53;GRM7;GSDME;COL4A3;DCDC2;ATP6V0A4;ALDH7A1;EML2;WHRN;RIPOR2;PIEZO2;CLIC5
prerank,ganglion development (GO:0061548),-0.6228722046141045,-1.4938244051517033,0.029082774049217,0.63260682107256,1.0,4/11,7.32%,NRP2;NRP1;CTNNB1;SEMA3A
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.49646830568848205,-1.493261150101403,0.04776119402985075,0.6284333216536149,1.0,9/24,18.87%,DAB2;PID1;BCL2L1;TGFB1;RHOQ;TMEM59;NUMB;TMBIM1;ITGB1BP1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.6321106966836411,1.4926506897610663,0.07283763277693475,0.5906160174008993,1.0,5/28,6.25%,ATP2A1;MAP3K5;ITPR1;BCL2;DAB2IP
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.6436750859897903,1.4926006572587778,0.08536585365853659,0.5885122348403913,1.0,5/24,11.18%,PDE3A;CGAS;PEX5L;PRKAR1B;PDE4D
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.6228129410101775,1.48986730658481,0.08088235294117647,0.5955965383093632,1.0,8/26,13.12%,ANO1;ADCY5;NR1H4;KLF7;TRPM4;NR1D1;LRP5;PPP3CB
prerank,chondrocyte differentiation (GO:0002062),0.6085963852574828,1.489799140723389,0.06451612903225806,0.5936391649562807,1.0,3/32,0.71%,SOX6;SOX5;MEF2C
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5498631163930697,1.4888483232274172,0.053462940461725394,0.5948138887500086,1.0,16/70,11.19%,NTN4;ITGA8;ACTN1;MEF2C;LAMA5;FERMT2;PEAK1;LAMC1;LAMB2;YTHDF2;ITGB3;ITGA4;EPHA2;PARVA;TBCD;RB1
prerank,regulation of cellular respiration (GO:0043457),0.6821719470686612,1.4886174879731513,0.06957928802588997,0.5933946480257187,1.0,1/17,0.27%,PRDM16
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.636176327717361,1.488359783588277,0.07280832095096583,0.5920341133822543,1.0,3/23,2.58%,TPM1;MYL2;MYL3
prerank,cardiac muscle cell contraction (GO:0086003),0.6676206437178488,1.4880916425358517,0.07755775577557755,0.5907145220621383,1.0,3/19,3.16%,CACNA1C;CACNA2D1;CAMK2D
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.48166560518860996,-1.4877573525790944,0.0429042904290429,0.6465346959412925,1.0,7/30,10.98%,SPTBN1;VAMP5;GOLGA4;OPTN;GCC2;GOLPH3;BLZF1
prerank,thyroid hormone generation (GO:0006590),0.7396018578680704,1.486521835907488,0.0922242314647378,0.5939822257871669,1.0,2/10,7.65%,TG;DIO2
prerank,inhibitory synapse assembly (GO:1904862),0.7295613321527755,1.486297844132824,0.09225092250922509,0.5925904868629224,1.0,5/11,11.98%,FGF13;PLXNB1;GABRB2;CBLN4;GABRB3
prerank,peripheral nervous system development (GO:0007422),0.6383278984503965,1.4849019174005793,0.07526881720430108,0.5952824494190694,1.0,2/23,0.99%,NTF3;SERPINI1
prerank,cellular response to organic cyclic compound (GO:0071407),0.5102741831520158,1.483503257801673,0.0227765726681128,0.5977018074291398,1.0,28/141,13.20%,PDE3A;MEF2C;RAP1A;AKAP6;ADCY5;NR1H4;PDGFB;ADCY2;ABCB4;RORA;P2RY2;IGFBP5;CCL5;ACTB;TAF1;ARL6IP5;AR;MED1;IMPACT;GABRB2;ADCY6;GPER1;ROCK2;GABRB3;TRPM2;HCN2;DMTN;ZFP36L1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5489096314129819,1.4831163522901725,0.06649616368286446,0.596879317592313,1.0,5/53,4.27%,LHCGR;HTR1B;NPY1R;ANXA1;TSHR
prerank,neural tube development (GO:0021915),-0.5613452111448505,-1.482435580115158,0.06615776081424936,0.6636178743924713,1.0,5/15,12.08%,ALDH1A2;PTCH1;PKD2;TGFB1;SOX4
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3979146524596964,-1.48161559757761,0.01775147928994083,0.6608274891814572,1.0,13/65,7.13%,LEF1;GAB2;FOXP1;IL31RA;PIR;IL15;MAPK14;BMP4;KIT;SBNO2;LGALS9;PML;CASP8
prerank,cardiac muscle cell action potential (GO:0086001),0.6217265994451465,1.4813417046653252,0.07624633431085044,0.6005601307639884,1.0,6/30,5.82%,DMD;CACNA1C;CACNA2D1;SLC8A1;SLC4A3;ATP1B1
prerank,blood vessel diameter maintenance (GO:0097746),0.603254242468235,1.4803878123851604,0.08513708513708514,0.6015136044822633,1.0,4/34,2.26%,AGTR1;EDNRA;ROCK1;EDNRB
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.3841686964831839,-1.4794025688366634,0.0,0.6648277290127541,1.0,24/74,19.27%,EYA2;IGF1;EYA1;EYA4;SH3RF1;TCF7L2;BMP4;DDX3X;ITGA6;BIRC6;TNFSF10;ITGAV;CASP8;BCL2L1;NOS3;RNF34;TGFBR1;FAIM;AKT1;GPX1;SERPINE1;SIAH2;TMBIM1;PARK7
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.4742368447949289,-1.4789360555107713,0.027190332326283987,0.6602853528170416,1.0,15/30,18.98%,TGFBR3;SMAD3;FSTL1;DKK3;ENG;LTBP4;LATS2;FKBP1A;SMURF2;SFRP4;TGFB1;TRIM33;SMAD2;SMAD4;TWSG1
prerank,regulation of interleukin-13 production (GO:0032656),-0.5828600963740596,-1.4782826229383523,0.04871794871794872,0.6568016792129898,1.0,3/13,5.31%,LEF1;IL18;LGALS9
prerank,V(D)J recombination (GO:0033151),-0.6182210506720773,-1.4779294962703593,0.046511627906976744,0.6520253346244814,1.0,8/11,35.66%,HMGB1;PRKDC;LIG3;DCAF1;LIG1;HMGB2;TCF3;LIG4
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6589413288501922,1.4778031183583975,0.07480916030534351,0.6084197599604751,1.0,10/21,15.34%,DMD;CAV1;CNKSR3;GPD1L;PDE4D;DMTN;NCK2;MLXIPL;INPP5J;PTEN
prerank,membrane depolarization during action potential (GO:0086010),0.6250549340899983,1.4750912708275525,0.0907715582450832,0.6159943137855715,1.0,4/26,2.70%,SCN4A;CACNA1C;CACNA1H;SLC8A1
prerank,nucleosome disassembly (GO:0006337),0.7018018596112429,1.4741541765419166,0.08304498269896193,0.6149436907330882,1.0,4/14,6.18%,SMARCD3;ARID1A;SET;SMARCB1
prerank,chromatin disassembly (GO:0031498),0.7018018596112429,1.4741541765419166,0.08304498269896193,0.6149436907330882,1.0,4/14,6.18%,SMARCD3;ARID1A;SET;SMARCB1
prerank,protein monoubiquitination (GO:0006513),-0.44600345665678487,-1.473369623990088,0.03424657534246575,0.6666097022662093,1.0,13/36,15.22%,CUL3;RNF20;KLHL12;UBE2D3;CTR9;TOPORS;TRIM25;PRKN;MGRN1;KLHL22;DTX3L;LEO1;OBI1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.6341698688333699,1.4732524464237815,0.08500772797527048,0.615868062284459,1.0,11/23,12.26%,TUBA1C;HOOK2;KIF1A;F8A1;KIF5B;HOOK1;KIF1C;DYNC1I2;KIF5C;MYO10;KIF5A
prerank,negative regulation of complement activation (GO:0045916),-0.6335474421444487,-1.47319140647572,0.059063136456211814,0.661023555216638,1.0,6/10,32.53%,CD55;CD46;SERPING1;A2M;CR1L;CR2
prerank,phasic smooth muscle contraction (GO:0014821),0.7368478708374187,1.4721205720133597,0.10646387832699619,0.6175983037106106,1.0,4/10,11.68%,PTGER3;EDNRB;GDNF;HTR2B
prerank,positive regulation of cell development (GO:0010720),0.6046407852051495,1.4716215464144184,0.08223201174743025,0.6173525025309974,1.0,2/31,1.60%,PDE3A;LMOD3
prerank,acidic amino acid transport (GO:0015800),-0.5336318270551779,-1.4712398292335842,0.0625,0.6630071778818116,1.0,5/17,3.81%,SLC6A13;SLC1A3;GJA1;SLC6A1;SLC6A6
prerank,regulation of focal adhesion assembly (GO:0051893),0.5674037546538808,1.4701872786912609,0.06524466750313676,0.6201149622124065,1.0,14/54,8.18%,DLC1;VCL;ROCK1;LIMS1;FERMT2;PHLDB2;CLASP2;ACTG1;PEAK1;ARHGAP6;DUSP3;VEGFA;CORO1C;DAPK3
prerank,protein-DNA complex disassembly (GO:0032986),0.6855409436942346,1.4693719623350854,0.08561643835616438,0.6208692853685921,1.0,4/16,6.18%,SMARCD3;ARID1A;SET;SMARCB1
prerank,cellular response to drug (GO:0035690),0.626317726368294,1.46892341077874,0.08191653786707882,0.6202542844866148,1.0,6/25,9.85%,MEF2C;HTR1B;PPM1E;TP53;CERS1;RAP2A
prerank,regulation of microtubule nucleation (GO:0010968),0.72590141152647,1.4684249133632599,0.0940959409594096,0.6199192835167335,1.0,1/10,0.35%,ARHGEF7
prerank,glycogen metabolic process (GO:0005977),0.6327852844142173,1.467240279942699,0.07909604519774012,0.6217973042448077,1.0,11/27,12.40%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1;NR1D1;NHLRC1;GYS1;PHKA1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5716725146376038,1.466845797666225,0.08701472556894244,0.6209244368742306,1.0,10/42,8.34%,ROCK1;CD36;LIMS1;CDK6;FERMT2;CDH13;UTRN;RRAS;VEGFA;RIN2
prerank,negative regulation of organelle assembly (GO:1902116),-0.44519982323216456,-1.4665749046748064,0.040293040293040296,0.6786425555389713,1.0,19/35,29.37%,NUPR1;LIMK2;CEP97;TBC1D30;MDM1;SMAD4;SCFD1;ODF2L;NBDY;TBC1D7;FEZ1;CHMP4B;CHMP4A;SMCR8;PHF23;CCP110;KAT2A;TESK1;STYXL1
prerank,nitric oxide mediated signal transduction (GO:0007263),0.667451922118299,1.4649267396407264,0.10815307820299501,0.6254604227011046,1.0,3/16,3.85%,GUCY1A1;CD36;GUCY1B1
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.5801425332164708,-1.4649057370683842,0.06293706293706294,0.6805135215309569,1.0,7/13,23.99%,NUPR1;SCFD1;FEZ1;CHMP4B;CHMP4A;SMCR8;PHF23
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.6240589440360652,-1.4648521503518361,0.0665083135391924,0.6746051395368653,1.0,3/10,16.14%,IL18;LGALS9;RARA
prerank,telomere capping (GO:0016233),-0.5476748356060775,-1.4635973786170529,0.05925925925925926,0.6743594436338123,1.0,14/16,35.57%,PRKDC;STN1;MRE11;RAD50;NBN;CTC1;TERF2IP;DCLRE1A;DCLRE1B;TINF2;TEN1;ACD;TFIP11;DCLRE1C
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.6219283780655331,1.462385157696858,0.0838235294117647,0.6324311635180467,1.0,2/26,0.28%,PLN;TRDN
prerank,T-helper cell differentiation (GO:0042093),-0.5747661966944273,-1.461533025364915,0.06060606060606061,0.6776610288875243,1.0,3/14,1.71%,LEF1;FOXP1;HMGB1
prerank,ketone body metabolic process (GO:1902224),-0.6232908849462531,-1.460877486731101,0.07589285714285714,0.6745540230331112,1.0,6/10,17.29%,ACSS3;HMGCL;HMGCLL1;HMGCS2;BDH2;AACS
prerank,negative regulation of ion transport (GO:0043271),0.6308342939076764,1.4600957803626613,0.08592592592592592,0.6381850775373001,1.0,7/24,9.97%,PLN;HTR1B;PACSIN3;NEDD4;WNK2;HRH3;ACTN2
prerank,positive regulation of vasoconstriction (GO:0045907),0.7111362701526748,1.459794829021929,0.0962566844919786,0.6371110481412988,1.0,5/13,19.21%,ADRA1D;CAV1;TRPM4;TBXA2R;ADRA1A
prerank,positive regulation of cytokinesis (GO:0032467),-0.46671208368506706,-1.4597417981053609,0.05063291139240506,0.6742423651378731,1.0,12/32,21.44%,PKP4;CDC14B;CUL3;SPAST;PRKCE;CDC25B;GIPC1;CIT;CDC42;SVIL;CSPP1;DRD2
prerank,response to glucocorticoid (GO:0051384),0.6155597370253965,1.4577338991675144,0.08592592592592592,0.6421932585337272,1.0,6/26,14.26%,SLIT3;ANXA1;GOT1;HNRNPU;ZFP36L1;PDCD7
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.6267215610689976,1.4575330193860478,0.09812409812409813,0.6407199621261923,1.0,2/27,0.65%,AGTR1;GPR20
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.49124292531810776,-1.4574662698014382,0.06683804627249357,0.6779228628965801,1.0,5/21,9.32%,PRKCB;FOXP1;PRKCH;SLC39A10;IKBKG
prerank,regulation of cell junction assembly (GO:1901888),0.601100892001789,1.4561686876772377,0.08827785817655572,0.6432690828352691,1.0,8/27,11.12%,MEF2C;RAP1A;PDLIM5;ROCK1;CBFB;SNAI2;ROCK2;RUNX1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.715875393827416,1.4559455699073411,0.10301953818827708,0.6418888366060352,1.0,4/11,13.97%,TRDN;LPCAT3;STX18;BNIP1
prerank,acylglycerol metabolic process (GO:0006639),0.5861640195203953,1.4556837113483523,0.08493150684931507,0.6406259324568959,1.0,9/37,13.67%,DGKB;DGKG;LPL;CAV1;MGLL;DGKD;DGAT1;PNPLA3;DGKZ
prerank,positive regulation of dendrite development (GO:1900006),-0.6348517832724776,-1.4549724614021287,0.08185840707964602,0.6826450988403802,1.0,6/10,13.62%,PTN;COBL;BMP7;ZDHHC15;ALK;LRP8
prerank,amide transport (GO:0042886),-0.4835256182020221,-1.4545787699026766,0.04046242774566474,0.6786278520729002,1.0,9/26,21.80%,ABCG2;PDPN;PLTP;SLC25A32;CERT1;PLEKHA3;SLC38A5;ABCB9;TAP1
prerank,xenobiotic transport (GO:0042908),-0.5310464529151631,-1.4533908071532928,0.049868766404199474,0.6782819667154624,1.0,6/17,13.70%,ABCG2;SLC47A1;GJA1;SLC7A5;SLC22A4;SLC22A18
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.6097851532385523,-1.4527617886046544,0.06407322654462243,0.675397528713832,1.0,5/11,24.69%,DAB2;RDX;PRKN;EIPR1;MTMR2
prerank,acetyl-CoA metabolic process (GO:0006084),0.6601250349362677,1.4521930654393451,0.10084033613445378,0.6507184177368973,1.0,4/15,8.57%,ACSS1;NUDT7;ACACB;MVD
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.3873034869880967,-1.4521400247416147,0.039603960396039604,0.6724329434261693,1.0,16/63,11.77%,IGF1;SH3RF1;TCF7L2;DEPTOR;BMP4;ITGA6;WWOX;BIRC6;TNFSF10;ITGAV;PML;CASP8;STX4;MADD;SP100;TGFBR1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.6055495073488861,-1.4516571777274458,0.08026030368763558,0.6691252960204519,1.0,3/10,15.80%,PRKCB;CTTNBP2NL;AKT1
prerank,cellular response to growth factor stimulus (GO:0071363),0.49497714031207984,1.451542026296085,0.026143790849673203,0.6508265862844125,1.0,26/151,7.89%,PDE3A;SOX6;SOX5;HJV;MEF2C;RAP1A;NTRK3;LIMS1;PDGFB;NR4A1;ANXA1;CCL5;ACVR2A;BMPR1A;MTSS2;HAS2;MAPT;DAB2IP;MAPKAPK2;DUSP3;VEGFA;MED1;GAREM1;SOX9;SNAI2;RELA
prerank,oligodendrocyte differentiation (GO:0048709),0.6396518908749251,1.4510962236423643,0.09917355371900827,0.6500996909697085,1.0,3/19,7.68%,SOX6;TPPP;SOX9
prerank,BMP signaling pathway (GO:0030509),-0.3903784358206413,-1.45074135371879,0.031088082901554404,0.6676530399618881,1.0,17/62,10.61%,BMP6;TGFBR3;SMAD3;DDX5;BMP7;BMP4;SMAD6;ENG;RUNX2;ACVRL1;RGMB;BMPR2;MEGF8;SMAD9;TMEM100;TGFB1;PDCD4
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.6297858841970944,1.449881817701747,0.09688013136288999,0.6521769427333068,1.0,6/22,6.59%,LMCD1;ROCK1;MLIP;CAMK2D;MEF2A;PARP1
prerank,purine ribonucleotide transport (GO:0015868),-0.5375413942825561,-1.449666198254237,0.04050632911392405,0.6667839761101274,1.0,10/16,36.44%,SLC25A17;ABCC4;LRRC8D;LRRC8A;ABCC5;SLC25A24;SLC35B2;SLC17A9;SLC25A4;SLC19A1
prerank,vasodilation (GO:0042311),0.6936188119124945,1.4492487519085318,0.10104529616724739,0.6523551062250865,1.0,1/13,0.29%,KCNMA1
prerank,regulation of acrosome reaction (GO:0060046),0.7270039250143621,1.4474270349390483,0.12267657992565056,0.6566503995527113,1.0,2/10,8.04%,CACNA1H;PLCB1
prerank,androgen metabolic process (GO:0008209),0.6470307178741296,1.447422866421651,0.10197368421052631,0.6545084612677143,1.0,5/18,11.04%,HSD17B10;HSD17B7;HSD17B4;MED1;SRD5A3
prerank,sulfate transport (GO:0008272),-0.5713000789482638,-1.4470468671647072,0.04702970297029703,0.6727829424257116,1.0,6/14,17.16%,SLC13A4;SLC26A7;SLC25A14;SLC26A2;SLC25A30;SLC25A11
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.6551527887441831,1.4469473420260461,0.1125,0.6539407337879636,1.0,5/16,6.59%,AKAP6;ROCK1;CAMK2D;MEF2A;PARP1
prerank,negative regulation of developmental process (GO:0051093),0.5354470216418817,1.446206774003245,0.0580964153275649,0.6543894578978469,1.0,17/69,14.00%,HEY2;TBX2;ROCK1;ALPK2;CDK6;LOXL2;KANK1;PTPRS;KLF7;MAPT;SOX9;ROCK2;MUL1;FOXJ1;GAS6;ADCK1;HOPX
prerank,mitotic spindle assembly (GO:0090307),0.5648727089957931,1.4460798779893536,0.09486166007905138,0.6527327520552204,1.0,11/42,10.70%,FLNA;CLASP2;KIF2A;TOGARAM2;KIF3B;TPX2;PIBF1;TOGARAM1;CEP192;WRAP73;AAAS
prerank,response to fatty acid (GO:0070542),0.669352095279044,1.4448265159761082,0.09178743961352658,0.6547840128385981,1.0,6/17,7.68%,NR1H4;CD36;PDK4;LPL;IRS1;SOX9
prerank,amino acid import across plasma membrane (GO:0089718),-0.4880310119113479,-1.444692469276102,0.05555555555555555,0.6775457167505146,1.0,8/24,9.67%,SLC6A13;SLC1A3;SLC47A1;SLC6A6;SLC3A2;SLC7A5;SLC6A9;SLC22A4
prerank,mesenchymal cell development (GO:0014031),0.6342620983641953,1.4434718072026234,0.1043338683788122,0.6575548915379785,1.0,5/18,8.70%,HEY2;HEYL;TAPT1;SNAI2;CDH2
prerank,adenine nucleotide transport (GO:0051503),-0.521618955467195,-1.4427826659220124,0.05912596401028278,0.6811396449921089,1.0,10/17,36.44%,SLC25A17;ABCC4;LRRC8D;LRRC8A;ABCC5;SLC25A24;SLC35B2;SLC17A9;SLC25A4;SLC19A1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6776288005898823,1.440530063101414,0.11964285714285715,0.6656108944168044,1.0,6/13,18.00%,HEY2;TAF1;TMSB4X;SIN3A;MAD2L2;DDIT3
prerank,positive regulation of wound healing (GO:0090303),0.5863919264999181,1.4381528262870584,0.0927536231884058,0.672052595409898,1.0,6/36,3.63%,MYLK;FERMT2;ANXA1;KANK1;ACTG1;ITGB1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7101662587848966,1.4374234793913485,0.10990990990990991,0.6725756947794862,1.0,2/10,1.91%,CD36;MYD88
prerank,embryonic heart tube development (GO:0035050),0.6708841545997829,1.4354305991138996,0.11409395973154363,0.6775186428110366,1.0,2/14,1.35%,RYR2;TBX2
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.7040234945469656,1.4354299173791987,0.1013745704467354,0.6753638600637156,1.0,2/11,2.79%,MEF2C;ANXA1
prerank,peptidyl-threonine modification (GO:0018210),0.5283375394404837,1.4345167895600812,0.06382978723404255,0.6765059910219803,1.0,27/66,18.87%,MYLK2;ROCK1;DYRK2;CAMK2D;GALNT16;DYRK1A;TAF1;DYRK1B;CHEK1;MAP3K10;MAP2K1;ROCK2;PRKCD;GALNT3;ACVR1B;GALNT2;CDC42BPB;MAPK1;GALNT1;LRRK2;PRKCA;HIPK2;MARK2;GALNT11;GALNTL6;PRKD1;ULK1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.574258003590542,-1.4332203260325005,0.06502242152466367,0.7176628532098057,1.0,4/12,5.38%,EPHA4;GLI2;MYCBP2;PAFAH1B1
prerank,calcium ion transmembrane transport (GO:0070588),0.5118147621918343,1.4330871882679659,0.061465721040189124,0.6795761645740742,1.0,15/86,8.89%,ATP2A1;CACNA1C;ATP2B4;TRPC6;CACNA2D1;ATP2A2;ANO6;SLC8A2;SLC8A1;GRIN2C;AFG3L2;TRPV2;ATP2B1;TRPM4;TRPC5
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6236662140440953,1.4330552755658357,0.08809135399673736,0.6775654371369466,1.0,5/20,11.08%,PLN;CAMK2D;NEDD4;ACTN2;GOPC
prerank,embryonic digit morphogenesis (GO:0042733),0.6372658675112723,1.4316157136703365,0.10158730158730159,0.6805927873736786,1.0,3/18,4.91%,MAP3K20;TBX2;OSR2
prerank,regulation of activated T cell proliferation (GO:0046006),-0.43805021855825144,-1.4311785818565408,0.05228758169934641,0.7212829537242744,1.0,6/30,8.50%,IGF1;IGFBP2;HMGB1;IL18;LGALS9;IGF2
prerank,regulation of wound healing (GO:0061041),0.5588540016796777,1.4297503312657982,0.1094391244870041,0.6850296197270458,1.0,8/42,6.76%,MYLK;ANXA1;KANK1;ACTG1;ITGB1;ALOX5;CAV1;AJAP1
prerank,negative regulation of calcium ion transport (GO:0051926),0.674110456063557,1.4296286437664962,0.11889250814332247,0.683281432918091,1.0,2/15,2.84%,PLN;PACSIN3
prerank,regulation of monooxygenase activity (GO:0032768),-0.4848134992927984,-1.4289158756211136,0.059322033898305086,0.7260423029057917,1.0,13/23,21.39%,POR;EGFR;NOS1AP;LYPLA1;NOSTRIN;NOS3;DDAH1;SNCA;AKT1;NOSIP;DDAH2;CYGB;SPR
prerank,positive regulation of protein depolymerization (GO:1901881),0.6963458975351609,1.428777863592657,0.1423670668953688,0.6842975749577649,1.0,4/11,8.01%,SEMA5A;WDR1;PLEK;CFL2
prerank,Notch signaling involved in heart development (GO:0061314),0.6814224098771472,1.4282768784800528,0.10771992818671454,0.6840346214317689,1.0,4/11,7.71%,HEY2;HEYL;JAG1;SNAI2
prerank,ceramide metabolic process (GO:0006672),-0.41065684858954843,-1.427649085020969,0.043859649122807015,0.7266114726894185,1.0,11/49,9.94%,SGMS1;SGMS2;CERS5;CERK;SPTLC2;ST6GALNAC3;PPP2CA;SPTSSA;ACER2;CERS6;ASAH2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.45657472350093437,-1.4275643860500002,0.060240963855421686,0.7214116065271732,1.0,11/29,18.55%,IL31RA;IFNAR2;IL15;GHR;PKD2;SOCS2;CTR9;STAT2;IFNAR1;STAT5A;STAT6
prerank,positive regulation of protein polymerization (GO:0032273),0.5255245952956032,1.4274741887469236,0.0773067331670823,0.6848150536114584,1.0,6/65,7.53%,LMOD1;LMOD2;CDC42EP3;MAPT;TPPP;TOGARAM1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.605921288151881,1.4256335080452078,0.11044776119402985,0.6891901933508173,1.0,5/25,5.28%,NDST3;CSGALNACT1;EXT2;HS2ST1;HAS2
prerank,relaxation of cardiac muscle (GO:0055119),0.6766599672784422,1.4251918138832018,0.10720562390158173,0.6886578920350612,1.0,4/13,5.82%,PLN;SLC8A1;CAMK2D;ATP1B1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5834318214729257,1.4250265650617375,0.09510086455331412,0.6871726218569079,1.0,11/33,10.84%,HIP1;BCAR3;NUP62;FBXW7;DOK1;NEU3;AREG;ADAM17;DGKD;HBEGF;GPER1
prerank,SNARE complex assembly (GO:0035493),-0.609924560032513,-1.4242912412866184,0.08113590263691683,0.7309683772917394,1.0,5/10,20.21%,STXBP1;SNCA;VAMP8;UVRAG;VAMP1
prerank,inorganic cation transmembrane transport (GO:0098662),0.4674277118394944,1.4236591784132302,0.02053388090349076,0.6900676437819688,1.0,28/268,5.82%,KCNAB1;ATP2A1;SCN4A;CACNA1C;ASIC3;ATP2B4;TRPC6;ATP2A2;KCNJ12;CACNA1H;SLC6A17;ANO6;SLC8A2;SLC8A1;KCNQ5;ATP5MF;KCNA5;SLC4A8;SLC6A2;SLC6A5;KCNQ4;KCNN2;UCP3;KCNB1;CCDC51;ATP6V1H;KCNH1;ATP1B1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.5788283769295328,1.4227866125053283,0.11494252873563218,0.6910833397763455,1.0,11/32,14.26%,FGF13;TRIM54;CLASP2;ARHGEF2;DYRK1A;HDGFL3;TPX2;TBCD;CLIP3;CLASP1;STMN2
prerank,positive regulation of behavior (GO:0048520),0.699926322390895,1.4226749154568983,0.12991452991452992,0.6893757225778478,1.0,1/10,0.71%,MEF2C
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.6768535713522167,1.4223217445154328,0.1375,0.6885536392652992,1.0,3/12,4.69%,LAMA5;ACTG1;ACTB
prerank,retinoic acid metabolic process (GO:0042573),-0.5504124615334016,-1.4217938163297357,0.10779816513761468,0.736955139427129,1.0,2/14,2.98%,ALDH1A2;CYP26B1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5576451957675432,1.4209638971752834,0.0970464135021097,0.6913097848441654,1.0,3/40,0.77%,NTF3;EDNRA;NTRK3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.4984953533317711,1.42022235879816,0.056433408577878104,0.6919173511196789,1.0,22/107,12.38%,TRDN;ATP2A1;RYR2;ATP2B4;ATP2A2;CSRP3;SLC8A2;SLC8A1;STIM1;CCL5;ATP1B1;CAV1;RMDN3;ATP2B1;PTH1R;SLC30A5;ATP2A3;CCL14;SLC39A14;HTR2B;DMPK;CHRNA7
prerank,positive regulation of transporter activity (GO:0032411),0.6704516937446574,1.4201253418428452,0.1169284467713787,0.6902002079630067,1.0,2/13,2.04%,TRPC6;KCTD7
prerank,epithelial structure maintenance (GO:0010669),-0.5904572667069075,-1.4198581078676393,0.08370044052863436,0.740408516337031,1.0,2/11,4.19%,CXADR;RBP4
prerank,ruffle organization (GO:0031529),0.6584690154998983,1.417732865764418,0.11451612903225807,0.6966188143184414,1.0,3/16,7.51%,TPM1;CYFIP1;PLEK
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5545673494680698,1.4172730168623742,0.0921595598349381,0.6962006510292227,1.0,7/39,8.12%,DMD;FGF13;FGF14;CAMK2D;UTRN;NEDD4;WNK2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5477445844738222,1.4169883893826185,0.08322147651006712,0.6951846517074985,1.0,5/48,2.58%,FLNA;ARHGEF7;LIMS1;FERMT2;SS18L2
prerank,entry into host (GO:0044409),-0.5569750531115293,-1.4167409949174232,0.06726457399103139,0.7495129080425853,1.0,5/13,7.11%,GRB2;CDH1;ITGAV;CTNND1;CTNNB1
prerank,apoptotic mitochondrial changes (GO:0008637),0.575868123297224,1.4144908924701907,0.11030478955007257,0.7023366418678657,1.0,10/32,12.48%,ATP2A1;HK2;BCL2;NDUFS1;FZD9;THEM4;DNM1L;GGCT;BOK;CLU
prerank,activation of protein kinase B activity (GO:0032148),0.5901922604740153,1.4124016753703614,0.10134128166915052,0.7078594392193546,1.0,4/29,2.09%,NTF3;NTRK3;FGF1;PDGFB
prerank,positive regulation of protein secretion (GO:0050714),0.5253975303653389,1.4123323366305403,0.0761789600967352,0.7060418184996142,1.0,2/69,0.37%,MYOM1;TTN
prerank,protein localization to cell surface (GO:0034394),0.6034297592040442,1.412146820329046,0.11764705882352941,0.7046528700299971,1.0,4/26,4.90%,FLNA;ANGPT1;VCL;JAM3
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5039783046438645,-1.4121445756080562,0.08064516129032258,0.7662010333703863,1.0,7/18,20.94%,UNC13C;UNC13B;GRIK3;SLC17A6;GRID2;GRIK1;SLC1A4
prerank,basement membrane organization (GO:0071711),0.6613131995650745,1.4116771884406942,0.12908777969018934,0.7042857226581701,1.0,4/14,6.92%,NTN4;COL4A1;PXDN;LAMB2
prerank,regulation of cell-cell adhesion (GO:0022407),-0.4133946594083992,-1.4115762420716527,0.040892193308550186,0.7633202769977956,1.0,9/39,10.30%,AFDN;EPHA7;PTPRG;NF2;PTK2;PODXL;CDH1;TENM3;TGFB1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6898729890470473,1.4112807924471633,0.12788632326820604,0.7037545079334271,1.0,2/11,2.43%,ATP2B4;MLIP
prerank,regulation of execution phase of apoptosis (GO:1900117),0.7036203326532924,1.4112548312346633,0.14487632508833923,0.7018096679863646,1.0,5/11,11.59%,DLC1;PTGIS;TP53;SIRT2;BOK
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.42528448507427685,-1.4101602828872686,0.0547945205479452,0.7642630562814531,1.0,12/36,15.51%,MECOM;DLG1;ITCH;FOXO1;PTPN22;PRKN;SIRPA;SH3RF2;PER1;IGBP1;AIDA;DUSP1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6160450760638818,-1.4091758575762545,0.10151187904967603,0.7635369646334766,1.0,5/10,11.87%,DCN;SEMA6A;XDH;PIK3CB;SPRY2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.6152247611337621,1.4080896499124385,0.10395314787701318,0.7110463704174224,1.0,3/24,1.66%,RYR1;RYR2;ITPR1
prerank,RNA destabilization (GO:0050779),0.6248306393667598,1.407794031446123,0.11967213114754098,0.7100324473147511,1.0,8/18,14.01%,RBM24;ROCK1;YTHDF2;CELF1;FTO;ROCK2;DXO;GIGYF2
prerank,glucose import (GO:0046323),0.6637617888473105,1.4072280246738298,0.13658536585365855,0.7100339911606974,1.0,3/13,6.45%,SLC2A4;SORT1;SLC2A10
prerank,negative regulation of protein depolymerization (GO:1901880),0.6043233148890499,1.4070484284765399,0.12917933130699089,0.7085981430454655,1.0,6/24,7.13%,FGF13;TRIM54;CLASP2;ARHGEF2;HDGFL3;TPX2
prerank,diol metabolic process (GO:0034311),-0.5007061570417118,-1.4061088826084382,0.09090909090909091,0.7718509969615247,1.0,10/19,22.94%,NAAA;SGPP1;NOS3;ASAH2;GCH1;PRKG2;AKT1;PTS;SPR;SPHK1
prerank,negative regulation of nervous system development (GO:0051961),0.6402349236951451,1.4059222821479378,0.10869565217391304,0.710687812170222,1.0,1/17,0.19%,SLIT1
prerank,regulation of membrane repolarization (GO:0060306),0.6676733873337766,1.4046390408021001,0.12784588441331,0.7133119442560771,1.0,3/13,6.08%,AKAP6;CACNA2D1;CAV1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.5759751991880995,1.4045165369838224,0.11209439528023599,0.7116458933914108,1.0,7/29,10.29%,RBM24;TENT5B;CIRBP;GDNF;NBAS;FUS;HNRNPU
prerank,import into cell (GO:0098657),-0.41269064585850873,-1.4044121124447035,0.04878048780487805,0.7743946624301449,1.0,8/41,5.98%,ATP1A2;SLC6A13;SLC1A3;GLUL;SLC47A1;SLC12A7;SLC6A6;SLC7A5
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.47397412490579055,1.4041902701703035,0.05508474576271186,0.7107468554779944,1.0,19/159,6.20%,NEXN;PALLD;MYOT;CDH6;MYPN;IGFN1;ROBO3;CDH13;MILR1;ITGB1;CDH4;KIRREL3;PTPRS;IGSF21;GPC4;CDHR3;PCDHB14;PTPRF;DSCAM
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.46109862442893546,1.4041121625594044,0.014112903225806451,0.7090063929234924,1.0,39/348,7.68%,MYOM1;ACTA2;NTF3;MYLK2;TTN;ACTG2;MEF2C;NTRK3;HEY2;ACTA1;ANGPT1;ROCK1;FGF1;CD36;LIMS1;MYD88;PDGFB;GABPA;HINFP;ACTG1;MUSK;RBMS3;UBR5;OSR2;SLC38A2;EMILIN1;TESC;TP53;SLC2A10;VEGFA;PTPN1;AR;PPARGC1A;MED1;CELF1;YAP1;NAT8;C1QTNF1;SOX9
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.6495410260791221,1.4038237389216692,0.10350877192982456,0.7081199260477382,1.0,2/15,2.63%,RYR2;ZFAND2B
prerank,protein localization to synapse (GO:0035418),-0.5666294864775203,-1.4037900009214062,0.1010752688172043,0.7720088748249637,1.0,5/12,15.29%,NLGN1;ZDHHC15;NRXN1;NLGN2;PCLO
prerank,regulation of tube diameter (GO:0035296),0.6463347659777554,1.4036536556005033,0.14893617021276595,0.7047606979493137,1.0,2/13,1.43%,AGTR1;ROCK1
prerank,vascular process in circulatory system (GO:0003018),0.6463347659777554,1.4036536556005033,0.14893617021276595,0.7047606979493137,1.0,2/13,1.43%,AGTR1;ROCK1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6084447880993127,1.4027699288111393,0.10755813953488372,0.7059205064540115,1.0,3/26,1.66%,RYR1;RYR2;ITPR1
prerank,eye morphogenesis (GO:0048592),-0.4968260165693297,-1.401827230523528,0.09743589743589744,0.7761573507419762,1.0,9/19,9.35%,SHROOM2;FBN1;NF1;EFEMP1;FBN2;MFAP5;IFT122;COL5A1;TENM3
prerank,neuromuscular junction development (GO:0007528),0.6167957669553765,1.4015948077666516,0.11526479750778816,0.708080565834569,1.0,7/24,7.03%,CACNB2;PDZRN3;MUSK;CACNB4;DOK7;PPFIBP2;NEDD4
prerank,response to interferon-beta (GO:0035456),-0.4813453585675391,-1.4001469800072572,0.09259259259259259,0.7785599025076863,1.0,16/22,37.76%,IFNAR2;IRGM;BST2;IFITM1;SHFL;IFITM3;PNPT1;IFITM2;IKBKE;HTRA2;CDC34;XAF1;NDUFA13;TRIM6;PLSCR1;IRF1
prerank,transepithelial transport (GO:0070633),-0.5255732314175356,-1.3993283012241289,0.09535452322738386,0.7768244838286589,1.0,4/15,4.09%,SLC1A3;ABCG2;SLC12A2;CXADR
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.6946358625821741,1.3979848571213667,0.1551094890510949,0.718938729290886,1.0,1/10,0.53%,AOC3
prerank,mitotic chromosome condensation (GO:0007076),0.5773915938334379,1.39697010192836,0.12812960235640647,0.7206086629111611,1.0,6/26,11.64%,TTN;SET;NCAPD3;TENT4A;RB1;NCAPD2
prerank,outflow tract septum morphogenesis (GO:0003148),-0.4786004769374319,-1.3967547367452693,0.09243697478991597,0.783566034089396,1.0,9/24,5.55%,ROBO1;SEMA3C;NRP2;BMP4;SMAD6;NRP1;ENG;ZFPM2;BMPR2
prerank,protein K48-linked ubiquitination (GO:0070936),-0.382879513646839,-1.3966135129752035,0.04932735426008968,0.7789410765744437,1.0,19/54,15.68%,TTC3;NEDD4L;RNF146;ITCH;CUL3;UBE2D3;RNF6;PELI1;TOPORS;UBE2E2;UBE2E3;PRKN;UBE3A;RNF34;SKP2;DTX3L;UBE2H;RNF115;KLHL3
prerank,regulation of cellular component organization (GO:0051128),0.4745094678071069,1.3963325745876778,0.06835722160970231,0.7209933554105205,1.0,22/135,7.03%,AGTR1;RAP1A;PAPPA2;STK38L;ROCK1;CD36;PLCE1;HIP1;RASGRP2;CDH13;PACSIN3;PACSIN2;CAMK2D;NET1;ERMN;ATAD3A;PRKCQ;SLITRK4;DAB2IP;SLC2A10;PTPN1;NEDD4
prerank,regulation of endothelial cell migration (GO:0010594),-0.34815004297230095,-1.39622390782406,0.03205128205128205,0.7757486903914743,1.0,24/85,10.07%,PTN;SASH1;NF1;DCN;FOXP1;GLUL;NRP2;SPARC;BMP4;SLIT2;APOE;TEK;NRP1;PTK2;WNT5A;ACVRL1;PTPRM;BMPR2;PTK2B;FOXC2;PIK3CB;BMPER;ANXA3;ADAMTS9
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5373866501201914,1.3953317635920557,0.10573248407643313,0.7224984988857975,1.0,10/46,9.69%,NTN4;ITGA8;LAMA5;FERMT2;PEAK1;LAMC1;LAMB2;ITGB3;ITGA4;PARVA
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.6746007042073425,1.3952003451896975,0.15034965034965034,0.7209940026721382,1.0,5/12,17.10%,IRS1;PPARGC1A;PPARA;IRS2;MTLN
prerank,cellular response to misfolded protein (GO:0071218),-0.48284946608244267,-1.394851081894706,0.06561679790026247,0.7769590645553286,1.0,8/20,11.28%,ATXN3;CUL3;RNF185;DNAJB12;DERL1;UFD1;UGGT2;STUB1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.4409398232346785,-1.394688512735073,0.0756578947368421,0.772566394486695,1.0,8/30,11.67%,IGF1;NOTCH2;GRB2;RASGRF1;RAPGEF1;ITGAV;RASGEF1A;LYN
prerank,eye photoreceptor cell differentiation (GO:0001754),0.662099417193893,1.3945902711154863,0.16393442622950818,0.7212102782922775,1.0,4/12,6.50%,NKD1;CEP290;DSCAM;VEGFA
prerank,mitochondrion distribution (GO:0048311),0.6954924545669049,1.3943308280841067,0.13157894736842105,0.7202389888493365,1.0,6/12,14.40%,MEF2A;MAPT;TRAK1;ATCAY;DNM1L;LRRK2
prerank,heart looping (GO:0001947),0.5490520846071487,1.3942223519680208,0.10096818810511757,0.7186802023733799,1.0,3/39,1.52%,MEF2C;TBX2;MICAL2
prerank,regulation of cellular localization (GO:0060341),0.5474778798329037,1.3942097182405886,0.10469798657718121,0.7167466562516692,1.0,12/46,14.51%,STXBP2;ADCY5;NR1H4;CAMK2D;UNC13D;PARP1;BRSK1;NR1D1;LRP5;CSNK1E;LRRK2;DVL1
prerank,regulation of synapse assembly (GO:0051963),0.5359504602250988,1.3940566867243978,0.11507936507936507,0.715333291501368,1.0,5/46,5.68%,SLIT1;MEF2C;PDLIM5;MUSK;GPC4
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.4332427311768736,-1.394001177229758,0.07216494845360824,0.7704850819024637,1.0,21/35,38.61%,ACSS3;PAM;FAR2;HMGCL;HMGCLL1;PPT1;HMGCS2;ACLY;BDH2;AACS;GGT7;HPGD;ALOX12;HSD17B8;BDH1;GCDH;SLC25A1;SCD;ACACA;AWAT2;GGT1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.6764257759551271,1.3937219653460262,0.13686131386861314,0.7145679153071401,1.0,2/11,1.88%,WTIP;LIMD1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.5611929716472069,-1.3935930239558525,0.1111111111111111,0.7675580214764521,1.0,6/12,10.30%,PTPN14;BMP4;KHDRBS1;UHMK1;SIRT7;TGFB1
prerank,regulation of cell motility (GO:2000145),0.47892839773980406,1.3925593060865469,0.05733186328555678,0.7166442330052837,1.0,12/121,3.93%,NEXN;FLNA;ROCK1;FGF1;CAVIN1;CDK6;PLXND1;PLXNB1;KIF2A;SERPINE2;DOCK10;NTN1
prerank,protein N-linked glycosylation (GO:0006487),-0.3688726000881276,-1.3916264924005195,0.0427807486631016,0.7713389147900541,1.0,28/66,25.73%,MAN1C1;TUSC3;MGAT4C;B4GALT1;ST3GAL1;MGAT1;PGM3;SLC39A8;FUT8;MGAT4B;UGGT2;ENTPD5;OSTC;MGAT5;MCFD2;PMM2;MPDU1;LMAN1;ALG14;B4GALT7;ALG1;ALG12;GFPT2;RPN2;MGAT2;DPM3;MGAT4A;STT3B
prerank,regulation of protein acetylation (GO:1901983),-0.5730355532317117,-1.3911509612672435,0.10377358490566038,0.768660010738446,1.0,5/12,19.27%,DDX3X;CAMK1;TAOK1;TERF2IP;PARK7
prerank,neural crest cell migration (GO:0001755),-0.41995244500871526,-1.3911474080110378,0.059027777777777776,0.7636763575233819,1.0,10/36,7.79%,SEMA3D;SEMA3C;SEMA6A;FN1;NRP1;RADIL;ANXA6;SEMA7A;SEMA3A;SEMA4D
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.5121863763992256,1.3903552043323113,0.08466257668711656,0.7226543040197071,1.0,11/78,9.52%,MYOCD;PDGFB;CCNA2;CCND2;NR2F2;ACTB;HEXIM1;CCND1;ADAM17;CCNT1;CDK7
prerank,oligosaccharide metabolic process (GO:0009311),-0.40169520020917804,-1.3902013243611622,0.046511627906976744,0.7631020529550221,1.0,12/46,11.00%,ST3GAL4;B4GALT1;ST3GAL6;ST8SIA4;ST6GALNAC3;ST8SIA1;AMY1C;AMY1B;AMY1A;FUT8;ST3GAL3;ST8SIA2
prerank,cellular response to BMP stimulus (GO:0071773),-0.3706507322433357,-1.3897512643043124,0.0425531914893617,0.7601878275646655,1.0,17/66,10.61%,BMP6;TGFBR3;SMAD3;DDX5;BMP7;BMP4;SMAD6;ENG;RUNX2;ACVRL1;RGMB;BMPR2;MEGF8;SMAD9;TMEM100;TGFB1;PDCD4
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.6003824487494258,-1.3897499590913034,0.10321100917431193,0.755353366342079,1.0,3/10,18.64%,RC3H2;NFKBIZ;ZC3H12A
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.5059827683447422,-1.3890264631951446,0.0975609756097561,0.7539185957495831,1.0,5/17,8.83%,ATP1A2;BMP7;BMP4;TFPI;NR3C1
prerank,sodium ion homeostasis (GO:0055078),-0.4835980912663805,-1.3889955064059591,0.07629427792915532,0.7493176668250725,1.0,4/21,3.01%,ATP1A2;ATP1B3;NEDD4L;SLC12A2
prerank,"wound healing, spreading of cells (GO:0044319)",0.5960539146669086,1.3888034163129501,0.11214953271028037,0.726219966272276,1.0,4/24,3.40%,FLNA;CCN1;LCP1;MRTFA
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.5341163227185739,-1.3881764636474563,0.10353535353535354,0.748063654396435,1.0,9/13,39.21%,GAB2;STX4;LAMP1;SYK;AP1G1;ITGB2;ITGAM;FGR;SPHK2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.48655466097338573,1.3873993992267326,0.0746606334841629,0.729377039200747,1.0,14/112,7.86%,PDE3A;SOX6;SOX5;MEF2C;LIMS1;FERMT2;LRRC32;TGFB3;ITGB1;GCNT2;BMPR1A;ITGB5;SOX9;TGFB2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.48143874877052584,1.3872149259871356,0.06659267480577137,0.7280901998501242,1.0,17/116,9.47%,LHCGR;GPR20;ADCY5;CRHR2;FCGR3A;ADCY2;VIPR2;MYH9;ADCY9;TSHR;CYSLTR2;RAMP1;PRKACB;ADAM17;PRKAR1B;PTH1R;ADCY6
prerank,ERAD pathway (GO:0036503),-0.3518119111830613,-1.3860500940451785,0.0440251572327044,0.7525806613258968,1.0,28/83,18.63%,ECPAS;ATXN3;SEL1L;RNF185;UBXN4;UBQLN1;DNAJB12;DERL1;UFD1;HSPA5;DNAJC10;USP19;UGGT2;TRIM25;PRKN;SGTA;UBE4B;STUB1;RCN3;DNAJB2;HSP90B1;SGTB;OS9;UBQLN2;SYVN1;UBXN8;DNAJB9;HERPUD1
prerank,positive regulation of receptor internalization (GO:0002092),0.594078443370105,1.3855007954557201,0.13174603174603175,0.732355529866198,1.0,5/22,10.44%,NTF3;ANGPT1;VEGFA;ATAD1;SCYL2
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5423743038046295,-1.3852422316644646,0.10739856801909307,0.7515618325131144,1.0,3/13,9.72%,ATP1A2;ATP1B3;ATP1B2
prerank,response to ketone (GO:1901654),0.6050729977148454,1.3850770055508375,0.13476263399693722,0.7319404618819687,1.0,6/24,7.86%,SLIT3;ABCB4;TGFB3;CAV1;YAP1;TGFB2
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.41647082037000666,-1.3839302476983324,0.08487084870848709,0.7531992722525642,1.0,15/39,27.18%,TCF7L2;MYRIP;RBP4;MCU;PSMD9;NNAT;SOX4;NLGN2;CAPN10;ACSL4;AACS;DRD2;HFE;ADCYAP1;LRRC8A
prerank,protein depolymerization (GO:0051261),0.5833219634084937,1.3836569549413174,0.13146233382570163,0.7351682192788914,1.0,8/27,14.26%,DSTN;MICAL2;WDR1;KIF2A;CFL2;MICAL3;KIF18A;STMN2
prerank,pharyngeal system development (GO:0060037),-0.5168618247450603,-1.3835306916122316,0.1025,0.7505522012792336,1.0,6/15,11.77%,BMP7;BMP4;PTCH1;BMPR2;HES1;TGFBR1
prerank,positive regulation of vascular permeability (GO:0043117),0.6597365081363402,1.3834052361393456,0.1445578231292517,0.7341204391654024,1.0,2/12,1.26%,PDE3A;ANGPT1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.46658116342158357,-1.3831985772280608,0.09253731343283582,0.7473163968703456,1.0,6/25,6.44%,KIT;B2M;WNT5A;CD55;SLC7A5;PLCG2
prerank,positive regulation of B cell proliferation (GO:0030890),0.5808857234539558,1.3824470877009334,0.13444108761329304,0.7357390377483985,1.0,4/29,4.50%,MEF2C;IL2;TNFSF13B;BCL2
prerank,positive regulation of viral life cycle (GO:1903902),0.6016746537279805,1.3821851239858336,0.1253968253968254,0.7347896277871422,1.0,6/22,13.43%,TMPRSS4;AXL;CHMP2B;TSG101;KPNA2;CHMP2A
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.40620012697156016,-1.3821271481641324,0.05531914893617021,0.7475241533392918,1.0,23/47,22.36%,BMP7;CARM1;MEDAG;ASXL2;SOX13;NOCT;TMEM64;NAPEPLD;SIX1;CREBL2;AAMDC;CREB1;PTGS2;CEBPB;AKT1;TFE3;PPARG;LMO3;CDS1;ZC3H12A;METRNL;SYAP1;CCDC71L
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.4831603165265621,-1.3821159243107557,0.10432569974554708,0.743097313554804,1.0,5/18,8.50%,IGF1;IGFBP2;HMGB1;IL18;IGF2
prerank,metanephric mesenchyme development (GO:0072075),-0.5972041082751947,-1.3818454129014148,0.09777777777777778,0.7397814466153735,1.0,4/10,10.88%,WNT4;PKD2;OSR1;SIX1
prerank,axon extension (GO:0048675),0.5912335570648314,1.381744819726736,0.15433070866141732,0.7343905052320342,1.0,4/23,3.78%,SLIT3;SLIT1;SEMA5A;MAP1B
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6874116509780487,1.3808734313204467,0.13518197573656845,0.7355576749186274,1.0,4/10,11.28%,PRKG1;SERPINE2;C1QTNF1;PRKCD
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6612625689226822,1.3808678265989998,0.14136125654450263,0.7336609331566082,1.0,4/14,8.72%,ATP2B4;PKIB;PKIA;PRKAR1B
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.45794293589455365,-1.3801039486243338,0.09243697478991597,0.742531237924004,1.0,10/25,11.28%,ATXN3;CUL3;RNF185;NGLY1;DERL1;UFD1;ZER1;UGGT2;ZYG11B;STUB1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5499247378755927,-1.3800164499819714,0.11538461538461539,0.7384127421848494,1.0,8/12,23.57%,SEC62;HSPA5;SEC63;SGTA;SGTB;SEC61A1;CHMP4B;CHMP4A
prerank,spindle assembly (GO:0051225),0.5149569969033375,1.3797588526167825,0.1003671970624235,0.7357766813635858,1.0,22/67,17.28%,FLNA;CLASP2;KIF2A;TOGARAM2;HAUS8;KIF3B;MAPRE2;TUBGCP6;TPX2;PIBF1;TOGARAM1;CEP192;WRAP73;AAAS;CLASP1;HAUS7;HAUS2;MAPRE3;ABRAXAS2;MAP9;INO80;STARD9
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.6312632329786461,1.3775300411010243,0.15460526315789475,0.741959527600953,1.0,4/17,4.11%,ANGPTL8;LPL;SORT1;HDAC9
prerank,positive regulation of DNA repair (GO:0045739),-0.3929387604032047,-1.377423806895331,0.06640625,0.7452145754115692,1.0,13/46,17.43%,EYA2;EYA1;EYA4;HMGB1;EGFR;SLF2;SMCHD1;XRCC1;BRCC3;SLF1;NPAS2;FAM168A;WRAP53
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4981573943620918,-1.3766140561119462,0.11023622047244094,0.7444210248265541,1.0,6/16,18.64%,APPL2;APOD;ADCY7;PDCD4;SIRPA;ZC3H12A
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.48804616237919723,-1.376074387833402,0.09973753280839895,0.7423707563000375,1.0,4/18,5.54%,PRKCB;PRKAG2;SLC2A1;OCLN
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5667688687932908,-1.375927755942754,0.1048951048951049,0.7387267992920277,1.0,5/11,11.08%,DDX5;BMP4;EGFR;TGFB1;MAP2K2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.4644099343043939,-1.3758947608865286,0.10122699386503067,0.734559328010064,1.0,9/25,19.68%,SDF2;DNAJB12;HSPA5;BAG1;HSPA13;HSPA9;HSPE1;DNAJB4;ST13
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4900233393947317,1.3755686555718207,0.08275058275058275,0.7469623938750196,1.0,22/93,16.16%,NTF3;DMD;NTRK3;ATP2B4;HRC;BCAR3;CAV1;VEGFA;CNKSR3;GPD1L;PDE4D;PDCD10;FNIP2;DMTN;NCK2;GAS6;MLXIPL;INPP5J;PTEN;RAF1;NOS1;MAD2L2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4783531448523743,1.3755322431414363,0.07461024498886415,0.7452101551129732,1.0,17/117,9.47%,LHCGR;GPR20;ADCY5;CRHR2;FCGR3A;ADCY2;VIPR2;MYH9;ADCY9;TSHR;CYSLTR2;RAMP1;PRKACB;ADAM17;PRKAR1B;PTH1R;ADCY6
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.506143906488717,-1.3747389076381187,0.0967741935483871,0.7353495726745645,1.0,7/16,17.73%,AUTS2;CTR9;CTNNB1;SNW1;BCOR;SMAD4;KDM1A
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5334436539819077,1.3741330788821562,0.11011523687580026,0.7483805841373347,1.0,3/48,3.36%,CCDC3;SLIT3;PADI2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5136319787679222,1.3740383386285884,0.10424710424710425,0.7468038614016425,1.0,17/59,14.87%,MYLK2;ROCK1;DYRK2;CAMK2D;DYRK1A;TAF1;DYRK1B;CHEK1;MAP3K10;MAP2K1;ROCK2;PRKCD;ACVR1B;CDC42BPB;MAPK1;LRRK2;PRKCA
prerank,polyol biosynthetic process (GO:0046173),-0.5158531355418609,-1.3740244837299986,0.08651399491094147,0.7343747426914631,1.0,9/16,25.06%,CYP27A1;IP6K1;ISYNA1;IP6K2;PPIP5K2;FGF2;ITPKB;IPPK;CYP2R1
prerank,lamellipodium organization (GO:0097581),0.5745489730078347,1.373920818635406,0.14852941176470588,0.7452894554499444,1.0,7/29,9.05%,ARHGEF7;VCL;CDH13;ITGB1;CYFIP1;WHAMM;ARHGEF4
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5248633166434236,-1.3732041994873434,0.11085450346420324,0.733734985884064,1.0,6/14,17.22%,SPRED2;XDH;ZEB1;OSR1;SPRY2;NOTCH4
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.4460042148371206,-1.3731800202972109,0.07267441860465117,0.729747729345691,1.0,16/26,36.51%,ITCH;PPM1B;MAPKBP1;ILRUN;PCBP2;IRAK3;TRIB1;TRIM21;NLRC3;NFKBIL1;TNFAIP3;NMI;SIGIRR;TYRO3;LYAR;DHX58
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.5254575300703668,-1.3726723581478806,0.10837438423645321,0.7278129234071559,1.0,6/14,17.38%,KMT2E;AUTS2;CTR9;CTNNB1;SNW1;SMAD4
prerank,renal filtration (GO:0097205),0.7014220542354129,1.3718373459510145,0.15875912408759124,0.7508285333143176,1.0,3/10,2.73%,MCAM;MYO1E;ITGA3
prerank,positive regulation of GTPase activity (GO:0043547),0.4617561167363178,1.3716058115992484,0.04936974789915966,0.7497477338288949,1.0,36/188,10.64%,NTF3;ARHGEF7;RAP1A;NTRK3;RALGAPA2;TBC1D1;RGS6;ABR;LIMS1;RASGRP2;FERMT2;DOCK8;PLXNB1;BCAR3;DOCK10;ITGB1;CCL5;NET1;TBC1D20;RSU1;ARHGEF16;LARS1;MTSS2;MAPRE2;RABGAP1;PIN1;CORO1C;RAPGEF6;RASGRP1;RALGAPA1;EVI5;RALGAPB;EPHA2;AGRN;CCL14;SNX18
prerank,modification-dependent protein catabolic process (GO:0019941),-0.31072824742116717,-1.3711232339543722,0.0,0.7305115831339638,1.0,64/193,19.46%,TTC3;NEDD4L;ARRB1;FBXL7;TRIP12;RNF146;ATXN3;AREL1;ITCH;FBXO10;CUL3;RNF185;ANAPC1;RNF20;UBQLN1;BIRC6;RC3H2;RNF144B;RNF217;UBL7;RNF6;UFD1;RNF13;WDR91;PSMD9;PSMD13;RNF213;MDM2;TOPORS;CDC23;FBXO7;TRIM25;SMURF2;RNF144A;PRKN;DDB1;UBE4B;UBC;RNF34;STUB1;RNF125;DTX3L;RNF166;SIAH1;OS9;BUB3;PSMC2;UBE2H;CDC26;TOLLIP;RNF43;KLHL3;UBQLN2;UBE2S;ANAPC4;SIAH2;SYVN1;RNF130;HERPUD1;CHFR;ARRDC1;ARIH1;SPSB4;BTRC
prerank,regulation of actin filament polymerization (GO:0030833),0.4978355981586835,1.370924814571777,0.10891089108910891,0.7502559035324012,1.0,4/69,3.29%,LMOD1;LMOD2;CDC42EP3;KANK1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5034337790299804,1.370758018388381,0.10268948655256724,0.7489370987359453,1.0,13/65,9.18%,ASPN;PRDM16;LTBP1;VASN;TGFB1I1;EMILIN1;CAV1;SLC2A10;PPM1A;PIN1;PPARA;ADAM17;SKI
prerank,regulation of chemotaxis (GO:0050920),-0.42860125452870995,-1.3702646136888472,0.08389261744966443,0.729920051700324,1.0,12/30,12.72%,PDGFRA;EFNB2;ADGRA2;MYCBP2;STX3;ZSWIM6;CYRIB;STX4;TGFB1;ZSWIM5;ZSWIM4;PPM1F
prerank,Rho protein signal transduction (GO:0007266),0.5108048314857158,1.3697854921767665,0.10951760104302477,0.7506012932906344,1.0,13/53,11.25%,AGTR1;ROCK1;CDC42EP3;CDH13;MYO9B;NTN1;ARHGAP6;ARHGDIG;RHOJ;GNA12;ARHGAP1;ROCK2;ARHGAP5
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.3920649403912249,-1.3697094131614307,0.0823045267489712,0.728144701542291,1.0,11/45,5.66%,PIK3CA;EFEMP1;GRB2;TGFA;PDPK1;PTPN11;EGFR;PTK2;SLC30A10;GAB1;PTK2B
prerank,cellular response to oxygen-containing compound (GO:1901701),0.44832874704841447,1.3695946383196569,0.032520325203252036,0.7493370360461593,1.0,49/291,11.28%,PDE3A;TPM1;MEF2C;RAP1A;ATP2B4;AKAP6;NR1H4;MYD88;PDGFB;ABCB4;PDK4;RORA;VIM;FZD4;LPL;P2RY2;IGFBP5;GUCY1B1;TSHR;CAMKK2;ACTB;UPF1;CD14;LARS1;TESC;IRS1;TAF1;MAPT;DAB2IP;CHMP5;CPEB1;SOX9;NFKBIB;RELA;ADNP2;IMPACT;GSTP1;CAPN2;NR1D1;ADCY6;RRAGB;CERS1;AXL;BRINP1;SH3BP4;GPER1;ROCK2;CD180;PRKCD
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.5723044589110589,-1.3695583605386865,0.13211845102505695,0.724776101191009,1.0,3/11,1.66%,AFDN;TJP1;TJP2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.49509325850007374,1.3681225973423072,0.10403916768665851,0.7528116441192008,1.0,10/69,7.62%,NTF3;MEF2C;PLA2G3;CRLF1;TGFB3;SET;BCL2;GDNF;PPARGC1A;FZD9
prerank,vasculature development (GO:0001944),-0.514376401579647,-1.3680839501731101,0.12056737588652482,0.7264272501912137,1.0,6/16,9.24%,PIK3CA;PDGFRA;CDH5;ACVRL1;BMPR2;STK11
prerank,positive regulation of interferon-beta production (GO:0032728),-0.42194668154369297,-1.3675055258429998,0.07857142857142857,0.7249018793438083,1.0,13/33,25.15%,DDX3X;PTPN11;RNF135;POLR3F;RIOK3;POLR3B;POLR3A;TRIM56;TLR3;OAS2;POLR3C;TOMM70;POLR3D
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.5223574956554624,1.3670218319244125,0.11957950065703023,0.7548715176625906,1.0,10/48,9.99%,GUCY1A1;AMPD1;ADCY5;ADCY2;ADCY9;GUCY1B1;AMPD2;NUDT2;ADCY6;NPR2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5733630475184459,1.3660521815238986,0.13901345291479822,0.7563405155641217,1.0,2/27,1.23%,MAP3K20;MAP3K5
prerank,mRNA splice site selection (GO:0006376),-0.4340613270262794,-1.3659168961950328,0.09006211180124224,0.7277750754065834,1.0,8/30,11.14%,CELF2;KHDC4;SRSF6;SRSF5;CELF4;SETX;SFSWAP;ISY1
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5636194757693409,-1.3655185866904125,0.09885057471264368,0.7256512662691798,1.0,6/12,19.77%,SLIT2;NBL1;CCN3;DUSP1;AKT1;MIA3
prerank,negative regulation of protein catabolic process (GO:0042177),0.5367259753978224,1.3651695926835972,0.11470985155195682,0.7577355111092142,1.0,12/40,16.28%,FLNA;ROCK1;DAB2IP;PIN1;TIMP4;SF3B3;SIRT2;ADGRB1;CTSA;AZIN2;MAD2L2;AGAP2
prerank,DNA damage checkpoint signaling (GO:0000077),0.5601173011869041,1.3651211762342927,0.125,0.7560130836099924,1.0,11/28,14.23%,MAP3K20;HINFP;BRIP1;CHEK1;RAD9A;ERCC6;STK33;FBXO6;RHNO1;CLOCK;INTS7
prerank,liver development (GO:0001889),-0.43486175067853083,-1.3648037198507446,0.10493827160493827,0.7246401309493455,1.0,9/32,13.45%,TGFBR3;NF1;COBL;WNT4;PKD2;LSR;PCK2;CEBPB;CCDC39
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6612925249223428,1.3644478032142182,0.17572463768115942,0.756569676026497,1.0,3/11,6.96%,ARHGEF7;KANK1;CORO1C
prerank,motor neuron axon guidance (GO:0008045),0.6307540365159826,1.3632345728130646,0.15171288743882544,0.7589572196310492,1.0,3/15,4.73%,SLIT1;NTN1;CHN1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.5651166595142253,1.3624716464118696,0.13172804532577903,0.7598859589079211,1.0,9/34,15.30%,MEF2C;GABRE;GRIN2C;GABRA4;GABRA5;GABRG1;INSYN2A;LRRK2;CHRNA4
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.6568172403093195,1.3622558894305616,0.19576719576719576,0.7569755886828099,1.0,3/11,10.24%,TRDN;CALM1;SRI
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.6568172403093195,1.3622558894305616,0.19576719576719576,0.7569755886828099,1.0,3/11,10.24%,TRDN;CALM1;SRI
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4508391875334131,-1.362223099623023,0.10364145658263306,0.7316770499868562,1.0,14/24,28.39%,PALM;DOCK11;NRP1;NLGN1;FNBP1L;RIPOR2;DPYSL3;RHOQ;CDC42;FMR1;GPM6A;FSCN1;ARAP1;TENM1
prerank,B cell homeostasis (GO:0001782),0.659793969629314,1.3615354613927904,0.14285714285714285,0.7576787768711165,1.0,2/10,3.54%,MEF2C;DOCK10
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.6467545770783822,1.3614862821400529,0.18324607329842932,0.7541174752451664,1.0,2/12,1.15%,AKAP6;LMCD1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6467545770783822,1.3614862821400529,0.18324607329842932,0.7541174752451664,1.0,2/12,1.15%,AKAP6;LMCD1
prerank,modulation by symbiont of host process (GO:0044003),-0.5748335737208308,-1.3609852663726116,0.13598326359832635,0.7327285479968175,1.0,7/10,30.62%,B2M;UBC;PGK1;HGS;UBB;ENO1;MRC1
prerank,neural crest cell differentiation (GO:0014033),0.6048373963440422,1.3604763917829366,0.15590551181102363,0.7559209324395533,1.0,5/18,11.68%,MEF2C;TAPT1;SNAI2;CDH2;HTR2B
prerank,protein glycosylation (GO:0006486),-0.32091895582171837,-1.3604751342942318,0.02631578947368421,0.7311689667448833,1.0,45/125,25.73%,MAN1C1;ST3GAL4;TUSC3;MGAT4C;B4GALT1;ST3GAL6;ST8SIA4;ST3GAL1;GALNT10;ST3GAL5;ST8SIA1;TET3;MGAT1;PGM3;SLC39A8;SERP2;FUT8;MGAT4B;TET2;ENTPD5;ST3GAL3;FUT10;OGT;ST8SIA2;B3GALNT1;PLOD2;MGAT5;PMM2;COG7;B4GALT7;ALG1;PLOD3;ALG12;B3GNT2;POMT1;B3GALT2;GFPT2;RPN2;NPC1;EOGT;MGAT2;DPM3;MGAT4A;SERP1;STT3B
prerank,positive regulation of glucose metabolic process (GO:0010907),0.630055822556892,1.3596820337150315,0.16040955631399317,0.7568814731676307,1.0,6/14,14.92%,PMAIP1;IRS1;PPARGC1A;ARPP19;NNMT;IRS2
prerank,protein localization to Golgi apparatus (GO:0034067),-0.4396565684990763,-1.3592994674078913,0.11538461538461539,0.732242703953367,1.0,12/27,22.43%,VPS13A;GBF1;ZDHHC15;OPTN;ARL5B;GCC2;TMED10;GOLPH3;COG7;OBSL1;SYS1;GBP5
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5634636970325542,1.358686301096133,0.12884333821376281,0.758569043210768,1.0,6/27,8.61%,AGTR1;CD36;PLA2G3;LPL;ITGB3;PPARA
prerank,regulation of ossification (GO:0030278),-0.4130184335705703,-1.3581557953746468,0.0959409594095941,0.7330079832251197,1.0,9/36,5.55%,PTN;SGMS2;BMP4;CHSY1;SMAD6;PTPN11;BMP2K;WNT5A;BMPR2
prerank,potassium ion transport (GO:0006813),0.4702463568670454,1.3580824081371117,0.09497206703910614,0.7587640868906703,1.0,11/120,5.58%,KCNAB1;KCNMA1;KCNJ12;KCNMB1;KCNQ5;KCNA5;KCNQ4;KCNN2;KCNB1;CCDC51;KCNH1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.3574912000666924,-1.3574512957353089,0.03977272727272727,0.7321955259873043,1.0,24/69,18.63%,ECPAS;SEL1L;RNF185;UBXN4;UBQLN1;DNAJB12;DERL1;UFD1;HSPA5;DNAJC10;USP19;TRIM25;SGTA;UBE4B;STUB1;DNAJB2;HSP90B1;SGTB;OS9;UBQLN2;SYVN1;UBXN8;DNAJB9;HERPUD1
prerank,regulation of phospholipase C activity (GO:1900274),0.62108209866401,1.3574238126167526,0.14492753623188406,0.7592490060974201,1.0,2/15,0.77%,NTF3;NTRK3
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.3643907446146131,-1.3560168710951732,0.061224489795918366,0.7343889631787274,1.0,12/66,5.39%,TGFBR3;ROBO1;MCC;NF1;SULF1;SPARC;NUPR1;APOE;B2M;XDH;MTSS1;PTPRM
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5766917227606772,1.355936733246434,0.1267175572519084,0.7625242412790582,1.0,7/25,10.84%,HIP1;BCAR3;NUP62;DOK1;NEU3;DGKD;GPER1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.45675906651105375,-1.3551687683255413,0.0851063829787234,0.7339781850321031,1.0,10/26,16.75%,IGF1;OSBPL8;PTPN11;OCLN;CREBL2;APPL1;RHOQ;INSR;AKT1;CAPN10
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5867068618793458,-1.3535973820150238,0.11467889908256881,0.7362950730955191,1.0,8/10,34.79%,FN1;HSP90AB1;FURIN;GATA6;CD24;TSKU;TYROBP;CDH3
prerank,chromosome condensation (GO:0030261),0.5369220014081676,1.3526671479165444,0.1368124118476728,0.7723099690376923,1.0,8/36,11.64%,TTN;H1-0;SET;NCAPD3;TENT4A;GPER1;RB1;NCAPD2
prerank,receptor-mediated endocytosis (GO:0006898),-0.323105557750703,-1.3526304233921722,0.03529411764705882,0.7367012608652495,1.0,39/132,19.15%,DAB2;DNM3;LRP1;SPARC;GRB2;FCHO2;DNAJC6;CALCRL;APOE;LDLR;FNBP1L;CTSL;SCARB2;CXCL16;CANX;DNM1;TMEM108;PPT1;EPS15;SCARF1;ARHGAP27;DNAJC13;RAMP2;RABEPK;HSP90B1;AP2S1;GRK2;CALR;SNCA;INSR;NLGN3;CLN3;LMBRD1;STAB1;CLTB;M6PR;AP2A2;CUBN;CLTA
prerank,cellular response to fatty acid (GO:0071398),0.672153938900462,1.3525157441889637,0.16695957820738136,0.7709735965061992,1.0,4/12,5.88%,NR1H4;PDK4;LPL;IRS1
prerank,cellular defense response (GO:0006968),0.5228085825238551,1.3505414194465961,0.13963328631875882,0.7760836415552167,1.0,5/40,7.89%,NCF2;LGALS3BP;ITGB1;VEZF1;RELA
prerank,negative regulation of cell cycle (GO:0045786),0.4989584216993081,1.3501083547052042,0.10676156583629894,0.7758172299974255,1.0,14/73,11.39%,MYOCD;CDK6;NR4A1;GMNN;BTG2;NR2F2;RPS6KA2;HEXIM1;HECA;BTG1;BRINP1;GPER1;RB1;TRIM35
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.3471462834140738,-1.3500506267177825,0.038461538461538464,0.7434790923317163,1.0,39/91,25.39%,SEC62;RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;SEC63;RPLP0;RPS29;RPL28;RPS10;RPLP1;RPS20;RPL23A;RPL34;RPL36A;RPS8;RPS21;RPL9;SSR1;SEC61A1;RPS7;RPL27;RPL11;SRPRA;SRP9;RPL18A;RPL37A;SSR2;RPL38;RPL29;RPL10A;RPL32;RPS4X;RPS27
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3762995091986262,-1.3495528978347717,0.08203125,0.7418304175762925,1.0,13/46,10.73%,LGR4;ALDH1A1;ZNF423;IL15;NRDC;NPR3;IP6K1;ID1;FOXC2;NOVA1;STK11;LAMA4;RHEB
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.33758807477642416,-1.3493982104755329,0.03870967741935484,0.7387874991071185,1.0,32/88,22.19%,VPS13A;ARRB1;DNAJC6;APP;RABEP1;MON2;SCAMP2;GBF1;PUM1;STX4;COMMD1;SORCS1;DTNBP1;FTL;AP1M1;EPS15;FTH1;EXOC2;HGS;STEAP2;VAMP8;EXOC1;SCFD1;SH3GL2;CLINT1;CLTA;ACBD3;SCAMP3;AP1B1;VAMP7;SCAMP1;SYS1
prerank,microvillus organization (GO:0032528),0.6572615023233754,1.3491887722927032,0.17204301075268819,0.7774383274476905,1.0,6/13,12.21%,RAP1A;RAP2C;STK26;RAPGEF6;RAP2A;TNIK
prerank,regulation of cell-matrix adhesion (GO:0001952),0.49652397821488387,1.3490746570494105,0.13027295285359802,0.775986772877258,1.0,13/64,8.18%,VCL;ROCK1;CD36;CDK6;CDH13;JAG1;ACTG1;PEAK1;UTRN;DUSP3;AJAP1;CORO1C;DAPK3
prerank,DNA integrity checkpoint signaling (GO:0031570),0.532313856663468,1.3483919296700264,0.11908177905308465,0.7766437056134411,1.0,12/36,14.23%,MAP3K20;HINFP;BRIP1;TIPIN;CHEK1;RAD9A;ERCC6;HUS1B;FBXO6;RHNO1;CLOCK;INTS7
prerank,positive regulation of intracellular transport (GO:0032388),0.5371864477582013,1.348307421385881,0.13688760806916425,0.7750814174472742,1.0,10/38,12.63%,ATP2A1;OAZ2;EHD2;TBC1D20;CEP290;NEDD4;ACTN2;STX18;KIF20B;PDCD10
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5772122418059913,-1.3480248171940497,0.1308641975308642,0.7405770238354593,1.0,3/11,11.77%,TGFBR3;TGFB1;TGFBR1
prerank,negative regulation of inflammatory response (GO:0050728),0.4541967326235631,1.347827766404459,0.06482465462274177,0.7747988491054975,1.0,34/182,11.28%,LHCGR;GPR20;ADCY5;CRHR2;NR1H4;FCGR3A;ADCY2;VIPR2;MYH9;RORA;FEM1A;ADCY9;PTGIS;TSHR;ALOX5;MFHAS1;CYSLTR2;CD200R1;TNFAIP6;CD200;RAMP1;LPCAT3;PRKACB;PPARA;ADAM17;PRKAR1B;GSTP1;NR1D1;PTH1R;ADCY6;AOAH;GPER1;RB1;PRKCD
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.513895704917731,-1.3473945350926777,0.10835214446952596,0.7393881502217831,1.0,9/15,30.53%,USP46;STXBP1;NLGN1;SYN3;NLGN2;CLN3;DRD2;BAIAP3;CNTNAP4
prerank,positive regulation of protein binding (GO:0032092),-0.36608323357225714,-1.3468125737982768,0.04424778761061947,0.738187901411781,1.0,15/56,10.06%,LRP1;TCF7L2;BMP4;APOE;APP;VTN;B2M;PPP2CA;NVL;CLDN5;PPP2CB;DERL1;NMD3;FKBP1A;PRKN
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5492122266416493,1.346247746242101,0.1432469304229195,0.7783126361975039,1.0,3/33,3.36%,NTF3;ABR;SLC4A8
prerank,cell junction organization (GO:0034330),0.4857259958236581,1.3461116671835571,0.13090909090909092,0.7769235625387241,1.0,14/71,7.86%,FLNA;MYOT;LIMS1;FERMT2;SLC8A2;ACTG1;TGFB3;FLNC;ACTB;PPFIBP2;MAPT;LIMS2;PIN1;TGFB2
prerank,actin crosslink formation (GO:0051764),0.6505365017127521,1.3457638717259406,0.18421052631578946,0.77632873527208,1.0,2/12,3.35%,FLNA;LCP1
prerank,heterochromatin organization (GO:0070828),0.6271478005535641,1.3457586904763417,0.17452006980802792,0.7745321073241892,1.0,2/14,2.95%,PRDM16;LOXL2
prerank,triglyceride homeostasis (GO:0070328),0.5891844465806557,1.3452069262744626,0.14896755162241887,0.7746568564133925,1.0,4/26,3.34%,NR1H4;ANGPTL8;RORA;LPL
prerank,macrophage migration (GO:1905517),0.6333941136450186,1.3449017048633571,0.1855123674911661,0.773911182238834,1.0,2/13,3.64%,EDNRB;CCL5
prerank,sensory organ development (GO:0007423),-0.3804020173395577,-1.344820067930509,0.048458149779735685,0.7427377777408153,1.0,8/51,9.46%,SHROOM2;SMOC1;CHD7;PBX3;RBP4;ECE1;SMCHD1;MEIS2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5160742589630078,1.3438471463368824,0.12566844919786097,0.77584279638823,1.0,11/47,11.28%,AGTR1;CD36;PDGFB;SLC5A3;DHRS4;MAPT;TP53;CBR1;GSTP1;PDGFRB;PRKCD
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5142064774616709,-1.3438271290034374,0.12560386473429952,0.7429265033107411,1.0,4/15,3.01%,ATP1A2;ATP1B3;NEDD4L;SLC12A2
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.5209767312348241,-1.343084023915576,0.1466346153846154,0.742105818153545,1.0,8/14,18.55%,PXN;GHR;PTK2;SOCS2;LYN;PRLR;STAT5A;STAT6
prerank,sphingosine metabolic process (GO:0006670),-0.4846546111658149,-1.3428895614495524,0.12105263157894737,0.7393606727721993,1.0,5/17,9.94%,SPTLC2;ACER2;NAAA;SGPP1;ASAH2
prerank,negative regulation of hemostasis (GO:1900047),-0.5384621791670385,-1.342042572894849,0.11643835616438356,0.739265626439629,1.0,5/12,8.27%,APOE;VTN;TFPI;CD34;THBD
prerank,positive regulation of lyase activity (GO:0051349),0.6308542036433574,1.34104418129401,0.17993079584775087,0.7839643577659946,1.0,3/14,4.46%,CACNA1C;STIM1;FXN
prerank,barbed-end actin filament capping (GO:0051016),-0.48531388634025624,-1.340761664241365,0.1246684350132626,0.7373843003515566,1.0,3/18,3.49%,ADD3;EPS8;CAPZA1
prerank,actin filament capping (GO:0051693),-0.48531388634025624,-1.340761664241365,0.1246684350132626,0.7373843003515566,1.0,3/18,3.49%,ADD3;EPS8;CAPZA1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6516860690068563,1.3400844700113437,0.18038528896672504,0.7855432814366421,1.0,4/13,11.08%,FLNA;NFKBIE;GET4;GOPC
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5971453877191653,1.3400414369800782,0.17166666666666666,0.78388578575496,1.0,4/18,6.86%,AGTR1;SIRT3;FXN;GDNF
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.5329696258484314,1.3386917447812168,0.13426573426573427,0.7868476926165427,1.0,9/39,8.64%,ACTN4;MYO1E;MYO1D;MYO1B;MYO5C;KIF1A;F8A1;KIF5B;TRAK1
prerank,synaptic vesicle recycling (GO:0036465),-0.4227853945745692,-1.3381653150256498,0.09731543624161074,0.7440105876919197,1.0,13/31,16.01%,FCHO2;RAB5A;NLGN1;SYT1;CANX;STON2;OPHN1;TBC1D24;SNCA;NLGN2;NLGN3;PLD2;STX1A
prerank,estrogen metabolic process (GO:0008210),0.6196401293002896,1.3376109514940184,0.19482758620689655,0.7887927046592623,1.0,3/15,5.64%,HSD17B10;HSD17B7;HSD17B4
prerank,reticulophagy (GO:0061709),-0.542060605752093,-1.3371044381154948,0.1261904761904762,0.74475389232619,1.0,5/12,13.03%,RB1CC1;RETREG1;TEX264;ATG2B;ATG2A
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.657787278716015,1.336959704039343,0.1746880570409982,0.789172655837835,1.0,4/11,7.86%,HEY2;JAG1;BMPR1A;TGFB2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5337577068698104,-1.3365794303314544,0.13425925925925927,0.743234025592507,1.0,7/13,19.06%,BMP7;SOX13;NAPEPLD;SIX1;PTGS2;TFE3;METRNL
prerank,microvillus assembly (GO:0030033),0.6444748100626123,1.3353072034429052,0.17832167832167833,0.7931658567647156,1.0,6/14,12.21%,RAP1A;RAP2C;STK26;RAPGEF6;RAP2A;TNIK
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.43836978208643834,-1.3351300367238763,0.09792284866468842,0.7458655393585683,1.0,8/25,5.55%,FOXD1;SULF1;ZNF423;BMP4;CDH5;ENG;ACVRL1;BMPR2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.611794368481977,1.3336914344794109,0.17803660565723795,0.7971931560978819,1.0,4/16,5.14%,MEF2C;AKAP6;TBX2;BMPR1A
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.589556344805144,1.332854298683544,0.16237942122186494,0.798436907731101,1.0,5/17,7.71%,HEY2;HEYL;JAG1;BMPR1A;SNAI2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5355142340107067,1.3327347952652726,0.15499254843517138,0.7970098601869915,1.0,13/33,19.08%,MAP3K5;ANXA1;NET1;FXN;RELA;IMPACT;PRKCD;TRPM2;PLEKHA1;ANKZF1;SIGMAR1;HDAC6;ABL1
prerank,phosphatidic acid metabolic process (GO:0046473),0.5163865657408747,1.332375345753979,0.1455026455026455,0.7964853541864606,1.0,3/48,2.32%,DGKB;DGKG;PLA2G3
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.29308836974134955,-1.3321576996448632,0.0,0.7543110447284304,1.0,49/173,19.77%,SPTBN1;ANK2;SPTAN1;TGFA;DCTN4;CUL3;SPAST;PROS1;CAPZA1;DYNC1I1;KLHL12;DYNC1LI2;USO1;CD55;GBF1;VTI1A;TMED5;KDELR1;NRBP2;STX5;ERGIC3;TMED7;TMED10;COPB2;COG6;ARFGAP2;SEC24B;RAB2A;ACTR10;MCFD2;ARFGAP1;COPE;TRAPPC11;ARFGAP3;RAB1A;RAB29;F8;YKT6;LMAN1;COG7;COG2;TMED3;SCFD1;TRIP11;RAB1B;TRAPPC3;TFG;TMED4;MIA3
prerank,determination of heart left/right asymmetry (GO:0061371),0.5181709894204733,1.3320801769264727,0.14051841746248295,0.7957723818465449,1.0,3/42,1.52%,MEF2C;TBX2;MICAL2
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4654231550984647,-1.3319771398758842,0.11351351351351352,0.7516394467265014,1.0,5/21,4.91%,LRP1;PLTP;APOE;PTCH1;NFKBIA
prerank,keratan sulfate metabolic process (GO:0042339),-0.4175691368615586,-1.3317680079954577,0.09967845659163987,0.7490675154581958,1.0,15/31,23.36%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL1;B4GALT6;ST3GAL3;HEXA;FMOD;B4GALT4;GALNS;CHST2;SLC35D2;OMD;B3GNT2;B4GALT3
prerank,cellular protein catabolic process (GO:0044257),-0.36779903654188195,-1.3313715345738588,0.04411764705882353,0.747155840195089,1.0,20/59,20.63%,DENND3;RAB12;CTSL;CTSH;CASP8;MDM2;AFG1L;PRKN;AP2S1;CTSB;TCIRG1;YME1L1;CLPX;CHEK2;SIAH2;AP2A2;CLTA;BNIP3L;CLPP;CTSS
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.3212951668000243,-1.3310160342989141,0.011363636363636364,0.7451229456760727,1.0,35/128,13.67%,BMP6;TGFBR3;SMAD3;APPL2;DDX5;BMP7;BMP4;COL1A2;CDH5;PXN;SMAD6;ENG;PTK2;RUNX2;ACVRL1;RGMB;BMPR2;MEGF8;ID1;SMAD9;CLDN5;ZMIZ1;FURIN;FKBP1A;SMURF2;ZMIZ2;TMEM100;TGFB1;PDCD4;UBC;STUB1;TGFBR1;ZYX;ARHGEF18;APPL1
prerank,lamellipodium assembly (GO:0030032),0.5762974419497475,1.3307699506267843,0.16358024691358025,0.7986265858653092,1.0,7/26,9.05%,ARHGEF7;VCL;CDH13;ITGB1;CYFIP1;WHAMM;ARHGEF4
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.4999279197993221,-1.3307106117275878,0.12839506172839507,0.7430075957169017,1.0,4/16,24.31%,CLDN5;CLDN11;CLDN1;CLDN14
prerank,embryonic limb morphogenesis (GO:0030326),0.5431064182418696,1.330597947411476,0.13908205841446453,0.7974308574387297,1.0,7/34,10.15%,MAP3K20;CACNA1C;TBX2;OSR2;TGFB2;SKI;MBNL1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.33669063821842615,-1.330448955048779,0.05063291139240506,0.7406841822075995,1.0,24/87,13.67%,TGFBR3;SMAD3;APPL2;COL1A2;CDH5;PXN;SMAD6;ENG;PTK2;ACVRL1;ID1;SMAD9;CLDN5;ZMIZ1;FURIN;FKBP1A;ZMIZ2;TGFB1;UBC;TGFBR1;ZYX;ARHGEF18;FMOD;APPL1
prerank,positive regulation of gene expression (GO:0010628),0.4350455967674682,1.330362620398456,0.021105527638190954,0.7964403579820909,1.0,52/442,8.44%,MYOM1;ACTA2;MYLK2;TTN;ACTG2;MEF2C;NTRK3;RBM24;HEY2;ACTA1;ANGPT1;ROCK1;FGF1;CD36;POLR2L;LIMS1;MYD88;PDGFB;VIM;GABPA;HINFP;SAMD4A;ACTG1;NAT10;MUSK;RBMS3;UBR5;ACTB;OSR2;SLC38A2;EMILIN1;DYRK1A;TESC;U2AF2;MYBBP1A;TP53;SLC2A10;VEGFA;RPS27L;CIRBP;AR;PPARGC1A;MED1;CELF1;YAP1;NAT8;ERCC6;C1QTNF1;SOX9;PYM1;CUX2;TENT4A
prerank,cell junction assembly (GO:0034329),0.46594668115145926,1.3298448438516945,0.13058419243986255,0.796597291807016,1.0,19/100,8.70%,FLNA;CDH6;IGFN1;LIMS1;GJC1;FERMT2;FZD5;PLXND1;ACTG1;FLNC;KIRREL3;ACTB;CDHR3;PCDHB14;DSCAM;LIMS2;TLN1;PCDHB11;CDH2
prerank,regulation of cytoskeleton organization (GO:0051493),0.4680396033856407,1.3293008060638631,0.10919540229885058,0.796726858630533,1.0,30/108,17.16%,NEXN;DLC1;ROCK1;PHLDB2;PLXNB1;RHOBTB3;BICD2;MAPT;TPPP;ARHGAP17;RHOF;CAPN2;PAK2;PDGFRB;PDGFA;ROCK2;PRKCD;RHOH;ARHGAP35;RICTOR;DMTN;CLASP1;MAPK1;PRKAA2;RHOG;CDK2AP2;CLIC4;S100A8;S100A9;MARK2
prerank,positive regulation of response to wounding (GO:1903036),0.5675627918341489,1.3291909974366778,0.17061611374407584,0.7953086455237688,1.0,5/24,3.63%,MYLK;ANXA1;KANK1;ACTG1;ITGB1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3878621012034591,-1.3291113997858104,0.09486166007905138,0.7430438690584317,1.0,13/44,15.51%,NF1;BMP7;BMP4;APOE;STK38;PIK3CB;PTPN22;IRAK3;PDCD4;LYN;SPRY2;AIDA;DUSP1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.5095922336442846,1.3286661396772557,0.13486005089058525,0.7953894551286431,1.0,4/47,6.81%,SERPINB8;SERPINI1;SERPINE2;TIMP4
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5103598970323164,1.3285000923066925,0.13411458333333334,0.7942026011025751,1.0,8/49,8.05%,MYL9;MEF2C;THPO;CBFB;CNOT4;PRKCQ;TESC;KMT2D
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6341691979636981,1.3283358150489062,0.1795774647887324,0.7930271091352851,1.0,2/12,2.86%,CD36;SLC5A3
prerank,protein targeting to ER (GO:0045047),-0.3346509823615218,-1.326843070669048,0.040983606557377046,0.7485799184391786,1.0,44/99,25.39%,SEC62;RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;SRPRB;RPS13;SEC63;RPLP0;SGTA;RPS29;RPL28;RPS10;RPLP1;SGTB;RPS20;RPL23A;RPL34;RPL36A;RPS8;RPS21;RPL9;SEC61A1;RPS7;RPL27;RPL11;SRPRA;SRP9;RPL18A;RPL37A;RPL38;ZFAND2A;RPL29;RPL10A;CHMP4B;CHMP4A;RPL32;SPCS1;RPS4X;RPS27
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.574207581730534,1.3266229340373852,0.1712121212121212,0.7973944915034863,1.0,6/24,6.50%,ROCK1;LIMS1;FERMT2;MAPRE2;DUSP3;VEGFA
prerank,C4-dicarboxylate transport (GO:0015740),-0.5093002957276683,-1.3265020411341244,0.1386861313868613,0.7464867119626338,1.0,10/14,31.80%,SLC25A14;SLC25A30;SLC25A11;LRRC8D;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC13A5;SLC1A6
prerank,regulation of stress fiber assembly (GO:0051492),0.4828238992724022,1.3263047247357105,0.1347517730496454,0.7967676641166648,1.0,11/74,4.86%,TPM1;DLC1;ROCK1;SYNPO2L;FERMT2;PHLDB2;CLASP2;ACTG1;TGFB3;PPM1E;ARHGAP6
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5399112840734922,1.326175173468654,0.15683453237410072,0.7955054311057356,1.0,5/33,5.38%,MEF2C;ATP2B4;ANGPT2;ANGPT4;MMRN2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5335222995759409,1.3253161420548023,0.15083798882681565,0.7966708692355863,1.0,6/33,6.51%,ATP2B4;TCIM;FAM83D;MN1;TAF1;FBXW7
prerank,negative regulation of heart contraction (GO:0045822),0.65549386010284,1.3248846742888611,0.18596491228070175,0.7964478629333669,1.0,1/11,0.13%,PLN
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5844808374350114,-1.3245654260219009,0.12723214285714285,0.7509007008682733,1.0,5/10,21.44%,APP;RAB5A;SHANK3;SYP;DRD2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.466975035603299,1.3241120659448207,0.11350737797956867,0.797347331111947,1.0,19/104,10.68%,ASPN;PRDM16;RBPMS2;VASN;CRIM1;FST;ACVR2A;TGFB1I1;BMPR1A;EMILIN1;CAV1;SLC2A10;PPM1A;PIN1;PPARA;ADAM17;SKI;VWC2L;UBE2D1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.4377601732612979,-1.324038032223027,0.07621951219512195,0.7497297233171973,1.0,11/26,22.94%,SPTLC2;ACER2;CYP1B1;NOS3;ASAH2;GCH1;AKT1;DDAH2;SPR;ABCA2;SPHK1
prerank,protein localization to cell junction (GO:1902414),-0.4511098165497017,-1.3238667369321018,0.10684931506849316,0.7471910364618919,1.0,9/22,15.29%,TJP1;CGNL1;TJP2;HEG1;NLGN1;NECTIN1;ARHGEF18;NLGN2;PCLO
prerank,vascular transport (GO:0010232),-0.3380393381699351,-1.3235180002591753,0.046357615894039736,0.7454423048956854,1.0,25/81,10.48%,SLC24A3;ATP1A2;SLC6A13;LEPR;SLC16A12;SLC1A3;SLC13A3;LRP1;SLC22A8;ABCG2;SLC2A13;ATP8A1;SLC2A1;SLC12A2;SLCO2B1;SLC6A1;SLC6A6;SLC16A1;SLCO1C1;SLC7A5;SLC6A9;SLCO3A1;ABCC4;ATP1B2;SLC5A5
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.6158767786746577,1.3229238226429587,0.18494271685761046,0.799812343882286,1.0,2/15,2.51%,FGF1;SEMA5A
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.4090793005290054,-1.3226652164005448,0.10508474576271186,0.7455742295178803,1.0,10/31,11.77%,PDGFRA;HOXB3;HOXA3;DSCAML1;HOXB4;MEGF8;OSR1;FGFR2;SIX1;TGFBR1
prerank,hexose transmembrane transport (GO:0008645),0.5626459491846068,1.3219755868266128,0.17378048780487804,0.8014276588541595,1.0,3/21,6.45%,SLC2A4;SLC5A3;SLC2A10
prerank,positive regulation of acute inflammatory response (GO:0002675),0.6124603847120692,1.321590175451888,0.18213660245183888,0.8010228447309454,1.0,1/14,1.47%,PTGER3
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.44507372919650395,1.3212206948411713,0.10596026490066225,0.8005501770782668,1.0,33/140,11.60%,OBSCN;ARHGEF7;DLC1;KALRN;ABR;PLCE1;ARHGEF17;MYO9B;DEPDC1B;ITSN1;NET1;NUP62;ARHGAP21;ARHGAP10;ARHGEF16;CHN1;ARHGAP6;ARHGEF2;ARHGDIG;RHOJ;ARHGAP17;RHOF;ARHGAP39;ARHGAP30;ARHGEF4;ARHGAP1;ARHGAP12;VAV1;INPP5B;ARHGAP15;ARHGAP5;RHOH;ARHGAP35
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.4115311762521546,-1.3211209301220614,0.11986301369863013,0.7484151028084366,1.0,22/33,37.59%,STN1;MRE11;HSP90AB1;RAD50;ANKRD28;CTC1;PPP6R3;TERF2IP;WRAP53;TELO2;CDK2;DCLRE1B;GAR1;TINF2;PPP6C;NOP10;ZBTB48;ACD;RAD51;RPA1;RFC1;NHP2
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.546064381938017,-1.3210661547411442,0.13924050632911392,0.7454607384038765,1.0,10/11,44.05%,PARP11;PARP10;PARP3;PARP14;PARP12;PARP4;PARP16;PARP6;PARP8;PARP9
prerank,triglyceride biosynthetic process (GO:0019432),-0.474872764186393,-1.3206231729705202,0.1447721179624665,0.743859991316007,1.0,6/18,18.54%,AGMO;LPGAT1;LPIN2;PCK2;GPAM;LPIN3
prerank,proteoglycan metabolic process (GO:0006029),-0.43669044662418466,-1.3205181633246654,0.12852664576802508,0.7410954519890613,1.0,10/26,20.00%,IGF1;CHST11;SULF1;BMPR2;CHST9;CANT1;XYLT1;FOXL1;CHST12;B4GALT7
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.5141106297577466,-1.3201702678264613,0.1493975903614458,0.739307249364643,1.0,8/14,27.38%,ERN1;NCBP2;CPSF2;CPSF6;CSTF2T;CPSF4;CSTF2;CPSF1
prerank,sphingoid metabolic process (GO:0046519),-0.545389585058474,-1.3190253888552457,0.13480392156862744,0.7405447440823704,1.0,9/12,43.92%,NAAA;SGPP1;ASAH2;SPHK1;DEGS2;PLPP2;SPHK2;PLPP1;SPTLC3
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6264418927716914,1.318908315526752,0.18360655737704917,0.8053141144391396,1.0,5/16,6.96%,DLC1;PHLDB2;CLASP2;ARHGAP6;CORO1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6264418927716914,1.318908315526752,0.18360655737704917,0.8053141144391396,1.0,5/16,6.96%,DLC1;PHLDB2;CLASP2;ARHGAP6;CORO1C
prerank,cellular response to glucagon stimulus (GO:0071377),0.6062132548579477,1.3186620685937687,0.1765704584040747,0.804491431844121,1.0,7/17,9.47%,ADCY5;ADCY2;ADCY9;CYSLTR2;PRKACB;PRKAR1B;ADCY6
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.6255293877039431,1.3185370087512505,0.20535714285714285,0.803193154298968,1.0,3/13,4.75%,CACNA1H;SYT10;KCNB1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.5160273382575933,-1.318396339430491,0.13734939759036144,0.7399265622658387,1.0,7/14,21.87%,PIK3CA;NRP1;GAB1;KDR;VEGFC;VEGFB;FLT4
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5115066548208581,1.3182124206064934,0.15633423180592992,0.8025713700306726,1.0,2/46,0.44%,DGKB;DGKG
prerank,protein localization to cell periphery (GO:1990778),0.4536369713348548,1.3180114298001668,0.1061269146608315,0.8015536991620024,1.0,40/133,16.59%,CACNB2;FLNA;TSPAN32;FGF13;RAP1A;ROCK1;CLASP2;EHD2;KCNB1;FYB2;KCNIP3;TESC;ATP1B1;ZDHHC2;CAV1;TTC7A;RAB3A;RAMP1;RAPGEF6;LIN7C;EPHA2;RAP2A;ACTN2;ROCK2;DPP10;TMEM88;TNIK;PACSIN1;RAB40C;SLMAP;GAS6;TSPAN17;RAB34;RAB8B;FLOT1;PRAM1;ANK1;LIN7A;SMURF1;RAB8A
prerank,regulation of telomere maintenance (GO:0032204),-0.43648250215937573,-1.3177067467596308,0.10434782608695652,0.7394514934240033,1.0,15/26,25.44%,XRCC5;SMG1;MRE11;PML;RAD50;USP7;GNL3;NBN;HNRNPD;TERF2IP;SMG6;YLPM1;ERCC1;ERCC4;TINF2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.48040522911477784,1.316820418311582,0.12440191387559808,0.8040726398238599,1.0,16/75,11.23%,MEF2C;SDC2;MAP1B;CDHR1;SLITRK5;ACTB;KLF7;MEF2A;SLITRK4;AFG3L2;RAB3A;BRSK1;S100A6;TBCD;RB1;ZDHHC17
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.42423386284331976,-1.3167350496480914,0.08996539792387544,0.7400498693426972,1.0,17/29,28.65%,DCPS;LSM1;DIS3;EXOSC1;DCP2;EXOSC9;EDC4;LSM7;EXOSC2;EDC3;LSM2;LSM5;EXOSC7;EXOSC3;EXOSC5;LSM3;LSM6
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.4880610769612149,1.3163905616893155,0.14846625766871166,0.8037696555810407,1.0,16/65,12.03%,ARHGEF7;HIP1;ITGA1;CDH13;BCAR3;NUP62;DAB2IP;DUSP3;DOK1;NEU3;AREG;DGKD;HBEGF;STAM2;GPER1;TSG101
prerank,protein import into mitochondrial matrix (GO:0030150),-0.4808889195177375,-1.3158220314789033,0.13744075829383887,0.7402670927532351,1.0,12/18,40.30%,TIMM44;DNAJC19;TIMM17B;TOMM70;TIMM21;TIMM23;GRPEL1;DNLZ;TOMM40L;TOMM40;TIMM50;GRPEL2
prerank,negative regulation of leukocyte migration (GO:0002686),0.6532571876263572,1.3157766248180913,0.1956521739130435,0.8042989870687625,1.0,4/10,8.34%,EMILIN1;CD200R1;CD200;CD300A
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.618995584852378,1.3144719985044964,0.17993079584775087,0.8070744221932162,1.0,9/13,19.53%,UBA2;ATG7;SAE1;UBA3;SENP6;UBA1;DESI2;DESI1;ATG10
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.4927335317502953,1.3140288922312655,0.14904458598726114,0.8069690240228453,1.0,6/54,2.09%,MEF2C;ATP2B4;ANGPT2;ANGPT1;ANGPT4;PDGFB
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.4239658549464351,-1.313751829177627,0.12615384615384614,0.7449002621754256,1.0,11/29,20.83%,SMAD3;AGO3;SRRT;PUM1;METTL3;ADAR;SMAD2;ZC3H7A;TUT4;TUT7;ZC3H7B
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5341030504616711,-1.3133661213973669,0.15102974828375287,0.7433756444985641,1.0,5/12,16.54%,F3;APOD;SNCA;HGS;NDRG4
prerank,peptidyl-amino acid modification (GO:0018193),-0.5557855922460038,-1.3132088603297671,0.15883668903803133,0.7409515091309167,1.0,3/10,11.03%,METAP1D;TTLL4;FKBP10
prerank,sodium ion transport (GO:0006814),0.46334451513831704,1.3125892109281854,0.12440191387559808,0.8103667486674837,1.0,10/85,3.95%,FGF13;SCN4A;ASIC3;SLC6A17;ANO6;SLC8A2;SLC8A1;SLC4A8;SLC6A2;SLC6A5
prerank,synapse organization (GO:0050808),0.45670814572474666,1.3123003938011342,0.10491071428571429,0.8096358720606969,1.0,24/125,8.70%,CACNB2;MYOT;IGFN1;FZD5;PLXND1;SLC8A2;PDZRN3;MUSK;CACNB4;KIRREL3;PTPRS;DOK7;GPC4;PPFIBP2;PCDHB14;PTPRF;MAPT;DSCAM;PIN1;NEDD4;CYFIP1;PCDHB11;ARHGAP39;CDH2
prerank,positive regulation of hydrolase activity (GO:0051345),0.4511693026557685,1.3122329950196776,0.11339092872570194,0.8081765149391771,1.0,23/137,8.17%,ARHGEF7;RAP1A;RGS6;LIMS1;RASGRP2;FERMT2;DOCK8;PLXNB1;BCAR3;DOCK10;ITGB1;CCL5;NET1;TBC1D20;RSU1;LARS1;MAPRE2;PIN1;CD200;CALM1;RAPGEF6;RASGRP1;EVI5
prerank,neuromuscular process (GO:0050905),-0.4794416731698192,-1.31210856448183,0.14719626168224298,0.7421322730374391,1.0,7/16,25.88%,MYCBP2;PAFAH1B1;NRXN1;GCH1;CLN3;TPP1;UBA5
prerank,axon guidance (GO:0007411),0.43795218878619785,1.3119492516689544,0.07740585774058577,0.8074167132148453,1.0,26/201,7.09%,NTN4;NEXN;SLIT3;SLIT1;NOTCH3;PALLD;ENAH;MYPN;ROBO3;LAMA5;SEMA5A;PLXND1;PLXNB1;NTN1;PDLIM7;CHN1;SEMA6C;KLF7;PRKCQ;DOK4;DSCAM;DOK2;VEGFA;DOK1;GDNF;CYFIP1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.464482398673619,-1.3114363060523317,0.14361702127659576,0.7415899624754536,1.0,5/19,18.64%,IGF1;PYDC1;CX3CL1;GIT1;ZC3H12A
prerank,regulation of DNA repair (GO:0006282),-0.38649987011716846,-1.3114359377668194,0.08812260536398467,0.7385923408282595,1.0,9/44,9.53%,EYA2;EYA1;EYA4;TRIP12;EGFR;PML;SIRT7;SMCHD1;BRCC3
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.6473447376503166,1.3111900582828004,0.1960431654676259,0.8084284648312695,1.0,2/11,3.06%,ANXA1;SOCS5
prerank,dorsal/ventral pattern formation (GO:0009953),-0.4615534656088699,-1.3096390613956996,0.12256267409470752,0.7425646961698928,1.0,5/20,4.13%,NBL1;GLI2;PTCH1;DSCAML1;ACVRL1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6367746792814275,1.3093618997301693,0.1872852233676976,0.8129538106235037,1.0,4/13,3.63%,CD36;CDH13;LPL;ITGB1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6044551350910561,1.3091127373339262,0.18887015177065766,0.8120988307829546,1.0,2/16,6.50%,AGTR1;VEGFA
prerank,regulation of cell adhesion (GO:0030155),0.44937437205916647,1.3087766673716474,0.1197339246119734,0.8115358422813106,1.0,20/129,6.97%,TPM1;PPP1R12A;ZFHX3;ANGPT1;ROCK1;PPP3CA;SEMA5A;PLXND1;PLXNB1;CDH13;CYTIP;CCL5;RSU1;ARHGDIG;TESC;CBLL1;ZDHHC2;DSCAM;VEGFA;YTHDF2
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.6486738295579615,1.3081590293647163,0.17989417989417988,0.8120426410193267,1.0,1/11,0.93%,AKAP6
prerank,respiratory chain complex IV assembly (GO:0008535),-0.45383946678653025,-1.3080203320341774,0.1347708894878706,0.7458573300238786,1.0,14/21,35.38%,COA8;COX10;COX20;SMIM20;COX14;TIMM21;BCS1L;COX17;COX16;COA3;SURF1;COA6;COX18;FASTKD3
prerank,regulation of endocytic recycling (GO:2001135),0.6480538223167238,1.3077880958983938,0.21869488536155202,0.8116095525113948,1.0,4/11,9.97%,PLA2G3;EHD2;ARHGAP1;ACTN2
prerank,regulation of hemopoiesis (GO:1903706),-0.5597336506463026,-1.307248138043939,0.17298578199052134,0.745836278400048,1.0,2/10,0.40%,PTN;PRKCB
prerank,negative regulation of developmental growth (GO:0048640),0.5422178647537894,1.3067951892990155,0.1732394366197183,0.8132853272457811,1.0,3/30,4.99%,FGF13;NKD1;PTPRS
prerank,histone monoubiquitination (GO:0010390),-0.4287672346236435,-1.3067886155384985,0.13095238095238096,0.7446379788996929,1.0,7/24,16.65%,RNF20;RYBP;CTR9;DDB1;DTX3L;LEO1;BCOR
prerank,regulation of vasoconstriction (GO:0019229),0.5609410036203573,1.306621939370771,0.16842105263157894,0.8122206458867794,1.0,5/27,8.74%,AGTR1;ADRA1D;CAV1;ATP2B1;TRPM4
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5544685154986346,-1.3062736886404012,0.15502183406113537,0.7438276447330799,1.0,4/10,12.71%,UFD1;SEC14L1;RIOK3;RNF125
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.4730305689349833,1.3043966545539911,0.1440677966101695,0.8184612083850958,1.0,14/75,11.28%,MYOCD;SLC8A1;NR2F2;DAB2IP;PKIB;HEXIM1;PTPN1;PKIA;CD300A;PRKAR1B;GSTP1;RB1;LRP5;PRKCD
prerank,regulation of amyloid fibril formation (GO:1905906),-0.49386793985160793,-1.304166008933291,0.16705882352941176,0.7487804875960175,1.0,4/15,6.93%,APOE;APP;LDLR;IAPP
prerank,actin polymerization or depolymerization (GO:0008154),0.4944316539206646,1.3035169346147657,0.15782493368700265,0.8198295592451654,1.0,7/50,8.53%,ENAH;DSTN;MICAL2;WDR1;ARHGAP6;CFL2;SPIRE1
prerank,catecholamine biosynthetic process (GO:0042423),-0.5322651238772429,-1.3033912853233274,0.15815085158150852,0.7487389880103212,1.0,4/11,18.31%,MOXD1;SNCA;GCH1;DDC
prerank,Golgi to plasma membrane transport (GO:0006893),-0.36485897097561387,-1.3025212959764718,0.09917355371900827,0.7489148277706765,1.0,12/47,17.50%,SPTBN1;VAMP5;RABEP1;GOLGA4;COMMD1;OPTN;GCC2;GOLPH3;BLZF1;EXOC2;STEAP2;EXOC1
prerank,epithelial tube morphogenesis (GO:0060562),0.5367987770215024,1.3020546834832971,0.1793400286944046,0.823406310181937,1.0,3/32,0.87%,RYR2;MEF2C;COL4A1
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.4238178534206881,-1.3018565933548438,0.13043478260869565,0.7486063694081091,1.0,13/26,23.36%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL1;B4GALT6;ST3GAL3;FMOD;B4GALT4;CHST2;SLC35D2;OMD;B3GNT2;B4GALT3
prerank,negative regulation of neuron death (GO:1901215),0.45428750466466483,1.301727575154793,0.14153132250580047,0.8227711367702389,1.0,13/93,7.62%,NTF3;MEF2C;PLA2G3;CRLF1;TGFB3;INPP5A;SET;BCL2;CD200R1;GDNF;CD200;PPARGC1A;FZD9
prerank,negative regulation of microtubule polymerization (GO:0031115),0.6155157006083715,1.3012814028548843,0.20976491862567812,0.8224910554964772,1.0,5/12,14.26%,ARHGEF7;DYRK1A;TBCD;CLIP3;STMN2
prerank,neuronal action potential (GO:0019228),0.5677267434554093,1.3008665021492125,0.16938110749185667,0.8221821791209015,1.0,2/22,1.95%,SCN4A;CACNA1H
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.4677390922590968,-1.3006720344812348,0.15577889447236182,0.7500916325380598,1.0,6/17,4.01%,DOCK4;IGF1;DOCK5;VTN;NRP1;ADAMTS1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.368562956197225,-1.3004995593571618,0.0873015873015873,0.7478140810761276,1.0,17/46,15.11%,ATP1A2;TSHZ3;GRM3;GRM7;NLGN1;PTK2B;SHANK3;SYT1;DGKI;CACNG4;NRXN1;GRIK3;OPHN1;GRM5;NLGN2;NLGN3;CLN3
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.6414344463747512,1.299735148789707,0.21153846153846154,0.8245074994203914,1.0,1/10,0.13%,PLN
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.44177358538621764,-1.2994353936239567,0.13672922252010725,0.7490909097460628,1.0,12/24,31.53%,APOE;EPHA4;PTK2B;UBE3A;GPX1;NUB1;PSME3;UBB;PSME1;CTSC;USP14;PSME2
prerank,excitatory postsynaptic potential (GO:0060079),0.5932306914772865,1.2991988639716532,0.19391025641025642,0.8246281207361872,1.0,2/19,2.87%,MEF2C;GRIN2C
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.45579181897214505,1.2984617680675097,0.12485811577752554,0.8254716981505689,1.0,23/102,11.28%,LHCGR;SLC2A4;ADCY5;ADCY2;NR4A1;ADCY9;HDAC9;TSHR;CYSLTR2;IRS1;CAV1;SORBS1;CPEB1;PARP1;GOT1;RELA;PRKACB;PRKAR1B;NR4A2;ADCY6;SLC39A14;GPER1;PRKCD
prerank,triglyceride catabolic process (GO:0019433),0.5645236912563808,1.2979568725278263,0.19967532467532467,0.8255824553328204,1.0,3/19,13.34%,LPL;FABP4;PNPLA3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5215030955873668,1.2969611434474027,0.17503392130257803,0.8275024061603384,1.0,15/37,18.37%,ROCK1;PHLDB2;CLASP2;BICD2;MAPRE2;MAPT;TPPP;CLASP1;STMN2;PRKAA2;MAPRE3;CDK2AP2;MARK2;BICD1;MAP6
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.621486957324101,1.296845280542643,0.20795660036166366,0.8262056047176907,1.0,6/13,7.03%,MMRN2;EMILIN1;EPN2;DAB2IP;PTPN1;NEDD4
prerank,presynapse organization (GO:0099172),-0.5578715523388242,-1.2963429978942196,0.15524193548387097,0.75792507626697,1.0,4/10,14.47%,WNT5A;NLGN1;NLGN2;NLGN3
prerank,regulation of vasculogenesis (GO:2001212),0.6247270209252015,1.2963257876216319,0.19055944055944055,0.8263880082339,1.0,4/14,8.34%,RAP1A;HEY2;RRAS;RIN2
prerank,sterol metabolic process (GO:0016125),-0.34991256303009377,-1.2962586782355063,0.10267857142857142,0.7553053525416886,1.0,33/60,36.87%,PRKAG2;CYP27A1;APOE;ABCA1;LBR;CYP26B1;CYP1B1;CYP51A1;HMGCR;SOAT1;ARV1;INSIG1;PIP4P1;SQLE;GBA2;PMVK;LIPA;FDXR;CLN8;RXRA;INSIG2;EBP;TSKU;PPARD;ANGPTL3;ABCA5;CLN6;SC5D;TM7SF2;SCAP;DHCR7;CH25H;LCAT
prerank,mesenchyme morphogenesis (GO:0072132),0.5844974476918364,1.2961482565222062,0.19935691318327975,0.8253398346642634,1.0,5/17,7.86%,TBX2;HEYL;BMPR1A;SOX9;TGFB2
prerank,phospholipid transport (GO:0015914),-0.3609387510436303,-1.295612584166426,0.10434782608695652,0.7548312663546644,1.0,13/52,8.34%,OSBPL8;PITPNA;ATP8A1;PLTP;APOE;ABCA1;ABCA4;LDLR;ATP11C;ATP8A2;SCARB2;PITPNC1;TMEM30A
prerank,regulation of innate immune response (GO:0045088),-0.35185063567348324,-1.2947872825709812,0.09734513274336283,0.754862194318406,1.0,37/57,38.59%,APPL2;IFNAR2;PTPN11;RNF135;POLR3F;CASP8;HSP90AB1;BIRC2;PTPN22;IRAK3;SAMHD1;RIOK3;POLR3B;LRP8;APPL1;BIRC3;TIRAP;SLC15A4;GBP5;RNASEL;TRIM21;POLR3C;NLRC3;POLR3D;USP18;TNFAIP3;NMI;TYRO3;LYAR;PTPN6;PLSCR1;DHX58;ADAM8;XIAP;IRF1;FGR;FCGR2B
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.49534980920434446,-1.2944700831878115,0.14218009478672985,0.753153523997447,1.0,7/15,18.63%,SEL1L;DERL1;UFD1;HSP90B1;OS9;SYVN1;HERPUD1
prerank,negative regulation of peptidase activity (GO:0010466),0.49831343392076355,1.2924726938004607,0.15315315315315314,0.8365476126828046,1.0,4/47,6.81%,SERPINB8;SERPINI1;SERPINE2;TIMP4
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.41064750915944875,-1.292106562625466,0.11009174311926606,0.7593264400956926,1.0,11/30,19.27%,DDX3X;TNFSF10;CASP8;BCL2L1;NOS3;RNF34;FAIM;GPX1;SERPINE1;TMBIM1;PARK7
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5908398928294265,1.292086495389399,0.19865319865319866,0.836187461195495,1.0,5/16,8.04%,MEF2C;RBM24;SMYD1;BTG1;PLCB1
prerank,monosaccharide transmembrane transport (GO:0015749),0.5859774083651803,1.2919090465911474,0.20166666666666666,0.8351205141473964,1.0,4/16,8.04%,SLC5A3;SLC2A10;SLC23A2;SLC23A1
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.3478967213725318,-1.2917971182233297,0.091324200913242,0.7576890824077407,1.0,18/61,17.43%,EYA2;EYA1;EYA4;HMGB1;EGFR;MRE11;PML;RAD50;PARP3;USP7;SMCHD1;BRCC3;RGCC;GNL3;NBN;FGF2;NPAS2;WRAP53
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.48444775862564615,-1.2915346219680155,0.16791979949874686,0.755790582199287,1.0,10/17,19.77%,ROBO1;EFNB2;SLIT2;NRP1;PIK3R3;KDR;AKT1;FGF2;EPHB4;MIA3
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.5085748416614252,-1.2914765264891084,0.17142857142857143,0.7531593817865938,1.0,10/13,44.77%,B3GALNT1;B3GNT2;B3GALT2;B3GALT1;B3GNT9;B3GNT3;B3GNT8;GAL3ST3;B3GNT6;B4GAT1
prerank,regulation of protein localization to cell surface (GO:2000008),-0.3906036575884409,-1.2914676219923793,0.12413793103448276,0.7503901718518105,1.0,16/33,28.23%,NEDD4L;STX3;GBF1;CTNNB1;HSP90AB1;STX4;COMMD1;RAB11FIP5;ABCA2;RIC3;LEPROTL1;KCNAB2;TOR1A;HFE;EGF;TAX1BP3
prerank,regulation of neuron differentiation (GO:0045664),0.4706303869669049,1.2910159046294045,0.14993954050785974,0.8364650323877301,1.0,7/76,5.09%,NTF3;MEF2C;ZFHX3;ROCK1;HEYL;MMD;ARHGEF2
prerank,gliogenesis (GO:0042063),0.5903930418488905,1.2903416996967743,0.19370860927152317,0.8370276988162361,1.0,5/15,11.79%,CDK6;ANXA1;TGFB2;CDH2;NDUFS2
prerank,regulation of gastrulation (GO:0010470),0.6057073744037065,1.2903068688340902,0.19382504288164665,0.8354924520934001,1.0,2/14,2.63%,PHLDB2;CLASP2
prerank,Golgi inheritance (GO:0048313),-0.5378634289342319,-1.2895115225108749,0.15827338129496402,0.7550809969729947,1.0,6/11,23.80%,GBF1;STX5;VCPIP1;STK25;YWHAZ;PLK5
prerank,positive regulation of peptidase activity (GO:0010952),-0.45677068006775856,-1.28930221033054,0.14804469273743018,0.7531158698694244,1.0,11/20,35.23%,CTSH;APH1A;RCN3;NCSTN;APH1B;GRN;PSME3;PSENEN;PSME1;PSME2;NDUFA13
prerank,female gonad development (GO:0008585),0.5578321719636071,1.2892024679165819,0.1767515923566879,0.8377323977855462,1.0,4/19,10.61%,LHCGR;NR2F2;VEGFA;NUP107
prerank,synaptic vesicle endocytosis (GO:0048488),-0.399594657955083,-1.2876936504060195,0.11971830985915492,0.7561821948103524,1.0,13/33,16.01%,DNM3;FCHO2;DNAJC6;NLGN1;SYT1;CANX;DNM1;STON2;OPHN1;SNCA;NLGN2;NLGN3;STX1A
prerank,necroptotic process (GO:0070266),0.589511262952373,1.287542874555742,0.20627062706270627,0.8418443216331782,1.0,3/16,10.73%,ITPK1;CD14;DNM1L
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.45590168327287833,1.2869848013822693,0.13450292397660818,0.8419995154620731,1.0,13/90,7.65%,PRDM16;PRKAB2;CD36;PDGFC;EBF2;TSHR;CAV1;VEGFA;TRPV2;FABP4;PPARGC1A;PPARGC1B;DIO2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.6157996354439964,1.286575673092813,0.20701754385964913,0.8417967394133932,1.0,6/11,12.63%,MAP3K5;ARL6IP5;STK24;PRKCD;DIABLO;PDCD10
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.3527462354130879,-1.28567620675072,0.08755760368663594,0.7613307401614239,1.0,24/58,25.05%,HMGB1;KDM2A;PRKDC;XRCC5;MRE11;RAD50;HERC2;BRCC3;LIG3;MDC1;POLM;XRCC6;NBN;SMC5;ATM;DCLRE1A;IFFO1;UVRAG;NSMCE2;PRPF19;SMARCAL1;ERCC1;ERCC4;DCLRE1B
prerank,macrophage differentiation (GO:0030225),-0.5076267866484354,-1.2856656106797404,0.17096018735362997,0.7585650522296511,1.0,4/13,7.13%,IL31RA;IL15;BMP4;CASP8
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5012002528573756,-1.2851771909844412,0.1813953488372093,0.7577889736084066,1.0,2/14,0.77%,ANK2;ATP1B3
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.48189643164709794,-1.285003988336487,0.1619047619047619,0.7556789951792585,1.0,5/15,23.38%,EDA;GLI2;HDAC2;WNT6;ANKRD11
prerank,negative regulation of hippo signaling (GO:0035331),0.6254426116550458,1.2849111361602767,0.2171628721541156,0.8458458209510853,1.0,2/12,1.88%,WTIP;LIMD1
prerank,neuromuscular process controlling balance (GO:0050885),-0.5170388298006993,-1.284783717074953,0.1662921348314607,0.75370751859053,1.0,8/12,39.00%,PAFAH1B1;NRXN1;CLN3;TPP1;PCDH15;CDH23;MYO7A;SHANK1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.5725053500096877,1.2846428170006579,0.21316614420062696,0.8451455084809104,1.0,5/18,13.52%,PMAIP1;BCL2;HEBP2;THEM4;MUL1
prerank,negative regulation of JNK cascade (GO:0046329),-0.4024801184360134,-1.2844282600378991,0.13609467455621302,0.752393992099631,1.0,13/31,24.18%,MECOM;ITCH;PTPN22;PRKN;PDCD4;SIRPA;SH3RF2;PER1;AIDA;HIPK3;DACT1;MAPK8IP1;CYLD
prerank,polyol metabolic process (GO:0019751),0.5005421933146249,1.2842840133836337,0.18989071038251365,0.8446758063126517,1.0,13/46,12.09%,ITPK1;PLCE1;INPP4B;PLCB4;SLC5A3;INPP5A;NUDT4;CALM1;PLCB1;INPPL1;PLCD1;INPP5B;ITPKC
prerank,positive regulation of axonogenesis (GO:0050772),-0.38108384617013713,-1.2837040167769114,0.11188811188811189,0.7524234419113941,1.0,9/43,8.24%,PLXNA2;ROBO1;SLIT2;SEMA7A;RUFY3;TIAM2;GOLGA4;SEMA4D;PLXNA4
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.4106663277394141,-1.2820456510030014,0.1510574018126888,0.7561615405657832,1.0,11/27,16.03%,FLT1;PDGFRA;KIT;TEK;PTK2;PTK2B;TGFB1;AMBRA1;EPHA8;TNFAIP8L3;FGF2
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.3868074139466982,-1.2806555783557299,0.14339622641509434,0.7583897412619,1.0,15/39,21.40%,BMP6;WNK1;NF2;PTK2;PODXL;CDH1;FXYD5;RDX;TGFB1;RGCC;PPM1F;AKT1;NOTCH4;MIA3;ASS1
prerank,cellular response to virus (GO:0098586),-0.408143520386264,-1.2802944561854288,0.13454545454545455,0.7570907684240076,1.0,12/30,18.66%,MAPK14;DDX3X;GSDME;LGALS9;GBF1;RIOK3;CHUK;IRGM;LGALS8;BAX;ZC3H12A;FMR1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.6101740401959285,1.2798308347775365,0.22282608695652173,0.8584712028107933,1.0,4/12,9.38%,GMNN;TIPIN;WRNIP1;KAT7
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5342460553588972,1.2797421115531644,0.18952234206471494,0.8570980279623941,1.0,6/25,9.97%,DMD;TRPC6;STAC;ATP1B1;WNK2;ACTN2
prerank,mitochondrion disassembly (GO:0061726),-0.39076907819016626,-1.2790065956248984,0.12418300653594772,0.7593082595865082,1.0,20/34,28.28%,RB1CC1;CISD2;ATG3;FBXO7;ATG5;PRKN;ATG2B;AMBRA1;WIPI2;ATG2A;FIS1;GABARAPL2;WDR45B;MAP1LC3A;ULK2;GABARAPL1;WIPI1;SQSTM1;MAP1LC3B;ATG12
prerank,intestinal lipid absorption (GO:0098856),0.6400951740941397,1.278981903692487,0.22304832713754646,0.8582435346397741,1.0,1/11,1.73%,CD36
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.381520768342423,-1.2788848154988468,0.11683848797250859,0.7570616594073669,1.0,14/39,11.13%,PIK3CA;PI4KA;PIK3R3;IP6K1;EFR3A;SMG1;SOCS7;PIP4K2B;PI4K2A;SOCS2;EFR3B;PIK3CB;TTC7B;IP6K2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5202117038462135,1.2777376836217593,0.18972895863052783,0.860831985570443,1.0,6/36,6.25%,MEF2C;ATP2B4;ANGPT2;ANGPT4;NR2F2;DAB2IP
prerank,cellular response to nitrogen compound (GO:1901699),0.5749950721182646,1.2777334190351084,0.19092331768388107,0.8591814751362421,1.0,2/20,1.64%,ATP2B4;NR1H4
prerank,blood vessel morphogenesis (GO:0048514),-0.3521742927807706,-1.2774524147558428,0.11764705882352941,0.7597057386325909,1.0,20/54,14.31%,TGFBR3;FLT1;NF1;EFNB2;LAMA1;CCBE1;RASA1;NRP1;ENG;ID1;CYP1B1;RASIP1;CUL7;TGFB1;HES1;ITGB8;TGFBR1;RAMP2;KDR;SOX17
prerank,positive regulation of mitochondrial translation (GO:0070131),0.6047619959572598,1.2773830959394379,0.2205128205128205,0.8587716526843446,1.0,9/14,20.37%,RPUSD3;TRMT10C;RCC1L;RPUSD4;FASTKD2;TRUB2;RMND1;UQCC2;C1QBP
prerank,cellular response to hormone stimulus (GO:0032870),0.46973314695667423,1.2767985309191363,0.1481028151774786,0.8591085826822755,1.0,9/69,7.29%,SLIT3;LHCGR;MEF2C;CACNA1H;CAV1;ARID5A;AR;RAMP1;MED1
prerank,axonogenesis (GO:0007409),0.42280894850461287,1.2761006013545733,0.08884297520661157,0.8599476924170121,1.0,27/237,7.09%,NTN4;NEXN;SLIT3;SLIT1;NOTCH3;PALLD;ENAH;MYPN;ROBO3;LAMA5;SEMA5A;MAP1B;PDLIM7;SLITRK5;ACTB;SEMA6C;KLF7;PRKCQ;SLITRK4;DOK4;DSCAM;DOK2;AFG3L2;DOK1;GDNF;RAB3A;CYFIP1
prerank,regulation of receptor binding (GO:1900120),0.6430516895277409,1.2759598366413323,0.24680073126142596,0.8587805880124169,1.0,4/10,10.32%,ATP2A2;GREM2;PTPRF;ATP2A3
prerank,regulation of lipid metabolic process (GO:0019216),0.45458749303088114,1.2741251087471093,0.1467780429594272,0.8636558663165751,1.0,19/88,15.95%,CCDC3;SMARCD3;ANGPTL8;RORA;RARRES2;CAV1;ACACB;IDI1;MED1;MVD;PPARA;NR1D1;SREBF2;TGS1;ZFP69;EDF1;IRS2;SIN3A;SP1
prerank,cell-cell junction assembly (GO:0007043),0.47322087467793833,1.2738205236489388,0.17530864197530865,0.8630815619628046,1.0,15/63,11.42%,CDH6;VCL;GJD3;GJC1;WDR1;ACTG1;ACTB;JAM3;CDHR3;TLN1;CDH2;PKN2;PAK2;TBCD;GJA4
prerank,cAMP metabolic process (GO:0046058),0.6312672324516967,1.2732235365640774,0.21651376146788992,0.8635753256420933,1.0,6/13,11.18%,ADCY5;ADCY2;ADCY9;ADCY6;EPHA2;PDE4D
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.43922061787373645,-1.2729681555641934,0.1619047619047619,0.7741260681679119,1.0,7/23,11.47%,PRKAG2;CEMIP;BMP7;APP;WNK3;TGFB1;IRGM
prerank,amino sugar metabolic process (GO:0006040),0.6391885971462898,1.2727022789381672,0.25475285171102663,0.863710259171721,1.0,4/10,10.21%,CSGALNACT1;GNE;GFPT1;ST6GAL1
prerank,presynaptic endocytosis (GO:0140238),-0.4298515902913953,-1.2723227203996665,0.15915915915915915,0.7738779533808207,1.0,10/24,16.01%,FCHO2;NLGN1;SYT1;CANX;STON2;OPHN1;SNCA;NLGN2;NLGN3;STX1A
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.46334414476521485,1.2716302142004752,0.1701093560145808,0.8658198573968959,1.0,6/73,6.50%,NTF3;NTRK3;ATP2B4;BCAR3;CAV1;VEGFA
prerank,oogenesis (GO:0048477),-0.49125324810590437,-1.271126299224248,0.19743589743589743,0.7756838624481912,1.0,3/15,8.81%,PTN;MARF1;METTL3
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5751482449591865,1.271117250800713,0.2280130293159609,0.8659709276622901,1.0,1/16,0.89%,ACSS1
prerank,somite development (GO:0061053),-0.5244951934744008,-1.2711069938685686,0.2076749435665914,0.7730527985748104,1.0,5/11,26.30%,PTCH1;MEOX2;SMO;LOXL3;SOX11
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.49928643258243777,-1.2691918361478671,0.1773049645390071,0.777114608510528,1.0,2/13,5.81%,NFAT5;IRAK1
prerank,T cell migration (GO:0072678),-0.4946348266574419,-1.2687833189905668,0.20374707259953162,0.7762122580527776,1.0,2/13,6.66%,SLC12A2;CXCL16
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.39910293047308476,-1.2670688015107994,0.14556962025316456,0.7799813958538451,1.0,16/32,26.51%,CDC14B;MRE11;RINT1;BRCC3;BLM;NBN;TAOK1;FOXN3;NOP53;ATM;HMGA2;TAOK2;TRIM39;CLSPN;CDKN1A;DONSON
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.34791893028424814,-1.2669286255405912,0.08450704225352113,0.7779180973258919,1.0,14/57,12.18%,IGF1;IL31RA;IL15;KIT;GHR;NF2;IL18;PPP2CA;ARL2BP;TNFRSF1A;IL6R;HES1;LYN;PARP14
prerank,C-terminal protein amino acid modification (GO:0018410),0.6150290610883511,1.2668169600273542,0.25457875457875456,0.879411547382501,1.0,2/11,5.48%,AGBL1;ATG7
prerank,regulation of neuroinflammatory response (GO:0150077),-0.45285339128125207,-1.2667876710039336,0.16101694915254236,0.7757887385417651,1.0,6/19,12.31%,IGF1;NUPR1;IL18;DAGLA;PTGS2;IL33
prerank,plasma membrane tubulation (GO:0097320),0.60358560404972,1.26618635475156,0.25,0.8799808418305954,1.0,6/13,12.60%,PACSIN3;PACSIN2;EHD2;WHAMM;PACSIN1;SNX9
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.380684941426335,-1.265861544820205,0.10606060606060606,0.7764916310941218,1.0,10/37,14.57%,PRKAG2;CEMIP;BMP7;APP;SPRED2;WNK3;TGFB1;IRGM;SPRY2;DGKQ
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.6005971470096862,1.2656433693231142,0.2171628721541156,0.8803244017823958,1.0,2/14,7.40%,AGTR1;ENPEP
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6077565667451458,1.2648272364194257,0.23198594024604569,0.881542007238247,1.0,3/13,5.14%,MEF2C;TBX2;BMPR1A
prerank,positive regulation of interleukin-17 production (GO:0032740),0.5490689624776239,1.2637307477273039,0.2064,0.8837668534442314,1.0,4/22,5.51%,NR1H4;MYD88;IL2;PRKCQ
prerank,negative regulation of histone methylation (GO:0031061),-0.5294519623983338,-1.2637099748919587,0.18733509234828497,0.7818079484709001,1.0,6/10,37.71%,BCOR;KDM1A;JARID2;BRCA1;DNMT3B;AASS
prerank,cAMP biosynthetic process (GO:0006171),0.6427649430629301,1.26335065376322,0.244140625,0.8834654169906596,1.0,4/10,9.47%,ADCY5;ADCY2;ADCY9;ADCY6
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5528002156318047,-1.2623461427029439,0.19686800894854586,0.7841112296043026,1.0,2/10,7.11%,WNT5A;CTNNB1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.5086447993122184,1.2620652784699469,0.2054794520547945,0.8863113353052225,1.0,5/32,7.09%,ARHGEF7;PLCE1;ACTR3;CORO1C;CYFIP1
prerank,lipoprotein catabolic process (GO:0042159),-0.5219867249089863,-1.26201242460972,0.19419642857142858,0.782764078082234,1.0,8/11,31.36%,APOE;LYPLA1;PPT1;NOTUM;ABHD17C;LYPLA2;CTSD;ABHD10
prerank,regulation of glycogen metabolic process (GO:0070873),0.6049076584580547,1.261804247141827,0.21739130434782608,0.8855838891018132,1.0,1/12,1.10%,PPP1R3A
prerank,membrane assembly (GO:0071709),-0.39469410108653796,-1.2617765069095248,0.15384615384615385,0.7809533962217657,1.0,10/34,15.07%,SPTBN1;ANXA2;SPAST;NLGN1;STX4;PTPRD;NRXN1;NLGN2;NLGN3;S100A10
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4267743133111597,1.261740333690617,0.13326110509209102,0.8841222466870564,1.0,20/152,9.65%,LHCGR;PTGER3;ADCY5;CRHR2;S1PR3;HTR1B;NPY1R;ADCY2;VIPR2;ADRA1D;ADCY9;TSHR;GNAO1;GNAZ;RAMP1;PRKACB;GNA12;PTH1R;ADCY6;ADGRL2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.5256598625253326,-1.2615961052896008,0.18571428571428572,0.7763667357992169,1.0,5/11,27.84%,AGO3;TNRC6A;NOTCH4;AGO4;ZFP36
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.5256598625253326,-1.2615961052896008,0.18571428571428572,0.7763667357992169,1.0,5/11,27.84%,AGO3;TNRC6A;NOTCH4;AGO4;ZFP36
prerank,positive regulation of cellular component movement (GO:0051272),0.531900800441072,1.2611942535127936,0.20030349013657056,0.8844005659872904,1.0,6/24,8.65%,ACTN4;CAVIN1;NTN1;VEGFA;TUBB2B;ADAM17
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.38093103431934533,-1.2610631220816133,0.13099041533546327,0.7757453486252912,1.0,10/32,16.29%,IGF1;ZBTB20;PID1;NUPR1;APP;ENTPD5;PFKFB2;ARNT;INSR;PRXL2C
prerank,cellular response to reactive oxygen species (GO:0034614),0.4689639595150265,1.2605882764261298,0.18508997429305912,0.884848586175098,1.0,14/59,14.25%,TPM1;MAP3K5;ANXA1;NET1;FXN;CAMKK2;MAPT;RELA;IMPACT;PRKCD;TRPM2;PDK2;MAPK1;PLEKHA1
prerank,protein polymerization (GO:0051258),0.4705087308105958,1.2602989967029399,0.1821656050955414,0.8841769849869441,1.0,9/55,8.53%,FGF13;CASQ1;ARHGAP6;MAP7D3;MAPT;TPPP;PIN1;HDGFL3;SPIRE1
prerank,regulation of synapse organization (GO:0050807),0.5346244901191021,1.2594797332141063,0.2094081942336874,0.8853484002869841,1.0,6/26,11.33%,MEF2C;PDLIM5;SLITRK4;NEDD4;ABHD17B;IL1RAPL1
prerank,negative regulation of secretion (GO:0051048),0.6221282481543511,1.2579088519435364,0.2490566037735849,0.8891098516649394,1.0,1/10,1.47%,PTGER3
prerank,activation of protein kinase activity (GO:0032147),0.44060473541798667,1.2566051854669862,0.1724537037037037,0.8920506961385726,1.0,25/106,13.74%,NTF3;NTRK3;ANGPT1;FGF1;ADCY5;PDGFB;ADCY2;ADCY9;VEGFA;TPX2;PIBF1;ITGB3;TGFB2;PRKACB;PRKAR1B;PAK2;ADCY6;PRR5;PRKCD;COPS8;RICTOR;TNIK;TAOK3;GAS6;TNFRSF10B
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5377400064311462,1.2565403136369189,0.19374068554396423,0.8906552064824803,1.0,15/28,20.86%,CLASP2;MAP1B;PRUNE1;MAPRE2;MAPT;CLASP1;STMN2;MAPRE3;FKBP4;MAP1A;MAP1S;ABL1;CAMSAP1;STMN3;MAPRE1
prerank,positive regulation of glycolytic process (GO:0045821),-0.44431482059201177,-1.2563446642133775,0.175,0.7884501720359164,1.0,10/20,21.64%,IGF1;ZBTB20;APP;ENTPD5;PFKFB2;ARNT;INSR;PRXL2C;PFKFB3;PRKAA1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.44431482059201177,-1.2563446642133775,0.175,0.7884501720359164,1.0,10/20,21.64%,IGF1;ZBTB20;APP;ENTPD5;PFKFB2;ARNT;INSR;PRXL2C;PFKFB3;PRKAA1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.5059350899220658,-1.2554251851560376,0.20665083135391923,0.7892545023344366,1.0,9/12,44.77%,B3GALNT1;B3GNT2;B3GALT2;B3GALT1;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.42304124497412854,1.2544192147098285,0.13268608414239483,0.896376854838707,1.0,35/166,13.03%,NOTCH3;NR1H4;CAVIN1;POLR2L;POLR2I;RORA;NR4A1;TEAD3;HDAC9;GTF2H4;NR2C1;POLR2G;TAF1;RXRG;TAF8;MAML2;AR;PPARGC1A;MED1;YAP1;MAML3;PPARA;NR4A2;NR1D1;CDK7;POLR1E;NAT14;NR2C2;TEAD1;TFB2M;ESRRA;POLR1H;NR6A1;SMARCA5;POLR2J
prerank,protein localization to plasma membrane (GO:0072659),0.4344847188902647,1.2542899062106276,0.14933628318584072,0.8952616911498831,1.0,18/129,7.19%,CACNB2;FLNA;TSPAN32;FGF13;RAP1A;ROCK1;CLASP2;EHD2;KCNB1;FYB2;KCNIP3;TESC;ATP1B1;ZDHHC2;TTC7A;RAB3A;RAMP1;RAPGEF6
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.3502480894473264,-1.2541859223151852,0.12093023255813953,0.7915618988482296,1.0,17/49,21.03%,LDLRAD4;HMGB1;DDX3X;SMAD6;HSPA5;IAPP;PYDC1;PEX5;RIOK3;EP300;AIDA;NOP53;CDC42;PMEPA1;HSF1;PARK7;DACT1
prerank,negative regulation of protein transport (GO:0051224),-0.4158187917489739,-1.2529407268454584,0.17455621301775148,0.7936203144312117,1.0,10/25,29.16%,APOE;ERP29;CYP51A1;HMGCR;PPM1F;PKDCC;SNX3;DRD2;SNX12;RHBDF2
prerank,regulation of interferon-beta production (GO:0032648),-0.35294657811683894,-1.2528569917900039,0.10619469026548672,0.791341801781262,1.0,18/46,25.15%,DDX3X;PTPN11;PPM1B;RNF135;POLR3F;RIOK3;POLR3B;POLR3A;SIRPA;RELB;TRIM56;TLR3;OAS2;TIRAP;POLR3C;TOMM70;NLRC3;POLR3D
prerank,protein O-linked glycosylation via serine (GO:0018242),0.6321947358004184,1.2527977245760735,0.25181159420289856,0.8989014694746349,1.0,4/10,14.21%,GALNT16;GALNT3;GALNT2;GALNT1
prerank,regulation of myoblast differentiation (GO:0045661),0.5155407822826794,1.2525889015027591,0.2106782106782107,0.8979788783686923,1.0,7/32,8.04%,MEF2C;RBM24;SMYD1;ANKRD2;BTG1;SOX9;PLCB1
prerank,regulation of gluconeogenesis (GO:0006111),-0.4045346744731248,-1.2525675983618307,0.14461538461538462,0.7898477389055726,1.0,12/27,23.13%,CRY1;USP7;SIRT7;SIK1;DDB1;OGT;EP300;DGKQ;C1QTNF3;PTPN2;CLK2;PGP
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.41993858573184195,-1.2522005661347289,0.16045845272206305,0.7887431266350643,1.0,9/24,11.12%,SEMA3D;SEMA3C;SEMA6A;NRP1;SEMA7A;MEGF8;SEMA3A;SEMA4D;SEMA6D
prerank,neuron migration (GO:0001764),0.48521325737375054,1.2519488556012737,0.2073490813648294,0.8985682055794925,1.0,10/48,9.10%,FGF13;MEF2C;ASTN2;MAP1B;MARK1;VEGFA;TUBB2B;CEP85L;ASTN1;NR4A2
prerank,ovarian follicle development (GO:0001541),0.5846876780404677,1.25166713960187,0.21578947368421053,0.8979289978522667,1.0,2/13,6.50%,LHCGR;VEGFA
prerank,ear morphogenesis (GO:0042471),-0.44482327589644677,-1.2514875901774067,0.20527859237536658,0.7888987516451996,1.0,9/20,26.21%,ZIC1;CHD7;OSR1;FGFR2;SIX1;MYO6;EPHB2;PAX8;TWIST1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.4476255641287863,1.2512840365645772,0.17990654205607476,0.897637820119531,1.0,21/88,15.51%,SYNPO2;SYNPO2L;EMILIN1;MPP7;TPPP;DAB2IP;VEGFA;TRABD2B;PLEK;SLX4;SYNPO;HRK;STX18;TSG101;CLU;FNIP2;CHMP2A;HYAL1;PRKCA;STAM;FLOT1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.5279664626447726,1.2512235710854145,0.2175226586102719,0.8962074605891776,1.0,8/25,15.82%,CHMP4C;SORT1;LYST;CHMP5;DENND10;CHMP2B;CHMP2A;LEPROT
prerank,positive regulation of metabolic process (GO:0009893),0.44003595364181153,1.2507030454072685,0.1632183908045977,0.8964363019851775,1.0,15/103,7.65%,PRDM16;PRKAB2;CD36;PDGFC;EBF2;TSHR;PIGA;CAV1;VEGFA;TRPV2;ACACB;FABP4;PPARGC1A;PPARGC1B;DIO2
prerank,regulation of platelet aggregation (GO:0090330),0.5714027945902379,1.2502737524197405,0.22990353697749197,0.8963420844095596,1.0,7/17,14.87%,PRKG1;SERPINE2;PRKCQ;C1QTNF1;PRKCD;DMTN;PRKCA
prerank,defense response to tumor cell (GO:0002357),0.6119187673360953,1.2497463600017331,0.26411290322580644,0.8965599068769413,1.0,2/10,4.20%,DLEC1;RBMS3
prerank,cellular response to cAMP (GO:0071320),0.5208751040728065,1.249219895635059,0.22594142259414227,0.8968613470750653,1.0,3/30,3.49%,RAP1A;AKAP6;IGFBP5
prerank,regulation of mast cell degranulation (GO:0043304),0.5964516129516554,1.2488020886464661,0.2456445993031359,0.8967173129284001,1.0,3/14,8.34%,STXBP2;UNC13D;CD300A
prerank,regulation of protein kinase C signaling (GO:0090036),0.5867638819548496,1.2487670040562175,0.25539568345323743,0.8952397323880369,1.0,4/14,11.09%,DGKG;VEGFA;DGKD;GPD1L
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.39333654635321996,-1.2480581057001006,0.17684887459807075,0.7990312216727032,1.0,11/29,16.03%,FLT1;PDGFRA;KIT;TEK;PTK2;PTK2B;TGFB1;AMBRA1;EPHA8;TNFAIP8L3;FGF2
prerank,gastrulation (GO:0007369),-0.48690546230681897,-1.247740152527889,0.18877551020408162,0.7976520601753041,1.0,6/15,25.08%,MEGF8;UGDH;LMBRD1;SMAD2;GPC3;MKKS
prerank,protein deacetylation (GO:0006476),0.4935026580742967,1.247562213294893,0.20110957004160887,0.8978908589258182,1.0,16/41,18.90%,FLNA;HDAC9;SIRT3;MSL3;MTA3;SIRT2;MIDEAS;BAZ2A;MORF4L1;SIRT4;MTA1;SIN3A;SIRT6;HDAC1;RBM14;HDAC6
prerank,presynapse assembly (GO:0099054),-0.4532754784244215,-1.2474433161234628,0.1855421686746988,0.7961654414766942,1.0,6/16,15.29%,WNT5A;NLGN1;PTPRD;NLGN2;NLGN3;PCLO
prerank,organic acid transport (GO:0015849),-0.311344123189731,-1.2470249925249621,0.0847457627118644,0.7952302465942321,1.0,19/94,9.39%,SLC7A11;SLC6A13;SLC13A3;ABCG2;PDPN;SLCO2B1;SLC6A12;SLC6A6;SLC26A7;SLC16A1;SLCO1C1;NCOA1;SLC25A17;SLC7A14;SLC3A2;SLC25A32;SLC22A6;SLC25A14;ABCC4
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.4601832585885354,-1.2465588076494845,0.20565552699228792,0.7944052986329229,1.0,3/16,5.81%,NFAT5;ST3GAL4;IRAK1
prerank,regulation of myotube differentiation (GO:0010830),0.5335337533509715,1.245887627068332,0.22473604826546004,0.9020605834717339,1.0,3/24,4.11%,RBM24;SMYD1;HDAC9
prerank,telomere maintenance (GO:0000723),-0.3387180605379845,-1.2447183015704053,0.10699588477366255,0.798804069409726,1.0,25/50,28.38%,ATR;PRKDC;XRCC5;STN1;MRE11;RAD50;PARP3;SP100;BLM;XRCC6;NBN;CTC1;SMC5;TPRKB;TERF2IP;LTO1;HUS1;ATM;NSMCE2;ERCC4;DCLRE1B;TINF2;RPA3;DNA2;TEN1
prerank,regulation of response to biotic stimulus (GO:0002831),-0.4019838315926559,-1.2442954005007723,0.16611295681063123,0.7978249687703198,1.0,13/28,14.62%,APPL2;FOXP1;RNF135;CD55;CASP8;BIRC2;PTPN22;SAMHD1;TRIM5;CX3CL1;LRP8;APPL1;BIRC3
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5674532658532023,1.244288917283488,0.25137614678899084,0.9060612126627202,1.0,5/15,10.88%,ROCK1;CAMK2D;MEF2A;PARP1;ROCK2
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.41989277479102377,-1.2442265923468558,0.16666666666666666,0.795556480416709,1.0,11/24,24.63%,NIBAN2;DACH1;XRCC5;ACVRL1;BMPR2;BLM;TERF2IP;MSH6;CDKN1A;ERCC1;ERCC4
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.43802275048306666,1.2441888994297396,0.17016317016317017,0.904816539273534,1.0,22/94,14.19%,ATP2A1;CRIP1;MAP3K5;PMAIP1;ITPR1;BCL2;CUL2;MYBBP1A;DAB2IP;ARL6IP5;TP53;BCL2L2;EPHA2;STK24;ATP2A3;PRKCD;BOK;DIABLO;FNIP2;PDK2;TNFRSF10B;MCL1
prerank,negative regulation of platelet activation (GO:0010544),0.5656568615125063,1.2437759441622078,0.2356687898089172,0.9047072608436202,1.0,6/16,11.28%,PRKG1;PDGFB;SERPINE2;C1QTNF1;PDGFA;PRKCD
prerank,protein homotetramerization (GO:0051289),0.4831244108875165,1.2436989735377144,0.19544846050870146,0.9033552264009432,1.0,10/49,12.48%,RYR1;KCNJ12;HSD17B10;CRYZ;ACACB;TRPM4;ALDOA;GLS;OSBPL2;TRPM2
prerank,positive regulation of protein acetylation (GO:1901985),-0.5045780667874414,-1.2427901684318463,0.19294117647058823,0.7984165692083733,1.0,6/12,28.00%,DDX3X;CAMK1;TAOK1;TERF2IP;PRKAA1;RAPGEF3
prerank,fatty acid transmembrane transport (GO:1902001),0.5517627197068322,1.2420644376150198,0.24247226624405704,0.9074830994197757,1.0,7/19,14.41%,PRKAB2;CD36;ACACB;CPT1B;ABCD4;CPT1A;PRKAA2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.4618988369295974,1.2417283275014845,0.20174346201743462,0.9069713928654585,1.0,7/63,4.50%,MEF2C;ANXA1;IL2;TNFSF13B;CCL5;CD276;BCL2
prerank,regulation of protein export from nucleus (GO:0046825),-0.42807285687918495,-1.2406684219185231,0.1794871794871795,0.8037603878264113,1.0,8/23,14.82%,PTPN14;TCF7L2;CAMK1;UHMK1;SIRT7;RANGAP1;SP100;EMD
prerank,programmed necrotic cell death (GO:0097300),0.553633033130962,1.2396323344806361,0.23322683706070288,0.9127383384918553,1.0,3/18,10.73%,ITPK1;CD14;DNM1L
prerank,response to hydrogen peroxide (GO:0042542),0.4805746071814438,1.2393569758437035,0.20670391061452514,0.9120166684304749,1.0,12/45,14.25%,MAP3K5;ANXA1;NET1;FXN;STK26;RELA;IMPACT;STK24;PRKCD;TRPM2;PDCD10;PLEKHA1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4219045845018131,1.2385410304897007,0.1686746987951807,0.9132816487164714,1.0,26/138,10.69%,NOTCH3;NR1H4;POLR2L;POLR2I;RORA;NR4A1;TEAD3;HDAC9;GTF2H4;NR2C1;POLR2G;TAF1;RXRG;TAF8;MAML2;AR;PPARGC1A;MED1;YAP1;MAML3;PPARA;NR4A2;NR1D1;CDK7;NR2C2;TEAD1
prerank,activin receptor signaling pathway (GO:0032924),0.573234476399629,1.2380756367465422,0.2467741935483871,0.9132653502330655,1.0,2/15,4.04%,HJV;ACVR2A
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.35897577063425684,-1.2371567962280874,0.15441176470588236,0.8144205772913398,1.0,6/41,9.05%,AFDN;TJP1;BMP7;PODXL;CD44;PIEZO1
prerank,regulation of autophagosome assembly (GO:2000785),-0.3794784800721487,-1.2371500469565675,0.16549295774647887,0.8119173776034183,1.0,17/33,24.88%,NUPR1;RAB5A;PIP4K2B;NPRL3;IFT88;RAB3GAP2;UBQLN2;SCFD1;RAB1B;RALB;TBC1D14;FEZ1;CHMP4B;CHMP4A;SMCR8;PHF23;LRSAM1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5408073299741379,-1.2369106945474537,0.22566371681415928,0.8102872534875741,1.0,3/10,9.30%,ADGRV1;WHRN;IFT88
prerank,negative regulation of immune response (GO:0050777),0.42010931581664956,1.2367670349035491,0.14193548387096774,0.9161511567254274,1.0,21/154,9.92%,LHCGR;GPR20;ADCY5;CRHR2;FCGR3A;ADCY2;VIPR2;MYH9;ADCY9;TSHR;HAVCR2;CYSLTR2;RAMP1;PRKACB;CD300A;ADAM17;PRKAR1B;PTH1R;ADCY6;SAMSN1;SIRT2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.41695200711447045,1.236489694032991,0.13138686131386862,0.9154977302580113,1.0,22/199,7.87%,MYOCD;MEF2C;ATP2B4;HEY2;VASN;ROCK1;NR1H4;ALPK2;ADAMTS5;LOXL2;PLCL1;HDAC9;ASB1;KLF7;TBX18;LNPEP;PROCR;SDHAF2;DAB2IP;CORO1C;SOX9;ATP2B1
prerank,negative regulation of bone remodeling (GO:0046851),-0.5039651702722113,-1.2357257289710535,0.19469026548672566,0.8122646184715736,1.0,9/11,44.91%,GPR137B;TMEM119;GPR137;TNFAIP3;UBASH3B;GREM1;CALCA;SFRP1;CARTPT
prerank,regulation of peptide hormone secretion (GO:0090276),0.45598494881969387,1.2355530482255461,0.20924574209245742,0.9170913744487628,1.0,7/67,4.75%,CACNA1C;RAP1A;ITPR1;KCNA5;CCL5;ALOX5;KCNB1
prerank,negative regulation of hormone secretion (GO:0046888),-0.5339842502687587,-1.234600269176222,0.21521739130434783,0.8138217297903466,1.0,3/10,13.40%,GJA1;RAB11FIP5;RAB11FIP1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4895425717492479,1.2343973335904677,0.2206266318537859,0.9195530282454716,1.0,5/44,3.74%,TPM1;SYNPO2L;FERMT2;TGFB3;PPM1E
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.4420334679025107,-1.2337722434177674,0.19047619047619047,0.8144079414369799,1.0,7/20,11.12%,SEMA3D;SEMA3C;SEMA6A;SEMA7A;SEMA3A;SEMA4D;SEMA6D
prerank,sodium-independent organic anion transport (GO:0043252),-0.5294630846876134,-1.233696181591414,0.20689655172413793,0.8121942165283033,1.0,4/10,8.85%,SLCO2B1;SLCO1C1;SLCO2A1;SLCO3A1
prerank,response to glucagon (GO:0033762),0.5507683860289704,1.2335063997828195,0.25120772946859904,0.920927619127301,1.0,7/19,9.47%,ADCY5;ADCY2;ADCY9;CYSLTR2;PRKACB;PRKAR1B;ADCY6
prerank,glycoprotein biosynthetic process (GO:0009101),-0.31576061592671045,-1.2333917339155664,0.09876543209876543,0.8108206449865013,1.0,24/79,20.02%,IGF1;CHST11;ST3GAL4;ST3GAL6;ST8SIA4;ST3GAL5;ST8SIA1;BMPR2;MGAT1;CHST9;SERP2;GOLPH3;ST3GAL3;FUT10;ST8SIA2;B3GALNT1;PMM2;CANT1;XYLT1;FOXL1;COG7;CHST12;B4GALT7;ALG1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.37610393648419416,-1.2325529170258154,0.16339869281045752,0.8113428310365031,1.0,13/34,16.03%,FLT1;PDGFRA;KIT;TEK;PIK3R3;PTK2;PTK2B;WDR91;TGFB1;AMBRA1;EPHA8;TNFAIP8L3;FGF2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5554193426720223,1.2324805495663635,0.23053892215568864,0.9227654344740305,1.0,6/18,9.57%,LTBP1;ITGB6;LRRC32;CD200;TGFB2;HIF1A
prerank,aminoglycan metabolic process (GO:0006022),-0.5260567407019714,-1.2321399254678544,0.2080536912751678,0.8104141031020672,1.0,9/10,44.74%,CHST9;XYLT1;B4GALT7;B3GAT1;CLN6;B3GAT3;B3GALT6;B3GAT2;GAL3ST3
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.40276952652023834,-1.2316003108015061,0.17105263157894737,0.8098030559817911,1.0,10/30,19.68%,SDF2;DNAJB12;HSPA5;ENTPD5;BAG1;HSPA13;HSPA9;HSPE1;DNAJB4;ST13
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4420228259217179,1.2315501569765717,0.19901719901719903,0.9244118908497039,1.0,14/75,10.88%,RGS6;ROCK1;PLCE1;RGS4;CCL5;SAG;RPGRIP1L;CALM1;PLEK;PLCB1;MGLL;SLC39A14;GPER1;ROCK2
prerank,membrane depolarization (GO:0051899),0.5061926580821642,1.2303769278461463,0.24489795918367346,0.9269869999973099,1.0,11/32,19.08%,SCN4A;CACNA1H;CACNB4;CAV1;CACNA1B;CHRNA4;YWHAH;CACNA1I;KCNH2;P2RX4;ABL1
prerank,protein insertion into membrane (GO:0051205),-0.3843311054828568,-1.230368484272821,0.1485148514851485,0.8116848697915388,1.0,10/32,16.39%,APP;EGFR;ALDH3A2;CYB5A;STX5;SGTA;MAIP1;EMD;STX1A;TRAM2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.32577978832196713,-1.230017450748899,0.13333333333333333,0.8105272714936468,1.0,19/67,8.28%,ELMO1;FLT1;PIK3CA;SULF1;NRP2;MAPK14;CYFIP2;PXN;NRP1;PTK2;ABI1;BAIAP2;PTK2B;VAV2;WASF2;ITGAV;NCK1;PIK3CB;CLEC14A
prerank,positive regulation of endocytosis (GO:0045807),-0.3517358483574299,-1.229626089737343,0.11983471074380166,0.8095839499661728,1.0,9/45,4.37%,DAB2;APPL2;LRP1;NEDD4L;APOE;VTN;B2M;HNRNPK;NLGN1
prerank,replication fork processing (GO:0031297),-0.3644032383766609,-1.229527420719358,0.18867924528301888,0.8075283994528011,1.0,18/38,37.92%,ATR;MRE11;FBH1;SAMHD1;BLM;MMS22L;PRIMPOL;SMARCAL1;NUCKS1;ALYREF;DNA2;ATRX;BOD1L1;RFWD3;TRAIP;RAD51;CENPX;GEN1
prerank,odontogenesis (GO:0042476),-0.37155337097257146,-1.229410135894995,0.17525773195876287,0.8056352820926173,1.0,10/35,16.65%,EDA;BMP4;COL1A2;GLI2;OSR1;LAMB1;FGFR2;HDAC2;WNT6;BCOR
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5478491746244869,1.2289573532262075,0.26283048211508553,0.9303349773886311,1.0,4/19,6.50%,ROCK1;LIMS1;FERMT2;VEGFA
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5196124530852458,1.228607695301611,0.23413258110014104,0.9299277888385183,1.0,4/30,3.96%,ABRA;GPR20;SYNPO2L;NET1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.46375346705563647,-1.228442058823973,0.21445221445221446,0.8066307195716063,1.0,4/15,7.39%,DAB2;AAK1;BMP2K;PIK3CB
prerank,endothelial cell differentiation (GO:0045446),-0.49914588155768014,-1.2280204177008425,0.22139303482587064,0.8057690673761301,1.0,5/12,6.40%,FSTL1;ACVRL1;BMPR2;SCUBE1;TIE1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5395545083554061,1.227862971588295,0.22993827160493827,0.9308996723256742,1.0,4/22,7.51%,DYNLL1;ROCK1;TP53;PLEK
prerank,mRNA stabilization (GO:0048255),0.4806191460830145,1.2277085293532155,0.21399730820995963,0.9297736532805246,1.0,9/40,11.70%,RBM24;TENT5B;MYD88;MAPKAPK2;CIRBP;GDNF;FUS;HNRNPU;HNRNPC
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5170748194540203,1.2276732416633165,0.23546099290780143,0.9282932879075336,1.0,11/27,18.84%,CAMK2G;MARK1;NCS1;BRSK1;IL1RAPL1;FRMD7;HOMER1;PTEN;VPS35;ULK4;BRSK2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.42501394877420345,-1.2265778198291615,0.164804469273743,0.8084101007074885,1.0,6/23,9.37%,UACA;BMP7;DDX3X;PPM1B;HDAC7;CCN3
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4948602866329904,-1.2261481373586822,0.22717149220489977,0.8075620953909838,1.0,3/12,6.93%,APOE;LDLR;IAPP
prerank,positive regulation of histone methylation (GO:0031062),-0.3960008417007599,-1.2258241740386542,0.1762917933130699,0.806395432011583,1.0,7/24,17.38%,AUTS2;CTR9;CTNNB1;OGT;SNW1;CHTOP;SMAD4
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.39637912176975076,-1.2258194815790175,0.1834862385321101,0.8040684538113446,1.0,6/28,8.38%,PTN;APOE;APP;EPHA4;SHANK3;ADCY1
prerank,acylglycerol homeostasis (GO:0055090),0.5547656911137686,1.225773108894653,0.25,0.9334849378183375,1.0,3/20,3.34%,ANGPTL8;RORA;LPL
prerank,hyaluronan catabolic process (GO:0030214),-0.43549714954824537,-1.2255917350413201,0.2230769230769231,0.8025045801950085,1.0,6/18,16.03%,CEMIP;CD44;TGFB1;HEXA;CEMIP2;FGF2
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5543324097513401,1.2254375167197236,0.2555746140651801,0.9329736156017121,1.0,3/15,7.16%,ENTPD1;AK7;ENTPD7
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5200304411727268,-1.2252354950549986,0.20046620046620048,0.8015401867214009,1.0,3/10,23.33%,BMP4;SALL1;PAX8
prerank,regulation of cholesterol esterification (GO:0010872),0.6194037695404838,1.2250168650360755,0.2711864406779661,0.9328596759241384,1.0,1/10,0.46%,AGTR1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4429315097509513,1.2250165192746436,0.21393034825870647,0.9312650439994818,1.0,18/66,14.41%,MAP3K5;FGF1;MST1R;PDGFB;PDGFC;PDGFD;TNFRSF11A;DAB2IP;VEGFA;RASGRP1;MAP3K10;PDGFRB;PDGFA;HTR2B;PDCD10;TAOK3;LRRK2;DIRAS2
prerank,leukocyte tethering or rolling (GO:0050901),0.5522333844935479,1.2249857403799347,0.2768729641693811,0.9297791186173155,1.0,4/17,8.26%,ROCK1;ITGB1;ADD2;ITGA4
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.25072431772831044,-1.2244523234867484,0.0,0.801962959513913,1.0,57/248,14.82%,RNF220;BICC1;MCC;DAB2;MLLT3;LRRK1;LGR4;TLE1;IGFBP2;COL1A1;TCF7L2;ADGRA2;DKK3;APOE;WNK1;RNF146;FZD6;DDX3X;PTK7;CUL3;EGFR;LYPD6;TNKS2;WNT5A;KLHL12;SOX13;PPM1B;CTNND1;TMEM64;CTNNB1;LATS2;PSMD7;PSMD9;PSMD13;WLS;ATP6AP2;STK11;SMURF2;KREMEN1;PRKN;SFRP4;TGFB1;IGFBP6;FGFR2;PSMB3;CCNY;SOX4;WWTR1;ZBED3;PSMC5;PSMA5;NOTUM;PSMA1;PSMC2;SOX17;HECW1;EMD
prerank,wound healing (GO:0042060),0.45626438104952494,1.2242460938692297,0.2095006090133983,0.9306255500965671,1.0,10/62,7.86%,TPM1;FGF1;FER1L5;PPP3CA;DYSF;MYH9;DST;RAB3A;ITGB3;TGFB2
prerank,positive regulation of developmental process (GO:0051094),0.41936235149149176,1.2230723773387042,0.1723404255319149,0.9331656056960829,1.0,33/164,13.00%,SOX6;ARHGEF7;SOX5;PDGFB;PHLDB2;CLASP2;FST;FZD4;TMEM79;BMPR1A;TAPT1;DAB2IP;VEGFA;GDNF;CORO1C;PA2G4;AR;SOX9;MIEF2;PLCB1;MIEF1;SPIRE1;TRPM4;RBM19;PAXIP1;RIF1;NR2C2;DNM1L;ACVR1B;BMPR1B;PACSIN1;CPEB3;CLASP1
prerank,organic substance transport (GO:0071702),-0.28909896724112516,-1.2230200466495027,0.0392156862745098,0.8050027908422567,1.0,38/121,23.08%,ABCG2;SLC47A1;ATP8A1;ABCA9;PLTP;CALCRL;ABCA1;SLCO2B1;CHKA;ABCA4;SLCO2A1;SCAMP2;SLC22A6;PPT1;SLC22A4;SLC35F3;SPNS2;RCN3;RAMP2;HSP90B1;TOM1;ABCA6;ABCD3;SLC22A18;NDC1;PICK1;ABCB9;SLC50A1;ARRDC1;CUBN;SCAMP3;MIA3;TAP1;SCAMP1;ABCA2;MFSD2A;TXNIP;ARRDC4
prerank,neuron projection extension (GO:1990138),-0.383571163804291,-1.222690447496138,0.17475728155339806,0.8038737468067662,1.0,9/32,9.11%,ALCAM;NRP2;AUTS2;NRP1;CTNNB1;HSP90AB1;SEMA3A;TMEM108;CDKL3
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5595115384581228,1.2223273300902477,0.2457627118644068,0.9340921418928936,1.0,3/17,4.10%,RYR2;SNTA1;KCNE4
prerank,histone H2B ubiquitination (GO:0033523),-0.524275817452044,-1.2222756751824417,0.22687224669603523,0.8030952886771864,1.0,4/10,13.88%,RNF20;CTR9;DTX3L;LEO1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5642283016795036,1.2222682213591356,0.2668977469670711,0.93267676690061,1.0,6/16,10.74%,PDGFB;PDGFC;PDGFD;PTPN1;PDGFRB;PDGFA
prerank,water transport (GO:0006833),-0.4996722317326161,-1.222190983010312,0.22448979591836735,0.801086674502613,1.0,1/12,1.63%,PDPN
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.5193733252409345,1.2220771418128609,0.25188536953242835,0.9318231237943683,1.0,6/25,11.23%,PFKP;ENO3;HK2;ADPGK;ALDOA;PFKM
prerank,nitrogen compound transport (GO:0071705),-0.27955446026800335,-1.2218830905735838,0.06172839506172839,0.7999314749964287,1.0,43/141,23.08%,SLC7A11;SLC6A13;ABCG2;PDPN;CALCRL;SLC12A2;SLC6A12;SLC6A6;SLC7A14;SCAMP2;SLC3A2;SCARB2;SLC52A1;SLC7A5;SEC14L1;TMEM30A;CERT1;PPT1;SLC22A4;SLC35F3;RCN3;RALBP1;SLC43A2;RAMP2;HSP90B1;TOM1;NDC1;SLC38A5;PICK1;SLC7A7;ARRDC1;CUBN;SLC15A4;LRRC8D;SCAMP3;MIA3;SLC1A4;SLC36A1;SLC43A1;SCAMP1;SLC5A7;TXNIP;ARRDC4
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5861132426778363,1.2218145753821252,0.2513464991023339,0.9311829946525216,1.0,4/10,14.92%,PMAIP1;IRS1;PTH1R;IRS2
prerank,telomere organization (GO:0032200),-0.3486061434552811,-1.2217850057186752,0.1471698113207547,0.7980436094314757,1.0,16/43,18.12%,ATR;PRKDC;XRCC5;STN1;MRE11;RAD50;PARP3;SP100;BLM;XRCC6;NBN;CTC1;TERF2IP;LTO1;HUS1;ATM
prerank,regulation of insulin secretion (GO:0050796),0.42820180652091727,1.2213788514598727,0.1984216459977452,0.9311851258164505,1.0,23/101,15.87%,CACNA1C;RAP1A;ADCY5;NR1H4;ITPR1;KCNA5;CCL5;ALOX5;KCNB1;IRS1;ENSA;NR1D1;ABCC8;GPER1;LRP5;PPP3CB;SIRT4;CLOCK;PRKCA;IRS2;GIPR;HADH;RFX3
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.47264836636596064,1.2206314057970569,0.2255541069100391,0.9321828302731215,1.0,13/44,14.01%,RBM24;ROCK1;BTG2;UPF1;POLR2G;YTHDF2;CELF1;FTO;ROCK2;CNOT7;CPEB3;ZFP36L1;GIGYF2
prerank,substrate-dependent cell migration (GO:0006929),-0.4781108946080466,-1.2205856331414509,0.22693266832917705,0.7999822005201997,1.0,8/14,18.87%,NRP1;ANKS1A;CD2AP;SDCBP;OPHN1;EPHA8;VEGFC;ITGB1BP1
prerank,endocardial cushion morphogenesis (GO:0003203),0.5475892838590438,1.2205295673091847,0.26198083067092653,0.9309304884929378,1.0,5/18,7.86%,TBX2;HEYL;BMPR1A;SOX9;TGFB2
prerank,negative regulation of blood coagulation (GO:0030195),-0.3623806908076157,-1.2201572665024758,0.16608996539792387,0.7992190785649063,1.0,9/38,9.33%,PDGFRA;APOE;VTN;TFPI;PLAT;F3;CD34;THBD;NOS3
prerank,positive regulation of nervous system development (GO:0051962),-0.35368590055329935,-1.2198426456430638,0.13709677419354838,0.7980290896053858,1.0,20/42,28.55%,NLGN1;SPEN;PTPRD;SNW1;NRXN1;FAIM;NLGN2;NLGN3;NUMB;LRRC4B;GRID2;NAP1L1;IL1RAP;EPHB2;SRPX2;MME;TRIM32;SOX11;EPHB3;SYNDIG1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.4092223556899718,1.2198163421072679,0.16421052631578947,0.9318052804270128,1.0,47/190,15.38%,PDE3A;DGKG;WTIP;ATP2B4;NR1H4;ITPR1;LIMD1;RORA;BCL2;CARD19;CAV1;DAB2IP;DUSP3;PPM1A;PHLDA3;PLEK;BCL2L2;RELA;TNIP1;OTUD7A;PPARA;GSTP1;NR1D1;NDUFS3;DGKD;EPHA2;THEM4;EPM2A;NPRL2;ARHGAP12;RTKN2;SH3BP4;GPER1;GPD1L;PDE4D;RHOH;SHANK2;MUL1;MAP2K3;TMSB4X;MCL1;PLEKHA1;PRKAA2;VGLL4;URI1;PTEN;STAT1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5004919560219081,1.219503891810569,0.23863636363636365,0.9313533001079418,1.0,5/35,8.09%,CDH6;CDH13;CDHR3;PCDHB14;PCDHB11
prerank,negative regulation of axon extension (GO:0030517),-0.3957321945990555,-1.2192294817873643,0.22945205479452055,0.7979140591366234,1.0,10/30,12.47%,SEMA3D;SEMA3C;SEMA6A;SEMA7A;RNF6;SEMA3A;SEMA4D;CDKL3;SEMA6D;RTN4
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5857453859639594,1.219207535634026,0.27768014059753954,0.9308874993191644,1.0,3/12,5.71%,MYO1E;JAG1;KLF15
prerank,positive chemotaxis (GO:0050918),0.5506455544239162,1.2189746510710964,0.2727272727272727,0.9300911024511447,1.0,3/17,6.50%,ANGPT1;SEMA5A;VEGFA
prerank,autophagy of mitochondrion (GO:0000422),-0.3570036709702751,-1.2187070631466117,0.16776315789473684,0.7973940088915477,1.0,20/38,28.28%,RB1CC1;CISD2;ATG3;FBXO7;ATG5;PRKN;ATG2B;AMBRA1;WIPI2;ATG2A;FIS1;GABARAPL2;WDR45B;MAP1LC3A;ULK2;GABARAPL1;WIPI1;SQSTM1;MAP1LC3B;ATG12
prerank,regulation of receptor internalization (GO:0002090),0.48726506923435725,1.2184674078031745,0.2538569424964937,0.930249366697463,1.0,6/35,10.44%,NTF3;ANGPT1;ATXN2;VEGFA;ATAD1;SCYL2
prerank,cellular macromolecule catabolic process (GO:0044265),-0.3478219967734486,-1.2182605044694976,0.15953307392996108,0.7967222870442887,1.0,19/49,27.91%,NGLY1;DENND3;RAB12;RNASEH2B;PRKN;ADAMTS9;HNRNPD;CHEK2;SIAH2;PNPT1;FBXO17;PABPC4;MAGEC2;PPP1R8;EXOSC7;STT3B;SND1;HTRA2;FBXO44
prerank,regulation of store-operated calcium entry (GO:2001256),0.6084551730742934,1.2181994671141594,0.26220614828209765,0.929632120983968,1.0,4/10,12.68%,CASQ1;STIM1;GRAMD2A;HOMER1
prerank,mitotic nuclear division (GO:0140014),0.44490524177000007,1.2177933209385887,0.2105911330049261,0.9294281422680494,1.0,22/71,17.20%,FLNA;CLASP2;KIF2A;TOGARAM2;NUP62;KIF3B;TPX2;PIBF1;TOGARAM1;ZWINT;CEP192;WRAP73;AAAS;CLASP1;CHMP2A;KIF18A;KNSTRN;ABRAXAS2;MAP9;INO80;DSN1;CENPK
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.48553139246521354,-1.217596704009179,0.2326086956521739,0.7967561651582101,1.0,3/12,6.84%,UNC13C;UNC13B;SYT1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5913050743222996,1.2174951443748772,0.26737967914438504,0.9274025260445223,1.0,3/12,6.96%,ACTN4;KANK1;CORO1C
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5913050743222996,1.2174951443748772,0.26737967914438504,0.9274025260445223,1.0,3/12,6.96%,ACTN4;KANK1;CORO1C
prerank,plasma membrane repair (GO:0001778),0.5695306715472286,1.2169419243473556,0.2637931034482759,0.9276745556566106,1.0,4/13,7.05%,FER1L5;DYSF;MYH9;RAB3A
prerank,activation of GTPase activity (GO:0090630),0.43296427796441495,1.216802774663508,0.19506462984723855,0.9265840139877246,1.0,14/89,9.51%,NTF3;NTRK3;RALGAPA2;TBC1D1;ABR;ARHGEF16;MTSS2;RABGAP1;CORO1C;RASGRP1;RALGAPA1;EVI5;RALGAPB;EPHA2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5735553199354609,1.216458499451917,0.25900514579759865,0.9262598569320775,1.0,4/16,13.20%,RBM24;UPF1;CPEB3;ZFP36L1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.41906889054197743,-1.2158795713422879,0.2037037037037037,0.80064589121113,1.0,3/21,5.06%,OSBPL8;OSBPL10;PLA1A
prerank,acute inflammatory response (GO:0002526),0.5177664604713963,1.2156906334409356,0.27896341463414637,0.9274145999806074,1.0,4/23,7.82%,ITIH4;ANO6;MBL2;IL22
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.45262978465552073,1.2155474658226044,0.21975308641975308,0.9263539455746425,1.0,15/72,10.84%,NTF3;NTRK3;PDGFB;PDGFC;ROR1;PLXNB1;CCL5;PDGFD;PIK3AP1;NEDD4;SOX9;TGFB2;PDGFRB;PDGFA;GPER1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.42795396680974634,-1.2153359461757645,0.18528610354223432,0.8003360359358918,1.0,6/19,19.38%,CAMK1D;MOSPD2;MCU;RIPOR2;NCKAP1L;TIRAP
prerank,generation of neurons (GO:0048699),0.4070807365555702,1.214670853926683,0.1703011422637591,0.927850449705604,1.0,28/190,9.13%,FGF13;MEF2C;HEY2;CDK6;FZD5;ASTN2;HEYL;IRX5;FZD4;MAP1B;PRUNE1;MARK1;FZD8;ITM2C;MAPT;EML1;TUBB2B;PIN1;YTHDF2;CEP85L;YAP1;ERCC6;TGFB2;ADNP2;ASTN1;MAP2K1;NR4A2;BRSK1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5418278968895207,1.214592982572078,0.2519809825673534,0.926618485449268,1.0,3/20,7.56%,WTIP;LIMD1;CELF1
prerank,L-serine metabolic process (GO:0006563),-0.5255859754947134,-1.2144795388102343,0.22637362637362637,0.8012183183041311,1.0,5/10,26.81%,SERINC5;SRR;PSPH;PSAT1;CBS
prerank,substantia nigra development (GO:0021762),0.4835405088333929,1.2142590525726704,0.24583333333333332,0.9262969204096612,1.0,8/37,9.92%,DYNLL1;SYPL2;PADI2;ACTB;CALM1;MBP;NDUFS3;SIRT2
prerank,smooth muscle tissue development (GO:0048745),0.6031386790775661,1.2137315333311243,0.3069852941176471,0.9265328025262126,1.0,1/10,0.26%,MYLK
prerank,cell chemotaxis (GO:0060326),0.4441562171231381,1.2134505644304725,0.20906801007556675,0.9259973953873794,1.0,13/60,11.28%,AGTR1;PDGFB;SEMA5A;NR4A1;ARHGEF16;PRKCQ;CXCR6;VEGFA;EPHA2;PARVA;PDGFRB;HBEGF;PRKCD
prerank,histone H3-K36 demethylation (GO:0070544),-0.5193690240197811,-1.2129967444999206,0.2383073496659243,0.8043792123272487,1.0,3/10,12.77%,KDM7A;KDM2A;RIOX2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.4399102678204575,-1.2123133887836803,0.20899470899470898,0.8046471275785675,1.0,6/17,19.38%,CAMK1D;MOSPD2;MCU;RIPOR2;NCKAP1L;TIRAP
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5414458413142086,1.2121870422378112,0.2859450726978998,0.9287584626400949,1.0,4/17,8.61%,PRKAB2;PDK4;CAV1;PPARA
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.48833491949540636,1.2119537344896778,0.23184357541899442,0.9280187570815449,1.0,3/32,6.08%,AKAP6;CASQ1;CAV1
prerank,positive regulation of cellular respiration (GO:1901857),-0.4952285952946758,-1.2109689552134502,0.23008849557522124,0.807226470687409,1.0,4/11,22.48%,NUPR1;IFNAR1;PARK7;ISCU
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.4812474330392648,-1.2102113369184317,0.22811059907834103,0.8074915764916629,1.0,7/13,27.38%,NCBP2;CPSF2;CPSF6;CSTF2T;CPSF4;CSTF2;CPSF1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5436797956255927,1.2100100479971827,0.2805872756933116,0.9330233417004711,1.0,5/17,10.29%,FERMT2;THPO;TERT;KAT7;HNRNPU
prerank,protein localization to chromosome (GO:0034502),-0.3731369186750288,-1.209597680933273,0.1903114186851211,0.8075210377407057,1.0,18/34,34.07%,ATR;TNKS2;XRCC5;PARP3;SLF2;ESR1;SLF1;LEMD2;TERF2IP;IFFO1;TPP1;TINF2;CHMP7;BOD1;ATRX;ACD;MCM8;RPA2
prerank,negative chemotaxis (GO:0050919),0.4850494406721171,1.2094625150013023,0.24785100286532952,0.933351766274851,1.0,4/33,4.74%,SLIT3;SLIT1;NTN1;SEMA6C
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.4094662560472775,-1.2094072436934358,0.20058997050147492,0.8060049808749215,1.0,6/23,20.37%,IGF1;PYDC1;CX3CL1;GIT1;ZC3H12A;CEACAM1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5253554149642371,1.2093730662129627,0.27917981072555204,0.9321801596323489,1.0,6/21,15.26%,FZD5;CAV1;AMER1;PPP1CA;DVL1;CSNK1A1
prerank,intermediate filament organization (GO:0045109),0.5451606410756527,1.2091045983534334,0.27287853577371046,0.9316467404392188,1.0,2/17,2.61%,DES;VIM
prerank,regulation of actin filament-based process (GO:0032970),0.44364128024234895,1.208866498812637,0.21151439299123906,0.93097477877253,1.0,15/70,12.98%,DLC1;ROCK1;CNN2;ABRACL;RHOBTB3;ARHGAP17;RHOF;PDGFRB;PDGFA;ROCK2;PRKCD;RHOH;ARHGAP35;RICTOR;DMTN
prerank,response to interleukin-6 (GO:0070741),-0.5122061983252975,-1.2087701038948595,0.24943820224719102,0.805996830389757,1.0,3/10,2.87%,PID1;ST3GAL6;SBNO2
prerank,regulation of cellular amide metabolic process (GO:0034248),0.49967420891951037,1.2084457913954627,0.24787535410764872,0.930887228172532,1.0,8/32,11.38%,ROCK1;NR1H4;ATXN2;CYFIP1;SAMD8;PRKCD;DDX25;RBM3
prerank,regulation of interleukin-17 production (GO:0032660),0.4949264465834474,1.2082214469452428,0.2510948905109489,0.9301583036958221,1.0,4/31,5.51%,NR1H4;MYD88;IL2;PRKCQ
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.3435261133605655,-1.2078776014096506,0.1487603305785124,0.8069688429086005,1.0,12/49,12.18%,IGF1;IL31RA;IL15;KIT;GHR;IL18;ARL2BP;TNFRSF1A;IL6R;HES1;LYN;PARP14
prerank,regulation of hydrolase activity (GO:0051336),-0.3193107446090823,-1.2077785124430374,0.15294117647058825,0.8051237819420786,1.0,20/71,12.34%,PLXNA2;NF1;FGD6;FGD5;EPHA4;PTK2;FGD4;CHN2;TBC1D15;SIPA1L1;EPHA3;PAFAH1B1;VAV2;SCARB2;PLXNA4;RDX;RASIP1;RAB3GAP2;ARHGAP27;RALBP1
prerank,reverse cholesterol transport (GO:0043691),-0.4746143599305078,-1.2069924451235179,0.23863636363636365,0.805510537873818,1.0,2/13,2.40%,APOE;ABCA1
prerank,positive regulation of cell motility (GO:2000147),0.4004697744416139,1.2065874740404043,0.159375,0.9340880133080692,1.0,34/205,10.88%,NTF3;MYLK;NTRK3;ACTN4;FGF1;CAVIN1;PDGFB;CCN1;PPP3CA;PDGFC;FERMT2;SEMA5A;CDH13;ACTG1;ITGB1;CCL5;GCNT2;PDGFD;NTN1;SEMA6C;HAS2;SYNE2;CBLL1;CAV1;VEGFA;SNAI2;SUN2;ADAM17;WASHC1;PDGFRB;HBEGF;PDGFA;GPER1;ROCK2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.5162744554460803,-1.2062381585761837,0.24324324324324326,0.8058731237755484,1.0,8/10,44.88%,KIT;LYN;CD24;BTLA;FGR;BAG6;CD40;LILRB1
prerank,positive regulation of macrophage activation (GO:0043032),-0.43690850239324597,-1.2061125314344894,0.2262210796915167,0.8041433857668009,1.0,5/17,21.37%,LBP;WNT5A;IL33;TTBK1;HSPD1
prerank,regulation of ion transmembrane transport (GO:0034765),0.497723150282498,1.205580560986316,0.24615384615384617,0.9359763197046055,1.0,5/33,9.42%,AKAP6;KCNJ12;ANO6;NEDD4;AHCYL1
prerank,negative regulation of protein metabolic process (GO:0051248),0.45483534892230115,1.205473342586782,0.24,0.93487513609639,1.0,12/48,16.28%,FLNA;ROCK1;EDNRB;PIN1;ITGB3;SF3B3;SIRT2;CLU;ADGRB1;AZIN2;MAD2L2;AGAP2
prerank,inositol phosphate metabolic process (GO:0043647),0.46810124392925734,1.204880946140401,0.23473541383989144,0.9353552833837401,1.0,12/46,12.09%,ITPK1;PLCE1;INPP4B;PLCB4;INPP5A;NUDT4;CALM1;PLCB1;INPPL1;PLCD1;INPP5B;ITPKC
prerank,regulation of interleukin-12 production (GO:0032655),-0.3339185847064283,-1.2043701156262083,0.17427385892116182,0.8079645758720625,1.0,6/47,8.66%,FOXP1;HMGB1;MAPK14;LGALS9;PLCG2;IRAK3
prerank,negative regulation of cell differentiation (GO:0045596),0.4037164598541363,1.2038129419266412,0.1664899257688229,0.9374384068060813,1.0,32/181,11.57%,MYOCD;VASN;CHADL;CRIM1;LIMD1;CDK6;FERMT2;RORA;RUNX1T1;JAG1;ANKRD2;ASXL1;SDHAF2;CAV1;DAB2IP;BBS12;YTHDF2;MED1;ITGB3;YAP1;SOX9;SNAI2;PPARA;TRPM4;IQCB1;SKI;SIRT2;HNRNPU;GPER1;RB1;LRP5;ABCG1
prerank,T cell mediated immunity (GO:0002456),-0.48235627030404016,-1.2037986289378204,0.2505353319057816,0.8078887369454834,1.0,5/13,12.26%,CADM1;CD55;CTSH;CD46;GNL1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.4156809623503576,-1.2035286597517247,0.23097826086956522,0.8066827315041538,1.0,7/22,5.65%,ROBO1;EFNB2;CDH5;SLIT2;NRP1;PIK3R3;ID1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.4377821988898608,-1.2034243603964119,0.21750663129973474,0.8048881695224541,1.0,12/18,35.38%,COA8;COX20;SMIM20;COX14;TIMM21;BCS1L;COX17;COX16;COA3;SURF1;COX18;FASTKD3
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.4406790498270592,-1.2030562385991763,0.2119047619047619,0.804066135154773,1.0,7/17,18.63%,SEL1L;DERL1;UFD1;HSP90B1;OS9;SYVN1;HERPUD1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.3733846692162003,-1.2027531372648699,0.1950354609929078,0.8029788610763597,1.0,9/31,26.69%,HMGB1;MAPK14;LGALS9;PLCG2;TLR3;TIRAP;HSPD1;SYK;LAPTM5
prerank,postsynaptic membrane organization (GO:0001941),-0.44035696901983684,-1.2019522830499503,0.24936386768447838,0.8038503828485468,1.0,10/17,28.37%,APOE;NLGN1;SHANK3;NRXN1;NLGN2;NLGN3;DNAJA3;CHRNB1;SHISA7;LHFPL4
prerank,regulation of kinase activity (GO:0043549),0.4282568502899894,1.2018020435441883,0.22523584905660377,0.942742137748755,1.0,17/89,11.19%,TTN;NTRK3;MERTK;PLCE1;MST1R;ROR1;SMG8;MUSK;CAMKK2;MAPT;ANKRD54;EPHA2;AXL;NPRL2;PDGFRB;HNRNPU;RB1
prerank,myoblast fusion (GO:0007520),0.5769810745305568,1.2017651873030557,0.29525483304042177,0.9413927103481693,1.0,3/12,5.58%,CACNA1H;ADAMTS5;KCNH1
prerank,heme catabolic process (GO:0042167),-0.4704758426562848,-1.2015917822518383,0.25181598062953997,0.8008332205295523,1.0,3/14,11.22%,ABCG2;SLCO2B1;BLVRB
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.4704758426562848,-1.2015917822518383,0.25181598062953997,0.8008332205295523,1.0,3/14,11.22%,ABCG2;SLCO2B1;BLVRB
prerank,regulation of microtubule-based process (GO:0032886),0.4861267059299711,1.2011860824460987,0.23570432357043236,0.9418623910062062,1.0,13/36,18.90%,ROCK1;PHLDB2;CLASP2;BICD2;MAPT;TPPP;CLASP1;PRKAA2;CDK2AP2;MARK2;BICD1;MAP6;HDAC6
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.5048267557307256,-1.2010337337771713,0.23990498812351543,0.8006058263741098,1.0,6/11,14.62%,YBX3;NUPR1;CASP8;BIRC2;PELI1;BIRC3
prerank,regulation of neuron apoptotic process (GO:0043523),0.4233683770450713,1.2010238377156082,0.21662763466042154,0.9408755050597393,1.0,13/96,7.86%,NTF3;MEF2C;TRIM2;PLA2G3;CRLF1;TGFB3;SET;BCL2;KCNB1;GDNF;PPARGC1A;FZD9;TGFB2
prerank,regulation of intracellular transport (GO:0032386),0.4803283832557077,1.199781858102281,0.26164383561643834,0.9435953887519086,1.0,4/38,6.82%,MYLK2;PLA2G3;LCP1;PTPN1
prerank,early endosome to Golgi transport (GO:0034498),-0.5131225918360778,-1.1992906967869945,0.25476190476190474,0.8043186039199658,1.0,5/11,19.16%,STX5;SURF4;RBSN;LMAN1;EHD3
prerank,RNA catabolic process (GO:0006401),-0.3467101698539501,-1.1987719023381793,0.1875,0.8039857488969768,1.0,20/46,28.65%,AGO3;RNASEH2B;METTL3;ERN1;DCP2;HNRNPD;PNPT1;METTL16;PABPC4;LSM2;LSM5;PPP1R8;EXOSC7;CNOT10;SND1;NUDT12;AGO4;DNA2;ZFP36;LSM6
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.4823231839297647,-1.197529772360305,0.24681933842239187,0.8062132872725517,1.0,4/12,7.33%,TNKS2;PARP11;PARP10;PARP3
prerank,gonad development (GO:0008406),0.47903467783313797,1.197333830832473,0.2587601078167116,0.9504773937560232,1.0,8/41,10.61%,LHCGR;IRX5;NR2F2;CSDE1;AR;SOX9;TGFB2;NUP107
prerank,membrane lipid catabolic process (GO:0046466),-0.5197447927635975,-1.1972085643040948,0.2538293216630197,0.8051975196932192,1.0,4/10,20.45%,ENPP2;CYP1B1;PPT1;NAGA
prerank,nucleic acid-templated transcription (GO:0097659),0.47052909889456573,1.1971267274778221,0.25065616797900264,0.9496404294974926,1.0,11/42,13.03%,POLR2L;POLR2I;MLF1;PWP1;MEF2A;POLR2G;TERT;NFKBIB;NR4A2;BAZ2A;POLR2J
prerank,regulation of macrophage migration (GO:1905521),0.5970063752070496,1.1965842681574141,0.2807625649913345,0.9500819167535522,1.0,3/10,6.99%,EMILIN1;CD200R1;CD200
prerank,protein ADP-ribosylation (GO:0006471),0.5089204301000705,1.1965743732013419,0.26180257510729615,0.9486307239238976,1.0,7/28,13.71%,ART1;SIRT3;PARP1;ART4;SIRT2;HPF1;SIRT4
prerank,protein mannosylation (GO:0035268),-0.4188996606701295,-1.1965363457467315,0.20365535248041775,0.8054915147533537,1.0,6/22,7.46%,TMTC1;TMTC2;DPY19L4;RXYLT1;TMTC4;DPY19L1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.4953653811262261,-1.1964778418447202,0.24634146341463414,0.8036586160043147,1.0,6/12,15.44%,KDELR1;HSPA5;ANKRD13C;OS9;RER1;INSIG1
prerank,positive regulation of secretion (GO:0051047),-0.47919978228499066,-1.1962768147208807,0.24008810572687225,0.8022235495117734,1.0,2/11,9.95%,NPR1;ACSL3
prerank,positive regulation of cell differentiation (GO:0045597),0.3984980544646354,1.1961548732791452,0.15854922279792746,0.9485105096306193,1.0,38/237,8.81%,SOX6;AGTR1;SOX5;MEF2C;RAP1A;RBM24;SMYD1;CD36;CCN1;PLA2G3;FERMT2;LOXL2;HEYL;LPL;TGFB3;GCNT2;MMD;ACVR2A;TGFB1I1;SP7;ARHGEF2;BMPR1A;MEF2A;RARRES2;RRAS;GDNF;PA2G4;AR;BTG1;YAP1;SOX9;TGFB2;PLCB1;RIN2;CDH2;TRPM4;SUCO;IMPACT
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.42689465152966977,-1.1961314856406369,0.23096446700507614,0.8006546350572767,1.0,6/18,11.08%,DDX5;BMP4;EGFR;ESR1;TGFB1;MAP2K2
prerank,histone ubiquitination (GO:0016574),-0.41662386185538536,-1.1958010522827183,0.24210526315789474,0.7998606728349863,1.0,6/21,13.88%,RNF20;UBR2;CTR9;PHC1;DTX3L;LEO1
prerank,cytoplasmic translation (GO:0002181),-0.2963243214297155,-1.1957117732050673,0.09615384615384616,0.7981533129719612,1.0,40/91,29.91%,RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;RPLP0;ZC3H15;RPS29;RPL28;RWDD1;EIF2B3;RPS10;RPLP1;RPS20;RPL23A;RPL34;RPL36A;RPS8;RPS21;RPL9;RPS7;RPL27;RPL11;RPL18A;RPL37A;RPL38;RPL29;RPL10A;RPL32;RPS4X;RPS27;GSPT2;RPL4;RPS5;RPS15;RPL35A
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.5304071806449059,1.195153949236922,0.26480263157894735,0.95043244310772,1.0,6/19,11.08%,FZD5;CAMKK2;FBXW7;VDAC1;DNM1L;SREBF2
prerank,carboxylic acid catabolic process (GO:0046395),-0.4728112927939453,-1.1949533874441358,0.2533039647577093,0.7987319284312051,1.0,10/12,48.06%,RENBP;ACOT8;AMDHD2;NPL;GNPDA1;PON3;NAGK;IL4I1;BCKDK;GNPDA2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5333452293454561,1.1940914277923376,0.27543035993740217,0.9525876137386886,1.0,5/19,9.35%,NDST3;CSGALNACT1;EXT2;HS2ST1;HS6ST1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.5041237039572296,1.1940868047507591,0.25,0.9511143908488786,1.0,4/24,6.29%,PPP1R3A;DYRK2;IRS1;SORBS1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5198519419619563,1.1940741130532913,0.29154078549848944,0.9496714637978857,1.0,8/22,10.74%,PDGFB;PDGFC;PDGFD;RAP2C;VEGFA;CALM1;RAP2A;PDGFA
prerank,digestive tract development (GO:0048565),-0.3805207209528438,-1.1938589606687102,0.21843003412969283,0.8005326095569212,1.0,10/32,14.92%,CLMP;COBL;KIT;PCSK5;GLI2;MEGF8;SALL1;FGFR2;CCDC39;PKDCC
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.5875230761470495,1.1938574126786465,0.30755711775043937,0.9488946471119891,1.0,3/11,13.57%,MERTK;AXL;GAS6
prerank,positive regulation of cell adhesion (GO:0045785),0.43859582221893684,1.193649322249886,0.22616136919315402,0.9481771907358174,1.0,10/74,9.26%,TPM1;ZFHX3;LIMS1;PDGFB;PPP3CA;CCL5;RSU1;VEGFA;TGFB2;MAGI1
prerank,secondary palate development (GO:0062009),-0.4618571813645401,-1.1936211848747473,0.2457831325301205,0.7993791973036222,1.0,4/14,3.76%,TGFBR3;LEF1;CHD7;WNT5A
prerank,positive regulation of vasculogenesis (GO:2001214),0.6033968642988665,1.19245700511376,0.29764065335753176,0.9507626555787649,1.0,3/10,8.34%,RAP1A;RRAS;RIN2
prerank,inorganic ion transmembrane transport (GO:0098660),0.5983531323825488,1.1923564468131251,0.2961672473867596,0.9496542245314017,1.0,3/12,9.37%,CACNA1H;TRPM4;ABCC8
prerank,regulation of cell migration (GO:0030334),0.38790694616405086,1.191344909639314,0.1309164149043303,0.9516129782001288,1.0,44/382,7.06%,NTF3;NEXN;FLNA;MYLK;TPM1;NTRK3;DLC1;ACTN4;VCL;TMIGD3;ROCK1;FGF1;NKD1;PDGFB;CCN1;PPP3CA;PDGFC;FERMT2;SEMA5A;PLXND1;PLXNB1;CDH13;ANXA1;JAG1;KIF2A;KANK1;SERPINE2;IGFBP5;DOCK10;ACTG1;ITGB1;CCL5;GCNT2;PDGFD;SEMA6C;HAS2;SYNE2;CBLL1;CAV1;RAP2C;DUSP3;VEGFA;CORO1C;STK26
prerank,regulation of necroptotic process (GO:0060544),-0.4011369873052233,-1.1912712973545014,0.22839506172839505,0.8056895327861638,1.0,8/23,14.62%,YBX3;CASP8;BIRC2;PELI1;SDCBP;OGT;STUB1;BIRC3
prerank,mesenchymal cell differentiation (GO:0048762),0.45228137522831074,1.190688232717425,0.2522639068564036,0.9523686744673732,1.0,14/51,11.68%,MEF2C;HEY2;ROCK1;LIMS1;FAM83D;LOXL2;HEYL;SOX9;SNAI2;TGFB2;AKNA;HIF1A;ROCK2;HTR2B
prerank,endothelial cell development (GO:0001885),0.5127019859639868,1.1905533875062344,0.2844574780058651,0.9513575452758738,1.0,2/25,0.72%,COL18A1;RAP1A
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4610263185958905,-1.1903360688448448,0.24047619047619048,0.8070136489842288,1.0,6/14,33.17%,MOXD1;DAGLA;SLC5A7;DAGLB;ALDH9A1;SLC22A2
prerank,camera-type eye development (GO:0043010),-0.40136953712683554,-1.1899083828584747,0.24788732394366197,0.8064355054554424,1.0,9/25,9.35%,SHROOM2;FBN1;NF1;EFEMP1;LAMA1;FBN2;IFT122;CYP1B1;TENM3
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.49870089759566516,-1.1897491687110051,0.2566585956416465,0.8049382790908298,1.0,7/12,20.87%,CTSL;CTSH;RDX;CTSB;THRB;CTSS;LMO2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.4271524748830643,-1.189171946381171,0.22797927461139897,0.8049598112135298,1.0,14/19,33.56%,PGM3;RENBP;UGDH;PMM2;SLC35D1;UAP1;AMDHD2;GFPT2;UAP1L1;GNPDA1;PMM1;NANS;GNPNAT1;MPI
prerank,positive regulation of protein sumoylation (GO:0033235),0.5949005349428421,1.1889173096596932,0.2961608775137112,0.9553809736559803,1.0,3/10,6.07%,UBA2;PIAS4;SAE1
prerank,cellular response to heat (GO:0034605),0.48257435246754044,1.188746901594567,0.25806451612903225,0.9545232462708474,1.0,5/35,9.67%,FGF1;ANO1;TCIM;MAPT;BAG3
prerank,negative regulation of transposition (GO:0010529),-0.44425633529466,-1.1886476774305286,0.23095823095823095,0.8047796442247528,1.0,7/16,30.99%,UBR2;SIRT7;TUT4;TEX15;TUT7;MOV10;SMYD5
prerank,regulation of osteoclast differentiation (GO:0045670),-0.35634846978719514,-1.1886032524788646,0.20761245674740483,0.8029100199964218,1.0,11/33,33.69%,FBN1;TCTA;CEBPB;PRXL2A;TLR3;GPR137B;MAFB;GPR137;CAMK4;FSTL3;UBASH3B
prerank,activation of protein kinase A activity (GO:0034199),0.5507218319453943,1.1884881792535438,0.2745762711864407,0.9538762715809703,1.0,6/16,9.47%,ADCY5;ADCY2;ADCY9;PRKACB;PRKAR1B;ADCY6
prerank,histone H3-K9 demethylation (GO:0033169),-0.49972868829856537,-1.1884300551098614,0.27586206896551724,0.8015264091258646,1.0,4/11,17.73%,KDM7A;KDM3B;KDM4D;KDM1A
prerank,response to cAMP (GO:0051591),0.4780687965634369,1.1881512172004673,0.26907630522088355,0.9535808927981315,1.0,3/37,3.49%,RAP1A;AKAP6;IGFBP5
prerank,positive regulation of cyclase activity (GO:0031281),0.5606708996982475,1.188116511816203,0.2793103448275862,0.9522686184296887,1.0,2/14,3.42%,CACNA1C;STIM1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.41747215258184156,-1.1880552014573622,0.23622047244094488,0.8007267217277999,1.0,8/20,12.38%,ITCH;DCUN1D3;UBQLN1;ZMIZ1;HSP90AB1;PRKN;TGFBR1;DNAJB2
prerank,cellular response to calcium ion (GO:0071277),0.440487402942666,1.1880538344575413,0.24907063197026022,0.9510429384089113,1.0,7/67,5.58%,RYR1;MEF2C;RASGRP2;CAMK2D;SYT10;MEF2A;KCNH1
prerank,pentose-phosphate shunt (GO:0006098),-0.5072144164137057,-1.1877045783858289,0.25279642058165547,0.7999946080850283,1.0,5/11,26.79%,PGD;TKT;SHPK;DERA;PGLS
prerank,regulation of axon guidance (GO:1902667),-0.5028146303650687,-1.1875550544968,0.2539325842696629,0.7985157693600586,1.0,5/10,12.48%,NRP1;MYCBP2;ZSWIM6;ZSWIM5;ZSWIM4
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4924438906923836,-1.1859362123531296,0.2851063829787234,0.8021079129100882,1.0,5/11,22.31%,RASA1;PCBP2;NOVA1;NOVA2;PCBP4
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.49236440599670134,1.1857858442432947,0.25547445255474455,0.9573068229241402,1.0,7/30,12.98%,NTF3;CAV1;PIBF1;CD300A;SAMSN1;PRKCD;DMTN
prerank,glycoprotein metabolic process (GO:0009100),-0.3336181501354927,-1.1857778658025167,0.18433179723502305,0.8006655945754783,1.0,13/53,11.00%,MAN1C1;ST3GAL4;ST8SIA4;NGLY1;ST6GALNAC3;ST8SIA1;FUT8;MGAT4B;GANAB;GOLPH3;MAN2A1;ADAMTS9;ST8SIA2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.5059806949098345,-1.1856352936456347,0.24883720930232558,0.7991701348994563,1.0,6/11,30.78%,LGALS9;PARK7;PIH1D1;HTRA2;GSN;PLAUR
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4967210255371284,1.1855158743693983,0.2709497206703911,0.9566954232732325,1.0,7/32,6.96%,DLC1;PHLDB2;CLASP2;JAG1;ARHGAP6;AJAP1;CORO1C
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.4134570901831138,1.1847122753146904,0.23155505107832008,0.957978125272917,1.0,26/118,13.33%,WTIP;MEF2C;PDLIM5;SDC2;INF2;FERMT2;PLXND1;PHLDB2;CLASP2;CHN1;KIF1A;MAPT;GDNF;NEDD4;CDH2;BRSK1;PAK2;EPHA2;RAP2A;TSPAN12;ARHGAP35;TNIK;SARM1;CLASP1;BCL6;CAPZB
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5846778788872826,1.184653258463097,0.3248175182481752,0.9567080910010312,1.0,2/10,6.44%,ACTN4;RXRG
prerank,positive regulation of cell killing (GO:0031343),-0.474304587384892,-1.184075556346041,0.24343675417661098,0.8024287486743061,1.0,6/13,37.66%,WNT5A;SYK;DVL2;MAPK8;NOXO1;NOX1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.3971903815794223,-1.1838457836655853,0.23708206686930092,0.8012698153726746,1.0,5/24,16.45%,RBBP4;PPHLN1;AEBP2;PPM1D;MPHOSPH8
prerank,mRNA destabilization (GO:0061157),0.4732707247771316,1.1837196878077874,0.2596685082872928,0.9583119554308747,1.0,11/38,14.01%,RBM24;ROCK1;UPF1;YTHDF2;CELF1;FTO;DIS3L2;ROCK2;CPEB3;ZFP36L1;GIGYF2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.5811000046005739,1.1827564476793109,0.30855018587360594,0.9601648027336476,1.0,2/11,6.73%,PRKCQ;IL12RB1
prerank,cellular response to osmotic stress (GO:0071470),0.5206715564038313,1.182587080146782,0.2934609250398724,0.9592545469279877,1.0,3/21,8.14%,MYLK;ARHGEF2;RCSD1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5280598429075591,1.1819533230601877,0.292436974789916,0.9599581110152541,1.0,3/18,4.35%,RAP1A;SLC4A8;RIMS3
prerank,regulation of lymphocyte migration (GO:2000401),-0.5167351225024778,-1.1819384739745649,0.27705627705627706,0.8058300749315864,1.0,4/10,19.77%,JAM2;AKT1;SLC8B1;MIA3
prerank,peptide hormone secretion (GO:0030072),0.4886918563136362,1.1809880089267133,0.29685157421289354,0.9617517793981143,1.0,2/26,2.79%,CAMK2G;ANXA1
prerank,regulation of neutrophil migration (GO:1902622),0.5878440529308689,1.1806364783968362,0.3157894736842105,0.9614361005191161,1.0,4/10,15.31%,JAM3;RHOH;MPP1;RHOG
prerank,organelle organization (GO:0006996),0.38493813256396686,1.1802819456425742,0.13880445795339413,0.9611915796364006,1.0,71/388,14.15%,PALLD;TPM1;ARHGEF7;WTIP;MAST4;MICAL2;CHMP4C;PLCE1;LIMD1;SYNE1;ATP8B1;CNN2;DES;CLASP2;HSD17B10;PACSIN3;GABPA;PACSIN2;ARMC2;SORT1;GEM;TBC1D20;ARHGAP21;ARHGAP10;SIRT3;ATAD3A;DST;MARK1;LNPK;MYO18A;PEX2;CAV1;PITPNB;SEC31B;CHMP5;TERT;PARP1;ABCA3;YTHDF2;PPARGC1A;OPA1;MREG;MTX1;AUP1;MIEF2;ABCD4;LONP1;NSFL1C;DNM1L;TFB2M;PEX19;LONP2;KIF5C;KIFAP3;ESRRA;NECTIN2;CHMP2B;TNIK;PACSIN1;MICAL3;CDC42BPB;DMTN;CLASP1;MAST1;CAPZB;PNPLA3;CHMP2A;SIRT4;ADCK1;BNIP1;RAB14
prerank,chloride transmembrane transport (GO:1902476),0.4512764693384685,1.180109964615618,0.26861702127659576,0.9603580872940743,1.0,10/48,11.98%,ANO1;GABRE;ANO6;SLC4A8;GABRA4;GABRA5;GABRB2;GABRG1;ANO3;GABRB3
prerank,sulfur amino acid catabolic process (GO:0000098),0.5900716921668681,1.179805289143548,0.30824372759856633,0.9598949325348236,1.0,2/10,5.94%,TXN2;BLMH
prerank,epithelial cell migration (GO:0010631),0.47596370738704996,1.1796963606424395,0.25204359673024523,0.9588123288376627,1.0,7/37,3.29%,PTP4A3;ROCK1;ZEB2;PLXND1;CDH13;LOXL2;KANK1
prerank,sodium ion transmembrane transport (GO:0035725),0.41359467794636423,1.1788125568348442,0.24822695035460993,0.9602782700518806,1.0,10/84,5.82%,SCN4A;ASIC3;SLC6A17;ANO6;SLC8A2;SLC8A1;SLC4A8;SLC6A2;SLC6A5;ATP1B1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5089689363766658,1.1779669851365806,0.2857142857142857,0.9615376133749435,1.0,3/20,5.82%,KCNMA1;SLC8A1;ATP1B1
prerank,negative regulation of cytokine production (GO:0001818),-0.26194084078534585,-1.177928004757523,0.12162162162162163,0.8172711337213603,1.0,43/163,21.01%,LGR4;LEF1;APPL2;ARRB1;HMGB1;FN1;ITCH;APOD;RNF135;OTUD7B;MAPKBP1;LGALS9;HDAC7;ADCY7;ILRUN;UFD1;SRGN;PCBP2;CD34;NAV3;PTPN22;IRAK3;TRIM25;HOMER3;PDCD4;RGCC;SIRPA;RNF125;CX3CL1;ANXA4;SYT11;C1QTNF3;SSC5D;RARA;NLRC5;UBA7;NCKAP1L;ZC3H12A;TWSG1;BCL3;CEACAM1;CD274;PPP1R11
prerank,positive regulation of neutrophil migration (GO:1902624),-0.41577085415919024,-1.1777862537801473,0.22797927461139897,0.8157537311588822,1.0,6/18,19.38%,CAMK1D;MOSPD2;MCU;RIPOR2;NCKAP1L;TIRAP
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5169299515485465,1.1773493118512603,0.2961240310077519,0.9621928835526988,1.0,5/25,12.03%,CNRIP1;SOCS5;SOCS4;PPARA;TSG101
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5349598678712824,1.1772017726190716,0.2895927601809955,0.9612590710889173,1.0,4/18,4.36%,DLC1;ITGA3;KANK1;TNFAIP1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.4993881031975662,1.1771610687803844,0.2867540029112082,0.9599757049834274,1.0,5/28,7.29%,PRKAB2;NR1H4;PDK4;CCL5;MED1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.49157593583042253,-1.1771119460957313,0.2671081677704194,0.8162454952119319,1.0,8/11,30.91%,TET3;CTR9;TET2;OGT;SETD1A;PRDM9;KMT2A;BEND3
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.48947843686439996,1.1765879006535178,0.2983508245877061,0.9604578712478783,1.0,4/28,6.97%,NOTCH3;TCIM;FBXW7;YTHDF2
prerank,long-term synaptic potentiation (GO:0060291),0.5152524612382825,1.176284040974274,0.29635258358662614,0.9600651524966588,1.0,3/21,2.87%,CRHR2;SLC8A2;GRIN2C
prerank,response to muramyl dipeptide (GO:0032495),0.5720538176870522,1.175041606148539,0.30319148936170215,0.9627803549076527,1.0,3/12,6.34%,VIM;ARHGEF2;CHMP5
prerank,negative regulation of protein modification process (GO:0031400),0.4253442741287203,1.1747023448631837,0.24299065420560748,0.962435404267756,1.0,13/79,9.37%,DMD;NTRK3;ATP2B4;SNTA1;CRTAP;MFHAS1;MAPT;TPPP;DAB2IP;CORO1C;ENSA;IMPACT;CDYL
prerank,superoxide metabolic process (GO:0006801),0.4808013495756581,1.1743894655779747,0.28059701492537314,0.9620685144212187,1.0,1/29,0.36%,NCF2
prerank,vesicle transport along microtubule (GO:0047496),0.5056159590922015,1.1741998984227968,0.2876712328767123,0.9613062964789824,1.0,9/23,12.26%,KIF3B;KIF1A;KIF5B;TRAK1;FYCO1;KIF1C;KIFAP3;FBXW11;KIF5A
prerank,skin development (GO:0043588),0.4449089631691932,1.173619629762687,0.2753441802252816,0.9617862997351728,1.0,12/65,12.43%,RYR1;ITGA3;ANXA1;JAG1;TMEM79;FA2H;SLC2A10;MED1;EPHA2;PDGFA;BCR;COL3A1
prerank,response to laminar fluid shear stress (GO:0034616),-0.5104003514336036,-1.1735835808453214,0.2740899357601713,0.8260387431404737,1.0,5/10,24.60%,ABCA1;SMAD6;KLF2;ASS1;MAPK7
prerank,purine nucleotide metabolic process (GO:0006163),-0.3922614651649055,-1.1734930592162713,0.23380281690140844,0.8243482964070947,1.0,10/24,23.52%,XDH;NT5E;GART;HPRT1;PRPSAP2;ITPA;GPX1;PNP;GUK1;PRPS2
prerank,positive regulation of bone mineralization (GO:0030501),0.47833600902905316,1.1731904877630523,0.2793914246196404,0.9618844387250788,1.0,11/35,7.87%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;FZD9;ATP2B1
prerank,insulin secretion (GO:0030073),0.5203897532183785,1.1731688627731451,0.3051948051948052,0.9605445784454901,1.0,2/19,2.79%,CAMK2G;ANXA1
prerank,Ras protein signal transduction (GO:0007265),0.39821762827054075,1.1731131731324436,0.22850924918389554,0.959302466603355,1.0,27/137,11.36%,AGTR1;RAP1A;ROCK1;CDC42EP3;PLCE1;CCNA2;RASGRP2;CDH13;MYO9B;RERG;NTN1;KSR1;ARHGAP6;ARHGDIG;RAP2C;TP53;RRAS;CYFIP1;RAPGEF6;RASGRP1;GNA12;ARHGAP1;RAP2A;ROCK2;RB1;ARHGAP5;RHOH
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.371252332146072,-1.1730277297415161,0.24749163879598662,0.8240311408634763,1.0,7/29,13.88%,LEF1;TLE1;TCF7L2;BCL9L;CTNNB1;EP300;LEO1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.5638988804360355,1.172583289987609,0.30122591943957966,0.9596179589370947,1.0,4/13,7.85%,D2HGDH;DLST;GOT1;GOT2
prerank,protein localization to organelle (GO:0033365),-0.2711630077502648,-1.1725141320964794,0.09615384615384616,0.8237602393839526,1.0,39/133,17.26%,ANK2;COL1A1;BBS9;ZNF423;BMP7;BMP4;APP;DDX3X;RAB11A;CEP68;IFT122;GBF1;ALDH3A2;CEP250;CYB5A;TULP3;STX5;CNTLN;OPTN;TMEM30A;MDM2;GCC2;TOPORS;SSB;TOR1AIP1;SCG3;SGTA;SIX1;CALR;EMD;TOLLIP;EHD1;STX1A;LMBRD1;TRAM2;XPA;GABARAPL2;COG7;OBSL1
prerank,regulation of B cell proliferation (GO:0030888),0.45924237486770847,1.172205613300081,0.26422764227642276,0.9595168703786701,1.0,6/44,10.86%,MEF2C;IL2;TNFSF13B;BCL2;CD300A;TNFRSF21
prerank,angiogenesis involved in wound healing (GO:0060055),0.5757492660259897,1.172151638841298,0.30594405594405594,0.9583190469322511,1.0,3/11,7.48%,MCAM;VEGFA;ITGB3
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5405976753021727,1.1705934704752405,0.29411764705882354,0.9620554941403462,1.0,3/14,10.84%,ANO6;ITGA4;GPER1
prerank,negative regulation of GTPase activity (GO:0034260),-0.40001975421717606,-1.1695816527444765,0.25,0.8320171197367505,1.0,8/22,18.42%,CPEB2;WNK1;GMIP;GPSM1;RDX;RCC2;LRCH1;ARL2
prerank,regulation of gene expression (GO:0010468),0.37999880591496865,1.1687296258852615,0.079,0.9667871131636848,1.0,120/903,11.82%,MYOM1;ACTA2;CCDC3;SOX6;MLF2;MYLK2;TMPRSS4;TTN;WTIP;ACTG2;MEF2C;NTRK3;CRIP1;ATP2B4;HEY2;ZFHX3;ACTA1;ANGPT1;PTP4A3;ROCK1;FGF1;CD36;LIMS1;LIMD1;MYD88;PDGFB;NAB1;ALPK2;CDK6;PLA2G3;RORA;SLC8A2;SLC8A1;MLF1;GABPA;HINFP;RBM38;SORT1;ACTG1;GCNT2;RBAK;PRDM1;CD276;MUSK;RBMS3;UBR5;ATXN1;OSR2;HAVCR2;BMPR1A;SLC38A2;EMILIN1;PRKCQ;TESC;ATP1B1;MYBBP1A;TAF1;MAPT;TERT;TP53;SLC2A10;VEGFA;FBXW7;PIN1;ZBTB38;GDNF;SFPQ;YTHDF2;AR;PPARGC1A;TRAF3;MED1;PPARGC1B;ZNF431;CELF1;REXO4;BTG1;YAP1;NAT8;C1QTNF1;SOX9;SNAI2;DICER1;TGFB2;RELA;KMT2D;ADNP2;DAPK3;CUX2;TRIM68;MBNL2;MAP2K1;MSL3;FUS;NSD3;PPIE;KAT7;RPL5;HIF1A;PTBP2;MBNL1;NR2C2;NUP107;TOB2;GPER1;ROCK2;SRSF10;RUNX1;ANKRA2;RB1;RHOH;TERF2;BAZ2A;AFF1;NFX1;ACVR1B;ESRRA;CNOT7;PSPC1;USP13
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.2991987351199956,-1.167923931565463,0.21693121693121692,0.8356839568341574,1.0,18/70,7.71%,ELMO1;PIK3CA;GRB2;CYFIP2;PTK2;ABI1;WIPF2;BAIAP2;ARPC5;VAV2;WASF2;PLCG2;ARPC3;NCK1;HSP90AB1;PIK3CB;ARPC4;PRKCE
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.44254320913408074,-1.1679166629310482,0.2717948717948718,0.8337268887239181,1.0,7/16,19.06%,BMP7;SOX13;NAPEPLD;SIX1;PTGS2;TFE3;METRNL
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.4031534756854658,-1.1677693076155153,0.2727272727272727,0.8302410803751553,1.0,3/21,1.39%,EYA2;EYA1;EYA4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.4031534756854658,-1.1677693076155153,0.2727272727272727,0.8302410803751553,1.0,3/21,1.39%,EYA2;EYA1;EYA4
prerank,response to thyroid hormone (GO:0097066),-0.4799549405561075,-1.1676986844567565,0.27053140096618356,0.828509042722352,1.0,7/13,20.87%,CTSL;CTSH;RDX;CTSB;THRB;CTSS;LMO2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.48943776187702853,-1.1675311235784491,0.30697674418604654,0.8271619817402183,1.0,4/11,16.30%,SCARA3;CASP8;UNC93B1;TLR3
prerank,regulation of phospholipase activity (GO:0010517),-0.5031851899995128,-1.1675157781555578,0.25840336134453784,0.8252832672865904,1.0,4/10,14.15%,LRP1;PDPK1;FGFR2;SNCA
prerank,response to copper ion (GO:0046688),-0.4052892626790299,-1.1673619021027593,0.2605042016806723,0.8238541373527145,1.0,11/20,18.89%,SNCA;MT2A;MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1F;MT1B;HSF1
prerank,protein localization to membrane (GO:0072657),0.38992126207221034,1.167274731611032,0.23449001051524712,0.9703410035907357,1.0,48/187,16.94%,CACNB2;FLNA;TSPAN32;FGF13;RAP1A;ROCK1;FERMT2;CLASP2;EHD2;KCNB1;FYB2;KCNIP3;TESC;ATP1B1;ZDHHC2;CAV1;TTC7A;RAB3A;RAMP1;RAPGEF6;SAV1;ITGA4;LIN7C;EPHA2;RAP2A;ACTN2;AGRN;ROCK2;DPP10;TMEM88;TNIK;PACSIN1;RAB40C;SLMAP;GAS6;DVL1;TSPAN17;RAB34;RAB8B;FLOT1;PRAM1;RFTN1;ANK1;LIN7A;SMURF1;RAB8A;TM9SF2;RAB38
prerank,positive regulation of response to external stimulus (GO:0032103),-0.27013587389609484,-1.1668064039595458,0.15517241379310345,0.823767500452104,1.0,35/128,17.45%,PTN;BMP6;SASH1;IL15;APP;IL18;WNT5A;STX3;NFKBIA;PUM1;POLR3F;GPR4;STX4;NAPEPLD;TNFRSF1A;THBD;OPTN;TGFB1;RIOK3;PDCD4;SCARF1;POLR3B;DDX60;IL33;NFKBIZ;PPM1F;CX3CL1;SNCA;ANKRD17;PLA2G7;TLR3;GRN;SERPINE1;PDE2A;CCN4
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.31991329215895625,-1.1666145315571752,0.175,0.8225202020244106,1.0,21/59,19.28%,LEF1;AGO3;MED13;TCF7L2;CDK8;RUNX2;MED15;MED17;CTNNB1;MED25;MED27;SETX;TNRC6A;MED6;CEBPB;MED7;PPM1D;BAX;TNRC6B;MED24;MECP2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.41123384823013087,1.1661788681323606,0.24496644295302014,0.972486097518003,1.0,15/100,7.86%,NTF3;NTRK3;PIP5K1B;PDGFB;PDGFC;ROR1;PIP4K2A;PLXNB1;CCL5;PDGFD;PIK3AP1;DAB2IP;NEDD4;SOX9;TGFB2
prerank,carnitine shuttle (GO:0006853),0.5730172912165987,1.1661290786266372,0.3242258652094718,0.9712530133016408,1.0,5/11,14.41%,PRKAB2;ACACB;CPT1B;CPT1A;PRKAA2
prerank,sprouting angiogenesis (GO:0002040),-0.3212390508302215,-1.1656337283548512,0.23873873873873874,0.8237558602372527,1.0,25/51,19.77%,ROBO1;EFNB2;ADGRA2;BMP4;SLIT2;CCBE1;TEK;NRP1;ENG;PIK3R3;ACVRL1;RECK;PTK2B;JMJD6;RNF213;BMPER;RAMP2;KDR;VEGFC;AKT1;FGF2;VEGFB;ITGB1BP1;EPHB4;MIA3
prerank,response to UV-B (GO:0010224),0.5636118907435059,1.165579015064095,0.2987012987012987,0.9716733068317699,1.0,4/12,16.73%,CRIP1;RELA;HYAL1;MSH2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.4596776408363157,-1.1655080203272963,0.2777777777777778,0.8222864496554398,1.0,9/13,31.08%,ELOVL7;HACD4;ELOVL4;ELOVL6;HACD2;ELOVL1;HACD3;ELOVL5;TECRL
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.2984001452132706,-1.1654214568534609,0.20212765957446807,0.8206776330454939,1.0,18/71,7.71%,ELMO1;PIK3CA;GRB2;CYFIP2;PTK2;ABI1;WIPF2;BAIAP2;ARPC5;VAV2;WASF2;PLCG2;ARPC3;NCK1;HSP90AB1;PIK3CB;ARPC4;PRKCE
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5324621205570654,1.165380511236709,0.3201320132013201,0.9709205520303034,1.0,4/15,12.13%,CD36;MYD88;EIF2AK2;USP50
prerank,hippo signaling (GO:0035329),-0.3777721113744884,-1.1652067560394812,0.2564102564102564,0.8194650675417192,1.0,9/26,13.00%,TJP1;TJP2;AMOTL1;TEAD4;LATS2;WWC1;TEAD2;WWTR1;MOB1B
prerank,cellular potassium ion homeostasis (GO:0030007),0.540108092314801,1.165097740380172,0.32220367278797996,0.970466788658858,1.0,2/13,5.82%,KCNMA1;ATP1B1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.44716534191408613,1.165022891881028,0.2751322751322751,0.9693517133192361,1.0,13/48,12.81%,POLR2L;PADI2;H1-0;ARID1A;ACTB;MYBBP1A;CHEK1;ERCC6;POLR1E;SERTAD2;POLR1H;SMARCA5;SF3B1
prerank,cellular component assembly (GO:0022607),0.38159865026512807,1.1648612010673964,0.20901639344262296,0.9685016097457287,1.0,47/253,13.57%,FLNA;TCAP;PLS3;CALD1;LIMS1;FERMT2;LCP1;SH3BGR;ACTG1;MYO1B;SKAP2;FLNC;RSPH1;ACTB;CEP290;HAS2;CHAF1B;AFG3L2;LIMS2;TP53;ABCA3;LAMC1;RHOJ;YTHDF2;CYFIP1;PPARGC1A;MDN1;TOGARAM1;YAP1;SOX9;ADD2;MAGI1;PARVA;PAWR;SYCP2;TEAD1;DNM1L;PDGFA;TLCD2;RHOH;KIFAP3;SNX9;PDCD10;DMTN;KPNA3;FOXJ1;GAS6
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.3502909788672024,-1.164494014048907,0.21830985915492956,0.8200201334922635,1.0,8/36,8.60%,RBBP4;CBX5;MGA;TFDP1;RYBP;PHC3;PHC1;MAX
prerank,response to lipid (GO:0033993),-0.2853155358802787,-1.1643731656347975,0.12096774193548387,0.8185834238957168,1.0,32/105,17.24%,FOXP1;SMAD6;LBP;RBP4;FOXO1;LGALS9;SOCS2;ACER2;CTSH;IRAK1;NOCT;RPS6KA3;CTNNB1;PAQR7;PTPN22;IRAK3;PELI1;SPP1;NOS3;TAB2;ESR1;TGFB1;PAQR8;VPS4B;PCK2;SNCA;GCH1;IFNAR1;RARA;SRR;PPARG;TRIM16
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.29167738934592957,-1.164362823632867,0.14388489208633093,0.8167375434525141,1.0,28/91,17.80%,BMP6;ABCG2;CP;FBXL5;APP;SLC39A10;SLC30A10;SCARA5;ABCB7;SLC39A8;ATOX1;FTL;ATP6AP1;ATP6V1G1;FTH1;SLC30A1;ACO1;SLC39A6;MT2A;SMAD4;MT1A;MT1H;MT1M;MT1E;MT1X;MT1G;MT1F;MT1B
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4972975250129077,1.1637971109078218,0.3172514619883041,0.9705963012270067,1.0,2/25,2.87%,MEF2C;GRIN2C
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.4578932699492924,-1.1636742270319373,0.27522935779816515,0.817284320002521,1.0,4/14,5.71%,WNK1;WNT5A;PTK2B;ADAM10
prerank,regulation of establishment of protein localization (GO:0070201),0.5591997269088295,1.1634625892155885,0.33448275862068966,0.9702885708468159,1.0,5/13,19.23%,PTP4A3;CEP290;CEP120;CEP295;CEP135
prerank,alcohol catabolic process (GO:0046164),-0.4994232872865588,-1.1627657116971277,0.29318181818181815,0.8183198741505159,1.0,3/10,10.72%,CYP27A1;APOE;SCARF1
prerank,external encapsulating structure organization (GO:0045229),0.38943361007929495,1.1627166588802285,0.22280334728033474,0.9713792765283913,1.0,28/205,8.54%,ITGA8;TTR;MMP17;COL18A1;COL4A2;COL4A1;ITGB6;ELN;ADAMTS14;ITGA7;LAMA5;PDGFB;ITGA1;ITGA3;ADAMTS5;ADAMTS19;COL4A6;ITGB1;BGN;JAM3;PXDN;ITGB5;LAMC1;LAMB2;ITGB3;ITGA4;COL27A1;COL4A5
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5023242270013394,1.161909193649236,0.3068535825545171,0.9726787552959941,1.0,5/24,8.26%,ROCK1;ITGB1;CCL5;TNIP1;ITGA4
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.4969974690028899,-1.1617306749444496,0.3050847457627119,0.8199634248685783,1.0,4/10,17.22%,BMP6;RGCC;PPM1F;NOTCH4
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.45788019459722695,-1.1616423145586503,0.2867647058823529,0.8183330909441332,1.0,7/13,21.39%,NOS3;GCH1;PRKG2;AKT1;PTS;FPGS;SPR
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.4988919787726484,1.1614667534590257,0.300462249614792,0.9727337666815525,1.0,5/22,13.14%,IL2;LAG3;CBFB;RUNX1;BCL6
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.2970300191102553,-1.1614120607631784,0.1837837837837838,0.8173094160233831,1.0,18/73,7.71%,ELMO1;PIK3CA;GRB2;CYFIP2;PTK2;ABI1;WIPF2;BAIAP2;ARPC5;VAV2;WASF2;PLCG2;ARPC3;NCK1;HSP90AB1;PIK3CB;ARPC4;PRKCE
prerank,extracellular structure organization (GO:0043062),0.3883797559881982,1.1609740953982064,0.22291666666666668,0.9728799163144622,1.0,28/204,8.54%,ITGA8;TTR;MMP17;COL18A1;COL4A2;COL4A1;ITGB6;ELN;ADAMTS14;ITGA7;LAMA5;PDGFB;ITGA1;ITGA3;ADAMTS5;ADAMTS19;COL4A6;ITGB1;BGN;JAM3;PXDN;ITGB5;LAMC1;LAMB2;ITGB3;ITGA4;COL27A1;COL4A5
prerank,negative regulation of lipid storage (GO:0010888),-0.42494763144470343,-1.1608552027228871,0.24728260869565216,0.8172587331615766,1.0,5/19,6.78%,OSBPL8;ABCA1;NFKBIA;ITGAV;ABHD5
prerank,negative regulation of TORC1 signaling (GO:1904262),0.5545231167677243,1.1606295546109415,0.32646048109965636,0.9725450805845101,1.0,5/13,15.37%,RNF152;KPTN;CASTOR1;CASTOR2;ITFG2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.4557637347242968,1.1605870941089536,0.2883845126835781,0.9712917335691711,1.0,10/43,12.03%,ARHGEF7;ITGA1;SOCS5;SOCS4;DAB2IP;DUSP3;AREG;HBEGF;STAM2;TSG101
prerank,actin filament bundle assembly (GO:0051017),0.4680053677237823,1.1604644655029428,0.29461756373937675,0.9703198522289274,1.0,6/33,10.16%,PLS3;CALD1;LCP1;MYO1B;ADD2;PAWR
prerank,nuclear membrane disassembly (GO:0051081),-0.4551517326136182,-1.1600880637033166,0.2773722627737226,0.8179421823797695,1.0,4/14,16.58%,PRKCB;AKAP8L;NEK9;NEK6
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5517682599871601,1.1598866002395585,0.3286219081272085,0.9708187339085628,1.0,2/12,7.14%,CACNA1H;AKR1B1
prerank,neuron maturation (GO:0042551),-0.4198150252492265,-1.1593295944434618,0.2493573264781491,0.8186410119355316,1.0,10/18,21.23%,APP;ADGRB3;B4GALT6;ANKS1A;SCARF1;CX3CL1;EPHA8;PICK1;LGI4;MTCH1
prerank,negative regulation of coagulation (GO:0050819),-0.44869389563401785,-1.1592972933225807,0.27294117647058824,0.8169188146426888,1.0,5/14,8.27%,APOE;VTN;TFPI;CD34;THBD
prerank,fatty acid elongation (GO:0030497),-0.46586129678160043,-1.1591601929510238,0.28045977011494255,0.8155189653872875,1.0,7/13,22.85%,ELOVL7;HACD4;ELOVL4;ELOVL6;HACD2;ELOVL1;HACD3
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3407620748377655,-1.1589098136461449,0.23693379790940766,0.8145230425152864,1.0,13/39,18.87%,TSPAN5;ROBO1;AAK1;BMP2K;ZMIZ1;NOS3;CCN3;SNW1;EP300;JAG2;MAML1;NOTCH4;ITGB1BP1
prerank,ventricular septum morphogenesis (GO:0060412),0.4847503730690725,1.1587839321960867,0.32047477744807124,0.9730618666078388,1.0,5/27,7.86%,SLIT3;HEY2;HEYL;BMPR1A;TGFB2
prerank,kidney development (GO:0001822),0.43453652283924044,1.1587595108059567,0.2901618929016189,0.9717579621247114,1.0,8/65,7.86%,ITGA8;AGTR1;OSR2;CEP290;HAS2;VEGFA;GDNF;TGFB2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.45490870576229425,1.1582995656863768,0.30517711171662126,0.9719053365706898,1.0,7/39,6.96%,ACTN4;JAG1;KANK1;FZD4;GCNT2;AJAP1;CORO1C
prerank,eye development (GO:0001654),-0.32232328497941504,-1.15826280298239,0.19457013574660634,0.8147324478700608,1.0,9/54,6.53%,SHROOM2;FBN1;SMOC1;EFEMP1;LAMA1;PBX3;FBN2;RBP4;COL5A1
prerank,anion transmembrane transport (GO:0098656),-0.3054445957745545,-1.1581236718194483,0.2,0.8133649610568469,1.0,34/67,33.13%,SLC6A13;SLC13A4;SLC16A12;SLC1A3;SLC13A3;LRRC8B;SLC3A2;SLC7A5;SLC39A8;SLC6A9;SLC25A14;SFXN2;SLC35A2;SLC25A30;SLC38A5;SLC25A11;SLC25A38;LRRC8D;SLC1A1;SLC6A8;SLC25A22;LRRC8A;ABCC5;SLC25A19;SLC25A21;SLC1A2;SLC5A6;SLC35C2;SLC25A18;SFXN3;SLC13A5;SLC1A6;SLC35B1;PRAF2
prerank,fluid transport (GO:0042044),-0.47104907998000356,-1.158023508653229,0.28978622327790976,0.8119437312290633,1.0,1/12,1.63%,PDPN
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.47162418683505797,1.1578907480607379,0.27692307692307694,0.9718266276474139,1.0,2/35,0.77%,NTF3;NTRK3
prerank,bile acid and bile salt transport (GO:0015721),0.5005221502863166,1.1578897405836455,0.3156297420333839,0.9704681412332481,1.0,3/24,2.91%,NR1H4;ATP8B1;SLC10A1
prerank,histone H3 acetylation (GO:0043966),-0.34175172838201273,-1.157769143704742,0.22435897435897437,0.8110033593701115,1.0,13/40,18.19%,LEF1;MBIP;TADA2A;YEATS2;TADA1;DR1;BRPF1;PER1;NAA60;TAF12;MEAF6;TRIM16;TAF6L
prerank,cellular response to interleukin-6 (GO:0071354),-0.3687966555158596,-1.1574412663017213,0.25925925925925924,0.8103440077636925,1.0,6/26,8.49%,PID1;ST3GAL6;SBNO2;PTPN11;CTR9;IL6R
prerank,regulation of blood coagulation (GO:0030193),-0.3914126143875401,-1.1573907764984928,0.23885350318471338,0.8087373529897024,1.0,6/27,8.27%,ST3GAL4;APOE;VTN;TFPI;CD34;THBD
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.48647965876197363,-1.157101740524573,0.28337236533957844,0.807874580439897,1.0,6/11,23.00%,IP6K1;IP6K2;PPIP5K2;FGF2;ITPKB;IPPK
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4552086670530095,1.156887337857942,0.28360215053763443,0.9723038301495446,1.0,11/40,7.87%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;FZD9;ATP2B1
prerank,digestive tract morphogenesis (GO:0048546),0.5416143451494833,1.156441307959098,0.3167495854063018,0.9723789879650133,1.0,1/14,0.81%,RBPMS2
prerank,ganglioside metabolic process (GO:0001573),-0.40780221324237015,-1.1564008270281423,0.2440944881889764,0.8085811783197748,1.0,10/20,29.51%,ST8SIA4;ST3GAL5;ST6GALNAC3;ST8SIA2;HEXA;ST6GALNAC5;ABCA2;NEU1;ST6GALNAC4;ST8SIA3
prerank,renal water homeostasis (GO:0003091),0.5081116973042932,1.1562445855216688,0.30112721417069244,0.9716576136543382,1.0,9/23,15.25%,ADCY5;ADCY2;ADCY9;PRKACB;PRKAR1B;ADCY6;MYO5B;PRKACA;RAB11FIP2
prerank,genitalia development (GO:0048806),0.5492825199124644,1.1559064675205737,0.3333333333333333,0.9713877207152685,1.0,1/12,0.60%,LHCGR
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5500537757708557,1.155877477932239,0.3380281690140845,0.9701339469793054,1.0,3/12,8.12%,DMD;ATP1B1;WNK2
prerank,protein polyubiquitination (GO:0000209),-0.2447489169189929,-1.15577049345976,0.05263157894736842,0.8088306612535906,1.0,72/297,14.53%,TTC3;SASH1;NEDD4L;FBXL7;TRIP12;FBXL5;RNF146;AREL1;ITCH;FBXO10;CUL3;TNKS2;ANAPC1;RNF20;PPIL2;UBE2D3;NPEPPS;RNF135;RC3H2;RNF144B;SHPRH;RNF217;UNKL;RNF6;UBR2;CTNNB1;BIRC2;FBXO9;PSMD7;PSMD9;PSMD13;RNF213;MDM2;PELI1;FBXO4;TOPORS;UBE2E2;CDC23;UBE2E3;FBXO7;RBCK1;WWP1;SMURF2;RNF144A;RNF31;PRKN;UBE3A;UBE4B;PSMB3;UBC;TRIM5;RNF34;STUB1;HECTD2;RMND5A;SKP2;DZIP3;LONRF1;TRIM14;RNF125;DTX3L;RNF166;PSMC5;FBXW8;SIAH1;PSMA5;PSMA1;PSMC2;UBE2H;RNF115;HECW1;CDC26
prerank,regulation of coagulation (GO:0050818),0.5727474034455977,1.1556866355336823,0.3293310463121784,0.9693574192934332,1.0,2/11,6.08%,PROCR;CAV1
prerank,myeloid cell development (GO:0061515),-0.4098802106445436,-1.155600869921302,0.26666666666666666,0.8076200879516678,1.0,5/18,7.97%,FOXP1;KIT;ANXA2;APP;ALAS1
prerank,response to interleukin-1 (GO:0070555),0.41373226573097527,1.1555558139078546,0.2807646356033453,0.9684172771925071,1.0,17/73,14.87%,MYD88;ANXA1;CCL5;PTGIS;UPF1;HAS2;TNFRSF11A;DAB2IP;SOX9;RELA;NR1D1;HIF1A;CCL14;YTHDC2;GBP2;HYAL1;PRKCA
prerank,peptidyl-proline hydroxylation (GO:0019511),0.5569089505556617,1.155359510037195,0.3134057971014493,0.9677229692211452,1.0,4/11,10.29%,P3H2;CRTAP;P4HTM;P4HA2
prerank,regulation of histone methylation (GO:0031060),-0.46133590041982386,-1.154927067023288,0.2691358024691358,0.8081106537328671,1.0,8/13,37.74%,NSD1;CTR9;CHTOP;PIH1D1;JARID2;PAF1;AASS;TTLL12
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.5551773280949273,1.154718095343508,0.3217391304347826,0.9684789973515622,1.0,2/12,6.73%,PRKCQ;IL12RB1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.3729524927715481,-1.1544192224352325,0.26126126126126126,0.8080027424874378,1.0,12/27,30.50%,ENPP2;PLA2G6;GDPD1;ABHD12;PLA2G7;GDE1;GPCPD1;PNPLA6;INPP5F;ENPP6;PNPLA8;SMPD4
prerank,positive regulation of JUN kinase activity (GO:0043507),0.49277570075002586,1.153820498729977,0.3181818181818182,0.9700482002208971,1.0,4/23,8.12%,MAP3K5;TNFRSF11A;DAB2IP;MAP3K10
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.533998808540344,1.153673524984035,0.3225283630470016,0.9691731744059813,1.0,3/15,5.82%,KCNA5;KCNN2;ATP1B1
prerank,positive regulation of cell migration (GO:0030335),0.37956567951825243,1.153534139779976,0.22336065573770492,0.9682904347380429,1.0,48/253,13.36%,NTF3;MYLK;ARHGEF7;NTRK3;ACTN4;FGF1;PDGFB;CCN1;PPP3CA;PDGFC;FERMT2;SEMA5A;CLASP2;CDH13;ACTG1;ITGB1;CCL5;GCNT2;PDGFD;SEMA6C;ARHGEF2;HAS2;SYNE2;CBLL1;CAV1;DAB2IP;VEGFA;SOX9;SNAI2;TGFB2;SUN2;ADAM17;WASHC1;HIF1A;PDGFRB;DOCK1;HBEGF;PDGFA;GPER1;ROCK2;ACVR1B;KIF20B;PDCD10;DMTN;CLASP1;CPNE3;FGF10;CEP43
prerank,regulation of pseudopodium assembly (GO:0031272),0.5797724269874991,1.1531124073590169,0.32575757575757575,0.9669919437402311,1.0,2/10,8.93%,CDC42EP3;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5797724269874991,1.1531124073590169,0.32575757575757575,0.9669919437402311,1.0,2/10,8.93%,CDC42EP3;WASHC1
prerank,magnesium ion transport (GO:0015693),-0.463864925558472,-1.1519211583284283,0.30114942528735633,0.8142808062758381,1.0,5/12,19.06%,TUSC3;SLC41A1;NIPAL2;NIPAL3;MMGT1
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.39625482660250116,-1.151871424253071,0.27123287671232876,0.8126705301637289,1.0,9/23,18.63%,SEL1L;DERL1;UFD1;SURF4;HSP90B1;OS9;LMAN1;SYVN1;HERPUD1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.46394881309914754,1.1511242067027352,0.29207232267037553,0.9720180554647422,1.0,8/32,11.28%,DLC1;ITGA1;PPP2R5A;PIN1;CALM1;CD300A;PDGFRB;PRKCD
prerank,regulation of microglial cell activation (GO:1903978),-0.4365426740623636,-1.1507524817831989,0.29797979797979796,0.8143892644683045,1.0,6/15,22.94%,LDLR;CX3CL1;SYT11;GRN;TTBK1;SPHK1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.45884781085783355,-1.1504166919399268,0.2850574712643678,0.8137609508514552,1.0,4/12,21.36%,HDAC4;CCN3;BHLHE41;TMEM119
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.31020789162763707,-1.149795032185513,0.22321428571428573,0.814032886886504,1.0,20/56,17.60%,KMT2E;DDX3X;CUL3;CCND3;EGFR;RAB11A;ADAMTS1;TFDP1;RDX;UBE2E2;CDC23;RGCC;VPS4B;RCC2;CDC25B;ANKRD17;AKT1;CDC25A;KLHL18;ANAPC4
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.36608029249071544,-1.1496783874832521,0.24242424242424243,0.8126834564035732,1.0,6/29,11.59%,ZBTB20;APOE;LDLR;LPGAT1;CREBL2;CREB1
prerank,diol biosynthetic process (GO:0034312),-0.4314073865996604,-1.1496251237398425,0.28391959798994976,0.8110786903910834,1.0,7/15,22.94%,SPTLC2;ACER2;ASAH2;GCH1;SPR;ABCA2;SPHK1
prerank,protein neddylation (GO:0045116),0.5554838714779171,1.1495565609728002,0.3406193078324226,0.9756651443478881,1.0,5/13,12.09%,DCUN1D2;RNF7;UBE2F;DCUN1D1;UBA3
prerank,regulation of cell growth (GO:0001558),0.3797417899084034,1.1494431249081307,0.24008350730688935,0.974657557346105,1.0,41/204,14.70%,SLIT3;AGTR1;AKAP6;PAPPA2;MYL2;PLCE1;RASGRP2;CAMK2D;IL2;RERG;FHL1;NET1;PABIR1;ATAD3A;FXN;BCL2;JADE1;PRKCQ;NDRG3;TP53;BTG1;TGFB2;ADNP2;ADAM17;NDUFS3;CRLF3;SERTAD2;SH3BP4;RB1;TCHP;ACVR1B;DCBLD2;HDGFL2;BCL6;CEP43;MUL1;SGK1;N6AMT1;HYAL1;NUBP1;VGLL4
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.32408922946610774,-1.1493263276996548,0.248868778280543,0.8102974286842776,1.0,10/53,9.53%,EYA2;EYA1;EYA4;DDX5;SPRED2;ATR;EGFR;FBH1;SMCHD1;BRCC3
prerank,actin filament bundle organization (GO:0061572),0.4683284625916785,1.1478590691578041,0.30403458213256485,0.9785133456365178,1.0,6/33,10.16%,PLS3;CALD1;LCP1;MYO1B;ADD2;PAWR
prerank,positive regulation of protein import into nucleus (GO:0042307),0.4674901192181906,1.1470193131466526,0.3217391304347826,0.979959195420938,1.0,5/28,13.54%,FLNA;UBR5;BAG3;PRKCD;TRIM28
prerank,cellular response to interleukin-4 (GO:0071353),-0.49425293009164695,-1.1466930740141712,0.2903930131004367,0.8170314460796977,1.0,3/10,20.34%,LEF1;STAT6;SHPK
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5680107613781988,1.1465295705981604,0.3403880070546737,0.9801786145930796,1.0,2/10,5.44%,CHADL;EMILIN1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.39107172319983485,1.1463554003241923,0.2649945474372955,0.9794180333046828,1.0,22/151,10.84%,RAP1A;NTRK3;ANGPT1;CD36;PDGFB;PDGFC;FERMT2;ROR1;THPO;CCL5;GCNT2;PDGFD;MFHAS1;TNFRSF11A;FBXW7;GAREM1;RASGRP1;MAP2K1;PDGFRB;CCL14;PDGFA;GPER1
prerank,regulation of protein import into nucleus (GO:0042306),0.4524084747619793,1.146002984770335,0.30392156862745096,0.9791616740105513,1.0,3/36,4.55%,FLNA;CABP1;UBR5
prerank,positive regulation of tissue remodeling (GO:0034105),0.5653419150241602,1.145795140336428,0.33134920634920634,0.978524299086478,1.0,2/10,3.19%,ROCK1;IL2
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3824538170697389,-1.1456357639803334,0.26373626373626374,0.8188027598135128,1.0,3/22,1.84%,ALDH1A2;RBP1;VKORC1L1
prerank,stabilization of membrane potential (GO:0030322),-0.4347506225911444,-1.1453057726907747,0.2825,0.8182117526115703,1.0,2/16,6.56%,KCNK2;KCNK5
prerank,glycine transport (GO:0015816),0.5640041213453065,1.1452043265957779,0.34824902723735407,0.9791680248773952,1.0,3/10,10.38%,SLC6A17;SLC6A5;SLC7A8
prerank,histone H2A ubiquitination (GO:0033522),-0.4230519478609066,-1.1452009025321812,0.2793733681462141,0.8167886153812985,1.0,6/17,22.78%,RYBP;UBR2;DDB1;DTX3L;BCOR;UBE2B
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.45365743904366146,1.1451071409211426,0.3012211668928087,0.9781230806302325,1.0,7/43,5.14%,RBPMS2;HTR1B;PDGFB;CDH13;IGFBP5;CCL5;BMPR1A
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.271096780890084,-1.1450765931347962,0.102803738317757,0.8155053238728418,1.0,29/113,17.14%,PTN;BMP6;IGF1;NRP2;AKT3;NOTCH2;TCF7L2;TGFA;BMP4;TEK;NRP1;EGFR;WNT5A;F3;BMPR2;SRSF6;OSR1;LAMB1;FGFR2;TGFBR1;RTN4;KDR;ARNT;VEGFC;AKT1;FGF2;GRN;STAT5A;VEGFB
prerank,maintenance of blood-brain barrier (GO:0035633),0.47332784892325874,1.1450758881112681,0.2838235294117647,0.9769033110263204,1.0,8/30,7.75%,DMD;VCL;ACTG1;ITGB1;ACTB;JAM3;LAMC1;MBP
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.37062022305695874,-1.1448909876027087,0.2733333333333333,0.8143684173922718,1.0,18/29,37.59%,MRE11;HSP90AB1;RAD50;ANKRD28;PPP6R3;TERF2IP;WRAP53;TELO2;CDK2;GAR1;TINF2;PPP6C;NOP10;PPIA;ACD;RPA1;RFC1;NHP2
prerank,protein tetramerization (GO:0051262),0.423726720577696,1.1447704344552865,0.2883895131086142,0.9765875739119331,1.0,11/67,12.68%,RYR1;KCNJ12;HSD17B10;CRYZ;ACACB;TRPM4;ALDOA;GLS;OSBPL2;TRPM2;HOMER1
prerank,regulation of cellular component movement (GO:0051270),0.4371728253498633,1.1445466536271838,0.3023560209424084,0.9759617010894485,1.0,10/49,10.88%,ACTN1;ACTN4;ROCK1;CDK6;VEGFA;DAPK3;ADAM17;PKN2;HBEGF;ROCK2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.3375301744354328,-1.1444570214578178,0.2397003745318352,0.8139447018875599,1.0,13/40,12.16%,DAB2;SMAD3;LEF1;COL1A1;PDPN;TCF7L2;BCL9L;CTNNB1;SDCBP;TGFB1;TGFBR1;RGCC;WWTR1
prerank,neuron projection morphogenesis (GO:0048812),0.3924015789360203,1.144355449060689,0.28324324324324324,0.9752273953278175,1.0,33/137,15.42%,NTF3;SDC2;ROCK1;PLXNB1;DOCK10;MAP1B;SLITRK5;ACTB;KLF7;MEF2A;SLITRK4;DAB2IP;AFG3L2;RAB3A;DICER1;IMPACT;BRSK1;FLRT1;S100A6;ZDHHC17;TNIK;PACSIN1;KIF20B;TAOK3;SGK1;EPHB1;LRRK2;ADGRB1;DVL1;ANKRD27;CNTNAP1;PTEN;DNM2
prerank,negative regulation of receptor binding (GO:1900121),0.5645637825262068,1.144188322616044,0.33676975945017185,0.9744629416518525,1.0,3/10,10.32%,ATP2A2;PTPRF;ATP2A3
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4036926062880687,1.1440926661407491,0.2744630071599045,0.9734525122245348,1.0,14/98,10.44%,NTF3;AGTR1;ANGPT1;PDGFB;DHRS4;CCL5;TP53;VEGFA;ACACB;CBR1;PPARA;ATAD1;PDGFRB;SCYL2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.37037305221247796,-1.143929394981392,0.271875,0.8139390421789645,1.0,12/29,26.99%,VTI1A;COPB2;COG6;COPE;GABARAPL2;COG2;NAPG;TRAPPC3;COPB1;GOLGA5;COPG2;GOSR1
prerank,negative regulation of lyase activity (GO:0051350),-0.42250032930213616,-1.1439102204948624,0.2947103274559194,0.8123159959200835,1.0,3/16,2.21%,ADGRV1;PALM;GRM3
prerank,regulation of actin filament depolymerization (GO:0030834),0.5525015063736236,1.1435927416617828,0.34262295081967215,0.9736956230034166,1.0,4/12,8.01%,SEMA5A;WDR1;PLEK;CFL2
prerank,nucleotide catabolic process (GO:0009166),-0.43288310047772915,-1.1432470555303842,0.2860520094562648,0.8128264193149491,1.0,7/16,19.77%,XDH;NT5E;SAMHD1;NUDT3;ITPA;GPX1;PNP
prerank,positive regulation of ossification (GO:0045778),0.4579182613037153,1.143036127398675,0.30707610146862485,0.9741706805570932,1.0,12/39,7.87%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;FZD9;TGFB2;ATP2B1
prerank,limb morphogenesis (GO:0035108),-0.39845827467327705,-1.1427057423993476,0.2796610169491525,0.8128671811091237,1.0,4/20,5.56%,PCSK5;CYP26B1;PTCH1;MEGF8
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4231493428989666,1.1425093858621058,0.29142185663924797,0.9745694933595684,1.0,10/72,5.09%,ABRA;GPR20;DLC1;SYNPO2L;ITGA3;MYO9B;KANK1;NET1;TNFAIP1;ARHGEF2
prerank,regulation of cholesterol efflux (GO:0010874),-0.3693089541172953,-1.1413486153492403,0.29906542056074764,0.8155557375234581,1.0,6/30,4.91%,LRP1;PLTP;APOE;PTCH1;LAMTOR1;NFKBIA
prerank,nitric oxide metabolic process (GO:0046209),-0.44036613887451204,-1.1413285860208622,0.30751708428246016,0.8139354723056442,1.0,6/14,21.39%,CYP1B1;NOS3;GCH1;AKT1;DDAH2;SPR
prerank,phosphatidylserine metabolic process (GO:0006658),-0.3502911733385379,-1.141257770107385,0.24675324675324675,0.8125116511966779,1.0,8/32,14.01%,OSBPL8;OSBPL10;PLA1A;SERINC1;PTDSS2;SERINC5;PLAAT3;ABHD12
prerank,Golgi ribbon formation (GO:0090161),-0.45283470060081776,-1.1409111586493483,0.30023640661938533,0.8119360999059672,1.0,7/13,20.67%,VTI1A;TMED5;OPTN;GCC2;GOLPH3;TRIP11;STX6
prerank,ethanol metabolic process (GO:0006067),0.5549952996673276,1.1408456840921293,0.34513274336283184,0.9785733095111407,1.0,1/12,0.89%,ACSS1
prerank,cochlea morphogenesis (GO:0090103),0.5559919989479957,1.140626861851013,0.33072407045009783,0.9779477985422976,1.0,2/10,7.68%,TBX18;SOX9
prerank,response to organic cyclic compound (GO:0014070),0.43340278011200367,1.14024223674101,0.3018134715025907,0.977927445219661,1.0,7/52,6.40%,PMAIP1;ABCB4;ANXA1;IGFBP5;CCL5;STRN3;ARL6IP5
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.3208875809842904,-1.1399292195633621,0.20320855614973263,0.8133422351645047,1.0,29/52,29.70%,DCPS;RC3H2;SAMD4B;LSM1;DIS3;EXOSC1;DCP2;PAN2;EXOSC9;PAN3;EDC4;CNOT11;TUT4;TUT7;LSM7;EXOSC2;EDC3;LSM2;LSM5;EXOSC7;EXOSC3;CNOT10;EXOSC5;LSM3;ZFP36;LSM6;PNLDC1;PDE12;POLR2D
prerank,positive regulation of type 2 immune response (GO:0002830),-0.44315082796549954,-1.1395179231558217,0.2971698113207547,0.813030870364626,1.0,4/14,24.60%,IL18;DENND1B;RARA;CD86
prerank,diterpenoid metabolic process (GO:0016101),0.42875910012742313,1.139329315166721,0.294973544973545,0.9795379347633957,1.0,7/55,7.14%,TTR;SDC2;LPL;DHRS3;RARRES2;GPC4;AKR1B1
prerank,mitochondrion morphogenesis (GO:0070584),-0.4674433582210067,-1.1391407056523772,0.3274725274725275,0.8126073830145998,1.0,5/11,22.17%,PID1;FIS1;PNPT1;NUBPL;SLIRP
prerank,regulation of gene silencing by miRNA (GO:0060964),0.4245627985536628,1.1391271407166454,0.28886168910648713,0.9789148589048143,1.0,20/62,19.65%,WTIP;POLR2L;LIMD1;POLR2I;NUP62;POLR2G;SEC13;NUP153;NUP107;AAAS;POLR2J;NUP98;NUP37;NUP210;STAT3;DHX9;NUP54;NUP160;NUP133;AGO1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.47202071143783764,-1.1390537090595572,0.32779097387173395,0.8112441767849173,1.0,5/12,27.47%,PPHLN1;SETDB1;MPHOSPH8;RESF1;SETDB2
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.3337400487609714,-1.1387056797525168,0.23137254901960785,0.8106866967051034,1.0,19/43,24.02%,CDC14B;NAE1;MRE11;RINT1;INTS3;BRCC3;BLM;NBN;TAOK1;FOXN3;NOP53;HUS1;ATM;CHFR;HMGA2;TAOK2;TRIM39;CLSPN;CDKN1A
prerank,peptide catabolic process (GO:0043171),-0.38375068018012337,-1.1384091978330684,0.2678062678062678,0.8099804137254751,1.0,6/23,10.15%,ANPEP;XPNPEP1;NPEPPS;CTSH;ECE1;ACE
prerank,adherens junction organization (GO:0034332),0.4423411714233789,1.1383749235460232,0.2989556135770235,0.980074733623612,1.0,13/48,12.73%,CDH6;VCL;FERMT2;CDH13;CDH4;ACTB;JAM3;CDHR3;CDH2;PAK2;TBCD;NECTIN2;CDH10
prerank,membrane lipid biosynthetic process (GO:0046467),-0.3110628229568802,-1.1382651928516756,0.26108374384236455,0.8087959844585122,1.0,13/58,9.47%,SGMS1;ST3GAL4;SGMS2;ELOVL7;CERS5;HACD4;SPTLC2;SPTSSA;ACER2;ALDH3A2;CERS6;SGPP1;CERT1
prerank,negative regulation of phagocytosis (GO:0050765),0.5131210070553048,1.1382409927648338,0.3274478330658106,0.9791920313112064,1.0,4/17,8.34%,FER1L5;DYSF;PIP4P2;CD300A
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5126608187181037,1.1382133707442317,0.33171521035598706,0.9779882157416655,1.0,4/18,8.26%,ROCK1;ITGB1;ADD2;ITGA4
prerank,synapse assembly (GO:0007416),0.42264047012657396,1.137606529190666,0.30934343434343436,0.9787148169837768,1.0,17/67,15.34%,FGF13;IGFN1;FZD5;PLXND1;PLXNB1;KIRREL3;PCDHB14;DSCAM;PCDHB11;CDH2;GABRB2;CBLN4;GABRB3;SHANK2;PLXNB2;DVL1;PTEN
prerank,organic hydroxy compound transport (GO:0015850),0.4619792811589696,1.137589566452986,0.3062937062937063,0.9774735828961001,1.0,4/36,2.91%,NR1H4;ATP8B1;SLC5A3;SLC10A1
prerank,neuron projection regeneration (GO:0031102),-0.47382823920648376,-1.1374865215701515,0.3080260303687636,0.8096129513693168,1.0,2/10,10.39%,PTN;MAPK8IP3
prerank,negative regulation of chemotaxis (GO:0050922),-0.358070815175147,-1.1374169983859175,0.2508250825082508,0.8082672209436326,1.0,8/31,7.79%,ROBO1;SEMA3D;SEMA3C;SEMA6A;SLIT2;SEMA7A;SEMA3A;SEMA4D
prerank,response to prostaglandin E (GO:0034695),-0.4902839506406189,-1.1372264575819964,0.32286995515695066,0.8071909543452417,1.0,1/10,0.16%,TGFBR3
prerank,peptidyl-lysine methylation (GO:0018022),0.47558884921768513,1.1366035256660416,0.32779456193353473,0.9793071702276327,1.0,8/26,15.16%,SMYD1;SETD6;SUV39H2;SETD3;ATPSCKMT;VCPKMT;N6AMT1;EEF1AKMT2
prerank,regulation of GTPase activity (GO:0043087),0.38254706070546685,1.136596319859144,0.25236593059936907,0.9780406094004165,1.0,33/177,11.20%,ARHGEF7;RAP1A;PRKG1;RGS6;LIMS1;RASGRP2;FERMT2;DOCK8;PLXND1;PLXNB1;BCAR3;DOCK10;ITGB1;CCL5;NET1;TBC1D20;RSU1;CHN1;LARS1;MAPRE2;RABGAP1;DAB2IP;PIN1;RAPGEF6;RASGRP1;EVI5;AGRN;ARHGAP12;CCL14;SNX18;VAV1;SH3BP4;ARHGAP15
prerank,T cell homeostasis (GO:0043029),0.56430096255084,1.1364058719278785,0.3333333333333333,0.9773403067452872,1.0,1/10,1.50%,PMAIP1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5573770009827783,1.1362749675819397,0.35150375939849626,0.9751416148310394,1.0,5/11,15.34%,INPP5A;SYNJ2;INPP5B;INPP5J;PTEN
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5573770009827783,1.1362749675819397,0.35150375939849626,0.9751416148310394,1.0,5/11,15.34%,INPP5A;SYNJ2;INPP5B;INPP5J;PTEN
prerank,positive regulation of protein processing (GO:0010954),0.49821632089842366,1.1358235280590425,0.3122977346278317,0.9752841175674655,1.0,4/19,13.17%,ANGPTL8;MYH9;LPCAT3;BAG2
prerank,embryonic axis specification (GO:0000578),-0.4283641907763349,-1.1355515883566742,0.28978622327790976,0.8110091004633916,1.0,3/15,3.58%,COBL;SMAD6;PTCH1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5544386438387574,1.1354821754265545,0.3605683836589698,0.9751318421351102,1.0,3/11,19.40%,PKD1L3;LPO;RTP4
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5092890907802053,1.1354734647990739,0.34755134281200634,0.9738866936034664,1.0,3/19,5.14%,MEF2C;TBX2;BMPR1A
prerank,autophagy of peroxisome (GO:0030242),-0.4593411894128734,-1.1353768761238934,0.30454545454545456,0.8100074575138345,1.0,6/12,28.27%,RB1CC1;PEX5;ACBD5;ATM;SQSTM1;MAP1LC3B
prerank,vitamin D metabolic process (GO:0042359),0.541855078014633,1.1352987324489772,0.34629629629629627,0.9732009090034803,1.0,2/13,5.63%,PIAS4;GC
prerank,secretion (GO:0046903),-0.4496242482672511,-1.1351664142581734,0.26666666666666666,0.809000380073163,1.0,4/14,15.79%,SLC22A6;NPR1;SLC22A4;FBLN5
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5454632556401462,1.135136014151925,0.33515482695810567,0.9724391135148549,1.0,4/11,10.01%,PADI2;ARID1A;CHEK1;SERTAD2
prerank,positive regulation of locomotion (GO:0040017),0.47813777728651147,1.1348210995135208,0.3101449275362319,0.9721048614488977,1.0,4/27,5.41%,CAVIN1;PDGFB;NTN1;RARRES2
prerank,nitric oxide biosynthetic process (GO:0006809),-0.44785912611123746,-1.134708902555565,0.3125,0.8088184625325632,1.0,6/13,21.39%,CYP1B1;NOS3;GCH1;AKT1;DDAH2;SPR
prerank,regulation of axonogenesis (GO:0050770),-0.32197982282256643,-1.1346695062419643,0.23412698412698413,0.8073562444691463,1.0,9/51,8.24%,PLXNA2;ROBO1;SLIT2;KIF13B;EPHA4;SIPA1L1;RUFY3;TIAM2;PLXNA4
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.4538754498735596,1.1342597665637932,0.3142857142857143,0.9726298423954625,1.0,9/39,12.03%,ARHGEF7;ITGA1;PTPN18;DAB2IP;DUSP3;AREG;HBEGF;STAM2;TSG101
prerank,regulation of multicellular organismal development (GO:2000026),-0.38645289308726966,-1.1341390465215453,0.27945205479452057,0.807472101225959,1.0,11/25,30.54%,PTN;TRIP12;INSR;SOX17;OAS2;SPAAR;DUSP6;KAT2A;CD24;TDG;RACGAP1
prerank,methylguanosine-cap decapping (GO:0110156),-0.4692731801367862,-1.1341118177598282,0.3273542600896861,0.8059480272439704,1.0,6/10,22.61%,DCPS;LSM1;DCP2;EDC4;PNRC2;EDC3
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.46043694231207904,-1.1338881593969135,0.30699774266365687,0.804959030951357,1.0,4/13,8.50%,AKT3;HMGB1;PDPK1;IGF2
prerank,positive regulation of B cell activation (GO:0050871),0.4379313406761253,1.1338514677294425,0.3099870298313878,0.9727135081819724,1.0,11/50,17.14%,MEF2C;IL2;TNFSF13B;BCL2;PAXIP1;RIF1;IRS2;KMT5B;MAD2L2;VAV3;MIF
prerank,pyroptosis (GO:0070269),-0.44099803553414446,-1.133843279121164,0.31738035264483627,0.8035090669692482,1.0,4/15,18.82%,GSDME;CASP8;GSDMD;CASP4
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5423843021121637,1.1338322350448868,0.35714285714285715,0.9715073988042155,1.0,1/13,1.50%,PMAIP1
prerank,negative regulation of protein binding (GO:0032091),0.4107914633145063,1.1335312172546224,0.3047735618115055,0.9711582515640566,1.0,17/71,14.51%,XIRP1;ROCK1;ATP2A2;PDGFB;ACTB;CAV1;PTPRF;PIN1;ITGA4;PPP1CA;PSME3IP1;ATP2A3;PRKCD;BAG2;CSNK1E;LRRK2;DVL1
prerank,zinc ion transmembrane transport (GO:0071577),-0.39764099816745074,-1.1327875593585692,0.28212290502793297,0.8050631750929138,1.0,7/22,15.28%,SLC39A10;SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC39A1;SLC39A6
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3664690077056428,1.132161839198065,0.23939393939393938,0.9743551222630396,1.0,55/390,10.88%,NTF3;ARHGEF7;NCF2;NTRK3;COL4A2;SDC2;ANGPT2;ANGPT1;ROCK1;FGF1;KALRN;MERTK;POLR2L;MST1R;PDGFB;POLR2I;PDGFC;PDK4;ROR1;FRK;ITSN1;COL4A6;BCAR3;SORT1;ACTG1;PDGFD;MUSK;ACTB;ACTR3;CHN1;RARRES2;POLR2G;ATP6V1H;IRS1;SORBS1;ATP6V0A2;MAPKAPK2;VEGFA;CYFIP1;LCP2;ITGB3;PLCB1;PAK2;SLA;EPHA2;ATP6V1C1;AXL;SIRT2;PDGFRB;DOCK1;FLRT1;SLC39A14;PDGFA;VAV1;ROCK2
prerank,positive regulation of apoptotic process (GO:0043065),0.3729781924561849,1.1321099692837793,0.25,0.9732357836289612,1.0,45/293,12.53%,KCNMA1;OBSCN;ARHGEF7;MAP3K20;DLC1;MAP3K5;PMAIP1;KALRN;ABR;ARHGEF17;ANO6;ITSN1;TGFB3;ITGB1;NET1;PTGIS;ARHGEF16;ARHGEF2;ATG7;MYBBP1A;DAB2IP;RPS6KA2;ARL6IP5;TP53;PHLDA3;BTG1;FZD9;TGFB2;MAP3K10;DAPK3;TNFAIP8;ARHGEF4;HRK;SIRT2;PAWR;DNM1L;VAV1;GPER1;TRIM35;BOK;CLIP3;CSRNP3;DIABLO;CLU;ITGB3BP
prerank,Rap protein signal transduction (GO:0032486),0.5679271242419792,1.1314606823566313,0.3692022263450835,0.9739850411410064,1.0,3/10,9.85%,RAP1A;RAP2C;RAP2A
prerank,protein insertion into ER membrane (GO:0045048),-0.34345008350682626,-1.1310272017264058,0.23986486486486486,0.8090055291755475,1.0,12/37,19.06%,APP;EMC2;ALDH3A2;CYB5A;STX5;SGTA;EMC3;EMC8;EMD;STX1A;TRAM2;MMGT1
prerank,negative regulation of cyclase activity (GO:0031280),-0.43863928237705274,-1.130934092356213,0.2938388625592417,0.8076955027296023,1.0,3/14,2.21%,ADGRV1;PALM;GRM3
prerank,epithelial to mesenchymal transition (GO:0001837),0.4321458341918174,1.1308678236561867,0.3160690571049137,0.9745596404630432,1.0,12/47,10.88%,HEY2;ROCK1;LIMS1;FAM83D;LOXL2;HEYL;SOX9;SNAI2;TGFB2;AKNA;HIF1A;ROCK2
prerank,positive regulation of chemotaxis (GO:0050921),0.44740754210888944,1.1306188426188912,0.32545931758530183,0.974089475979537,1.0,9/43,10.07%,NTRK3;PDGFB;SEMA5A;CDH13;RARRES2;DSCAM;VEGFA;ADAM17;PDGFRB
prerank,ephrin receptor signaling pathway (GO:0048013),0.404640702669938,1.1296423209779944,0.2998776009791922,0.975995862095122,1.0,9/82,4.73%,ARHGEF7;SDC2;ROCK1;KALRN;ITSN1;ACTG1;ACTB;ACTR3;CHN1
prerank,regulation of inclusion body assembly (GO:0090083),-0.474352272079411,-1.1291435341692764,0.3393258426966292,0.8117446300862874,1.0,6/11,35.64%,SNCAIP;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.44217345310576744,-1.1288011236437627,0.3087248322147651,0.8113295757353499,1.0,3/13,2.21%,ADGRV1;PALM;GRM3
prerank,regulation of leukocyte migration (GO:0002685),0.5307206719765036,1.1284818436302333,0.3451178451178451,0.9783310293981178,1.0,4/16,15.31%,ANXA1;VEGFA;RHOH;RHOG
prerank,extracellular matrix organization (GO:0030198),0.37105182855703955,1.1284028991328967,0.25635808748728384,0.9773211356143271,1.0,45/276,10.79%,ITGA8;TTR;MMP17;COL18A1;COL4A2;COL4A1;ITGB6;ELN;ADAMTS14;ITGA7;LAMA5;P3H2;PDGFB;ITGA1;ITGA3;ADAMTS5;LOXL2;HTRA1;KLK2;CRTAP;ADAMTS19;LCP1;COL4A6;ITGB1;BGN;DST;JAM3;HAS2;PXDN;ITGB5;LAMC1;LAMB2;ITGB3;TGFB2;ITGA4;COL27A1;COL4A5;WASHC1;CAPN2;ITGA9;AGRN;P4HA2;COL19A1;PDGFA;THSD4
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.49121389911323987,1.1281552639498176,0.32965299684542587,0.9768933339364834,1.0,4/19,6.80%,DYRK2;TP53;PHLDA3;RPS27L
prerank,potassium ion transmembrane transport (GO:0071805),0.3878263752325057,1.1278549424098843,0.2993421052631579,0.9766802878938118,1.0,17/135,11.35%,KCNAB1;KCNJ12;KCNQ5;KCNA5;KCNQ4;KCNN2;KCNE4;KCNB1;CCDC51;KCNH1;ATP1B1;KCNT2;SLC9A8;ABCC8;KCNH8;KCNK3;KCNA2
prerank,canonical glycolysis (GO:0061621),0.48120650406636706,1.127175723335748,0.3515151515151515,0.9763342825344692,1.0,5/24,11.23%,PFKP;ENO3;HK2;ALDOA;PFKM
prerank,glucose catabolic process to pyruvate (GO:0061718),0.48120650406636706,1.127175723335748,0.3515151515151515,0.9763342825344692,1.0,5/24,11.23%,PFKP;ENO3;HK2;ALDOA;PFKM
prerank,cellular response to lipid (GO:0071396),0.3741849736760942,1.1265783561029894,0.2840670859538784,0.9769495761820881,1.0,31/191,11.11%,MEF2C;ADCY5;NR1H4;MYD88;ADCY2;ABCB4;PDK4;RORA;VIM;FZD4;LPL;UPF1;CD14;TESC;IRS1;DAB2IP;CHMP5;AR;MED1;SOX9;NFKBIB;RELA;ADNP2;GSTP1;NR1D1;ADCY6;AXL;BRINP1;GPER1;ROCK2;CD180
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.4754613466092134,-1.126462802405732,0.32210526315789473,0.8170548708715091,1.0,4/10,19.06%,EMC2;EMC3;EMC8;MMGT1
prerank,regulation of T cell migration (GO:2000404),0.5027582489796327,1.1257498809018978,0.36082474226804123,0.9784369472903506,1.0,4/18,6.99%,DOCK8;CCL5;CD200R1;CD200
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5290964116386426,1.1254923923472506,0.3546099290780142,0.9779643321167055,1.0,5/14,9.32%,RAD51AP1;PARP1;ERCC6;FUS;FANCB
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.4481809206085261,-1.1254093013452788,0.3294930875576037,0.8186725173149937,1.0,2/13,2.35%,DKK3;APOE
prerank,defense response to symbiont (GO:0140546),0.39557599548148864,1.1253820302743467,0.3071593533487298,0.9770583705562104,1.0,9/92,7.89%,FLNA;PMAIP1;MYD88;CGAS;BCL2;ATG7;LYST;ABCE1;RELA
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.48084277507001005,-1.124722052202829,0.32905982905982906,0.8191639202055102,1.0,2/10,2.40%,APOE;ABCA1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.40784420116023884,-1.1241367548534555,0.3007915567282322,0.8193274949798189,1.0,4/18,11.42%,PTN;NF1;PTPRZ1;HES1
prerank,regulation of osteoblast proliferation (GO:0033688),0.5086180494409495,1.1231576816059348,0.3338815789473684,0.9827356233921385,1.0,4/17,10.61%,CCN1;PLXNB1;MN1;EIF2AK2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4763183757234275,-1.1229957312070022,0.3211845102505695,0.8211786731808215,1.0,4/10,14.02%,PRKCB;VTN;ITGA5;ARNT
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.34039382832723986,-1.1228821896476393,0.29591836734693877,0.8199499505124462,1.0,13/38,25.15%,BMP6;SASH1;PUM1;POLR3F;RIOK3;POLR3B;DDX60;ANKRD17;GRN;SLC15A4;GBP5;POLR3C;POLR3D
prerank,regulation of protein kinase A signaling (GO:0010738),0.4930773520119915,1.122423781490697,0.3486088379705401,0.9836851965280738,1.0,2/20,2.08%,AKAP6;TCIM
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5078047341100428,1.122367713658726,0.35581787521079256,0.9826129521814418,1.0,5/15,14.92%,PMAIP1;IRS1;PPARA;LDLRAP1;IRS2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.48374414589451203,-1.1223671831111015,0.3424036281179138,0.8199170968328665,1.0,4/10,14.57%,USP7;SIRT7;OGT;DGKQ
prerank,negative regulation of immune system process (GO:0002683),0.5266230060492868,1.1215809450543996,0.3684210526315789,0.9838338306535028,1.0,4/16,12.43%,CD200;SOX9;GPER1;COL3A1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.41236287217885453,-1.121555715832397,0.32,0.8208773164938008,1.0,7/17,19.66%,ARRB1;OTUD7B;MAPKBP1;PTPN22;ANXA4;SSC5D;BCL3
prerank,membrane repolarization (GO:0086009),-0.4291689760271338,-1.1214834310445123,0.3018867924528302,0.8194994545339437,1.0,4/15,9.85%,ATP1A2;ATP1B3;ATP1B2;KCND3
prerank,type I interferon signaling pathway (GO:0060337),-0.32146459315996323,-1.1208238669316117,0.2748091603053435,0.8183536686281073,1.0,18/41,22.75%,IFNAR2;IRAK1;SAMHD1;IP6K2;SP100;STAT2;IRF9;IFIT1;IFIT3;IFNAR1;ADAR;BST2;IFITM1;OAS2;IFITM3;IFIT2;RNASEL;IFI27
prerank,cellular response to type I interferon (GO:0071357),-0.32146459315996323,-1.1208238669316117,0.2748091603053435,0.8183536686281073,1.0,18/41,22.75%,IFNAR2;IRAK1;SAMHD1;IP6K2;SP100;STAT2;IRF9;IFIT1;IFIT3;IFNAR1;ADAR;BST2;IFITM1;OAS2;IFITM3;IFIT2;RNASEL;IFI27
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.36246532712178975,-1.1205673038949164,0.28530259365994237,0.8174812458977868,1.0,8/26,19.27%,POR;APOE;NPR3;NOS1AP;PIK3CB;GCH1;AKT1;PARK7
prerank,acute-phase response (GO:0006953),0.5442109855179927,1.1203982713361678,0.3496376811594203,0.9862764216055658,1.0,3/12,7.82%,ITIH4;MBL2;IL22
prerank,synaptic vesicle membrane organization (GO:0048499),-0.42303909759961456,-1.120128091289306,0.3249370277078086,0.8172324517892311,1.0,8/17,26.78%,STX3;STX4;SNAP29;STX1A;SYP;STX2;TOR1A;SYNGR2
prerank,lipid transport (GO:0006869),-0.27955356810066484,-1.1199017351575586,0.18181818181818182,0.8163835192830939,1.0,26/97,15.20%,OSBPL8;PITPNA;ATP8A1;ABCA9;PLTP;APOE;ABCA1;SLCO2B1;LBP;CHKA;ABCA4;LDLR;SLCO1C1;NCOA1;SLC25A17;SLCO2A1;PITPNC1;SLCO3A1;ABCC4;CERT1;SPNS2;PLEKHA3;ABCA6;ABCD3;CLN3;TNFAIP8L3
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.4454006454068393,1.1198846799389013,0.3342857142857143,0.9865750534107709,1.0,6/35,10.07%,PPP1R12A;ITGA1;CALM1;NUAK1;CD300A;PDGFRB
prerank,regulation of mitochondrial translation (GO:0070129),0.48875391984784056,1.119193941680109,0.33690658499234305,0.9874710860916276,1.0,11/21,20.37%,RPUSD3;TRMT10C;RCC1L;TSFM;RPUSD4;FASTKD2;TRUB2;RMND1;MALSU1;UQCC2;C1QBP
prerank,toxin transport (GO:1901998),-0.47259528076641055,-1.1190999448227639,0.3528138528138528,0.8172320471613019,1.0,7/10,45.88%,ADAM10;RAB29;RAB40B;ANTXR2;SLC22A2;SLC22A3;SLC29A4
prerank,ERBB signaling pathway (GO:0038127),-0.30196585922750857,-1.118730474306937,0.2596685082872928,0.8167160258276728,1.0,14/64,11.28%,PIK3CA;EFEMP1;GRB2;TGFA;PDPK1;PTPN11;EGFR;PTK2;SLC30A10;GAB1;PTK2B;NRG2;TGFB1;STUB1
prerank,sphingosine biosynthetic process (GO:0046512),-0.4595089483799435,-1.1186362612247156,0.3301204819277108,0.8138734655705147,1.0,5/11,22.94%,SPTLC2;ACER2;ASAH2;ABCA2;SPHK1
prerank,sphingoid biosynthetic process (GO:0046520),-0.4595089483799435,-1.1186362612247156,0.3301204819277108,0.8138734655705147,1.0,5/11,22.94%,SPTLC2;ACER2;ASAH2;ABCA2;SPHK1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.38519450674827493,-1.1185735593487893,0.2981029810298103,0.8125282744888132,1.0,11/25,21.40%,SMAD3;PKD2;NOS1AP;HSP90AB1;DDAH1;PTGS2;KLF2;INSR;AKT1;DDAH2;ASS1
prerank,negative regulation of leukocyte activation (GO:0002695),0.5251084818558922,1.1183194899613993,0.34290843806104127,0.9888792289140595,1.0,5/15,10.84%,MILR1;HAVCR2;CD200;CD300A;GPER1
prerank,regulation of leukocyte activation (GO:0002694),0.5089102481345611,1.1182492936489847,0.35130718954248363,0.9879006883939047,1.0,4/14,10.84%,MFHAS1;MYO18A;CD200;GPER1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.41599215451885185,1.1176304342669898,0.32684824902723736,0.9885846149763486,1.0,8/55,10.07%,AGTR1;PDGFB;DHRS4;ALOX5;TP53;CBR1;SIRT2;PDGFRB
prerank,cellular response to gamma radiation (GO:0071480),0.5040378934304207,1.1173186207173589,0.3640699523052464,0.9883763930986709,1.0,3/17,7.59%,MAP3K20;TP53;YAP1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.45075460142808443,-1.1165851300548548,0.3581395348837209,0.8170574413811622,1.0,5/13,8.24%,PLXNA2;NRP2;NRP1;SEMA3A;PLXNA4
prerank,regulation of protein neddylation (GO:2000434),0.553845010887083,1.1165181385484295,0.3714821763602251,0.9897155353374142,1.0,4/10,9.57%,DCUN1D2;DCUN1D1;RPL5;HIF1A
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.34282670000290466,-1.1163267017688783,0.2956810631229236,0.8163333498835099,1.0,7/30,21.37%,HMGB1;LGALS9;PLCG2;CD34;CD46;CD274;HSPD1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.4496271897383543,1.1158051896848695,0.33469945355191255,0.9907178218401712,1.0,5/35,4.74%,FLNA;SEMA5A;PLXND1;PLXNB1;SEMA6C
prerank,protein localization to cell-cell junction (GO:0150105),-0.4275190959432996,-1.1157680135550911,0.31840796019900497,0.8165211012984748,1.0,5/15,6.56%,TJP1;CGNL1;TJP2;CDH5;LSR
prerank,epithelial cell morphogenesis (GO:0003382),0.5001872351074106,1.115593820764609,0.3448275862068966,0.9901425750813372,1.0,1/17,0.72%,COL18A1
prerank,stress fiber assembly (GO:0043149),0.5202470722017062,1.115430344593043,0.34318555008210183,0.9881754302947631,1.0,7/15,12.63%,PDLIM1;ITGB1;TNFAIP1;ITGB5;SORBS1;FHDC1;PDCD10
prerank,contractile actin filament bundle assembly (GO:0030038),0.5202470722017062,1.115430344593043,0.34318555008210183,0.9881754302947631,1.0,7/15,12.63%,PDLIM1;ITGB1;TNFAIP1;ITGB5;SORBS1;FHDC1;PDCD10
prerank,positive regulation of chromosome organization (GO:2001252),-0.4232604108569472,-1.1151792623140475,0.33753148614609574,0.8168453644907329,1.0,5/15,12.84%,MRE11;PML;RAD50;GNL3;NBN
prerank,negative regulation of translation (GO:0017148),0.3990977287264253,1.1151045204956094,0.31338028169014087,0.9879054103417375,1.0,20/87,14.33%,RBM24;ROCK1;IGFBP5;SAMD4A;MRPL13;BTG2;EIF4EBP1;CPEB1;YTHDF2;CELF1;FTO;DAPK3;EIF3E;EIF2AK2;ROCK2;CNOT7;CPEB3;SYNCRIP;GIGYF2;EPRS1
prerank,visual perception (GO:0007601),-0.27579879983553807,-1.1149750320124572,0.20945945945945946,0.8159600688279629,1.0,12/84,9.56%,PITPNA;COL1A1;EYA4;EFEMP1;ABLIM1;ADGRV1;COL11A1;SLC4A10;ZIC2;CEP250;EML2;MYO9A
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.4521877453653931,-1.114948419719979,0.32304038004750596,0.8145026104589845,1.0,3/12,16.58%,PRKCB;NEK9;NEK6
prerank,male gonad development (GO:0008584),0.4560019087356937,1.1147495222455404,0.3274215552523875,0.9878501851073872,1.0,5/34,7.86%,LHCGR;CSDE1;AR;SOX9;TGFB2
prerank,endocardial cushion development (GO:0003197),0.48976236065242357,1.114630459243165,0.34789391575663026,0.9869794781376626,1.0,5/21,7.86%,TBX2;HEYL;BMPR1A;SOX9;TGFB2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.40350043741679226,-1.114238367902647,0.30319148936170215,0.8151259331087503,1.0,7/18,18.04%,NLGN1;PTK2B;SHANK3;NRXN1;NLGN2;NLGN3;RIMS2
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.29140573435769657,-1.1142358696267067,0.23484848484848486,0.8136161591255113,1.0,35/87,25.39%,RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;SEC63;RPLP0;RPS29;RPL28;RPS10;RPLP1;RPS20;RPL23A;RPL34;RPL36A;RPS8;RPS21;RPL9;SEC61A1;RPS7;RPL27;RPL11;SRP9;RPL18A;RPL37A;RPL38;RPL29;RPL10A;RPL32;RPS4X;RPS27
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3960334243877942,-1.1139364740997904,0.3192090395480226,0.8130372770212175,1.0,4/20,7.18%,B2M;IL18;CD55;DENND1B
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.47755722703690673,-1.1135086033159405,0.34467120181405897,0.8129004363733116,1.0,5/10,14.45%,ATP1A2;NEDD4L;PRKCE;OSR1;HECW1
prerank,autophagy of nucleus (GO:0044804),-0.4131677331483635,-1.1133428732997417,0.32281553398058255,0.8119296456604902,1.0,10/16,28.28%,RB1CC1;ATG3;ATG5;ATG2B;WIPI2;ATG2A;WDR45B;ULK2;WIPI1;ATG12
prerank,bone development (GO:0060348),-0.3291285709885597,-1.1133305903960713,0.311787072243346,0.810471860627766,1.0,9/39,10.58%,RANBP3L;AKAP13;SULF1;GJA1;GNAS;CYP26B1;SLC10A7;SFRP4;FGFR2
prerank,regulation of endopeptidase activity (GO:0052548),0.4200038034257846,1.1128170941968623,0.3203517587939699,0.9912496632158608,1.0,3/59,3.37%,SERPINB8;SERPINI1;SERPINE2
prerank,signal transduction in response to DNA damage (GO:0042770),0.4226684140081844,1.112250634200621,0.3151595744680851,0.9918259517291618,1.0,12/49,10.63%,MAP3K20;HINFP;BRIP1;NDRG1;TP53;CHEK1;RAD9A;ERCC6;PAXIP1;STK33;FBXO6;RHNO1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3672626452702219,-1.1119412150691912,0.30140845070422534,0.8132285624274561,1.0,10/25,18.55%,IL31RA;IFNAR2;GHR;PKD2;SOCS2;CTR9;STAT2;IFNAR1;STAT5A;STAT6
prerank,organophosphate ester transport (GO:0015748),-0.37210633057310033,-1.1113788721448106,0.28735632183908044,0.8134703682644441,1.0,5/24,6.16%,OSBPL8;PITPNA;PLTP;LDLR;PITPNC1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.4634604606841017,-1.1112337863862132,0.35033259423503327,0.812362567975446,1.0,5/11,15.51%,RIN3;SLIT2;NBL1;CCN3;DUSP1
prerank,natural killer cell mediated immunity (GO:0002228),0.5166849288631268,1.1110574112775013,0.33889816360601,0.994377334838926,1.0,2/15,7.78%,LYST;KIF5B
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.449407196773848,1.110942439122011,0.3333333333333333,0.9935368272305788,1.0,7/32,11.77%,CAVIN1;POLR2L;GTF2H4;TAF1;CDK7;POLR1E;POLR1H
prerank,telomere maintenance via telomerase (GO:0007004),-0.3627991402731061,-1.1104318862757705,0.29508196721311475,0.8133929062902453,1.0,17/28,37.59%,MRE11;HSP90AB1;RAD50;ANKRD28;PPP6R3;TERF2IP;WRAP53;TELO2;CDK2;GAR1;TINF2;PPP6C;NOP10;ACD;RPA1;RFC1;NHP2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.3859817039469673,-1.1102656118595258,0.3203592814371258,0.8123735688850556,1.0,4/20,13.39%,IGF1;NIBAN2;TGFB1;EP300
prerank,regulation of organelle organization (GO:0033043),0.4031186323703666,1.1093580758634827,0.31058823529411766,0.9971628569299328,1.0,20/80,17.16%,NEXN;PDE4DIP;ZEB2;PLXNB1;MAPT;MIEF2;CAPN2;PAK2;STX18;DNM1L;PDCD10;MUL1;MAPK1;RHOT1;VPS35;CLIC4;PREB;S100A8;S100A9;MARK2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3673862762226529,1.1092153484562757,0.29771784232365145,0.9963232473676819,1.0,37/214,11.75%,RAP1A;NTRK3;ANGPT1;CD36;PDGFB;CCN1;PDGFC;FERMT2;ROR1;FAM83D;THPO;CCL5;GCNT2;PDGFD;MFHAS1;EMILIN1;DAB2IP;DUSP3;RRAS;FBXW7;PIN1;PTPN1;GAREM1;RASGRP1;WNK2;TNIP1;MAP2K1;GSTP1;CNKSR3;EPHA2;PDGFRB;CCL14;PDGFA;GPER1;ZDHHC17;HTR2B;DUSP29
prerank,ventricular septum development (GO:0003281),0.4437686290036775,1.109068175047043,0.3565459610027855,0.9955071305016396,1.0,5/37,7.86%,SLIT3;HEY2;HEYL;BMPR1A;TGFB2
prerank,negative regulation of dephosphorylation (GO:0035305),0.4978613898406108,1.1089567793009436,0.3667711598746082,0.9946321951902771,1.0,5/18,15.29%,PPP1R26;MFHAS1;ENSA;ARPP19;URI1
prerank,ureteric bud morphogenesis (GO:0060675),-0.4245338619743795,-1.1087144837580964,0.3391959798994975,0.8154789199814306,1.0,5/16,16.03%,BMP4;PKD2;SALL1;SIX1;FGF2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.449362942770749,1.1084543115867593,0.34054054054054056,0.9949676373932272,1.0,9/35,12.18%,DLC1;ITGA3;KANK1;TNFAIP1;DAB2IP;TGFB2;MFN2;ARHGAP35;SCAI
prerank,positive regulation of protein import (GO:1904591),0.44849473394433126,1.1084123059368096,0.35014409221902015,0.9938764050647543,1.0,5/30,13.54%,FLNA;UBR5;BAG3;PRKCD;TRIM28
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5052910169386406,1.1082193135904175,0.3542757417102967,0.9932816243050172,1.0,2/14,7.16%,ENTPD1;ENTPD7
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.2283558007425287,-1.1080246448089783,0.0,0.8161449008403028,1.0,83/314,19.50%,ECPAS;NEDD4L;ARRB1;FBXL7;FBXL5;ATXN3;AREL1;ITCH;CUL3;SEL1L;RNF185;ANAPC1;UBXN4;UBQLN1;UBE2D3;DNAJB12;PML;DERL1;UFD1;UBR2;HSPA5;DNAJC10;CTNNB1;USP19;BIRC2;PCBP2;FBXO9;PSMD7;PSMD9;PSMD13;LTN1;MDM2;PELI1;FBXO4;TOPORS;CDC23;RBCK1;TRIM25;WWP1;ARMC8;SMURF2;PRKN;KCTD2;RMND5B;DDB1;SGTA;UBE4B;PSMB3;UBC;KLHL22;RNF34;STUB1;RMND5A;SKP2;DNAJB2;HSP90B1;PSMC5;SGTB;SIAH1;NEMF;PSMA5;OS9;PSMA1;BUB3;PSMC2;HECW1;CDC26;NHLRC3;UBXN1;UBQLN2;AMN1;UBE2S;ANAPC4;SIAH2;SYVN1;UBXN8;FBXW5;DNAJB9;HERPUD1;SPOPL;SPSB4;BTRC;FBXO31
prerank,defense response to virus (GO:0051607),0.3872999055190358,1.1078988597094526,0.32909930715935337,0.9930391256836436,1.0,10/100,7.89%,FLNA;PMAIP1;MYD88;CGAS;ATAD3A;BCL2;ATG7;LYST;ABCE1;RELA
prerank,cellular response to leucine starvation (GO:1990253),0.5522547782096858,1.1077980882976737,0.38857142857142857,0.9921490360599209,1.0,3/10,9.52%,LARS1;IMPACT;RRAGB
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3915055190029165,1.1077149745074537,0.31885714285714284,0.9912052112796543,1.0,14/95,9.18%,ASPN;PRDM16;VASN;ZEB2;ITGA3;TGFB1I1;EMILIN1;CAV1;SLC2A10;PPM1A;PIN1;PPARA;ADAM17;SKI
prerank,negative regulation of lymphocyte activation (GO:0051250),0.4878438286778741,1.10770490391775,0.33986928104575165,0.9900291660579538,1.0,6/21,13.52%,LAX1;DUSP3;PIBF1;SAMSN1;PAG1;FOXJ1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.39156612959201526,1.10758840458938,0.3131548311990687,0.9892017567701321,1.0,19/101,10.74%,ATP2B4;FGF1;MST1R;TCIM;PDGFB;PDGFC;FERMT2;CCND2;SLC8A2;PDGFD;DAB2IP;VEGFA;CALM1;RASGRP1;CCND1;ADAM17;MAP2K1;PDGFRB;PDGFA
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4917549527836517,1.1074722954454272,0.35239567233384855,0.9882861204425066,1.0,1/19,0.51%,RYR2
prerank,carboxylic acid metabolic process (GO:0019752),0.4460709877430443,1.107250270854089,0.3361945636623748,0.9877732765025921,1.0,10/33,14.48%,CSGALNACT1;PTGIS;GNE;TBXAS1;SLC23A2;SLC23A1;ST6GAL1;SIRT4;PLA2G4A;CYB5R3
prerank,cranial nerve development (GO:0021545),-0.46267664860349167,-1.107039862943939,0.35648148148148145,0.8176163129233645,1.0,3/11,21.56%,CHD7;SALL1;TMEM126A
prerank,response to interleukin-4 (GO:0070670),-0.4809346178441595,-1.107020570461743,0.34831460674157305,0.8161720677777654,1.0,1/10,0.83%,LEF1
prerank,regulation of NMDA receptor activity (GO:2000310),-0.3527502534603446,-1.1066000766255435,0.2967741935483871,0.8160068240563972,1.0,8/32,8.41%,DAPK1;DLG1;APP;NLGN1;PTK2B;LRRC7;SLC6A9;NEFL
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.45934117545625514,-1.1063812495952514,0.34894613583138173,0.8151733396795614,1.0,4/11,13.03%,NECAB1;ITM2A;BACE2;SOAT1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5305069362894022,1.1062931900807773,0.35241502683363146,0.9893521169678979,1.0,5/11,18.30%,TP53;RPS27L;MAD2L2;HIPK2;RPS6KA6
prerank,protein K11-linked ubiquitination (GO:0070979),-0.3602114464165009,-1.106122321525792,0.2737430167597765,0.8144665891335758,1.0,10/27,17.60%,ANAPC1;UBE2D3;UBE2E2;CDC23;UBE2E3;PRKN;UBE2H;CDC26;UBE2S;ANAPC4
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.2652256496016734,-1.1060304479014376,0.21311475409836064,0.8132599170959355,1.0,40/110,25.39%,UPF2;PPP2CA;RPL27A;SMG1;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;PABPC1;RPLP0;RPS29;RPL28;RPS10;RPLP1;RPS20;RPL23A;RPL34;NCBP2;RPL36A;RPS8;RPS21;RPL9;SMG6;RPS7;RPL27;RPL11;PNRC2;RPL18A;RPL37A;RPL38;RPL29;RPL10A;RPL32;RNPS1;RPS4X;RPS27
prerank,purine nucleotide catabolic process (GO:0006195),-0.44223375614527694,-1.1059094105564642,0.3440366972477064,0.812170242119411,1.0,6/13,19.77%,XDH;NT5E;HINT1;ITPA;GPX1;PNP
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.46645961851814377,-1.105136786804268,0.3269689737470167,0.812942901254239,1.0,3/10,7.84%,ANXA2;EPHA4;FURIN
prerank,positive regulation of telomerase activity (GO:0051973),0.46515669386564706,1.1047030684948727,0.36363636363636365,0.9929095949041846,1.0,5/33,8.19%,PARM1;PARN;PRKCQ;PKIB;NAF1
prerank,dermatan sulfate metabolic process (GO:0030205),-0.4364008332216686,-1.104702269487636,0.3431372549019608,0.8127767779759957,1.0,3/13,1.18%,UST;DCN;DSE
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.38086032385763,-1.1043768372189415,0.3359375,0.8123279950095498,1.0,4/22,2.35%,AKAP13;AEBP1;PIK3CA;APOE
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5199157014816411,1.1041214478184882,0.36185383244206776,0.9934772881907293,1.0,4/13,10.01%,PADI2;ARID1A;CHEK1;SERTAD2
prerank,neurogenesis (GO:0022008),0.4342071357592719,1.1041182561000225,0.3481781376518219,0.992287402264618,1.0,8/43,8.64%,CLN5;CDK6;ANXA1;BTBD2;MAPT;ERCC6;TGFB2;TRAK1
prerank,negative regulation of DNA recombination (GO:0045910),0.43312972783774667,1.1040465900793017,0.34185733512786004,0.9912972520187922,1.0,13/43,16.73%,POLR2L;POLR2I;CGAS;H1-0;POLR2G;FANCB;RIF1;TERF2;RMI2;POLR2J;ZRANB3;MAD2L2;MSH2
prerank,negative regulation of type I interferon production (GO:0032480),-0.3296883530050894,-1.1037202958976047,0.3228346456692913,0.8128451197556649,1.0,17/40,27.46%,ITCH;PPM1B;RNF135;ILRUN;UFD1;PCBP2;TRIM25;SIRPA;RNF125;RELB;NLRC5;UBA7;NLRX1;CYLD;NLRC3;IKBKE;GPATCH3
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.31427505039016657,-1.1028228086814997,0.2912280701754386,0.8141713156353192,1.0,12/45,11.99%,DDX5;BMP4;POLR2A;EGFR;NMD3;SIRT7;RBM20;SETX;TGFB1;DIMT1;MAP2K2;ERN1
prerank,regulation of viral entry into host cell (GO:0046596),0.4596935630936271,1.1025720439622497,0.3613933236574746,0.9945546606472796,1.0,1/30,0.21%,TMPRSS4
prerank,P-body assembly (GO:0033962),0.5306630869961773,1.101857707325896,0.3868092691622103,0.9955093208594173,1.0,2/12,5.76%,LIMD1;ATXN2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4118784202746018,-1.1013626447869058,0.3373493975903614,0.8170549533235832,1.0,6/16,15.80%,APOE;NPR3;NOS1AP;PIK3CB;GCH1;AKT1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.37641576687271583,-1.1011810628421215,0.32492997198879553,0.816129518739214,1.0,10/26,18.18%,SMAD3;PKD2;NOS1AP;HSP90AB1;DDAH1;PTGS2;KLF2;INSR;AKT1;DDAH2
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.4447833761350659,-1.1010426041604189,0.35121951219512193,0.815085864872448,1.0,3/12,1.18%,UST;DCN;DSE
prerank,manganese ion transport (GO:0006828),0.5241366683168218,1.101019170760022,0.36505190311418684,0.9969597881249249,1.0,3/14,10.71%,TRPC6;TRPC5;SLC39A14
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3638607519507955,1.100880653468304,0.30010172939979657,0.996177911161278,1.0,44/308,11.73%,SOX6;PRDM16;SOX5;ROCK1;PRKAB2;CD36;PDGFB;PDGFC;PLA2G3;FERMT2;FST;EBF2;ADRA1D;LOXL2;IL2;TGFB3;GCNT2;TSHR;TGFB1I1;BMPR1A;TAPT1;CAV1;TERT;VEGFA;TRPV2;FABP4;GDNF;PPARGC1A;MED1;PPARGC1B;DIO2;SOX9;TGFB2;PLCB1;TRPM4;RBM19;PAXIP1;RIF1;NR2C2;EIF2AK2;MFN2;NKX6-1;HTR2B;ACVR1B
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.36862683566290344,-1.10063463102715,0.3293051359516616,0.8148489870363317,1.0,9/24,16.94%,HMGB1;SLIT2;NBL1;MOSPD2;CCN3;LYN;PLA2G7;DUSP1;SERPINE1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.3998554731153183,-1.1005113920234848,0.30670103092783507,0.8137716398055301,1.0,10/17,26.21%,CD44;MDM2;PRKN;RNF34;PTTG1IP;KDM1A;ARMC10;SNAI1;YJU2;TWIST1
prerank,positive regulation of programmed cell death (GO:0043068),0.36182104450922825,1.099883252759348,0.3120494335736354,0.9980451505053083,1.0,39/272,12.53%,KCNMA1;OBSCN;ARHGEF7;MAP3K20;MAP3K5;PMAIP1;KALRN;ABR;ARHGEF17;ANO6;ITSN1;TGFB3;ITGB1;NET1;ARHGEF16;ARHGEF2;ATG7;DAB2IP;RPS6KA2;ARL6IP5;TP53;PHLDA3;FZD9;MAP3K10;DAPK3;TNFAIP8;ARHGEF4;HRK;PAWR;DNM1L;VAV1;GPER1;TRIM35;BOK;CLIP3;CSRNP3;DIABLO;CLU;ITGB3BP
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.46145472825910544,1.0995508125331823,0.3567073170731707,0.997872158470891,1.0,4/27,4.89%,ATP2B4;SNTA1;CAMK2D;UTRN
prerank,sterol transport (GO:0015918),0.48854652578126745,1.0994191914436489,0.3648424543946932,0.9970481270269261,1.0,5/19,13.96%,CD36;CAV1;OSBPL2;LDLRAP1;OSBPL5
prerank,regulation of protein kinase activity (GO:0045859),0.3870729592759556,1.0993614367709392,0.3314285714285714,0.996042035316899,1.0,23/106,14.58%,TTN;RAP1A;PLCE1;CCN1;SMG8;PPM1E;MMD;CAMKK2;RAP2C;LCP2;ANKRD54;GSTP1;PAK2;CENPE;RB1;CEP85;SNX9;CEP43;GAS6;MAP2K3;GNAQ;DVL1;MAPRE3
prerank,regulation of lipase activity (GO:0060191),0.5219004728730786,1.0991917394285837,0.3694581280788177,0.9953490706553991,1.0,2/13,3.34%,ANGPTL8;LPL
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.23024753185456573,-1.0990678673884067,0.09090909090909091,0.8168451098762701,1.0,120/341,26.04%,TTC3;NEDD4L;ARRB1;FBXL7;TRIP12;RNF146;ATXN3;AREL1;ITCH;FBXO10;CUL3;RNF185;ANAPC1;RNF20;UBQLN1;UBE2D3;OTUD7B;BIRC6;RC3H2;RNF144B;RNF217;UBL7;RNF6;PML;UFD1;CTNNB1;BIRC2;PCBP2;UBAP1;RNF13;PSMD7;WDR91;PSMD9;PSMD13;RNF213;MDM2;PELI1;TOPORS;CDC23;FBXO7;RBCK1;TRIM25;WWP1;ARMC8;SMURF2;RNF144A;PRKN;KCTD2;RMND5B;DDB1;UBE4B;PSMB3;KLHL22;RNF34;STUB1;RMND5A;SKP2;VPS4B;RNF125;DTX3L;RNF166;PSMC5;SIAH1;PSMA5;OS9;PSMA1;BUB3;PSMC2;UBE2H;RNF115;HECW1;CDC26;TOLLIP;NHLRC3;UBXN1;RNF43;KLHL3;UBQLN2;UBE2S;ANAPC4;MVB12B;SIAH2;SYVN1;FBXW5;RNF130;HERPUD1;CHFR;SPOPL;ARRDC1;ARIH1;SPSB4;BTRC;UBAP1L;PPP1R11;NUB1;ZFAND2A;WDR81;SHARPIN;KCTD17;PSME3;PSMC4;ZNRF3;KEAP1;IFI27;UBE2B;PSMB6;MVB12A;UBR4;FBXL19;RAD23B;TBL1XR1;VPS37C;SIAH3;UCHL1;PSMB10;ANAPC15;HECTD3;SPSB1;TRIM32;RNF19B
prerank,regulation of Golgi organization (GO:1903358),0.4899001838446039,1.0986475977506136,0.350547730829421,0.9958183126816678,1.0,5/17,14.04%,PDE4DIP;MAP2K1;STX18;PDCD10;MAPK1
prerank,protein ubiquitination (GO:0016567),-0.23404818867147742,-1.0983708767844684,0.2,0.8176007339026451,1.0,112/471,15.38%,RNF220;SASH1;NEDD4L;ARRB1;SH3RF1;FBXL7;TRIP12;FBXL5;RNF146;AREL1;ITCH;RNF38;FBXO10;CUL3;RNF185;TNKS2;PRKDC;MYCBP2;RNF20;PPIL2;KLHL12;PEX14;UBE2D3;NPEPPS;RNF135;BIRC6;RC3H2;ATG3;RNF144B;SHPRH;RNF217;UNKL;TRIM24;RNF6;DERL1;UBR2;CTR9;CTNNB1;BIRC2;FBH1;PHC1;RNF25;RNF13;FBXO9;PSMD7;USP7;HERC2;PSMD9;PSMD13;COMMD1;RNF213;MDM2;PELI1;FBXO4;TOPORS;UBE2E2;CDC23;UBE2E3;FBXO7;RBCK1;TRIM25;WWP1;PEX5;SH3RF3;KLHL2;SMURF2;CUL7;RNF144A;RNF31;PRKN;UBE3A;MGRN1;FBXO25;MKRN2;RNF181;DDB1;UBE4B;PSMB3;UBC;TRIM5;KLHL22;RNF34;STUB1;HECTD2;RMND5A;SKP2;DZIP3;LONRF1;DTX1;TRIM33;VPS18;TRIM14;RNF125;DTX3L;RNF166;RTF1;PSMC5;FBXW8;SH3RF2;SIAH1;PSMA5;LEO1;OS9;PSMA1;PSMC2;UBE2H;RNF115;HECW1;RNF10;OBI1;NHLRC3;RNF43
prerank,regulation of hippo signaling (GO:0035330),0.5078823167222237,1.098103097546509,0.3844884488448845,0.9962875289651979,1.0,2/17,1.88%,WTIP;LIMD1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.41767763271907615,-1.0976932464888174,0.35170603674540685,0.8181668012205157,1.0,4/16,10.83%,POGZ;PDS5A;MAU2;NAA50
prerank,response to alcohol (GO:0097305),0.4606189484467059,1.0976003076637468,0.35106382978723405,0.996695668267822,1.0,1/27,0.19%,SLIT3
prerank,primary miRNA processing (GO:0031053),-0.48749263848006136,-1.0975817353260249,0.3355408388520971,0.8170373039345326,1.0,4/10,16.33%,SMAD3;SRRT;METTL3;SMAD2
prerank,regulation of G0 to G1 transition (GO:0070316),-0.3276421934181491,-1.097353302500746,0.29818181818181816,0.8163235618377637,1.0,8/38,8.60%,RBBP4;CBX5;MGA;TFDP1;RYBP;PHC3;PHC1;MAX
prerank,negative regulation of axonogenesis (GO:0050771),0.4624033182152515,1.0973453737268821,0.35766423357664234,0.9962937798130294,1.0,2/27,4.99%,FGF13;PTPRS
prerank,potassium ion import across plasma membrane (GO:1990573),-0.31266447518568097,-1.0969488179844364,0.30196078431372547,0.8161907037013225,1.0,6/41,10.17%,ATP1A2;ATP1B3;SLC12A2;SLC12A7;ATP1B2;KCNJ13
prerank,alpha-amino acid catabolic process (GO:1901606),0.4639087084527701,1.096895366886636,0.37057991513437055,0.9964312146705563,1.0,6/29,10.70%,HSD17B10;BLMH;HGD;KMO;GOT2;SARDH
prerank,transport along microtubule (GO:0010970),0.5256682528586283,1.0966607979897462,0.36313868613138683,0.9959925704399074,1.0,5/13,11.84%,APBA1;ARHGAP21;BAG3;DYNC1I2;CLIP3
prerank,regulation of signal transduction (GO:0009966),0.3649904871705443,1.096548625999007,0.32146596858638743,0.9951578391947369,1.0,40/190,14.47%,IGFBP7;LIFR;RGS6;CD36;PLCE1;SEMA5A;RORA;RGS4;ZFAND2B;SLC8A2;ITGA3;SOCS5;IGFBP5;NUP62;DHRS3;CBFB;CASTOR1;IFT81;RFNG;PTPN1;IGFBP4;GDNF;YJEFN3;ANKRD54;PLCB1;MGLL;AMFR;CDC42SE2;SREBF2;RUNX1;ZDHHC17;TSPAN12;CHRNA7;CLU;HOMER1;NCK2;USP20;RGS5;LRRK2;CASTOR2
prerank,positive regulation of binding (GO:0051099),-0.2778831394210112,-1.0961455825477355,0.24358974358974358,0.8171285012957026,1.0,29/84,22.26%,IGF1;LRP1;TCF7L2;HMGB1;BMP4;APOE;APP;VTN;B2M;NVL;CLDN5;DERL1;NMD3;GPSM1;MED25;FKBP1A;PRKN;HES1;DTX3L;SPPL3;RARA;PPARG;KDM4D;RALB;RPL11;DACT1;NME1;RAN;STMN1
prerank,cellular response to fluid shear stress (GO:0071498),0.5477362946055055,1.0959289705663686,0.3822975517890772,0.9958401764547307,1.0,3/12,11.08%,MEF2C;HAS2;SREBF2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.4219547760511176,1.09592162726653,0.3537234042553192,0.9946839347856472,1.0,7/46,5.98%,RBPMS2;ELN;PDGFB;CDH13;IGFBP5;CCL5;OGN
prerank,regulation of cell differentiation (GO:0045595),0.37204468345782277,1.0957567586219028,0.3293864370290635,0.9939802005536909,1.0,24/148,13.30%,NTF3;HEY2;ZFHX3;ROCK1;CDK6;PHLDB2;CLASP2;ALOX5;CBFB;TAF8;GDNF;PA2G4;AR;SNAI2;NR1D1;EIF2AK2;RUNX1;BMPR1B;MOSMO;CLASP1;BCL6;NSUN2;ZFP36L1;CASZ1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5373169562970049,1.0953929788265915,0.3726235741444867,0.9938612860516427,1.0,4/12,12.34%,JAG1;YTHDF2;HNRNPU;NELFB
prerank,B cell receptor signaling pathway (GO:0050853),0.4541045856348507,1.0953771512333368,0.3681948424068768,0.9927362624989268,1.0,3/32,4.50%,MEF2C;CD79A;BCL2
prerank,neuromuscular synaptic transmission (GO:0007274),0.49450122412680425,1.0952296718169157,0.37796610169491524,0.9920114404071915,1.0,4/18,9.76%,DTNA;STAC3;RIMBP2;FCHSD2
prerank,telomere maintenance via recombination (GO:0000722),-0.45343110095151673,-1.0950631835459708,0.34953703703703703,0.8188308101322669,1.0,6/11,24.63%,RAD50;SMC5;TPRKB;NSMCE2;ERCC1;ERCC4
prerank,establishment of protein localization to membrane (GO:0090150),-0.2880625549557836,-1.0945490887400202,0.2768361581920904,0.8190435924517905,1.0,13/66,13.38%,AFDN;EGFR;RAB11A;ZDHHC18;ATG3;SYNE3;ZDHHC15;SDCBP;SEC63;RAB3GAP2;FRMPD1;ZDHHC9;ZDHHC20
prerank,positive regulation of insulin secretion (GO:0032024),-0.33081757478089363,-1.0945258366139232,0.31353135313531355,0.8176700196532374,1.0,13/36,17.29%,TCF7L2;MYRIP;RBP4;MCU;PSMD9;STX4;NNAT;SOX4;PLA2G6;NLGN2;CAPN10;ACSL4;AACS
prerank,catecholamine metabolic process (GO:0006584),-0.4309554671964343,-1.0943807217426074,0.37376237623762376,0.816661616062443,1.0,4/14,21.44%,SNCAIP;PRKN;DDC;DRD2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.42238525409625793,1.094319908596093,0.34704370179948585,0.993577241775632,1.0,13/48,16.73%,CRIP1;DYRK2;BCL2;TP53;PHLDA3;RPS27L;BCL2L2;EPHA2;BOK;FNIP2;MCL1;HIPK2;MSH2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4973951432567427,1.094310004897432,0.3554817275747508,0.99243608548205,1.0,3/17,4.10%,CACNA2D1;SNTA1;KCNE4
prerank,peptidyl-asparagine modification (GO:0018196),-0.3449764448559714,-1.0940634562048916,0.2977346278317152,0.8162638188013193,1.0,14/31,28.12%,TUSC3;MGAT1;FUT8;UGGT2;OSTC;MGAT5;MCFD2;LMAN1;HIF1AN;RPN2;MGAT2;DPM3;STT3B;ASGR1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.36963706570267973,-1.0940519187977296,0.3303303303303303,0.8148756776994819,1.0,18/24,46.27%,XRCC1;LIG3;UBC;UBB;LIG1;RPA3;RFC3;RPA2;POLD3;LIG4;RPA1;RFC1;POLE;RFC4;RFC5;POLB;POLD2;RFC2
prerank,apical junction assembly (GO:0043297),-0.30927571721355074,-1.0934209131638546,0.3225806451612903,0.8154825389186209,1.0,8/53,6.83%,AFDN;DLG1;CDH5;PECAM1;PARD6G;OCLN;CLDN5;CLDN11
prerank,dephosphorylation (GO:0016311),0.37356225165933105,1.0926606750745267,0.33587786259541985,0.9961996900407735,1.0,29/147,13.12%,PPP1R12A;PPM1L;PPM1J;PPP3CA;MTMR7;DUSP5;PPP2R1B;ACP3;PPM1E;PTPN18;PTPRS;LHPP;SDHAF2;PTPRF;DUSP3;PPP2R5A;PPM1A;PTPN1;PLPPR1;PPP1CB;PPP1CA;CTDSP2;DUSP29;FBXW11;SBF1;CTDSP1;TPTE;DUSP16;PPP3CB
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.45099191425005797,1.0923736729820663,0.35389133627019087,0.995891352697646,1.0,6/29,10.84%,PMAIP1;PPP2R1B;CAV1;PAK2;DEDD2;GPER1
prerank,regulation of centrosome cycle (GO:0046605),0.48199872725119,1.0913960284015845,0.3663522012578616,0.9977419988609646,1.0,5/21,13.43%,CHMP4C;NAT10;CHMP5;CHMP2B;CHMP2A
prerank,muscle tissue development (GO:0060537),0.5147034936756343,1.0913357351292003,0.3769633507853403,0.9967510879459207,1.0,2/13,1.66%,CSRP1;CSRP3
prerank,rRNA transcription (GO:0009303),0.500164670856096,1.091240276187363,0.38436482084690554,0.9958778958167457,1.0,6/17,19.12%,CAVIN1;GTF3C4;POLR1E;SPIN1;GTF3A;NIFK
prerank,regulation of cell population proliferation (GO:0042127),0.35378600238016467,1.0911665695930628,0.242,0.9949309543435045,1.0,77/691,8.83%,MYOCD;NTF3;AGTR1;IGFBP7;COL18A1;NTRK3;DLC1;LIFR;ELN;TBX2;TMIGD3;FGF1;S1PR3;LIMS1;P3H2;MST1R;SPEG;PDGFB;ITGA1;PDGFC;CDK6;TRNP1;CCND2;CDH13;CRLF1;FRK;ADRA1D;THPO;JAG1;IL2;RERG;TGFB3;GCNT2;BTG2;PDGFD;NACC2;NUP62;IL12RB2;TSHR;TGFB1I1;FXN;BCL2;KSR1;OSR2;ARHGEF2;BMPR1A;HAS2;TESC;KCNH1;JUND;IRS1;TNFRSF11A;DAB2IP;RPS6KA2;TIPIN;TP53;VEGFA;GDNF;CD200;AREG;AR;BNIPL;GAREM1;CELF1;BTG1;YAP1;SOX9;TGFB2;RELA;NUAK1;KMT2D;WNK2;DIS3L2;MVD;ADAM17;TRPM4;MAP2K1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3876202378918818,1.0909993504909483,0.36061684460260973,0.9942367524269269,1.0,16/87,12.98%,NEB;DLC1;ROCK1;RHOBTB3;ARHGAP17;DAPK3;RHOF;PDGFRB;PDGFA;ROCK2;PRKCD;RHOH;ARHGAP35;RICTOR;TRPM2;DMTN
prerank,urogenital system development (GO:0001655),0.5363830145765102,1.0908345439057947,0.39436619718309857,0.9935516172059348,1.0,3/11,7.68%,ANXA1;OSR2;SOX9
prerank,protein polyglutamylation (GO:0018095),0.5405577564818377,1.090705757853517,0.39186691312384475,0.9927744710534367,1.0,2/11,3.99%,TTLL7;CEP41
prerank,negative regulation of cellular process (GO:0048523),0.3583264736227714,1.0906767607455268,0.2672672672672673,0.991708025492575,1.0,74/521,11.80%,MYOCD;SLIT3;ACTN1;IGFBP7;COL18A1;DLC1;ANGPT1;MYL2;TMIGD3;FER1L5;P3H2;SPEG;CCN1;ITGA1;CDK6;FERMT2;DYSF;MYH9;SEMA5A;PLXND1;PLXNB1;CDH13;NR4A1;FRK;RERG;TGFB3;GMNN;BTG2;FHL1;NACC2;NUP62;ALOX5;PIP4P2;TGFB1I1;BCL2;JADE1;ARHGDIG;EMILIN1;TESC;CBLL1;DSCAM;DAB2IP;NDRG3;TMEM98;RPS6KA2;TP53;CD200;AR;BNIPL;CELF1;BTG1;TGFB2;ADNP2;WNK2;LPCAT3;DIS3L2;IMPACT;MAP2K1;SKI;NDUFS3;CRLF3;SIRT2;SERTAD2;BRINP1;EIF2AK2;SH3BP4;GPER1;TNFRSF21;RB1;COPS8;TCHP;HTR2B;ACVR1B;CNOT7
prerank,histone lysine methylation (GO:0034968),0.4358190592337656,1.0906617211679042,0.36429608127721336,0.9906079684108153,1.0,9/33,16.57%,SMYD1;SETD6;SUV39H2;KMT2D;SETD3;PAXIP1;N6AMT1;WDR5B;ASH2L
prerank,purine-containing compound catabolic process (GO:0072523),-0.4342648535493763,-1.0904626697814166,0.36711711711711714,0.8232778766571814,1.0,6/13,19.77%,XDH;NT5E;ITPA;DPYD;GPX1;PNP
prerank,fatty acid transport (GO:0015908),0.4802133180499284,1.0895924365326004,0.37225042301184436,0.9927507339876275,1.0,4/17,7.85%,CD36;FABP4;CPT1B;GOT2
prerank,negative regulation of autophagy (GO:0010507),-0.29706095799577953,-1.0895753664959895,0.25892857142857145,0.8245177673186295,1.0,21/54,23.82%,LEPR;PIK3CA;NUPR1;FOXK2;SMG1;DAP;NRBP2;PTPN22;RASIP1;TAB2;KLHL22;EIF4G3;SNCA;DAPL1;AKT1;ZKSCAN3;QSOX1;TLK2;TBC1D14;LZTS1;SMCR8
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.4364381896906523,1.0890712883245517,0.37,0.9931120020278701,1.0,6/32,6.80%,PMAIP1;DYRK2;MYBBP1A;TP53;PHLDA3;RPS27L
prerank,potassium ion export across plasma membrane (GO:0097623),0.5260180140412865,1.0889637884042034,0.38648180242634317,0.9922848542813956,1.0,3/13,7.75%,KCNA5;KCNE4;KCNT2
prerank,regulation of lymphocyte activation (GO:0051249),0.5337113386797451,1.087872999163775,0.3929824561403509,0.9944742654866287,1.0,2/12,9.74%,CCL5;PAG1
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.3227829401110457,-1.0878464200843811,0.3076923076923077,0.8282642641247544,1.0,16/39,26.33%,ABCA1;SEL1L;RAB12;CANX;STEAP3;GOLPH3;PDIA4;RCN3;ARFGAP3;MON1A;RAB13;MIA3;PPY;SVBP;RAB3D;COPG2
prerank,organophosphate catabolic process (GO:0046434),-0.4450498220196445,-1.0871190098448207,0.34782608695652173,0.8290543473250397,1.0,2/11,14.01%,ENPP2;ABHD12
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.38118094010188186,1.0870984023375279,0.3598130841121495,0.9956341599711848,1.0,15/95,11.11%,MEF2C;MYD88;FZD5;VIM;UPF1;CD14;DAB2IP;CHMP5;NFKBIB;RELA;GSTP1;NR1D1;AXL;SIRT2;CD180
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3586691596792202,1.0870082028558756,0.3271794871794872,0.9947511107272683,1.0,33/259,10.53%,FLNA;MYLK;ARHGEF7;RAP1A;DYNLL1;VCL;PLA2G3;KIF27;ANO6;CDH13;EHD2;ITGB1;NTN1;CEP41;KIF3B;ACTR3;CEP290;IFT43;RAP2C;IFT81;STK26;CYFIP1;RAPGEF6;PIBF1;BBIP1;WHAMM;ARHGEF4;IQCB1;PARVA;RAP2A;ACTN2;EXOC6;RAB11FIP3
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5000993318289301,1.0868475743784485,0.352,0.9941248310072761,1.0,5/16,15.82%,CHMP4C;CHMP5;VPS36;STAM;LEPROT
prerank,global genome nucleotide-excision repair (GO:0070911),-0.35257563478632,-1.0866293936166769,0.34540389972144847,0.8290823577312009,1.0,13/26,24.63%,USP45;DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;ERCC1;RAD23B;ERCC4
prerank,cellular response to glucose stimulus (GO:0071333),-0.3466001601604227,-1.086613331977849,0.30033003300330036,0.8277393088198541,1.0,8/30,12.74%,ZBTB20;UNC13B;PTPRN2;TRA2B;RAB11FIP5;ERN1;SOX4;PCK2
prerank,regulation of fibroblast migration (GO:0010762),0.49097917005786057,1.0865354000230518,0.37603993344425957,0.9939016397478444,1.0,4/20,8.68%,ARHGEF7;ITGB1;CORO1C;GNA12
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.46449824242992793,1.0861688218620444,0.3891402714932127,0.9938617016946146,1.0,6/27,9.06%,FBXL22;CRTC1;USP2;TP53;PPP1CB;PPP1CA
prerank,regulation of biosynthetic process (GO:0009889),0.5328498143585999,1.0857104099312185,0.4109848484848485,0.9940841148017682,1.0,6/11,22.88%,ALOX5;GSTP1;SLC25A33;THRSP;PIKFYVE;MID1IP1
prerank,histone mRNA metabolic process (GO:0008334),-0.352295967918805,-1.0857015588638244,0.32,0.8290676475878203,1.0,9/27,18.84%,SSB;SLBP;LSM1;DCP2;NCBP2;TUT4;ATM;CPSF2;TUT7
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.37587424918615414,1.0855993142795275,0.34151785714285715,0.9932812318459069,1.0,39/128,20.35%,PPP1R12A;PPP1R12B;DYNLL1;CCNA2;FBXL22;CEP41;HAUS8;CEP290;ENSA;PLCB1;PPP1CB;BRSK1;CDK7;CEP192;DYNC1I2;NEDD1;FBXW11;ARPP19;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PRKACA;DNM2;PLK4;CDK14;DCTN1;MASTL;MNAT1;HAUS4;BRSK2;CEP135;CKAP5;ACTR1A;KDM8;SFI1
prerank,negative regulation of cell activation (GO:0050866),0.501919199751675,1.0853829793928909,0.3925686591276252,0.992758589262667,1.0,7/14,10.84%,PDGFB;EMILIN1;CD200;C1QTNF1;NR1D1;PDGFA;GPER1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.4522848148031203,-1.0853605933208503,0.3691588785046729,0.8286735511486296,1.0,5/12,22.47%,STX3;STX4;SNAP29;STX1A;STX2
prerank,apical protein localization (GO:0045176),0.5463733178923866,1.0849879380601415,0.3747747747747748,0.9927745001611094,1.0,5/10,11.08%,ATP8B1;ACTB;JAM3;INSC;GOPC
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3933994206875067,1.0848076794386454,0.36609336609336607,0.9921345796274049,1.0,10/72,7.13%,FGF13;TRIM54;CHADL;CLASP2;KANK1;ARHGEF2;EMILIN1;DYRK1A;HDGFL3;TPX2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.33830364533861174,-1.0845695026210238,0.3440514469453376,0.829558504014197,1.0,6/30,6.47%,DAB2;FOXP1;DDX5;SAFB2;RNF6;PRMT2
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4366304744970254,1.0840374629885132,0.3594864479315264,0.9933131462681356,1.0,8/34,10.84%,FERMT2;RORA;RUNX1T1;ASXL1;BBS12;YAP1;SIRT2;GPER1
prerank,B cell activation (GO:0042113),0.4004573399742251,1.0839963603879932,0.34701492537313433,0.9923271197847189,1.0,10/68,9.73%,MEF2C;CD79A;ITGB1;LAX1;HDAC9;BCL2;RASGRP1;ITGA4;ADAM17;TPD52
prerank,iron ion transmembrane transport (GO:0034755),-0.4691876437953372,-1.0839178487404901,0.39915966386554624,0.8302862614573847,1.0,4/10,14.04%,SCARA5;ABCB7;SLC39A8;SLC25A28
prerank,sensory perception of light stimulus (GO:0050953),-0.26697906243021086,-1.0836058108368447,0.26573426573426573,0.8297981499780858,1.0,12/87,9.56%,PITPNA;COL1A1;EYA4;EFEMP1;ABLIM1;ADGRV1;COL11A1;SLC4A10;ZIC2;EML2;WHRN;MYO9A
prerank,regulation of type I interferon production (GO:0032479),-0.27266121105905916,-1.0835891260637676,0.2597402597402597,0.8284495854068312,1.0,42/84,27.71%,ITCH;PRKDC;XRCC5;RNF135;MRE11;IRAK1;ILRUN;POLR3F;UFD1;CTNNB1;PCBP2;PTPN22;TRIM25;POLR3B;POLR3A;XRCC6;RNF125;EP300;NLRP4;TRIM56;POLR3H;NLRC5;POLR3E;UBA7;STAT6;POLR2K;TIRAP;POLR2F;POLR2H;POLR3GL;TRIM21;NLRX1;POLR3C;CYLD;DDX41;POLR3D;TRIM32;NFKB2;POLR2E;IKBKE;GPATCH3;PQBP1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.41403045617748996,1.0833461287598403,0.36,0.9931385459864772,1.0,14/51,15.42%,NTF3;PLXNB1;DAB2IP;DICER1;TNIK;PACSIN1;KIF20B;TAOK3;SGK1;LRRK2;ANKRD27;SNX1;CNTNAP1;DNM2
prerank,photoperiodism (GO:0009648),0.45919083303179514,1.0830815185802727,0.39642324888226527,0.9928327229866557,1.0,8/28,14.12%,FBXL22;CRTC1;USP2;TP53;PPP1CB;PPP1CA;CLOCK;MTA1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5226657651098984,1.0827871522814687,0.37522768670309653,0.9925992386012246,1.0,4/10,15.38%,SOX9;PDGFA;LRP5;STAT1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.5055317217391143,1.082686211133901,0.3777372262773723,0.9917844289028355,1.0,5/13,16.02%,CRLF1;OASL;STAT1;JAK2;STAT3
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.34939226640452753,-1.0824799806187217,0.35691318327974275,0.8303111035079711,1.0,9/27,18.64%,ARRB1;PTPN22;IRAK3;SIRPA;CX3CL1;SYT11;C1QTNF3;NCKAP1L;ZC3H12A
prerank,cardiac ventricle development (GO:0003231),0.4707621363987454,1.0814034958688192,0.3853211009174312,0.9944275571562905,1.0,2/20,3.09%,HEY2;HEYL
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.477109602580659,1.0813794482473573,0.36891679748822603,0.993390034555083,1.0,4/20,10.84%,ANO6;PIAS4;ITGA4;GPER1
prerank,histone H4-K8 acetylation (GO:0043982),0.4987722062489227,1.0810442533925069,0.37037037037037035,0.9921717472816416,1.0,6/15,12.59%,MCRS1;JADE1;KAT7;KANSL3;JADE3;KANSL1
prerank,histone H4-K5 acetylation (GO:0043981),0.4987722062489227,1.0810442533925069,0.37037037037037035,0.9921717472816416,1.0,6/15,12.59%,MCRS1;JADE1;KAT7;KANSL3;JADE3;KANSL1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.4444801070806037,-1.081017348506755,0.3696581196581197,0.833244304428453,1.0,4/11,9.08%,RNF185;DERL1;UFD1;UGGT2
prerank,protein localization to nucleus (GO:0034504),-0.2691829930691829,-1.080353393433872,0.24770642201834864,0.8337353459314618,1.0,35/102,22.22%,APPL2;COL1A1;BMP7;BMP4;E2F3;FAM53A;NUP88;PML;ARL2BP;TOR1AIP2;MDM2;TOPORS;NUTF2;IPO8;TOR1AIP1;SIX1;PTTG1IP;APPL1;NUP50;CALR;AKT1;EIF4ENIF1;NOP53;XPA;TBRG1;ARL2;RPL11;NUP85;BCL3;TAF3;IPO11;RPF2;NXT2;NUP214;RAN
prerank,ion homeostasis (GO:0050801),0.4483838787384716,1.0801199980079819,0.3688046647230321,0.9938485589183972,1.0,7/30,8.12%,CAMK2D;SLC4A8;P2RY2;FHL1;SLC4A3;SLC4A7;WNK2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.4094703303851322,-1.0799234487118545,0.3657289002557545,0.8337272066208992,1.0,6/16,17.72%,PRKDC;PARP3;SMCHD1;DTX3L;WRAP53;KDM4D
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.4087398756828028,-1.0793156465564873,0.3656716417910448,0.8341504839212014,1.0,14/15,59.16%,CD55;PNP;SYK;CCR2;HSPH1;NKAP;SHH;GLI3;IL12A;IL23A;EBI3;IHH;IL23R;IL12B
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3674503464221755,-1.079238624378208,0.3545706371191136,0.8329721618832082,1.0,9/22,22.71%,MAN1C1;SEL1L;RNF185;UGGT2;UBC;OS9;SYVN1;UBB;MAN1A2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.42167934988714395,1.0790878626670517,0.3951715374841169,0.9957513325671566,1.0,11/48,15.55%,PRDM16;NUP62;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP98;NUP37;NUP210
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.301107313467007,-1.078802021585252,0.31601731601731603,0.8328844807998139,1.0,17/50,20.79%,ZIC1;PTCH1;GAS1;DCDC2;IFT122;MEGF8;TULP3;INTU;HERC4;MGRN1;FGFR2;EVC;GLIS2;TXNDC15;BTRC;GPC3;PDCL
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5514944086120115,1.0788008380338898,0.4,0.9954755079565987,1.0,2/10,6.50%,SMARCD3;VEGFA
prerank,long-chain fatty acid transport (GO:0015909),0.4473429367190047,1.0785990883230545,0.3997050147492625,0.9949423063852788,1.0,6/30,8.96%,PRKAB2;CD36;ACACB;FABP4;CPT1B;ABCD4
prerank,regulation of inflammatory response (GO:0050727),0.3544615087296243,1.0785888104365642,0.34355179704016914,0.9938538172446534,1.0,30/190,11.28%,AGTR1;NR1H4;MYD88;RORA;ANXA1;IL2;LPL;FEM1A;CCL5;PTGIS;ALOX5;MFHAS1;SETD6;CD200R1;PIK3AP1;TNFAIP6;CD200;CELF1;RELA;TNIP1;LPCAT3;PPARA;NR1D1;MGLL;AKNA;AOAH;GPSM3;GPER1;RB1;PRKCD
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.4426176469309441,-1.0782469417915415,0.375886524822695,0.8332164734437065,1.0,2/12,1.03%,DAB2;FOXP1
prerank,positive regulation of embryonic development (GO:0040019),-0.37842445687975207,-1.0780618718272141,0.36578947368421055,0.8323856670628087,1.0,4/19,12.54%,NIBAN2;WNT4;OSR1;ZBED3
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.46891991075542333,1.0778913244935089,0.3887240356083086,0.9947460889675821,1.0,9/23,17.85%,MTMR7;PIP4P2;SYNJ2;SACM1L;INPP5B;TPTE;INPP5J;PTEN;MTMR3
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.4287663215296529,-1.0772027021213038,0.3672055427251732,0.8335239141194881,1.0,4/13,9.75%,GLUL;ALDH4A1;NOS3;DDAH1
prerank,sulfation (GO:0051923),-0.4519617227302445,-1.0771816019495233,0.3873239436619718,0.8321977510080997,1.0,1/11,0.11%,UST
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.39341991544143606,1.0770274731610934,0.36573511543134873,0.9961434570390356,1.0,14/79,10.68%,RBPMS2;ATP2B4;CRIM1;ACVR2A;BMPR1A;MMRN2;EMILIN1;EPN2;DAB2IP;PTPN1;NEDD4;SKI;VWC2L;UBE2D1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.42217772812643145,1.0770164233150272,0.3746630727762803,0.9950623882304744,1.0,6/40,7.22%,PMAIP1;BCL2;NDUFS1;MAPT;ARL6IP5;HEBP2
prerank,cytoplasmic translational initiation (GO:0002183),0.4932535285793303,1.0763246973007188,0.3868954758190328,0.9960177897013357,1.0,4/17,8.82%,DENR;EIF3M;EIF2D;EIF4A1
prerank,stress granule assembly (GO:0034063),0.47004689467553346,1.0760738945037207,0.38461538461538464,0.9956652012638451,1.0,9/20,17.73%,CSDE1;ATXN2;MAPT;CIRBP;YTHDF2;RPS23;G3BP1;PRRC2C;BICD1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.3951999492784377,1.0758794888471117,0.38170731707317074,0.9951226821571664,1.0,10/66,11.28%,FLNA;FERMT2;MCRS1;UBR5;TERT;YAP1;KAT7;BAG3;CCT3;PRKCD
prerank,proteoglycan biosynthetic process (GO:0030166),-0.3356796489000228,-1.075564197834342,0.3543046357615894,0.8355954354279029,1.0,15/31,21.50%,IGF1;CHST11;EXTL3;BMPR2;CHST9;UGDH;HS3ST3B1;GLCE;CANT1;XYLT1;PXYLP1;FOXL1;CHST12;B4GALT7;B3GAT1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.436106002747135,1.0754387274125328,0.3788546255506608,0.9952944821002709,1.0,4/27,8.83%,WTIP;LIMD1;TP53;MAP2K1
prerank,regulation of glycolytic process (GO:0006110),-0.2835390289791857,-1.0752839686033613,0.29508196721311475,0.835043463676148,1.0,22/68,21.68%,IGF1;ZBTB20;PRKAG2;NUPR1;APP;NUP88;HDAC4;ENTPD5;OGT;PFKFB2;EP300;NUP50;ARNT;INSR;PRXL2C;NDC1;GIT1;NUP85;PFKFB3;PRKAA1;NUP214;CBFA2T3
prerank,embryonic eye morphogenesis (GO:0048048),-0.45404248671738767,-1.0750214971284109,0.41920374707259955,0.8344913702818185,1.0,4/11,3.63%,FBN1;EFEMP1;FBN2;MFAP5
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4278814184928324,1.0747465585543288,0.3607681755829904,0.9961314129420447,1.0,9/40,13.26%,NTF3;ANGPT1;HIP1;VEGFA;DGKD;ATAD1;SCYL2;CLU;LDLRAP1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.4133655832138423,1.0743568424470726,0.3696808510638298,0.9961919343628469,1.0,4/45,3.34%,CD36;MYD88;FZD5;LPL
prerank,carboxylic acid transport (GO:0046942),-0.29894947046732034,-1.0740027765931721,0.33181818181818185,0.836229764415093,1.0,21/55,22.84%,SLC6A13;SLC16A12;SLC13A3;SLC16A9;SLC6A12;SLC6A6;SLC16A1;SLC3A2;SLC7A5;SLC16A11;SLC6A9;SLC6A11;CLN3;SLC66A1;SLC38A5;SLC38A6;SLC15A4;SLC1A4;PSAP;SLC36A1;SLC1A1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.49213682387908353,1.0738470150515387,0.3967741935483871,0.9965721566752601,1.0,6/18,14.08%,NAT8L;GOT1;GOT2;ADI1;SMS;SLC25A12
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3415125046459261,-1.0737660819303834,0.37209302325581395,0.8355415304147427,1.0,13/33,16.03%,TJP1;GLUL;SEMA6A;PDPK1;EPN1;PIK3CB;ITGA5;BMPER;ADAMTS9;CEMIP2;KLF2;CREB3L1;FGF2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.35532578303766876,1.0734218423515178,0.35010266940451745,0.9967182658464699,1.0,24/234,8.37%,MYOCD;ABRA;CD36;MYD88;ROR1;CRTC1;ARID5B;FZD4;CRTC3;ARHGEF2;PRKCQ;MTDH;TNFRSF11A;CAV1;TAF1;SMARCB1;VEGFA;CD200;AR;PPARGC1A;PPARGC1B;NFKBIB;RELA;TRIM68
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.362765693951457,-1.073377592325623,0.3255131964809384,0.8353540744736468,1.0,8/23,19.38%,SLIT2;CAMK1D;MOSPD2;MCU;RIPOR2;DPP4;NCKAP1L;TIRAP
prerank,regulation of cilium assembly (GO:1902017),-0.2872993960534995,-1.0732668905524787,0.3034825870646766,0.8343693811592625,1.0,31/62,26.18%,TBC1D16;LIMK2;TBC1D15;DCDC2;CEP97;ATG3;TBC1D2B;TBC1D13;TBC1D5;TBC1D8;IFT88;ATG5;TBC1D9B;RABEP2;TBC1D24;TBC1D30;TBC1D22A;SGSM3;DYNLT2B;ODF2L;TBC1D10A;TBC1D7;SDCCAG8;KCTD17;TBC1D14;CYLD;CCP110;CROCC;TBC1D2;CDKL1;BBS4
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.44998317535976873,-1.0728027314724413,0.3810623556581986,0.8343275341129288,1.0,4/11,19.27%,SLC30A10;ABCB7;COA8;PARK7
prerank,ribosomal small subunit assembly (GO:0000028),-0.40233190561543997,-1.072409006361613,0.35128205128205126,0.8341661525186324,1.0,10/16,29.79%,PRKDC;XRCC5;RPS19;RPSA;ERAL1;RRP7A;RPS27;MRPS11;RPS5;RPS15
prerank,regulation of nervous system development (GO:0051960),0.42376257866731337,1.0723583880751046,0.38514442916093533,0.9986714316953749,1.0,7/37,9.92%,HEY2;HEYL;PRUNE1;GBX1;YTHDF2;YAP1;SIRT2
prerank,regulation of mitotic spindle assembly (GO:1901673),0.47487182041965464,1.0723133878885367,0.3864734299516908,0.9977229673592272,1.0,5/19,13.43%,CHMP4C;CHMP5;HNRNPU;CHMP2B;CHMP2A
prerank,peptide cross-linking (GO:0018149),0.4581505828609751,1.0722899420869563,0.37329286798179057,0.9966886486630184,1.0,2/25,2.79%,FCGR3A;ANXA1
prerank,response to molecule of bacterial origin (GO:0002237),-0.2829365255570521,-1.0720739645800972,0.30120481927710846,0.833777909582601,1.0,17/69,16.15%,FOXP1;SMAD6;LBP;LGALS9;IRAK1;NOCT;RPS6KA3;CYRIB;PTPN22;IRAK3;PELI1;NOS3;TAB2;SNCA;GCH1;IFNAR1;SRR
prerank,regulation of AMPA receptor activity (GO:2000311),0.45367359753549974,1.0718863193844905,0.3871951219512195,0.9967107954253626,1.0,4/25,7.44%,MEF2C;SHISA9;CNIH2;GSG1L
prerank,sphingolipid biosynthetic process (GO:0030148),-0.282469267855443,-1.071879698549692,0.3388888888888889,0.8329926918962964,1.0,16/71,9.94%,SGMS1;SGMS2;ELOVL7;CERS5;HACD4;ST3GAL5;SPTLC2;ST8SIA1;SPTSSA;B4GALT6;ACER2;ALDH3A2;CERS6;SGPP1;CERT1;ASAH2
prerank,monocyte chemotaxis (GO:0002548),0.4331024989365696,1.0715186093855558,0.3876967095851216,0.9966158904042213,1.0,5/32,10.43%,PDGFB;ANXA1;CCL5;TNFRSF11A;CCL14
prerank,regulation of neuron death (GO:1901214),0.3835435821330113,1.0713217981255005,0.36524822695035464,0.9961242237457683,1.0,17/82,14.96%,MEF2C;MAP3K5;TRIM2;CCL5;INPP5A;CD200R1;MAPT;CD200;PPARGC1A;FAIM2;CHRNA7;CLU;SARM1;EPHB1;LRRK2;SNCG;DHCR24
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.38081309759273163,-1.0712188571856975,0.3933933933933934,0.8335007755656795,1.0,9/20,18.09%,MCU;LETM1;SPG7;MCUB;MICU2;MAIP1;STOML2;YME1L1;SLC8B1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.4262256542114758,-1.0710436137473096,0.35944700460829493,0.8326533680395685,1.0,3/12,5.56%,CYP26B1;PTCH1;MEGF8
prerank,regulation of cellular component size (GO:0032535),0.44243656031521583,1.0710054875983575,0.38205499276411,0.9959466370441473,1.0,4/30,10.78%,NEB;LARS1;PPP1CA;VAV1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3561615519296055,1.070724336148434,0.38259958071278827,0.9956538269388988,1.0,37/198,13.21%,ITPK1;PLCE1;LIMD1;PFKP;INPP4B;PPP3CA;PLA2G3;PLCB4;PIP4K2A;DUSP5;HK2;LPL;ACP3;PFKFB1;INPP5A;NUDT4;GFPT1;LHPP;COQ8A;DUSP3;PPM1A;CALM1;PLPPR1;PLCB1;PPP1CA;PAK2;INPPL1;PLCD1;ALDOA;INPP5B;PFKM;HTR2B;ITPKC;TPTE;DUSP16;PPP3CB;PLB1
prerank,synaptic vesicle exocytosis (GO:0016079),-0.3247549860479322,-1.0706643762484693,0.33916083916083917,0.832373492907805,1.0,13/40,22.47%,UNC13C;UNC13B;STX3;SYT1;STX4;SNAP29;SNCA;PCLO;SNPH;STX1A;RIMS2;SYT2;STX2
prerank,hexose biosynthetic process (GO:0019319),0.41857612719977944,1.0705966227113448,0.3544827586206897,0.9949147768034738,1.0,12/42,15.43%,ENO3;PFKFB1;MDH1;AKR1B1;PPARGC1A;GOT1;GOT2;SLC39A14;ALDOA;CRTC2;SLC25A12;GAPDHS
prerank,receptor clustering (GO:0043113),0.44495875963685544,1.0699530150878904,0.38181818181818183,0.9956960815595295,1.0,5/27,10.06%,FLNA;MUSK;SAV1;ITGA4;AGRN
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.378439241925033,-1.0699181182709858,0.3646112600536193,0.8331018284598695,1.0,7/20,11.67%,LBP;IL18;IRAK1;PRKCE;PTPN22;TGFB1;LYN
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.3222897263432063,-1.0698485457176785,0.3218390804597701,0.8319576778250936,1.0,14/39,17.22%,BMP4;SLIT2;GLI2;NRP1;ENG;PKD2;TIE1;CTNNB1;RASIP1;SALL1;SIX1;KDR;FGF2;NOTCH4
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5266450789962164,1.0695495318426758,0.4180478821362799,0.9957141335011149,1.0,2/11,9.92%,MST1R;SIRT2
prerank,organophosphate biosynthetic process (GO:0090407),-0.32763916136963916,-1.0695123616907818,0.3563218390804598,0.8315983632823466,1.0,17/37,30.30%,AGPAT4;IP6K1;GNPAT;IP6K2;TKT;PPIP5K2;GPAM;FGF2;AGPAT5;ITPKB;GK5;IPPK;FADS1;GK;NFS1;TPI1;PPIP5K1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.2563591677468548,-1.0687833654189192,0.30434782608695654,0.8325165358302796,1.0,29/129,14.23%,RNF220;LRRK1;LGR4;COL1A1;ADGRA2;WNK1;RNF146;DDX3X;PTK7;EGFR;LYPD6;TNKS2;PPM1B;PSMD7;PSMD9;PSMD13;WLS;ATP6AP2;SMURF2;SFRP4;TGFB1;FGFR2;PSMB3;SOX4;ZBED3;PSMC5;PSMA5;PSMA1;PSMC2
prerank,triglyceride metabolic process (GO:0006641),-0.3050264871421507,-1.068674335055618,0.3371212121212121,0.8315421843692601,1.0,5/48,4.78%,AGMO;APOE;SEL1L;LPGAT1;LPIN2
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5181676735895769,1.0685689357927959,0.3978102189781022,0.9974377461365773,1.0,3/10,15.16%,SETD6;SETD3;EEF1AKMT2
prerank,anterior/posterior axis specification (GO:0009948),0.4994483235266498,1.068286215096527,0.39327731092436974,0.997176901643441,1.0,2/15,9.18%,FZD5;SKI
prerank,peptide metabolic process (GO:0006518),0.3796588783718069,1.0679661231790416,0.3800959232613909,0.9970204963058846,1.0,12/75,12.11%,DMD;CLN5;ETHE1;LNPEP;APEH;GSTT1;ENPEP;NAT8;GSTP1;MIPEP;OPLAH;GSTA4
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.36637734067352823,-1.0677780670887085,0.3743169398907104,0.8328423781802884,1.0,7/22,13.52%,SLIT2;KANK3;CYRIB;SSH2;PFN2;PFN1;SSH1
prerank,protein transport (GO:0015031),-0.22434022518963825,-1.067707441955297,0.25,0.8316908054601211,1.0,91/332,19.78%,SPTBN1;PRKCB;LRP1;VAMP5;CALCRL;APOE;TBC1D16;ABCA1;SNX27;SEL1L;RABGAP1L;RAB5A;STXBP1;STX3;TBC1D15;RAB12;USO1;SCAMP2;ERP29;TBC1D8B;ATP6V0A4;GOLGA4;TMED5;SEC23IP;TBC1D2B;SCG5;TBC1D13;SLC10A7;CANX;STEAP3;STX5;HERC2;TBC1D5;STX4;OPTN;ARL5B;GCC2;TMED7;TMED10;WLS;COPB2;GOLPH3;TBC1D8;PPT1;ATP6AP1;ATP6V1G1;RAB3GAP2;SNX6;PDIA4;ARF3;BLZF1;UNC93B1;SNX15;ARFIP2;RCN3;RAMP2;TBC1D25;HSP90B1;TOM1;TBC1D9B;SGSM1;GRTP1;MYO6;ARFGAP3;RAB1A;TBC1D30;RAB29;TBC1D22A;TBC1D9;MON1A;EHD1;STX1A;TCIRG1;SGSM3;PPARG;NDC1;COG7;PICK1;TMED3;RAB13;SCFD1;STX8;RAB1B;NAPG;ARRDC1;TBC1D10A;TMED4;MCOLN1;SCAMP3;MIA3;PPY
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4692525961119307,1.0676370395177532,0.39209726443769,0.9968504639482451,1.0,3/22,6.18%,RASL11A;PWP1;SMARCB1
prerank,spliceosomal complex assembly (GO:0000245),-0.30610543094587905,-1.0675234364008925,0.34285714285714286,0.8309265818828195,1.0,13/46,19.07%,CELF2;KHDC4;RBM5;SNRNP200;SRSF6;SRSF5;CELF4;SETX;CRNKL1;SNRPD1;SMN1;SRPK1;SCAF11
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.5318905771950466,1.0674701847363013,0.42418772563176893,0.9962602414606659,1.0,4/10,12.84%,DGKD;GAP43;HTR2B;PRKD3
prerank,T cell proliferation (GO:0042098),0.5080150966373376,1.0666988043716354,0.425531914893617,0.9973895423908934,1.0,4/13,13.12%,DOCK8;RASGRP1;LMBR1L;PPP3CB
prerank,endoderm development (GO:0007492),0.507893284490509,1.0666468817782266,0.42086956521739133,0.9964619109171531,1.0,2/13,6.91%,DUSP5;LAMC1
prerank,aerobic electron transport chain (GO:0019646),0.38723990174654493,1.06656809858836,0.390452876376989,0.9956167506625697,1.0,24/68,18.71%,NDUFS1;COX7A2L;NDUFA11;NDUFA2;SDHC;SDHAF2;COX8A;NDUFC1;NDUFB6;NDUFS3;COX7B;NDUFV2;NDUFB8;NDUFS2;SDHA;NDUFAB1;NDUFA1;UQCRFS1;NDUFAF1;COX6C;UQCRH;COX5B;NDUFV3;UQCRQ
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3288860095159838,-1.0664627194987315,0.3242320819112628,0.8326743634654902,1.0,15/34,18.87%,FLT1;PIK3CA;SEMA6A;MAPK14;NRP1;GAS1;GAB1;SPRY2;ERN1;RAMP2;KDR;VEGFC;VEGFB;MT1G;ITGB1BP1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.36480347094856497,-1.0664375870522513,0.3697478991596639,0.8314494647883569,1.0,12/22,29.56%,URB1;ERI3;EXOSC9;RPS21;FTSJ3;NOP9;EXOSC2;UTP20;EXOSC7;EXOSC3;PES1;RRS1
prerank,inorganic anion transmembrane transport (GO:0098661),0.39409262183478155,1.0664356479960617,0.38721804511278196,0.9948984461435876,1.0,11/63,9.82%,ANO1;GABRE;ANO6;SLC4A8;SLC20A2;GABRA4;GABRA5;GABRB2;XPR1;GABRG1;ANO3
prerank,cell projection organization (GO:0030030),0.4442568380027772,1.0662648984239482,0.38904899135446686,0.9943303747401503,1.0,8/30,11.36%,PACSIN2;ITGB1;RHOJ;CYFIP1;PLEK;PARVA;PDGFA;RHOH
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.28401340369648626,-1.0660306861823494,0.32298136645962733,0.8313005672293167,1.0,18/76,10.61%,NFAT5;SASH1;UACA;BMP7;DLG1;APP;DDX3X;EGFR;NOD1;PPM1B;NFKBIA;LGALS9;IRAK1;HDAC7;RASSF2;PTPN22;CCN3;PDCD4
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.33540947841197694,-1.0660131662044667,0.36271186440677966,0.8300291868237482,1.0,8/35,5.39%,FLT1;NF1;SULF1;SPARC;APOE;XDH;COL4A3;PTPRM
prerank,amyloid fibril formation (GO:1990000),0.40459739184897797,1.0659876838274371,0.38258575197889183,0.993992250245981,1.0,6/51,7.63%,TTR;MFGE8;CD36;MAPT;CALB1;NAT8
prerank,organelle assembly (GO:0070925),0.3488394188213046,1.0658852197243451,0.3556231003039514,0.9932157118805914,1.0,89/384,18.90%,LMOD1;FLNA;DYNLL1;LMOD2;LMOD3;ATP2A2;CHMP4C;LIMD1;PLA2G3;KIF27;EHD2;CEP41;NUP62;HAUS8;KIF3B;ACTR3;CSDE1;CEP290;ATG16L2;ATG7;GABARAP;MAPRE2;ATXN2;IFT43;TUBGCP6;MAPT;IFT81;CHMP5;ABCA3;CIRBP;YTHDF2;PIBF1;AUP1;BBIP1;SYNPO;IQCB1;ANLN;PARVA;IST1;CENPE;EXOC6;NSFL1C;RPS23;RAB11FIP3;STX12;STAM2;FHDC1;WDR45;CHMP2B;TSG101;HPS4;STK36;VPS36;PIK3C3;CHMP2A;FOXJ1;TTC39C;G3BP1;HAUS7;HAUS2;MAPRE3;PLA2G4C;STAM;RAB8B;STX7;CCDC66;ATG13;CFAP43;RFX3;PLK4;PRRC2C;RAB8A;CENPW;INO80;RAB38;STARD9;DZIP1L;UBXN2B;VPS4A;GALNT11;BICD1;SH3PXD2B;DHX29;FARP2;RBM14;MRPL22;HAUS4;ULK1;HDAC6
prerank,epithelial cell differentiation (GO:0030855),0.37066126083922984,1.065624631576654,0.38443396226415094,0.9928726012773511,1.0,9/88,8.75%,TAGLN;ANXA1;JAG1;TAGLN2;DMBT1;VEGFA;CNN3;CBR1;VDAC1
prerank,cytoplasmic microtubule organization (GO:0031122),0.39811460617775035,1.0654940928533605,0.4023746701846966,0.9921719728979331,1.0,6/54,6.20%,TRDN;HOOK2;DST;TUBGCP6;MAPT;TPPP
prerank,post-translational protein modification (GO:0043687),0.3482053584311645,1.0652709538156404,0.36363636363636365,0.9917065027043731,1.0,53/332,12.46%,IGFBP7;MFGE8;LTBP1;SPARCL1;SDC2;ASB15;HRC;ASB10;KCTD7;CCN1;ASB18;FBXL22;FBXO40;SOCS5;IGFBP5;FEM1C;FEM1A;LMO7;ASB2;ASB1;CUL2;SOCS6;RNF7;NUCB1;ASB8;PSMC6;ELOC;FBXW7;FBXO30;FBXL18;KTN1;IGFBP4;LAMC1;LAMB2;RAB3A;UBE2F;CUL9;DCUN1D1;CDH2;HIF1A;PSME4;FBXO6;SUMF1;PSMB1;MBTPS1;PSMD5;FBXO32;COPS8;FBXW11;UBA3;WSB1;PSMB2;DCAF11
prerank,regulation of glucose metabolic process (GO:0010906),0.42617949901705815,1.0652522995196647,0.38950276243093923,0.990705309801251,1.0,4/34,5.88%,PMAIP1;PDK4;RORA;IRS1
prerank,lipid translocation (GO:0034204),-0.3632008282939081,-1.065141602856349,0.335243553008596,0.8312685507538626,1.0,7/21,8.34%,ATP8A1;ABCA1;ABCA4;ATP11C;ATP8A2;RFT1;TMEM30A
prerank,gluconeogenesis (GO:0006094),0.42019061777795436,1.0647092323140444,0.38333333333333336,0.991172061117758,1.0,11/39,15.43%,ENO3;PFKFB1;MDH1;PPARGC1A;GOT1;GOT2;SLC39A14;ALDOA;CRTC2;SLC25A12;GAPDHS
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4957529270947699,1.0646608050650532,0.40371621621621623,0.9902423762940058,1.0,2/13,6.50%,COL4A1;VEGFA
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.40603528885199097,1.0645096092217552,0.38076923076923075,0.9896131035215798,1.0,14/52,11.84%,ATP2B4;STAC;ITGA3;ITGB1;ARHGEF16;ZDHHC2;CNST;SORBS1;STAC3;KIF5B;EPHA2;GPER1;DPP10;CLIP3
prerank,histone H4-K16 acetylation (GO:0043984),0.47514279687791394,1.0639447467072047,0.38283828382838286,0.9901932748701657,1.0,8/19,15.23%,MCRS1;JADE1;MSL3;KAT7;KANSL3;JADE3;KANSL1;MSL1
prerank,transcription by RNA polymerase I (GO:0006360),0.4247118091656419,1.063774278170238,0.38429172510518933,0.9896339677575986,1.0,7/34,11.77%,CAVIN1;POLR2L;GTF2H4;TAF1;CDK7;POLR1E;POLR1H
prerank,adipose tissue development (GO:0060612),0.5140154725691298,1.0636603782861325,0.38860103626943004,0.9889016803964941,1.0,5/11,17.89%,ARID5B;DYRK1B;LRP5;NAMPT;SH3PXD2B
prerank,ESCRT complex disassembly (GO:1904896),0.5151146651515353,1.0634783186750765,0.4,0.9873138735595018,1.0,5/10,17.60%,CHMP5;IST1;CHMP2B;CHMP2A;VPS4A
prerank,ESCRT III complex disassembly (GO:1904903),0.5151146651515353,1.0634783186750765,0.4,0.9873138735595018,1.0,5/10,17.60%,CHMP5;IST1;CHMP2B;CHMP2A;VPS4A
prerank,regulation of myeloid cell differentiation (GO:0045637),0.39538381133084977,1.0633843982826436,0.3960639606396064,0.9865395730802827,1.0,6/62,5.51%,MYL9;MEF2C;CDK6;CBFB;CNOT4;PRKCQ
prerank,regulation of biomineral tissue development (GO:0070167),0.4392030617323427,1.062991802426647,0.40212443095599393,0.9865873181368477,1.0,7/26,16.46%,HEY2;ROCK1;SOX9;ROCK2;GAS6;FBXO5;ANKH
prerank,positive regulation of axon extension (GO:0045773),0.45999576837250855,1.0627888376572008,0.4142857142857143,0.9860675207742103,1.0,5/22,6.50%,SEMA5A;NTN1;MAPT;DSCAM;VEGFA
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.5108383516821124,1.0627736528367102,0.40391459074733094,0.9850617135053544,1.0,8/12,20.19%,CDYL;LRIF1;HNRNPU;PCGF5;PCGF3;RBM15;RLIM;YTHDC1
prerank,response to interferon-alpha (GO:0035455),-0.39780652791355375,-1.062444379146216,0.37745098039215685,0.837823870900275,1.0,10/16,30.01%,IFNAR2;IFNAR1;ADAR;BST2;IFITM1;IFITM3;RO60;IFITM2;PDE12;KLHL20
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5012472579863614,1.0622414458335339,0.4107806691449814,0.9855673599347734,1.0,2/12,3.64%,DOCK8;CCL5
prerank,cellular component maintenance (GO:0043954),0.5124356706592077,1.0619577676837924,0.4232142857142857,0.9853316565345162,1.0,2/12,4.94%,ITGA3;LNPK
prerank,regulation of feeding behavior (GO:0060259),-0.4446586201031927,-1.0618831711952466,0.38562091503267976,0.8381274222966402,1.0,1/11,0.87%,LEPR
prerank,establishment of endothelial barrier (GO:0061028),-0.3287391170290784,-1.061178573819912,0.3333333333333333,0.8389244888057191,1.0,7/29,8.64%,AFDN;TJP1;TJP2;PECAM1;RAPGEF1;RAP1B;RDX
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.4505490955390565,-1.0611365118054654,0.42920353982300885,0.8363947621668472,1.0,4/10,41.34%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.4505490955390565,-1.0611365118054654,0.42920353982300885,0.8363947621668472,1.0,4/10,41.34%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.4928047269642643,1.0611140459814719,0.40947546531302875,0.9866520122792906,1.0,4/15,11.73%,FST;ACVR2A;SKI;ACVR1B
prerank,regulation of mitochondrial fusion (GO:0010635),-0.4431359901648973,-1.0611002961329599,0.4119047619047619,0.8351850977493828,1.0,2/11,10.06%,PID1;PRKN
prerank,protein heterooligomerization (GO:0051291),-0.39546707599178577,-1.0609144818918743,0.3746898263027295,0.8343816042265002,1.0,4/17,13.81%,PKD2;KCNC2;FARSB;TMEM120A
prerank,cell cycle G2/M phase transition (GO:0044839),0.3667779113768524,1.0607589612502464,0.3705357142857143,0.9865754099134381,1.0,39/129,20.35%,PPP1R12A;PPP1R12B;DYNLL1;CCNA2;FBXL22;CEP41;HAUS8;CEP290;ENSA;PLCB1;PPP1CB;BRSK1;CDK7;CEP192;DYNC1I2;NEDD1;FBXW11;ARPP19;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PRKACA;DNM2;PLK4;CDK14;DCTN1;MASTL;MNAT1;HAUS4;BRSK2;CEP135;CKAP5;ACTR1A;KDM8;SFI1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4898561245718033,1.0604600216135978,0.408130081300813,0.9863664693238199,1.0,5/17,11.57%,FGF1;LPCAT3;MBTPS1;SREBF2;ABCG1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.44582421704276054,1.0604195345378948,0.3991031390134529,0.9854256403103406,1.0,10/28,13.74%,SORT1;BCL2;GABARAP;DAB2IP;BAG3;DEDD2;CASP8AP2;DIABLO;DEDD;TNFRSF10B
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.4766559082463895,1.060037397284012,0.4159869494290375,0.9854538381711826,1.0,6/17,12.48%,ROCK1;RTN2;PIN1;RTN1;CHRNA7;CLU
prerank,metal ion export (GO:0070839),0.4339934584092696,1.0599215358925402,0.39882697947214074,0.9847733624172581,1.0,5/31,7.75%,ATP2B4;KCNA5;KCNE4;ATP1B1;KCNT2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3251423553534991,-1.0594476605358545,0.3639344262295082,0.8373276330290668,1.0,3/33,1.02%,IGF1;NF1;PIK3CA
prerank,phosphorylation (GO:0016310),0.3455274859026217,1.0592928950701717,0.35555555555555557,0.9854339721920319,1.0,90/385,17.24%,DGKB;DGKG;MAP3K20;STK38L;TNNI3K;PRKG1;MAP3K5;ROCK1;DYRK2;MERTK;LIMD1;PDGFB;CDK6;PDK4;FRK;FAM20A;CAMK2D;ACVR2A;CAMKK2;PEAK1;MARK1;BMPR1A;DYRK1A;MAP4K3;MAP4K5;TAF1;COQ8A;MAPKAPK2;DYRK1B;STK26;CHEK1;FGGY;TGFB2;NUAK1;WNK2;DAPK3;PRKACB;PRKAR1B;MAP2K1;CCNT1;BRSK1;PKN2;PAK2;DGKD;CDK7;STK24;CDK18;EIF2AK2;ROCK2;PRKCD;COPS8;HTR2B;ACVR1B;CDK12;DMPK;BMPR1B;TNIK;BCR;CDC42BPB;STK36;TAOK3;FNIP2;CDK15;MAST1;PPP3CB;GAS6;CSNK1E;PDK2;DGKZ;SGK1;STK10;MAPK1;LRRK2;PRKAA2;PRKCA;PRKACA;SRPK2;CSNK1A1;JAK2;STAT3;PLK4;HIPK2;STRADB;RYK;MAP3K13;EIF2AK3;NADK;CDK14;MARK2;POMK
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3563372396931522,1.0591605482515083,0.39400428265524623,0.9847626419771475,1.0,32/182,12.63%,CCDC3;MEF2C;ATP2B4;HEY2;PDGFB;PLA2G3;HINFP;RBMS3;HAVCR2;BMPR1A;EMILIN1;ATXN2;TAF1;MAPT;TERT;SLC2A10;VEGFA;FBXW7;CELF1;YAP1;DICER1;TGFB2;MAP2K1;HIF1A;GPER1;ROCK2;RUNX1;RB1;TERF2;CNOT7;CITED2;PDCD10
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.47927616933181416,1.0584815649273118,0.40789473684210525,0.98555738884035,1.0,4/16,14.87%,ACP3;SLC39A14;GPER1;PRKCA
prerank,regulation of intracellular signal transduction (GO:1902531),0.34219166974929055,1.0580038641642941,0.3686868686868687,0.9857945948429317,1.0,84/420,14.62%,OBSCN;ARHGEF7;NTRK3;AKAP6;DLC1;FGF1;KALRN;PRKAB2;DYRK2;LBH;ABR;PIP5K1B;ARHGEF17;PIP4K2A;FAM83D;MYO9B;DEPDC1B;ITSN1;BRIP1;NET1;PRDM1;ARHGAP21;ARHGAP10;ARHGEF16;USP2;CHN1;ARHGAP6;ARHGEF2;ARHGDIG;TAF1;MAPT;CASTOR1;DAB2IP;TP53;RRAS;VEGFA;PIN1;RHOJ;TPX2;TRAF3;CHEK1;RAD9A;ANKRD54;RELA;PEX5L;NUAK1;ARHGAP17;RHOF;ARHGAP39;GNA12;ARHGAP30;PRKAR1B;ARHGEF4;PAK2;ARHGAP1;RRAGB;RPL5;ARHGAP12;TRAF5;PRR5;RHNO1;VAV1;INPP5B;ARHGAP15;ARHGAP5;RHOH;ZFAND6;ARHGAP35;RICTOR;TNIK;BCR;ARHGAP32;TPTE;RMI2;TAOK3;CHD4;SGK1;TMSB4X;MAPK1;LRRK2;PRKAA2;CASTOR2;ARHGAP24;UFL1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4935853545916561,1.0579177462147988,0.4245614035087719,0.9850070298678633,1.0,3/12,13.12%,ANO1;TRPM4;PPP3CB
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.36381763085637425,1.0573438734234846,0.40497737556561086,0.9855968800533124,1.0,15/121,7.48%,NTF3;ANGPT1;ANGPT4;PDGFB;CRLF1;CSPG4;IL2;CCL5;ARHGEF2;DOK7;TP53;VEGFA;PTPN1;PIBF1;ITGB3
prerank,leukotriene metabolic process (GO:0006691),0.47628504231199337,1.0569229556801802,0.4222222222222222,0.9857548233818784,1.0,4/19,14.18%,ALOX5;MAPKAPK2;PTGR1;PLA2G4A
prerank,cation transmembrane transport (GO:0098655),-0.3100680602053574,-1.0565847586891948,0.3360995850622407,0.8443752007296621,1.0,8/44,9.92%,TRPM3;ATP1A2;TRPM6;PKD2;SLC3A2;SLC7A5;SLC6A9;SFXN2
prerank,phospholipid translocation (GO:0045332),-0.33495234319212946,-1.056190890031854,0.32802547770700635,0.8441922346662335,1.0,8/28,8.34%,PLSCR4;ATP8A1;ABCA1;PLSCR2;ABCA4;ATP11C;ATP8A2;TMEM30A
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.43003318103373833,-1.055888077903562,0.40401785714285715,0.8437647766698785,1.0,3/12,5.66%,NOTCH2;DOCK11;PTK2B
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3815678322488253,1.055770361097148,0.39952153110047844,0.9879364132753101,1.0,11/75,12.67%,ATP2B4;CACNA2D1;KCNJ12;SLC8A2;SLC8A1;ATP1B1;TRPV2;TRPM4;SLC39A14;TRPM2;HCN2
prerank,defense response to protozoan (GO:0042832),0.5233129669815332,1.0553751549887092,0.4395017793594306,0.9879779380851265,1.0,3/12,12.29%,MYD88;LYST;GBP2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.45763710200624214,1.0552709909001345,0.3915756630265211,0.9872179586519357,1.0,2/21,6.32%,ATP2A1;AFG3L2
prerank,positive regulation of cellular process (GO:0048522),0.3419692509599536,1.0552641475276021,0.34468937875751504,0.9862146184076558,1.0,114/565,17.54%,NTF3;TPM1;RYR2;NTRK3;AKAP6;LIFR;ACTN4;ZFHX3;TBX2;FGF1;MERTK;CD36;S1PR3;MST1R;PDGFB;PPP3CA;PDGFC;CCND2;CRLF1;ADRA1D;THPO;IL2;TGFB3;CCL5;GCNT2;PDGFD;PABIR1;IL12RB2;TSHR;FXN;BCL2;OSR2;HAS2;IRS1;TNFRSF11A;CAV1;MAPT;TPPP;TIPIN;VEGFA;ACACB;GDNF;PA2G4;AREG;AR;GAREM1;CHEK1;CELF1;SOX9;DICER1;TGFB2;RELA;KMT2D;ADNP2;CCND1;MVD;ADAM17;TRPM4;SIRT2;PDGFRB;RTKN2;IL13RA1;CCL14;HBEGF;PDGFA;GPER1;LRP5;PRKCD;HTR2B;CNOT7;BMPR1B;HDGFL2;CHRNA7;CITED2;KIF20B;PDCD10;POU3F3;NSMCE4A;SHANK2;ZFP36L1;FGF10;CEP43;GAS6;N6AMT1;S1PR2;HYAL1;PRKAA2;UFL1;PRKCA;MLXIPL;IRS2;FBXO5;SRPK2;RHOG;PTEN;CIAO1;FLOT1;NAMPT;TUB;ASH2L;MT3;INO80;DDX49;RPS6;MTLN;S100A8;S100A9;FGFR3;FAF1;EIF4G2;DNAJA2;ADRA2A;MAP1A;HDAC1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.3821752737955014,1.0545998029903814,0.40269277845777235,0.9870499385104419,1.0,24/69,18.71%,NDUFS1;COX7A2L;NDUFA11;NDUFA2;SDHC;SDHAF2;COX8A;NDUFC1;NDUFB6;NDUFS3;COX7B;NDUFV2;NDUFB8;NDUFS2;SDHA;NDUFAB1;NDUFA1;UQCRFS1;NDUFAF1;COX6C;UQCRH;COX5B;NDUFV3;UQCRQ
prerank,artery morphogenesis (GO:0048844),0.44099975798850805,1.0545820774333081,0.40384615384615385,0.9860811915709413,1.0,7/30,10.07%,HEY2;TBX2;JAG1;BMPR1A;VEGFA;TGFB2;PDGFRB
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.44876613548079003,-1.05431341726611,0.42920353982300885,0.8469187338449078,1.0,3/10,19.38%,LBP;PTPN22;TIRAP
prerank,bicarbonate transport (GO:0015701),0.4484255361775039,1.054119852417266,0.4058192955589586,0.9863904556971221,1.0,4/25,8.07%,CA3;SLC4A8;SLC4A3;SLC4A7
prerank,positive regulation of DNA binding (GO:0043388),-0.3282676416717326,-1.0538983240127535,0.3795379537953795,0.8468226612766179,1.0,12/31,27.56%,IGF1;NIBAN2;HMGB1;PRKN;TGFB1;HES1;PPARG;PARK7;NME1;TWIST1;HMGB2;EGF
prerank,hemopoiesis (GO:0030097),-0.26520725414542556,-1.053767016099469,0.3402777777777778,0.8458722529869783,1.0,17/87,11.03%,TGFBR3;FLT1;MECOM;NOTCH2;BMP4;KIT;TEK;RUNX2;MFAP5;WNT5A;PGM3;CD34;TET2;FUT10;TGFB1;FGFR2;FLT3LG
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.4343925484472566,-1.0534986831321964,0.4218009478672986,0.8452617285082128,1.0,7/12,29.16%,SETX;IRGM;INSR;UVRAG;SMCR8;JMJD4;ADRB2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.4379743089450904,-1.0534054868246239,0.38388625592417064,0.8442490490562462,1.0,4/12,19.46%,CDC14B;RAB1A;UBE2S;BTRC
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.4137071660807897,-1.0532367486404044,0.3944954128440367,0.8434494365113135,1.0,9/13,30.46%,SART3;PRPF19;LSM2;AAR2;PRPF31;PRPF8;SRSF12;PRPF3;DDX20
prerank,positive regulation of MAPK cascade (GO:0043410),0.34655447331942646,1.052893347092699,0.38065843621399176,0.9887814720446657,1.0,34/245,10.88%,RAP1A;NTRK3;ANGPT1;ROCK1;FGF1;CD36;MST1R;PDGFB;PDGFC;FERMT2;ROR1;ADRA1D;THPO;BCAR3;CCL5;GCNT2;PDGFD;MFHAS1;KSR1;DAB2IP;ARL6IP5;VEGFA;FBXW7;GAREM1;RASGRP1;TGFB2;MAP2K1;PDGFRB;CCL14;PELI2;EIF2AK2;PDGFA;GPER1;ROCK2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.22787979003712297,-1.0527903159215946,0.25,0.8434414960839056,1.0,40/186,14.82%,BICC1;MCC;DAB2;MLLT3;TLE1;LRP1;IGFBP2;TCF7L2;NXN;DKK3;APOE;FZD6;CUL3;WNT5A;APCDD1;WWOX;KLHL12;SOX13;CTNND1;TMEM64;LATS2;PSMD7;PSMD9;PSMD13;RNF213;STK11;KREMEN1;PRKN;SFRP4;IGFBP6;PSMB3;WWTR1;PSMC5;PSMA5;NOTUM;PSMA1;PSMC2;SOX17;HECW1;EMD
prerank,protein complex oligomerization (GO:0051259),-0.2631322360570251,-1.0526788259766313,0.2994011976047904,0.8424727217063611,1.0,28/85,24.43%,SPAST;PKD2;RNF135;MCU;LETM1;WDCP;JMJD6;RNF213;UGDH;KCNC2;BLM;GSDMD;UPB1;TMEM120A;SNCA;STOML2;EHD1;G3BP2;YME1L1;PNPT1;ZC3H12A;EHD3;LRRC8D;CLDN1;RBMX;CPSF6;ALS2;ZBTB1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.5066317262640164,1.0521638911375524,0.42857142857142855,0.9897870381187803,1.0,5/13,14.84%,SLC8A2;SHISA9;RAB3A;PPFIA3;SHISA6
prerank,regulation of autophagosome maturation (GO:1901096),-0.42054644317247625,-1.0516236780827115,0.39285714285714285,0.8442578744819583,1.0,7/13,29.16%,IRGM;TBC1D25;CLN3;UVRAG;SMCR8;PHF23;ADRB2
prerank,release of cytochrome c from mitochondria (GO:0001836),0.47349354233028285,1.0516152501017293,0.40456769983686786,0.9902487455779686,1.0,8/17,18.02%,BCL2;FZD9;DNM1L;GGCT;BOK;CLU;MFF;BBC3
prerank,mitotic sister chromatid segregation (GO:0000070),0.3702999123066686,1.051608100727427,0.3784722222222222,0.9892410099295745,1.0,24/98,17.60%,TTN;CHMP4C;NUP62;SET;NCAPD3;CHMP5;PIBF1;DIS3L2;TENT4A;ZWINT;CENPE;WRAP73;RB1;NCAPD2;CHMP2B;CHMP2A;KIF18A;KNSTRN;TEX14;RAD21;INO80;DSN1;CENPK;VPS4A
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.37803626604694573,-1.051123538919186,0.3970223325062035,0.8445226692497926,1.0,7/18,17.31%,APOE;ADAM10;APH1A;NCSTN;CLN3;APH1B;PSEN2
prerank,positive regulation of rRNA processing (GO:2000234),-0.4585629911935335,-1.0510185552534599,0.4314159292035398,0.8435204746223957,1.0,6/10,35.67%,SIRT7;DIMT1;BUD23;HEATR1;RIOK2;TRMT112
prerank,positive regulation of signaling (GO:0023056),-0.32051732823289025,-1.050991097296875,0.34108527131782945,0.8422952806661759,1.0,13/37,26.31%,ANXA2;SYT1;ECE1;WLS;SNCA;RAB29;RIMS2;CD80;NMU;SCRIB;INPP5F;SOX11;EDN3
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3693416758220905,-1.0509591492535457,0.38961038961038963,0.8411027386084365,1.0,7/20,18.66%,APOE;NLGN1;SHANK3;CAMK1;LRP8;DBN1;FMR1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.4004409622241606,-1.0509496551378184,0.42824074074074076,0.8398345132381388,1.0,5/16,11.92%,DDX5;SRSF6;CELF4;HNRNPM;DDX17
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.4374268131193246,1.05062884917061,0.41904761904761906,0.9898737581178041,1.0,13/32,20.76%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,tRNA export from nucleus (GO:0006409),0.4374268131193246,1.05062884917061,0.41904761904761906,0.9898737581178041,1.0,13/32,20.76%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,chemical synaptic transmission (GO:0007268),0.3454625617315708,1.0501013044957976,0.3944672131147541,0.9902910290989183,1.0,44/284,12.68%,CACNB2;STXBP2;HCRTR1;APBA1;HTR1B;DTNA;GABRE;KCNMB1;GRIN2C;SLC6A2;SLC6A5;CACNB4;CAMKK2;SYT10;GABARAP;PCDHB14;STAC3;RPS6KA2;GABRA4;CALM1;RAB3A;GABRA5;MBP;PCDHB11;PRKACB;PRKAR1B;RAPSN;GRIK5;LIN7C;GABRB2;RIMBP2;BRSK1;GABRG1;HRH3;FCHSD2;CBLN2;KCNK3;CACNA1B;HTR2B;GABRB3;KIF5A;CHRNA7;CHRFAM7A;HOMER1
prerank,regulation of neurotransmitter transport (GO:0051588),0.48307427523113533,1.0498951008973958,0.408130081300813,0.9898320435297501,1.0,1/16,0.71%,MEF2C
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3721312615907194,1.049870019996176,0.38941176470588235,0.9888826236398957,1.0,13/76,10.68%,KLHL40;ANGPT1;UBA2;DCUN1D2;PIAS4;SAE1;CAV1;FBXW7;DCUN1D1;TNIP1;AMER1;PAXIP1;UBE2D1
prerank,negative regulation of catabolic process (GO:0009895),0.4019177852786269,1.0496397092729828,0.4205729166666667,0.9884937306938669,1.0,6/47,9.92%,FLNA;PFKFB1;PIN1;SF3B3;PPARA;SIRT2
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.4399766403786375,-1.0496181167656677,0.4178082191780822,0.8423526589157134,1.0,3/10,24.62%,LGALS9;CD274;SCRIB
prerank,photoreceptor cell development (GO:0042461),0.49157244855902504,1.0493001219357003,0.4165232358003442,0.9883996687043486,1.0,3/14,6.50%,CDHR1;CEP290;VEGFA
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.38578853981504496,-1.0492880117490584,0.38345864661654133,0.8419456414783912,1.0,4/17,11.42%,PTN;PTPRZ1;TGFB1;HES1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.399576118705514,-1.0491976124088411,0.3615023474178404,0.8409062861165683,1.0,4/14,16.30%,PUM1;DDX60;ANKRD17;TLR3
prerank,negative regulation of macrophage activation (GO:0043031),-0.4038417470919501,-1.049015449637376,0.4180929095354523,0.840165792684401,1.0,6/16,18.64%,IL31RA;LDLR;CX3CL1;SYT11;GRN;ZC3H12A
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.27172375188532316,-1.0489510124174821,0.3567251461988304,0.839080409217076,1.0,27/72,25.45%,CARM1;TFDP1;ACER2;PML;ARID3A;MDM2;SP100;RGCC;SOX4;NBN;EP300;MYO6;PLK2;BAX;CNOT11;CRADD;CHEK2;ATM;E2F4;USP10;BCL3;PCBP4;PLAGL1;CDKN1A;SESN2;TFAP4;CNOT10
prerank,positive regulation of cell population proliferation (GO:0008284),0.3411376752247637,1.048610631481088,0.3698492462311558,0.9893174423014522,1.0,81/423,15.38%,NTF3;MEF2C;NTRK3;RBPMS2;LIFR;TBX2;FGF1;S1PR3;MST1R;PDGFB;CCN1;PDGFC;CDK6;CCND2;CDH13;CRLF1;ADRA1D;THPO;IL2;TGFB3;CCL5;GCNT2;PDGFD;IL12RB2;TSHR;FXN;BCL2;OSR2;BMPR1A;HAS2;IRS1;TNFRSF11A;TERT;TIPIN;VEGFA;GDNF;LAMC1;AREG;AR;GAREM1;YAP1;FZD9;SOX9;TGFB2;RELA;KMT2D;SAAL1;MVD;ADAM17;TRPM4;PDGFRB;RTKN2;HNRNPU;IL13RA1;CCL14;HBEGF;S100A6;PDGFA;GPER1;LRP5;HTR2B;CNOT7;CHRNA7;KIF20B;PDCD10;POU3F3;SHANK2;FGF10;CEP43;GAS6;S1PR2;HYAL1;UFL1;MLXIPL;IRS2;FBXO5;SRPK2;RHOG;PTEN;CIAO1;STAT1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.4722823381764104,1.0483021727974198,0.42295081967213116,0.9891486691261893,1.0,4/18,6.99%,CRTC1;CRTC3;VEGFA;CD200
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.4192645937785081,-1.048009488552403,0.4027777777777778,0.8406157915283649,1.0,3/12,15.17%,PTK2;LYN;BST2
prerank,regulation of protein modification process (GO:0031399),-0.29215710117301275,-1.0479836920575187,0.35135135135135137,0.8394170576866233,1.0,13/50,17.72%,CDH5;FN1;SPRED2;PTK2;PPP2CA;ASPSCR1;PML;IGF2;STAT2;LYN;GRM5;NOP53;KDM4D
prerank,positive regulation of DNA recombination (GO:0045911),0.4501095212395508,1.0478382606183487,0.4200913242009132,0.9894129163152784,1.0,10/27,16.16%,RAD51AP1;ZCWPW1;PARP1;ERCC6;FUS;FANCB;PAXIP1;RIF1;KMT5B;MAD2L2
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3928446540094298,-1.0475613390326388,0.3961352657004831,0.8393851163813341,1.0,5/16,4.96%,ST8SIA4;ST3GAL5;ST6GALNAC3;ST8SIA1;B4GALT6
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.45471080401694763,1.0473198178842065,0.41853512705530643,0.9898487693958374,1.0,4/23,9.45%,CHMP4C;PABIR1;CHEK1;ZWINT
prerank,negative regulation of protein polymerization (GO:0032272),-0.3491957346994441,-1.0470576366904705,0.3799392097264438,0.8395827075494635,1.0,10/27,14.15%,CDH5;SLIT2;KANK3;CYRIB;EML2;SSH2;PFN2;PFN1;SSH1;SNCA
prerank,histone H3-K4 methylation (GO:0051568),-0.34287546624286125,-1.0465702881895864,0.37910447761194027,0.8397725991024941,1.0,13/26,30.91%,TET3;CTR9;TET2;OGT;KMT2C;DPY30;SETD1A;KDM6A;PRDM9;CXXC1;KMT2A;RBBP5;BEND3
prerank,microtubule nucleation (GO:0007020),0.465470111616126,1.0465288460161148,0.42197452229299365,0.9909931088672368,1.0,4/19,7.13%,CLASP2;TUBGCP6;TPPP;TPX2
prerank,regulation of telomerase activity (GO:0051972),0.4174486648874757,1.0464596049386794,0.4151436031331593,0.9901762861406597,1.0,7/45,9.59%,PARM1;PARN;PRKCQ;TP53;PKIB;NAF1;CERS1
prerank,regulation of protein autophosphorylation (GO:0031952),0.42121224103250016,1.0463932816639927,0.40460081190798375,0.9893536635811576,1.0,10/36,10.74%,PDGFB;PDGFC;PDGFD;RAP2C;VEGFA;PPP2R5A;CALM1;IMPACT;RAP2A;PDGFA
prerank,negative regulation of MAPK cascade (GO:0043409),-0.2606339828629633,-1.046262299914802,0.36496350364963503,0.8393554787208122,1.0,24/87,22.01%,NF1;FBLN1;SEMA6A;BMP7;DLG1;BMP4;APOE;SPRED2;FOXO1;STK38;PIK3CB;IRAK3;LYN;SPRY2;SIRPA;IGBP1;DUSP1;LMO3;SMAD4;ITGB1BP1;QARS1;PTPN2;PEBP1;EPHB2
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4619202898987995,1.0461186469635322,0.4194577352472089,0.9890871152449503,1.0,6/19,12.48%,ROCK1;RTN2;PIN1;RTN1;CHRNA7;CLU
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.36471768974963137,-1.0457445268179477,0.3791208791208791,0.8396531444068565,1.0,6/22,16.41%,ZBTB20;APOE;CREBL2;CREB1;AKT1;PPARG
prerank,midbody abscission (GO:0061952),0.46459175525406593,1.0456860559594392,0.4003322259136213,0.9892623179837176,1.0,4/17,13.43%,CHMP4C;CHMP5;CHMP2B;CHMP2A
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.3760459122001097,-1.0453240044837706,0.3994910941475827,0.8395928021554852,1.0,8/19,24.98%,TPST1;BPNT2;SLC26A2;ENPP1;PAPSS1;PAPSS2;SLC35B3;BPNT1
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.34997004345844507,-1.0447081481496416,0.38328530259365995,0.8401557708454183,1.0,9/24,25.12%,NF1;EPHA7;NUPR1;CTNNB1;GRN;BAX;ATF4;FOXO3;CDK5R1
prerank,response to retinoic acid (GO:0032526),-0.2882552290672476,-1.044558263836827,0.31746031746031744,0.8392999250223395,1.0,18/59,18.29%,PTK7;WNT5A;RBP4;EPHA3;ACER2;PTK2B;CTSH;WNT9A;SETX;ABL2;SNW1;CREB1;LYN;RARA;WNT6;TRIM16;ATM;RORB
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.4971513178073488,1.0445011437226275,0.4077181208053691,0.9914819680545058,1.0,4/13,11.96%,LARGE1;CHST5;CHST3;CHST1
prerank,sphingolipid metabolic process (GO:0006665),-0.24712357929898135,-1.0444210576788142,0.35772357723577236,0.838430798109693,1.0,23/108,11.74%,SGMS1;SGMS2;ELOVL7;CERS5;CERK;HACD4;SPTLC2;ST6GALNAC3;PPP2CA;SPTSSA;ACER2;ALDH3A2;ENPP2;SERINC1;SUMF2;CERS6;SGPP1;CERT1;PPT1;ASAH2;HEXA;B3GALNT1;SPNS2
prerank,myeloid dendritic cell activation (GO:0001773),-0.4329380840919793,-1.0440752244272475,0.4134831460674157,0.8381916348233849,1.0,9/12,52.83%,HMGB1;DOCK2;CAMK4;BATF;PYCARD;BATF2;TGFBR2;IL4;BATF3
prerank,positive regulation of chemokine production (GO:0032722),-0.29649993235111005,-1.0439509470195654,0.3755656108597285,0.8372548067239484,1.0,7/44,8.49%,HMGB1;APP;DDX3X;IL18;WNT5A;LGALS9;IL6R
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.43914670851586884,-1.0439372458924154,0.41685144124168516,0.8360421818579192,1.0,6/11,14.79%,SEMA6A;EPN1;PIK3CB;ADAMTS9;KLF2;CREB3L1
prerank,negative regulation of receptor internalization (GO:0002091),-0.4244341548634524,-1.0439121255342176,0.3925,0.83487339920431,1.0,4/12,16.13%,RIN3;ANKRD13A;SDCBP;UBQLN2
prerank,regulation of vacuole organization (GO:0044088),-0.36203006968767737,-1.0436949269391465,0.40412979351032446,0.8342478791492743,1.0,10/20,24.08%,ANXA2;RAB5A;NPRL3;SCARB2;IFT88;UBQLN2;RAB1B;ENO2;TBC1D14;ENO1
prerank,positive regulation of defense response (GO:0031349),0.3646066723189737,1.042716486441727,0.40784780023781214,0.9953701346745376,1.0,6/89,3.64%,AGTR1;MEF2C;IL2;LPL;FEM1A;CCL5
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4902891632500444,1.0427105497301086,0.43005181347150256,0.994379378953957,1.0,2/14,3.06%,ANXA1;SOCS5
prerank,negative regulation of cell growth (GO:0030308),0.3623491613459752,1.042483822276258,0.40979955456570155,0.993973746132488,1.0,23/121,14.70%,SLIT3;FGF13;MYL2;RERG;FHL1;JADE1;PTPRS;NDRG3;TP53;BTG1;TGFB2;NDUFS3;CRLF3;SERTAD2;SH3BP4;RB1;TCHP;ACVR1B;DCBLD2;BCL6;MUL1;HYAL1;VGLL4
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4566012761131056,1.0418027277671509,0.4251968503937008,0.9948386451639588,1.0,3/22,6.81%,ROCK1;PACSIN3;TIMP4
prerank,glutamate receptor signaling pathway (GO:0007215),-0.3099518562628501,-1.0417157877318288,0.43018867924528303,0.8387193695562929,1.0,13/37,19.56%,GRM3;APP;GRM7;PTK2B;HOMER3;GRIN3A;DAGLA;GRIK3;GRM5;CLN3;GRID2;FMR1;GRIK1
prerank,potassium ion homeostasis (GO:0055075),0.44209651792638693,1.0406323349316087,0.41654357459379615,0.9971136337961426,1.0,2/23,5.82%,KCNMA1;ATP1B1
prerank,atrial septum morphogenesis (GO:0060413),0.5099939316364124,1.0405448323927478,0.4221014492753623,0.9963608003160767,1.0,2/10,7.86%,HEY2;TGFB2
prerank,regulation of macrophage cytokine production (GO:0010935),-0.41763501761682215,-1.039182959465098,0.4406392694063927,0.8446197906605647,1.0,5/13,10.30%,WNT5A;SEMA7A;PLCG2;IRAK3;TGFB1
prerank,activation of phospholipase C activity (GO:0007202),0.43661425753147914,1.0391555328309594,0.40923076923076923,0.999092259042795,1.0,2/29,4.86%,EDNRA;ARHGAP6
prerank,positive regulation of neuron differentiation (GO:0045666),0.4080945970638215,1.0389169214370177,0.39752407152682256,0.9987807767243514,1.0,6/40,10.56%,MEF2C;HEYL;MMD;ARHGEF2;IMPACT;BRINP1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3937697895927042,1.0388791566344198,0.40707964601769914,0.997876495437639,1.0,1/54,0.09%,CCDC3
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4690240696546788,1.038380065204477,0.42258064516129035,0.9971916315932867,1.0,5/19,13.03%,POLR2L;POLR2I;POLR2G;TERF2;POLR2J
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4690240696546788,1.038380065204477,0.42258064516129035,0.9971916315932867,1.0,5/19,13.03%,POLR2L;POLR2I;POLR2G;TERF2;POLR2J
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.422269021255233,-1.0382231675227651,0.42409638554216866,0.8461531256434254,1.0,3/12,7.19%,MYCBP2;B4GALT6;HSP90AB1
prerank,negative regulation of anoikis (GO:2000811),0.4913945649539757,1.0377900867033447,0.42589437819420783,0.9978865198590178,1.0,5/14,7.71%,PDK4;ITGB1;BCL2;CAV1;SNAI2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.3647269132868326,-1.0375914669365869,0.39617486338797814,0.8466972846297047,1.0,13/21,42.50%,EPHA7;BIRC2;DELE1;BIRC3;TTBK1;PSMB9;PYCARD;NGF;GRIN1;AIM2;FYN;BEX3;GRIN2B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.2849193714080847,-1.0368288787652937,0.34146341463414637,0.8450438107735906,1.0,18/61,19.23%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;SCFD1;RAB1B;TRAPPC3;TFG
prerank,COPII vesicle coating (GO:0048208),-0.2849193714080847,-1.0368288787652937,0.34146341463414637,0.8450438107735906,1.0,18/61,19.23%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;SCFD1;RAB1B;TRAPPC3;TFG
prerank,vesicle coating (GO:0006901),-0.2849193714080847,-1.0368288787652937,0.34146341463414637,0.8450438107735906,1.0,18/61,19.23%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;SCFD1;RAB1B;TRAPPC3;TFG
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.40210948427301085,-1.0367280944449087,0.41075794621026895,0.8441068663783885,1.0,2/15,2.55%,CPEB2;DDX3X
prerank,negative regulation of binding (GO:0051100),0.37361113664159085,1.0365414332194702,0.4351515151515152,1.0,1.0,15/81,14.51%,PLN;XIRP1;ROCK1;PDGFB;ACTB;CAV1;PIN1;PPP1CA;PSME3IP1;PEX19;PRKCD;BAG2;CSNK1E;LRRK2;DVL1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.4747535829430326,1.0362222316493972,0.43521594684385384,1.0,1.0,4/15,13.20%,ANXA1;HNRNPU;GPER1;ZFP36L1
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3565410408236679,-1.0361916948050014,0.3843843843843844,0.8444776489407717,1.0,6/22,19.44%,APPL2;PTPRZ1;TAFA1;NES;KDM1A;NAP1L1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.34452027875131064,1.0361566264848325,0.42707240293809023,0.9994013805278064,1.0,34/224,12.68%,CACNB2;HCRTR1;APBA1;HTR1B;DTNA;GABRE;KCNMB1;SLC6A2;SLC6A5;CACNB4;CAMKK2;SYT10;GABARAP;PCDHB14;RPS6KA2;GABRA4;CALM1;GABRA5;MBP;PCDHB11;PRKACB;PRKAR1B;RAPSN;GABRB2;GABRG1;HRH3;KCNK3;CACNA1B;HTR2B;GABRB3;KIF5A;CHRNA7;CHRFAM7A;HOMER1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.4999856869549799,1.0360146365417826,0.4397810218978102,0.9987855415088148,1.0,4/11,16.02%,IL12RB2;STAT1;JAK2;STAT3
prerank,endochondral bone morphogenesis (GO:0060350),0.5086528109641643,1.0359285840652799,0.4113597246127367,0.9980310704606508,1.0,3/11,12.19%,MEF2C;INPPL1;BMPR1B
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.4166993495052976,1.035849628679273,0.43496503496503497,0.9972351815986813,1.0,13/38,18.23%,NDUFS1;NDUFA11;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFAB1;NDUFA1;NDUFAF1;NDUFV3
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4823966661714227,1.035266788569213,0.4211382113821138,0.9978193598688608,1.0,4/15,11.96%,LARGE1;CHST5;CHST3;CHST1
prerank,protein destabilization (GO:0031648),-0.32079837968199754,-1.0351174217159016,0.3967741935483871,0.8462898536131227,1.0,9/32,14.31%,CUL3;CTSH;DERL1;MDM2;PRKN;IRGM;EP300;SNCA;SOX17
prerank,monocarboxylic acid transport (GO:0015718),0.4018233893122282,1.0349050256009396,0.4087968952134541,0.9978464277519357,1.0,6/51,2.91%,NR1H4;CD36;ATP8B1;ABCB4;SLC16A7;SLC10A1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.4673777036254376,1.0347754815529846,0.43456375838926176,0.9971769195155908,1.0,4/15,17.16%,MYD88;HIF1A;STAT3;TICAM1
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.24334814457309972,-1.0345206546429941,0.4270833333333333,0.8466769930150139,1.0,31/132,14.52%,IGF1;ZBTB20;DAPK1;DCN;HMGB1;APOE;APP;NRDC;ITCH;TPCN1;FOXO1;ABHD5;PRR5L;PIK3CB;TFEB;FURIN;OPTN;RDX;STK11;ENTPD5;TRIM5;IRGM;GTPBP1;PTTG1IP;TRIM14;DTX3L;PFKFB2;ARNT;SNCA;INSR;TMEM59
prerank,mitotic cytokinetic process (GO:1902410),0.4501901918731964,1.0343148438200769,0.4022801302931596,0.9973855781475639,1.0,6/20,17.60%,CHMP4C;CHMP5;CHMP2B;CHMP2A;CNTROB;VPS4A
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3369871765013991,1.0341567610209157,0.4006024096385542,0.996797817740235,1.0,46/476,9.80%,ACTA2;MYOCD;PRDM16;TNNI2;MEF2C;HEY2;MAP3K5;ZFHX3;SMARCD3;LBH;NR1H4;PDGFB;RORA;ETS2;FZD4;HINFP;TGFB3;NUP62;ARID1A;NR2F2;TGFB1I1;CAMKK2;OSR2;CEP290;DYRK1A;TESC;TP53;DYRK1B;PPM1A;AR;PPARGC1A;MED1;YAP1;MED12;SOX9;RELA;PLCB1;SETD3;ZXDC;PPARA;MAP2K1;NSD3;NR1D1;HIF1A;CRLF3;SFR1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.38011653460179406,-1.0339991035747897,0.3989501312335958,0.8469085322937668,1.0,15/18,49.60%,OFD1;CCDC39;SPEF2;NEK10;CFAP53;ROPN1L;ADCY10;SPAG17;AQP4;SPA17;DNAAF2;ODAD4;NPHP3;CCDC40;DNAAF4
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.3759072600969071,-1.0338210509579118,0.3978201634877384,0.8462019210311762,1.0,7/17,34.98%,PDE3B;ALK;AKT1;PRKAA1;MFSD2A;BSCL2;GPLD1
prerank,negative regulation of metabolic process (GO:0009892),0.39324914902701286,1.0336323777125807,0.4127604166666667,0.9972442775052847,1.0,7/54,9.23%,CCDC3;ADAMTS5;PLCL1;LNPEP;ADAM17;GSTP1;NR1D1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3567839860065448,1.033345827814865,0.4142212189616253,0.9970359903966255,1.0,12/110,9.65%,LHCGR;PTGER3;ADCY5;S1PR3;ADCY2;ADRA1D;ADCY9;TSHR;RAMP1;PTH1R;ADCY6;ADGRL2
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.350426859266567,1.0331950051720866,0.4078389830508475,0.996458471699122,1.0,35/172,15.72%,DGKB;DGKG;PIP5K1B;INPP4B;PIP4K2A;MTMR7;SLC44A5;PITPNM3;STARD7;SYNJ2;SACM1L;SLC44A1;LPCAT3;AGPAT3;INPPL1;DGKD;MTMR14;PCYT2;TAMM41;GPD1L;CDIPT;SBF1;CPNE3;PNPLA3;PIK3C3;DGKZ;RAB14;PLA2G4A;CHKB;PLEKHA1;PLA2G4C;INPP5J;PITPNM2;PTEN;VAC14
prerank,regulation of protein metabolic process (GO:0051246),-0.30177728152555044,-1.0326028980185271,0.3890909090909091,0.8483758712408557,1.0,17/44,18.85%,NEDD4L;APOE;APP;LDLR;LTBP4;HSP90AB1;FURIN;FKBP1A;MDM2;ACE;KLF2;SSH1;HGS;GSAP;CHEK2;ODC1;SPOPL
prerank,secretory granule organization (GO:0033363),-0.44013564189012855,-1.0320966946638868,0.43736730360934184,0.8485338727308965,1.0,3/10,8.94%,ABCA1;SRGN;DTNBP1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5040476186207816,1.0318044468874248,0.4414715719063545,0.9990933664840099,1.0,5/12,16.80%,CGAS;CAV1;MUL1;FLOT1;DHX9
prerank,cellular response to hexose stimulus (GO:0071331),-0.3416380480680531,-1.031643394837664,0.3988919667590028,0.848502005906968,1.0,6/23,12.74%,ZBTB20;UNC13B;TRA2B;ERN1;SOX4;PCK2
prerank,epithelium development (GO:0060429),0.3543973681465687,1.0313736793988955,0.41638225255972694,0.9993115592810438,1.0,11/107,8.75%,TAGLN;TBX2;VCL;TAGLN2;DMBT1;VEGFA;CNN3;SOX9;SNAI2;CBR1;VDAC1
prerank,translesion synthesis (GO:0019985),-0.3077541904448495,-1.031210230644109,0.4235294117647059,0.8485929142757793,1.0,22/42,37.18%,UFD1;PARP10;TRIM25;POLDIP2;UBC;REV1;POLN;USP10;PRIMPOL;UBB;POLE2;ZBTB1;POLI;RPA3;RFC3;USP43;RPA2;POLD3;PCLAF;RPA1;RFC1;RFC4
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.41472980855155883,1.0311049502411311,0.4243281471004243,0.9990370179218381,1.0,14/37,18.02%,PMAIP1;NACC2;BCL2;CAV1;TP53;SFPQ;EIF5A;DNM1L;BOK;S100A8;S100A9;BCAP31;DDIT3;BBC3
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.37046790723853157,-1.0310551629785787,0.4132029339853301,0.847836229010524,1.0,9/18,27.91%,NGLY1;SAMHD1;ADAMTS9;FBXO17;BPGM;NAGA;STT3B;DERA;FBXO44
prerank,neuron development (GO:0048666),-0.23839898708909257,-1.0306048463537878,0.3838383838383838,0.8479227386972332,1.0,42/141,18.50%,PLP1;PBX3;HMGB1;APOE;WNK1;THOC2;APP;FRYL;GLI2;RASGRF1;RAB11A;STX3;NLGN1;B4GALT6;PTPRM;TDP2;ATP8A2;UHMK1;TMEM108;DTNBP1;TENM3;UGDH;PPT1;LAMB1;ALK;UNK;MANF;LYN;OPHN1;EPHA8;TBC1D24;STMN4;EHD1;VSX1;CNTN4;RAB13;SH3GL2;ATXN10;LGI4;RP1;CDK16;RAB35
prerank,positive regulation of biosynthetic process (GO:0009891),0.4062477907763407,1.030245296491871,0.42916093535075656,1.0,1.0,12/40,14.89%,CD36;VIM;SLC5A3;TGFB3;CCL5;SORBS1;PPARA;SUCO;RUNX1;SIRT4;ADGRB1;MLXIPL
prerank,gene silencing by miRNA (GO:0035195),0.42246262716409955,1.0301924872165662,0.45161290322580644,0.9994163319435372,1.0,2/32,1.88%,WTIP;LIMD1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3903704731133715,-1.0301758652748039,0.38944723618090454,0.8479021155261011,1.0,5/16,26.91%,LDLR;ABHD5;MFSD2A;DAGLB;PNPLA2
prerank,cellular amino acid catabolic process (GO:0009063),0.3756378686565689,1.030002780650665,0.43507972665148065,0.9989317449809748,1.0,15/87,11.00%,BCAT2;MCCC2;HSD17B10;CARNS1;HIBADH;BLMH;DLD;HGD;KMO;DLST;GOT1;GOT2;SARDH;GLS2;GLS
prerank,C21-steroid hormone metabolic process (GO:0008207),0.4548583596698518,1.0299314193873232,0.4442675159235669,0.9981637835000677,1.0,2/20,7.14%,HSD17B10;AKR1B1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3381054503812058,1.0297687759878869,0.44072948328267475,0.997652610456619,1.0,58/348,14.04%,NTF3;RBPMS;RAP1A;NTRK3;ATP2B4;ANGPT1;FGF1;ANGPT4;PDGFB;CCN1;PDGFC;CCND2;CSPG4;THPO;FAM20A;BCAR3;TGFB3;MMD;PDGFD;ACVR2A;MUSK;CAMKK2;ARHGEF2;BMPR1A;RARRES2;CAV1;RAP2C;TP53;VEGFA;PIN1;CALM1;LCP2;RASGRP1;ITGB3;SOX9;TGFB2;CCND1;ADAM17;PAK2;GDF1;RAP2A;CENPE;PELI2;PDGFA;GPER1;ROCK2;CLIP3;TNIK;AKTIP;CHRNA7;SNX9;PDCD10;FNIP2;FGF10;GAS6;MAP2K3;S1PR2;MAPK1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.3313390761880084,-1.0296643922522177,0.3933333333333333,0.8480950112244354,1.0,13/30,28.12%,TUSC3;MGAT1;FUT8;UGGT2;OSTC;MGAT5;MCFD2;LMAN1;RPN2;MGAT2;DPM3;STT3B;ASGR1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.38891306593667624,1.0291202833444844,0.4177545691906005,0.9984229897375868,1.0,9/48,9.57%,ANGPT1;ANGPT4;PDGFB;ANXA1;HDAC9;VEGFA;RHOJ;ADAM17;HIF1A
prerank,nucleoside phosphate catabolic process (GO:1901292),0.48182870193944255,1.0286916596978228,0.42105263157894735,0.9986347477728365,1.0,2/13,7.16%,ENTPD1;ENTPD7
prerank,mitochondrial gene expression (GO:0140053),0.3981084693427754,1.0286373297979188,0.4185733512786003,0.9978091346328649,1.0,17/42,20.51%,FASTKD5;GATB;IARS2;MRPS28;MRPL51;MRPL23;GFM2;MRPL16;TFB2M;MRPL47;LARS2;FASTKD2;MRPS21;TEFM;GATC;MRPS14;SLC25A33
prerank,negative regulation of chemokine production (GO:0032682),-0.39767579682032916,-1.0285001141461905,0.40694789081885857,0.8502547870563529,1.0,4/14,15.25%,APOD;LGALS9;SIRPA;C1QTNF3
prerank,mitotic spindle organization (GO:0007052),0.34856733308346693,1.028146411926436,0.43743199129488575,0.9981983620520838,1.0,29/153,14.15%,FLNA;DYNLL1;CLASP2;KIF2A;CENPP;TOGARAM2;KIF3B;DCTN6;EFHC1;EML1;TPX2;PIBF1;TOGARAM1;SUN2;CENPO;SEC13;ZWINT;CEP192;CENPE;WRAP73;NUP107;AAAS;DYNC1I2;ITGB3BP;CLASP1;MAP4;NUP98;KIF18A;NUP37
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.30949487244788343,-1.0280691058993439,0.39416058394160586,0.8502528672197909,1.0,7/35,9.60%,VTN;B2M;HNRNPK;AAK1;BMP2K;PIK3CB;PPT1
prerank,regulation of interleukin-4 production (GO:0032673),-0.34815473050904694,-1.027874888829805,0.39941690962099125,0.8495677819307382,1.0,8/21,26.07%,LEF1;LGALS9;SLC7A5;CEBPB;RARA;CD86;SYK;ZFPM1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.41979850880188585,1.027844701572087,0.4366812227074236,0.9980259799392889,1.0,6/30,11.77%,CAVIN1;POLR2L;GTF2H4;CDK7;POLR1E;POLR1H
prerank,T cell activation involved in immune response (GO:0002286),0.49352527279934016,1.0277138322981305,0.4594594594594595,0.997423206180129,1.0,1/12,3.35%,LCP1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.33082891660751257,-1.027654984475934,0.4171597633136095,0.8490345709773489,1.0,5/25,9.37%,RIN3;APP;ANKRD13A;ITGAV;SDCBP
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5008781067956187,1.027396132032324,0.41935483870967744,0.9973144074468441,1.0,4/10,10.48%,FBXW7;AREG;ADAM17;HBEGF
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.32317065806829326,-1.0270368994163976,0.40524781341107874,0.8496281564106952,1.0,19/31,40.30%,PEX14;PEX5;TIMM44;DNAJC19;AIFM1;TIMM17B;HSPD1;TOMM70;TIMM21;TIMM23;GRPEL1;PEX6;PEX16;DNLZ;TOMM40L;TOMM40;TIMM50;PEX12;GRPEL2
prerank,development of primary male sexual characteristics (GO:0046546),0.42089040067658073,1.0266426902418098,0.4344262295081967,0.9983483280253579,1.0,5/34,7.86%,LHCGR;CSDE1;AR;SOX9;TGFB2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.36681822484534166,1.0264089432063712,0.40613931523022434,0.9979759906435799,1.0,17/86,13.32%,NTF3;ANGPT1;ANGPT4;PDGFB;CSPG4;ARHGEF2;RAP2C;TP53;VEGFA;ITGB3;PAK2;SAMSN1;PDGFA;PRKCD;CNOT7;DMTN;FGF10
prerank,regulation of dendrite development (GO:0050773),-0.31064406375447384,-1.026337346369068,0.4107142857142857,0.8504333604070786,1.0,9/37,10.02%,PTN;COBL;NEDD4L;BMP7;ADGRB3;CAMK1D;ZDHHC15;SEMA4D;ALK
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5019192320679136,1.0261958876667412,0.4290909090909091,0.9976017057805461,1.0,4/10,18.30%,TP53;RPS27L;HIPK2;RPS6KA6
prerank,macrophage activation involved in immune response (GO:0002281),0.495616630449898,1.0259090005700968,0.45694200351493847,0.9973908874331208,1.0,2/13,2.43%,FER1L5;DYSF
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.2366701922678785,-1.0256636674240174,0.323943661971831,0.8511876306984324,1.0,32/152,14.23%,RNF220;LRRK1;LGR4;SULF1;COL1A1;ADGRA2;WNK1;RNF146;DDX3X;PTK7;EGFR;LYPD6;TNKS2;PPM1B;PSMD7;PSMD9;PSMD13;WLS;ATP6AP2;SMURF2;SALL1;SFRP4;RSPO2;TGFB1;FGFR2;PSMB3;SOX4;ZBED3;PSMC5;PSMA5;PSMA1;PSMC2
prerank,fatty acid beta-oxidation (GO:0006635),0.3867393046796392,1.0253195338928798,0.4420103092783505,0.9979081021296944,1.0,12/51,10.20%,HSD17B10;PEX2;HSD17B4;ACAD11;CRAT;MECR;ETFA;ABCD4;ACADS;ACAD10;HADHB;SCP2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.42636429566128653,-1.0251127035319545,0.46808510638297873,0.8515361176261268,1.0,5/11,12.06%,LGALS9;CD34;ATP6AP2;PTGS2;CD46
prerank,thymus development (GO:0048538),-0.41908628120584523,-1.025074957917214,0.4268292682926829,0.850431914595363,1.0,6/13,27.22%,SIX1;HES1;TGFBR1;ZBTB1;FOXE1;EPHB3
prerank,regulation of protein ubiquitination (GO:0031396),-0.2466186750053084,-1.02491384705846,0.3898305084745763,0.8496565122052778,1.0,29/108,15.80%,SASH1;ARRB1;NXN;CUL3;MYCBP2;UBQLN1;CRY1;DERL1;HSP90AB1;BIRC2;PRMT3;COMMD1;FKBP1A;SIRT7;FBXO4;PRKN;UBE3A;OGT;STUB1;TGFBR1;SPRY2;SOX4;DNAJB2;PTTG1IP;SH3RF2;FANCI;BIRC3;UBXN1;AKT1
prerank,regulation of interleukin-1 production (GO:0032652),-0.38756375537098114,-1.0248093805977514,0.3923705722070845,0.8487465527671179,1.0,4/15,12.16%,FOXP1;HMGB1;TMED10;SIRPA
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4832515496656068,1.0247842400325637,0.437609841827768,0.9983612979490131,1.0,6/13,18.66%,GLRX5;ISCA1;ISCA2;GLRX3;CIAO1;NFU1
prerank,cellular response to retinoic acid (GO:0071300),-0.29984959376127474,-1.0247383405032495,0.4094488188976378,0.8477275877737012,1.0,13/42,18.29%,PTK7;WNT5A;EPHA3;PTK2B;WNT9A;SETX;ABL2;SNW1;CREB1;LYN;WNT6;ATM;RORB
prerank,regulation of cell development (GO:0060284),0.40288438815343003,1.0246968950857758,0.4462809917355372,0.9976431574118131,1.0,6/36,7.59%,HEY2;HEYL;HDAC9;PRUNE1;YTHDF2;YAP1
prerank,error-prone translesion synthesis (GO:0042276),-0.3556560323063739,-1.0245706907995842,0.44266666666666665,0.847012507182748,1.0,12/21,37.18%,UBC;REV1;PRIMPOL;UBB;POLE2;POLI;RPA3;RFC3;RPA2;RPA1;RFC1;RFC4
prerank,regulation of small molecule metabolic process (GO:0062012),0.43019852356727944,1.0236689338950302,0.4289985052316891,0.9993465610457112,1.0,3/28,2.57%,NR1H4;PDK4;RORA
prerank,cellular lipid catabolic process (GO:0044242),-0.32470129754436633,-1.0235601548736917,0.4176470588235294,0.848684167056415,1.0,8/27,18.54%,LPIN2;ENPP2;CYP1B1;ACOT8;ACBD5;ABHD12;ACOX1;LPIN3
prerank,cellular protein modification process (GO:0006464),0.3312532718350098,1.023194361587582,0.426,0.9996589960251371,1.0,181/983,14.87%,ART1;PPP1R12A;MAP3K20;IGFBP7;MFGE8;LTBP1;SPARCL1;STK38L;SDC2;TNNI3K;PRKG1;MAP3K5;ASB15;PPM1L;ROCK1;HRC;DYRK2;MERTK;PPM1J;ASB10;FCGR3A;KCTD7;PDGFB;CCN1;PPP3CA;ASB18;CDK6;LARGE1;FBXL22;FBXO40;PDK4;ANXA1;FRK;MTMR7;LOXL2;FAM20A;DUSP5;SOCS5;CAMK2D;PPP2R1B;IGFBP5;FEM1C;FEM1A;PPM1E;GCNT2;ACVR2A;SIRT3;MCRS1;LMO7;ASB2;CAMKK2;PTPN18;ASB1;PEAK1;MARK1;SEPHS1;CUL2;PTPRS;SOCS6;RNF7;BMPR1A;LHPP;NUCB1;DYRK1A;ATG7;PHKA2;MAP4K3;CHST5;MAP4K5;SDHAF2;ASB8;PTPRF;TAF1;PSMC6;ELOC;COQ8A;MAPKAPK2;DYRK1B;FBXW7;FBXO30;PPP2R5A;FBXL18;PPM1A;PARP1;ART4;KTN1;PTPN1;IGFBP4;LAMC1;LAMB2;RAB3A;STK26;UBE2F;CUL9;CHEK1;TGFB2;NUAK1;DCUN1D1;SETD3;WNK2;DAPK3;PRKACB;DDOST;CDH2;PRKAR1B;MAP2K1;UBE2E1;CCNT1;PPP1CB;PPP1CA;BRSK1;PKN2;PAK2;CDK7;HIF1A;PSME4;SIRT2;STK24;FBXO6;CTDSP2;SUMF1;CDK18;PSMB1;MBTPS1;PSMD5;EIF2AK2;ROCK2;PHEX;FBXO32;ST8SIA5;PRKCD;COPS8;ACVR1B;DUSP29;WDR45;FBXW11;CDK12;UBA3;MAN2A2;DMPK;BMPR1B;TNIK;WSB1;BCR;PSMB2;SBF1;COL3A1;DCAF11;CDC42BPB;CTDSP1;STK36;MACROD1;TPTE;DUSP16;TAOK3;FNIP2;CDK15;MAST1;PPP3CB;ST3GAL2;PRSS23;PIK3C3;GAS6;CSNK1E;DNAJC3;PDK2;SIRT4;SGK1;STK10;MAPK1;LRRK2;PRKAA2;UFL1;PIGH;PSMB7;FEM1B;PSMD3;TNC;KCTD6;PRKCA;PRKACA
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.4886450627190533,1.022812165866872,0.4398563734290844,0.9997223832005634,1.0,4/13,15.39%,SOCS5;SOCS4;TSG101;CBLB
prerank,glycolytic process (GO:0006096),0.4237816738056045,1.022394546043325,0.4396423248882265,0.999859845018032,1.0,8/28,19.37%,ENO3;HK2;PFKFB1;ALDOA;PFKM;GAPDHS;LDHA;PKM
prerank,establishment of protein localization to organelle (GO:0072594),0.36884596110667167,1.0223803603753259,0.4356796116504854,0.9989381084655649,1.0,20/72,16.02%,RYR2;HK2;NUP62;RANBP17;IL10RA;SPRN;NEURL1B;SEC13;NUP153;PPP1R10;NUP107;PEX19;RANBP6;TNPO3;FAM53B;IPO4;TSPAN17;IPO7;FAM53C;STAT3
prerank,endocrine system development (GO:0035270),0.4472494308572219,1.0223399419574712,0.44153846153846155,0.9980913169763127,1.0,1/21,0.40%,TG
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3061946327746361,-1.0220822170434607,0.38686131386861317,0.8514671753688638,1.0,13/38,18.20%,DDX3X;TNFSF10;CASP8;BCL2L1;STX4;MADD;NOS3;RNF34;SP100;FAIM;GPX1;SERPINE1;TMBIM1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.42967532727438823,1.0220363429507708,0.4406528189910979,0.9979586786534084,1.0,4/26,8.61%,CD36;SLC5A3;ALOX5;PPARA
prerank,response to progesterone (GO:0032570),0.4667509954304072,1.0218740309071797,0.4565916398713826,0.9974127399514991,1.0,4/18,7.86%,TGFB3;CAV1;YAP1;TGFB2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.39157638204078077,-1.021779299167139,0.4268292682926829,0.8510793962719592,1.0,5/14,19.38%,IRAK1;CARD10;CARD14;TLR3;TIRAP
prerank,protein localization to kinetochore (GO:0034501),-0.40155247391996585,-1.0215636758551503,0.4467005076142132,0.8505422221426192,1.0,8/14,41.80%,IK;RCC2;BUB3;ZWILCH;KNL1;TTK;CENPT;SPDL1
prerank,T cell differentiation in thymus (GO:0033077),0.476392086975694,1.021398434105763,0.453448275862069,0.9976792209983462,1.0,5/14,21.70%,ADAM17;ZFP36L1;MR1;PTPRC;ZFP36L2
prerank,NAD biosynthetic process (GO:0009435),0.4446743049026397,1.0212620646186703,0.43740095087163233,0.9970766334123458,1.0,6/20,15.71%,NMNAT2;PTGIS;NAXE;NMNAT1;NNMT;NAMPT
prerank,regulation of protein localization to nucleus (GO:1900180),-0.29405164510732384,-1.0212254269716063,0.39591836734693875,0.8503814122400236,1.0,11/43,12.75%,GLUL;BMP4;LIMK2;OTUD7B;NVL;ILRUN;LATS2;CARD10;TGFB1;WWTR1;DTX3L
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4547984979981823,1.0211412801656017,0.4297253634894992,0.9964383492223039,1.0,4/18,8.08%,SUV39H2;ASH1L;KMT2D;SETD3
prerank,inositol phosphate catabolic process (GO:0071545),0.4931825396920314,1.0205414821030363,0.4648148148148148,0.997045971327299,1.0,5/12,15.34%,INPP5A;SYNJ2;INPP5B;INPP5J;PTEN
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.4746952344677857,1.020318238527483,0.44499178981937604,0.9966900360764597,1.0,6/15,20.58%,SEMA5A;VEGFA;TMSB4X;P2RX4;PRKD1;HSPB1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.33549002821810114,-1.0202491089930075,0.4353312302839117,0.8518865846827196,1.0,8/26,19.45%,HMGB1;DDX3X;LBP;PTPN22;RTN4;TLR3;TIRAP;SLC15A4
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.49556210287888447,1.0200062624116228,0.4404973357015986,0.9965666197291071,1.0,2/12,4.48%,CCDC68;BICD2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.41682705226337874,1.019648359450954,0.459802538787024,0.9965867800239544,1.0,10/38,11.36%,NR1H4;RORA;CARD19;DAB2IP;PPM1A;TNIP1;OTUD7A;GSTP1;NR1D1;RHOH
prerank,negative regulation of innate immune response (GO:0045824),-0.31204822547014316,-1.019595768360235,0.4270833333333333,0.8524818425308891,1.0,20/34,37.74%,RPS19;IRAK3;METTL3;SAMHD1;STAT2;GRN;SERPING1;NLRC5;YTHDF3;PTPN2;TRIM21;A2M;NLRC3;USP18;TNFAIP3;NMI;TYRO3;LYAR;DHX58;TTLL12
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.43303769808336967,1.0190088185535322,0.4557926829268293,0.9973936552489053,1.0,9/25,12.81%,DDX23;TXNL4A;SF3B3;SRSF4;PRPF4;SRSF10;SF3A3;SRRM1;SF3B1
prerank,base conversion or substitution editing (GO:0016553),-0.423618132156661,-1.0185735272321639,0.4638009049773756,0.8541443205415715,1.0,4/11,33.92%,METTL3;ADAR;ADARB2;NUDT16
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.34709565003687093,-1.018389366703743,0.41641337386018235,0.8534555407071698,1.0,9/21,22.01%,CGNL1;SLIT2;CYRIB;CD2AP;SPRY2;ARHGAP25;SYNGAP1;MAPKAP1;EPHB2
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4268218690912342,1.0183498075386432,0.45809248554913296,0.9982173147866518,1.0,4/27,8.19%,CD36;MYD88;CD14;TNIP1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.37387382409075914,-1.0180365760244459,0.42710997442455245,0.8533311496148719,1.0,5/17,13.13%,BMP6;SASH1;CD55;TRIM5;CX3CL1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.40314243511610764,-1.017869045526622,0.4339622641509434,0.8526568797108252,1.0,4/13,9.82%,BMP7;BMP4;NR3C1;ESR1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4366300784545705,1.0178644377464647,0.4421875,0.9985905652963595,1.0,12/26,20.46%,SOCS5;SOCS4;FBXW7;AREG;ADAM17;HBEGF;TSG101;NCK2;CBLB;ADRA2A;SHC1;ERRFI1
prerank,secondary alcohol metabolic process (GO:1902652),-0.2975773763532604,-1.0175911895834528,0.42657342657342656,0.852278836683371,1.0,20/42,37.27%,CYP27A1;APOE;ABCA1;SOAT1;PIP4P1;SQLE;GBA2;IDH3G;CLN8;RXRA;EBP;TSKU;PPARD;ANGPTL3;ABCA5;CLN6;SCAP;CH25H;LCAT;IDH1
prerank,plasma membrane organization (GO:0007009),0.3784201531268192,1.0172828478452782,0.43813131313131315,0.9991807849770541,1.0,16/61,12.66%,FER1L5;DYSF;MYH9;ANO6;PACSIN3;PACSIN2;EHD2;FA2H;RAB3A;WHAMM;TLCD2;OSBPL2;NSF;PACSIN1;SNX9;A4GALT
prerank,regulation of apoptotic process (GO:0042981),0.32946477113206507,1.0171583293759885,0.45245245245245247,0.9985903188837024,1.0,100/676,13.74%,NTF3;FLNA;KCNMA1;OBSCN;ARHGEF7;MAP3K20;ACTN1;MEF2C;NAA38;ACTN4;MAP3K5;ANGPT1;PMAIP1;KALRN;NR1H4;ABR;HIP1;ANGPT4;MYD88;TCIM;TRIM2;ARHGEF17;ALPK2;ANO6;CCND2;ANXA1;IL2;ITSN1;TGFB3;ITGB1;NET1;NUP62;ARHGAP10;ATAD3A;FXN;BCL2;ARHGEF16;ARHGEF2;MYO18A;ATG7;MTDH;NDRG1;DAB2IP;RPS6KA2;ARL6IP5;TP53;VEGFA;PHLDA3;GDNF;STK26;PA2G4;MED1;BCL2L2;FZD9;NAT8;OPA1;SOX9;RELA;MAP3K10;DAPK3;API5;CBX4;VDAC1;TNFAIP8;GSTP1;ARHGEF4;PAK2;HRK;BAG3;AXL;ACTN2;FAIM2;PAWR;DNM1L;VAV1;GPER1;GLS2;TRIM35;ZFAND6;BOK;HTR2B;ZBTB7A;CLIP3;TNFRSF25;CSRNP3;DIABLO;CLU;CITED2;ITGB3BP;PDCD10;POU3F3;TMEM219;PERP;BCL6;RBM25;GAS6;DNAJC3;SON;SGK1;TNFRSF10B
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.33272180136924956,1.0170975062944803,0.4594594594594595,0.9977845757801809,1.0,70/509,11.23%,NTF3;FLNA;NTRK3;ACTN4;ANGPT1;PTP4A3;ROCK1;FGF1;PMAIP1;LIMS1;HIP1;MYD88;MST1R;TCIM;PDGFB;PDGFC;FERMT2;SEMA5A;ROR1;PLXNB1;CDH13;ADRA1D;THPO;CGAS;BCAR3;ITGB1;CCL5;GCNT2;PDGFD;NUP62;MFHAS1;BCL2;KSR1;CD14;LARS1;MTDH;PIK3AP1;IRS1;CAV1;DAB2IP;TP53;VEGFA;PPM1A;HEXIM1;NEDD4;AREG;SOX9;GOLT1B;TIFA;TGFB2;RELA;TRIM68;SEC13;RRAGB;THEM4;EDAR;AXL;PDGFRB;RTKN2;TRAF5;HBEGF;PELI2;EIF2AK2;DNM1L;PDGFA;VAV1;GPER1;ROCK2;DDX1;ZDHHC17
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3614631928278503,1.0170242851531586,0.43542857142857144,0.9970480813301482,1.0,19/98,11.84%,ATP2B4;STAC;PMAIP1;ITGA3;SLC5A3;ITGB1;BCL2;ARHGEF16;KCNB1;SORBS1;STAC3;TP53;KIF5B;MIEF2;MIEF1;EPHA2;GPER1;DPP10;CLIP3
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.27318203463179674,-1.017014849525427,0.40217391304347827,0.852773881071117,1.0,29/57,35.85%,GLUL;RPS19;SDAD1;NVL;RPS24;NOC2L;RRP36;PAK1IP1;LTO1;RPS7;RPL11;DDX31;RPF2;RPL38;EMG1;SURF6;EBNA1BP2;BYSL;RBIS;PES1;NIP7;RRS1;RPS15;RPL35A;RIOK2;WDR74;URB2;RPL14;MRTO4
prerank,negative regulation of nuclear division (GO:0051784),-0.42258448158853124,-1.0168408627151342,0.45045045045045046,0.8520444769786881,1.0,2/11,2.12%,BMP7;BMP4
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.33234660147756706,1.016666474071712,0.45989847715736043,0.9969904333965072,1.0,45/327,11.82%,SOX6;MLF2;WTIP;MEF2C;ACTN4;ZFHX3;PTP4A3;LIMD1;NAB1;RORA;MLF1;HINFP;RBAK;ATXN1;PRKCQ;MYBBP1A;TP53;ZBTB38;SFPQ;PPARGC1A;PPARGC1B;ZNF431;REXO4;BTG1;SNAI2;RELA;KMT2D;DAPK3;MSL3;FUS;NSD3;PPIE;KAT7;HIF1A;NR2C2;NUP107;SRSF10;RB1;RHOH;BAZ2A;NFX1;ACVR1B;ESRRA;PSPC1;USP13
prerank,cellular response to amino acid starvation (GO:0034198),0.37192105000185527,1.0165426194629017,0.4419431279620853,0.9963635398823588,1.0,22/71,20.44%,MAP3K5;RNF152;LARS1;KPTN;ATP6V1H;CASTOR1;IMPACT;SEC13;RRAGB;ATP6V1C1;NPRL2;EIF2AK2;ATP6V0D2;MAPK1;CASTOR2;ITFG2;EIF2AK3;EIF2AK4;PRKD1;ATP6V0C;LAMTOR3;EIF2S1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3535165432335919,1.0162813231755938,0.4645760743321719,0.9961005917797602,1.0,15/101,11.11%,MEF2C;MYD88;VIM;CCL5;UPF1;CD14;MTDH;DAB2IP;CHMP5;NFKBIB;RELA;GSTP1;NR1D1;AXL;CD180
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.47195371360583743,1.015972350767123,0.4458041958041958,0.9959704790540511,1.0,5/14,18.40%,NMNAT2;AK7;NMNAT1;CMPK1;CMPK2
prerank,negative regulation of cell adhesion (GO:0007162),0.36980824084751596,1.0156569751975923,0.44038929440389296,0.995910607513814,1.0,13/72,7.71%,ANGPT1;SEMA5A;PLXND1;PLXNB1;CDH13;JAG1;FZD4;GCNT2;JAM3;ARHGDIG;CBLL1;DSCAM;SNAI2
prerank,cellular response to interleukin-15 (GO:0071350),-0.40773452266958676,-1.0155049281818402,0.4756380510440835,0.8534197878341739,1.0,4/13,16.94%,GRB2;IL15;IL15RA;STAT5A
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.40773452266958676,-1.0155049281818402,0.4756380510440835,0.8534197878341739,1.0,4/13,16.94%,GRB2;IL15;IL15RA;STAT5A
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4485063969330071,1.015318801899029,0.45499181669394434,0.9958827920646453,1.0,6/21,13.20%,ROCK1;CBFB;KLF7;ROCK2;RUNX1;ZFP36L1
prerank,mitotic cell cycle phase transition (GO:0044772),0.3427671966236369,1.0153115622775306,0.44739638682252925,0.9949674945215993,1.0,40/203,14.87%,PPP1R12A;PPP1R12B;DYNLL1;CCNA2;CDK6;FBXL22;CLASP2;CCND2;HINFP;CEP41;EIF4EBP1;HAUS8;CUL2;CEP290;ENSA;PLCB1;CCND1;PPP1CB;BRSK1;CDK7;CEP192;CRLF3;DYNC1I2;RB1;GSPT1;ACVR1B;NEDD1;FBXW11;ARPP19;CLASP1;CEP72;CEP43;CHMP2A;CSNK1E;DCTN3;HAUS7;HAUS2;CCNJL;EIF4E;PRKACA
prerank,sulfur compound catabolic process (GO:0044273),0.3934672786081025,1.015223919436933,0.44761904761904764,0.9942460789419397,1.0,5/38,5.98%,CSPG4;NUDT7;BGN;TXN2;OGN
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.3380251387244199,-1.0151841472680982,0.43823529411764706,0.8531748454579146,1.0,3/26,1.39%,EYA2;EYA1;EYA4
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.4191404480537285,-1.0150642923975781,0.4343675417661098,0.8523029472144028,1.0,6/11,21.39%,NOS3;GCH1;PRKG2;AKT1;PTS;SPR
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.24856426261252385,-1.0150446111308435,0.41353383458646614,0.8511921340731242,1.0,47/108,28.23%,TLE1;LRP1;SULF1;NXN;APP;PTK7;APCDD1;WWOX;PPP2CA;DCDC2;CTNNB1;WLS;ATP6AP2;KREMEN1;ESR1;SALL1;PRKN;SFRP4;RSPO2;FGFR2;CCNY;NOTUM;TMEM237;EMD;RNF43;FOXL1;SNX3;DISC1;CTNND2;DACT3;BTRC;MDFI;GPC3;DACT1;RSPO3;NFATC1;AXIN1;CBY1;SULF2;CSNK2A1;SOX7;HHEX;MDFIC;TIAM1;HMGXB4;RACK1;TAX1BP3
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3749323037569749,1.0150356573980257,0.42983565107458915,0.9937928976142654,1.0,12/65,9.92%,PMAIP1;ANGPT4;RORA;PTGIS;SUV39H2;NDRG1;TERT;TP53;CPEB1;VEGFA;HIF1A;SIRT2
prerank,retinoid metabolic process (GO:0001523),0.37009323568854197,1.014770727977813,0.4379746835443038,0.9935702116180286,1.0,7/71,7.14%,TTR;SDC2;LPL;DHRS3;RARRES2;GPC4;AKR1B1
prerank,ribosomal large subunit assembly (GO:0000027),0.4294736305617751,1.0147676053901324,0.4626865671641791,0.9926476234173771,1.0,7/24,17.33%,RPL3L;NLE1;MDN1;RPL5;DHX30;FASTKD2;BOP1
prerank,response to amino acid starvation (GO:1990928),0.3707401654159155,1.014755828833944,0.4437869822485207,0.9917550928585103,1.0,23/72,20.84%,MAP3K5;RNF152;LARS1;KPTN;ATP6V1H;CASTOR1;IMPACT;SEC13;RRAGB;ATP6V1C1;NPRL2;EIF2AK2;ATP6V0D2;MAPK1;CASTOR2;ITFG2;EIF2AK3;EIF2AK4;PRKD1;ATP6V0C;LAMTOR3;EIF2S1;LARP1
prerank,regulation of sodium ion transport (GO:0002028),0.41164053932426903,1.0141724923382074,0.4490674318507891,0.9923197154703887,1.0,11/34,15.59%,ATP2B4;SNTA1;NEDD4;PRSS8;WNK2;CNKSR3;AHCYL1;GPD1L;SLMAP;YWHAH;NOS1
prerank,regulation of programmed cell death (GO:0043067),0.34307752282840637,1.0137841107654475,0.46047008547008544,0.9924000031559994,1.0,29/161,15.91%,NTF3;ACTN1;ACTN4;PMAIP1;HIP1;ALPK2;NUP62;NDRG1;TP53;STK26;SOX9;DAPK3;ACTN2;GLS2;ZBTB7A;TNFRSF25;CLU;TMEM219;PERP;BCL6;RBM25;SGK1;TNFRSF10B;LRRK2;USP42;STAT1;RAF1;MAGED1;JAK2
prerank,tRNA transport (GO:0051031),0.4192923530505987,1.0133071678853154,0.4637096774193548,0.9926693342760464,1.0,13/35,20.76%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.4368001740607085,-1.0131600884571534,0.4794816414686825,0.8551838114147606,1.0,6/10,30.65%,PTPN22;PDCD4;AIDA;HIPK3;MAPK8IP1;DUSP19
prerank,miRNA metabolic process (GO:0010586),0.44267998161808964,1.0131353220814006,0.4425981873111782,0.9921538711592697,1.0,6/20,13.83%,PARN;DICER1;DIS3L2;XPO5;DROSHA;DGCR8
prerank,polyamine metabolic process (GO:0006595),0.49077281491933483,1.0126225138326677,0.45969125214408235,0.9924964151803907,1.0,4/13,14.98%,OAZ2;SAT2;SMS;PAOX
prerank,inositol phosphate-mediated signaling (GO:0048016),0.45571099092853673,1.0123223974705873,0.46192052980132453,0.992344890061794,1.0,3/19,4.05%,PLCE1;PPP3CA;INPP5A
prerank,regulation of anoikis (GO:2000209),0.45338291439633877,1.011983452310885,0.4481132075471698,0.992292582457524,1.0,6/19,7.71%,PDK4;ITGB1;BCL2;MYBBP1A;CAV1;SNAI2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.4056543391605874,1.011969650342146,0.4441340782122905,0.991405313576284,1.0,5/37,6.30%,DYNLL1;DYNLRB1;KIF3B;IFT43;IFT81
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.3651424162360103,-1.011922373253532,0.45524296675191817,0.8575397364011957,1.0,8/18,24.28%,RAB11A;VPS4B;RCC2;CDC25B;CDC25A;MECP2;CDC7;RAD51C
prerank,sensory perception of chemical stimulus (GO:0007606),0.4791620303016624,1.011566580669532,0.441025641025641,0.9915753159360672,1.0,2/15,4.63%,CD36;SYT10
prerank,positive regulation of translation (GO:0045727),0.3555392624318429,1.010970507400198,0.44673539518900346,0.9921864225762866,1.0,35/94,20.84%,VIM;SAMD4A;CCL5;NAT10;RPUSD3;POLR2G;TRMT10C;RCC1L;RPS27L;CIRBP;YTHDF2;PYM1;RPL5;EIF3E;EIF5AL1;EIF5A;RBM3;ZCCHC4;CPEB3;PLXNB2;RPUSD4;FASTKD2;PIWIL2;DHX9;EEF2;TRUB2;RMND1;UPF3A;HABP4;PKM;NSUN5;UQCC2;C1QBP;ERBB2;LARP1
prerank,positive regulation of dephosphorylation (GO:0035306),0.42590900146737576,1.010848515914288,0.43948126801152737,0.9915753325046455,1.0,4/27,7.02%,DLC1;PPP2R5A;PIN1;CALM1
prerank,chemical homeostasis (GO:0048878),-0.2715838170778623,-1.0107561038517068,0.4460093896713615,0.8596666268597782,1.0,10/61,8.18%,ZBTB20;RBP1;NEDD4L;WNK1;DDX3X;SLC4A10;WNK4;ABHD5;WNK3;SLC4A2
prerank,positive regulation of immune effector process (GO:0002699),-0.32394829163476224,-1.0106068257289358,0.4371069182389937,0.8588787890173845,1.0,7/27,15.16%,APPL2;LBP;LGALS9;RPS19;DDX60;CD46;ANKRD17
prerank,COPII-coated vesicle budding (GO:0090114),-0.27273561041144995,-1.0103722914978754,0.42528735632183906,0.8583665472553702,1.0,34/68,35.43%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC23B;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;SCFD1;RAB1B;TRAPPC3;TFG;MIA3;F5;TRAPPC2;SAR1A;PEF1;SEC16B;PPP6C;CTSC;PPP6R1;TRAPPC6A;SAR1B;CSNK1D;SCAP;TRAPPC5;CNIH3
prerank,response to endoplasmic reticulum stress (GO:0034976),0.35101919292870987,1.0103085312433062,0.43792325056433407,0.9921199387174816,1.0,8/107,6.42%,ATP2A1;MAP3K5;ATP2A2;ITPR1;TMEM259;BCL2;DAB2IP;TP53
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.2872059615916247,-1.0100022417056882,0.4336734693877551,0.8582219388419957,1.0,19/54,25.45%,CARM1;TFDP1;PML;ARID3A;MDM2;RGCC;SOX4;EP300;PLK2;BAX;CNOT11;CRADD;CHEK2;ATM;E2F4;PCBP4;PLAGL1;CDKN1A;CNOT10
prerank,regulation of macroautophagy (GO:0016241),-0.24571033571471337,-1.0099600573991274,0.4375,0.8571457374346846,1.0,35/105,25.17%,PRKAG2;DCN;PIK3CA;RB1CC1;PAFAH1B2;CAPNS1;LAMTOR1;UBQLN1;SMG1;NRBP2;GPSM1;IKBKG;ATP6V1G1;SNX6;RHEB;ERN1;TBC1D25;KDR;CLN3;AKT1;UBQLN2;EXOC1;EXOC7;BNIP3L;QSOX1;PRKAG3;PRKAA1;LZTS1;SMCR8;ATP6V0D1;RRAGD;SESN2;UCHL1;CDK5R1;LAMTOR2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3432820682116161,1.0098559748980656,0.46936542669584247,0.9923777076650615,1.0,16/138,10.07%,NTF3;NTRK3;LIFR;MERTK;MST1R;ROR1;FRK;ACVR2A;MUSK;PTPRF;LCP2;SLA;EPHA2;AXL;NPR2;PDGFRB
prerank,retrograde axonal transport (GO:0008090),0.45244819122798724,1.0096634092701418,0.44908180300500833,0.991965573601374,1.0,6/16,12.26%,DST;KIF1A;KIF5B;KIF1C;FBXW11;KIF5A
prerank,chloride transport (GO:0006821),0.36789179155965235,1.0094571004329782,0.45073891625615764,0.9915719790864632,1.0,12/74,9.82%,ANO1;GABRE;ANO6;SLC4A8;CLCN6;GABRA4;TTYH1;GABRA5;ANO10;GABRB2;GABRG1;ANO3
prerank,positive regulation of coagulation (GO:0050820),-0.44569631019213385,-1.0094371112987246,0.4662309368191721,0.8562483128473619,1.0,3/10,19.34%,ST3GAL4;SERPINE1;ENPP4
prerank,positive regulation of hemostasis (GO:1900048),-0.44569631019213385,-1.0094371112987246,0.4662309368191721,0.8562483128473619,1.0,3/10,19.34%,ST3GAL4;SERPINE1;ENPP4
prerank,ncRNA 3'-end processing (GO:0043628),-0.38650154625480876,-1.0094082834739984,0.4593908629441624,0.8551871579913525,1.0,8/14,28.48%,INTS6;TRNT1;SSB;INTS2;PTCD1;ELAC2;INTS14;TOE1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.32655981045239646,-1.0092538842245555,0.44642857142857145,0.854424030505456,1.0,11/26,15.80%,KMT2E;DDX3X;CCND3;EGFR;ADAMTS1;TFDP1;RDX;UBE2E2;RGCC;ANKRD17;AKT1
prerank,endothelial cell migration (GO:0043542),0.40763621172104686,1.0089612192411175,0.44273743016759776,0.9918946676692031,1.0,6/37,2.95%,PTP4A3;MYH9;PLXND1;CDH13;NR4A1;LOXL2
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.37016912337749414,1.0089428544389445,0.45041816009557945,0.9910354061413031,1.0,11/74,7.86%,VASN;FERMT2;PHLDB2;CLASP2;LOXL2;TGFB3;GCNT2;TGFB1I1;SDHAF2;DAB2IP;TGFB2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.44311955399574604,1.008736483283106,0.4553846153846154,0.9906581077346736,1.0,4/21,5.14%,HTR1B;PDGFB;IGFBP5;BMPR1A
prerank,negative regulation of cell population proliferation (GO:0008285),0.332532695796282,1.00853439216674,0.4661274014155713,0.9902890948277531,1.0,39/351,9.18%,MYOCD;IGFBP7;COL18A1;DLC1;TMIGD3;P3H2;SPEG;ITGA1;CDK6;PLXNB1;CDH13;FRK;RERG;IGFBP5;TGFB3;BTG2;NACC2;NUP62;TGFB1I1;PEX2;TESC;MN1;OGN;DAB2IP;RPS6KA2;TP53;CD200;AR;BNIPL;CELF1;BTG1;SOX9;TGFB2;WNK2;CD300A;DIS3L2;MAP2K1;GSTP1;SKI
prerank,regulation of interleukin-8 production (GO:0032677),-0.2658081745564122,-1.0084788461571712,0.44654088050314467,0.8553884637365536,1.0,17/69,19.66%,ARRB1;HMGB1;LBP;F3;NOD1;OTUD7B;MAPKBP1;LGALS9;PTPN22;ANXA4;RAB1A;SSC5D;TLR3;SERPINE1;PARK7;TIRAP;BCL3
prerank,regulation of extracellular matrix organization (GO:1903053),-0.38671974745243554,-1.008372306083559,0.4520884520884521,0.8545396161022873,1.0,3/15,6.40%,AEBP1;LRP1;TIE1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5100005455514212,1.0083056956844032,0.45652173913043476,0.9899789067152449,1.0,3/10,8.97%,ACAD11;ETFA;ACADS
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.33919733015254494,-1.0082307431049804,0.45879120879120877,0.8537883968518019,1.0,10/23,23.13%,NUPR1;CRY1;HDAC4;SIK1;EP300;C1QTNF3;GIT1;CBFA2T3;CLK2;PGP
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.43996907369908456,-1.008127058091397,0.45021645021645024,0.8529487540814293,1.0,4/10,15.42%,NT5E;UPP2;UPB1;DPYD
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.4736893209304955,1.0080910304255506,0.446843853820598,0.9895817277123682,1.0,5/14,17.10%,IRS1;PPARA;LONP2;IRS2;MTLN
prerank,T cell receptor signaling pathway (GO:0050852),-0.23419503486970317,-1.0079424844236828,0.47474747474747475,0.8523078715024974,1.0,29/138,15.98%,PIK3CA;WNK1;PDPK1;KHDRBS1;RC3H2;FYB1;PLCG2;NCK1;DENND1B;PIK3CB;PSMD7;PSMD9;PSMD13;PTPN22;IKBKG;RBCK1;TAB2;RNF31;PSMB3;CHUK;EIF2B3;NFKBIZ;PSMC5;PSMA5;PSMA1;PSMC2;STOML2;SPPL3;THEMIS
prerank,negative regulation of lymphocyte migration (GO:2000402),0.492729364626703,1.0077117326769751,0.4875,0.9896167905591448,1.0,3/10,6.99%,PADI2;CD200R1;CD200
prerank,nervous system development (GO:0007399),0.32893409107439286,1.0075668294841613,0.4884422110552764,0.9890895714924799,1.0,47/429,10.76%,SOX6;NTF3;FGF13;MEF2C;SERPINI1;IGFN1;KALRN;MERTK;CRIM1;APBA1;MST1R;ZEB2;PDGFC;NAB1;CLN5;EDNRB;FZD5;SEMA5A;PLXND1;DPYSL4;JAG1;KIRREL3;ATXN1;DYRK1A;BTBD2;MBD5;PCDHB14;DSCAM;VEGFA;GDNF;YAP1;FZD9;ERCC6;MBP;PCDHB11;TRAK1;CDH2;TRPC5;GSTP1;AXL;MBNL1;COX7B;HAPLN2;NR2C2;TEAD1;GFRA1;NDUFV2
prerank,regulation of mRNA stability (GO:0043488),0.3422005734615704,1.0074711394219524,0.4610318331503842,0.9884113476186464,1.0,29/145,14.87%,RBM24;TENT5B;ROCK1;VIM;SAMD4A;PARN;SET;PSMC6;MAPKAPK2;CIRBP;GDNF;YTHDF2;CELF1;FTO;FASTKD1;FUS;PSME4;HNRNPU;PSMB1;PSMD5;ROCK2;PRKCD;DCP1A;PSMB2;ZFP36L1;GIGYF2;PSMB7;PSMD3;PRKCA
prerank,signal release from synapse (GO:0099643),0.3916169505616428,1.0070951075894206,0.45403111739745405,0.9885102985742736,1.0,6/43,9.42%,STXBP2;SYT10;RAB3A;LIN7C;BRSK1;HRH3
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.32096330567735903,-1.0070250723585334,0.4212328767123288,0.8537054508405392,1.0,11/31,18.89%,ATXN3;DNAJB12;HSPA5;OPTN;PRKN;STUB1;ERN1;HSPA13;BAX;HSPA9;HSF1
prerank,regulation of fibrinolysis (GO:0051917),-0.39971121853223684,-1.0069427627739032,0.45146726862302483,0.8527950206074157,1.0,11/13,60.06%,THBD;SERPINE1;USF1;HRG;FAP;KLKB1;APOH;PLG;THBS1;F11;F2
prerank,neural crest cell development (GO:0014032),-0.2994653861691838,-1.0066899560915976,0.432,0.8523526312160318,1.0,9/44,7.79%,SEMA3D;SEMA3C;SEMA6A;KLHL12;RADIL;ANXA6;SEMA7A;SEMA3A;SEMA4D
prerank,histone mRNA catabolic process (GO:0071044),-0.37952476879209285,-1.006503769790923,0.45202020202020204,0.8516923355432621,1.0,6/15,18.84%,SSB;LSM1;DCP2;TUT4;ATM;TUT7
prerank,regulation of developmental growth (GO:0048638),-0.3220761836857948,-1.0064773440999997,0.45896656534954405,0.8506276914236477,1.0,11/29,24.02%,IGF1;APOE;GHR;APP;LATS2;SIX1;INSR;STAT5A;SPAAR;MFSD2A;OLFM1
prerank,negative regulation of wound healing (GO:0061045),0.4182567233299246,1.0063017142154753,0.4661764705882353,0.9896239842122524,1.0,5/28,6.76%,PHLDB2;CLASP2;SERPINE2;ALOX5;AJAP1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4395644891430424,1.0062576092341193,0.45839874411302983,0.9888525138194185,1.0,5/20,7.86%,HEY2;HEYL;HAS2;SNAI2;TGFB2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.32953544865458073,-1.0061781881861638,0.46534653465346537,0.8502984344421938,1.0,9/26,18.07%,LGR4;APPL2;BIRC2;IRAK3;APPL1;BIRC3;GPR108;TLR3;LRRC14
prerank,mucosal immune response (GO:0002385),-0.37955007630529874,-1.0058061567695749,0.4625322997416021,0.850194549390627,1.0,2/15,9.13%,OTUD7B;DEFA6
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.46014481445791244,1.0055637853307822,0.43674176776429807,0.9897756309165372,1.0,6/16,12.88%,AMPD1;LHPP;AMPD2;NUDT2;PPAT;ADSS1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.45478437292347557,1.0052937170569187,0.4576547231270358,0.9895837945432611,1.0,4/17,7.68%,KLF7;CAV1;AJAP1;SOX9
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2561922281298382,-1.0052345865517869,0.42196531791907516,0.8505753902994254,1.0,23/76,18.64%,ARRB1;BMP7;ITCH;NFKBIA;IRAK1;PRMT2;PARP10;DAP;USP7;COMMD1;CYP1B1;IRAK3;PYDC1;RBCK1;IRAK2;CHUK;ANXA4;G3BP2;MTURN;NLRC5;LRRC14;NWD1;ZC3H12A
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.38485808490425294,-1.0051268914217804,0.45588235294117646,0.8497214370736054,1.0,6/15,16.77%,IGF1;GHITM;BCL2L1;PRKN;AKT1;GPX1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.31678985767792467,-1.0050623329579123,0.43416370106761565,0.8487790612721892,1.0,17/31,28.65%,DCPS;LSM1;DIS3;EXOSC1;DCP2;EXOSC9;EDC4;LSM7;EXOSC2;EDC3;LSM2;LSM5;EXOSC7;EXOSC3;EXOSC5;LSM3;LSM6
prerank,ERBB2 signaling pathway (GO:0038128),-0.3170335342973895,-1.0050417588816365,0.43252595155709345,0.847701767933864,1.0,6/31,11.28%,PIK3CA;GRB2;EGFR;GAB1;NRG2;STUB1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.3032066666692583,-1.0049979387764854,0.4666666666666667,0.846683470024604,1.0,20/36,33.93%,SGMS1;DEPTOR;MADD;ASAH2;TGFBR1;MAZ;CX3CL1;CRADD;BCL2L12;QARS1;TRIM39;TMBIM6;CYLD;CSNK2A2;CSNK2A1;STYXL1;PPIA;TRAF1;TPD52L1;ING5
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5079496801193011,1.004925765613803,0.47784200385356457,0.9895893740795326,1.0,2/10,5.71%,SET;KLF15
prerank,myelination (GO:0042552),-0.28068891130797596,-1.0047924760888507,0.4296577946768061,0.8461179627364801,1.0,14/46,20.42%,NF1;PLP1;ADGRG6;B4GALT6;SBF2;PLLP;MAL;ARHGEF10;CMTM8;LGI4;MYOC;EIF2B5;PMP22;BCAS1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.25667158050765637,-1.0047259871923648,0.4840764331210191,0.8451822159262207,1.0,28/77,25.49%,IGF1;SH3RF1;TCF7L2;BMP4;DDX3X;ITGA6;BIRC6;ITGAV;GHITM;BCL2L1;ASAH2;PRKN;TGFBR1;MAZ;CX3CL1;NOC2L;AKT1;GPX1;SIAH2;HERPUD1;PARK7;QARS1;PSME3;TMBIM6;SLC35F6;PELI3;CSNK2A2;CSNK2A1
prerank,regulation of telomere capping (GO:1904353),-0.3418724790188409,-1.0043874100234058,0.4460227272727273,0.8449261850833847,1.0,8/23,18.12%,TNKS2;RAD50;USP7;NBN;MAP3K4;HNRNPD;SMG6;ATM
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.4019884218300128,-1.0043821918073939,0.4634146341463415,0.84382383425894,1.0,2/13,3.17%,BMP4;GLI2
prerank,positive regulation of autophagy (GO:0010508),-0.24747497859079823,-1.0036206651911759,0.45348837209302323,0.8448065509252539,1.0,24/81,19.67%,DAPK1;DCN;HMGB1;PAFAH1B2;TPCN1;FOXO1;GPSM1;PIK3CB;TFEB;OPTN;STK11;FBXO7;IKBKG;PRKN;TRIM5;IRGM;TRIM14;KDR;TMEM59;PLK2;MID2;ZC3H12A;PARK7;BNIP3L
prerank,organic anion transport (GO:0015711),-0.26248868015986515,-1.003448536256669,0.4012738853503185,0.8441946209360909,1.0,15/76,9.39%,ABCG2;SLC4A10;SLCO2B1;SLC26A7;SLCO1C1;SLC25A17;SLCO2A1;SLC52A1;CYB5R4;CA2;SLC39A8;SLC22A6;SLC4A2;SLCO3A1;ABCC4
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.3428512123662685,-1.003151712023244,0.477088948787062,0.8439257784950609,1.0,7/21,18.54%,CYP26B1;LPIN2;ACOT8;ACBD5;HOGA1;ACOX1;LPIN3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.4858198569921597,1.003003624672721,0.479933110367893,0.9935293497204903,1.0,3/13,5.14%,RBPMS;TGFB3;BMPR1A
prerank,positive regulation of protein modification process (GO:0031401),0.3322014960084928,1.0028457078645798,0.47291666666666665,0.9930245586323689,1.0,34/203,12.38%,NTRK3;DLC1;ANGPT1;FGF1;CCN1;CCND2;THPO;FAM20A;ACVR2A;MUSK;CAMKK2;RARRES2;DYRK1A;ATG7;VEGFA;PPP2R5A;PIN1;TRABD2B;CALM1;RAMP1;RASGRP1;ITGB3;SOX9;CCND1;ADAM17;RAP2A;PELI2;GPER1;ROCK2;PRKCD;CLIP3;TNIK;AKTIP;CHRNA7
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.38346818521018394,1.0027516753063008,0.46357615894039733,0.9923682908633302,1.0,8/50,10.61%,ACTN4;PTP4A3;LIMS1;TCIM;CD14;RELA;RTKN2;EIF2AK2
prerank,regulation of bone mineralization (GO:0030500),0.38466317190194904,1.0024270651023575,0.4592496765847348,0.992305595656866,1.0,12/55,8.74%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;FZD9;ATP2B1;TRPM4
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.4019025052394177,-1.0020749075142392,0.4715261958997722,0.8456868695052391,1.0,10/14,28.88%,ADK;GMPS;ADSS2;PFAS;GART;ATIC;RFK;IMPDH1;IMPDH2;PAICS
prerank,negative regulation of cellular component movement (GO:0051271),0.45668246772796756,1.0018207906489867,0.46469622331691296,0.9929188140444285,1.0,2/15,6.74%,ACTN1;PIN1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3850678849426956,-1.0010621242344269,0.47073170731707314,0.8472923205774092,1.0,4/15,17.24%,BMP4;PRKCH;SFRP4;TRIM16
prerank,protein sumoylation (GO:0016925),0.3907352076845533,1.0010203437663767,0.47680412371134023,0.9940292150901332,1.0,20/49,19.61%,UBA2;NUP62;PIAS4;SAE1;TRPM4;NUP153;NUP107;AAAS;PIAS2;TRIM28;NUP98;NUP37;NUP210;PIAS1;BCL11A;NUP54;SUMO1;UBE2I;NUP160;NUP133
prerank,rRNA pseudouridine synthesis (GO:0031118),0.5079627389902303,1.0008140459938573,0.47027972027972026,0.9936872248704388,1.0,3/10,13.51%,RPUSD3;NAF1;RPUSD4
prerank,regulation of centrosome duplication (GO:0010824),0.41630121343060233,1.0001886544715917,0.4585152838427948,0.9944119309764802,1.0,9/29,19.55%,CHMP4C;NAT10;CHMP5;CHMP2B;CEP120;CHMP2A;CCNF;CEP295;CENATAC
prerank,regulation of neuron migration (GO:2001222),-0.32574703802409954,-1.000186859314255,0.45901639344262296,0.8485965270528161,1.0,4/26,7.32%,PHACTR1;SEMA6A;SRGAP2;SEMA3A
prerank,positive regulation of growth (GO:0045927),0.3659311477841916,1.0000012061642398,0.4678787878787879,0.9939940149487857,1.0,25/64,21.28%,AKAP6;IL2;PABIR1;FXN;BCL2;TGFB2;PLCB1;ADNP2;ADAM17;HDGFL2;CEP43;N6AMT1;HYAL1;RFTN1;INO80;DDX49;S100A8;S100A9;EIF4G2;WFS1;SLC25A33;ERBB2;TAF9B;H3-3A;LGI1
prerank,bile acid biosynthetic process (GO:0006699),0.4310588449706192,0.9998430946199254,0.470679012345679,0.9934949316620483,1.0,5/24,11.78%,HSD17B10;CYP7B1;HSD17B4;SCP2;OSBPL2
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.2952088442691857,-0.9996940153862767,0.4423791821561338,0.848873622281613,1.0,20/39,32.76%,RPS19;RPSA;RPS24;RIOK3;WDR3;RRP36;DDX52;RPS7;ERAL1;RRP7A;EMG1;SURF6;NOL11;RPS27;LSM6;MRPS11;RPS5;RPS15;RIOK2;TSR3
prerank,hexose metabolic process (GO:0019318),-0.2976580894409717,-0.9996802698815357,0.45514950166112955,0.847806789405212,1.0,15/39,27.96%,APOD;BRAT1;SORD;PMM2;HECTD4;SLC35A2;FPGT;GALK2;FUCA2;PGM1;ALDOC;GALM;GALK1;PMM1;GDPGP1
prerank,peptidyl-serine modification (GO:0018209),0.3406148442803369,0.999558913269501,0.4817204301075269,0.993286935913653,1.0,44/166,17.52%,STK38L;ROCK1;MAST4;DYRK2;PDGFB;CAMK2D;GALNT16;MARK1;DYRK1A;PRKCQ;TAF1;RPS6KA2;MAPKAPK2;DYRK1B;PARP1;MAP3K10;BRSK1;PKN2;PAK2;ROCK2;PRKCD;GALNT3;RICTOR;GALNT2;DMPK;HPF1;MAST1;GAS6;CSNK1E;SGK1;MAPK1;GALNT1;LRRK2;PRKCA;PRKACA;SRPK2;MAPK12;CSNK1A1;HIPK2;MAST3;MAP3K13;EIF2AK3;MARK2;MASTL
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.44358044329223445,0.9995357027850279,0.4805389221556886,0.9924482508275639,1.0,4/21,6.45%,RBPMS;TGFB3;BMPR1A;SLC2A10
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.4394851972102969,0.9983366163493281,0.4658573596358118,0.994531658854948,1.0,3/21,7.62%,SMARCD3;VEGFA;FZD9
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3804572692049586,-0.9982365447277641,0.45073891625615764,0.8504681513449869,1.0,3/14,3.93%,ATR;TNKS2;XRCC5
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.40250224925568856,0.998043662547667,0.463768115942029,0.9943917266431456,1.0,9/35,10.84%,PADI2;ARID1A;UBR5;NEDD4;AR;MED1;PPARGC1B;YAP1;GPER1
prerank,positive regulation of cellular component organization (GO:0051130),-0.23301166459540357,-0.9976781699795128,0.5094339622641509,0.8509055593971987,1.0,29/107,20.52%,DAB2;FRMPD4;LRP1;NEDD4L;BMP7;CDH5;APOE;ABCB7;SHANK3;SLF2;CAMK1;TMEM30A;SURF4;ICE1;TGFB1;SLF1;NRXN1;TGFBR1;SNCA;INSR;MMP1;GPX1;LMAN1;BAX;PARK7;TIRAP;AJUBA;BID;GPC3
prerank,regulation of ERAD pathway (GO:1904292),-0.4090601656403191,-0.9974458267808533,0.4750593824228028,0.850462592388671,1.0,7/11,23.53%,ATXN3;RNF185;USP19;UBXN1;HERPUD1;RNFT1;USP25
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.42488010086572503,-0.9974385752811561,0.491725768321513,0.8493717450897861,1.0,2/10,1.71%,SH3RF1;HMGB1
prerank,histone deubiquitination (GO:0016578),-0.3623861546789734,-0.9973991600880204,0.45979899497487436,0.8483798082553653,1.0,4/18,14.70%,USP7;BRCC3;USP3;ATXN7
prerank,protein export from nucleus (GO:0006611),-0.3244079155812224,-0.9973740748690585,0.44281524926686217,0.8473447425789163,1.0,8/27,22.22%,RANBP3L;NUTF2;RANBP3;TGFB1;CALR;CCHCR1;NUP214;RAN
prerank,carboxylic acid transmembrane transport (GO:1905039),0.3946358984335768,0.9972383621469155,0.4766619519094767,0.9955428993037927,1.0,6/40,10.38%,SLC38A11;SLC16A7;SLC38A2;SLC23A2;SLC23A1;SLC7A8
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.47545425486555903,0.9972209442264712,0.46234676007005254,0.9947019084154999,1.0,1/11,2.68%,CDH13
prerank,negative regulation of blood pressure (GO:0045776),-0.4093485738523204,-0.9971589115110339,0.48868778280542985,0.8468219564419589,1.0,4/13,21.44%,BMPR2;NOS3;SCPEP1;DRD2
prerank,mitochondrial membrane organization (GO:0007006),0.4025000876764799,0.9967009494551229,0.4636627906976744,0.995126295137809,1.0,7/32,11.30%,PMAIP1;BCL2;RCC1L;OPA1;MTX1;DNAJC11;MFN2
prerank,negative regulation of growth (GO:0045926),0.34581393486183254,0.9965052244755858,0.49278579356270813,0.9947020721373664,1.0,22/121,14.70%,SLIT3;TMPRSS4;MYL2;RERG;FHL1;JADE1;NDRG3;TP53;BTG1;TGFB2;NDUFS3;CRLF3;SERTAD2;SH3BP4;RB1;TCHP;ACVR1B;DCBLD2;BCL6;MUL1;HYAL1;VGLL4
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.48035215611074267,0.996392861951915,0.5,0.9941037732493377,1.0,3/12,6.29%,DYRK2;IRS1;SORBS1
prerank,receptor catabolic process (GO:0032801),-0.32843312928292917,-0.9963834403717423,0.4691011235955056,0.8478516695550797,1.0,11/24,30.63%,GPRASP1;TGFB1;AP2S1;RNF43;AP2A2;CLTA;UVRAG;ZNRF3;MVB12A;AP2M1;SNX25
prerank,carbohydrate catabolic process (GO:0016052),0.3904121028187053,0.9963602036661616,0.45799457994579945,0.9932941414617896,1.0,7/38,11.56%,ENO3;HK2;PFKFB1;NEU3;ALDOA;PFKM;MAN2C1
prerank,long-term memory (GO:0007616),0.4387559940094647,0.9955259730536602,0.46919431279620855,0.9945097677972901,1.0,4/19,13.73%,SLC2A4;CALB1;CPEB3;SGK1
prerank,regulation of membrane depolarization (GO:0003254),0.44747214215990855,0.9955144032021698,0.45840130505709625,0.9936553762780453,1.0,5/18,16.10%,CAMK2D;FHL1;GPD1L;LRRK2;GJA5
prerank,regulation of stem cell proliferation (GO:0072091),-0.3646157183844093,-0.995351151194833,0.45542168674698796,0.8495478528506144,1.0,3/17,1.74%,AGO3;FBLN1;GJA1
prerank,collagen fibril organization (GO:0030199),0.3572904529427649,0.9953395242696577,0.4664310954063604,0.9932245428512286,1.0,19/88,13.25%,COL18A1;COL4A2;COL4A1;ADAMTS14;P3H2;LOXL2;CRTAP;COL4A6;DST;PXDN;TGFB2;COL27A1;COL4A5;P4HA2;COL19A1;COL6A3;COL3A1;COL14A1;COL8A1
prerank,regulation of integrin activation (GO:0033623),0.45954335950974734,0.9952013120857378,0.4759535655058043,0.9926727196776782,1.0,3/15,7.51%,FERMT2;JAM3;PLEK
prerank,regulation of water loss via skin (GO:0033561),0.45922182112669324,0.9951507633609318,0.47572815533980584,0.9910271234705441,1.0,2/15,4.19%,TMEM79;FA2H
prerank,establishment of skin barrier (GO:0061436),0.45922182112669324,0.9951507633609318,0.47572815533980584,0.9910271234705441,1.0,2/15,4.19%,TMEM79;FA2H
prerank,regulation of defense response to virus (GO:0050688),-0.38913940550730797,-0.99513071825768,0.5012106537530266,0.849057587166356,1.0,4/14,7.42%,ITCH;PPM1B;ILRUN;PCBP2
prerank,regulation of chemokine production (GO:0032642),-0.2979069296021521,-0.9950272384583263,0.42424242424242425,0.8482341231269173,1.0,6/36,8.49%,FOXP1;APP;IL18;WNT5A;LGALS9;IL6R
prerank,nucleic acid metabolic process (GO:0090304),0.36730582835184555,0.9948878383183232,0.46079613992762364,0.9908055347947387,1.0,14/69,13.68%,LSM8;POLR2L;POLR2I;HNRNPR;POLR2G;ATXN2;HNRNPU;DDX1;HNRNPC;POLG;KPNA2;POLR2J;DXO;DNASE1L1
prerank,positive regulation of type I interferon production (GO:0032481),-0.2569177149044603,-0.9945412600807813,0.4375,0.8484148612481659,1.0,33/73,26.59%,DDX3X;PTPN11;PRKDC;XRCC5;RNF135;MRE11;IRAK1;POLR3F;CTNNB1;PTPN22;RIOK3;POLR3B;CHUK;POLR3A;XRCC6;EP300;TRIM56;TLR3;POLR3H;OAS2;POLR3E;STAT6;POLR2K;HSPD1;POLR2F;POLR2H;POLR3GL;POLR3C;DDX41;TOMM70;POLR3D;NFKB2;POLR2E
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.47467152034775484,0.9943889230555112,0.49746192893401014,0.9911828230188203,1.0,3/13,6.29%,DYRK2;IRS1;SORBS1
prerank,regulation of protein processing (GO:0070613),0.4332703618703924,0.9937364414844914,0.4664586583463339,0.9918889256042352,1.0,5/21,14.40%,ANGPTL8;SERPINE2;RUNX1;BAG2;LRRK2
prerank,cellular response to organic substance (GO:0071310),0.34301991460596387,0.9935583055384879,0.48361581920903957,0.9914582676950606,1.0,12/116,7.15%,SLIT3;AKAP6;NR1H4;CACNA1H;PDGFB;IGFBP5;CCL5;ACVR2A;PTPN18;BMPR1A;ARL6IP5;RAMP1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.3256315192270084,-0.9934647850178563,0.44871794871794873,0.850101624127194,1.0,11/26,33.55%,PDE8A;FBXO7;PRKN;AKT1;PARK7;ATF4;MAPK7;BAG5;HTRA2;PPIA;GPR37
prerank,cellular respiration (GO:0045333),0.3795741367760636,0.9932720706525026,0.4684065934065934,0.9912752508860714,1.0,17/41,22.11%,SIRT3;ME3;NDUFS1;SDHC;PPARGC1A;ETFA;SDHA;LYRM7;UQCRFS1;UQCRH;MTLN;MDH2;ATP5F1D;NDUFS4;OXA1L;COQ10A;ETFRF1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.44216732799282543,0.9932579286984228,0.48747913188647746,0.9904231689514117,1.0,2/20,2.65%,ENTPD1;ANO6
prerank,regulation of intracellular protein transport (GO:0033157),-0.3071746513215649,-0.9922282943540679,0.44410876132930516,0.8523810669795725,1.0,10/32,10.30%,PTPN14;BMP4;PCM1;RUFY3;PRR5L;UHMK1;SIRT7;GCC2;ICE1;TGFB1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.42975742818329904,0.9919575288293648,0.4891304347826087,0.9928582120044042,1.0,6/24,13.20%,ROCK1;CBFB;MED1;ROCK2;RUNX1;ZFP36L1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.3129580261453364,-0.9918914013915053,0.4473684210526316,0.8522622076534643,1.0,11/32,16.03%,JCAD;STARD13;AKT3;MEOX2;HDAC7;FOXC2;MAP3K3;CARD10;PTGS2;KDR;FGF2
prerank,regulation of spindle assembly (GO:0090169),0.4237020845952465,0.9916097167565606,0.48714069591527986,0.9928493921026667,1.0,6/25,13.43%,CHMP4C;CHMP5;HNRNPU;CHMP2B;SENP6;CHMP2A
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.4599536699983725,0.9914203831671465,0.4965635738831615,0.9924529655167846,1.0,5/16,16.16%,CGAS;FANCB;RIF1;RMI2;MAD2L2
prerank,regulation of axon regeneration (GO:0048679),-0.39686482333381584,-0.991357280008046,0.46292134831460674,0.8526834887177913,1.0,2/12,2.92%,PTN;EPHA4
prerank,response to peptide hormone (GO:0043434),0.3846310911346566,0.9912896202539611,0.47368421052631576,0.9918931088094389,1.0,11/43,16.02%,ROCK1;ANXA1;IGFBP5;SORT1;IRS1;CAV1;GPER1;ROCK2;ZFP36L1;STAT1;STAT3
prerank,response to unfolded protein (GO:0006986),-0.28445370778610185,-0.9912567887481621,0.43859649122807015,0.8518722144640859,1.0,19/48,21.37%,HSPA4L;HSPA4;SERPINH1;DERL1;HSPA5;HSP90AB1;OPTN;PRKN;ERN1;DNAJB2;HSPA13;BAX;HSPA9;HSPE1;HERPUD1;DNAJB4;HSF1;DNAJC4;HSPD1
prerank,mesonephros development (GO:0001823),0.49023560661056365,0.9912174372863971,0.46938775510204084,0.9912090286569939,1.0,2/11,4.91%,FGF1;OSR2
prerank,positive regulation of interleukin-1 production (GO:0032732),0.37393615984298595,0.9911654626211757,0.5006435006435006,0.9904519001122035,1.0,4/51,3.34%,CD36;MYD88;FZD5;LPL
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3233017829771575,0.9911292335839331,0.5267947421638018,0.9896840075874707,1.0,51/366,11.82%,SOX6;MLF2;WTIP;MEF2C;ZFHX3;PTP4A3;LIMD1;CCNA2;NAB1;RORA;MLF1;HINFP;GMNN;RBAK;ATXN1;PRKCQ;ATXN2;MYBBP1A;TP53;ZBTB38;SFPQ;CYFIP1;PPARGC1A;PPARGC1B;ZNF431;REXO4;BTG1;SNAI2;RELA;KMT2D;DAPK3;MSL3;FUS;NSD3;PPIE;KAT7;HIF1A;NR2C2;NUP107;PDGFA;SRSF10;RB1;DDX25;RHOH;RBM3;BAZ2A;NFX1;ACVR1B;ESRRA;PSPC1;USP13
prerank,neurotransmitter secretion (GO:0007269),0.3824213511859591,0.9908667576182237,0.47331460674157305,0.9895039972911254,1.0,6/44,9.42%,STXBP2;SYT10;RAB3A;LIN7C;BRSK1;HRH3
prerank,negative regulation of defense response (GO:0031348),0.3586849224856021,0.9907808558809805,0.4712230215827338,0.9888558108858856,1.0,15/77,11.28%,NR1H4;RORA;FEM1A;PTGIS;ALOX5;MFHAS1;TNFAIP6;LPCAT3;PPARA;NR1D1;SIRT2;AOAH;GPER1;RB1;PRKCD
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.42076988312233576,0.9907232518252973,0.4815384615384615,0.9881452248497518,1.0,5/25,10.84%,PMAIP1;TP53;HRK;DNM1L;GPER1
prerank,regulation of defense response (GO:0031347),0.35540191202121496,0.9906646555257906,0.4789915966386555,0.9874278487790427,1.0,12/76,9.50%,AGTR1;MYD88;ANXA1;ALOX5;ELMOD2;SETD6;PIK3AP1;TRAF3;CELF1;RELA;MGLL;AKNA
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.4222982675785741,0.9903715657718035,0.47112462006079026,0.9873010244630712,1.0,12/25,20.32%,ELL;HEXIM1;HNRNPU;CDK12;NELFB;NELFCD;ZMYND11;BRD4;CDK13;EAPP;WDR43;NELFA
prerank,axon development (GO:0061564),0.3588271746228567,0.9903714641654939,0.48708920187793425,0.986437244039219,1.0,24/78,19.87%,SEMA5A;MAP1B;SLITRK5;ACTB;KLF7;SLITRK4;MAPT;AFG3L2;RAB3A;BRSK1;GAP43;S100A6;ZDHHC17;ARHGAP35;ADGRB1;RTN4RL1;RAB8A;RYK;MARK2;MAP1A;MAP1S;BRSK2;NREP;PARD3
prerank,positive regulation of T cell proliferation (GO:0042102),-0.2665198946183451,-0.9900488137326514,0.46534653465346537,0.8540132957138071,1.0,8/55,8.50%,IGF1;IGFBP2;HMGB1;IL15;IL18;VCAM1;NCK1;IGF2
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.42228718115083635,-0.9898478880057735,0.48048780487804876,0.8534660391323354,1.0,2/11,0.31%,DAB2;MLLT3
prerank,regulation of chromatin organization (GO:1902275),-0.3786897782354217,-0.989711216601889,0.4841628959276018,0.8527615887231598,1.0,5/14,22.36%,MLLT3;IGF2;SETD5;SETD1A;TLK2
prerank,plasma membrane invagination (GO:0099024),0.4171502368441368,0.989567784234545,0.47754491017964074,0.9875617712013234,1.0,7/29,12.60%,CD36;MYH9;SPIRE1;ARHGAP12;DOCK1;SNX18;SNX9
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.4435733970317953,0.9895645312114123,0.48198970840480276,0.9867064785988509,1.0,2/16,2.57%,PDK4;RORA
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3329274757456671,-0.9892847965416526,0.48476454293628807,0.8527940639296485,1.0,10/24,26.56%,B2M;CANX;SEC24B;ACE;CALR;ABCB9;TAP1;TAPBP;HFE;TAPBPL
prerank,sphingolipid catabolic process (GO:0030149),-0.37408599629126565,-0.9887704835222958,0.4784688995215311,0.8530532846666902,1.0,4/15,9.94%,ACER2;ENPP2;PPT1;ASAH2
prerank,defense response to fungus (GO:0050832),0.4401653336507486,0.9886989204389917,0.45166666666666666,0.9879192142324416,1.0,4/17,17.14%,RARRES2;FAM3A;S100A8;S100A9
prerank,regulation of phagocytosis (GO:0050764),0.3785802281193435,0.9886795428138634,0.4670886075949367,0.9870970755517343,1.0,4/53,4.33%,MERTK;FER1L5;DYSF;PIP4P2
prerank,phospholipid catabolic process (GO:0009395),-0.3288395133346677,-0.9884818949174258,0.4881656804733728,0.8527618917268736,1.0,10/24,32.72%,ENPP2;GDPD1;ABHD12;GDE1;GPCPD1;PNPLA6;ENPP6;SMPDL3A;SMPD4;ANGPTL3
prerank,cellular response to starvation (GO:0009267),0.3395579992041975,0.987969381478019,0.5032537960954447,0.9879671295711362,1.0,32/147,14.47%,MAP3K5;PMAIP1;RNF152;PDK4;LARS1;KPTN;ATG7;GABARAP;ATP6V1H;MYBBP1A;CASTOR1;TP53;STK26;NUAK1;PPARA;IMPACT;SEC13;XPR1;BRSK1;RRAGB;ATP6V1C1;STK24;NPRL2;EIF2AK2;SREBF2;WDR45;ATP6V0D2;PIK3C3;MAPK1;LRRK2;PRKAA2;CASTOR2
prerank,neutrophil activation (GO:0042119),-0.4038697883375104,-0.9878322664289019,0.5,0.8534075116947002,1.0,2/12,2.05%,KMT2E;IL15
prerank,regulation of protein localization to centrosome (GO:1904779),0.5028476734806456,0.9876917422735781,0.48659003831417624,0.9877887409205449,1.0,5/10,17.73%,NUP62;NSFL1C;CEP72;UBXN2B;BICD1
prerank,regulation of fatty acid oxidation (GO:0046320),0.4564317946474176,0.9869495978851333,0.4864864864864865,0.9886909629513729,1.0,6/16,13.71%,PDK4;PPARGC1A;SOX9;PPARA;LONP2;SIRT4
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3450686473306144,0.9868687956235451,0.4910913140311804,0.9880231571074062,1.0,28/109,15.72%,PIP5K1B;INPP4B;PLA2G3;PIP4K2A;MTMR7;PITPNM3;PIP4P2;SYNJ2;SACM1L;PLEK;PLCB1;INPPL1;PLCD1;MTMR14;PDGFRB;INPP5B;CDIPT;SBF1;TPTE;PIK3C3;RAB14;PLA2G4A;PLEKHA1;PLA2G4C;INPP5J;PITPNM2;PTEN;VAC14
prerank,multivesicular body organization (GO:0036257),0.39837822124889416,0.9865104830809127,0.46403385049365303,0.9880274421662648,1.0,9/31,15.01%,CHMP4C;CHMP5;IST1;STAM2;CHMP2B;TSG101;VPS36;CHMP2A;STAM
prerank,regulation of Notch signaling pathway (GO:0008593),0.35597183377084307,0.9864997563096247,0.49150485436893204,0.9871975599485813,1.0,16/76,12.63%,NOTCH3;TCIM;JAG1;EPN2;FBXW7;RFNG;MAML2;YTHDF2;YJEFN3;YAP1;TGFB2;MAML3;SREBF2;ZBTB7A;TM2D3;PDCD10
prerank,multivesicular body assembly (GO:0036258),0.40233537596017704,0.9858099713212735,0.46418338108882523,0.9880892219198998,1.0,9/30,15.01%,CHMP4C;CHMP5;IST1;STAM2;CHMP2B;TSG101;VPS36;CHMP2A;STAM
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.37195517048276794,-0.9857540231086811,0.4949238578680203,0.8576774062252811,1.0,3/15,1.18%,UST;DCN;DSE
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.4435334484501812,0.9857038819275304,0.4796084828711256,0.9874821985482476,1.0,5/19,12.92%,AMPD1;TERT;AMPD2;POLD1;GMPR
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3898639519549224,-0.9854142120869128,0.491566265060241,0.857571333911486,1.0,9/14,35.20%,NT5E;UPP2;UPB1;DPYD;DHODH;NT5C1A;UMPS;CAD;ERH
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4063419409808914,0.9847461280377177,0.4809590973201692,0.9889232981002649,1.0,3/29,6.25%,VASN;SDHAF2;DAB2IP
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.27871383442797604,-0.9847035077630607,0.43349753694581283,0.8583270885737655,1.0,12/51,17.14%,PTN;HMGB1;PTK2;LGALS9;MOSPD2;IL6R;AKIRIN1;VEGFC;CALR;PLA2G7;SERPINE1;VEGFB
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3039355941332623,-0.9840099119919357,0.46283783783783783,0.8592023860931477,1.0,13/35,24.18%,SASH1;DLG1;XDH;LGALS9;RELL1;PTPN22;MAP3K4;PER1;DUSP1;ZC3H12A;GADD45B;SPHK1;CYLD
prerank,positive regulation of viral process (GO:0048524),0.36741669121541953,0.983116887624574,0.4721549636803874,0.9920347602990807,1.0,19/60,18.18%,POLR2L;POLR2I;CCL5;TBC1D20;POLR2G;PPARA;CCNT1;PPIE;PKN2;AXL;CNOT7;KPNA2;NELFB;POLR2J;SRPK2;NELFCD;DHX9;VPS4A;RSF1
prerank,regulation of interleukin-2 production (GO:0032663),-0.2816328590702404,-0.9830097074465743,0.4696969696969697,0.8606612338511052,1.0,6/43,10.06%,SPTBN1;HDAC7;PLCG2;CD34;NAV3;HOMER3
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.3626418394089831,-0.9828877856047145,0.4763092269326683,0.8598960246828483,1.0,10/18,33.92%,PTBP3;RPS13;ESR1;TGFB1;NRDE2;ZC3H12A;TMBIM6;ZC3H10;NCOR1;NUDT16
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.31808551242615807,0.9827643745587101,0.554,0.9920157648593627,1.0,106/834,11.37%,MYOCD;NOTCH3;PPP1R12A;FHL5;HJV;ABRA;MEF2C;HEY2;ZFHX3;SMARCD3;FGF1;MICAL2;NR1H4;CSRP3;PDGFB;CCN1;PPP3CA;ZEB2;MLIP;FZD5;PLXND1;RORA;SS18L2;CDH13;NR4A1;CRTC1;GABPA;HEYL;JAG1;HINFP;MRTFA;TGFB3;CRTC3;FOSL2;ACVR2A;MCRS1;NR2F2;LMO7;VEZF1;ACTR3;ELL;OSR2;SP7;ARHGEF2;BMPR1A;KLF7;MEF2A;NCOA7;DBP;FOXJ3;ASXL1;KLF15;JUND;SMARCB1;DAB2IP;TERT;TP53;RXRG;VEGFA;PARP1;GRHL1;PIN1;ZBTB38;GDNF;MAML2;SFPQ;HOXC4;AR;PPARGC1A;MED1;PPARGC1B;YAP1;MED12;SOX9;TGFB2;RELA;KMT2D;SETD3;TNIP1;MAML3;PPARA;CCNT1;NR4A2;SKI;NR1D1;KAT7;PAXIP1;AKNA;CDK7;HIF1A;CRLF3;KANSL3;SIRT2;AGRN;HNRNPU;MED14;NR2C2;TEAD1;EIF5A;GPER1;PCGF5;SREBF2;RUNX1;PFKM;LRP5;ATF3
prerank,regulation of cytoplasmic translation (GO:2000765),0.4640576397651578,0.9820118048367479,0.5076400679117148,0.9929959345302584,1.0,2/14,6.43%,RBM24;CPEB1
prerank,regulation of protein sumoylation (GO:0033233),0.4465690374101511,0.9818272065874548,0.5048701298701299,0.9926125607686458,1.0,3/17,6.07%,UBA2;PIAS4;SAE1
prerank,response to organonitrogen compound (GO:0010243),-0.29928228881169217,-0.9813847110153336,0.4742647058823529,0.8628922007456634,1.0,13/38,22.57%,SEL1L;RNF185;DNAJB12;DERL1;GLRB;IRAK3;PRKN;GLRA2;RCN3;SYVN1;GLRA1;DRD2;CCDC47
prerank,negative regulation of cell division (GO:0051782),0.49108976051347913,0.9808400253952542,0.5140845070422535,0.9941093712533164,1.0,1/11,1.79%,CHMP4C
prerank,nucleosome organization (GO:0034728),0.3680333588708983,0.9805488578392336,0.5019157088122606,0.9939221691687403,1.0,15/55,19.30%,SMARCD3;H1-0;ARID1A;SET;CHAF1B;SMARCB1;SOX9;MCM3AP;SMARCA5;INO80;RSF1;NAP1L4;VPS72;NAP1L2;BRD2
prerank,cellular glucan metabolic process (GO:0006073),0.4942332456255778,0.9803784171262094,0.49559082892416223,0.9934987816658384,1.0,1/11,1.09%,PYGM
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.33702058896780807,-0.9803108167105101,0.4860335195530726,0.8646857780365541,1.0,12/20,37.29%,FAR2;PPT1;ACSL3;ACLY;ACSL4;HSD17B8;DGAT2;FITM2;GCDH;SLC25A1;SCD;ACACA
prerank,protein import (GO:0017038),-0.2476593529383081,-0.9798273968013343,0.47297297297297297,0.8648529813696685,1.0,28/84,22.22%,APPL2;APOE;HSPA4;E2F3;PEX14;FAM53A;SLC25A17;NUP88;ALDH3A2;NUTF2;IPO8;PEX5;ACBD5;PTTG1IP;ABCD3;APPL1;NUP50;FIS1;AKT1;EIF4ENIF1;SAMM50;NUP85;IPO11;NXT2;PXMP2;PEX13;NUP214;RAN
prerank,establishment of melanosome localization (GO:0032401),-0.3508706822799051,-0.9797041693423523,0.4768392370572207,0.8640716610066167,1.0,2/19,3.89%,SHROOM2;RAB11A
prerank,endoderm formation (GO:0001706),0.39317529390192274,0.9795828486919292,0.48360655737704916,0.9945569610540708,1.0,5/35,8.26%,COL4A2;ITGA7;DUSP5;ITGB5;ITGA4
prerank,embryonic digestive tract development (GO:0048566),0.4456385602874073,0.9795245061880773,0.47611464968152867,0.9938630259895708,1.0,3/18,7.86%,RBPMS2;RARRES2;TGFB2
prerank,cellular response to oxidative stress (GO:0034599),0.3412675697808423,0.9794404314780929,0.5027995520716685,0.9932339738945933,1.0,28/118,17.31%,TPM1;NCF2;ANKRD2;CAMKK2;MAPT;TP53;PARP1;PPARGC1A;ADNP2;SRXN1;NUDT2;GSTP1;LONP1;PYROXD1;HIF1A;SIRT2;PRKCD;TXNRD2;PDK2;MAPK1;LRRK2;PRKAA2;ZFAND1;RAD52;MT3;SOD3;PRDX5;PRDX6
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.46673806137230883,0.9793762455848898,0.49217391304347824,0.9925462900366484,1.0,2/13,5.63%,MYD88;PIK3AP1
prerank,steroid metabolic process (GO:0008202),0.35883615532760654,0.9793206094980518,0.5006090133982948,0.9918291693822799,1.0,7/72,5.64%,HSD17B10;CYP7B1;DHRS4;HSD17B7;PIAS4;GC;HSD17B4
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.32327792141800366,-0.9791189043980075,0.4936708860759494,0.8644785132875952,1.0,3/25,0.71%,IGF1;NSD1;NIBAN2
prerank,amino acid transport (GO:0006865),0.37681483328526016,0.9785020684033148,0.4940554821664465,0.9929642507815255,1.0,8/49,11.03%,SLC38A11;SLC6A17;SLC38A2;SLC25A29;SLC1A5;SLC7A8;SH3BP4;SLC6A15
prerank,regulation of mast cell activation (GO:0033003),0.4746945024689111,0.9782515433296665,0.48880597014925375,0.992697025125291,1.0,2/10,11.86%,MILR1;NECTIN2
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4500999731350451,0.9779724956635678,0.49517684887459806,0.9925508335551048,1.0,2/16,5.17%,RYR2;TAPT1
prerank,nucleus organization (GO:0006997),0.37781822340941107,0.977950108374326,0.47333333333333333,0.9917696607046235,1.0,14/47,19.61%,CHMP4C;SYNE1;PITPNB;CHMP5;SUN2;CHMP2B;DMPK;CHMP2A;NUP98;SUN1;USP36;VPS4A;NUP54;NUP133
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4185040524647207,0.9778430915369486,0.46401225114854516,0.9911758493732743,1.0,4/24,4.86%,DLC1;PHLDB2;CLASP2;ARHGAP6
prerank,keratinocyte differentiation (GO:0030216),0.4144713417032221,0.977809738163482,0.5088495575221239,0.9904245124982721,1.0,5/29,12.31%,ANXA1;JAG1;MED1;EPHA2;BCR
prerank,positive regulation of neurogenesis (GO:0050769),-0.2606485040190461,-0.9769283537579754,0.4845360824742268,0.8692597049224756,1.0,21/68,19.44%,PLXNA2;ROBO1;SLIT2;CUX1;TIAM2;SHANK3;CTNNB1;PLXNA4;CDKL3;SPEN;CUL7;PTPRD;SNW1;CX3CL1;FBXW8;FAIM;NUMB;OBSL1;KDM1A;DISC1;NAP1L1
prerank,inflammatory response (GO:0006954),0.32499974359938943,0.9765728760955544,0.5301587301587302,0.9925888993190081,1.0,13/195,7.89%,AGTR1;AOC3;TMIGD3;PTGER3;ANXA1;CCL5;HDAC9;MFHAS1;CD14;TNFAIP6;MAPKAPK2;IL22;RELA
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.35707666247892145,-0.9765480014048029,0.46446700507614214,0.8692651560220274,1.0,4/18,10.06%,HDAC7;CD34;NAV3;HOMER3
prerank,intracellular lipid transport (GO:0032365),0.41959618016812994,0.9763265229438935,0.486697965571205,0.992349864096938,1.0,6/21,14.41%,PRKAB2;ACACB;CPT1B;ABCD4;CPT1A;PRKAA2
prerank,Fc receptor signaling pathway (GO:0038093),-0.2352771348686996,-0.9753347563016871,0.5242718446601942,0.8713563012456158,1.0,22/110,14.23%,NFATC3;GAB2;PIK3CA;GRB2;KIT;PDPK1;VAV2;PLCG2;PIK3CB;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;PSMA5;PSMA1;PSMC2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.2893037145505723,-0.9753121198912569,0.5056603773584906,0.8703394898138173,1.0,10/43,12.79%,PRKCB;PID1;GKAP1;PTPN11;PIP4K2B;NCK1;IGF2;OGT;GRB14;ENPP1
prerank,regulation of interferon-gamma production (GO:0032649),0.3632094340743827,0.9752674708355819,0.5072463768115942,0.9940228534153297,1.0,10/71,11.18%,NR1H4;FZD5;IL12RB2;CD276;HAVCR2;CD14;IL12RB1;RASGRP1;AXL;PDE4D
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4138314827581311,-0.975181047397126,0.4967741935483871,0.8696053269837843,1.0,4/10,13.75%,WNK1;PODXL;PIEZO1;DPP4
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.3471710862911397,-0.9751604147557525,0.4774011299435028,0.8685829990764854,1.0,6/20,4.20%,IGF1;LRP1;SLIT2;VTN;NRP1;IGFBP3
prerank,anterior/posterior pattern specification (GO:0009952),-0.275287357106312,-0.975125347494804,0.5227272727272727,0.8675762971226864,1.0,12/53,12.18%,HOXB6;HOXB3;PCSK5;HOXA3;HOXB4;HOXA5;BMPR2;WLS;ATP6AP2;HES1;TGFBR1;BHLHE41
prerank,regulation of JUN kinase activity (GO:0043506),0.401304417434565,0.9749180051402678,0.4977843426883309,0.9940017144743604,1.0,5/33,8.98%,MAP3K5;TNFRSF11A;DAB2IP;MAP3K10;GSTP1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.3548114846889021,-0.9748957148205275,0.5150684931506849,0.8671288094723582,1.0,8/18,29.46%,DAB2;RDX;MAP2K2;DNAJC13;SNX3;MTMR2;SNX12;SRC
prerank,regulation of fat cell differentiation (GO:0045598),0.35517724265554634,0.974641612421848,0.4900990099009901,0.9938017497851799,1.0,16/74,11.24%,FERMT2;RORA;RUNX1T1;LPL;ALOX5;RARRES2;ASXL1;BBS12;TAF8;YAP1;FTO;TRPM4;NR1D1;SIRT2;GPER1;LRP5
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.374017643510064,0.9746004373937329,0.4883116883116883,0.9930745409315793,1.0,12/52,11.84%,ATP2B4;STAC;ITGA3;ITGB1;ARHGEF16;SORBS1;STAC3;KIF5B;EPHA2;GPER1;DPP10;CLIP3
prerank,response to gamma radiation (GO:0010332),0.41676999066674353,0.9741069147750382,0.4945904173106646,0.9934796941944646,1.0,3/24,7.59%,MAP3K20;TP53;YAP1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3716988387229265,0.974072309142908,0.4960212201591512,0.9927159796943638,1.0,6/47,11.38%,AGTR1;EDNRB;ATXN2;CYFIP1;DDX25;RBM3
prerank,regulation of MAPK cascade (GO:0043408),0.32951216949151024,0.9738658977283747,0.5179153094462541,0.9923852478940234,1.0,30/157,14.04%,NTRK3;ROCK1;LBH;PDGFB;CCN1;ROR1;ADRA1D;FAM83D;THPO;BCAR3;KSR1;CAV1;DAB2IP;DUSP3;RRAS;RASGRP1;MAP2K1;GSTP1;PAK2;EPHA2;PELI2;PDGFA;GPER1;ROCK2;ZDHHC17;TNIK;TAOK3;FGF10;EPHB1;MAPK1
prerank,positive regulation of viral transcription (GO:0050434),0.4216863713994366,0.9736755758699287,0.4818181818181818,0.991998545377876,1.0,9/25,18.18%,POLR2L;POLR2I;POLR2G;CCNT1;NELFB;POLR2J;NELFCD;DHX9;RSF1
prerank,cardiac atrium morphogenesis (GO:0003209),0.4593821469281426,0.9735244426682568,0.488135593220339,0.9915505977924041,1.0,2/16,7.86%,HEY2;TGFB2
prerank,negative regulation of cellular component organization (GO:0051129),-0.25244123595949575,-0.9730994337165585,0.5806451612903226,0.8707402264202303,1.0,18/74,16.79%,BMP6;DDX3X;XRCC5;EPHA3;MCTP1;HSPA5;IAPP;RDX;IRAK3;PEX5;RIOK3;SPRY2;DNAJB2;EP300;SYT11;AIDA;NOP53;CDC42
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.3859168792128929,0.9726529426165192,0.508130081300813,0.9927554546256337,1.0,3/39,2.65%,ANGPT1;SEMA5A;ANO6
prerank,fibrinolysis (GO:0042730),-0.3831342360191685,-0.9717185573461816,0.5102040816326531,0.8734451863462099,1.0,9/13,57.02%,PLAT;SERPINE1;PLAUR;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA
prerank,homeostasis of number of cells (GO:0048872),-0.38795733230919516,-0.9716689368799735,0.5011441647597255,0.8725185580642244,1.0,3/12,9.37%,NAPEPLD;NOS3;CCN3
prerank,glucose metabolic process (GO:0006006),0.3607330175251873,0.9712413432765022,0.49615384615384617,0.9952397228143443,1.0,14/58,15.43%,ENO3;PFKFB1;MDH1;ADPGK;PPARGC1A;GOT1;GOT2;SLC39A14;ALDOA;LRP5;CRTC2;SLC25A12;IRS2;GAPDHS
prerank,positive regulation of signal transduction (GO:0009967),0.32121253182949255,0.9709205940182674,0.5371900826446281,0.9951637137634012,1.0,48/238,15.41%,NTF3;FLNA;NTRK3;SLC2A4;FGF1;LIMS1;JAG1;DEPDC1B;KANK1;PTGIS;MN1;ASXL1;IRS1;MBD5;EPN2;SMARCB1;DAB2IP;SORBS1;LIMS2;TERT;MAML2;ITGB3;YAP1;TGFB2;TTC23;CUX2;MAML3;SKI;HIF1A;AXL;SLC39A14;GPER1;CD180;TM2D3;CHRNA7;CITED2;PDCD10;HOMER1;STK36;DMTN;SPIN1;GAS6;TUBD1;LRRK2;RAB34;PRKCA;PTEN;CAV2
prerank,negative regulation of viral transcription (GO:0032897),-0.3883129726193388,-0.9707388897505134,0.4769585253456221,0.8737798023328395,1.0,8/13,31.21%,TRIM14;LARP7;MID2;IFITM3;TRIM21;TRIM32;ZFP36;TRIM13
prerank,regulation of transposition (GO:0010528),-0.3869872827403765,-0.9707019406996015,0.5011764705882353,0.8728145863247898,1.0,3/13,18.07%,UBR2;SIRT7;TEX15
prerank,negative regulation of ossification (GO:0030279),0.42549366913694725,0.9705896697103126,0.5160796324655437,0.9950932303972084,1.0,3/23,8.74%,MEF2C;SOX9;TRPM4
prerank,response to chemokine (GO:1990868),-0.38732696602641004,-0.9704306623276336,0.4977578475336323,0.8724390009402269,1.0,6/13,18.64%,WNK1;SLC12A2;RIPOR2;DUSP1;LRCH1;ZC3H12A
prerank,regulation of filopodium assembly (GO:0051489),-0.2945002007331801,-0.970285682031718,0.5086505190311419,0.8717357538784792,1.0,15/38,24.75%,PALM;DOCK11;NRP1;RAB5A;NLGN1;FNBP1L;RIPOR2;DPYSL3;RHOQ;CDC42;FMR1;GPM6A;FSCN1;FXR1;ABITRAM
prerank,modulation of chemical synaptic transmission (GO:0050804),0.3427104867539946,0.9699032579966009,0.5056053811659192,0.9958611376296762,1.0,7/107,4.35%,NTF3;MEF2C;ABR;SLC8A2;SLC4A8;ITGB1;RIMS3
prerank,inner ear morphogenesis (GO:0042472),-0.3314479731970796,-0.9697134480864191,0.5026178010471204,0.8722317932333024,1.0,5/22,13.54%,ZIC1;CHD7;FGFR2;SIX1;MYO6
prerank,protein homotrimerization (GO:0070207),-0.38120787224665087,-0.9696202350727504,0.47761194029850745,0.8703571122118363,1.0,2/14,3.83%,CLYBL;SCARA5
prerank,protein trimerization (GO:0070206),-0.38120787224665087,-0.9696202350727504,0.47761194029850745,0.8703571122118363,1.0,2/14,3.83%,CLYBL;SCARA5
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.3962840559823597,-0.9694140084119369,0.5119825708061002,0.8698204491041113,1.0,2/11,2.36%,IGF1;GHR
prerank,protein palmitoylation (GO:0018345),0.39024608672348104,0.9692931735772189,0.5073099415204678,0.9965169007173983,1.0,12/30,18.76%,GOLGA7B;ZDHHC2;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;CLIP3;ZDHHC13;ZDHHC4;ZDHHC5;ZDHHC8;ZDHHC3
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4081382937008515,0.9687580198486585,0.48623853211009177,0.9961704767785321,1.0,8/22,18.76%,GOLGA7B;ZDHHC2;ZDHHC1;ZDHHC14;CLIP3;ZDHHC4;ZDHHC8;ZDHHC3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4081382937008515,0.9687580198486585,0.48623853211009177,0.9961704767785321,1.0,8/22,18.76%,GOLGA7B;ZDHHC2;ZDHHC1;ZDHHC14;CLIP3;ZDHHC4;ZDHHC8;ZDHHC3
prerank,regulation of dendrite morphogenesis (GO:0048814),0.39361098476898787,0.9683309531146213,0.5044117647058823,0.996399690207444,1.0,8/32,12.90%,SDC2;SS18L2;NEDD4;CUX2;RAP2A;IL1RAPL1;TNIK;SARM1
prerank,apoptotic process (GO:0006915),0.3168717176363474,0.967949017232804,0.5302083333333333,0.9964865793225245,1.0,31/203,12.39%,ATP2A1;DLC1;PMAIP1;RNF152;HIP1;MYD88;HK2;TNFAIP1;BCL2;JADE1;NDUFS1;CD14;PARP1;BNIPL;CHEK1;MAP3K10;DAPK3;NUDT2;VDAC1;TRPC5;ATCAY;AHCYL1;PAWR;TNFRSF21;PRKCD;RELT;TCHP;BOK;TNFRSF25;DMPK;DIABLO
prerank,negative regulation of neuron differentiation (GO:0045665),-0.334389621722034,-0.9677681719108333,0.5235457063711911,0.8730751668393206,1.0,6/22,16.85%,BMP7;B2M;HES1;DTX1;CALR;CNTN4
prerank,positive regulation of TOR signaling (GO:0032008),-0.2851920120731747,-0.9675173624255934,0.49466192170818507,0.8727167657480295,1.0,19/40,30.27%,PIK3CA;LAMTOR1;GOLPH3;RHEB;KLHL22;PIP4P1;NCKAP1L;GPR137B;MIOS;TELO2;SMCR8;RRAGD;LAMTOR2;GPR137;SIK3;PIH1D1;RRAGA;RPTOR;SLC38A9
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4332214406460192,0.9673151060250806,0.4967845659163987,0.9971122467894596,1.0,2/18,2.43%,FER1L5;DYSF
prerank,actin cytoskeleton reorganization (GO:0031532),0.3643818274830704,0.9673092524143433,0.5063131313131313,0.9962914928342772,1.0,15/63,13.99%,FLNA;MYH9;ANXA1;PTPN1;PLEK;WHAMM;PARVA;RAP2A;RICTOR;TNIK;CDC42BPB;DMTN;FGF10;MKLN1;S1PR2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.42929194615544736,0.9669613870834421,0.47761194029850745,0.9963231512307134,1.0,6/20,12.88%,AMPD1;NT5C2;LHPP;AMPD2;PPAT;ADSS1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.4313820125495332,0.9668956449778588,0.5134680134680135,0.9956367153821306,1.0,5/19,14.04%,CCL5;JAM3;RARRES2;MPP1;MAPK1
prerank,tRNA 5'-end processing (GO:0099116),0.44948349197462056,0.9665518115602686,0.4951923076923077,0.9955955178502676,1.0,2/15,5.56%,HSD17B10;TRMT10C
prerank,regulation of mitotic spindle organization (GO:0060236),0.3945433667220748,0.9664359909550266,0.5141643059490085,0.9950306869550438,1.0,9/35,17.37%,CHMP4C;NUP62;CHMP5;TPX2;HNRNPU;CHMP2B;CHMP2A;MAP9;DCTN1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.28598799662690133,-0.9662823515869103,0.5149253731343284,0.874818375678222,1.0,23/39,38.29%,ERCC5;FAN1;DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;ERCC1;ERCC4;OGG1;RPA3;RFC3;RPA2;ERCC3;POLD3;RPA1;RFC1;RFC4;NTHL1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2854930836579523,-0.9657364455374957,0.4669421487603306,0.8751523352947586,1.0,11/41,16.14%,IGF1;LBP;LGALS9;ILRUN;CD34;PTPN22;IRAK3;SIRPA;CX3CL1;SYT11;RARA
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.382597025579371,0.9656000222829697,0.52,0.9961540626476906,1.0,7/47,7.71%,ATP2B4;PTGIS;CAV1;FBXW7;PLEK;GLA;SNAI2
prerank,mitochondrial fusion (GO:0008053),0.4352425989696188,0.9647384260943341,0.5174708818635607,0.9973159643891195,1.0,9/18,21.72%,AFG3L2;OPA1;MIEF2;MIEF1;MFN2;USP30;MFF;MFN1;GDAP1
prerank,protein heterotetramerization (GO:0051290),-0.3864397973480298,-0.9647085137022597,0.5067873303167421,0.8768054461746624,1.0,6/13,42.50%,PKD2;FARSB;CPSF6;HSD17B8;GRIN1;GRIN2B
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.39527491934551123,0.9644019754490797,0.511921458625526,0.9972377179485886,1.0,7/31,11.24%,CRIM1;LIMD1;CDK6;SOX9;TRPM4;SKI;LRP5
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.3765184401414414,0.9641340100317327,0.5049088359046283,0.9970584043650105,1.0,11/42,16.51%,CGAS;RAD51AP1;PARP1;CHEK1;ERCC6;FUS;FANCB;RIF1;RMI2;MAD2L2;SIRT6
prerank,intracellular protein transport (GO:0006886),-0.20485533063247907,-0.9636987796334825,0.6923076923076923,0.8784090001965821,1.0,86/304,20.78%,RANBP3L;APPL2;TBC1D16;KIF13B;SNX27;E2F3;RABGAP1L;RAB5A;STXBP1;STX3;NLGN1;FAM53A;TBC1D15;USO1;ERP29;TBC1D8B;NUP88;TMED5;SEC23IP;RASSF9;TBC1D2B;SCG5;TBC1D13;STX5;HERC2;TBC1D5;STX4;ARL5B;TMED7;SURF4;TMED10;WLS;COPB2;NUTF2;IPO8;TBC1D8;FUT10;HOMER3;RANBP3;RAB3GAP2;TGFB1;SNX6;ARF3;UNC93B1;SNX15;ARFIP2;PTTG1IP;TBC1D25;TBC1D9B;SGSM1;GRTP1;MYO6;ARFGAP3;APPL1;NUP50;RAB1A;CALR;TBC1D30;MAIP1;GIPC1;RAB29;CCHCR1;TBC1D22A;TBC1D9;EHD1;AKT1;EIF4ENIF1;STX1A;SGSM3;LMAN1;COG7;PICK1;TMED3;SCFD1;STX8;RAB1B;NAPG;RPL11;TBC1D10A;SRPRA;TMED4;NUP85;IPO11;ARL4A;STX6;NXT2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3119609544871008,0.9634901038547854,0.631,0.9976951352014632,1.0,128/1082,11.24%,ACTA2;MYOCD;PRDM16;PPP1R12A;FHL5;TNNI2;HJV;ABRA;MEF2C;HEY2;MAP3K5;ZFHX3;SMARCD3;FGF1;LBH;NR1H4;CSRP3;RASL11A;PDGFB;CCN1;PPP3CA;ZEB2;MLIP;FZD5;RORA;SS18L2;CDH13;NR4A1;CRTC1;GABPA;ETS2;HEYL;JAG1;FZD4;PADI2;HINFP;MRTFA;TGFB3;H1-0;CRTC3;FOSL2;NUP62;ACVR2A;MCRS1;ARID1A;NR2F2;LMO7;TGFB1I1;VEZF1;CAMKK2;ACTR3;ELL;OSR2;SP7;ARHGEF2;BMPR1A;KLF7;CEP290;MEF2A;DYRK1A;NCOA7;TESC;DBP;FOXJ3;ASXL1;KLF15;JUND;SMARCB1;DAB2IP;TP53;RXRG;VEGFA;DYRK1B;PPM1A;PARP1;GRHL1;PIN1;ZBTB38;GDNF;MAML2;SFPQ;HOXC4;AR;PPARGC1A;MED1;PPARGC1B;CHEK1;YAP1;ERCC6;MED12;SOX9;RELA;PLCB1;KMT2D;SETD3;TNIP1;ZXDC;MAML3;PPARA;MAP2K1;CCNT1;NSD3;NR4A2;SKI;NR1D1;KAT7;AKNA;CDK7;HIF1A;CRLF3;SFR1;KANSL3;SIRT2;SERTAD2;AGRN;HNRNPU;NAT14;MED14;NR2C2;TEAD1;EIF5A;RAI1;GPER1;PCGF5;SREBF2;RUNX1;PFKM;LRP5
prerank,pore complex assembly (GO:0046931),-0.34926286839018583,-0.9634414965332021,0.496,0.8780264135418121,1.0,8/19,22.88%,AFDN;ADAM10;AHCTF1;GSDMD;RTN4;NDC1;PDZD11;PLEKHA7
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3976132809543099,-0.963297055775146,0.48872180451127817,0.8773805770296955,1.0,3/12,8.50%,GKAP1;PTPN11;IGF2
prerank,ncRNA export from nucleus (GO:0097064),0.400294831935805,0.9630887989690482,0.5313351498637602,0.9977937603301028,1.0,13/36,20.76%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,nucleotide metabolic process (GO:0009117),0.41677900957298947,0.9629760227451934,0.4900763358778626,0.9972410085871297,1.0,12/23,22.83%,NMNAT2;DCTD;AK7;NMNAT1;CMPK1;REXO2;CMPK2;DCK;FHIT;CTPS2;NMNAT3;NUDT5
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3648926689897732,0.9624998897404412,0.5210918114143921,0.9974953104796842,1.0,9/60,10.91%,PARM1;PDGFB;PARN;PRKCQ;PKIB;CHTF18;NAF1;PDGFRB;CCT3
prerank,lipid oxidation (GO:0034440),0.4599331462351017,0.9623675769608551,0.5122377622377622,0.9969512963853551,1.0,2/12,7.18%,ALOX5;PPARGC1A
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.33382211117412053,-0.9616930753731534,0.49554896142433236,0.8807182312576834,1.0,6/21,13.83%,IGF1;LGALS9;CTSH;ITGAV;MAP2K2;KDR
prerank,regulation of cellular component biogenesis (GO:0044087),0.379454817646159,0.960960746941507,0.5040871934604905,0.9994517627537254,1.0,3/39,1.73%,RAP1A;ROCK1;CD36
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.37235666201209655,0.9609413375443169,0.5122897800776197,0.9986763041292568,1.0,8/46,13.57%,FLNA;UBR5;TP53;NEDD4;BAG3;PRKCD;TRIM28;GAS6
prerank,positive regulation of interferon-gamma production (GO:0032729),0.3729243747885601,0.9607252295425772,0.5078740157480315,0.9983631996763758,1.0,6/48,7.37%,FZD5;IL12RB2;CD276;CD14;IL12RB1;RASGRP1
prerank,stem cell differentiation (GO:0048863),0.38302208888121414,0.9606999227873725,0.5089163237311386,0.9975944466871953,1.0,8/39,12.34%,MEF2C;SP7;SETD6;TP53;TGFB2;LMBR1L;HTR2B;NELFB
prerank,cholesterol metabolic process (GO:0008203),-0.2543959615688988,-0.9605200536258599,0.5311004784688995,0.8826919118931255,1.0,32/68,36.87%,CYP27A1;APOE;ABCA1;LBR;GGPS1;CYP51A1;SCARF1;HMGCR;ACLY;SOAT1;ARV1;INSIG1;PIP4P1;SQLE;GBA2;PMVK;LSS;MVK;CLN8;RXRA;INSIG2;EBP;TSKU;PPARD;ANGPTL3;ABCA5;CLN6;TM7SF2;SCAP;DHCR7;CH25H;LCAT
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3537614028625007,-0.9599543255254626,0.5179856115107914,0.8830602987474999,1.0,7/16,17.60%,IRAK3;OGFOD1;GLE1;TBC1D25;INSR;CLN3;SHFL
prerank,central nervous system myelination (GO:0022010),-0.39749900033606944,-0.9598411689499916,0.5147392290249433,0.8823295394922467,1.0,2/11,4.96%,PLP1;B4GALT6
prerank,positive regulation of sodium ion transport (GO:0010765),0.4565244857163998,0.9596998011640581,0.509090909090909,0.9991194868244235,1.0,5/12,15.59%,PRSS8;CNKSR3;AHCYL1;GPD1L;NOS1
prerank,protein O-linked glycosylation (GO:0006493),-0.23666687103524747,-0.9595305026757371,0.5405405405405406,0.882083357767034,1.0,15/96,13.02%,GXYLT2;TMTC1;ST3GAL4;TMTC2;ST3GAL1;GALNT10;TET3;RXYLT1;PGM3;TMTC4;TET2;ST3GAL3;OGT;PLOD2;GALNT12
prerank,intestinal absorption (GO:0050892),0.46686290920207024,0.9589833724754561,0.5231316725978647,0.9999581435419255,1.0,1/13,1.73%,CD36
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.3662724309722106,-0.9585625518962646,0.5200945626477541,0.883549601100943,1.0,4/15,11.77%,PDGFRA;FGFR2;SIX1;TGFBR1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.35900332674799174,0.9580731296097201,0.5236907730673317,1.0,1.0,15/61,16.90%,NR1H4;OAZ2;PDK4;CAV1;PSMC6;PPARA;PSME4;PSMB1;PSMD5;PSMB2;PDK2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,regulation of protein kinase B signaling (GO:0051896),0.32019420262339193,0.9580571553709428,0.5350785340314136,1.0,1.0,37/193,15.44%,NTRK3;ANGPT1;FGF1;HIP1;MST1R;PDGFB;FERMT2;SEMA5A;THPO;ITGB1;GCNT2;MFHAS1;MTDH;PIK3AP1;IRS1;RRAS;PHLDA3;AREG;PPARA;EPHA2;THEM4;AXL;PDGFRB;HBEGF;PDGFA;VAV1;GPER1;RICTOR;TPTE;FGF10;MUL1;GAS6;PLEKHA1;IRS2;RHOG;PTEN;MYDGF
prerank,negative regulation of cell cycle process (GO:0010948),-0.2493835091335912,-0.9573589009250508,0.5235602094240838,0.8857151242278992,1.0,10/61,8.60%,BMP7;RBBP4;BMP4;CBX5;MGA;TFDP1;RYBP;PHC3;PHC1;MAX
prerank,Wnt signaling pathway (GO:0016055),-0.2368954178237574,-0.9573543882528425,0.5935483870967742,0.8846681758416632,1.0,16/92,10.92%,LEF1;WNT4;TCF7L2;NXN;FZD6;DDX3X;WNT5A;KLHL12;BCL9L;DIXDC1;PLCG2;WNT9A;CTNNB1;WLS;SFRP4;UBC
prerank,protein processing (GO:0016485),0.33710035188972504,0.9564303460532219,0.54292343387471,1.0,1.0,6/102,6.32%,TMPRSS4;HJV;CLN5;KLK2;FXN;AFG3L2
prerank,establishment of spindle localization (GO:0051293),0.444465322697543,0.9563556656898771,0.5083612040133779,1.0,1.0,4/14,18.58%,CLASP2;CLASP1;MAP4;CFL1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4090809154298142,-0.9563154554421992,0.5295404814004376,0.8852453357251153,1.0,2/10,0.85%,NFAT5;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),-0.4090809154298142,-0.9563154554421992,0.5295404814004376,0.8852453357251153,1.0,2/10,0.85%,NFAT5;NFATC3
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3965889544289787,-0.9560200215457312,0.5378973105134475,0.8849666041790816,1.0,5/11,28.11%,FBXO7;PRKN;PARK7;ATF4;RACK1
prerank,protein import into peroxisome membrane (GO:0045046),-0.3257564035405014,-0.9558945251257747,0.528125,0.8842335294547647,1.0,9/22,21.53%,PEX14;SLC25A17;ALDH3A2;PEX5;ACBD5;ABCD3;FIS1;PXMP2;PEX13
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.45291765221696867,0.9558644208423808,0.5126050420168067,1.0,1.0,5/14,16.16%,PAXIP1;RIF1;NECTIN2;KMT5B;MAD2L2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.258394275298325,-0.9558581713366273,0.5170454545454546,0.8832588820841553,1.0,22/63,25.45%,CARM1;PRKDC;TFDP1;PML;ARID3A;MDM2;RGCC;SOX4;EP300;PLK2;BAX;CNOT11;CRADD;CHEK2;ATM;E2F4;FBXO31;PCBP4;PLAGL1;CDK2;CDKN1A;CNOT10
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.24960489400357644,-0.9555300213254282,0.5329341317365269,0.8830589205163903,1.0,19/80,17.93%,UACA;DAPK1;EPHA7;SH3RF1;HMGB1;DDX3X;NOD1;TNFSF10;RPS6KA3;CD44;DELE1;PDCD5;PPM1F;IGBP1;SNCA;FIS1;AKT1;GPX1;SIAH2
prerank,protein dephosphorylation (GO:0006470),0.3288779509163734,0.9553195445757641,0.5654565456545655,1.0,1.0,27/135,13.12%,PPP1R12A;PPM1L;PPM1J;PPP3CA;MTMR7;DUSP5;PPP2R1B;PPM1E;PTPN18;PTPRS;LHPP;SDHAF2;PTPRF;DUSP3;PPP2R5A;PPM1A;PTPN1;PPP1CB;PPP1CA;CTDSP2;DUSP29;FBXW11;SBF1;CTDSP1;TPTE;DUSP16;PPP3CB
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.26134928073039415,-0.955023590926718,0.5291828793774319,0.883280735536228,1.0,12/50,19.27%,SH3RF1;DDX3X;RPS6KA3;CD44;RNF34;IGBP1;SNCA;AKT1;GPX1;SIAH2;BCL2L12;PARK7
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3282448589668955,0.9544219760885719,0.5405405405405406,1.0,1.0,18/117,10.96%,CKM;CD36;CKMT2;MCCC2;LPL;FA2H;ME3;DLD;CPT1B;MECR;GOT2;PPARA;VDAC1;AASDHPPT;THEM4;SCP2;AOAH;PTGR1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.434676389288455,0.9541451445926741,0.49829931972789115,1.0,1.0,4/16,7.43%,PADI2;ARID1A;AR;PPARGC1B
prerank,melanosome localization (GO:0032400),-0.333518262189506,-0.9540626904708354,0.5252808988764045,0.8846627204734745,1.0,2/21,3.89%,SHROOM2;RAB11A
prerank,regulation of protein catabolic process (GO:0042176),0.3378969757562952,0.9539448792649253,0.540386803185438,1.0,1.0,10/99,7.94%,FLNA;NKD1;OAZ2;FAM83D;ATG7;ZDHHC2;DAB2IP;PIN1;NEDD4;SF3B3
prerank,linoleic acid metabolic process (GO:0043651),0.4227558161106977,0.9538689513995736,0.5016181229773463,1.0,1.0,3/17,8.98%,ALOX5;FADS2;GSTP1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.326502825860273,0.9535415955313746,0.5502702702702703,1.0,1.0,28/144,16.22%,FLNA;PMAIP1;OAZ2;FZD5;BCL2;UBR5;KCNB1;CEP290;ZDHHC2;SAE1;TP53;FBXW7;MIEF2;MIEF1;BAG3;SREBF2;PRKCD;KIF20B;PDCD10;HPS4;TRIM28;GAS6;MTCL1;ZFAND1;YWHAH;ATG13;LEPROT;SLC51B
prerank,regulation of T cell chemotaxis (GO:0010819),-0.4046527474056607,-0.9533357208182504,0.5384615384615384,0.8854318543341274,1.0,3/11,5.71%,WNK1;WNT5A;ADAM10
prerank,autonomic nervous system development (GO:0048483),-0.35467017562476016,-0.9531512272884491,0.4765625,0.8848771859268227,1.0,5/17,12.08%,NF1;FN1;NRP1;SEMA3A;SOX4
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.3005180561869307,-0.9530219773570651,0.5182072829131653,0.8831338288836061,1.0,9/29,30.57%,ACSF2;ACOT8;DBI;ACOT9;ACLY;CROT;ACOT7;ACOT11;OXSM
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.3005180561869307,-0.9530219773570651,0.5182072829131653,0.8831338288836061,1.0,9/29,30.57%,ACSF2;ACOT8;DBI;ACOT9;ACLY;CROT;ACOT7;ACOT11;OXSM
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.246212836074007,-0.9530059738039761,0.5668449197860963,0.8821377889486547,1.0,24/73,21.37%,ROBO1;SMAD3;XDH;F3;NOD1;COL4A3;SENP1;ACER2;TNFSF10;DAP;CASP8;EGLN3;SNCA;CASP9;PPARG;APAF1;BAX;HSPE1;CRADD;AIFM1;CASP4;BID;MTCH1;HSPD1
prerank,regulation of trophoblast cell migration (GO:1901163),-0.3683233626714683,-0.9530039619096645,0.5216284987277354,0.8811025828695359,1.0,5/14,19.47%,GJA1;SMURF2;ARHGDIB;CALR;YTHDF3
prerank,response to reactive oxygen species (GO:0000302),0.36385613313653287,0.9521707142016588,0.5115979381443299,1.0,1.0,12/54,14.35%,TPM1;CAMKK2;MAPT;STK26;GSTP1;HIF1A;STK24;TXNRD2;PDCD10;PDK2;MAPK1;HYAL1
prerank,proteasomal protein catabolic process (GO:0010498),-0.2089263486813914,-0.9518022128011475,0.65,0.8831736513108579,1.0,70/201,25.76%,NEDD4L;ARRB1;ATXN3;AREL1;ITCH;CUL3;SEL1L;RNF185;UBE2D3;DNAJB12;PML;DERL1;CTNNB1;BIRC2;PCBP2;PSMD7;PSMD9;PSMD13;MDM2;PELI1;TOPORS;RBCK1;WWP1;ARMC8;SMURF2;PRKN;KCTD2;RMND5B;DDB1;UBE4B;PSMB3;KLHL22;RNF34;STUB1;RMND5A;SKP2;RCN3;PSMC5;SIAH1;PSMA5;PSMA1;PSMC2;HECW1;NHLRC3;UBXN1;SIAH2;SYVN1;FBXW5;SPOPL;SPSB4;RNF41;BTRC;ZFAND2A;SHARPIN;KCTD17;PSME3;PSMC4;PRPF19;CCDC47;IFI27;UBE2B;PSMB6;FBXL19;RAD23B;TBL1XR1;SIAH3;UCHL1;PSMB10;HECTD3;SPSB1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.469564060574869,0.9517029311568338,0.5027223230490018,1.0,1.0,1/10,5.12%,SAG
prerank,response to glucose (GO:0009749),-0.2712101748573676,-0.9516667205408254,0.5534351145038168,0.8825040633713551,1.0,9/46,12.74%,ZBTB20;UNC13B;TCF7L2;TRA2B;EIF2B3;ERN1;SOX4;ZBED3;PCK2
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.4515764455106426,0.9514872958026538,0.5222602739726028,1.0,1.0,5/14,14.06%,TBC1D20;SEC31B;SEC13;SEC24A;SEC24C
prerank,detection of visible light (GO:0009584),-0.35304542686296075,-0.9514447334395557,0.5343137254901961,0.8821145423297748,1.0,7/16,41.40%,ABCA4;CEP250;RP1;CACNA2D4;TULP1;CNGB1;GNA11
prerank,selective autophagy (GO:0061912),-0.26177818731263663,-0.9511509946573763,0.5358649789029536,0.8818168206717116,1.0,23/56,22.15%,RB1CC1;DYNC1I1;DYNC1LI2;UBQLN1;RETREG1;TEX264;IFT88;PEX5;ATG5;PRKN;ATG2B;AMBRA1;UBC;ACBD5;ATG2A;LGALS8;KLHL3;ATM;PARK7;PCNT;DYNLL2;WDR81;UBB
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.29844015984470995,-0.9507708182371187,0.5283687943262412,0.8817783859057078,1.0,5/34,8.32%,WNT5A;RBP4;SLC7A5;STX4;PTPN22
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.42002194895668,-0.9504300927671739,0.5488888888888889,0.8816026527822682,1.0,3/10,5.71%,WNK1;WNT5A;ADAM10
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.3270655240807855,-0.9504237888947551,0.5273224043715847,0.88059161121425,1.0,8/20,28.97%,WNT4;PRMT3;SIK1;WDTC1;CEACAM1;ABCA2;ASXL3;ACADVL
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.378286841036772,-0.9502806010878855,0.5096153846153846,0.8799612318043865,1.0,2/12,1.71%,FOXP1;HMGB1
prerank,positive regulation of myelination (GO:0031643),0.46594828313921344,0.9498432959498654,0.5414364640883977,1.0,1.0,2/11,7.81%,TPPP;DICER1
prerank,positive regulation of cell projection organization (GO:0031346),0.32593548472482137,0.9493488164094656,0.5509049773755657,1.0,1.0,9/115,3.34%,RAP1A;NTRK3;SERPINI1;PLA2G3;PLXND1;ROR1;SS18L2;PLXNB1;FZD4
prerank,regulation of protein dephosphorylation (GO:0035304),0.38052561367672344,0.9491802247127732,0.5325936199722607,1.0,1.0,8/37,12.78%,DLC1;MFHAS1;PPP2R5A;PIN1;CALM1;ENSA;PRKCD;ARPP19
prerank,DNA packaging (GO:0006323),0.43253723143487954,0.9491752989708171,0.5042881646655232,1.0,1.0,4/16,10.54%,H1-0;CHAF1B;TP53;HAT1
prerank,synaptic vesicle transport (GO:0048489),0.45835624955910015,0.948971728371938,0.5257142857142857,1.0,1.0,6/11,21.95%,KIF5B;KIF5C;KIF5A;DNM2;SNAPIN;SYNJ1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.38232965543839875,-0.948638213529783,0.5381165919282511,0.8831110010759307,1.0,5/12,26.58%,WNK1;AKT1;MIA3;ASS1;SKAP1
prerank,mitochondrial genome maintenance (GO:0000002),0.4685979152914629,0.9484409535359662,0.5462633451957295,1.0,1.0,4/11,9.01%,MEF2A;PARP1;OPA1;LONP1
prerank,regulation of fibroblast proliferation (GO:0048145),0.37193384117396117,0.9483951058683443,0.5140939597315436,1.0,1.0,11/45,10.74%,PDGFB;PDGFC;CDK6;PEX2;DAB2IP;TP53;CD300A;GSTP1;SKI;S100A6;PDGFA
prerank,placenta development (GO:0001890),-0.3876375435805263,-0.9482922326012144,0.551980198019802,0.8829386391071707,1.0,3/12,16.41%,PTK2;CUL7;PPARG
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3454914771296657,0.9482584089581101,0.5380894800483675,1.0,1.0,10/75,9.57%,AGTR1;PDGFB;SEMA5A;CDH13;NR4A1;VEGFA;ITGB3;ITGA4;ADAM17;HIF1A
prerank,regulation of neuron projection development (GO:0010975),0.32061734899643957,0.9476436867703476,0.563034188034188,1.0,1.0,19/163,9.47%,RAP1A;NTRK3;PDLIM5;CAMK2G;SERPINI1;PLA2G3;ROR1;KANK1;CHN1;MARK1;PTPRS;ITM2C;KIF1A;DAB2IP;NCS1;CDH2;BRSK1;PAK2;ADCY6
prerank,pulmonary valve morphogenesis (GO:0003184),0.42186779886699605,0.9474666548764162,0.47854785478547857,1.0,1.0,4/17,7.86%,HEY2;HEYL;JAG1;TGFB2
prerank,regulation of catabolic process (GO:0009894),0.4296600413986965,0.9471515388469848,0.5121163166397416,1.0,1.0,4/18,5.87%,FAM83D;ITGB1;RARRES2;ZDHHC2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.4068347463869613,-0.9470006426993068,0.5347222222222222,0.8852772221857743,1.0,2/11,7.11%,WNT5A;CTNNB1
prerank,engulfment of apoptotic cell (GO:0043652),0.43677975928439555,0.9469456154153638,0.5142857142857142,1.0,1.0,4/15,15.31%,XKR4;RHOH;ADGRB1;RHOG
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3070583811829309,0.946882852603359,0.6342685370741483,1.0,1.0,89/572,13.14%,PRDM16;MYOZ2;HJV;MEF2C;HEY2;ZFHX3;TBX2;NR1H4;PDGFB;ZEB2;EDNRB;MLIP;ID4;FST;FRK;LOXL2;ETS2;ARID5B;ZNF436;H1-0;NACC2;PRDM1;HDAC9;NR2F2;ANKRD2;NR2C1;USP2;ATXN1;OSR2;CBFB;KLF7;KCNIP3;MEF2A;PEX2;MTDH;SUV39H2;CAV1;TAF1;DAB2IP;ARID5A;TP53;VEGFA;PPM1A;PARP1;HEXIM1;SFPQ;NEDD4;AR;MED1;ZNF431;YAP1;SOX9;SNAI2;HSF4;DICER1;RELA;CUX2;LIN37;CCND1;PPARA;CBX4;IMPACT;MTA3;NR4A2;SKI;NR1D1;LRRFIP1;BAG3;SIRT2;RIF1;HNRNPU;ZNF3;NR2C2;UBE2D1;SREBF2;RUNX1;RB1;ATF3;NKX6-1;ZBTB7A;NFX1;ORC2;CITED2;CPEB3;NR6A1;FNIP2;ZFP69;MXD4;BCL6
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.4609124978066738,0.9468389458085198,0.5470085470085471,1.0,1.0,2/13,3.01%,LTBP1;GREM2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.41053287994591264,-0.9467199943872405,0.5334773218142549,0.8849594950523332,1.0,5/10,36.60%,IRAK3;MAPK7;SIGIRR;TLE5;KLF4
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.4093670874079026,-0.9467126013868048,0.5216450216450217,0.883948863873089,1.0,5/10,24.73%,NF2;PPP2CA;PARP14;PTPN2;INPP5F
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.22143887853035732,-0.9465227908656179,0.6166666666666667,0.8833720616111143,1.0,49/168,20.30%,DDX5;UPF2;PPP2CA;RPL27A;DCPS;SMG1;RC3H2;RPS19;SAMD4B;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;PABPC1;LSM1;RPLP0;RPS29;RPL28;RPS10;DCP2;RPLP1;RPS20;RPL23A;RPL34;NCBP2;PAN2;EXOSC9;RPL36A;RPS8;PAN3;RPS21;CNOT11;TUT4;RPL9;SMG6;ATM;ZC3H12A;RPS7;RPL27;TUT7;RPL11;PNRC2;NBDY;RPL18A;RPL37A;RPL38
prerank,lytic vacuole organization (GO:0080171),0.3854061424575717,0.9464387221513249,0.533724340175953,1.0,1.0,9/32,14.40%,CLN5;HOOK2;ACP3;CLVS1;HOOK1;MBTPS1;AKTIP;HPS4;LRRK2
prerank,RNA modification (GO:0009451),0.35826629929641823,0.9463534859797363,0.5258278145695364,1.0,1.0,7/54,5.49%,WDR4;TRDMT1;NAT10;PARN;CDKAL1;TYW5;FTSJ1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4528307550834013,0.946303706501744,0.5244755244755245,1.0,1.0,4/13,8.61%,PDGFB;SOX9;RELA;PPARA
prerank,positive regulation of protein maturation (GO:1903319),0.46332364896221184,0.9461740821711339,0.5236363636363637,1.0,1.0,1/11,1.92%,ANGPTL8
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.2966069594369265,-0.9460030441823823,0.558641975308642,0.8836218700708282,1.0,5/30,5.55%,NIBAN2;DACH1;ACVRL1;STN1;BMPR2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3006948039283075,-0.9458616162194889,0.5275862068965518,0.8829449229725619,1.0,11/29,22.65%,IFNAR2;PTPN11;WNT5A;HSP90AB1;METTL3;SAMHD1;STAT2;NLRC5;YTHDF3;PTPN2;RNASEL
prerank,positive regulation of transmembrane transport (GO:0034764),0.4479479035328892,0.9455483355111872,0.5291095890410958,1.0,1.0,4/13,15.64%,ANO6;ACSL5;CLIP3;AZIN2
prerank,alanine transport (GO:0032328),0.46272096901835374,0.9455406638960022,0.5261121856866537,1.0,1.0,1/10,2.28%,SLC6A17
prerank,regulation of protein localization (GO:0032880),-0.256411312748096,-0.945272538775662,0.5752212389380531,0.8833967619033385,1.0,25/58,29.68%,AFDN;DLG1;AAK1;RABGAP1L;HSP90AB1;CAMK1;FKBP1A;TRIM25;RSL1D1;TRIM5;TRIM14;PPM1F;TMEM231;KDM1A;RAB9A;STX6;TRIM21;TRIM17;MAPK8;ADCYAP1;WDPCP;RACK1;TESK1;CTSD;TRIM46
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3781914015682769,0.9449337441643528,0.5328671328671328,1.0,1.0,7/38,12.48%,ATP2B4;CD36;PTGIS;CAV1;GLA;ROCK2;CLU
prerank,icosanoid metabolic process (GO:0006690),0.3673717800418827,0.9448931932745754,0.5340599455040872,1.0,1.0,12/40,19.50%,PTGIS;ALOX5;TBXAS1;MAPKAPK2;MGLL;PTGR1;PLA2G4A;PLA2G4C;EPHX1;PON2;FAAH;ABCC10
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.2908957254749851,-0.944829263205922,0.5379061371841155,0.8835223828521671,1.0,12/33,18.87%,PTPN11;PTK2;ACER2;FOXC2;CYP1B1;PDE3B;LYN;EPHA8;DPP4;SERPINE1;NCKAP1L;ITGB1BP1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.3123062118138183,-0.9446357030664868,0.5440251572327044,0.883014346615504,1.0,9/28,20.06%,PRKDC;PARP3;SIRT7;SMCHD1;DTX3L;WRAP53;KDM4D;HSF1;HMGA2
prerank,"phagocytosis, engulfment (GO:0006911)",0.38118382077900786,0.9443998689468712,0.5347222222222222,1.0,1.0,8/36,15.31%,CD36;MYH9;XKR4;ARHGAP12;DOCK1;RHOH;ADGRB1;RHOG
prerank,regulation of mitochondrion organization (GO:0010821),0.36201049692560316,0.9443883854377694,0.5264550264550265,1.0,1.0,16/47,18.90%,INF2;FZD5;MAPT;FBXW7;PPARGC1A;MIEF2;VDAC1;DNM1L;SREBF2;MUL1;LRRK2;RHOT1;VPS35;USP36;MFF;HDAC6
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.34849752175330395,0.9443852064010969,0.5439024390243903,1.0,1.0,14/70,16.90%,NCF2;CD36;LNPEP;PSMC6;ITGB5;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;MFSD6;PSMA2;PSMD14
prerank,muscle cell migration (GO:0014812),0.46755615295887043,0.9443820363011384,0.5138121546961326,1.0,1.0,2/10,7.48%,ROCK1;ITGB3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.34092636375333624,0.9443169448597113,0.5563725490196079,1.0,1.0,9/75,7.86%,COL4A2;ATP2B4;ROCK1;ANGPT4;ALOX5;EMILIN1;DAB2IP;YJEFN3;TGFB2
prerank,melanocyte differentiation (GO:0030318),0.47374136589628246,0.944237953087839,0.5409836065573771,1.0,1.0,3/11,11.82%,MEF2C;MREG;USP13
prerank,regulation of neuroblast proliferation (GO:1902692),-0.3631394567397727,-0.9441835892700645,0.5417721518987342,0.8831252483927897,1.0,8/15,21.44%,PTN;NF1;CTNNB1;TAFA1;CX3CL1;KDM1A;DISC1;DRD2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.4156252993890488,0.9441590886011448,0.5267295597484277,0.9996404623365943,1.0,4/21,3.64%,CSPG4;CHSY3;CSGALNACT1;BGN
prerank,regulation of ruffle assembly (GO:1900027),-0.3250976341866705,-0.9440615806918236,0.5342857142857143,0.8823906410178218,1.0,8/23,16.15%,EPS8;NLGN1;RDX;PLEKHM1;PFN2;PFN1;EPS8L2;EVL
prerank,regulation of cell morphogenesis (GO:0022604),0.3902115374016096,0.9435530043977954,0.5374449339207048,1.0,1.0,2/30,2.33%,WTIP;FERMT2
prerank,protein O-linked mannosylation (GO:0035269),-0.35070905188700374,-0.9423991009520601,0.5614457831325301,0.8856754956616425,1.0,4/18,7.12%,TMTC1;TMTC2;RXYLT1;TMTC4
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.40218203099816746,-0.9420985488676159,0.532293986636971,0.8854300167221807,1.0,5/10,14.45%,NEDD4L;PRKCE;COMMD1;OSR1;HECW1
prerank,mRNA catabolic process (GO:0006402),-0.2755600906836032,-0.9418833027156779,0.5676691729323309,0.884961726314376,1.0,20/44,29.77%,AGO3;DDX5;METTL3;ERN1;DCP2;EXOSC9;TUT4;PNPT1;TUT7;NBDY;METTL16;LSM2;LSM5;CNOT10;NUDT12;AGO4;ZFP36;LSM6;PDE12;THRAP3
prerank,negative regulation of apoptotic process (GO:0043066),0.3048560893216925,0.9415393150465832,0.6395582329317269,1.0,1.0,51/444,9.79%,NTF3;FLNA;MEF2C;NAA38;ANGPT1;NR1H4;MERTK;ANGPT4;MYD88;TCIM;PLA2G3;PDK4;CCND2;CRLF1;ANXA1;IL2;TGFB3;ITGB1;NUP62;ARHGAP10;SET;ATAD3A;FXN;BCL2;MYO18A;MTDH;CAV1;TP53;VEGFA;GDNF;SFPQ;PA2G4;PPARGC1A;MED1;BCL2L2;YAP1;FZD9;NAT8;OPA1;SOX9;SNAI2;RELA;API5;CBX4;VDAC1;TNFAIP8;GSTP1;NR4A2;PAK2;BAG3;AXL
prerank,negative regulation of transport (GO:0051051),0.3629922901251228,0.9414828603529455,0.517555266579974,1.0,1.0,6/51,7.48%,FER1L5;DYSF;PACSIN3;PIP4P2;ARL6IP5;ITGB3
prerank,positive regulation of macroautophagy (GO:0016239),-0.26080262050053926,-0.9414041536114433,0.5670995670995671,0.885239126355762,1.0,16/48,24.90%,DCN;PAFAH1B2;SPTLC2;PIP4K2B;GPSM1;OPTN;IKBKG;RAB3GAP2;IRGM;KDR;RALB;BNIP3L;UVRAG;SMCR8;LRSAM1;SESN2
prerank,regulation of dephosphorylation (GO:0035303),-0.3559415549058406,-0.9411973526098536,0.5417789757412399,0.8847399003679537,1.0,6/15,34.73%,MTMR4;IGBP1;SMG6;MTMR2;SRC;MTMR1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.31168720829711105,-0.9410276183863221,0.5496894409937888,0.8842002399471165,1.0,5/27,4.91%,LRP1;PLTP;APOE;PTCH1;NFKBIA
prerank,negative regulation of cellular protein localization (GO:1903828),-0.2950595767419669,-0.9409943298159475,0.5358361774744027,0.8832854094830825,1.0,7/34,8.79%,NEDD4L;ANKRD13A;OTUD7B;ILRUN;LATS2;COMMD1;RIPOR2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3096172973865703,-0.9398584916688041,0.5379939209726444,0.8851583164948936,1.0,7/26,15.91%,DAB2;FOXP1;CRY1;VPS18;PER1;CALR;CRY2
prerank,copper ion homeostasis (GO:0055070),-0.34772784225793996,-0.9398361655123746,0.5531914893617021,0.8842124004571196,1.0,5/17,22.59%,APP;COMMD1;ATOX1;MT2A;SLC31A1
prerank,cellular response to peptide (GO:1901653),0.35012053401913995,0.9397148767395488,0.538659793814433,1.0,1.0,8/56,8.26%,CACNA2D1;CD36;VIM;ARHGEF2;CAV1;CHMP5;TP53;ITGA4
prerank,nucleoside catabolic process (GO:0009164),-0.4011495554696475,-0.9396557116828309,0.5510204081632653,0.8836330675213174,1.0,6/11,29.44%,NT5E;UPP2;UPB1;DPYD;DERA;NT5C1A
prerank,eye photoreceptor cell development (GO:0042462),0.4261181178306531,0.9395404962341943,0.5146299483648882,1.0,1.0,3/15,6.50%,CEP290;RPGRIP1L;VEGFA
prerank,proteasome assembly (GO:0043248),0.4620585545845757,0.9394993211193959,0.5495652173913044,1.0,1.0,3/11,10.53%,ADRM1;OTUD6B;PSMD5
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.37115067177467437,-0.9393314364917755,0.5405405405405406,0.8835017446626215,1.0,5/14,16.89%,IGF1;LDLR;CX3CL1;SYT11;GRN
prerank,phospholipid dephosphorylation (GO:0046839),0.38006177306442507,0.9392941502711398,0.5459459459459459,1.0,1.0,9/37,15.34%,MTMR7;PIP4P2;SYNJ2;SACM1L;PLPPR1;INPP5B;TPTE;INPP5J;PTEN
prerank,regulation of JNK cascade (GO:0046328),-0.2320603075261019,-0.9389681209592777,0.584,0.8834679489372642,1.0,31/101,24.18%,TGFBR3;MECOM;SH3RF1;HMGB1;APP;ITCH;EGFR;PTK2B;MBIP;SEMA3A;RASSF2;SDCBP;SH3RF3;PRKN;MAPK8IP3;SIRPA;SH3RF2;TAOK1;PER1;AIDA;MTURN;TIRAP;GADD45B;DACT1;TAOK2;FLT4;MAP3K11;AXIN1;WNT16;MAPK8IP1;CYLD
prerank,cyclooxygenase pathway (GO:0019371),0.4596786423108296,0.9385985608018559,0.5427046263345195,1.0,1.0,3/10,8.49%,PTGIS;TBXAS1;CBR1
prerank,positive regulation of developmental growth (GO:0048639),-0.2722693840247134,-0.9385918199149309,0.55893536121673,0.8834089517369901,1.0,7/49,7.79%,NEDD4L;GHR;SEMA7A;RUFY3;GOLGA4;SYT1;SEMA4D
prerank,proteolysis (GO:0006508),0.3090265013189945,0.9382311321548444,0.6138002059732235,1.0,1.0,34/252,14.95%,TMPRSS4;TINAGL1;MMP17;PAPPA2;PGPEP1L;HTRA1;LNPEP;RNPEP;APEH;AFG3L2;TRABD2B;CPA4;CPA3;ENPEP;ADAM17;LONP1;CAPN2;MIPEP;FBXO6;MBTPS1;ATG4D;LONP2;PHEX;RSPRY1;UBA3;DDI2;ATG4A;DPP8;SENP6;HM13;SPPL2B;ADAM19;PCSK4;CTSA
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.3058737607126053,-0.9377163466662612,0.5459610027855153,0.8845487659163207,1.0,13/25,29.00%,EPHA4;PML;HSP90AB1;SGTA;OPHN1;GABARAPL2;RPS7;RPL11;TRIM39;CSNK2A2;CSNK2A1;HFE;PSMF1
prerank,respiratory tube development (GO:0030323),0.39239345260093383,0.9370915062243635,0.5520833333333334,1.0,1.0,5/28,7.58%,FGF1;ITGA3;VEGFA;ABCA3;HECA
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.34140027489737756,-0.9370360266262713,0.55,0.8852280524555642,1.0,7/18,15.32%,DCN;MCU;PRKN;DDHD1;RALBP1;KDR;FIS1
prerank,female gamete generation (GO:0007292),-0.29676313416592304,-0.937008414835616,0.5743243243243243,0.8842987958610715,1.0,2/29,1.34%,PTN;MARF1
prerank,regulation of MAP kinase activity (GO:0043405),0.33016857892377544,0.9369678210905963,0.5547785547785548,1.0,1.0,21/92,14.41%,FGF1;MST1R;PDGFB;PDGFC;PDGFD;KSR1;DAB2IP;VEGFA;PTPN1;RASGRP1;CD300A;GSTP1;PDGFRB;PDGFA;PRKCD;HTR2B;CDK12;TSG101;PDCD10;LRRK2;DIRAS2
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.3952700156044483,-0.936777041509179,0.5671981776765376,0.8838497479859087,1.0,5/11,27.47%,PPHLN1;SETDB1;MPHOSPH8;RESF1;SETDB2
prerank,histone acetylation (GO:0016573),-0.2529606902096071,-0.9357375675469753,0.5355191256830601,0.8853279082414824,1.0,18/69,18.19%,LEF1;PHF20;MBIP;TADA2A;YEATS2;TADA1;ATF2;NAA50;DR1;BRPF1;EP300;PER1;NAA60;TAF12;MORF4L2;MEAF6;TRIM16;TAF6L
prerank,regulation of sensory perception of pain (GO:0051930),0.4642568631251983,0.935728417389358,0.5352112676056338,1.0,1.0,3/11,11.92%,ACP3;MGLL;ATPSCKMT
prerank,defense response to Gram-positive bacterium (GO:0050830),0.36902895327592106,0.9355495862934619,0.5398351648351648,1.0,1.0,10/40,16.53%,MYD88;DMBT1;RARRES2;MBL2;ADAM17;GBP2;DROSHA;RNASE3;MR1;MPEG1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3577268159435402,0.9352746439112317,0.5307692307692308,1.0,1.0,14/52,18.33%,PMAIP1;FZD5;BCL2;SAE1;TP53;FBXW7;SREBF2;HPS4;YWHAH;ATG13;LEPROT;USP36;BBC3;TOMM7
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.40191878950287263,0.9349895468024918,0.5354449472096531,1.0,1.0,2/24,2.51%,ANGPT1;SEMA5A
prerank,carbohydrate derivative transport (GO:1901264),-0.34778049944299333,-0.9340841805700382,0.5406091370558376,0.8884704256127638,1.0,6/18,22.48%,PLTP;LBP;SLC10A7;CLN3;SLC15A4;MFSD2A
prerank,regulation of peptidase activity (GO:0052547),-0.33520183469828646,-0.9340732884669647,0.5392953929539296,0.8874941821247204,1.0,4/19,12.24%,NRDC;CTSH;FURIN;RCN3
prerank,endothelial cell proliferation (GO:0001935),0.42582479921281613,0.9339977535453629,0.5478119935170178,1.0,1.0,3/17,2.95%,ANGPT4;SEMA5A;LOXL2
prerank,positive regulation of innate immune response (GO:0045089),-0.3032548335959804,-0.9337725199121998,0.5415384615384615,0.8872729854509736,1.0,17/30,37.03%,LBP;WNT5A;RPS19;POLR3F;RIOK3;POLR3B;NLRC5;SLC15A4;GBP5;POLR3C;POLR3D;NMI;TRIM6;SPI1;PLSCR1;ADAM8;ZBP1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.4003582848000075,-0.933428743741888,0.5388127853881278,0.887135255865947,1.0,3/10,15.23%,ENPP2;PLA2G6;PLA2G7
prerank,cellular response to interferon-beta (GO:0035458),-0.3631686966254636,-0.9334085720725355,0.5533333333333333,0.8861940341202921,1.0,9/14,40.52%,IRGM;PNPT1;IFITM2;HTRA2;CDC34;NDUFA13;TRIM6;IRF1;AIM2
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.3892736558540822,-0.9332683130579873,0.572938689217759,0.8855571517002591,1.0,3/11,7.48%,MECOM;WNT5A;CD34
prerank,regulation of actomyosin structure organization (GO:0110020),0.445020353225633,0.9332239701191651,0.5481611208406305,1.0,1.0,2/13,3.59%,ROCK1;ACTG1
prerank,regulation of DNA replication (GO:0006275),-0.26677858744029426,-0.9329012725875544,0.576,0.8854559235963786,1.0,14/49,16.10%,ATR;GLI2;EGFR;ACVRL1;PPP2CA;STN1;PDS5A;ORC5;BLM;CTC1;TSPYL2;ANKRD17;OBI1;USP37
prerank,DNA recombination (GO:0006310),-0.2786422857855461,-0.9325992507560297,0.5845588235294118,0.8851792264093382,1.0,17/37,37.92%,HMGB1;MRE11;RAD50;FBH1;BLM;RAD51C;IGHMBP2;ERCC1;TSN;XRCC2;RAD54L;RPAIN;RAD51;LIG4;RPA1;HDAC10;GEN1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3289978112211161,0.9324801197809894,0.5833333333333334,1.0,1.0,19/101,13.37%,AGTR1;VIM;ASPH;SAMD4A;NAT10;ATG7;RPS27L;CIRBP;PYM1;AMER1;RPL5;IST1;EIF3E;RBM3;ZCCHC4;FBXW11;CPEB3;PERP;PLXNB2
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.43441187153087923,0.9321309088100185,0.5196078431372549,1.0,1.0,5/15,12.51%,BTG2;POLR2G;TENT4A;CNOT7;CPEB3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.3693526782149589,-0.9317949975467571,0.5406593406593406,0.8842077666268914,1.0,6/12,29.25%,CUL3;CDC23;ANAPC4;NSMCE2;CDC16;CDC27
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.3693526782149589,-0.9317949975467571,0.5406593406593406,0.8842077666268914,1.0,6/12,29.25%,CUL3;CDC23;ANAPC4;NSMCE2;CDC16;CDC27
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.3693526782149589,-0.9317949975467571,0.5406593406593406,0.8842077666268914,1.0,6/12,29.25%,CUL3;CDC23;ANAPC4;NSMCE2;CDC16;CDC27
prerank,mitochondrion organization (GO:0007005),0.3109179005457218,0.9314807473223167,0.5867237687366167,1.0,1.0,54/165,21.24%,ATP2A1;HSD17B10;GABPA;HK2;SIRT3;ATAD3A;NDUFS1;COX7A2L;MEF2A;AFG3L2;TERT;PARP1;PPARGC1A;OPA1;MTX1;MIEF2;MIEF1;TRAK1;ATCAY;LONP1;DNM1L;TFB2M;MFN2;ESRRA;MUL1;SIRT4;ADCK1;USP30;LRRK2;CAV2;DNM2;RHOT1;MGME1;TOMM5;ATP23;RAB38;BCAP31;MFF;TOMM7;ATP5F1D;GABPB1;AGTPBP1;VPS13C;PPRC1;HIGD2A;MTX3;PHB2;MFN1;SLC25A33;CLUH;BIK;TIMM9;TIMM22;OXA1L
prerank,serine family amino acid biosynthetic process (GO:0009070),0.4469468332571463,0.9314758220494822,0.5474452554744526,1.0,1.0,2/12,4.95%,SEPHS2;SEPHS1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4248755690791151,0.9310790316059695,0.5642737896494157,1.0,1.0,2/16,7.78%,LYST;KIF5B
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.27608315850304294,-0.9309615278152662,0.5535714285714286,0.885249461778225,1.0,13/43,20.41%,IGF1;LBP;LGALS9;ILRUN;CD34;PTPN22;IRAK3;SIRPA;CX3CL1;SYT11;RARA;ZC3H12A;CD274
prerank,membrane repolarization during action potential (GO:0086011),0.44640875243349576,0.9309505249100891,0.567062818336163,1.0,1.0,2/13,5.82%,KCNE4;ATP1B1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.4530373487209462,0.930888932491918,0.5309090909090909,1.0,1.0,3/12,12.38%,ROCK1;ROCK2;CHRNA7
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.41977709558545767,0.930383606500644,0.548489666136725,1.0,1.0,3/19,5.63%,NR1H4;CD14;PIK3AP1
prerank,in utero embryonic development (GO:0001701),-0.30718198168592886,-0.9302770931154584,0.5835866261398176,0.8858872506163638,1.0,7/25,11.77%,CHD7;ARNT2;ADAM10;FUT8;IGF2;FGFR2;TGFBR1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.45355416854967096,0.9302510520328768,0.5237226277372263,1.0,1.0,2/11,5.51%,CCL5;PRKCQ
prerank,peptidyl-serine phosphorylation (GO:0018105),0.31789369614058405,0.9298111740851426,0.5915032679738562,1.0,1.0,38/153,17.52%,STK38L;ROCK1;MAST4;DYRK2;PDGFB;CAMK2D;MARK1;DYRK1A;PRKCQ;TAF1;RPS6KA2;MAPKAPK2;DYRK1B;MAP3K10;BRSK1;PKN2;PAK2;ROCK2;PRKCD;RICTOR;DMPK;MAST1;GAS6;CSNK1E;SGK1;MAPK1;LRRK2;PRKCA;PRKACA;SRPK2;MAPK12;CSNK1A1;HIPK2;MAST3;MAP3K13;EIF2AK3;MARK2;MASTL
prerank,regulation of organelle assembly (GO:1902115),-0.23876653282053623,-0.929445066713939,0.6329787234042553,0.8870068377031799,1.0,30/72,25.61%,TBC1D16;RAB5A;TBC1D15;DCDC2;NPRL3;ATG3;TBC1D2B;TBC1D13;TBC1D5;RDX;TBC1D8;IFT88;ATG5;TBC1D9B;RABEP2;TBC1D24;TBC1D22A;PLK2;UBQLN2;SGSM3;DYNLT2B;RAB1B;TBC1D10A;SDCCAG8;KIF9;TBC1D14;CYLD;TBC1D2;CEP76;CDKL1
prerank,cholesterol efflux (GO:0033344),-0.32725131262741247,-0.929387955213227,0.5549597855227882,0.8861724329645878,1.0,2/20,2.40%,APOE;ABCA1
prerank,cellular response to alcohol (GO:0097306),-0.2675790235097551,-0.9293670484745236,0.5481481481481482,0.8852385032715041,1.0,14/42,18.13%,PTCH1;GRAMD1C;CDH1;ADCY7;CTNNB1;ADAM15;ADCY1;GOLPH3;AHR;GLRA2;BLM;GRAMD1A;ADCY3;PTGFR
prerank,bile acid metabolic process (GO:0008206),0.39170572250966024,0.9292873413877201,0.547112462006079,1.0,1.0,5/27,11.78%,HSD17B10;CYP7B1;HSD17B4;SCP2;OSBPL2
prerank,negative regulation of RNA splicing (GO:0033119),-0.3397093542739355,-0.9291855959690095,0.5498721227621484,0.8847012684046875,1.0,10/19,26.26%,PTBP3;SRSF7;SRSF6;RPS13;SFSWAP;RBMX;PCBP4;TMBIM6;RNPS1;SRSF12
prerank,negative regulation of viral release from host cell (GO:1902187),-0.37062308739658917,-0.9285113074066091,0.5665137614678899,0.8853983911622897,1.0,6/13,31.21%,PML;TRIM5;MID2;TRIM21;TRIM32;TRIM13
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.36041459487776933,0.9284953399002581,0.5463917525773195,1.0,1.0,9/51,12.19%,RBPMS2;CRIM1;GREM2;ACVR2A;BMPR1A;SKI;VWC2L;UBE2D1;BMPR1B
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4042558898961233,0.9280882925565654,0.5401234567901234,1.0,1.0,4/23,15.00%,PLA2G3;LPCAT3;PLA2G4A;PLA2G4C
prerank,synaptic membrane adhesion (GO:0099560),0.43176461130221694,0.9280093385382666,0.5493421052631579,1.0,1.0,3/14,6.09%,PTPRS;GPC4;PTPRF
prerank,cellular response to ionizing radiation (GO:0071479),0.36126405513963555,0.9279437914381227,0.5608108108108109,1.0,1.0,6/47,7.61%,MAP3K20;NET1;RAD51AP1;TP53;YAP1;RAD9A
prerank,protein hydroxylation (GO:0018126),0.42943574304417675,0.9275869712931606,0.5504424778761062,1.0,1.0,2/15,2.85%,P3H2;ASPH
prerank,regulation of collagen biosynthetic process (GO:0032965),0.41439325022156104,0.9273599522268033,0.5460218408736349,1.0,1.0,5/19,11.12%,VIM;TGFB3;EMILIN1;SUCO;RUNX1
prerank,Golgi to endosome transport (GO:0006895),-0.3559039877586727,-0.9267105788169236,0.5593667546174143,0.8887493178500425,1.0,4/16,10.59%,VPS13A;MON2;GBF1;EPS15
prerank,AMP metabolic process (GO:0046033),0.4362435251143469,0.9262580722480065,0.5350877192982456,1.0,1.0,4/13,12.88%,AMPD1;AMPD2;NUDT2;ADSS1
prerank,positive regulation of histone modification (GO:0031058),-0.29153204796237003,-0.9261890607158577,0.5670103092783505,0.8890691212917287,1.0,16/33,35.76%,ARRB1;TADA2A;AKAP8;AKAP8L;SART3;CHTOP;KDM1A;FMR1;RPS6KA4;ZBTB7B;TADA2B;RUVBL2;SAP30BP;APLNR;PAF1;BRCA1
prerank,vitamin transport (GO:0051180),-0.2887317777944276,-0.926142273944847,0.5775862068965517,0.8882159767938914,1.0,5/29,9.84%,ABCG2;PDPN;SLC25A32;SLC52A1;SLC35F3
prerank,regulation of response to external stimulus (GO:0032101),0.31938033201548144,0.9259852886180225,0.5663322185061316,1.0,1.0,17/121,9.93%,AGTR1;CD36;MYD88;ANXA1;ALOX5;ELMOD2;SAG;SETD6;PIK3AP1;CAV1;CALM1;TRAF3;CELF1;RELA;MGLL;AKNA;STK24
prerank,double-strand break repair (GO:0006302),-0.20746616212856092,-0.9257994109658707,0.7051282051282052,0.8880980059367676,1.0,55/158,28.16%,EYA1;HMGB1;KDM2A;PRKDC;XRCC5;TDP2;MRE11;RAD50;PARP3;ACTR8;FBH1;HERC2;ERCC5;XRCC1;FAN1;SAMHD1;BRCC3;SETX;LIG3;MDC1;POLM;BLM;XRCC6;DTX3L;NBN;RMI1;SMC5;UBXN1;MMS22L;ZSWIM7;HUS1;POLN;KDM4D;CHEK2;ATM;DCLRE1A;IFFO1;ACTR5;NSMCE2;PRPF19;ZFYVE26;SMARCAL1;NSMCE1;NUCKS1;RAD51C;ERCC1;ERCC4;AP5Z1;DCLRE1B;MAPK8;HMGB2;RPA3;DNA2;CYREN;XRCC2
prerank,positive regulation of ERAD pathway (GO:1904294),-0.3668288161445966,-0.9251662286615511,0.6020671834625323,0.8886354163238235,1.0,7/13,19.17%,ATXN3;RNF185;UBQLN1;SGTA;UBQLN2;HERPUD1;RNFT1
prerank,tRNA 5'-leader removal (GO:0001682),-0.36166103175874076,-0.9245719850941834,0.5742092457420924,0.8891407339366791,1.0,7/13,43.55%,SSB;POP1;POP4;RPP38;RPP21;RPP25L;POP7
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.3836957097009457,-0.9242762531694694,0.54421768707483,0.888889599524056,1.0,6/11,37.29%,STX4;CAMK4;TYROBP;ITGB2;SPI1;ITGAM
prerank,positive regulation of transferase activity (GO:0051347),0.3174222678731211,0.9241755193520451,0.6004366812227074,1.0,1.0,19/142,10.07%,PARM1;NTRK3;MERTK;MST1R;ROR1;DCUN1D2;MUSK;PARN;PRKCQ;FBXW7;PKIB;PIN1;CD200;CHTF18;DCUN1D1;NAF1;EPHA2;AXL;PDGFRB
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.320822042479522,-0.9240502345775743,0.581267217630854,0.8884449198171365,1.0,8/21,24.28%,RAB11A;VPS4B;RCC2;CDC25B;CDC25A;MECP2;CDC7;RAD51C
prerank,UV-damage excision repair (GO:0070914),-0.3830331671196707,-0.9238776234800709,0.5474613686534217,0.8879061949669688,1.0,7/12,41.61%,DDB1;XPA;ACTR5;ERCC1;POLD3;XPC;POLA1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.41057398027018144,0.9235884667277385,0.5486862442040186,1.0,1.0,5/20,9.57%,CHD6;VEGFA;RELA;CARF;HIF1A
prerank,ncRNA metabolic process (GO:0034660),0.37803299604683777,0.9235183612940285,0.5555555555555556,1.0,1.0,10/37,19.45%,PARN;DTD1;MAPT;DICER1;XPO5;DROSHA;DGCR8;PIWIL2;NIFK;PRKRA
prerank,regulation of dendritic spine development (GO:0060998),0.41683450671812916,0.923429199729066,0.5609756097560976,1.0,1.0,3/19,6.12%,MEF2C;PTPRS;KIF1A
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4544845527666987,0.923282255479833,0.5334448160535117,1.0,1.0,3/10,12.36%,TERT;DICER1;DROSHA
prerank,cellular response to tumor necrosis factor (GO:0071356),0.31028757646872235,0.9224220878468355,0.60828025477707,1.0,1.0,38/175,17.39%,ACTN4;LIMS1;TNFSF13B;CCL5;ARHGEF2;HAS2;TNFRSF11A;PSMC6;DAB2IP;TP53;TRAF3;RELA;ADAM17;NR1D1;PSME4;EDAR;TRAF5;PSMB1;CCL14;PSMD5;EIF5A;GPER1;TNFRSF21;ZFAND6;TNFRSF25;GBP2;PSMB2;ZFP36L1;TMSB4X;HYAL1;PSMB7;PSMD3;STAT1;JAK2;PSMA2;DHX9;PSMD14;TNFSF12
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.31325910531050105,0.9221658027820939,0.6166306695464363,1.0,1.0,21/150,10.78%,ANGPT1;FGF1;HIP1;MST1R;PDGFB;FERMT2;SEMA5A;THPO;ITGB1;GCNT2;MFHAS1;MTDH;PIK3AP1;IRS1;AREG;THEM4;AXL;PDGFRB;HBEGF;PDGFA;VAV1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.37836207292938323,0.9220596502668112,0.5787965616045845,1.0,1.0,5/31,9.52%,POLR2L;POLR2I;GTF2H4;POLR2G;CDK7
prerank,7-methylguanosine RNA capping (GO:0009452),0.37836207292938323,0.9220596502668112,0.5787965616045845,1.0,1.0,5/31,9.52%,POLR2L;POLR2I;GTF2H4;POLR2G;CDK7
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.28761786234164677,-0.9219792091835549,0.5696594427244582,0.8915562930408288,1.0,7/30,10.30%,MLLT3;FLT1;BMP4;KIT;HOXB4;ACE;TGFB1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.41790200349900064,0.9218946855394706,0.5741626794258373,1.0,1.0,6/19,11.12%,ROCK1;CBFB;SNAI2;EPHA2;ROCK2;RUNX1
prerank,actin filament polymerization (GO:0030041),-0.29546303199612256,-0.9216383952188671,0.5846645367412141,0.8914189305370365,1.0,2/29,0.74%,GAS7;COBL
prerank,zymogen activation (GO:0031638),-0.2768960586609603,-0.9214329126229478,0.6156716417910447,0.8909248025630627,1.0,6/39,7.84%,CYFIP2;PLAT;CTSL;CTSH;CASP8;FURIN
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.36830558697913496,-0.9213460024696714,0.5785714285714286,0.8901709519721119,1.0,3/13,7.95%,STX3;HSP90AB1;STX4
prerank,protein targeting to membrane (GO:0006612),-0.22779275569003668,-0.9212006528798188,0.6285714285714286,0.8895681483752521,1.0,29/83,25.23%,SEC62;ZDHHC18;PEX14;SLC25A17;ATG3;ALDH3A2;ZDHHC15;SDCBP;PEX5;SEC63;SGTA;ACBD5;ZDHHC9;ZDHHC20;ABCD3;SGTB;FIS1;SSR1;SEC61A1;SRPRA;SSR2;CHM;PXMP2;PEX13;TAOK2;CHMP4B;CHMP4A;VPS37C;ZDHHC24
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.39023705758752886,0.9206475280649802,0.5545851528384279,1.0,1.0,11/27,20.45%,PDGFB;PDGFC;CDK6;S100A6;PDGFA;GAS6;DHX9;MIF;AGT;NDUFS4;DDR2
prerank,establishment of mitotic spindle localization (GO:0040001),0.38529122886426115,0.9201885381488082,0.5763993948562783,1.0,1.0,8/28,17.51%,CLASP2;ITGB1;INSC;NSFL1C;FBXW11;CLASP1;DCTN1;UBXN2B
prerank,mitochondrial protein processing (GO:0034982),0.4516029520505377,0.919959042724867,0.5531914893617021,1.0,1.0,6/11,18.38%,AFG3L2;MIPEP;PMPCB;PMPCA;ATP23;IMMP1L
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.32313379450331836,-0.9199487921413556,0.5939226519337016,0.8916136037336247,1.0,13/20,31.70%,HOXA5;PTK2B;CTR9;MEIS2;LEO1;HSPA9;HOXB8;HOXA9;MAFB;ZFP36;CIB1;LDB1;MEIS1
prerank,regulation of osteoblast differentiation (GO:0045667),0.33112300974114256,0.9199345995716405,0.5814506539833532,1.0,1.0,14/82,9.18%,MEF2C;CRIM1;LIMD1;CCN1;CDK6;FERMT2;ACVR2A;BMPR1A;YAP1;SOX9;SNAI2;TRPM4;SUCO;SKI
prerank,zinc ion transport (GO:0006829),-0.3211659273902121,-0.9198531422083619,0.5616438356164384,0.8909022315521934,1.0,6/21,15.28%,SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC39A1;SLC39A6
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.41225061696174004,0.9196122338367174,0.5639810426540285,1.0,1.0,2/17,3.64%,ANO6;CCL5
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.39569166892883934,-0.9195397593812089,0.5788288288288288,0.8906289959129506,1.0,4/10,9.36%,WNK1;ACER2;CYP1B1;PDE3B
prerank,neutrophil degranulation (GO:0043312),0.2998704508975551,0.9195003404243788,0.6851664984863775,1.0,1.0,67/425,14.95%,TTR;STXBP2;RAP1A;DYNLL1;VCL;ROCK1;CD36;FCGR3B;CNN2;ANO6;FRK;AGL;PADI2;ACP3;UNC13D;HMOX2;ALOX5;PLEKHO2;PYGB;CRISPLD2;CD14;CEP290;BRI3;ATG7;APEH;TNFAIP6;RAP2C;RAB3A;CYFIP1;PA2G4;HEBP2;CAP1;IGF2R;GLA;PRG2;STOM;STBD1;CD300A;DDOST;RHOF;GSTP1;GCA;PPIE;IST1;PSMB1;ALDOA;DGAT1;PRKCD;YPEL5;VPS35L;TRPM2;GM2A;CPNE3;DNAJC3;DNASE1L1;CFP;STK10;MAPK1;CD53;RAB14;GDI2;CYB5R3;PSMB7;PSMD3;CPPED1;GLB1;CTSA
prerank,neuropeptide signaling pathway (GO:0007218),0.34228880511960835,0.9191149944923382,0.5891472868217055,1.0,1.0,3/58,5.49%,HCRTR1;SORT1;CYSLTR2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.39651124708681157,0.9190138923009282,0.5349922239502333,1.0,1.0,8/24,9.57%,MMRN2;EMILIN1;EPN2;DAB2IP;PTPN1;NEDD4;ITGB3;HIF1A
prerank,negative regulation of synaptic transmission (GO:0050805),-0.3117086159713513,-0.9187541979501758,0.5808383233532934,0.8915477526126465,1.0,10/23,27.32%,STXBP1;GRIK3;SLC30A1;PRRT1;SYT11;PLK2;PICK1;DRD2;MTMR2;SLC24A2
prerank,ATP transport (GO:0015867),-0.3949949864915874,-0.9184016213917497,0.5694117647058824,0.891464930450211,1.0,4/10,35.75%,SLC25A17;SLC25A24;SLC17A9;SLC25A4
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.24184181823566478,-0.9181392133670785,0.6223404255319149,0.8911348772519004,1.0,13/66,8.81%,APPL2;KMT2E;DLG1;DDX3X;CCND3;EGFR;DCUN1D3;ADAMTS1;PKD2;TFDP1;PRMT2;RDX;UBE2E2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3553825407947414,-0.9181297735326918,0.5787037037037037,0.8902009842864741,1.0,7/14,23.72%,BCL2L1;PRKN;CREB3L1;SYVN1;HERPUD1;PARK7;TMBIM6
prerank,chromatin organization (GO:0006325),0.31762652428713595,0.9180123230379015,0.6024096385542169,1.0,1.0,18/132,12.71%,PRDM16;PADI3;SMARCD3;LOXL2;PADI2;CHRAC1;ARID1A;SUV39H2;SMARCB1;HMGN3;INO80C;SOX9;MCM3AP;RB1;BAZ2A;ZBTB7A;RUVBL1;SMARCA5
prerank,cellular senescence (GO:0090398),0.38696268768580055,0.9176486702100141,0.5598802395209581,1.0,1.0,5/27,11.53%,TBX2;OPA1;MAP2K1;PRKCD;TERF2
prerank,positive regulation of lipid transport (GO:0032370),-0.37464875755291116,-0.9176132263700841,0.5838779956427015,0.8904933587286461,1.0,4/12,10.54%,LRP1;APOE;SPP1;DBI
prerank,positive regulation of kinase activity (GO:0033674),0.3195197717251454,0.9175025045570733,0.6017897091722595,1.0,1.0,14/107,10.07%,RAP1A;NTRK3;MERTK;MST1R;CCN1;ROR1;MMD;MUSK;MAPT;LCP2;EPHA2;AXL;CENPE;PDGFRB
prerank,small GTPase mediated signal transduction (GO:0007264),0.3232604824144561,0.9174666111623253,0.5838150289017341,1.0,1.0,22/103,14.16%,ABR;PLCE1;CCNA2;RASGRP2;RRAD;RERG;NTN1;KSR1;NUCB1;TP53;RRAS;RAPGEF6;RASGRP1;RIN2;ARHGAP30;ARHGAP1;RB1;USP50;BCR;ARHGAP32;TRIM28;G3BP1
prerank,regulation of nuclear division (GO:0051783),0.41157804620099225,0.9169617481017812,0.5641891891891891,1.0,1.0,6/20,15.41%,PIN1;CUL9;DAPK3;KIF20B;FBXO5;CAV2
prerank,negative regulation of gene expression (GO:0010629),0.3013441212422908,0.9167138070004848,0.6540816326530612,1.0,1.0,44/302,12.63%,CCDC3;MEF2C;ATP2B4;HEY2;PDGFB;PLA2G3;HINFP;IGFBP5;SAMD4A;MRPL13;BTG2;HDAC9;RBMS3;ASB1;HAVCR2;BMPR1A;EMILIN1;TAF1;MAPT;TERT;SLC2A10;VEGFA;FBXW7;YTHDF2;CELF1;YAP1;DICER1;TGFB2;ATP2B1;DAPK3;DIS3L2;MAP2K1;HIF1A;PTBP2;EIF2AK2;GPER1;ROCK2;RUNX1;RB1;TERF2;CNOT7;CITED2;CPEB3;PDCD10
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.31159864420012134,-0.9164754847169845,0.546242774566474,0.8922938664512072,1.0,8/23,16.29%,IGF1;ZBTB20;APP;ENTPD5;PFKFB2;ARNT;INSR;PRXL2C
prerank,negative regulation of telomere maintenance (GO:0032205),-0.3455401146689367,-0.9164421873956895,0.5721153846153846,0.8914337453526846,1.0,8/15,24.63%,TNKS2;RAD50;NBN;TERF2IP;SMG6;ATM;ERCC1;ERCC4
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.2935657805559445,-0.9164208280586454,0.5942492012779552,0.890527513266694,1.0,13/29,30.92%,RPS19;RRP36;RPS8;RPS21;TSR2;NOP9;DCAF13;UTP20;HEATR1;UTP6;MRPS11;RRS1;TBL3
prerank,purine-containing compound salvage (GO:0043101),0.44692365848127746,0.9161474584844859,0.5661764705882353,1.0,1.0,2/12,6.85%,AMPD1;AMPD2
prerank,neutrophil activation involved in immune response (GO:0002283),0.29893310506642723,0.9160990565297488,0.6912209889001009,1.0,1.0,67/428,14.95%,TTR;STXBP2;RAP1A;DYNLL1;VCL;ROCK1;CD36;FCGR3B;CNN2;ANO6;FRK;AGL;PADI2;ACP3;UNC13D;HMOX2;ALOX5;PLEKHO2;PYGB;CRISPLD2;CD14;CEP290;BRI3;ATG7;APEH;TNFAIP6;RAP2C;RAB3A;CYFIP1;PA2G4;HEBP2;CAP1;IGF2R;GLA;PRG2;STOM;STBD1;CD300A;DDOST;RHOF;GSTP1;GCA;PPIE;IST1;PSMB1;ALDOA;DGAT1;PRKCD;YPEL5;VPS35L;TRPM2;GM2A;CPNE3;DNAJC3;DNASE1L1;CFP;STK10;MAPK1;CD53;RAB14;GDI2;CYB5R3;PSMB7;PSMD3;CPPED1;GLB1;CTSA
prerank,negative regulation of response to external stimulus (GO:0032102),0.32317335961892035,0.9160658544738587,0.5917901938426454,1.0,1.0,18/105,11.28%,NR1H4;RORA;FEM1A;PTGIS;ALOX5;MFHAS1;PTPRS;TNFAIP6;DUSP3;AJAP1;LPCAT3;PPARA;NR1D1;SIRT2;AOAH;GPER1;RB1;PRKCD
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.24877586002237162,-0.9159478574032662,0.643979057591623,0.8907136548147667,1.0,19/59,16.93%,NFKBIA;BIRC2;TNFRSF1A;NKIRAS1;IKBKG;RBCK1;TAB2;RNF31;IRAK1BP1;IRAK2;UBC;CHUK;TAB1;FAIM;BIRC3;RELB;AKT1;TLR3;PRDX4
prerank,regulation of amyloid-beta formation (GO:1902003),0.37119072530041713,0.9159113615730117,0.55,1.0,1.0,9/34,12.48%,ROCK1;RTN2;PIN1;RTN1;RELA;ROCK2;ABCG1;CHRNA7;CLU
prerank,establishment of vesicle localization (GO:0051650),-0.32950349796599204,-0.9158901606964457,0.563855421686747,0.8899146505908608,1.0,6/18,14.72%,LIMK2;RAB11A;TMEM230;CCDC186;IKBKG;SYT11
prerank,protein K63-linked ubiquitination (GO:0070534),-0.2676247684440244,-0.9158826506740512,0.6294964028776978,0.8889840138379826,1.0,17/41,25.60%,ITCH;RNF135;PELI1;UBE2E2;UBE2E3;PRKN;TRIM5;STUB1;RNF115;TRIM56;UBE2S;PRPF19;UBE2B;HECTD1;TRIM21;PELI3;UBE2O
prerank,negative regulation of neuron projection development (GO:0010977),-0.25486453331476955,-0.915653717248902,0.6135265700483091,0.8885818705938312,1.0,19/56,27.09%,EFNB2;LPAR1;APOE;EPHA4;NLGN1;RUFY3;SEMA3A;DPYSL3;RTN4;RAB29;CBFA2T2;HDAC2;PRAG1;PTPRO;EFNB3;PTPN9;BAG5;THY1;DENND5A
prerank,negative regulation of angiogenesis (GO:0016525),0.325446396780518,0.9156525294191655,0.5834333733493398,1.0,1.0,10/84,7.86%,COL4A2;ATP2B4;ROCK1;ANGPT4;ALOX5;EMILIN1;EPN2;DAB2IP;YJEFN3;TGFB2
prerank,retina homeostasis (GO:0001895),0.3988808717789432,0.9148010489434805,0.5747303543913713,1.0,1.0,3/23,4.69%,ACTG1;ACTB;POTEF
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.2969152059149185,-0.9146387523688742,0.5906432748538012,0.8901299733433816,1.0,12/27,26.05%,NIBAN2;DACH1;ACVRL1;BMPR2;RGCC;FGF2;SMG6;ATM;FGFR4;CDKN1A;PARP4;PRKD2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.20929771442927364,-0.9143332494046359,0.7313432835820896,0.8899142978885236,1.0,28/149,13.39%,PRKCB;EDA;APP;PRKCH;IL18;WNT5A;NOD1;NFKBIA;LGALS9;IRAK1;RNF25;IRAK3;SLCO3A1;IKBKG;RBCK1;TRIM25;TAB2;RNF31;ALK;IRAK2;UBC;TRIM5;CHUK;CARD14;TRIM14;CX3CL1;TAB1;EP300
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3676430761541124,-0.9142045946385541,0.5341772151898734,0.8892544190361392,1.0,3/13,8.50%,GKAP1;PTPN11;IGF2
prerank,natural killer cell activation (GO:0030101),0.3942787596470308,0.9137869759719079,0.5526717557251909,1.0,1.0,4/23,9.79%,IL2;RASGRP1;KAT7;AXL
prerank,regulation of T cell differentiation (GO:0045580),0.36913214100702485,0.91356064018042,0.5529573590096286,1.0,1.0,5/33,11.36%,IL2;PRDM1;CBFB;RUNX1;RHOH
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.2945365654880737,-0.913472760118709,0.5854430379746836,0.8899572903970221,1.0,11/26,26.60%,FBN1;TCTA;RARA;TLR3;GPR137B;PTPN2;CEACAM1;C1QC;ZFPM1;MAFB;GPR137
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3527777570320635,-0.913328599226762,0.5898058252427184,0.8893937601138585,1.0,4/14,18.54%,CHKA;LPIN2;SELENOI;LPIN3
prerank,regulation of RNA metabolic process (GO:0051252),-0.2500019242683558,-0.9133018506318916,0.6456310679611651,0.8885155330216533,1.0,11/59,10.17%,PTBP3;RASA1;RC3H2;AHNAK2;TRA2B;PCBP2;NOVA1;BRDT;AHNAK;RBM20;CLK3
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.21615973165912414,-0.9132874356786764,0.75,0.8876067377600649,1.0,30/110,21.02%,CDH5;APOE;ABCA1;DDX3X;HJURP;PTPN11;STXBP1;HSPA5;IAPP;SLF2;PEX5;HCFC1;ICE1;TGFB1;RIOK3;SLF1;IRGM;EP300;AIDA;NOP53;MMP1;CDC42;BAX;RALB;HSF1;PARK7;TIRAP;AJUBA;BID;KIF9
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.30547274804111335,-0.9128916336733225,0.598404255319149,0.8876405524270761,1.0,3/24,3.54%,PID1;LEPR;COQ10B
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.3896404975560348,-0.9128623158151341,0.5991189427312775,0.8867594959429598,1.0,8/10,44.52%,DLGAP1;DLGAP2;NPTXR;DLGAP3;AKAP9;BEGAIN;NPTX2;CACNG5
prerank,lysosome organization (GO:0007040),0.3609053672121473,0.9126197997187971,0.5690376569037657,1.0,1.0,9/36,14.40%,CLN5;HOOK2;ACP3;CLVS1;HOOK1;MBTPS1;AKTIP;HPS4;LRRK2
prerank,positive regulation of establishment of protein localization (GO:1904951),0.4062060672949924,0.9125579433197545,0.5494505494505495,1.0,1.0,3/18,12.24%,PTP4A3;CCT3;CEP120
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.38573171215004637,0.9125104037745496,0.5557228915662651,1.0,1.0,4/27,4.86%,DLC1;PHLDB2;CLASP2;ARHGAP6
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.40486570094894053,0.9116714864806892,0.5837245696400626,1.0,1.0,4/21,9.35%,NDST3;EXT2;HS2ST1;HS6ST1
prerank,monocyte differentiation (GO:0030224),-0.39454210920832733,-0.9109992166579636,0.5952380952380952,0.8902878380657271,1.0,6/10,17.79%,IL31RA;PIR;BMP4;THOC5;PPARG;MT1G
prerank,protein localization to condensed chromosome (GO:1903083),-0.37077732578732864,-0.9105508699116236,0.5961070559610706,0.8903485255497618,1.0,10/12,55.30%,IK;BUB3;ZWILCH;KNL1;TTK;SPDL1;CDK1;MTBP;AURKB;CHAMP1
prerank,regulation of platelet activation (GO:0010543),0.4005156514987611,0.9103888803327211,0.565284178187404,1.0,1.0,7/21,14.87%,PDGFB;PRKCQ;PLEK;C1QTNF1;PDGFA;PLA2G4A;PRKCA
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4457787647971539,0.9103728952120149,0.5667244367417678,1.0,1.0,4/10,12.51%,IMPACT;BAG3;SIRT2;CITED2
prerank,brain development (GO:0007420),0.3113642793577646,0.910288236897825,0.6229508196721312,1.0,1.0,13/136,10.44%,SOX6;COL4A1;ZFHX3;CLN5;SLC6A17;GRIN2C;ATXN1;SYNJ2;EML1;SLC23A1;CDH2;ADGRL2;SCYL2
prerank,neutrophil mediated immunity (GO:0002446),0.2967097574717806,0.9099522286402382,0.7036290322580645,1.0,1.0,68/432,14.95%,TTR;STXBP2;RAP1A;DYNLL1;VCL;ROCK1;CD36;FCGR3B;CNN2;ANO6;FRK;AGL;PADI2;ACP3;UNC13D;HMOX2;ALOX5;PLEKHO2;PYGB;CRISPLD2;CD14;CEP290;BRI3;ATG7;APEH;TNFAIP6;RAP2C;RAB3A;CYFIP1;PA2G4;HEBP2;CAP1;IGF2R;GLA;PRG2;STOM;STBD1;CD300A;DDOST;RHOF;ADAM17;GSTP1;GCA;PPIE;IST1;PSMB1;ALDOA;DGAT1;PRKCD;YPEL5;VPS35L;TRPM2;GM2A;CPNE3;DNAJC3;DNASE1L1;CFP;STK10;MAPK1;CD53;RAB14;GDI2;CYB5R3;PSMB7;PSMD3;CPPED1;GLB1;CTSA
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3451076605570049,0.9097819376001881,0.5517241379310345,1.0,1.0,11/41,16.23%,ALOX5;FADS3;HSD17B4;FADS2;GSTP1;MGLL;SCP2;PTGR1;PLA2G4A;PLA2G4C;EPHX1
prerank,cellular response to ATP (GO:0071318),0.4272649537479335,0.9089901885189743,0.5663265306122449,1.0,1.0,2/14,6.15%,P2RY2;TAF1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.38489053478926843,0.9089491314411318,0.5560821484992101,1.0,1.0,4/20,10.88%,ROCK1;LCP1;PLEK;ROCK2
prerank,response to interferon-gamma (GO:0034341),-0.24102340743642664,-0.9083565849069153,0.6473684210526316,0.8946460443956205,1.0,15/67,17.93%,DAPK1;WNT5A;LGALS9;GBP7;CXCL16;SP100;SIRPA;CX3CL1;GBP4;SNCA;GCH1;BST2;IFITM1;SHFL;IFITM3
prerank,regulation of cytokinesis (GO:0032465),-0.23711886071990076,-0.9083506222543404,0.6294117647058823,0.8937253812599572,1.0,26/78,26.50%,PKP4;CDC14B;CUL3;SPAST;RAB11A;BIRC6;AHCTF1;BCL2L1;PRKCE;CDC25B;GIPC1;CIT;PLK2;CDC42;GIT1;SVIL;UVRAG;CSPP1;DRD2;ZFYVE26;PLK5;CCP110;PRPF40A;CALM3;BBS4;KIF23
prerank,RNA metabolic process (GO:0016070),0.31178310926653385,0.9079865179092653,0.6214689265536724,1.0,1.0,23/127,13.07%,RBPMS;LSM8;POLR2L;POLR2I;HNRNPR;PARN;ATXN1;POLR2G;ATXN2;DICER1;FTO;FASTKD1;PAPOLA;DEDD2;DHX8;HNRNPU;PRPF4;RBM3;HNRNPC;RBM6;DROSHA;POLR2J;PCBP3
prerank,positive regulation of cell division (GO:0051781),-0.2802325850259199,-0.90791304346601,0.5869565217391305,0.8938243574142171,1.0,14/38,23.48%,PKP4;CDC14B;CUL3;SPAST;PRKCE;FGFR2;CDC25B;GIPC1;CIT;CDC42;SVIL;CSPP1;DRD2;TAL1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.3647995190353343,-0.9073083513273632,0.5961070559610706,0.8943770243034543,1.0,4/12,12.97%,ELF1;PTPN22;LYN;ELF2
prerank,negative regulation by host of viral process (GO:0044793),-0.39822505130311203,-0.9069803277561589,0.5822510822510822,0.8941711800615814,1.0,3/10,21.40%,PRKN;ZC3H12A;CCNK
prerank,cell cycle G1/S phase transition (GO:0044843),0.33915339126385924,0.9069463220493142,0.5944931163954944,1.0,1.0,11/61,11.73%,CCNA2;CDK6;HINFP;EIF4EBP1;CUL2;CCND1;CDK7;CRLF3;RB1;GSPT1;ACVR1B
prerank,cellular response to hypoxia (GO:0071456),0.31163515809013775,0.9067225333844625,0.6231721034870641,1.0,1.0,19/126,10.53%,PMAIP1;LIMD1;ANGPT4;RORA;PTGIS;CUL2;SUV39H2;PSMC6;NDRG1;ELOC;TERT;TP53;CPEB1;VEGFA;HIF1A;PSME4;SIRT2;PSMB1;PSMD5
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.40854788868744396,0.9066546075004706,0.5618892508143323,1.0,1.0,4/17,8.65%,PDGFB;CCND2;CCND1;ADAM17
prerank,regulation of steroid biosynthetic process (GO:0050810),0.45058689495824555,0.9065059841094774,0.5477386934673367,1.0,1.0,1/11,1.64%,NR1H4
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.27235936751846257,-0.9063443318793916,0.5894736842105263,0.894695172632125,1.0,7/37,10.06%,RIN3;APOE;ANKRD13A;ITGAV;OPTN;SDCBP;PRKN
prerank,regulation of response to cytokine stimulus (GO:0060759),0.39874692929061106,0.9063414428331275,0.5655608214849921,1.0,1.0,2/19,5.01%,LIFR;CBFB
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3436159924394958,0.9062693373904025,0.6015523932729625,1.0,1.0,19/56,21.64%,NDUFS1;NDUFA11;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFAB1;NDUFAF5;NDUFA1;NDUFAF2;NDUFAF1;NDUFV3;NDUFS4;OXA1L;NDUFA3;NDUFAF6
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3436159924394958,0.9062693373904025,0.6015523932729625,1.0,1.0,19/56,21.64%,NDUFS1;NDUFA11;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFAB1;NDUFAF5;NDUFA1;NDUFAF2;NDUFAF1;NDUFV3;NDUFS4;OXA1L;NDUFA3;NDUFAF6
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3904066677510614,0.9061675214510044,0.6005830903790087,1.0,1.0,2/26,2.53%,PRKAB2;PDK4
prerank,regulation of lipid storage (GO:0010883),0.4008258531853094,0.906099017356725,0.5718654434250765,1.0,1.0,4/22,8.00%,LPL;FBXW7;ITGB3;FTO
prerank,transcription by RNA polymerase II (GO:0006366),0.2969547764919783,0.9059253131971156,0.6700819672131147,1.0,1.0,44/305,12.61%,NOTCH3;SOX5;NR1H4;POLR2L;POLR2I;RORA;NR4A1;ADRM1;PRRX1;TEAD3;HDAC9;GTF2H4;NR2C1;WDR33;ELL;PCF11;CBFB;POLR2G;TAF1;ELOC;RXRG;PARP1;TAF8;MAML2;AR;PPARGC1A;MED1;YAP1;ERCC6;PAPOLA;MAML3;PPARA;CCNT1;NR4A2;NR1D1;CDK7;NR2C2;TEAD1;NFX1;ESRRA;CDK12;NELFB;INTS5;NR6A1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.34246039941365236,0.9059195749064216,0.5985130111524164,1.0,1.0,7/62,7.60%,ABRA;GPR20;SYNPO2L;NET1;MAPRE2;RASGRP1;GPR17
prerank,regulation of presynapse organization (GO:0099174),-0.3337797097557379,-0.9056560185338557,0.6141732283464567,0.8943530804281202,1.0,5/18,17.30%,GPC6;APP;PTPRD;SNCA;LRRC4B
prerank,regulation of presynapse assembly (GO:1905606),-0.3337797097557379,-0.9056560185338557,0.6141732283464567,0.8943530804281202,1.0,5/18,17.30%,GPC6;APP;PTPRD;SNCA;LRRC4B
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.37067858704432316,-0.9051290944094029,0.5951327433628318,0.8947116078415636,1.0,8/11,32.18%,PGM3;RENBP;UAP1;AMDHD2;GFPT2;UAP1L1;GNPDA1;GNPNAT1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.35116951626657117,0.9048677930964906,0.5865139949109415,1.0,1.0,18/50,21.18%,POLR2L;POLR2I;NUP62;POLR2G;SEC13;NUP153;NUP107;AAAS;POLR2J;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;AGO1;TPR;H3-3A
prerank,regulation of gene silencing by RNA (GO:0060966),0.35116951626657117,0.9048677930964906,0.5865139949109415,1.0,1.0,18/50,21.18%,POLR2L;POLR2I;NUP62;POLR2G;SEC13;NUP153;NUP107;AAAS;POLR2J;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;AGO1;TPR;H3-3A
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.43979172680458667,0.9041815567053881,0.5737410071942446,1.0,1.0,3/12,7.68%,VEGFA;GDNF;SOX9
prerank,positive regulation of phospholipid transport (GO:2001140),0.4511619319949288,0.9039223463746338,0.5591603053435115,1.0,1.0,2/10,6.65%,ABCB4;ABCA3
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.33547596332161533,-0.9038380125322076,0.5971563981042654,0.8968121585246028,1.0,6/17,12.59%,FSTL1;SULF1;SLIT2;TMEM204;SFRP4;CASK
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.300921614817992,-0.9036405693784872,0.5783475783475783,0.8963288183672524,1.0,6/23,12.68%,KIT;GHR;PTK2B;CYP1B1;HES1;PRLR
prerank,negative regulation of T cell proliferation (GO:0042130),-0.28757956040973764,-0.9034649406004218,0.6130030959752322,0.8958305409987285,1.0,7/28,24.62%,LGALS9;CEBPB;SDC4;CD80;CD274;CD86;SCRIB
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3253263739887963,0.9034270097130362,0.611244019138756,1.0,1.0,13/85,7.86%,ANGPT1;FGF1;LIMS1;CDK6;NR4A1;OSR2;PEX2;DAB2IP;VEGFA;LAMC1;YAP1;SOX9;TGFB2
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3007390672327978,-0.9034090417310194,0.5761194029850746,0.8950073978655878,1.0,9/26,19.15%,FCHO2;DNAJC6;FNBP1L;CANX;AP2S1;LMBRD1;CLTB;AP2A2;CLTA
prerank,negative regulation of bone mineralization (GO:0030502),-0.36413838764480844,-0.9032530154726744,0.6148148148148148,0.8944319749253729,1.0,7/13,34.94%,PTK2B;SRGN;ENPP1;BCOR;RFLNA;RFLNB;GREM1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.36989912385568485,0.9027533295097181,0.5724743777452416,1.0,1.0,7/29,14.86%,STRN3;CBFB;YAP1;KMT2D;RUNX1;UFL1;KCTD6
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3425497188715429,0.9026622562845402,0.5744400527009222,1.0,1.0,19/49,18.02%,PMAIP1;BCL2;CAV1;TP53;BCL2L2;NDUFS3;RTKN2;DNM1L;BOK;MCL1;URI1;PTPMT1;EIF2AK3;S100A8;S100A9;BCAP31;DAPK2;DDIT3;BBC3
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2934347384700217,0.9026599941269584,0.795,1.0,1.0,124/807,13.60%,FLNA;PRDM16;MYOZ2;HJV;MEF2C;HEY2;ZFHX3;TBX2;LBH;NR1H4;LIMS1;LIMD1;PDGFB;ZEB2;NAB1;EDNRB;ATP8B1;MLIP;ID4;FST;FRK;LOXL2;ETS2;ARID5B;RUNX1T1;HEYL;PBXIP1;HINFP;GMNN;ZNF436;H1-0;RBAK;NACC2;PRDM1;HDAC9;SET;NR2F2;ANKRD2;NR2C1;USP2;MTERF3;ATXN1;OSR2;PIAS4;CBFB;KLF7;KCNIP3;MEF2A;PEX2;MTDH;SUV39H2;MYBBP1A;CAV1;TAF1;DAB2IP;ARID5A;TP53;VEGFA;PPM1A;PARP1;HEXIM1;ZBTB38;SFPQ;BCL7A;PA2G4;AR;L3MBTL2;MED1;ZNF431;YAP1;SOX9;SNAI2;HSF4;DICER1;RELA;PLCB1;MAP3K10;CUX2;LIN37;CCND1;PPARA;CBX4;IMPACT;MTA3;NR4A2;SKI;NR1D1;LRRFIP1;KAT7;ZBTB33;SIRT2;DEDD2;MIDEAS;RIF1;PCGF6;SPINDOC;HNRNPU;ZNF3;NR2C2;UBE2D1;SREBF2;RUNX1;RB1;ATF3;NKX6-1;ZBTB7A;NFX1;CNOT7;PSPC1;FBXW11;ORC2;CITED2;CPEB3;NR6A1;POU3F3;FNIP2;ZFP69;MXD4;BCL6;IKZF1;FOXJ1;TRIM28;GAS6;ZBTB5
prerank,hyaluronan metabolic process (GO:0030212),-0.29786527344722014,-0.9025248173608468,0.5983379501385041,0.8952589083140632,1.0,6/23,16.03%,CEMIP;CD44;TGFB1;HEXA;CEMIP2;FGF2
prerank,regulation of myelination (GO:0031641),-0.2905487039170788,-0.9023753875970313,0.6226993865030674,0.8946502195005208,1.0,3/25,5.83%,PTN;JAM2;PTPRZ1
prerank,regulation of angiogenesis (GO:0045765),0.3016334207346292,0.9023222452604394,0.6323529411764706,1.0,1.0,22/192,7.86%,COL4A2;ATP2B4;ROCK1;FGF1;ANGPT4;HSPB6;SEMA5A;PLXND1;HK2;STIM1;ITGB1;PTGIS;ALOX5;EMILIN1;MTDH;DAB2IP;RRAS;VEGFA;RHOJ;YJEFN3;BTG1;TGFB2
prerank,cellular protein-containing complex assembly (GO:0034622),0.30587426520797134,0.9022974294023068,0.6275346851654215,1.0,1.0,24/159,14.20%,DMD;ANGPT1;PDE4DIP;CASQ1;HIP1;ADRM1;COX7A2L;MAPT;BBS12;OTUD6B;LONP1;ANLN;NUP153;CENPE;NUP107;TBCD;CLU;SNX9;CHMP2A;NCK2;HOPX;NUP98;PTGES3L;SRP19
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.32753823775321816,0.9022576776584478,0.6105137395459976,1.0,1.0,32/82,23.06%,DYNLL1;CEP41;HAUS8;CEP290;TP53;TPX2;CEP192;DYNC1I2;NEDD1;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PRKACA;PLK4;DCTN1;HAUS4;CEP135;CKAP5;ACTR1A;SFI1;MAPRE1;ODF2;PPP2R1A;NINL;TUBA4A;CEP63;YWHAG;NDE1
prerank,negative regulation of cell motility (GO:2000146),0.31328130167365364,0.9017603386579408,0.5970488081725313,1.0,1.0,11/108,7.06%,TPM1;DLC1;VCL;TMIGD3;JAG1;KANK1;IGFBP5;RAP2C;DUSP3;PIN1;STK26
prerank,aminoglycan biosynthetic process (GO:0006023),0.34470581796240934,0.9016388479263525,0.574002574002574,1.0,1.0,7/49,10.06%,SDC2;EXT2;GCNT2;HS2ST1;GPC4;HS6ST1;AGRN
prerank,neurotransmitter transport (GO:0006836),0.33318214916093264,0.9016182891422152,0.5913461538461539,1.0,1.0,15/73,14.51%,STXBP2;APBA1;SLC6A2;SLC38A2;RAB3A;LIN7C;BRSK1;HRH3;GLS2;GLS;SLC6A15;SLC29A1;PPFIA3;SLC38A1;DVL1
prerank,positive regulation of synapse assembly (GO:0051965),-0.28813108423954437,-0.9015366013055943,0.6030769230769231,0.8957082557615323,1.0,13/27,28.55%,NLGN1;SEMA4D;PTPRD;NRXN1;NLGN2;NLGN3;LRRC4B;GRID2;IL1RAP;EPHB2;SRPX2;EPHB3;SYNDIG1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.3028323836895206,-0.9015200196186709,0.6186440677966102,0.8948249003852446,1.0,5/22,11.85%,KIT;GHR;CYP1B1;HES1;MGAT5
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.28946703751685376,-0.9013450194048896,0.6277602523659306,0.8942733406070738,1.0,5/27,12.16%,NFAT5;IRAK1;CYRIB;CD44;SIRPA
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.3752695910597396,-0.900786230934617,0.5906040268456376,0.8946485539748439,1.0,3/11,18.89%,CASP8;TGFB1;HSF1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.352950483395979,-0.9007453978899636,0.5906976744186047,0.8938188454595223,1.0,8/13,32.18%,PGM3;RENBP;UAP1;AMDHD2;GFPT2;UAP1L1;GNPDA1;GNPNAT1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.2933358299472185,-0.900466336914987,0.6017699115044248,0.8935006565079331,1.0,8/26,14.47%,APP;NLGN1;PTK2B;SHANK3;TMEM108;NRXN1;NLGN2;NLGN3
prerank,brain morphogenesis (GO:0048854),-0.3589490715509828,-0.9000477064613163,0.5945273631840796,0.8935614480412974,1.0,6/12,30.52%,PAFAH1B1;SHANK3;SPEF2;MKKS;BBS4;CTNNA2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.32417104536108615,-0.8999000444581665,0.6229946524064172,0.8929946440258201,1.0,14/18,47.13%,LIG3;GINS3;LIG1;RFC3;GINS4;POLD3;GINS1;POLE;RFC4;MCM3;POLE3;POLA1;POLD2;GINS2
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.22005811501549896,-0.899854532412832,0.7326732673267327,0.8921797269482772,1.0,21/109,14.23%,NFATC3;GAB2;PIK3CA;GRB2;PDPK1;VAV2;PLCG2;PIK3CB;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;PSMA5;PSMA1;PSMC2
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4345961445169475,0.8994733744420171,0.566003616636528,1.0,1.0,2/12,6.25%,ATP2B4;DAB2IP
prerank,intracellular sterol transport (GO:0032366),-0.35733672323694327,-0.8994392292735742,0.5990888382687927,0.8921848716858385,1.0,6/13,23.59%,ABCA1;ARV1;STARD4;OSBP;RELCH;NPC1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3662641152369286,-0.8990351413414926,0.5914221218961625,0.8922044971392435,1.0,4/12,17.43%,GNL3;CCT8;CCT4;WRAP53
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.4460343233824348,0.8990157338805516,0.5683453237410072,1.0,1.0,2/10,8.34%,ANO6;CD300A
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.43294657307449114,0.8990059446258375,0.5724381625441696,1.0,1.0,6/12,20.32%,HEXIM1;HNRNPU;NELFB;NELFCD;EAPP;NELFA
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.3620808326529861,0.898622370729012,0.5904255319148937,1.0,1.0,8/34,12.90%,MFHAS1;PTPRS;CD14;DAB2IP;CD300A;NR1D1;OTUD4;SARM1
prerank,protein maturation (GO:0051604),0.32053763933954915,0.8985074323549284,0.582089552238806,1.0,1.0,17/95,15.36%,TMPRSS4;TSPAN32;TESC;AFG3L2;ISCA1;ADAM17;LONP2;PHEX;NDUFAB1;GALNT2;DDI2;TSPAN17;ADAM19;PCSK4;NAA35;GLRX3;CIAO1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4329408482354605,0.8975445859813042,0.5931623931623932,1.0,1.0,5/13,18.84%,EDEM2;UBE2J1;SVIP;BCAP31;BRSK2
prerank,negative regulation of cell migration (GO:0030336),0.3079771723703709,0.8971331941904448,0.6263616557734205,1.0,1.0,15/137,7.06%,TPM1;DLC1;VCL;TMIGD3;PHLDB2;CLASP2;JAG1;KANK1;IGFBP5;BMPR1A;RAP2C;DAB2IP;DUSP3;CORO1C;STK26
prerank,transport across blood-brain barrier (GO:0150104),0.32127846018481093,0.8970113785325712,0.6,1.0,1.0,12/83,6.98%,ATP2B4;SLC2A4;CD36;SLC6A17;SLC16A7;SLC8A2;SLC5A3;SLC4A8;SLC38A2;SLC4A3;SLC2A10;SLC44A1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.38993545853818584,-0.8965775417372861,0.604494382022472,0.8970061269584422,1.0,5/10,18.55%,GHR;LYN;PRLR;STAT5A;STAT6
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.27218326897301226,-0.8965082216928274,0.6319218241042345,0.8962494919184494,1.0,11/33,19.27%,DDX5;CARM1;SAFB2;RNF6;PRMT2;ESR1;EP300;GPAM;CALR;KDM1A;PARK7
prerank,negative regulation of cartilage development (GO:0061037),0.4172268918749662,0.8962364850997026,0.5856,1.0,1.0,3/13,7.71%,CHADL;SOX9;SNAI2
prerank,cellular protein metabolic process (GO:0044267),0.2912354045760577,0.8962122694723325,0.7214934409687185,1.0,1.0,32/396,6.93%,IGFBP7;MFGE8;LTBP1;SPARCL1;PAPPA2;SDC2;LMCD1;MSRB3;RPL3L;HRC;CCN1;CLN5;LOXL2;IGFBP5;D2HGDH;MRPL36;MRPL13;MCRS1;HARS2;SEPHS1;DMBT1;NUCB1;PHKA2;ZDHHC2;DAB2IP;AFG3L2;ABCA3;KTN1;IGFBP4;LAMC1;LAMB2;RPL8
prerank,protein-containing complex subunit organization (GO:0043933),0.3098866570538792,0.8955844861733545,0.6163594470046083,1.0,1.0,20/109,14.33%,TCAP;SH3BGR;SKAP2;AFG3L2;TP53;LAMC1;PPARGC1A;MDN1;YAP1;SOX9;ADD2;MAGI1;TEAD1;DNM1L;KIFAP3;SNX9;DMTN;KPNA3;NUP98;EPRS1
prerank,cellular response to increased oxygen levels (GO:0036295),0.4369177390117307,0.8955197455689297,0.5900514579759862,1.0,1.0,3/11,6.32%,ATG7;CAV1;ATP6V0A2
prerank,Rac protein signal transduction (GO:0016601),-0.32035236694998726,-0.8952397212713316,0.5911458333333334,0.8981766966209959,1.0,2/18,1.21%,ELMO1;EPS8
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.23467196518682326,-0.895098356358747,0.6842105263157895,0.8975887856739692,1.0,15/72,11.25%,ELF1;IFNAR2;PTPN11;IRAK1;CASP8;HSP90AB1;BIRC2;MADD;TNFRSF1A;IRAK3;IKBKG;RBCK1;RNF31;IRAK2;CHUK
prerank,protein oxidation (GO:0018158),0.43219137634295784,0.8950509393500866,0.5680580762250453,1.0,1.0,2/11,10.21%,LOXL2;SUMF1
prerank,histone methylation (GO:0016571),0.3774530771839072,0.8946459164470012,0.5950155763239875,1.0,1.0,5/26,9.03%,SMYD1;SETD6;SUV39H2;PRMT7;NSD3
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3729532453298098,0.89462437995753,0.5791788856304986,1.0,1.0,5/29,7.96%,DCUN1D2;FEM1A;FBXW7;PIN1;DCUN1D1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3187973591064481,0.8941628782553948,0.6139534883720931,1.0,1.0,13/95,5.98%,SDC2;ANGPT1;CSPG4;CHSY3;CSGALNACT1;BGN;EXT2;GCNT2;HS2ST1;HAS2;GPC4;CHST5;OGN
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.33908397239226373,-0.8936893889219456,0.6150234741784038,0.898986230145861,1.0,7/15,31.36%,DTNBP1;AP3M2;AP3S1;AP3M1;BLOC1S6;BLOC1S2;AP3S2
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.33908397239226373,-0.8936893889219456,0.6150234741784038,0.898986230145861,1.0,7/15,31.36%,DTNBP1;AP3M2;AP3S1;AP3M1;BLOC1S6;BLOC1S2;AP3S2
prerank,positive regulation of immune system process (GO:0002684),0.41993888223667963,0.8936404908238598,0.5778894472361809,1.0,1.0,3/16,7.86%,ANXA1;VEGFA;TGFB2
prerank,fatty acid oxidation (GO:0019395),0.3378682205647368,0.8934133259852307,0.6222509702457956,1.0,1.0,11/57,10.20%,HSD17B10;PEX2;HSD17B4;PPARGC1A;ACAD11;MECR;ABCD4;ACADS;ACAD10;HADHB;SCP2
prerank,regulation of tissue remodeling (GO:0034103),-0.32920477933447595,-0.8932547899363369,0.6394736842105263,0.899038356595985,1.0,3/18,3.27%,LEPR;IL15;IL18
prerank,positive regulation of actin nucleation (GO:0051127),0.4315447609837807,0.8930226394699134,0.5652951699463328,1.0,1.0,3/11,9.76%,CYFIP1;WHAMM;FCHSD2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.40083901997538524,0.8926704874188648,0.5782747603833865,1.0,1.0,5/19,17.10%,IRS1;PPARA;PRKCD;IRS2;MTLN
prerank,regulation of nervous system process (GO:0031644),-0.32273994783413407,-0.8926364839437094,0.6005089058524173,0.8994688747882867,1.0,6/18,12.38%,APP;DLGAP1;TMEM108;NOS3;DLGAP2;HTR2C
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.3213934228864721,0.8924420540676403,0.6206482593037215,1.0,1.0,17/84,14.33%,ROCK1;IGFBP5;SAMD4A;RTN2;MRPL13;BTG2;PIN1;RTN1;DAPK3;EIF2AK2;CNOT7;CHRNA7;CLU;CPEB3;SYNCRIP;GIGYF2;EPRS1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.35935259277910025,0.8915894324084587,0.6061026352288488,1.0,1.0,8/36,11.68%,ATP2B4;CAV1;TERT;CALM1;GLA;HIF1A;TERF2;HTR2B
prerank,negative regulation of immune effector process (GO:0002698),-0.3595226112740644,-0.8913649504942524,0.5985576923076923,0.9013882358756159,1.0,5/13,16.89%,RPS19;CD55;ENPP3;APPL1;GRN
prerank,mRNA 3'-end processing (GO:0031124),-0.23362692503717591,-0.8912092249535611,0.7052023121387283,0.9008006456660791,1.0,35/78,32.19%,THOC2;APP;PABPN1;SRSF7;SRSF6;SRSF11;SRSF5;POLDIP3;SLBP;PABPC1;THOC5;SRSF2;LEO1;NCBP2;CHTOP;PAPOLG;SRSF3;CPSF2;SARNP;SCAF8;CPSF6;CSTF2T;SSU72;CPSF4;RNPS1;DHX38;ALYREF;CSTF2;CPSF1;LSM11;CLP1;POLR2D;PAPOLB;SLU7;DDX39A
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3119058262690668,0.8911091407347289,0.6438356164383562,1.0,1.0,25/114,17.39%,ACTN4;LIMS1;TNFSF13B;TNFRSF11A;PSMC6;TP53;TRAF3;RELA;ADAM17;PSME4;EDAR;TRAF5;PSMB1;PSMD5;EIF5A;TNFRSF25;PSMB2;TMSB4X;PSMB7;PSMD3;STAT1;JAK2;PSMA2;PSMD14;TNFSF12
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.3122357099481638,-0.8910076184823749,0.6147959183673469,0.9002918659997724,1.0,8/19,17.74%,CUX1;CDKL3;CUL7;PTPRD;FBXW8;LRP8;OBSL1;DBN1
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.3447302842220613,-0.8907771627912898,0.6004962779156328,0.8998831299562335,1.0,6/14,15.51%,PPP2R2B;PPP2CA;PPP2CB;NCK1;PPM1F;DUSP1
prerank,visual system development (GO:0150063),-0.2734071121021974,-0.8905106281817728,0.6563573883161512,0.899561024880936,1.0,16/37,34.99%,SMOC1;PBX3;RBP4;MEIS2;MEIS3;PBX4;C1QA;SIPA1L3;PBX1;SMG9;ZDHHC16;MEIS1;ATF6;SALL2;C3;ADAMTS18
prerank,negative regulation of transferase activity (GO:0051348),0.3732014088611447,0.8905040129438495,0.5949008498583569,1.0,1.0,9/28,19.08%,MAPT;TP53;CERS1;NPRL2;HNRNPU;IRS2;FBXO5;MEN1;ABL1
prerank,MAPK cascade (GO:0000165),0.2906681661739616,0.8903769993284066,0.7125382262996942,1.0,1.0,59/295,16.90%,MAP3K20;FGF13;MEF2C;MAP3K5;ANGPT1;FGF1;PDGFB;RASAL2;DUSP5;IL2;CCL5;KSR1;CAMKK2;MEF2A;PRKCQ;IRS1;PSMC6;DAB2IP;MAPKAPK2;GDNF;CALM1;AREG;RASGRP1;SOX9;MBP;MAP2K1;PPP1CB;PSME4;ACTN2;PDGFRB;PSMB1;HBEGF;PSMD5;PDGFA;GFRA1;ABHD17B;HTR2B;FBXW11;TNIK;PSMB2;SPTB;TAOK3;ZFP36L1;FGF10;MAPK1;LRRK2;PSMB7;PSMD3;CSF2RA;IRS2;KARS1;MAPK12;RAF1;JAK2;PSMA2;RASGRP3;MT3;SHOC2;PSMD14
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.4010774102859422,0.8901895562156623,0.5711892797319933,1.0,1.0,6/18,9.18%,PEX2;DAB2IP;TP53;CD300A;GSTP1;SKI
prerank,cellular protein localization (GO:0034613),0.2935662180715274,0.8891736994531698,0.7135627530364372,1.0,1.0,50/285,16.94%,FLNA;DMD;STXBP2;HEY2;TBC1D1;ANGPT1;VCL;CSRP3;FERMT2;ITSN1;BICD2;JAM3;ARHGEF2;RABGAP1;SEC31B;VPS26A;EVI5;EIF2D;SEC13;VPS26B;RRAGB;RAP2A;STX12;MFN2;WDR45;SNX13;NSF;PACSIN1;SNX9;FGF10;FOXJ1;RAB14;LRRK2;SNX17;CTSA;SNX1;CNTNAP1;USP4;STX7;YWHAH;GGA2;ATG13;RUNDC1;TBC1D22B;VPS35;SMURF1;TM9SF2;TBC1D12;ARL4D;RAB38
prerank,DNA dealkylation (GO:0035510),0.4501144519518002,0.888844942999065,0.5756457564575646,1.0,1.0,5/10,26.25%,FTO;MPG;ASCC1;ALKBH1;ALKBH5
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.4501144519518002,0.888844942999065,0.5756457564575646,1.0,1.0,5/10,26.25%,FTO;MPG;ASCC1;ALKBH1;ALKBH5
prerank,peptidyl-lysine modification (GO:0018205),0.3123197848106976,0.888764453559237,0.6473265073947668,1.0,1.0,33/99,19.61%,UBA2;LOXL2;NUP62;HDAC9;SIRT3;PIAS4;SAE1;TRPM4;NUP153;SIRT2;NUP107;AAAS;PIAS2;ATPSCKMT;NDUFAB1;SENP6;TRIM28;VCPKMT;SIRT4;NUP98;NUP37;EEF1AKMT2;NUP210;PIAS1;BCL11A;ESCO1;HDAC6;NUP54;SUMO1;SENP2;UBE2I;NUP160;NUP133
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.32255929939579786,0.8881737058401469,0.6477683956574186,1.0,1.0,25/80,18.44%,VIM;SAMD4A;NAT10;SIRT3;RPS27L;CIRBP;RELA;PYM1;RPL5;EIF3E;ROCK2;PRKCD;RBM3;ZCCHC4;ABCG1;CHRNA7;CLU;CPEB3;PLXNB2;SP1;PIWIL2;LRRTM3;SMPD2;EEF2;UPF3A
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.41265067781837816,0.8881459987936129,0.576797385620915,1.0,1.0,6/16,17.30%,PIGN;PIGA;PIGH;PIGB;PIGP;DPM2
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.32805910329932886,-0.8881092167869639,0.5747422680412371,0.9039920920598264,1.0,4/18,12.58%,ATP1A2;NEDD4L;COMMD1;SLC43A2
prerank,long-chain fatty acid import into cell (GO:0044539),0.45277554063393716,0.8879040994888966,0.5824372759856631,1.0,1.0,1/10,1.73%,CD36
prerank,tRNA aminoacylation (GO:0043039),0.3542070674159922,0.88782221624526,0.6161335187760779,1.0,1.0,14/37,19.50%,HARS2;LARS1;GATB;IARS2;AIMP1;IARS1;SARS2;EPRS1;KARS1;LARS2;SARS1;FARS2;GARS1;GATC
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.31246093509883643,-0.8877679658758691,0.6204986149584487,0.9029161966567639,1.0,14/21,36.06%,ERCC5;DDB1;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;ERCC2;ERCC1;ERCC4;RPA3;RPA2;ERCC3;RPA1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.31246093509883643,-0.8877679658758691,0.6204986149584487,0.9029161966567639,1.0,14/21,36.06%,ERCC5;DDB1;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;ERCC2;ERCC1;ERCC4;RPA3;RPA2;ERCC3;RPA1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.36542221262911584,0.88695601085647,0.5950292397660819,1.0,1.0,7/33,10.69%,PDGFB;TERT;TP53;TGFB2;RELA;HIF1A;TEAD1
prerank,regulation of steroid metabolic process (GO:0019218),0.38704299362330574,0.8867200874821325,0.591743119266055,1.0,1.0,2/23,2.57%,NR1H4;RORA
prerank,RNA splicing (GO:0008380),0.31542267457984274,0.8867014560510682,0.6350877192982456,1.0,1.0,26/95,15.21%,DDX23;TXNL4A;SFPQ;PPARGC1A;SF3B3;SRSF4;SNRPN;PRPF18;FUS;ZMAT5;RBM8A;MBNL1;U2AF1;DHX8;PRPF4;SRSF10;SF3A3;HNRNPC;CDK12;SRRM1;SF3B2;SF3B1;ZCRB1;SYNCRIP;PDCD7;SRPK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.37534487345994616,-0.8866093108662936,0.6213151927437641,0.9028420593975472,1.0,5/11,27.04%,PPCDC;PANK1;DCAKD;ACOT7;PPCS
prerank,coenzyme A biosynthetic process (GO:0015937),-0.37534487345994616,-0.8866093108662936,0.6213151927437641,0.9028420593975472,1.0,5/11,27.04%,PPCDC;PANK1;DCAKD;ACOT7;PPCS
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.37534487345994616,-0.8866093108662936,0.6213151927437641,0.9028420593975472,1.0,5/11,27.04%,PPCDC;PANK1;DCAKD;ACOT7;PPCS
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.38948777774704524,0.8865732534792858,0.5978593272171254,1.0,1.0,3/23,6.42%,PMAIP1;BCL2;TP53
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.38948777774704524,0.8865732534792858,0.5978593272171254,1.0,1.0,3/23,6.42%,PMAIP1;BCL2;TP53
prerank,positive regulation of leukocyte activation (GO:0002696),-0.3201600209382446,-0.8864390153725775,0.613941018766756,0.9023180801020818,1.0,3/18,12.31%,LBP;WNT5A;IL33
prerank,pulmonary valve development (GO:0003177),0.39300042919709766,0.885945894085487,0.5826513911620295,1.0,1.0,4/18,7.86%,HEY2;HEYL;JAG1;TGFB2
prerank,translational termination (GO:0006415),0.3104509001140887,0.8854949591984321,0.6176808266360505,1.0,1.0,33/95,22.04%,MRPL36;MRPS31;MRPL13;APEH;MRPL30;ABCE1;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;GSPT1;MRPL47;MRPL9;MRPL42;N6AMT1;ETF1;MRPL14;MRPL4;MRPS21;MRPL40;MRPL22;MRPL50;MRPS14;MRRF;OXA1L;MRPL24;MRPS12;MRPS10
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.35268235230203787,-0.8854642263057495,0.6314553990610329,0.9035577299691114,1.0,7/13,40.39%,DUSP1;ANAPC15;DYNC1LI1;MAD2L1;GEN1;NDC80;XRCC3
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.23075739938000517,-0.8854040058283498,0.7218543046357616,0.9027612825494079,1.0,29/80,24.06%,GBF1;RINT1;KDELR1;ERGIC3;TMED7;SURF4;TMED10;COPB2;GOLPH3;ARFGAP2;ARF3;ARFGAP1;COPE;ARFGAP3;RAB1A;RER1;KLC2;COG7;PICK1;TMED3;SCFD1;RAB1B;UVRAG;KIF26A;ARF5;ATP9A;USE1;COPB1;TAPBP
prerank,positive regulation of vasculature development (GO:1904018),0.31622209385172173,0.8846755489762657,0.6332179930795848,1.0,1.0,12/94,7.58%,FGF1;ANGPT4;HSPB6;SEMA5A;HK2;STIM1;ITGB1;PTGIS;MTDH;RRAS;VEGFA;BTG1
prerank,regulation of stem cell differentiation (GO:2000736),0.3156782335376284,0.88461886449765,0.6287069988137604,1.0,1.0,20/89,14.71%,RBM24;JAG1;CBFB;SP7;BMPR1A;PSMC6;GDNF;YTHDF2;YAP1;PSME4;HNRNPU;PSMB1;PSMD5;EIF2AK2;RUNX1;PSMB2;NELFB;NSUN2;PSMB7;PSMD3
prerank,protein phosphorylation (GO:0006468),0.28839494375534386,0.8845192116930252,0.7735470941883767,1.0,1.0,86/479,15.26%,MYLK2;MAP3K20;STK38L;TNNI3K;PRKG1;MAP3K5;ROCK1;MAST4;DYRK2;MERTK;PDGFB;CCNA2;CDK6;PDK4;FRK;FAM20A;CAMK2D;ACVR2A;MUSK;GTF2H4;CAMKK2;PEAK1;MARK1;BMPR1A;DYRK1A;PRKCQ;MAP4K3;MAP4K5;TAF1;DAB2IP;RPS6KA2;COQ8A;MAPKAPK2;DYRK1B;STK26;CHEK1;TGFB2;NUAK1;MAP3K10;WNK2;DAPK3;PRKACB;PRKAR1B;MAP2K1;CCNT1;BRSK1;PKN2;PAK2;CDK7;STK33;STK24;PDGFRB;CDK18;EIF2AK2;ROCK2;PRKCD;COPS8;ACVR1B;CDK12;RICTOR;DMPK;BMPR1B;TNIK;BCR;CDC42BPB;STK36;TAOK3;FNIP2;CDK15;MAST1;PPP3CB;EEF2K;GAS6;CSNK1E;PDK2;SGK1;STK10;EPHB1;MAPK1;LRRK2;PRKAA2;PRKCA;PRKACA;SRPK2;MAPK12;CSNK1A1
prerank,embryonic organ morphogenesis (GO:0048562),0.3452407188230559,0.8841767173326535,0.607764390896921,1.0,1.0,4/42,6.96%,RYR2;RBPMS2;OSR2;HOXC4
prerank,cellular response to glucose starvation (GO:0042149),0.3457695753998029,0.8839788546725226,0.6126482213438735,1.0,1.0,13/41,18.84%,PMAIP1;KPTN;MYBBP1A;TP53;NUAK1;IMPACT;BRSK1;PIK3C3;PRKAA2;ITFG2;EIF2AK3;MTMR3;BRSK2
prerank,regulation of T cell cytokine production (GO:0002724),0.4117303403068572,0.883927611457137,0.5886178861788618,1.0,1.0,2/15,8.74%,FZD5;TRPM4
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2553450166117713,-0.883859734428627,0.6704980842911877,0.9053924983071604,1.0,9/44,17.93%,SH3RF1;DDX3X;RPS6KA3;CD44;IGBP1;SNCA;AKT1;GPX1;SIAH2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.32712971950667674,0.883836911086701,0.636919315403423,1.0,1.0,13/67,17.84%,NCF2;CD36;PSMC6;ITGB5;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14;SNAP23
prerank,regulation of vasculature development (GO:1901342),-0.28998374729685195,-0.8838123284252564,0.6228070175438597,0.9046017017429067,1.0,5/26,11.43%,NF1;ADGRA2;CTNNB1;BMPER;SP100
prerank,amino sugar biosynthetic process (GO:0046349),-0.3486063666767845,-0.8836625002602797,0.6124721603563474,0.9040244215831199,1.0,7/12,27.00%,PGM3;RENBP;UAP1;AMDHD2;GFPT2;UAP1L1;GNPDA1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.344382957821143,0.8836033727298687,0.5937921727395412,1.0,1.0,6/42,6.96%,LIMS1;PDGFB;FZD4;GCNT2;RSU1;CORO1C
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.31868871945724725,0.8833647661768125,0.621301775147929,1.0,1.0,16/78,11.84%,ATP2B4;STAC;ITGA3;ITGB1;ARHGEF16;ACTB;ZDHHC2;SORBS1;STAC3;PPP2R5A;AR;KIF5B;EPHA2;GPER1;DPP10;CLIP3
prerank,aspartate family amino acid catabolic process (GO:0009068),0.39639116364868626,0.8831567473841749,0.6133768352365416,1.0,1.0,4/19,7.85%,DLD;DLST;GOT1;GOT2
prerank,transcription by RNA polymerase III (GO:0006383),0.37635485204960917,0.8826454923003497,0.6118326118326118,1.0,1.0,3/27,4.85%,POLR2L;GTF3C4;ELL
prerank,chromatin assembly or disassembly (GO:0006333),0.4321835427356695,0.8823046489324263,0.5996343692870201,1.0,1.0,3/11,6.42%,CHAF1B;SUV39H2;TP53
prerank,snRNA 3'-end processing (GO:0034472),-0.31421712369142296,-0.8821258126782983,0.6491228070175439,0.9064794637103623,1.0,9/19,28.48%,INTS6;INTS2;EXOSC9;EXOSC2;EXOSC7;EXOSC3;EXOSC5;INTS14;TOE1
prerank,response to zinc ion (GO:0010043),0.3887460395276956,0.881868330558263,0.5996908809891809,1.0,1.0,2/25,3.50%,CRIP1;D2HGDH
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.30627081455892285,-0.8816034133174564,0.6260387811634349,0.906716957240819,1.0,8/19,25.87%,PRKDC;ZMIZ1;XRCC6;NCKAP1L;PPP2R3C;ZBTB1;MMP14;SYK
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3933530090770135,0.8813911559461256,0.596875,1.0,1.0,2/17,3.81%,ADRA1D;ADCY9
prerank,cellular response to unfolded protein (GO:0034620),-0.2945684037111319,-0.8813756028511937,0.6696969696969697,0.9063200744790758,1.0,12/26,29.36%,HSPA5;OPTN;PRKN;ERN1;HSPA13;BAX;HSPA9;HSF1;HSPD1;TMBIM6;PACRG;HSPA8
prerank,glucose homeostasis (GO:0042593),0.3139753759985145,0.8812644534414005,0.6155660377358491,1.0,1.0,19/83,17.43%,SLC2A4;PDK4;HK2;ALOX5;KCNB1;KLF7;IRS1;MBD5;PPARGC1A;NR1D1;HIF1A;CRTC2;PDK2;PRKAA2;MLXIPL;STAT3;SELENOT;RPS6;ADRA2A
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.34332710654215326,0.8812411289225799,0.5810439560439561,1.0,1.0,7/39,12.68%,TRPC6;FHL1;UTRN;NEDD4;AHCYL1;GPD1L;HOMER1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.2774111365824005,-0.8809694517902269,0.6476190476190476,0.9063168451015327,1.0,15/29,37.29%,ELOVL7;PPT1;ACSL3;ACLY;ACSL4;ELOVL6;HACD2;ELOVL1;ACSL1;HSD17B8;ELOVL5;GCDH;SLC25A1;SCD;ACACA
prerank,megakaryocyte differentiation (GO:0030219),0.43591061073874837,0.8808475884697478,0.5900178253119429,1.0,1.0,2/11,7.29%,THPO;MED1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.416592396293961,0.8805952384801804,0.5746527777777778,1.0,1.0,5/13,19.14%,KPNA4;KPNA2;KPNA3;CBLB;NUP54
prerank,transition metal ion homeostasis (GO:0055076),0.3692640089735393,0.8805800662422388,0.6030534351145038,1.0,1.0,4/28,10.71%,HJV;HMOX2;NEO1;SLC39A14
prerank,cellular response to UV (GO:0034644),0.31680487472243574,0.8802750056428194,0.645320197044335,1.0,1.0,11/76,11.28%,CRIP1;TAF1;TP53;PARP1;NEDD4;CHEK1;IMPACT;CERS1;RHNO1;POLD1;PRKCD
prerank,RNA processing (GO:0006396),0.29528662900491703,0.8802089992926067,0.6708994708994709,1.0,1.0,43/176,16.52%,RBPMS;HNRNPR;FASTKD5;DDX23;ATXN1;U2AF2;SFPQ;PPARGC1A;CELF1;DICER1;SF3B3;SRSF4;SNRPN;TENT4A;PRPF18;FUS;ZMAT5;DEDD2;RBM8A;MBNL1;U2AF1;DHX8;HNRNPU;PRPF4;RBM3;SF3A3;HNRNPC;RBM6;CDK12;SRRM1;DROSHA;SF3B2;SF3B1;ZCRB1;SON;SYNCRIP;PDCD7;PRKACA;FASTKD2;SRPK2;SF3A1;WBP4;PIWIL2
prerank,negative regulation of insulin secretion (GO:0046676),0.3889604837675188,0.8801978968936579,0.5886075949367089,1.0,1.0,3/17,5.88%,KCNB1;KLF7;IRS1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.31535763034584496,-0.8800823105424286,0.6354166666666666,0.9074336314355184,1.0,7/18,22.15%,SEL1L;RNF185;UGGT2;UBC;OS9;SYVN1;UBB
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.34250307480598163,0.8799314891344422,0.6263297872340425,1.0,1.0,6/45,9.58%,RBPMS;TGFB3;ACVR2A;BMPR1A;TGFB2;GDF1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4356394938752858,0.8797547564329359,0.6047297297297297,1.0,1.0,3/12,11.59%,DAB2IP;PTPN1;BOK
prerank,histone H4 deacetylation (GO:0070933),0.4364708896388123,0.8797229694170281,0.5973282442748091,1.0,1.0,4/10,19.59%,HDAC9;SIRT2;HDAC1;SMARCAD1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.3363078013571005,-0.8797227781354127,0.6384615384615384,0.9072982175177379,1.0,4/16,10.15%,BMPR2;PLCB3;DDAH1;ACE
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.39688176893177146,0.879688976354985,0.577922077922078,1.0,1.0,1/17,2.32%,PLA2G3
prerank,autophagosome maturation (GO:0097352),0.3592960308984139,0.879534681016969,0.5933232169954477,1.0,1.0,5/32,7.51%,ATP2A2;LIX1L;GABARAP;CALM1;LIX1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.30058283513954126,0.8794243697575345,0.6684491978609626,1.0,1.0,30/150,15.34%,NTF3;DMD;NTRK3;PPM1E;EMILIN1;CAV1;DAB2IP;CORO1C;CALM1;IMPACT;GSTP1;PAK2;CNKSR3;SAMSN1;SIRT2;GPD1L;PDE4D;RB1;PRKCD;CEP85;DMTN;CEP43;NCK2;DNAJC3;GNAQ;LRRK2;DVL1;MLXIPL;INPP5J;PTEN
prerank,glutathione biosynthetic process (GO:0006750),0.4375567216157367,0.8793940562226189,0.6089285714285714,1.0,1.0,5/11,20.63%,OPLAH;GGCT;CHAC2;CNDP2;HAGH
prerank,dendritic cell migration (GO:0036336),0.39647457896020194,0.8793843485726814,0.6168067226890757,1.0,1.0,4/16,12.48%,CCL5;ALOX5;TRPM4;TRPM2
prerank,myelin assembly (GO:0032288),0.4302296802237711,0.879247545577162,0.6003490401396161,1.0,1.0,3/10,15.12%,TPPP;DICER1;CNTNAP1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.31659854564106393,0.8789908212168372,0.6599045346062052,1.0,1.0,21/86,16.90%,LIMD1;ANKRD2;CUL2;PSMC6;ELOC;TP53;VEGFA;CHEK1;IMPACT;HIF1A;PSME4;BAG3;PSMB1;PSMD5;ATF3;PSMB2;PSMB7;PSMD3;PSMA2;INO80;PSMD14
prerank,regulation of establishment of cell polarity (GO:2000114),0.3926224836397769,0.8788201492810831,0.5851239669421487,1.0,1.0,4/16,12.58%,ROCK1;KANK1;ROCK2;KIF20B
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3985903317282897,0.8782987345252058,0.6038338658146964,1.0,1.0,4/18,11.82%,PMAIP1;TMEM259;BOK;USP13
prerank,regulation of primary metabolic process (GO:0080090),0.30293908245509205,0.8775225314740598,0.6517857142857143,1.0,1.0,27/126,16.90%,SMARCD3;PRKAB2;ANGPTL8;OAZ2;PSMC6;ACACB;IDI1;MED1;MVD;PPARA;NR1D1;PSME4;PSMB1;PSMD5;ROCK2;SREBF2;TGS1;PSMB2;ZFP69;EDF1;PSMB7;PSMD3;IRS2;SIN3A;SP1;PSMA2;PSMD14
prerank,carbohydrate transport (GO:0008643),0.4359780050992246,0.877479263542013,0.5953237410071942,1.0,1.0,2/11,8.04%,SLC23A2;SLC23A1
prerank,tyrosine metabolic process (GO:0006570),0.43543021431859896,0.8773000682660117,0.6003401360544217,1.0,1.0,2/11,10.78%,HGD;THAP4
prerank,regulation of ERBB signaling pathway (GO:1901184),0.41110595468070765,0.8770500456930714,0.6090604026845637,1.0,1.0,2/15,4.60%,CDH13;PTPN18
prerank,neuron fate commitment (GO:0048663),-0.3424439290464789,-0.8768262249351755,0.6432160804020101,0.9128116275135999,1.0,10/14,54.73%,TGFBR1;POU3F2;DLL4;DLL1;SHH;POU4F1;PAX6;ASCL1;ISL1;MYT1L
prerank,protein deubiquitination (GO:0016579),-0.18769295443935144,-0.8767016049218097,0.8095238095238095,0.9121700444801457,1.0,59/242,19.25%,SMAD3;ATXN3;USP46;FOXK2;USP11;ASXL2;NFKBIA;OTUD7B;WDR48;USP45;UFD1;USP19;BIRC2;ACTR8;PSMD7;USP7;USP12;PSMD9;PSMD13;MDM2;IKBKG;BRCC3;SMURF2;HCFC1;ESR1;SENP8;PRKN;OGT;PSMB3;UBC;TGFBR1;SKP2;USP3;IL33;SUDS3;PSMC5;TAB1;EP300;PSMA5;USP29;PSMA1;PSMC2;BIRC3;ATXN7;MINDY1;HGS;VCPIP1;USP37;OTUD3;SMAD2;CDC25A;EIF3F;USP24;SMAD4;SNX3;SIAH2;ZC3H12A;USP10;USP32
prerank,error-free translesion synthesis (GO:0070987),-0.2997599228736558,-0.8765642295867581,0.6628895184135978,0.9115857450103754,1.0,11/22,37.18%,UFD1;POLDIP2;UBC;REV1;UBB;RPA3;RFC3;RPA2;RPA1;RFC1;RFC4
prerank,skeletal system development (GO:0001501),0.29734176080300323,0.8762559043879762,0.6641711229946524,1.0,1.0,6/148,3.03%,SOX6;SOX5;PLS3;SNORC;ALX4;ETS2
prerank,DNA biosynthetic process (GO:0071897),0.40908580440860737,0.8761242950472133,0.5915966386554622,1.0,1.0,3/16,11.22%,TERT;WRNIP1;POLD1
prerank,positive regulation of integrin activation (GO:0033625),0.4321175442260796,0.8756960516001226,0.6,1.0,1.0,2/11,7.51%,FERMT2;PLEK
prerank,regulation of axon extension (GO:0030516),-0.26713367060662846,-0.8756566433500881,0.6830985915492958,0.9126708023218733,1.0,8/37,12.47%,APOE;SEMA7A;RUFY3;GOLGA4;RNF6;SEMA3A;CDKL3;RTN4
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.40156742043192145,0.8753287835148585,0.5952380952380952,1.0,1.0,3/14,7.71%,CHADL;SOX9;SNAI2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3428357103402297,0.8746694548546082,0.6152815013404825,1.0,1.0,9/43,12.19%,MEF2C;CCN1;FERMT2;ACVR2A;BMPR1A;YAP1;SUCO;LRP5;BMPR1B
prerank,regulation of mitochondrial fission (GO:0090140),0.3747832381657703,0.8744462078768239,0.5973451327433629,1.0,1.0,10/24,17.98%,INF2;MAPT;MIEF2;MIEF1;SPIRE1;DNM1L;MUL1;LRRK2;VPS35;MFF
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.24940434630047595,-0.8740943726902015,0.728448275862069,0.9152211153848514,1.0,14/52,15.44%,CELF2;DDX5;KHDRBS1;RBM5;RBFOX3;SRSF6;TRA2B;NOVA1;CELF4;DDX17;SMU1;RBFOX1;NOVA2;KHDRBS2
prerank,eosinophil chemotaxis (GO:0048245),0.41513513192288604,0.8737929431070238,0.6076388888888888,1.0,1.0,1/14,3.64%,CCL5
prerank,eosinophil migration (GO:0072677),0.41513513192288604,0.8737929431070238,0.6076388888888888,1.0,1.0,1/14,3.64%,CCL5
prerank,cortical cytoskeleton organization (GO:0030865),0.3400849482586454,0.8736258029974744,0.6497890295358649,1.0,1.0,7/41,11.36%,ROCK1;LCP1;RHOBTB3;PLEK;RHOF;ROCK2;RHOH
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3516925342937012,-0.8734709586592247,0.6387665198237885,0.9156861322501136,1.0,3/12,6.39%,ABCA1;NFKBIA;ITGAV
prerank,positive regulation of neuron projection development (GO:0010976),0.3084868339051558,0.8734552956019004,0.6414201183431952,1.0,1.0,5/85,2.57%,RAP1A;NTRK3;SERPINI1;PLA2G3;ROR1
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.28294057856322474,-0.8729605254530616,0.6381766381766382,0.9159259060274092,1.0,4/25,3.38%,APP;ITGA6;NRP1;EGFR
prerank,microtubule anchoring at centrosome (GO:0034454),0.43835435399282785,0.8726903081419566,0.6145454545454545,1.0,1.0,1/10,2.05%,CCDC68
prerank,microtubule anchoring (GO:0034453),0.41756624010646937,0.872414352726785,0.6036697247706422,1.0,1.0,2/12,4.48%,CLASP2;BICD2
prerank,regulation of dendrite extension (GO:1903859),-0.32103850016506996,-0.8723729668405286,0.6306532663316583,0.916341703104966,1.0,8/18,36.93%,NEDD4L;SYT1;RIMS2;SYT2;SYT3;PLAA;CPNE5;CPNE9
prerank,regulation of protein phosphorylation (GO:0001932),0.28818179231074675,0.871961678310461,0.717234262125903,1.0,1.0,41/256,13.57%,TTN;NTRK3;ANGPT1;FGF1;HRC;PLCE1;CCN1;CCND2;THPO;FAM20A;SMG8;ACVR2A;MUSK;CAMKK2;RARRES2;DAB2IP;VEGFA;PPP2R5A;PIN1;CORO1C;RASGRP1;ITGB3;SOX9;ANKRD54;CCND1;ADAM17;IMPACT;RAP2A;PELI2;PDGFA;GPER1;ROCK2;ATF3;CLIP3;TNIK;AKTIP;CHRNA7;FNIP2;FGF10;PLXNB2;GAS6
prerank,regulation of BMP signaling pathway (GO:0030510),0.32103695700028007,0.8717534641699595,0.635280095351609,1.0,1.0,7/73,5.14%,RBPMS2;CRIM1;CCN1;ITGA3;FST;ACVR2A;BMPR1A
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3476841161623069,0.8716653976816359,0.5926966292134831,1.0,1.0,3/31,4.75%,CACNA1H;SYT10;KCNB1
prerank,tRNA methylation (GO:0030488),0.35946619055527623,0.871579816979534,0.5985815602836879,1.0,1.0,8/34,16.95%,HSD17B10;TRDMT1;FTSJ1;TRMT10C;METTL6;NSUN2;TRMT44;WDR6
prerank,axonal transport of mitochondrion (GO:0019896),0.42949958926496945,0.8713389501866801,0.6170212765957447,1.0,1.0,4/11,9.57%,MAPT;OPA1;TRAK1;HIF1A
prerank,cardiac conduction system development (GO:0003161),0.377765174329186,0.8712407147736053,0.6182380216383307,1.0,1.0,3/24,5.24%,HEY2;BMPR1A;TBX18
prerank,stress-activated MAPK cascade (GO:0051403),0.3257959925250535,0.8712195002440674,0.6491228070175439,1.0,1.0,8/61,14.04%,MAP3K20;MAP3K5;MAP4K3;MAP3K10;FBXW11;ZFP36L1;MAP2K3;MAPK1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.369635338846504,0.8711768820099113,0.6251851851851852,1.0,1.0,14/26,23.23%,DAB2IP;DUSP3;MED1;GAREM1;SOX9;SNAI2;ZFP36L1;KNSTRN;PTPN12;ERBB2;ZFP36L2;DUSP22;ZPR1;PLCG1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.28085451538172235,0.8705430485497154,0.949,1.0,1.0,261/1646,15.59%,ACTA2;MYOCD;SOX6;MLF2;PRDM16;SOX5;TNNI2;WTIP;MEF2C;ATP2B4;HEY2;MAP3K5;ZFHX3;TBX2;SMARCD3;PTP4A3;LBH;NR1H4;POLR2L;LIMS1;EBF1;LIMD1;TCIM;PDGFB;ZEB2;NAB1;ATP8B1;ALX4;RORA;MLF1;ID4;NR4A1;EBF2;SIM2;LOXL2;GABPA;PRRX1;ETS2;ARID5B;IFRD1;RUNX1T1;HEYL;TEAD3;PBXIP1;CAMK2D;IRX5;FZD4;HINFP;BRIP1;TGFB3;GMNN;ZNF436;FOSL2;RBAK;NACC2;NUP62;PRDM1;HDAC9;ARID1A;SET;NR2F2;TGFB1I1;ANKRD2;NR2C1;VEZF1;MTERF3;CAMKK2;ATXN1;OSR2;PIAS4;CBFB;SP7;KLF7;CCNQ;CEP290;TBX18;MEF2A;GBX1;DYRK1A;NCOA7;KLF16;PRKCQ;MTDH;TESC;DBP;FOXJ3;KLF15;SUV39H2;MYBBP1A;JUND;SMARCB1;CHD2;DAB2IP;ELOC;ARID5A;TP53;RXRG;VEGFA;DYRK1B;PPM1A;GRHL1;ZNF418;HEXIM1;ZBTB38;HDGFL3;SFPQ;HOXC4;BCL7A;PA2G4;AR;PPARGC1A;ZFP28;L3MBTL2;MED1;PPARGC1B;ZNF431;MED29;REXO4;BTG1;YAP1;ERCC6;MED12;SOX9;SNAI2;HSF4;RELA;ZFP62;PLCB1;KMT2D;SETD3;MAP3K10;DAPK3;CUX2;EPC2;ZXDC;ZKSCAN4;PPARA;TRAK1;CBX4;BBX;MAP2K1;MED13L;MSL3;CARF;CCNT1;FUS;NSD3;MTA3;NR4A2;PPIE;NR1D1;LRRFIP1;KAT7;ZBTB33;HIF1A;CRLF3;SFR1;ZBTB41;SIRT2;DEDD2;MIDEAS;PCGF6;SPINDOC;CDK18;ZNF3;NAT14;MED14;NR2C2;NUP107;TEAD1;RAI1;SRSF10;PCGF5;SREBF2;RUNX1;RB1;LRP5;RHOH;ATF3;PIAS2;HOXC8;NKX6-1;ZKSCAN1;BAZ2A;ZBTB7A;NFX1;ACVR1B;ESRRA;CNOT7;PSPC1;LCORL;USP13;FBXW11;RUVBL1;LIN9;TSFM;CSRNP3;HDGFL2;TOX4;CITED2;CTDSP1;NR6A1;POU3F3;ZXDB;SMARCA5;MED8;ZBTB10;ZNF83;CDK15;ZFP69;MXD4;PPP3CB;BCL6;CHD4;IKZF1;CASZ1;MEF2B;HMG20A;FOXJ1;TRIM28;SPIN1;GAS6;ZBTB5;MAP2K3;RFX7;ZKSCAN7;CLOCK;ETV3;HOPX;ZNF276;ZBTB4;SP4;RFX1;EDF1;DVL1;MAPRE3;EBF3;VGLL4;UXT;IRF2BPL;PCGF3;MLXIPL;ZNF711;KLF6;KARS1;FBXO5;HOXB2;POFUT1;ZSCAN22;KDM2B;URI1;RHOG;RBM15;CIAO1;STAT1;DNM2;YWHAH;HOXC5;NR5A1;MAGED1;NOS1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.33145387235170953,0.8700598249427787,0.6372924648786717,1.0,1.0,13/57,13.95%,PMAIP1;CAMKK2;TP53;PPARGC1A;MIEF2;MIEF1;SPIRE1;HRK;DNM1L;GPER1;BOK;MUL1;ADCK1
prerank,steroid hormone biosynthetic process (GO:0120178),0.3574379487493713,0.869952070202808,0.5984962406015037,1.0,1.0,4/29,11.04%,HSD17B7;AKR1B1;MED1;SRD5A3
prerank,glycosphingolipid metabolic process (GO:0006687),0.34286599198974,0.8698581909878329,0.6208791208791209,1.0,1.0,11/42,14.95%,ESYT2;LARGE1;NEU3;GLA;SUMF1;ST8SIA5;A4GALT;GM2A;GLTP;GLB1;CTSA
prerank,regulation of ion transport (GO:0043269),-0.22501403314206023,-0.8693818860125923,0.7696335078534031,0.9218967090609737,1.0,16/76,14.72%,NEDD4L;WNK1;B2M;NKAIN3;SYT1;CA2;NKAIN4;DTNBP1;SIK1;PRKN;KCNJ13;SNX6;PER1;SNCA;SYT11;SYT12
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3246982574519218,-0.8693568944301855,0.653012048192771,0.9210333676086547,1.0,5/16,14.87%,DCPS;SNRNP200;CWC15;SFSWAP;NCBP2
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.33537072391619643,-0.8691177607721687,0.6240409207161125,0.9206012433415725,1.0,7/13,29.79%,SDAD1;NUP88;NMD3;NOP9;RAN;RRS1;RPS15
prerank,negative regulation of protein secretion (GO:0050709),-0.26197286700597044,-0.8685856742200204,0.6586206896551724,0.9208639261664964,1.0,9/38,13.40%,APOE;ERP29;PSMD9;CCN3;RAB11FIP5;PRKN;CYP51A1;HMGCR;RAB11FIP1
prerank,positive regulation of neuron death (GO:1901216),-0.24708853813613396,-0.8685119338103676,0.6752136752136753,0.9201104424611427,1.0,5/46,3.76%,NF1;EPHA7;EFNB2;NUPR1;WNT5A
prerank,cellular response to acid chemical (GO:0071229),0.3627476590960155,0.8684744689622959,0.6058282208588958,1.0,1.0,7/27,12.51%,LARS1;CPEB1;VEGFA;CAPN2;RRAGB;SH3BP4;CPEB3
prerank,regulation of cell cycle phase transition (GO:1901987),0.3117706599279057,0.8682167473707747,0.6536643026004728,1.0,1.0,21/91,17.86%,ATP2B4;TCIM;ANAPC10;MN1;TAF1;PSMC6;TP53;FBXW7;UBE2E1;PSME4;PSMB1;PSMD5;UBE2D1;PSMB2;PSMB7;PSMD3;FBXO5;PSMA2;PSMD14;ANAPC16;ANAPC5
prerank,regulation of defense response to virus by host (GO:0050691),0.3614500244853105,0.8681812645245599,0.6193181818181818,1.0,1.0,8/30,17.63%,CGAS;IL12RB1;ZDHHC1;MUL1;STAT1;SIN3A;DHX9;EIF2AK4
prerank,lung epithelium development (GO:0060428),-0.3734161389818283,-0.8681709437577206,0.6409185803757829,0.9199425266679419,1.0,2/10,12.24%,BMP4;RCN3
prerank,response to iron ion (GO:0010039),-0.3642400585805697,-0.8677599137458507,0.6240786240786241,0.9199271619944612,1.0,4/12,14.15%,BMP6;B2M;ACO1;SNCA
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.35766470999530997,0.8672079102833047,0.6120448179271709,1.0,1.0,4/33,4.59%,CDK6;FHL1;NACC2;JADE1
prerank,regulation of endocytosis (GO:0030100),0.32633143754723154,0.8671608619091106,0.6403508771929824,1.0,1.0,7/61,6.82%,ROCK1;HIP1;CDH13;PACSIN3;PACSIN2;CBLL1;PTPN1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.2601661319668221,-0.866849133383029,0.6607142857142857,0.9209855567004652,1.0,21/37,38.29%,ERCC5;DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;ERCC1;ERCC4;RPA3;RFC3;RPA2;ERCC3;POLD3;RPA1;RFC1;RFC4;NTHL1
prerank,positive regulation of inflammatory response (GO:0050729),0.30866105059039833,0.8666256538850527,0.6577669902912622,1.0,1.0,5/86,3.61%,AGTR1;PLA2G3;IL2;LPL;FEM1A
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.38752871298661984,0.8662894943517426,0.6168067226890757,1.0,1.0,6/17,15.87%,VEZF1;BTG1;SOX9;NKX6-1;FOXJ1;RFX3
prerank,icosanoid biosynthetic process (GO:0046456),0.4379476734231489,0.8662713877069116,0.5866425992779783,1.0,1.0,2/10,14.18%,ALOX5;PLA2G4A
prerank,snRNA metabolic process (GO:0016073),-0.32013688647855004,-0.8659747859601367,0.634020618556701,0.922018863330435,1.0,5/17,23.70%,INTS6;INTS3;INTS2;RBM7;INTS11
prerank,erythrocyte differentiation (GO:0030218),-0.25361994320801634,-0.8658822844622434,0.6831275720164609,0.9213058749344318,1.0,13/44,26.07%,TGFBR3;KMT2E;KIT;RPS19;ALAS1;LYN;HSPA9;SLC25A38;NCKAP1L;PTPN2;TAL1;UBA5;ZFPM1
prerank,intracellular cholesterol transport (GO:0032367),-0.3307731124066621,-0.8654640740465995,0.6666666666666666,0.9213271471642094,1.0,6/15,23.59%,ABCA1;LDLR;STARD4;OSBP;RELCH;NPC1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.31102391422904047,0.8652595976055037,0.6759581881533101,1.0,1.0,14/86,12.51%,RBPMS;CCN1;ZEB2;TGFB3;ACVR2A;TGFB1I1;BMPR1A;SLC2A10;TGFB2;ADAM17;GDF1;ACVR1B;BMPR1B;CITED2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.40653314850672834,0.8651487639505657,0.6258992805755396,1.0,1.0,2/14,5.41%,CCL5;RARRES2
prerank,ncRNA processing (GO:0034470),-0.2007763633058451,-0.8650596104142528,0.8863636363636364,0.9213162457275358,1.0,77/200,30.28%,SMAD3;AGO3;INTS6;RPL27A;SRRT;RPS19;SENP3;NVL;RPL21;RPS24;RPL36;RPL18;METTL3;INTS3;SSB;POP1;RPLP0;DIS3;C1D;EXOSC1;RPL28;WDR3;RPLP1;INTS2;RPL23A;RPL34;RRP36;MPHOSPH10;FCF1;ADAR;EXOSC9;RPL36A;NOP53;SMAD2;AARS1;TUT4;RPL9;DDX52;RPS7;RPL27;TUT7;RPL11;RPL18A;RPL37A;RPL38;RRP7A;EMG1;DCAF13;RPL29;EXOSC2;EBNA1BP2;UTP20;RPL10A;INTS11;RPL32;BYSL;NOL11;NOP56;EXOSC7;EXOSC3;UTP18;RPS27;HEATR1;NOLC1;IMP3;WDR18;EXOSC5;PIH1D1;AGO4;PES1;RPL4;UTP6;FBL;RPS15;RPL35A;NOL8;POP4
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.32057036441504744,-0.8649247914610912,0.6432432432432432,0.9206587614223253,1.0,7/17,23.42%,RNF20;CTR9;VIRMA;NCBP2;ZC3H3;HSF1;CPSF6
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.29646636984585556,-0.8649007000476604,0.6544502617801047,0.9198089928068774,1.0,7/22,22.94%,SASH1;XDH;RELL1;MAP3K4;ZC3H12A;GADD45B;SPHK1
prerank,regulation of pH (GO:0006885),0.4235005698429955,0.8647128190147857,0.5972222222222222,1.0,1.0,1/11,2.53%,PDK4
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.21811044023206846,-0.8645142741484996,0.7612903225806451,0.9197160695223063,1.0,32/80,28.66%,DENND2A;GBF1;VTI1A;TMEM87B;STX5;TBC1D5;GCC2;HEATR5A;SURF4;SNX6;RBSN;RAB29;YKT6;LMAN1;SNX3;VPS53;RAB9A;TBC1D10A;EHD3;VPS52;STX6;TBC1D14;BET1L;UBE2O;ARL1;ERC1;BAIAP3;GOSR1;PHETA1;DENND5A;RIC1;SNX12
prerank,regulation of stem cell population maintenance (GO:2000036),-0.3205553086796572,-0.8636249271707109,0.6259541984732825,0.9207367274600984,1.0,1/18,0.13%,PTN
prerank,positive regulation of dendrite extension (GO:1903861),-0.32776514960825254,-0.8636030002214168,0.648854961832061,0.9198825037972181,1.0,8/17,36.93%,NEDD4L;SYT1;RIMS2;SYT2;SYT3;PLAA;CPNE5;CPNE9
prerank,gland development (GO:0048732),0.3267004293134388,0.8634750239473761,0.6495507060333762,1.0,1.0,10/59,13.32%,TG;ANXA1;ARID5B;TGFB3;CAV1;SOX9;ARHGAP35;GFER;CITED2;FGF10
prerank,positive regulation of protein kinase activity (GO:0045860),0.2953536108450691,0.8634682668362628,0.6898047722342733,1.0,1.0,26/148,13.61%,RAP1A;PDGFB;CCN1;SLC8A2;CCL5;MMD;DOK7;DAB2IP;VEGFA;PTPN1;CALM1;TPX2;LCP2;ITGB3;TGFB2;MAP2K1;PAK2;CENPE;PRKCD;TNIK;CLU;SNX9;PDCD10;TAOK3;GAS6;MAP2K3
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.2246550342258232,-0.8633888229852126,0.779874213836478,0.9194189847595806,1.0,29/72,30.19%,MRE11;RAD50;FBH1;ERCC5;FAN1;DDB1;UBC;RNASE4;ENPP1;CHD1L;XPA;EDC4;GTF2H5;GTF2H2;ZC3H12A;PNRC2;GTF2H3;UBB;ERCC2;EDC3;ERCC1;ERCC4;SPO11;MUS81;OGG1;RPA3;DNA2;PDE12;RFC3
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.36828608398351437,0.862671698582843,0.625748502994012,1.0,1.0,4/27,3.64%,CSPG4;CHSY3;CSGALNACT1;BGN
prerank,lipid homeostasis (GO:0055088),-0.2407094008519824,-0.8621882338274449,0.7455357142857143,0.9210991911826829,1.0,5/57,2.55%,ZBTB20;RBP1;APOE;ABCA1;DDX3X
prerank,cell projection assembly (GO:0030031),0.3782008574824118,0.8613190403729166,0.6533127889060092,1.0,1.0,6/22,15.31%,RHOJ;CYFIP1;PARVA;PDGFA;RHOH;RHOG
prerank,chondroitin sulfate catabolic process (GO:0030207),0.41399193584746175,0.8610918320731221,0.6382608695652174,1.0,1.0,2/13,3.64%,CSPG4;BGN
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3064108208484975,0.8606033875570597,0.6632882882882883,1.0,1.0,17/104,12.63%,CCNA2;CCND2;SLC8A2;SLC8A1;KSR1;ACTB;DAB2IP;CALM1;CCND1;MAP2K1;CCNT1;CDK7;RB1;LRP5;CDK12;TSG101;PDCD10
prerank,carbohydrate homeostasis (GO:0033500),0.31863051761601624,0.8602365076274833,0.6613300492610837,1.0,1.0,7/67,5.92%,SLC2A4;PDK4;ALOX5;KCNB1;KLF7;IRS1;MBD5
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3093285128082972,0.8600955795785655,0.6691176470588235,1.0,1.0,18/79,15.69%,DYNLL1;KIF2A;LAG3;KIF3B;DCTN6;SEC13;CENPE;DYNC1I2;KIFAP3;KIF5A;SEC24A;CAPZB;DCTN3;SEC24C;KIF18A;MFSD6;DNM2;AP1S3
prerank,camera-type eye morphogenesis (GO:0048593),0.4242185204006595,0.8598931575573882,0.5818181818181818,1.0,1.0,3/10,9.18%,TBX2;VEGFA;SKI
prerank,cellular amide metabolic process (GO:0043603),-0.2109383766337942,-0.8594938810651065,0.7857142857142857,0.9258813821115225,1.0,24/102,22.28%,AEBP1;CERK;ST3GAL1;PPP2CA;SLC25A32;PCCA;NAAA;NAPEPLD;ACSF2;ASAH2;ACOT8;DBI;ACOT9;PLAAT3;CPD;CPXM1;MTHFS;ALDH1L1;FPGS;ABCB9;MCCC1;ATF4;ABCA2;PDZD11
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.3278452965369974,-0.8583651197755128,0.6519337016574586,0.9273973843468755,1.0,5/15,24.18%,ZC3H12B;POP1;ZC3H12C;ZC3H12A;KHNYN
prerank,endomembrane system organization (GO:0010256),0.2898772953812013,0.8583219074973607,0.7291220556745182,1.0,1.0,36/178,17.67%,ARHGEF7;FER1L5;SYNE1;ATP8B1;DYSF;CLASP2;HOOK2;TBC1D20;ARHGAP21;LNPK;MYO18A;SEC31B;SUN2;HOOK1;NSFL1C;DNM1L;TLCD2;OSBPL2;CHMP2B;USP50;DMPK;AKTIP;PLEKHJ1;A4GALT;CLASP1;BNIP1;LRRK2;CSNK1A1;CAV2;SUN1;EIF2AK3;TRAPPC12;VPS51;UBXN2B;VPS4A;ARFGEF2
prerank,regulation of TORC1 signaling (GO:1903432),0.3538709515490108,0.8581822222036989,0.6443148688046647,1.0,1.0,5/33,9.52%,RNF152;LARS1;KPTN;CASTOR1;RRAGB
prerank,negative regulation of cilium assembly (GO:1902018),-0.350470409873087,-0.8581617712574362,0.6497584541062802,0.9269215822029537,1.0,7/12,29.21%,LIMK2;CEP97;TBC1D30;ODF2L;TBC1D7;CCP110;TESK1
prerank,regulation of cellular response to heat (GO:1900034),0.3169154220984228,0.8578030033368081,0.6714116251482799,1.0,1.0,24/77,20.93%,CAMK2G;CAMK2D;NUP62;MAPT;MAPKAPK2;SEC13;NUP153;BAG3;NUP107;AAAS;BAG2;NUP98;MAPK1;NUP37;NUP210;FKBP4;HSPB8;DNAJB6;NUP54;NUP160;NUP133;HIKESHI;TPR;PTGES3
prerank,ribosome assembly (GO:0042255),0.3296614076040535,0.8576646092097004,0.6364812419146184,1.0,1.0,7/47,9.57%,RPL3L;MTERF3;RPS27L;NLE1;MDN1;PWP2;RPL5
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.2925005333213717,-0.8576131409557091,0.6744186046511628,0.9272369400154417,1.0,6/23,20.22%,HSP90AB1;IRGM;PARP14;PPARG;NLRC5;PTPN2
prerank,positive regulation of superoxide anion generation (GO:0032930),0.407284844496148,0.8575978076319233,0.5942760942760943,1.0,1.0,3/13,11.28%,MAPT;GSTP1;PRKCD
prerank,cell-cell junction organization (GO:0045216),0.31134131744754345,0.8570072579729819,0.6866746698679472,1.0,1.0,11/79,8.70%,CDH6;LIMS1;GJC1;CDH13;TGFB3;CDH4;CDHR3;LIMS2;TLN1;TGFB2;CDH2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.2979268411418993,-0.8568424349825525,0.6597402597402597,0.9279884002340142,1.0,10/22,24.55%,DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;RAD23B
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3200281181828301,0.8567046834596196,0.66875,1.0,1.0,13/64,13.03%,POLR2L;POLR2I;ADRM1;GTF2H4;ELL;POLR2G;ELOC;CCNT1;CDK7;POLR1E;CDK12;NELFB;POLR2J
prerank,cellular response to metal ion (GO:0071248),0.2986637239987716,0.8566797161953751,0.681465038845727,1.0,1.0,8/123,5.58%,RYR1;MEF2C;CACNA1H;RASGRP2;CAMK2D;SYT10;MEF2A;KCNH1
prerank,gas transport (GO:0015669),0.42734214022546674,0.8562772336146238,0.621268656716418,1.0,1.0,1/10,2.97%,MB
prerank,positive regulation of T cell differentiation (GO:0045582),-0.26133654994334754,-0.8561532546848443,0.6868327402135231,0.9285163028186381,1.0,7/36,19.77%,LEF1;GLI2;ZMIZ1;CD46;SOX4;NCKAP1L;PNP
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.23793116690036734,-0.855863089455452,0.7746478873239436,0.9282201314034033,1.0,22/57,24.02%,CDC14B;PRKDC;MRE11;RINT1;BRCC3;ATF2;MDC1;BLM;NBN;TAOK1;FOXN3;NOP53;HUS1;CHEK2;ATM;FBXO31;HMGA2;TAOK2;TRIM39;CLSPN;CDK2;CDKN1A
prerank,positive regulation of phosphorylation (GO:0042327),0.2834518374856314,0.8552538035899021,0.755440414507772,1.0,1.0,47/240,15.72%,NTRK3;ANGPT1;FGF1;MERTK;MST1R;CCN1;ROR1;CCND2;THPO;FAM20A;CCL5;PFKFB1;ACVR2A;MUSK;CAMKK2;RARRES2;DSCAM;VEGFA;PIN1;AR;RASGRP1;ITGB3;SOX9;CCND1;ADAM17;EPHA2;HIF1A;AXL;RAP2A;PDGFRB;PELI2;GPER1;ROCK2;CLIP3;TNIK;AKTIP;CHRNA7;FGF10;GAS6;EPHB1;LRRK2;PRKAA2;MLXIPL;GAPDHS;MYDGF;FLOT1;VAC14
prerank,regulation of microtubule-based movement (GO:0060632),-0.35366224713626054,-0.8552421332498316,0.6495535714285714,0.9286291687040048,1.0,7/11,46.42%,IGBP1;DYNLT2B;LAMP1;DRC1;HAP1;CCDC65;CFAP298
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2640200981978179,-0.8552083587369126,0.6945337620578779,0.9278057673301167,1.0,8/31,13.57%,TNKS2;MRE11;PML;RAD50;GNL3;NBN;MAP3K4;HNRNPD
prerank,aerobic respiration (GO:0009060),0.36970019267537974,0.8552017455131248,0.6170886075949367,1.0,1.0,3/20,5.60%,SIRT3;ME3;SDHC
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.3857839145894979,0.8551272790497926,0.6284779050736498,1.0,1.0,4/18,9.74%,LAX1;DUSP3;PPARA;PAG1
prerank,cognition (GO:0050890),0.3364339351731732,0.8551019304325386,0.6436170212765957,1.0,1.0,7/42,12.38%,LHCGR;SLC8A2;CYFIP1;CUX2;HRH3;CHMP2B;CHRNA7
prerank,endocytic recycling (GO:0032456),0.3289745747335905,0.855033061156053,0.6388174807197944,1.0,1.0,15/50,17.39%,EHD2;ANKRD50;VPS26A;WASHC1;RAB11FIP3;RAB11FIP4;DENND1A;VPS35L;VPS50;RAB14;ANKRD27;SNX17;VPS35;SNX4;VPS51
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.21878640245219402,-0.8549490555765831,0.781021897810219,0.9274501698423342,1.0,34/94,28.00%,NOD1;NFKBIA;IRAK1;PSMD7;PSMD9;PSMD13;IRAK3;PELI1;MAP3K3;IKBKG;TAB2;PSMB3;IRAK2;UBC;CHUK;PSMC5;TAB1;PSMA5;PSMA1;PSMC2;TOLLIP;BTRC;IL1RAP;PSME3;UBB;PSMC4;PSMB6;IRAK4;PSMB10;PELI3;RPS6KA4;PSMA4;SQSTM1;PSME1
prerank,acylglycerol catabolic process (GO:0046464),0.3545844588845476,0.8547710874305156,0.6407185628742516,1.0,1.0,4/30,13.34%,LPL;FABP4;MGLL;PNPLA3
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.3097332191853247,-0.8547299754531407,0.6837837837837838,0.927023074840556,1.0,6/18,26.60%,FBN1;TCTA;TLR3;GPR137B;MAFB;GPR137
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.32238555153055154,0.8545767233918756,0.6311053984575835,1.0,1.0,11/46,11.75%,EMILIN1;DAB2IP;DUSP3;PIN1;PTPN1;WNK2;TNIP1;GSTP1;CNKSR3;GPER1;DUSP29
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.2249556328610963,-0.8541564646776807,0.7664670658682635,0.9273145137517138,1.0,8/68,8.49%,HMGB1;APP;PTPN11;LBP;WNT5A;LGALS9;PLCG2;IL6R
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.35858273429450593,0.8541026249995901,0.6711111111111111,1.0,1.0,9/30,18.33%,FZD5;SAE1;FBXW7;SREBF2;HPS4;ATG13;LEPROT;USP36;TOMM7
prerank,iron-sulfur cluster assembly (GO:0016226),0.3638468312417964,0.8540806228733037,0.6081504702194357,1.0,1.0,8/24,15.36%,FXN;GLRX5;ISCA1;ISCA2;NUBP2;NUBP1;GLRX3;CIAO1
prerank,regulation of plasminogen activation (GO:0010755),0.41083193698261405,0.854005875814689,0.6256781193490054,1.0,1.0,2/12,11.12%,SERPINE2;RUNX1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.3399586788962868,-0.8538873471962142,0.6714628297362111,0.9269772903368949,1.0,5/13,21.19%,GLUL;ASPA;ACOT8;MTHFS;GAD1
prerank,cellular component disassembly (GO:0022411),0.31382690024482485,0.8531582597141298,0.6368286445012787,1.0,1.0,7/53,9.08%,ADAMTS5;HTRA1;KLK2;LCP1;LAMC1;WASHC1;CAPN2
prerank,regulation of melanin biosynthetic process (GO:0048021),0.4257564699759591,0.8529515517357811,0.6235955056179775,1.0,1.0,1/10,2.16%,ZEB2
prerank,endodermal cell differentiation (GO:0035987),0.3454191792094249,0.852659890708295,0.6306818181818182,1.0,1.0,4/31,8.26%,COL4A2;ITGA7;ITGB5;ITGA4
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.2228405108103491,-0.8525532790908211,0.7590361445783133,0.9288088651640902,1.0,27/72,29.00%,IRAK1;BIRC2;PSMD7;PSMD9;PSMD13;CARD10;PSMB3;CHUK;CARD14;PSMC5;PSMA5;PSMA1;PSMC2;BIRC3;RELB;AKT1;TLR3;TIRAP;BTRC;PSME3;PSMC4;PSMB6;PSMB10;NFKB2;PSMA4;PSME1;PSMF1
prerank,dendritic cell chemotaxis (GO:0002407),0.3949531342197735,0.8524863267701279,0.6503496503496503,1.0,1.0,3/14,12.48%,CCL5;TRPM4;TRPM2
prerank,negative regulation of TOR signaling (GO:0032007),0.3423553842486039,0.8523729523113147,0.6477900552486188,1.0,1.0,9/36,15.37%,RNF152;KPTN;CASTOR1;EPM2A;NPRL2;SH3BP4;PRKAA2;CASTOR2;ITFG2
prerank,membrane fusion (GO:0061025),0.34614455516950804,0.8512945202718663,0.6599131693198264,1.0,1.0,10/33,17.84%,FER1L5;DYSF;OPA1;GCA;NSFL1C;DNM1L;NSF;DNM2;UBXN2B;SNAP23
prerank,cellular copper ion homeostasis (GO:0006878),-0.33339511770093366,-0.8512804784795446,0.6556122448979592,0.9305088669663153,1.0,4/14,22.59%,APP;ATOX1;MT2A;SLC31A1
prerank,sterol biosynthetic process (GO:0016126),-0.27108173966603233,-0.8512543628708729,0.7346938775510204,0.9296835561865763,1.0,12/33,25.00%,PRKAG2;LBR;GGPS1;CYP51A1;HMGCR;ACLY;ARV1;INSIG1;SQLE;PMVK;LSS;MVK
prerank,transition metal ion transport (GO:0000041),0.34606367311225983,0.8508497846810322,0.6371308016877637,1.0,1.0,8/35,16.64%,TRPC6;TTYH1;TRPC5;SLC30A5;ATP7B;SLC31A2;IREB2;MT3
prerank,intraciliary retrograde transport (GO:0035721),-0.3439648632850895,-0.85040036881349,0.6921182266009852,0.9305956644535713,1.0,5/12,28.51%,IFT122;DYNC2H1;DYNLT2B;DYNC2I2;DYNC2I1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.2822025626662892,-0.850045908759902,0.7124600638977636,0.9304843405030124,1.0,8/27,18.54%,CHKA;LPIN2;NAAA;NAPEPLD;PLA2G6;PLAAT3;SELENOI;LPIN3
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.32445122077574573,-0.8499589598113585,0.6437346437346437,0.9297901164675088,1.0,10/14,59.16%,ATP6AP1;TYROBP;POU4F1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3349012112970545,0.8499484275530557,0.6565096952908587,1.0,1.0,7/41,10.48%,PDGFB;DOK7;FBXW7;PTPN1;AREG;ADAM17;HBEGF
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.29726759561003613,0.8498305492375607,0.7142857142857143,1.0,1.0,35/119,19.44%,PIP5K1B;INPP4B;PIP4K2A;MTMR7;SOCS5;PITPNM3;PIGN;SOCS6;SOCS4;SYNJ2;PIGA;SACM1L;TTC7A;INPPL1;MTMR14;ITPKC;CDIPT;SBF1;PIK3C3;RAB14;PLEKHA1;PIGH;INPP5J;PIGB;PITPNM2;PTEN;VAC14;PIGP;DPM2;PLEKHA2;MTMR3;INPP4A;MBOAT7;PIK3R2;PGAP4
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.40028453574856293,0.8493317517304365,0.632183908045977,1.0,1.0,2/15,7.86%,TGFB3;TGFB2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3189091847185122,0.8491619431958309,0.6637390213299874,1.0,1.0,8/56,9.58%,RBPMS;TGFB3;ACVR2A;BMPR1A;EMILIN1;PIN1;TGFB2;GDF1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.35705301630989883,-0.8489687740914543,0.6550868486352357,0.9309063833331261,1.0,4/11,20.41%,HMGB1;LGALS9;TWSG1;CD274
prerank,isotype switching (GO:0045190),-0.358377207286463,-0.84878841632387,0.6495726495726496,0.9303895768241606,1.0,5/10,35.66%,MSH6;HSPD1;EXOSC3;BATF;LIG4
prerank,cellular response to dsRNA (GO:0071359),0.400589823663616,0.8486015048091144,0.6074313408723748,1.0,1.0,5/15,16.80%,CGAS;CAV1;MUL1;FLOT1;DHX9
prerank,extracellular matrix disassembly (GO:0022617),0.3134782219893608,0.8484726619633549,0.6373056994818653,1.0,1.0,7/53,9.08%,ADAMTS5;HTRA1;KLK2;LCP1;LAMC1;WASHC1;CAPN2
prerank,regulation of keratinocyte migration (GO:0051547),0.4119023509177265,0.848364112250791,0.6159292035398231,1.0,1.0,5/12,24.11%,MAPRE2;FGF10;PTEN;ADAM9;IQSEC1
prerank,fatty acid metabolic process (GO:0006631),0.295149342306448,0.8479866295580664,0.699205448354143,1.0,1.0,18/115,14.01%,CD36;LPL;FA2H;ALOX5;PEX2;ACSL5;PPARGC1A;CPT1B;CRAT;MECR;PPARA;THEM4;NUDT19;AOAH;NDUFAB1;PNPLA3;CPT1A;ACOT6
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3583651556743871,-0.8477682666407629,0.6796116504854369,0.9315511487869437,1.0,5/10,44.88%,LGALS9;CEACAM1;ARRB2;FCGR2B;LILRB1
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.2709734213255778,-0.8476192735521711,0.7217125382262997,0.930970041843971,1.0,14/30,31.42%,ELOVL7;HACD4;ABCD3;ACOX1;ELOVL4;ELOVL6;HACD2;SLC27A4;ELOVL1;HACD3;ACSL1;ELOVL5;TECRL;SLC27A2
prerank,response to histamine (GO:0034776),0.4259734657285241,0.8474203280190149,0.649155722326454,1.0,1.0,2/10,11.98%,GABRB2;GABRB3
prerank,protein homooligomerization (GO:0051260),0.2963836068886574,0.8468887146110582,0.681766704416761,1.0,1.0,16/114,13.72%,RYR1;KCNJ12;HSD17B10;CRYZ;NACC2;ACACB;TIFA;TRPM4;FUS;SLC1A5;ALDOA;GLS;OSBPL2;TRPM2;CHMP2A;VSTM5
prerank,phosphate ion homeostasis (GO:0055062),-0.36601296651339166,-0.846763460367214,0.6542669584245077,0.9318080572248361,1.0,3/10,21.26%,SFRP4;ENPP1;FGFR4
prerank,mitochondrial fission (GO:0000266),-0.32152196184823534,-0.8465579692197561,0.6519480519480519,0.9313346414017393,1.0,5/16,15.32%,DNM3;DNM1;MTFR1;PRKN;FIS1
prerank,regulation of T cell activation (GO:0050863),0.32970428971789373,0.8461924322031689,0.6589986468200271,1.0,1.0,5/42,9.74%,CCL5;LAX1;PRKCQ;DUSP3;PAG1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.29287648360252405,0.8461230321988835,0.7075365579302587,1.0,1.0,16/124,11.49%,TPM1;ROCK1;FRY;ARMC2;BTG2;MAPT;GDNF;HDGFL3;NEDD4;CYFIP1;PLEK;ERCC6;ATCAY;SAMD14;RB1;KIFAP3
prerank,phagosome maturation (GO:0090382),0.33928426389324484,0.8459655350765442,0.6345609065155807,1.0,1.0,16/35,25.66%,ATP6V1H;ATP6V0A2;MREG;ATP6V1C1;ATP6V0D2;RAB14;RAB34;RAB38;ATP6V0C;PIKFYVE;ATP6V1F;ATP6V0E1;ATP6V1B2;ATP6V1G2;ATP6V0A1;RAB7A
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.33195683496189077,-0.8457947896712207,0.6987951807228916,0.9319828325428935,1.0,5/13,30.92%,RPS21;NOP9;UTP20;RRS1;TBL3
prerank,response to X-ray (GO:0010165),-0.32975409298252634,-0.8456400101969267,0.6674641148325359,0.9314123973630947,1.0,7/14,23.64%,XRCC5;BRCC3;BLM;XRCC6;ATM;IKBIP;NUCKS1
prerank,calcium import into the mitochondrion (GO:0036444),-0.35971936681539657,-0.8454829573407217,0.6910755148741419,0.9308397082940442,1.0,4/10,14.63%,MCU;MCUB;MICU2;MAIP1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.37933257794727676,0.8451200048382749,0.6687211093990755,1.0,1.0,3/21,5.29%,SAMD4A;PARN;CNOT4
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.40710564015665984,0.8450895860800614,0.6260869565217392,1.0,1.0,4/13,15.76%,IL12RB1;NECTIN2;STX7;MR1
prerank,arachidonic acid secretion (GO:0050482),0.4238523621967575,0.8437158327949469,0.6100746268656716,1.0,1.0,1/10,2.79%,ANXA1
prerank,arachidonate transport (GO:1903963),0.4238523621967575,0.8437158327949469,0.6100746268656716,1.0,1.0,1/10,2.79%,ANXA1
prerank,fat cell differentiation (GO:0045444),0.3154921065599647,0.8434408280065919,0.6679389312977099,1.0,1.0,7/57,11.84%,PRDM16;NR4A1;PPARGC1A;MED1;NR4A2;ZBTB7A;CLIP3
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.22959675870661062,-0.8433958624289174,0.7318181818181818,0.9341917077863656,1.0,21/52,30.33%,EXTL3;HSPA5;SRPRB;CUL7;ERN1;ARFGAP1;TSPYL2;ZBTB17;SYVN1;DNAJB9;SSR1;SRPRA;TPP1;ATP6V0D1;CXXC1;SERP1;WIPI1;PPP2R5B;ACADVL;KLHDC3;PARP16
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.30303909462195006,0.8428870372253967,0.6817625458996328,1.0,1.0,17/78,15.69%,DYNLL1;KIF2A;LAG3;KIF3B;DCTN6;SEC13;CENPE;DYNC1I2;KIFAP3;KIF5A;SEC24A;CAPZB;DCTN3;SEC24C;KIF18A;DNM2;AP1S3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.30303909462195006,0.8428870372253967,0.6817625458996328,1.0,1.0,17/78,15.69%,DYNLL1;KIF2A;LAG3;KIF3B;DCTN6;SEC13;CENPE;DYNC1I2;KIFAP3;KIF5A;SEC24A;CAPZB;DCTN3;SEC24C;KIF18A;DNM2;AP1S3
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.3408284056593982,0.8425562787468742,0.6595441595441596,1.0,1.0,9/33,16.02%,THPO;ACVR2A;TESC;MED1;ANKRD54;HIF1A;ACVR1B;STAT1;STAT3
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.340026699335168,0.8423909029352382,0.6568627450980392,1.0,1.0,6/36,8.04%,PPP3CA;FZD5;FZD4;GNAO1;CALM1;PLCB1
prerank,regulation of interleukin-6 production (GO:0032675),-0.21216339877238666,-0.8422583455297062,0.8492063492063492,0.9355669185821863,1.0,20/96,19.38%,ARRB1;HMGB1;APP;PTPN11;LBP;WNT5A;LGALS9;PLCG2;PTPN22;IL6R;IRAK3;SIRPA;IL33;CX3CL1;SYT11;C1QTNF3;TLR3;NCKAP1L;ZC3H12A;TIRAP
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.40251802420348787,0.8420249767261277,0.6325823223570191,1.0,1.0,1/12,2.54%,DPYSL4
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.34332708033337045,-0.8416854815361237,0.6751592356687898,0.9358406969242393,1.0,4/11,19.27%,UBQLN1;PRKN;P4HB;PARK7
prerank,cellular response to nutrient levels (GO:0031669),0.3167640208075439,0.8416254083623118,0.6830530401034929,1.0,1.0,13/62,14.41%,PDK4;LPL;KCNB1;ATG7;STK26;PPARA;RRAGB;STK24;SREBF2;WDR45;PDK2;LRRK2;PRKAA2
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.36163039170769096,-0.841507888522638,0.6809954751131222,0.9353091174005768,1.0,3/10,10.15%,MLLT3;HOXB4;ACE
prerank,regulation of embryonic development (GO:0045995),0.33947311793926893,0.8413000747395071,0.6393210749646393,1.0,1.0,7/34,14.15%,PHLDB2;CLASP2;PLCB1;RBM19;NR2C2;CLASP1;RAB14
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.3231492019972266,0.8411322321416046,0.6711590296495957,1.0,1.0,16/55,18.02%,PMAIP1;BCL2;CAV1;DAB2IP;TP53;PAK2;DEDD2;DNM1L;GPER1;BOK;S100A8;S100A9;TNFSF12;BCAP31;DDIT3;BBC3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.35971118881661557,0.8410720839956788,0.6537890044576523,1.0,1.0,5/27,6.82%,PIP4K2A;KANK1;PRKCQ;IRS1;PTPN1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.2862798933902949,-0.841050434911429,0.6656626506024096,0.9353661385036637,1.0,9/24,24.51%,SULF1;CCBE1;CYP1B1;TGFB1;PTGS2;ARNT;ATF4;FLT4;SULF2
prerank,Golgi organization (GO:0007030),0.29359163270097527,0.8409555535153002,0.7048997772828508,1.0,1.0,7/112,5.29%,ARHGEF7;SYNE1;ATP8B1;CLASP2;TBC1D20;ARHGAP21;MYO18A
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.2881889360710761,0.840814006419514,0.6986607142857143,1.0,1.0,14/113,7.51%,CD36;MYD88;FERMT2;LCP1;GTF2H4;MPP7;PSMC6;TPPP;DAB2IP;TP53;VEGFA;PARP1;TRABD2B;PLEK
prerank,cellular response to ketone (GO:1901655),0.33218617143520374,0.8404973814143619,0.6628895184135978,1.0,1.0,5/35,10.88%,ADCY5;ADCY2;AR;ADCY6;ROCK2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.31831731792642537,0.840441658356222,0.6593830334190232,1.0,1.0,7/54,10.06%,SDC2;EXT2;GCNT2;HS2ST1;GPC4;HS6ST1;AGRN
prerank,kinetochore organization (GO:0051383),-0.3378911146573653,-0.8403883551159996,0.7060301507537688,0.9357728566160038,1.0,2/13,5.53%,POGZ;CENPC
prerank,positive regulation of organelle assembly (GO:1902117),0.3235306551877479,0.8402127945610176,0.6606217616580311,1.0,1.0,9/44,16.21%,PIP4K2A;LCP1;NUP62;TAPT1;STX18;ARHGAP35;CEP120;G3BP1;PLK4
prerank,lung development (GO:0030324),0.33881670246471285,0.840140674600161,0.6447552447552447,1.0,1.0,4/33,6.65%,FGF1;ITGA3;VEGFA;ABCA3
prerank,steroid biosynthetic process (GO:0006694),-0.2261280233504968,-0.8400674845776281,0.7954545454545454,0.9355283681261269,1.0,27/56,36.68%,PRKAG2;CYP27A1;LBR;CYP51A1;ACOT8;HMGCR;PRLR;INSIG1;SQLE;OSBP;AMACR;DHRS11;PMVK;LSS;FDXR;OSBPL7;OSBPL9;INSIG2;EBP;SLC27A2;SC5D;STAR;TM7SF2;HSD11B1;SRD5A1;DHCR7;CH25H
prerank,spermatid development (GO:0007286),0.3413487205232196,0.8396424410996426,0.6599131693198264,1.0,1.0,6/32,12.06%,RSPH1;ACRBP;CDYL;DDX25;NECTIN2;YTHDC2
prerank,lipoprotein transport (GO:0042953),-0.3650812383408133,-0.8395813773609895,0.6754385964912281,0.9356301822379374,1.0,2/10,1.11%,PRKCB;LRP1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3785146487908544,0.8390781473816744,0.6322241681260946,1.0,1.0,3/15,8.93%,ACTR3;WHAMM;WASHC1
prerank,positive regulation of T cell migration (GO:2000406),0.3599091061068522,0.8390586366862929,0.6286644951140065,1.0,1.0,3/20,8.65%,DOCK8;CCL5;ADAM17
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.36045262602813466,-0.8389890694959861,0.7053571428571429,0.9358979646957077,1.0,5/10,22.15%,UBC;TUT4;CHFR;TUT7;UBB
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.31550554730755154,-0.8389793749355856,0.7216981132075472,0.9350406008017603,1.0,4/16,10.78%,AUTS2;RASGRF1;PIK3CB;OGT
prerank,protein K48-linked deubiquitination (GO:0071108),-0.28515501636899404,-0.838956285837737,0.7186629526462396,0.9342133931894085,1.0,12/23,34.13%,ATXN3;OTUD7B;MINDY1;VCPIP1;USP37;OTUD3;USP25;TNFAIP3;YOD1;USP34;MINDY2;BAP1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.28896204941213344,-0.838894601278282,0.6925064599483204,0.9334469822766149,1.0,4/21,10.06%,SLC30A10;ABCB7;COA8;PRKN
prerank,regulation of cholesterol storage (GO:0010885),0.39553442830232255,0.8387976351897167,0.6501650165016502,1.0,1.0,4/15,11.57%,LPL;PPARA;SREBF2;ABCG1
prerank,protein secretion (GO:0009306),-0.22923846214575166,-0.8386433997807152,0.7629310344827587,0.9330295225490218,1.0,18/56,19.78%,PCSK5;ABCA1;SEL1L;RAB12;CYB5R4;CANX;STEAP3;WLS;GOLPH3;PDIA4;RCN3;ARFGAP3;MON1A;RAB13;RIMS2;PARK7;MIA3;PPY
prerank,protein deacylation (GO:0035601),-0.2872689444053734,-0.8385463385879747,0.7090395480225988,0.9323499746084088,1.0,7/23,15.14%,LYPLA1;HDAC7;HDAC4;SIRT7;PPT1;NOTUM;ABHD17C
prerank,embryonic organ development (GO:0048568),0.311073837760613,0.8383382995171281,0.6588089330024814,1.0,1.0,9/61,10.74%,HEY2;TBX2;TEAD3;BMPR1A;RARRES2;GDNF;TGFB2;TEAD1;PDGFA
prerank,negative regulation of proteolysis (GO:0045861),0.3359648213319422,0.8381605324594181,0.6464088397790055,1.0,1.0,3/34,6.81%,ROCK1;SERPINE2;TIMP4
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3224093027521979,-0.8376018681193294,0.6717557251908397,0.9333557442633588,1.0,3/16,5.23%,HMGB1;CECR2;KPNA1
prerank,aorta development (GO:0035904),0.3894597625810514,0.8375646267769622,0.616871704745167,1.0,1.0,2/14,3.14%,TBX2;JAG1
prerank,respiratory electron transport chain (GO:0022904),0.3816313959975716,0.8374783073061685,0.6234887737478411,1.0,1.0,5/14,16.06%,PPARGC1A;ETFA;SDHA;SLC25A12;UQCRFS1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.32657948027869593,-0.8374521757512586,0.6707317073170732,0.9327941316480489,1.0,8/13,40.50%,TMEM30A;GCC2;INSIG1;SAR1A;SEC16B;SAR1B;TM9SF4;CD81
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.38557439696139006,0.836952728998773,0.6453781512605042,1.0,1.0,3/16,6.84%,ZFAND2B;IGFBP5;IGFBP4
prerank,sulfur amino acid metabolic process (GO:0000096),0.3644277345227038,0.8369488715407053,0.6452119309262166,1.0,1.0,4/24,10.81%,TXN2;ADI1;AHCY;SMS
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.2700463645205485,-0.8369279299261194,0.7287581699346405,0.932970811025086,1.0,8/29,16.30%,UBE2D3;CASP8;BIRC2;IKBKG;UBC;CHUK;BIRC3;TLR3
prerank,regulation of lipid biosynthetic process (GO:0046890),0.34344160674461033,0.8364858096853114,0.6634078212290503,1.0,1.0,9/32,15.54%,PRKAB2;PDK4;SORBS1;PPARA;GPER1;SIRT4;PRKAA2;MLXIPL;NR5A1
prerank,response to exogenous dsRNA (GO:0043330),0.3779665917219512,0.836390523859214,0.6438569206842923,1.0,1.0,7/18,17.16%,CGAS;CAV1;MUL1;FLOT1;RFTN1;DHX9;TICAM1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2753642132044189,0.836380389524711,0.8430583501006036,1.0,1.0,50/417,10.27%,PRDM16;HEY2;TBX2;LBH;LIMS1;LIMD1;PDGFB;NAB1;ATP8B1;ID4;LOXL2;ARID5B;RUNX1T1;HEYL;PBXIP1;HINFP;GMNN;RBAK;NACC2;HDAC9;SET;NR2F2;MTERF3;ATXN1;PIAS4;SUV39H2;MYBBP1A;DAB2IP;ARID5A;TP53;HEXIM1;ZBTB38;SFPQ;BCL7A;PA2G4;L3MBTL2;SOX9;RELA;PLCB1;MAP3K10;CBX4;MTA3;NR1D1;KAT7;ZBTB33;SIRT2;DEDD2;MIDEAS;PCGF6;SPINDOC
prerank,positive regulation of cell junction assembly (GO:1901890),0.3178127276108186,0.8360912252497351,0.6704119850187266,1.0,1.0,8/56,11.33%,ROCK1;LIMS1;FERMT2;CAV1;VEGFA;CUX2;EPHA2;IL1RAPL1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.36528577543986784,0.8360731185675694,0.6682847896440129,1.0,1.0,6/22,10.58%,PSMC6;TP53;MED1;MED12;PAXIP1;MED14
prerank,ncRNA transcription (GO:0098781),0.39937126720529087,0.835848807442902,0.6443298969072165,1.0,1.0,1/13,1.68%,CAVIN1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.36735129210607204,0.8357072871628729,0.6797101449275362,1.0,1.0,4/23,13.57%,NR1H4;HAVCR2;AXL;GAS6
prerank,DNA double-strand break processing (GO:0000729),-0.3119189230464132,-0.8355721821790629,0.6939313984168866,0.9347392383434641,1.0,5/18,18.12%,MRE11;RAD50;BLM;NBN;ATM
prerank,O-glycan processing (GO:0016266),-0.23102746799964952,-0.8353407715915758,0.822429906542056,0.934307638508129,1.0,4/54,3.34%,GXYLT2;ST3GAL4;ST3GAL1;GALNT10
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.28338706656417034,0.8350034605253122,0.7451403887688985,1.0,1.0,42/166,18.77%,DYRK2;CD36;PDGFB;ZEB2;VIM;BCAR3;SAMD4A;CCL5;NAT10;IRS1;SORBS1;RPS27L;CIRBP;PPARGC1A;PYM1;NR1D1;KAT7;PTH1R;RPL5;HIF1A;PDGFRB;EIF3E;RBM3;ZCCHC4;CLU;CPEB3;ARPP19;PLXNB2;NNMT;MLXIPL;IRS2;PAOX;SP1;PIWIL2;DHX9;FAF1;NR1H3;P2RX4;EEF2;UPF3A;EGR1;CCL19
prerank,myoblast differentiation (GO:0045445),0.39567331659692484,0.83496594157572,0.6593220338983051,1.0,1.0,5/14,11.19%,JAG1;HINFP;PLEKHM3;MBNL1;RB1
prerank,negative regulation of translational initiation (GO:0045947),0.4008766115993195,0.8346032719290362,0.6488294314381271,1.0,1.0,5/13,20.84%,EIF4EBP1;EIF3E;EIF2AK4;TPR;LARP1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3671348522077773,0.8342979350929216,0.6764252696456087,1.0,1.0,7/21,18.00%,PMAIP1;OPA1;BOK;LRRK2;EIF2AK3;CREB3;DDIT3
prerank,positive regulation of blood coagulation (GO:0030194),-0.3101825758645414,-0.8341380364528055,0.6699507389162561,0.9358090622685146,1.0,6/17,21.91%,ST3GAL4;F3;THBD;SERPINE1;ENPP4;USF1
prerank,ion transport (GO:0006811),0.2855431531714622,0.8337566964453588,0.6967963386727689,1.0,1.0,13/111,10.90%,TRPC6;ANO1;ANO6;SLC8A2;SLC8A1;SLC20A2;KCNN2;PKD1L3;SLC9A8;ANO10;VDAC1;SLC25A26;PANX1
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.24810620439799064,-0.8337140146902021,0.7537878787878788,0.9357809879139808,1.0,24/42,42.96%,PARP10;TRIM25;UBC;REV1;POLN;USP10;PRIMPOL;UBB;ZBTB1;POLI;RPA3;RFC3;USP43;RPA2;POLD3;PCLAF;RPA1;RFC1;POLE;RFC4;CDKN2D;DTL;POLA1;RFC5
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.33011322504248997,-0.8335473433265774,0.700228832951945,0.9352430781241841,1.0,7/13,27.91%,APP;SHANK3;ADCY1;EPHB2;SHISA7;SQSTM1;RELN
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.25094949299465746,-0.8333332201528878,0.7527272727272727,0.9347865378688451,1.0,19/37,26.45%,RYBP;PML;HSP90AB1;USP7;SDCBP;SGTA;OGT;GIPC1;UBXN1;NOP53;RPS7;RPL11;PARK7;TRIM39;TLK2;BAG5;CSNK2A2;CSNK2A1;HFE
prerank,positive regulation of defense response to virus by host (GO:0002230),0.3599044449159418,0.8332009785502326,0.6595419847328244,1.0,1.0,6/24,17.63%,CGAS;IL12RB1;ZDHHC1;STAT1;SIN3A;EIF2AK4
prerank,mononuclear cell differentiation (GO:1903131),-0.27661098623993496,-0.833040607658939,0.6852459016393443,0.9345207449072909,1.0,8/24,17.79%,IL31RA;PIR;BMP4;LYN;THOC5;RELB;PPARG;MT1G
prerank,lipoprotein localization (GO:0044872),-0.3520301712716051,-0.8329755361167652,0.6916299559471366,0.933799003152472,1.0,2/11,1.11%,PRKCB;LRP1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.37971955427888965,0.8325402288207943,0.6550079491255962,1.0,1.0,5/20,13.26%,NR1H4;LPCAT3;MBTPS1;SREBF2;LDLRAP1
prerank,axonal fasciculation (GO:0007413),-0.33555779193828567,-0.8324629825148058,0.6826923076923077,0.9339234690020475,1.0,8/12,27.22%,EPHA4;EPHA3;MEGF8;RTN4;CNTN4;EPHB2;CDK5R1;EPHB3
prerank,cellular response to mechanical stimulus (GO:0071260),0.3187485792618295,0.8321655208688588,0.6705276705276705,1.0,1.0,8/46,17.09%,MYD88;CNN2;CHEK1;SOX9;CASP8AP2;TNFRSF10B;MAP2K4;MAP3K2
prerank,protein modification process (GO:0036211),-0.21763224751457408,-0.8319601568864134,0.84,0.9340260623846467,1.0,25/76,27.41%,ST3GAL6;PLAT;ST8SIA4;ST3GAL1;PRKDC;UBE2D3;STK38;ATG3;CDKL3;ABL2;ST8SIA2;PLOD2;PPP4R2;NTAQ1;UBE2S;UBA7;CHRM3;B4GALT7;RPN2;FBXW2;USP25;SERP1;PARP4;LOX;QPCT
prerank,aggrephagy (GO:0035973),0.3454327664500447,0.8319266506562146,0.6573208722741433,1.0,1.0,2/27,2.61%,DYNLL1;VIM
prerank,negative regulation of viral genome replication (GO:0045071),-0.2478880576928577,-0.8318655667380065,0.7238805970149254,0.9333543355012724,1.0,15/40,25.32%,PARP10;SETDB1;IFIT1;BST2;MPHOSPH8;IFITM1;OAS2;SHFL;IFITM3;SRPK1;HMGA2;RNASEL;RESF1;ZC3HAV1;IFITM2
prerank,macrophage activation (GO:0042116),0.3413036551307517,0.8317063062184837,0.6519944979367263,1.0,1.0,4/34,6.17%,FER1L5;DYSF;CRTC3;MAPT
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3871751035287256,0.831593749452188,0.6598290598290598,1.0,1.0,3/14,10.75%,FASTKD5;FASTKD1;TFB2M
prerank,aminoglycan catabolic process (GO:0006026),0.34452228541913704,0.8315017081231846,0.64,1.0,1.0,3/28,10.06%,SDC2;GPC4;AGRN
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.28300601645939366,0.8314271532262659,0.7452025586353944,1.0,1.0,25/151,15.00%,DMD;PPM1L;LARGE1;SLC44A5;FA2H;STARD7;TYW5;HACD1;GSTT1;SLC44A1;TNIP1;LPCAT3;GSTP1;CERS1;MOCS1;SAMD8;ESD;GSTA4;SLC25A2;PRKD3;ST3GAL2;PLA2G4A;CHKB;SPTLC1;PLA2G4C
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.30287584218628233,-0.830725123858731,0.7257617728531855,0.934701650663048,1.0,3/18,8.06%,THOC2;PABPN1;POLDIP3
prerank,positive regulation of protein ubiquitination (GO:0031398),0.29469155847273837,0.8301842443571227,0.7001153402537486,1.0,1.0,10/80,10.68%,KLHL40;ANGPT1;DCUN1D2;CAV1;FBXW7;PIN1;DCUN1D1;AMER1;PAXIP1;UBE2D1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.29796219916898026,0.8301219171465738,0.6979949874686717,1.0,1.0,11/68,14.40%,AMPD1;NT5C2;SULT4A1;AMPD2;ENTPD7;OPA1;EPHA2;THEM4;ADSS1;ACOT6;LRRK2
prerank,fatty acid catabolic process (GO:0009062),0.3054373971202939,0.829995724342679,0.6925925925925925,1.0,1.0,12/67,10.20%,HSD17B10;NUDT7;PEX2;HSD17B4;ACAD11;MECR;ABCD4;ACADS;ACAD10;NUDT19;HADHB;SCP2
prerank,regulation of spindle organization (GO:0090224),0.37944559210905515,0.8298266942577449,0.6666666666666666,1.0,1.0,6/18,19.28%,NUP62;TPX2;SENP6;MAP9;DCTN1;CLTC
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.36219132530741976,-0.8297866835744407,0.7015250544662309,0.9356633772135423,1.0,5/10,21.50%,DSE;DSEL;XYLT1;PXYLP1;B3GAT1
prerank,regulation of monocyte differentiation (GO:0045655),0.3842491471872128,0.8297274053297823,0.6285211267605634,1.0,1.0,4/14,20.75%,CDK6;ZFP36L1;ACIN1;CTNNBIP1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.32748699681196464,-0.8292154283959212,0.6963470319634704,0.9359138739745628,1.0,3/14,10.27%,STARD13;MEOX2;CARD10
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.31913781308831624,-0.8289847529592846,0.6984126984126984,0.935487410075044,1.0,2/15,6.71%,GRB2;FRS2
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.26622803805287276,-0.8285649790873758,0.7491408934707904,0.9354104302598107,1.0,8/30,16.30%,UBE2D3;CASP8;BIRC2;IKBKG;UBC;CHUK;BIRC3;TLR3
prerank,regulation of T cell mediated immunity (GO:0002709),-0.35339164315687355,-0.8284984833508139,0.6916488222698073,0.9346970339271804,1.0,1/10,1.71%,HMGB1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.21110401497238682,-0.8282565348500738,0.8165680473372781,0.9343082989940465,1.0,34/85,31.53%,FZD6;PRICKLE2;VANGL1;WNT5A;MAGI2;PSMD7;PSMD9;PSMD13;SMURF2;PSMB3;PSMC5;AP2S1;PFN1;PSMA5;PSMA1;PSMC2;CDC42;AP2A2;PSME3;PSMC4;CELSR1;VANGL2;PSMB6;PSMB10;DVL2;TIAM1;PSMA4;PSME1;WNT11;PSMF1;AP2M1;ARHGEF19;PSMB9;PSME2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.3575060101770873,0.8281160276987554,0.6416,1.0,1.0,7/22,15.36%,FXN;GLRX5;ISCA1;ISCA2;NUBP2;NUBP1;CIAO1
prerank,regulation of RNA export from nucleus (GO:0046831),-0.34997550686132745,-0.8279341012286359,0.6764044943820224,0.9340855617592924,1.0,5/11,23.42%,KHDRBS1;AKAP8L;NCBP2;NRDE2;CPSF6
prerank,organelle fission (GO:0048285),-0.2748116693235153,-0.8277724299413943,0.6985507246376812,0.9335318810348646,1.0,7/24,15.32%,DNM3;DNM1;MTFR1;PRKN;ACOT8;TMCC1;FIS1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.37753014330687235,0.8275460950546681,0.6645569620253164,1.0,1.0,4/16,11.12%,VIM;TGFB3;SUCO;RUNX1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.31123605358080475,0.8272491239965803,0.6994949494949495,1.0,1.0,12/62,13.03%,POLR2L;POLR2I;ADRM1;GTF2H4;ELL;POLR2G;ELOC;CCNT1;CDK7;CDK12;NELFB;POLR2J
prerank,covalent chromatin modification (GO:0016569),-0.3209567554576754,-0.8267942009566196,0.717948717948718,0.9345937350680344,1.0,4/14,19.27%,SIRT7;CHD1;SETD5;PARK7
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.34349577827655015,-0.8267837590991232,0.7060240963855422,0.9337612304451514,1.0,3/11,26.45%,AHR;CEACAM1;HFE
prerank,N-terminal protein amino acid modification (GO:0031365),-0.32041797283080464,-0.8264257741642548,0.7321867321867321,0.9335333828777692,1.0,6/14,35.64%,METAP1D;NAA50;NAA60;NAA40;NAA10;NTMT1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.26589629166503026,0.8264140937320437,0.987,1.0,1.0,224/1668,13.63%,MYOCD;SOX6;PRDM16;PPP1R12A;FHL5;MYOZ2;SOX5;HJV;ABRA;MEF2C;ATP2B4;HEY2;ZFHX3;TBX2;SMARCD3;FGF1;NR1H4;CSRP3;EBF1;CCN1;PPP3CA;ZEB2;EDNRB;ALX4;MLIP;FZD5;RORA;SS18L2;CDH13;ID4;NR4A1;FST;FRK;EBF2;SIM2;CRTC1;LOXL2;GABPA;PRRX1;ETS2;ARID5B;IFRD1;HEYL;TEAD3;JAG1;CAMK2D;IRX5;HINFP;MRTFA;BRIP1;TGFB3;ZNF436;H1-0;CRTC3;FOSL2;RBAK;NACC2;ACVR2A;PRDM1;HDAC9;GTF2H4;MCRS1;ARID1A;NR2F2;LMO7;ANKRD2;NR2C1;VEZF1;USP2;ACTR3;ATXN1;OSR2;PIAS4;CBFB;SP7;ARHGEF2;BMPR1A;KLF7;CCNQ;TBX18;KCNIP3;MEF2A;PEX2;GBX1;NCOA7;KLF16;MTDH;DBP;FOXJ3;ASXL1;KLF15;SUV39H2;JUND;CAV1;TAF1;SMARCB1;CHD2;DAB2IP;ELOC;ARID5A;TP53;RXRG;VEGFA;PPM1A;PARP1;GRHL1;ZNF418;HEXIM1;PIN1;ZBTB38;GDNF;MAML2;HDGFL3;SFPQ;HOXC4;AR;PPARGC1A;ZFP28;MED1;PPARGC1B;ZNF431;MED29;YAP1;MED12;SOX9;SNAI2;HSF4;DICER1;RELA;ZFP62;KMT2D;SETD3;TNIP1;CUX2;EPC2;LIN37;ZXDC;ZKSCAN4;CCND1;MAML3;PPARA;TRAK1;CBX4;BBX;IMPACT;MED13L;CARF;CCNT1;FUS;MTA3;NR4A2;SKI;NR1D1;LRRFIP1;KAT7;ZBTB33;AKNA;CDK7;HIF1A;CRLF3;KANSL3;ZBTB41;SIRT2;MIDEAS;RIF1;AGRN;PCGF6;HNRNPU;ZNF3;MED14;NR2C2;UBE2D1;TEAD1;EIF5A;RAI1;GPER1;PCGF5;SREBF2;RUNX1;RB1;PFKM;LRP5;ATF3;PIAS2;HOXC8;NKX6-1;ZKSCAN1;ZBTB7A;NFX1;ESRRA;LCORL;CDK12;RUVBL1;LIN9;BMPR1B;CSRNP3;HDGFL2;TOX4;ORC2;CITED2;CPEB3;CTDSP1;NR6A1;POU3F3;ZXDB;SMARCA5;MED8;ZBTB10;FNIP2;CRTC2;ZNF83;ZFP69;MXD4;PPP3CB;BCL6;CHD4;IKZF1;CASZ1;MEF2B;NCK2;FOXJ1;TRIM28;ZBTB5;RFX7
prerank,response to estrogen (GO:0043627),0.33680635596027086,0.8257459410091548,0.6657142857142857,1.0,1.0,9/31,18.10%,CAV1;ARID5A;AR;KMT2D;SFR1;CITED2;PELP1;ASH2L;SERPINB9
prerank,integrin-mediated signaling pathway (GO:0007229),0.3032241927485749,0.825217541683269,0.691764705882353,1.0,1.0,10/73,7.51%,ITGB6;LAMA5;FERMT2;MYH9;ITGB1;DST;FYB2;ITGB5;ITGB3;PLEK
prerank,endoplasmic reticulum organization (GO:0007029),0.30110026399353906,0.8251911142150292,0.7120291616038882,1.0,1.0,13/72,17.01%,TRDN;LNPK;SEC31B;LPCAT3;STX18;DNM1L;GET4;TRAM1;BNIP1;LRRK2;CAV2;SEC61B;EIF2AK3
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.37213613997294237,0.8250540211334456,0.642512077294686,1.0,1.0,2/18,4.47%,CABP1;MFHAS1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.24323369046783105,-0.824764865556586,0.7915194346289752,0.9358317297000248,1.0,16/40,26.69%,PTK2;PTK2B;PML;COMMD1;UBE3A;SGTA;RPS7;RPL11;NUB1;TRIM39;AXIN1;RAD23B;CSNK2A2;CSNK2A1;HFE;LAPTM5
prerank,protein methylation (GO:0006479),-0.2420097423214343,-0.8246545995517699,0.7890909090909091,0.9352117253597431,1.0,6/40,9.40%,NSD1;CARM1;CAMKMT;PRMT2;PRMT3;EEF1AKMT1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.30954879109015354,-0.8245861107985534,0.6832151300236406,0.9344808617520092,1.0,3/15,7.84%,APOE;NRDC;FURIN
prerank,retinal metabolic process (GO:0042574),-0.34391115810845185,-0.8243018311710192,0.7025171624713958,0.9341562240829754,1.0,2/12,8.42%,ABCA4;CYP1B1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.34310070391007486,-0.8242341179178145,0.6643835616438356,0.9334404113033744,1.0,7/12,34.15%,ESR1;TGFB1;PPARG;ZC3H12A;ZC3H10;NCOR1;ELAVL1
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.23835105032629222,-0.8242178329255385,0.7407407407407407,0.9326269760965233,1.0,7/42,11.95%,LBP;RPS19;OPTN;IL6R;DEFA6;IRGM;GSDMD
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3627319501073534,0.8241727434954804,0.671875,1.0,1.0,9/22,20.16%,ELL;ERCC6;CCNT1;KAT7;CDK12;BRD4;HMGN1;CDK13;EAPP
prerank,regulation of viral transcription (GO:0046782),0.3264943962932264,0.8241255033848217,0.6815718157181572,1.0,1.0,10/39,18.18%,POLR2L;POLR2I;POLR2G;HEXIM1;CCNT1;NELFB;POLR2J;NELFCD;DHX9;RSF1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.370600855110401,0.8237072699599579,0.66723259762309,1.0,1.0,4/17,12.18%,DHDDS;MVD;SRD5A3;ALG13
prerank,cellular response to estrogen stimulus (GO:0071391),0.3880156235700021,0.823621270356239,0.6407599309153713,1.0,1.0,5/14,18.10%,ARID5A;AR;SFR1;PELP1;SERPINB9
prerank,protein localization to chromatin (GO:0071168),-0.2962650786434553,-0.8235117887084978,0.7058823529411765,0.9331390704303978,1.0,7/18,33.88%,PPHLN1;ESR1;LEMD2;CHMP7;PIH1D1;RUVBL2;MCM8
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.39417994047186944,0.823507197836125,0.664440734557596,1.0,1.0,4/13,12.51%,BTG2;POLR2G;CNOT7;CPEB3
prerank,positive regulation of collagen metabolic process (GO:0010714),0.37093575225527314,0.822930994667667,0.6593406593406593,1.0,1.0,4/17,11.12%,VIM;TGFB3;SUCO;RUNX1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.36113309190986354,0.8227990115082777,0.6645161290322581,1.0,1.0,2/18,3.29%,ROCK1;KANK1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3530303303848115,0.8223122460445103,0.6701183431952663,1.0,1.0,5/24,11.37%,CHD6;TP53;VEGFA;HIF1A;ATF3
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3563052662303039,0.8219482351971749,0.6499215070643642,1.0,1.0,5/22,12.82%,DUSP5;PPM1E;PPM1A;PPP1CA;DUSP16
prerank,regulation of hormone secretion (GO:0046883),0.3610901145417919,0.8215513196264945,0.6522491349480969,1.0,1.0,1/15,2.79%,ANXA1
prerank,glutathione derivative metabolic process (GO:1901685),0.36863754687469297,0.8213159263078895,0.6677577741407529,1.0,1.0,4/20,12.11%,GSTT1;GSTP1;ESD;GSTA4
prerank,glutathione derivative biosynthetic process (GO:1901687),0.36863754687469297,0.8213159263078895,0.6677577741407529,1.0,1.0,4/20,12.11%,GSTT1;GSTP1;ESD;GSTA4
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.3515443058026232,-0.8208056868634962,0.7014925373134329,0.9374521576780235,1.0,4/10,14.23%,HMGB1;ESR1;PSMC5;PSMC2
prerank,nuclear membrane organization (GO:0071763),-0.298164560576205,-0.8204591337770066,0.732824427480916,0.9372493507334676,1.0,9/19,26.55%,SPAST;TOR1AIP1;AKAP8L;TARDBP;EMD;TMEM43;CHMP4B;TOR1A;CHMP7
prerank,protein-containing complex disassembly (GO:0032984),0.31003158809362164,0.8204247734341437,0.6873315363881402,1.0,1.0,11/54,15.26%,FZD5;LIX1L;GABARAP;CAV1;LIX1;PYM1;AMER1;PPP1CA;TSG101;DVL1;CSNK1A1
prerank,regulation of transport (GO:0051049),-0.24798600900046142,-0.8201417068592658,0.7533333333333333,0.9369907405360821,1.0,8/36,14.46%,LEPR;NRP1;RAB11A;PRKN;WWC1;MYO6;SNCA;ICA1
prerank,regulation of translation (GO:0006417),0.27673462909309215,0.8200750720045387,0.7815482502651113,1.0,1.0,44/173,18.44%,VIM;IGFBP5;SAMD4A;MRPL13;BTG2;NAT10;UPF1;CSDE1;ATXN2;EIF1;RPS27L;CIRBP;CYFIP1;DAPK3;PYM1;IMPACT;RPL5;EIF3E;EIF2AK2;DDX1;GSPT1;DDX25;RBM3;ZCCHC4;CNOT7;EIF3H;TSFM;CPEB3;PLXNB2;SYNCRIP;GIGYF2;EPRS1;EIF4E;CTIF;NANOS1;ETF1;PIWIL2;DHX9;EIF2AK3;EIF4G2;METAP1;EIF2AK4;EEF2;UPF3A
prerank,myelination in peripheral nervous system (GO:0022011),-0.32868245458722956,-0.8199645261842241,0.6901408450704225,0.9364710651971621,1.0,5/13,19.29%,NF1;ADGRG6;ARHGEF10;LGI4;MYOC
prerank,regulation of acute inflammatory response (GO:0002673),0.35945742275810105,0.8199643287406274,0.6478632478632479,1.0,1.0,18/18,64.09%,GSTP1;OSMR;DNASE1L3;C2CD4A;F12;C2CD4B;PLA2G2D;DNASE1;FFAR2;OSM;IL6;CREB3L3;IL4;IL6ST;NLRP3;KLKB1;ADAM8;PTGES
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.36775436114901244,0.819556127062613,0.6520325203252032,1.0,1.0,4/18,11.97%,PARN;NAF1;CCT3;RUVBL1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2851857105804278,0.8195183692587611,0.7508305647840532,1.0,1.0,30/122,18.77%,DYRK2;PDGFB;VIM;BCAR3;SAMD4A;NAT10;IRS1;SORBS1;RPS27L;CIRBP;AR;TGFB2;PYM1;KAT7;RPL5;PDGFRB;EIF3E;RBM3;ZCCHC4;CPEB3;PLXNB2;IRS2;NAMPT;JAK2;PIWIL2;DHX9;FAF1;EEF2;UPF3A;CCL19
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4098556551450099,0.8194550696011562,0.6370235934664247,1.0,1.0,2/11,6.18%,PWP1;SMARCB1
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.19594937103624444,-0.8194341869407583,0.8981481481481481,0.936655811005602,1.0,23/124,14.23%,LEF1;AGO3;WNT4;TCF7L2;FZD6;PRICKLE2;VANGL1;WNT5A;PLCB3;CTNNB1;PSMD7;PSMD9;PSMD13;SMURF2;SFRP4;PSMB3;TNRC6A;PSMC5;AP2S1;PFN1;PSMA5;PSMA1;PSMC2
prerank,membrane protein proteolysis (GO:0033619),0.3226342959876531,0.8189139452364852,0.686030428769018,1.0,1.0,9/37,14.57%,MYH9;PRKCQ;AFG3L2;RELA;ADAM17;MBTPS1;HM13;SPPL2B;ADAM19
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.2683792704101576,-0.8182903023078261,0.7597597597597597,0.9379658513761032,1.0,17/29,36.06%,CCNH;ERCC5;DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;RAD23B;RPA3;CETN2;RPA2;ERCC3;RPA1
prerank,protein lipidation (GO:0006497),0.30459939591453256,0.8181825152978497,0.691025641025641,1.0,1.0,20/59,19.53%,PIGN;ATG7;ZDHHC2;PIGA;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;WDR45;PIK3C3;PIGH;PIGB;ZDHHC13;PIGP;DPM2;ZDHHC5;ZDHHC8;ZDHHC3;PGAP4;ATG10
prerank,regulation of endothelial cell proliferation (GO:0001936),0.2930166985570353,0.817398861034046,0.7260920897284534,1.0,1.0,10/88,7.48%,ANGPT1;PDGFB;SEMA5A;CDH13;NR4A1;ALOX5;NR2F2;CAV1;VEGFA;ITGB3
prerank,body fluid secretion (GO:0007589),-0.3154752250507903,-0.8167431121704304,0.7361111111111112,0.9399398641004719,1.0,3/15,12.68%,NPR1;SLC22A4;PRLR
prerank,aromatic amino acid family catabolic process (GO:0009074),0.3926673439101334,0.8165206905372945,0.6726973684210527,1.0,1.0,3/15,14.06%,HGD;KMO;QDPR
prerank,response to ethanol (GO:0045471),-0.31866372796949827,-0.8164658826239265,0.7037861915367484,0.9395839937922729,1.0,10/14,45.68%,ADCY7;GRIN3A;GLRA2;GLRA1;SDF4;GRIN2A;GRIN1;SOD1;GRIN2B;CHRNB2
prerank,positive regulation of nuclear division (GO:0051785),0.34829369574368985,0.8161920688440374,0.6830015313935681,1.0,1.0,5/25,11.24%,PDGFB;NUP62;SIRT2;PDGFRB;LRP5
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.22546599003524218,-0.8160896135079669,0.8193832599118943,0.9393668461220739,1.0,17/54,20.42%,ARRB1;NXN;DCUN1D3;CRY1;CTNNB1;PRMT3;SIRT7;OGT;SPRY2;SOX4;SH3RF2;UBXN1;AKT1;SPOPL;RPL11;PARK7;PIAS3
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.27940092779235126,-0.8153420897609932,0.7277936962750716,0.9399367858958778,1.0,5/22,13.67%,APPL2;LBP;PTPN22;LYN;APPL1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.35173800603339667,0.8153379713921608,0.6809815950920245,1.0,1.0,6/24,11.70%,NAT10;PARP1;SLX4;HNRNPU;TERF2;HNRNPC
prerank,L-glutamate transmembrane transport (GO:0015813),-0.35163983593057346,-0.8150268601925308,0.7149122807017544,0.9397060324170959,1.0,7/10,33.13%,SLC1A3;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6;PRAF2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.3412458640059034,-0.8145352049744649,0.7105263157894737,0.9397479683598866,1.0,8/12,28.88%,GMPS;ADSS2;PFAS;GART;ATIC;IMPDH1;IMPDH2;PAICS
prerank,negative regulation of signal transduction (GO:0009968),0.27018433048047774,0.813945097249357,0.8132094943240454,1.0,1.0,27/249,7.71%,NOTCH3;NKD1;TCIM;PIP4K2A;SOCS5;KANK1;IGFBP5;CCL5;NTN1;BCL2;PTPN18;MMRN2;EMILIN1;PRKCQ;ASXL1;RPGRIP1L;IRS1;EPN2;DAB2IP;SLC2A10;FBXW7;PTPN1;YTHDF2;TRABD2B;NEDD4;PLEK;SNAI2
prerank,organelle transport along microtubule (GO:0072384),0.3340681840921019,0.813856752946431,0.6832844574780058,1.0,1.0,10/31,18.34%,ARHGAP21;BICD2;MAPT;KIF5B;TRAK1;FBXW11;UXT;RHOT1;BICD1;MAP1S
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.35769022424672164,0.8131917913114491,0.6822429906542056,1.0,1.0,4/20,8.65%,PDGFB;CCND2;CCND1;ADAM17
prerank,amide biosynthetic process (GO:0043604),0.3131511605140938,0.8131538017418718,0.7161458333333334,1.0,1.0,2/47,4.19%,DMD;FA2H
prerank,regulation of catecholamine secretion (GO:0050433),-0.26255027861411995,-0.8131237440095394,0.7401812688821753,0.9414524957855273,1.0,16/29,31.38%,SYT1;DTNBP1;PRKN;GRK2;SNCA;SYT11;SYT12;STX1A;SYT6;SYT2;DRD2;SYT7;SYT9;CHGA;SYT13;SYT3
prerank,synaptic vesicle cycle (GO:0099504),-0.2543358552455348,-0.8130944205724966,0.7823343848580442,0.9406669304564367,1.0,7/30,16.01%,RAB5A;NLGN1;SNCA;SLC17A6;PLD2;PCLO;STX1A
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2791503635669712,0.8129829991736686,0.7556053811659192,1.0,1.0,21/125,14.15%,DYNLL1;CLASP2;KIF2A;CENPP;KIF3B;DCTN6;EFHC1;EML1;SUN2;CENPO;SEC13;ZWINT;CENPE;NUP107;DYNC1I2;ITGB3BP;CLASP1;MAP4;NUP98;KIF18A;NUP37
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.2774494196026048,-0.8129679323759712,0.7241379310344828,0.9400662439019712,1.0,12/22,44.88%,WNT5A;SLC7A5;TRIL;LAPTM5;NOD2;TRIM6;BTK;SPHK2;CCR2;LACC1;TNFRSF14;LILRB1
prerank,organelle fusion (GO:0048284),0.35088043243116124,0.8128958766858162,0.6861198738170347,1.0,1.0,9/22,21.72%,AFG3L2;OPA1;MIEF2;MIEF1;MFN2;USP30;MFF;MFN1;GDAP1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.271046557486759,-0.812602176998823,0.7687861271676301,0.9398866828245044,1.0,7/25,26.05%,SPTBN1;PLCG2;STOML2;PNP;CD80;CD86;PRKD2
prerank,iron ion transport (GO:0006826),-0.22861364428484635,-0.8118078682134532,0.8130081300813008,0.9405112233623256,1.0,8/47,10.80%,CP;SCARA5;ABCB7;ATP6V0A4;STEAP3;ATP6AP1;ATP6V1G1;FTH1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2901807896150959,0.8113948500370002,0.7432273262661955,1.0,1.0,19/85,15.53%,KLHL40;SOCS5;TMEM259;PABIR1;GABARAP;TAF1;PSMC6;DAB2IP;FBXW7;RNF180;SIRT2;USP13;CLU;BAG2;CSNK1E;LRRK2;DVL1;CSNK1A1;HSPBP1
prerank,regulation of humoral immune response (GO:0002920),-0.23612337842350253,-0.8113253605366098,0.7544483985765125,0.9405281705255173,1.0,19/44,40.50%,VTN;PROS1;CD55;CD46;SERPING1;C1QB;GATA6;CR1L;C1QC;C1QA;CFHR2;C2;CR2;C3;C3AR1;C6;FCGR2B;C7;CD81
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.3071206186214319,-0.8110755711504571,0.6958762886597938,0.940180475323847,1.0,5/15,18.43%,OSBPL8;ABHD5;PLIN2;PPARG;PLIN3
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3505520409784795,0.8108630120214552,0.6783536585365854,1.0,1.0,7/24,22.24%,PLA2G3;ABCA3;PLA2G4A;LPCAT1;PLA2G15;CRLS1;SERAC1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.3690803697906506,0.8105519929625015,0.6789915966386555,1.0,1.0,6/17,16.87%,ARL6IP5;TGFB2;EIF2AK2;PDCD10;TAOK3;SEMA4C
prerank,postreplication repair (GO:0006301),-0.23947257844766245,-0.8104684703537428,0.7629310344827587,0.9404471558084436,1.0,23/45,37.18%,PARP10;TRIM25;UBC;REV1;POLN;USP10;PRIMPOL;UBB;UBE2B;NSMCE1;ZBTB1;POLI;RPA3;RFC3;USP43;RAD18;RPA2;POLD3;BRCA1;PCLAF;RPA1;RFC1;RFC4
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.26214166626709284,-0.8104505629159461,0.75,0.9396454510367411,1.0,15/27,33.17%,SLC1A3;SLC47A1;SLC3A2;SLC7A5;SLC6A9;SLC38A5;SLC25A38;SLC1A4;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6;PRAF2;SLC22A2
prerank,response to ATP (GO:0033198),0.3637464685103459,0.8103845802996212,0.6827697262479872,1.0,1.0,2/18,6.15%,P2RY2;TAF1
prerank,positive regulation of cilium assembly (GO:0045724),0.3708541204890863,0.8102211362530591,0.680577849117175,1.0,1.0,4/18,12.24%,TAPT1;WRAP73;ARHGAP35;CEP120
prerank,cellular response to estradiol stimulus (GO:0071392),-0.2934068941255552,-0.8099035180789083,0.715,0.9398121047637604,1.0,12/18,52.68%,EGFR;ESR1;CCDC62;RUVBL2;FAM210B;SFRP1;NCOA3;SSTR2;POU4F1;RAMP3;CRHBP;SSTR1
prerank,apoptotic cell clearance (GO:0043277),0.33394702159586903,0.8094862736759094,0.671919770773639,1.0,1.0,8/30,17.46%,XKR4;ANXA1;ITGB3;RHOH;GAS6;ADGRB1;RHOG;NR1H3
prerank,regulation of exosomal secretion (GO:1903541),-0.2898437937622336,-0.8093719350352513,0.7341772151898734,0.9399482736451632,1.0,7/19,26.35%,SDCBP;PRKN;VPS4B;SDC4;HGS;ATP9A;SDC1
prerank,negative regulation of phosphorylation (GO:0042326),0.2891866119644785,0.8093502505834708,0.731651376146789,1.0,1.0,11/85,10.29%,NTRK3;DYNLL1;ROCK1;PFKFB1;MAPT;DAB2IP;CORO1C;PPARA;IMPACT;NPRL2;HNRNPU
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.351305262957556,0.8087412295609686,0.6750788643533123,1.0,1.0,6/21,14.57%,MYH9;PRKCQ;ADAM17;HM13;SPPL2B;ADAM19
prerank,signal transduction by p53 class mediator (GO:0072331),0.3342970717588428,0.8079665783630212,0.7067238912732475,1.0,1.0,7/30,13.66%,PMAIP1;MYBBP1A;NDRG1;TP53;PAXIP1;BOK;PDK2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.38570209308989756,0.8075796487934919,0.6618962432915921,1.0,1.0,4/11,15.38%,SOX9;PDGFA;LRP5;STAT1
prerank,meiosis I (GO:0007127),0.3497145164337595,0.8072502852660591,0.6896024464831805,1.0,1.0,2/23,5.67%,ZCWPW1;FOXJ3
prerank,establishment of spindle orientation (GO:0051294),0.33636350418772265,0.8065745300906811,0.6897590361445783,1.0,1.0,8/28,17.51%,ITGB1;INSC;NSFL1C;FBXW11;CLASP1;MAP4;DCTN1;UBXN2B
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3056630779712177,0.8065349842478038,0.7077509529860229,1.0,1.0,8/52,8.66%,D2HGDH;MDH1;ME3;MTHFD2L;DLST;GOT1;GOT2;ALDH1L2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3863918120440213,0.806358668688521,0.662431941923775,1.0,1.0,3/12,10.20%,HSD17B4;FADS2;SCP2
prerank,organonitrogen compound catabolic process (GO:1901565),-0.22868093986204605,-0.8061019635962848,0.8482142857142857,0.9449519626299574,1.0,21/57,27.86%,GGACT;ANPEP;NPEPPS;TRIM24;RENBP;ENPP2;PPT1;ACE;PLA2G6;SIAH1;PLA2G7;CLPX;AMDHD2;USE1;TPP1;NPL;LRSAM1;GNPDA1;PNPLA8;CPQ;CLN8
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.2353679719488339,-0.8060835339116569,0.8115384615384615,0.9441407986237598,1.0,18/40,37.92%,ATR;FBH1;BLM;MMS22L;PRIMPOL;SMARCAL1;NUCKS1;DONSON;ALYREF;ATRX;BOD1L1;TIMELESS;RFWD3;TRAIP;RAD51;POLE;CENPX;GEN1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.2987566379626255,-0.8056920064911846,0.7156398104265402,0.9439737638908365,1.0,7/16,23.25%,TRIM25;TRIM5;EXOC2;TRIM14;EXOC7;FUCA2;TRIM21
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.33764670061556384,-0.8053949966751276,0.7278911564625851,0.9436368947156437,1.0,5/12,17.24%,CYP26B1;SNW1;KLF2;CALR;TRIM16
prerank,pyruvate metabolic process (GO:0006090),0.30457781154997887,0.8051585551965488,0.7133592736705577,1.0,1.0,8/52,11.23%,ENO3;HK2;PFKFB1;ME3;DLD;VDAC1;ALDOA;PFKM
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.30985018875279574,-0.8050941789394402,0.7468354430379747,0.9433234206830201,1.0,5/15,17.73%,CD44;MDM2;PRKN;PTTG1IP;KDM1A
prerank,ameboidal-type cell migration (GO:0001667),0.30673312791361296,0.8048315587694782,0.72265625,1.0,1.0,7/51,9.21%,PDLIM1;SEMA5A;SEMA6C;GDNF;CORO1C;ITGA4;PKN2
prerank,negative regulation of locomotion (GO:0040013),-0.32157415617810514,-0.8043736441436394,0.7018779342723005,0.9438037261683141,1.0,4/12,20.22%,FBLN1;FRMD5;CCDC125;PTPN2
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2969910693667028,0.8041055632124268,0.745049504950495,1.0,1.0,4/66,3.34%,CD36;MYD88;FZD5;LPL
prerank,negative regulation of double-strand break repair (GO:2000780),0.3353467733067231,0.8040143809824202,0.6932153392330384,1.0,1.0,6/30,12.82%,CGAS;UBR5;ERCC6;FANCB;RIF1;RMI2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3540318683423895,0.8039741290971941,0.6832,1.0,1.0,4/18,6.95%,ANXA1;HDAC9;VEGFA;RHOJ
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.34116558921676976,0.8036629165190573,0.6821589205397302,1.0,1.0,8/29,20.62%,PLA2G3;LPCAT3;PLB1;PLA2G4A;PLA2G4C;NR1H3;MBOAT7;LPCAT1
prerank,acyl-CoA metabolic process (GO:0006637),-0.24387582023705046,-0.8036605463025525,0.8098360655737705,0.9442811182597527,1.0,6/35,11.39%,SUCLG2;ACSF2;HMGCS2;ACOT8;DBI;ACOT9
prerank,protein-DNA complex assembly (GO:0065004),-0.19644487661396232,-0.8036456522545801,0.9245283018867925,0.9434717150802028,1.0,53/116,36.06%,TCF4;CCNH;PSMD7;PSMD9;PSMD13;ERCC5;DDB1;PSMB3;ORC6;UBC;ORC5;PSMC5;PSMA5;NAA60;CHD1L;PSMA1;PSMC2;SART3;ASF1A;XPA;GTF2H5;GTF2H2;NAP1L1;GTF2H3;PSME3;UBB;PSMC4;ERCC2;PSMB6;ORC4;RAD23B;PSMB10;HMGB2;PSMA4;RPA3;PSME1;ORC1;SPTY2D1;PSMF1;ATRX;PSMB9;NAP1L3;PSME2;PSMA8;KAT6B;CETN2;MCM8;RPA2;ERCC3;RAD51;CHAF1A;PSMD8;RPA1
prerank,heterocycle biosynthetic process (GO:0018130),0.38323864343894615,0.8033504214762034,0.6672535211267606,1.0,1.0,2/14,9.62%,ALOX5;MOCS1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.29900857719785867,0.8026566752488968,0.7247474747474747,1.0,1.0,8/59,11.97%,HSD17B10;CYP7B1;LPL;ALOX5;HSD17B4;SCP2;OSBPL2;NDUFAB1
prerank,gene expression (GO:0010467),0.2655049757586687,0.80233070097109,0.8782961460446247,1.0,1.0,67/348,16.42%,TSPAN32;RBPMS;ANGPT2;RPL3L;POLR2L;POLR2I;MLF1;MRPL36;MRPL13;NUP62;PWP1;HARS2;WDR33;UPF1;ATXN1;MEF2A;POLR2G;TESC;U2AF2;RPL8;NFKBIB;MRPL43;SRSF4;TNIP1;SEC13;NR4A2;ZC3H11A;MRPL51;NUP153;RPL5;MCM3AP;MRPL23;DEDD2;RBM8A;U2AF1;DHX8;HNRNPU;RPS23;NUP107;AAAS;PRPF4;GSPT1;DDX25;THOC7;RBM3;BAZ2A;RBM6;MRPL9;GALNT2;SRRM1;DROSHA;POLR2J;MRPL42;SYNCRIP;RPL15;NUP98;NUP37;TSPAN17;EIF4E;FASTKD2;NUP210;RPL22;SARS1;FIP1L1;XAB2;RPL31;DNAJB11
prerank,negative regulation of response to wounding (GO:1903035),0.3568795283749478,0.802232061342611,0.6794258373205742,1.0,1.0,3/19,6.76%,ALOX5;PTPRS;AJAP1
prerank,vasculogenesis (GO:0001570),0.32601500369113534,0.8020766374247975,0.7223837209302325,1.0,1.0,5/32,10.07%,HEY2;HAS2;CAV1;VEGFA;PDGFRB
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.2775890905942626,-0.8016998587476748,0.7620396600566572,0.9460389900127333,1.0,8/22,19.27%,APOD;BAG4;RANGAP1;SP100;INSIG1;LMAN1;ITGB1BP1;PARK7
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.30464230787632723,-0.8012507514887338,0.7614213197969543,0.9459600611474144,1.0,6/15,20.22%,METTL3;SAMHD1;STAT2;NLRC5;YTHDF3;PTPN2
prerank,cardiolipin metabolic process (GO:0032048),0.38653507964823064,0.8011151759404782,0.6554770318021201,1.0,1.0,5/13,16.84%,HADHB;TAMM41;PLA2G4A;HADHA;PTPMT1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.3244640749888381,0.8006104138095594,0.7140804597701149,1.0,1.0,6/34,6.82%,DUSP5;PTPN18;PTPRS;PTPRF;DUSP3;PTPN1
prerank,regulation of myoblast fusion (GO:1901739),0.39805272293752736,0.800573652450477,0.6863799283154122,1.0,1.0,4/11,15.51%,EHD2;CD53;ADGRB1;FLOT1
prerank,limb development (GO:0060173),0.3344756809594625,0.7999216670760096,0.6911764705882353,1.0,1.0,2/28,4.94%,MAP3K20;LNPK
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.28617114894086126,0.7994469662336042,0.751472320376914,1.0,1.0,15/88,14.33%,EDNRB;SERPINE2;IGFBP5;SAMD4A;MRPL13;BTG2;DAB2IP;DAPK3;EIF2AK2;CNOT7;DNAJC1;CPEB3;SYNCRIP;GIGYF2;EPRS1
prerank,positive regulation of angiogenesis (GO:0045766),0.2794055727395216,0.7993632129312549,0.7541713014460512,1.0,1.0,12/108,7.58%,FGF1;ANGPT4;HSPB6;SEMA5A;HK2;STIM1;ITGB1;PTGIS;MTDH;RRAS;VEGFA;BTG1
prerank,respiratory system development (GO:0060541),0.33042896903185054,0.7992672540462553,0.7095375722543352,1.0,1.0,4/32,6.65%,FGF1;ITGA3;VEGFA;ABCA3
prerank,protein prenylation (GO:0018342),-0.3441738867902987,-0.798618237237873,0.734341252699784,0.9497774645765099,1.0,6/10,39.18%,CHM;RCE1;CHML;RABGGTA;FNTA;FNTB
prerank,protein localization to mitochondrion (GO:0070585),0.3970113809295987,0.7983805996850479,0.6895910780669146,1.0,1.0,3/11,17.91%,HK2;LRRK2;ISG15
prerank,positive regulation of endothelial cell migration (GO:0010595),0.2870204394841951,0.7982577007117658,0.7561837455830389,1.0,1.0,11/84,9.57%,ANGPT1;FGF1;ANGPT4;PDGFB;SEMA5A;RRAS;VEGFA;ITGB3;RIN2;ADAM17;HIF1A
prerank,regulation of autophagy (GO:0010506),0.2646352748685807,0.7980002917886442,0.8343815513626834,1.0,1.0,63/216,19.82%,ROCK1;PRKAB2;RNF152;ITPR1;FZD5;PIP4K2A;BCL2;MTDH;ATP6V1H;MAPT;ATP6V0A2;FBXW7;IL10RA;VPS26A;NEDD4;DAPK3;TRIM68;VDAC1;WASHC1;VPS26B;RRAGB;ATP6V1C1;SIRT2;NPRL2;DNM1L;SH3BP4;SREBF2;BOK;HTR2B;USP13;ATP6V0D2;MCL1;LRRK2;PRKAA2;UFL1;TRIM65;EIF4E;PRKACA;CTSA;ATG13;STAT3;VPS35;RAB8A;MT3;SVIP;WDR6;TICAM1;WDR41;EIF4G2;USP36;DAPK2;MTMR3;DDIT3;PRKD1;ULK1;HDAC6;KAT8;ABL1;PIK3R2;ATP6V0C;KDM4A;PRKAB1;DCAF12
prerank,vacuolar acidification (GO:0007035),0.34694578957265637,0.7979687452071776,0.6936507936507936,1.0,1.0,3/21,6.32%,CLN5;ATP6V1H;ATP6V0A2
prerank,early endosome to late endosome transport (GO:0045022),0.3497436701239511,0.7977087892976262,0.6987767584097859,1.0,1.0,5/20,14.57%,HOOK2;HOOK1;AKTIP;PIK3C3;ANKRD27
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.2749574817476598,-0.7976846665874949,0.760806916426513,0.9505277318642557,1.0,4/23,15.69%,CADM1;LGALS9;PIK3R6;PVR
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3123190687240118,0.7972891628554851,0.7133058984910837,1.0,1.0,8/40,12.48%,PMAIP1;FXN;TP53;OPA1;HRK;DNM1L;GPER1;CLU
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.20603785769446725,-0.7971393798175302,0.9090909090909091,0.9506478405178165,1.0,33/84,31.53%,CUL3;ANAPC1;PSMD7;PSMD9;PSMD13;CDC23;PSMB3;UBC;SKP2;PSMC5;PSMA5;PSMA1;BUB3;PSMC2;CDC26;UBE2S;ANAPC4;FBXO31;PSME3;UBB;PSMC4;CDK2;PSMB6;PSMB10;ANAPC15;PSMA4;PSME1;CDC16;PSMF1;CDC27;FZR1;PSMB9;PSME2
prerank,neural tube closure (GO:0001843),0.32292542228451515,0.7970892707407795,0.7375178316690443,1.0,1.0,7/34,16.87%,DLC1;TGFB2;SKI;PLXNB2;DVL1;KDM2B;SEMA4C
prerank,mitochondrial translation (GO:0032543),0.278355886567162,0.7969758883980468,0.7560137457044673,1.0,1.0,34/104,22.04%,MRPL36;MRPS31;MRPL13;MRPL30;GATB;MRPL43;IARS2;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;MRPL47;MRPL9;TSFM;MRPL42;LARS2;FASTKD2;MRPL14;MRPL4;MRPS21;MRPL40;MRPL22;MRPL50;GATC;MRPS14;MRRF;OXA1L;MRPL24;MRPS12;MRPS10
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.3072906875658466,-0.7969563428518073,0.7625,0.9501219603279233,1.0,6/15,23.18%,LRP1;PDPN;TGFB1;DPP4;FGFR4;FSCN1
prerank,pre-miRNA processing (GO:0031054),-0.3111944312997965,-0.7965364969958799,0.7703703703703704,0.949984332710955,1.0,4/14,18.84%,AGO3;ADAR;TUT4;TUT7
prerank,positive regulation of double-strand break repair (GO:2000781),0.32173926943110354,0.7965118802641858,0.7160839160839161,1.0,1.0,8/39,10.04%,RAD51AP1;ZCWPW1;PARP1;ERCC6;SPIRE1;FUS;FANCB;RIF1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.19122197627056775,-0.7963600255965355,0.9609375,0.9485990466850456,1.0,35/104,33.35%,PDPK1;PLCG2;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;EP300;PSMA5;PSMA1;PSMC2;KRAS;RELB;BTRC;PSME3;PSMC4;PSMB6;PSMB10;SYK;PSMA4;PSME1;PSMF1;ICAM2;SRC;NFKB1;PSMB9;PSME2;TYROBP;PSMA8;HRAS
prerank,cellular response to lectin (GO:1990858),-0.19122197627056775,-0.7963600255965355,0.9609375,0.9485990466850456,1.0,35/104,33.35%,PDPK1;PLCG2;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;EP300;PSMA5;PSMA1;PSMC2;KRAS;RELB;BTRC;PSME3;PSMC4;PSMB6;PSMB10;SYK;PSMA4;PSME1;PSMF1;ICAM2;SRC;NFKB1;PSMB9;PSME2;TYROBP;PSMA8;HRAS
prerank,regulation of superoxide anion generation (GO:0032928),0.3758479865451305,0.7963537702012214,0.6801346801346801,1.0,1.0,3/14,11.28%,MAPT;GSTP1;PRKCD
prerank,regulation of dopamine secretion (GO:0014059),-0.2677232566305263,-0.7962526199922716,0.7381615598885793,0.9479681588876905,1.0,13/25,31.38%,SYT1;DTNBP1;PRKN;SNCA;SYT11;SYT12;SYT6;SYT2;DRD2;SYT7;SYT9;SYT13;SYT3
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3210623048178221,0.7961469444390299,0.6800554016620498,1.0,1.0,4/33,8.61%,ANGPT1;SEMA5A;YAP1;PPARA
prerank,stem cell development (GO:0048864),0.35726703870427157,0.7961089219341513,0.7009966777408638,1.0,1.0,3/16,8.70%,TAPT1;SNAI2;CDH2
prerank,organic cation transport (GO:0015695),-0.2782305829415713,-0.795942180748849,0.7528089887640449,0.9476700923390345,1.0,5/20,13.70%,SLC47A1;SEC14L1;SLC22A4;RALBP1;SLC22A18
prerank,organelle disassembly (GO:1903008),-0.24440673809180608,-0.7955772055667549,0.7922535211267606,0.9474451731770113,1.0,12/33,25.88%,RB1CC1;GBF1;STX5;RETREG1;TEX264;ATG2B;ATG2A;KIF9;MTIF3;PLK5;ULK2;UBA5
prerank,oligodendrocyte development (GO:0014003),-0.30785180260268385,-0.7954324693330779,0.7648456057007126,0.946870077175719,1.0,3/15,11.81%,PLP1;B4GALT6;EIF2B3
prerank,regulation of macrophage activation (GO:0043030),-0.24942377818285513,-0.7952482685399983,0.7643312101910829,0.9463766516218404,1.0,9/30,22.94%,IL31RA;LBP;WNT5A;IL33;ZC3H12A;GPR137B;SHPK;HSPD1;SPHK1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.3914495330643993,0.7952154889372338,0.6819012797074955,1.0,1.0,4/11,15.12%,GMNN;TIPIN;ZRANB3;FBXO5
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.308602173504592,0.7950015923532467,0.7216216216216216,1.0,1.0,12/42,16.15%,NARS2;HARS2;LARS1;IARS2;AIMP1;IARS1;SARS2;EPRS1;KARS1;LARS2;SARS1;FARS2
prerank,regulation of translational initiation (GO:0006446),0.29714832934541197,0.7949853986443021,0.7241379310344828,1.0,1.0,21/63,20.84%,CCL5;EIF4EBP1;CSDE1;POLR2G;EIF1;YTHDF2;IMPACT;EIF3E;DDX1;ATF3;EIF3H;NCK2;DNAJC3;CTIF;EIF2AK3;EIF4G2;EIF2AK4;HABP4;HSPB1;TPR;LARP1
prerank,protein targeting to lysosome (GO:0006622),-0.2857223431372192,-0.7947040623434034,0.779746835443038,0.9465054383407548,1.0,10/20,30.77%,SCARB2;GCC2;GNPTAB;AP3M1;HGS;M6PR;NCOA4;LAPTM5;HSPA8;GGA3
prerank,heme biosynthetic process (GO:0006783),-0.27595445639083765,-0.7943939137057935,0.7643835616438356,0.9462292972899713,1.0,6/22,20.86%,ABCG2;ALAS1;COX10;PPOX;SLC25A38;UROS
prerank,mitochondrial translational elongation (GO:0070125),0.28305965093714036,0.7942627890761736,0.7573616018845701,1.0,1.0,17/88,13.16%,MRPL36;MRPS31;MRPL13;MRPL30;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;MRPL47;MRPL9;TSFM;MRPL42
prerank,positive regulation of DNA replication (GO:0045740),-0.2980025217314652,-0.7939842694915283,0.7475,0.9461135425144589,1.0,3/16,4.80%,GLI2;EGFR;STN1
prerank,regulation of establishment of planar polarity (GO:0090175),-0.20316559885086272,-0.7939239033533676,0.9,0.9453965594580387,1.0,34/88,31.53%,FZD6;PRICKLE2;VANGL1;WNT5A;PSMD7;PSMD9;PSMD13;SMURF2;PSMB3;PSMC5;AP2S1;PFN1;PSMA5;PSMA1;PSMC2;CDC42;AP2A2;DACT1;PSME3;PSMC4;CELSR1;VANGL2;PSMB6;PSMB10;DVL2;TIAM1;PSMA4;PSME1;WNT11;PSMF1;AP2M1;ARHGEF19;PSMB9;PSME2
prerank,mitochondrion transport along microtubule (GO:0047497),0.3818402331036848,0.7937022421221953,0.6812386156648452,1.0,1.0,6/13,18.34%,MAPT;OPA1;HIF1A;UXT;RHOT1;MAP1S
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.35258688815340183,0.7935772084017108,0.6955810147299509,1.0,1.0,3/18,13.20%,ANXA1;HNRNPU;ZFP36L1
prerank,nucleotide biosynthetic process (GO:0009165),0.35272205624677266,0.793175137932828,0.6869983948635634,1.0,1.0,3/18,12.20%,NMNAT2;NMNAT1;PPAT
prerank,response to peptide (GO:1901652),0.32203531256150003,0.7929940671889129,0.72,1.0,1.0,7/33,16.02%,ANXA1;IRS1;KAT7;CACNA1B;CHRNA7;STAT1;STAT3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.300730171194043,-0.79272858637089,0.751207729468599,0.9465964028191105,1.0,6/16,15.42%,NT5E;TET2;UPP2;DPYSL3;UPB1;DPYD
prerank,dendritic spine organization (GO:0097061),0.3351557422075991,0.7921908163700421,0.6762048192771084,1.0,1.0,5/26,15.34%,ITGA3;DOCK10;CHRNA7;EPHB1;PTEN
prerank,cellular response to chemical stress (GO:0062197),0.28006129299112725,0.792174823287288,0.7491408934707904,1.0,1.0,21/96,17.31%,NCF2;ATG7;CAV1;PARP1;PPARGC1A;ADNP2;SRXN1;NUDT2;GSTP1;LONP1;PYROXD1;SIRT2;TXNRD2;LRRK2;PRKAA2;ZFAND1;RAD52;MT3;SOD3;PRDX5;PRDX6
prerank,acylglycerol biosynthetic process (GO:0046463),-0.2678721167073677,-0.7920520941480775,0.7485549132947977,0.9468758118351532,1.0,3/23,4.78%,AGMO;LPGAT1;LPIN2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3027922214155847,-0.7919172109164648,0.7677261613691931,0.9462787824918525,1.0,4/17,12.26%,IL18;CD55;CD46;GNL1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.28382192803929285,0.7918046886497583,0.761297798377752,1.0,1.0,22/86,16.72%,DLC1;PLCE1;MYO9B;KANK1;NUP62;ARHGEF2;GABARAP;DAB2IP;RASGRP1;TGFB2;ARHGAP17;VAV1;DENND1A;MFN2;BCR;PDCD10;FGF10;IRS2;RAF1;JAK2;RALGPS1;SHOC2
prerank,DNA conformation change (GO:0071103),-0.28768769244807685,-0.7916178126464719,0.7512953367875648,0.9459738395750888,1.0,9/17,34.34%,HMGB1;TOP1;HHEX;HMGB2;TOP3B;TOP1MT;NAA10;TOP2A;ERCC3
prerank,positive regulation of T cell activation (GO:0050870),0.29564440895861027,0.791351447831911,0.7543640897755611,1.0,1.0,5/62,5.51%,DOCK8;ANXA1;CCL5;CD276;PRKCQ
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.19008862694732323,-0.7913022976766838,0.968,0.9456684082505928,1.0,35/105,33.35%,PDPK1;PLCG2;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;EP300;PSMA5;PSMA1;PSMC2;KRAS;RELB;BTRC;PSME3;PSMC4;PSMB6;PSMB10;SYK;PSMA4;PSME1;PSMF1;ICAM2;SRC;NFKB1;PSMB9;PSME2;TYROBP;PSMA8;HRAS
prerank,lymphocyte differentiation (GO:0030098),0.29508080387564245,0.790861525592002,0.7481203007518797,1.0,1.0,13/68,13.27%,CD79A;IL2;ITGB1;HDAC9;ITGA4;ADAM17;KAT7;TPD52;AXL;LMBR1L;RHOH;ZBTB7A;IKZF1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.26015328961295825,-0.7907361267748776,0.7652439024390244,0.9457745346249613,1.0,6/26,14.02%,SULF1;CCBE1;CYP1B1;TGFB1;PTGS2;ARNT
prerank,cell part morphogenesis (GO:0032990),-0.31293756426470476,-0.7906502481137717,0.7219626168224299,0.9450854196514541,1.0,6/13,22.17%,PID1;FIS1;PNPT1;CSPG5;NUBPL;SLIRP
prerank,positive regulation of vacuole organization (GO:0044090),-0.33920440643612915,-0.7906424442134992,0.7191780821917808,0.9442863154177813,1.0,5/10,18.54%,ANXA2;PIP4K2B;RAB3GAP2;GRN;RALB
prerank,nuclear export (GO:0051168),-0.20381254718363193,-0.7904779813943341,0.881578947368421,0.9437380000916973,1.0,16/80,14.97%,RANBP3L;THOC2;SRSF7;SRSF6;SRSF11;SRSF5;POLDIP3;NUTF2;RANBP3;TGFB1;THOC5;SRSF2;NEMF;CALR;NCBP2;CCHCR1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.37809888912123163,0.7902792889543622,0.699825479930192,1.0,1.0,6/13,20.32%,HEXIM1;HNRNPU;NELFB;NELFCD;EAPP;NELFA
prerank,tRNA processing (GO:0008033),0.29278086835234235,0.7899006976256456,0.7397260273972602,1.0,1.0,16/61,19.48%,WDR4;TRDMT1;CDKAL1;TYW5;FTSJ1;TRMT10C;RTCB;DDX1;NSUN2;KARS1;SARS1;FARS2;TRUB1;FAM98B;TRMT6;AARS2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.2958431402446985,-0.7898687247362502,0.7557603686635944,0.9438968720523615,1.0,4/15,16.42%,GGACT;ALDH4A1;ABHD12;HOGA1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.3045522794254551,-0.7895309081487949,0.7635467980295566,0.9436361184640214,1.0,7/16,24.73%,NF2;PPP2CA;PARP14;HGS;BCL3;PTPN2;INPP5F
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.3797756929732234,0.78941343215869,0.6761061946902654,1.0,1.0,3/12,8.49%,TP53;RPS27L;CCND1
prerank,central nervous system development (GO:0007417),0.25962978539163156,0.7894115029341353,0.8449691991786448,1.0,1.0,22/250,10.44%,SOX6;COL4A1;SERPINI1;ZFHX3;PDGFC;CLN5;SLC6A17;GRIN2C;ATXN1;SYNJ2;TPPP;EML1;SOX9;MBP;SLC23A1;CDH2;GSTP1;NR4A2;ADGRL2;COX7B;HAPLN2;SCYL2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2726345217223206,-0.7893648018435807,0.7643835616438356,0.9430464569200885,1.0,6/21,19.46%,CDC14B;RAB1A;UBE2S;RPS7;RPL11;BTRC
prerank,heterochromatin assembly (GO:0031507),-0.2817748092637673,-0.7893536912201806,0.7722222222222223,0.9422615674081818,1.0,6/20,20.70%,EZH1;SMCHD1;NRDE2;RRP8;HMGA2;SUV39H1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.36262770945706396,0.7893153157905067,0.6791530944625407,1.0,1.0,4/16,11.53%,PARP1;NAF1;SLX4;TERF2
prerank,negative regulation of cell communication (GO:0010648),0.34529066454242374,0.7889640695740473,0.7053140096618358,1.0,1.0,2/21,6.82%,SOCS5;PTPN1
prerank,glutathione metabolic process (GO:0006749),0.31326276543606224,0.7888559481776155,0.7346368715083799,1.0,1.0,7/38,12.11%,ETHE1;GSTT1;NAT8;GSTP1;OPLAH;GGCT;GSTA4
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.3606762700309066,0.7887673760847752,0.6964285714285714,1.0,1.0,3/16,10.46%,SLX4;HFM1;TOP2B
prerank,erythrocyte development (GO:0048821),0.3839785676381251,0.7885994023579876,0.697196261682243,1.0,1.0,3/10,12.98%,MED1;ZBTB7A;DMTN
prerank,L-amino acid transport (GO:0015807),-0.25423440963456356,-0.7885747557583288,0.8068535825545171,0.942750954541967,1.0,13/28,33.13%,SLC1A3;SLC3A2;SLC7A5;CTNS;SLC38A5;SLC1A4;SLC36A1;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6;PRAF2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.2667380464070732,-0.7880660050611396,0.8036253776435045,0.9426990205349276,1.0,11/23,31.75%,ELOVL7;FAR2;ACSL3;ACSL4;ELOVL6;HACD2;ELOVL1;ACOT7;ACSL1;ELOVL5;DGAT2
prerank,negative regulation of endocytosis (GO:0045806),0.34146636266089436,0.7878264513753638,0.7162162162162162,1.0,1.0,3/24,8.34%,PACSIN3;CAV1;CD300A
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.29739724976371695,-0.7877319168393293,0.7276995305164319,0.9424454184364017,1.0,7/15,35.62%,ANAPC1;CDC23;NEK6;CDC16;CDC27;RIOK2;TACC3
prerank,positive regulation of organelle organization (GO:0010638),0.32557696308271133,0.7872988584196411,0.7298444130127298,1.0,1.0,5/32,10.32%,ANXA1;LNPK;PPARGC1A;FYCO1;STX18
prerank,DNA replication checkpoint signaling (GO:0000076),0.3615261733817837,0.7872723541539131,0.6989966555183946,1.0,1.0,3/16,7.80%,TIPIN;RAD9A;HUS1B
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.3128863260190226,-0.7871922521945869,0.7669902912621359,0.9425151851908308,1.0,7/13,26.21%,CD44;MDM2;PTTG1IP;KDM1A;SNAI1;YJU2;TWIST1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.363703733348581,0.7867470228777402,0.7054908485856906,1.0,1.0,2/15,6.50%,FGF1;VEGFA
prerank,rRNA processing (GO:0006364),-0.18269588653099006,-0.7865080752170367,0.9811320754716981,0.9428163080936647,1.0,69/172,30.37%,NSA2;PRKDC;RPL27A;RPS19;SENP3;NVL;RPL21;RPS24;RPL36;RPL18;RSL1D1;RIOK3;RPLP0;DIS3;C1D;EXOSC1;RPL28;WDR3;RPLP1;RPL23A;MRPL1;RPL34;RRP36;MPHOSPH10;FCF1;EXOSC9;RPL36A;NOP53;RPL9;DDX52;RPS7;RPL27;RPL11;RPL18A;RPL37A;RPL38;RRP7A;EMG1;DCAF13;RPL29;EXOSC2;EBNA1BP2;UTP20;RPL10A;RPL32;BYSL;NOL11;THUMPD1;NOP56;EXOSC7;EXOSC3;UTP18;RPS27;HEATR1;NOLC1;IMP3;WDR18;EXOSC5;PIH1D1;PES1;RPL4;LSM6;UTP6;FBL;RPS15;RPL35A;NOL8;POP4;SART1
prerank,regulation of interleukin-10 production (GO:0032653),-0.22577822246142348,-0.786139261642932,0.80859375,0.9426002977439678,1.0,17/44,40.33%,HMGB1;LGALS9;PLCG2;CD34;CD46;CD274;HSPD1;SYK;TYROBP;NOD2;TRIB2;JAK3;PYCARD;FCGR2B;DLL1;AGER;TLR4
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.36682024741655894,0.7858372076360052,0.6998313659359191,1.0,1.0,1/13,1.50%,PMAIP1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.25027079211028636,-0.7854309742171995,0.8327974276527331,0.9429188430110966,1.0,9/32,18.12%,ATR;TNKS2;XRCC5;CTNNB1;FBXO4;MAP3K4;CCT8;CCT4;ATM
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2570762782078086,0.7852867405521797,0.91991991991992,1.0,1.0,55/497,10.27%,PRDM16;HEY2;TBX2;LBH;LIMS1;LIMD1;PDGFB;NAB1;ATP8B1;ID4;LOXL2;ARID5B;RUNX1T1;HEYL;PBXIP1;HINFP;IGFBP5;SAMD4A;GMNN;MRPL13;RBAK;BTG2;NACC2;HDAC9;SET;NR2F2;MTERF3;ATXN1;PIAS4;SUV39H2;MYBBP1A;DAB2IP;ARID5A;TP53;HEXIM1;ZBTB38;SFPQ;BCL7A;PA2G4;L3MBTL2;SOX9;RELA;PLCB1;MAP3K10;DAPK3;CBX4;MTA3;NR1D1;KAT7;ZBTB33;SIRT2;DEDD2;MIDEAS;PCGF6;SPINDOC
prerank,positive regulation of cell growth (GO:0030307),0.2770459932318968,0.7848226204997372,0.7866354044548651,1.0,1.0,23/96,17.44%,AKAP6;IL2;NTN1;PABIR1;FXN;BCL2;MAPT;TGFB2;ADNP2;ADAM17;ITSN2;HDGFL2;CEP43;N6AMT1;HYAL1;SMURF1;INO80;MAP3K13;DDX49;S100A8;S100A9;EIF4G2;RASAL1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.3403257942694886,-0.7845712310188264,0.7659574468085106,0.943511711032526,1.0,4/10,29.29%,STOML2;CDC7;DBF4;ATRX
prerank,leukotriene biosynthetic process (GO:0019370),0.38172156868460017,0.7843133151432659,0.7162872154115587,1.0,1.0,2/14,14.18%,ALOX5;PLA2G4A
prerank,dendrite morphogenesis (GO:0048813),0.31627124529123474,0.7836076535979382,0.7288378766140603,1.0,1.0,4/35,5.32%,SDC2;DOCK10;KLF7;MEF2A
prerank,protein localization to microtubule organizing center (GO:1905508),0.3576470750961697,0.7830422198403488,0.6843853820598007,1.0,1.0,4/15,11.87%,PIBF1;CEP192;C2CD3;NEDD1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3167528615910723,-0.7830283619405755,0.7827102803738317,0.9452400440563845,1.0,3/12,16.91%,CENPC;RMDN1;MAD1L1
prerank,pancreas development (GO:0031016),-0.31868893757186334,-0.7829413576078947,0.7410926365795725,0.9445806821697552,1.0,3/12,21.63%,TCF7L2;CCDC39;ZIC3
prerank,B cell mediated immunity (GO:0019724),0.3860155661561637,0.782711162854627,0.7032967032967034,1.0,1.0,10/10,61.42%,MSH2;CD27;CD70;CD74;CD19;SLA2;FCER1G;CARD9;TLR8;FCGR2B
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.26318333732066235,-0.7822873012128428,0.8096676737160121,0.9448147205391574,1.0,3/23,5.86%,SLC12A2;SLC12A7;ATP6V0A4
prerank,DNA methylation or demethylation (GO:0044728),-0.2795056433488408,-0.7820300533301083,0.7905604719764012,0.9436055596348083,1.0,11/19,45.31%,KMT2E;PPM1D;TEX15;ATRX;BEND3;DNMT3B;EHMT2;EHMT1;ATF7IP;DMAP1;FOS
prerank,DNA alkylation (GO:0006305),-0.2795056433488408,-0.7820300533301083,0.7905604719764012,0.9436055596348083,1.0,11/19,45.31%,KMT2E;PPM1D;TEX15;ATRX;BEND3;DNMT3B;EHMT2;EHMT1;ATF7IP;DMAP1;FOS
prerank,regulation of transmembrane transport (GO:0034762),0.3261726098937477,0.7819704361030313,0.7251798561151079,1.0,1.0,4/31,7.03%,KCNJ12;BCL2;ACTB;NEDD4
prerank,positive regulation of cellular senescence (GO:2000774),0.39067429648253044,0.7818186781490529,0.6862385321100918,1.0,1.0,1/10,3.13%,CGAS
prerank,regulation of DNA recombination (GO:0000018),0.3205661133720425,0.7817129528760917,0.7224669603524229,1.0,1.0,8/32,16.73%,H1-0;RAD51AP1;ZCWPW1;CHEK1;KPNA2;ZRANB3;SIRT6;MSH2
prerank,import into nucleus (GO:0051170),-0.20215699445702406,-0.7814582147215772,0.8616352201257862,0.9437195014818984,1.0,22/73,23.86%,APPL2;E2F3;FAM53A;NUP88;NUTF2;IPO8;PTTG1IP;GEMIN8;APPL1;NUP50;SNRPD1;AKT1;EIF4ENIF1;GEMIN7;SMN1;NUP85;IPO11;NXT2;NUP214;RAN;HTATIP2;IPO13
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.268626345761811,-0.7812402151964368,0.8051575931232091,0.9432728608036255,1.0,4/23,7.40%,HMGB1;CECR2;KPNA1;FBH1
prerank,regulation of neurogenesis (GO:0050767),0.29628426601879576,0.7812175136691236,0.7401055408970977,1.0,1.0,5/55,7.59%,HEY2;HEYL;PRUNE1;YTHDF2;YAP1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.26681349175285984,-0.7811159802733623,0.7787114845938375,0.9426830228375511,1.0,3/22,8.22%,BMP7;WNK1;CD44
prerank,cholesterol homeostasis (GO:0042632),0.2964540774451778,0.7809578377930475,0.7525252525252525,1.0,1.0,10/64,14.30%,RORA;CYP7B1;LPL;HDAC9;CAV1;NR1D1;LRP5;ABCG1;LDLRAP1;MTTP
prerank,fatty acid biosynthetic process (GO:0006633),-0.21444619244374552,-0.780757825730388,0.8852459016393442,0.9424492880453368,1.0,24/63,31.98%,ELOVL7;HACD4;ASAH2;PTGS2;ACLY;ABCD3;EPHX2;ABHD3;ELOVL4;ELOVL6;HACD2;DECR2;ELOVL1;HACD3;FADS1;ACOT7;HPGD;ALOX12;HSD17B8;DEGS1;OXSM;ELOVL5;TECRL;GPX4
prerank,regulation of neurotransmitter secretion (GO:0046928),0.31760404819088894,0.7802562585593242,0.7528248587570622,1.0,1.0,2/32,4.35%,MEF2C;RIMS3
prerank,positive regulation of leukocyte migration (GO:0002687),-0.2524024847996752,-0.7798203772470319,0.7956656346749226,0.9431574828046414,1.0,1/27,0.13%,PTN
prerank,glycerolipid catabolic process (GO:0046503),-0.275621537860822,-0.779691145147875,0.7897435897435897,0.9425801229409229,1.0,9/19,30.50%,GDPD1;ABHD12;GDE1;GPCPD1;PNPLA6;ABHD6;LYPLA2;ENPP6;SMPD4
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.21685441524693838,-0.7796800957927875,0.8232323232323232,0.9418127744262362,1.0,5/49,5.31%,HMGB1;LBP;F3;NOD1;LGALS9
prerank,membrane organization (GO:0061024),0.25728391226352443,0.7793415866824412,0.8557993730407524,1.0,1.0,38/227,13.43%,TRDN;CHMP4C;FER1L5;HIP1;DYSF;PACSIN2;ITSN1;FZD4;ACTG1;ACTB;ACTR3;TTPA;SYNJ2;EPN2;CHMP5;CORO1C;AREG;IGF2R;OPA1;SUN2;LPCAT3;GCA;STX18;NSFL1C;HBEGF;DNM1L;STAM2;TLCD2;MFN2;OSBPL2;CHMP2B;DMPK;SNX9;A4GALT;FNBP1;GLTP;LDLRAP1;CHMP2A
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.29089834879539306,0.7788923658054229,0.7534076827757125,1.0,1.0,14/65,17.60%,CHMP4C;FHL1;PABIR1;PSMC6;CHEK1;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14;VPS4A
prerank,response to UV-A (GO:0070141),-0.30501007946896486,-0.7785809380909597,0.7829268292682927,0.9428153094032459,1.0,4/14,16.36%,EGFR;MMP2;AKT1;MMP1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.3890645855362834,0.7785130399451223,0.720508166969147,1.0,1.0,2/10,13.32%,MAPRE2;FGF10
prerank,glucan biosynthetic process (GO:0009250),0.3770021694966815,0.7783650279069022,0.7181208053691275,1.0,1.0,3/12,10.14%,NR1D1;NHLRC1;GYS1
prerank,glycogen biosynthetic process (GO:0005978),0.3770021694966815,0.7783650279069022,0.7181208053691275,1.0,1.0,3/12,10.14%,NR1D1;NHLRC1;GYS1
prerank,regulation of cell size (GO:0008361),-0.2656190590602556,-0.7783281628904593,0.7645348837209303,0.9424293405225421,1.0,4/23,8.64%,DEPTOR;PRR16;VAV2;RDX
prerank,macroautophagy (GO:0016236),0.2673245411177847,0.7780626897621372,0.7852272727272728,1.0,1.0,32/118,20.61%,DYNLL1;PRKAB2;CHMP4C;PIP4K2A;MTERF3;LIX1L;ATG7;GABARAP;LIX1;VDAC1;MTMR14;STAM2;MFN2;CHMP2B;TSG101;VPS36;PIK3C3;CHMP2A;PRKAA2;STAM;ATG13;TOMM5;VPS4A;MTMR3;FUNDC1;TOMM7;ULK1;ATG10;VPS37A;PRKAB1;MFN1;LAMP2
prerank,nucleotide-sugar metabolic process (GO:0009225),0.3715867966908692,0.7780399939003706,0.6914893617021277,1.0,1.0,3/12,11.20%,CSGALNACT1;GFPT1;PARG
prerank,regulation of postsynapse organization (GO:0099175),0.3242488050273654,0.777850655130814,0.7070254110612855,1.0,1.0,8/28,16.45%,PDLIM5;KIF1A;ABHD17B;IL1RAPL1;HOMER1;LRRK2;LZTS3;VPS35
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3349031739243675,0.7778202666624071,0.7363770250368189,1.0,1.0,11/25,22.61%,ELL;ERCC6;CCNT1;KAT7;TSFM;ZMYND11;HMGN1;WDR43;HTATSF1;CCAR2;THOC1
prerank,atrial septum development (GO:0003283),0.36718278005394495,0.7774790764934908,0.6981450252951096,1.0,1.0,2/13,7.86%,HEY2;TGFB2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.31229815830602636,-0.7774491746450846,0.747072599531616,0.9430368771322157,1.0,3/13,12.79%,TPST1;BPNT2;ENPP1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.36107162084554373,0.7766626041694046,0.719551282051282,1.0,1.0,5/16,13.90%,PARP1;PPARGC1A;PPARA;ATPSCKMT;TMSB4X
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.2662132159832626,0.7761958070096684,0.8154696132596685,1.0,1.0,14/136,9.69%,FLNA;TMIGD3;HEYL;PTGIS;HAVCR2;SETD6;TAF1;DAB2IP;CD200;TRAF3;ZNF431;MAP3K10;PAXIP1;NFKBIE
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2615459403623717,0.7757589988186547,0.8637770897832817,1.0,1.0,27/208,11.68%,FLNA;NR1H4;MYD88;RORA;ROR1;NUP62;CARD19;MTDH;DAB2IP;PPM1A;TRAF3;GOLT1B;TIFA;RELA;TNIP1;TRIM68;OTUD7A;GSTP1;NR1D1;EDAR;TRAF5;PELI2;DDX1;ZDHHC17;RHOH;ZFAND6;HTR2B
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.27433085302198823,-0.7757160141692647,0.7818181818181819,0.944919422734503,1.0,4/20,8.43%,FKBP5;CWC27;PPIL2;FKBP1A
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3184803176858033,0.7752693456314284,0.7160493827160493,1.0,1.0,3/24,7.09%,PLCE1;ACTR3;CYFIP1
prerank,sterol homeostasis (GO:0055092),0.2946538323860003,0.7749849250596167,0.7648546144121365,1.0,1.0,10/65,14.30%,RORA;CYP7B1;LPL;HDAC9;CAV1;NR1D1;LRP5;ABCG1;LDLRAP1;MTTP
prerank,cellular response to amino acid stimulus (GO:0071230),0.31371527984526,0.774079374663103,0.7349570200573066,1.0,1.0,8/33,14.47%,LARS1;CASTOR1;CPEB1;CAPN2;RRAGB;SH3BP4;CPEB3;CASTOR2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.2729072752925314,0.7740535186402612,0.7827586206896552,1.0,1.0,14/92,10.88%,ANGPT1;FGF1;ANGPT4;CLASP2;MAPRE2;RRAS;VEGFA;ITGB3;SOX9;TGFB2;RIN2;HIF1A;DOCK1;ROCK2
prerank,B cell differentiation (GO:0030183),0.303125211433003,0.7740530753358807,0.7578659370725034,1.0,1.0,7/46,11.69%,CD79A;ITGB1;HDAC9;ITGA4;ADAM17;TPD52;ZBTB7A
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3056160394003655,0.7740219412726019,0.7334254143646409,1.0,1.0,9/43,10.69%,PDGFB;TERT;TP53;SOX9;TGFB2;RELA;PPARA;HIF1A;TEAD1
prerank,response to lipopolysaccharide (GO:0032496),0.263959347175542,0.77380365636365,0.827661909989023,1.0,1.0,15/138,9.79%,MEF2C;MYD88;VIM;UPF1;CD14;TNFRSF11A;DAB2IP;CHMP5;MAPKAPK2;NFKBIB;RELA;ADAM17;GSTP1;NR1D1;AXL
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2817215372946614,0.7732939237768222,0.7708333333333334,1.0,1.0,19/76,17.98%,KLHL40;SOCS5;PABIR1;GABARAP;TAF1;FBXW7;RNF180;SIRT2;CLU;BAG2;CSNK1E;LRRK2;DVL1;CSNK1A1;PTEN;HSPBP1;SMURF1;RCHY1;PIAS1
prerank,regulation of cellular catabolic process (GO:0031329),0.2876324012091639,0.773292411451782,0.7534591194968554,1.0,1.0,20/62,19.82%,ROCK1;ITPR1;PIP4K2A;MAPT;DAPK3;RRAGB;LONP2;BOK;USP13;LRRK2;RAB8A;WDR41;DAPK2;MTMR3;DDIT3;HDAC6;KAT8;ABL1;PIK3R2;DCAF12
prerank,cell-cell junction maintenance (GO:0045217),0.3865523375296012,0.7732549165725406,0.7070175438596491,1.0,1.0,1/11,2.33%,FERMT2
prerank,cholesterol transport (GO:0030301),0.3007701636045057,0.7731374191924416,0.7352941176470589,1.0,1.0,10/45,17.72%,CD36;CAV1;STX12;ABCG1;OSBPL2;CLU;LDLRAP1;OSBPL5;VPS4A;LIMA1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.29175972120553917,-0.7726390749754667,0.7711442786069652,0.9489437831571861,1.0,9/16,27.74%,KLHL22;PIP4P1;GPR137B;TELO2;RRAGD;GPR137;SIK3;PIH1D1;RRAGA
prerank,chondroitin sulfate metabolic process (GO:0030204),0.3186319884313409,0.772620580562358,0.7218155197657394,1.0,1.0,4/30,3.64%,CSPG4;CHSY3;CSGALNACT1;BGN
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.27576363736638027,0.7725889298057905,0.7744630071599046,1.0,1.0,14/87,14.35%,FGF1;POLR2L;POLR2I;NR4A1;CCL5;POLR2G;FLRT1;GALNT3;POLR2J;ZFP36L1;FGF10;MAPK1;RAB14;HYAL1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.22641198308256705,-0.772543501460961,0.8795180722891566,0.9483058967730501,1.0,14/42,23.81%,SMARCA2;RBBP4;CECR2;SMARCA1;ACTR8;CHD3;ACTR6;MTA2;HDAC2;ZNHIT1;SRCAP;ACTR5;SMARCD2;GATAD2B
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.34273386775225867,0.7725083366215382,0.7182866556836903,1.0,1.0,5/18,16.35%,PLCB1;HRH3;AGRN;GNAQ;RGS10
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.2957876237913305,0.7725003856463771,0.7452471482889734,1.0,1.0,6/50,9.52%,CCNA2;CCND2;ACTB;CCND1;CCNT1;CDK7
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.2513192378115323,-0.772143101741699,0.793002915451895,0.9481195827582232,1.0,14/26,31.23%,TET3;CTR9;TET2;OGT;SETD5;ETFBKMT;SETD1A;SUV39H1;PRDM9;EEF2KMT;KMT2A;BEND3;SMYD5;ANTKMT
prerank,positive regulation of cell cycle (GO:0045787),0.28896222664439164,0.7719355333700688,0.759493670886076,1.0,1.0,15/62,15.21%,PDGFB;CCND2;EIF4EBP1;USP2;DUSP3;CHEK1;TGFB2;CCND1;ADAM17;PKN2;CITED2;MAPRE3;EIF4E;PRKCA;SRPK2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2789807664662498,0.7718347013110793,0.7892813641900122,1.0,1.0,8/68,9.60%,CAVIN1;POLR2L;GTF2H4;WDR33;PCF11;PAPOLA;CDK7;POLR1E
prerank,regulation of macromolecule metabolic process (GO:0060255),0.26285084122807556,0.771781175397735,0.8356756756756757,1.0,1.0,23/170,13.47%,TMPRSS4;CRIP1;ALPK2;CDK6;SLC8A2;SLC8A1;HINFP;SORT1;PRDM1;ATP1B1;PIN1;GDNF;ADNP2;TRIM68;HIF1A;TOB2;ROCK2;ANKRA2;AFF1;PCBP3;ZFP36L1;HMG20A;MKLN1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.28467012639967154,0.7714059270677297,0.7791563275434243,1.0,1.0,17/69,15.34%,PLCE1;PLCB4;PLCL1;KCNH1;IRS1;PLCB1;PLCD1;SIRT2;PDGFRB;HTR2B;TPTE;ZFP36L1;PIK3C3;PLEKHA1;IRS2;PITPNM2;PTEN
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.32579785430045693,0.7703613494200718,0.7288629737609329,1.0,1.0,5/28,6.82%,PIP4K2A;KANK1;PRKCQ;IRS1;PTPN1
prerank,negative regulation of cell projection organization (GO:0031345),-0.22291215004208814,-0.7694312189415349,0.8597285067873304,0.9514225826614869,1.0,11/48,17.55%,EFNB2;LPAR1;APOE;EPHA4;SEMA3A;SPRY2;DPYSL3;RAB29;CBFA2T2;HDAC2;PRAG1
prerank,monoacylglycerol metabolic process (GO:0046462),0.3745822169834839,0.769335000514096,0.7251264755480608,1.0,1.0,4/13,18.67%,MGLL;DGAT1;PLA2G4A;FAAH
prerank,translational elongation (GO:0006414),0.2712034240203053,0.7688774047079874,0.8055878928987195,1.0,1.0,27/101,19.18%,EEFSEC;MRPL36;MRPS31;MRPL13;MRPL30;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;MRPL47;MRPL9;TSFM;MRPL42;EEF2K;GTPBP2;MRPL14;MRPL4;EEF2;MRPS21;MRPL40;MRPL22;MRPL50
prerank,negative regulation of T cell activation (GO:0050868),0.3068794042298549,0.7688059848445373,0.7440559440559441,1.0,1.0,5/35,10.86%,LAX1;HAVCR2;DUSP3;PAG1;TNFRSF21
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.2883767416819619,-0.7687158112365818,0.7716346153846154,0.9517328350156034,1.0,3/15,13.83%,EGFR;PTK2B;KDR
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.29550986558336223,-0.7686531791322425,0.7632850241545893,0.9510250869521018,1.0,10/13,49.88%,HES1;MGAT5;EGF;CRLF2;JAK3;PTPRT;PIGU;TSLP;IL7R;DOT1L
prerank,glycosaminoglycan catabolic process (GO:0006027),0.29082915084460303,0.7685404985821961,0.7660668380462725,1.0,1.0,5/55,5.98%,SDC2;CSPG4;BGN;GPC4;OGN
prerank,prostaglandin biosynthetic process (GO:0001516),0.3423866961596568,0.7680070732407065,0.7208538587848933,1.0,1.0,5/18,17.14%,PTGIS;TBXAS1;CBR1;PLA2G4A;MIF
prerank,anterograde axonal transport (GO:0008089),0.30300626573876815,0.7676343574514467,0.7580419580419581,1.0,1.0,10/37,17.50%,KIF3B;KIF1A;KIF5B;TRAK1;KIF1C;KIF5C;KIF5A;AP3B2;BLOC1S5;MAP1A
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.23766238370101056,-0.7674993423871207,0.8494983277591973,0.952006702078663,1.0,9/35,18.12%,ATR;TNKS2;XRCC5;CTNNB1;FBXO4;MAP3K4;CCT8;CCT4;ATM
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.32454395727484386,-0.7674337386971453,0.7700650759219089,0.9505140244666505,1.0,1/10,2.41%,WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.32454395727484386,-0.7674337386971453,0.7700650759219089,0.9505140244666505,1.0,1/10,2.41%,WNK1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.255720968967857,0.7673200975062698,0.877319587628866,1.0,1.0,53/241,16.32%,LSM8;POLR2L;POLR2I;HNRNPR;CWC25;RAVER2;DDX23;WDR33;PCF11;SF3B5;POLR2G;U2AF2;TXNL4A;SFPQ;SF3B3;SRSF4;PAPOLA;SNRPN;GPKOW;FUS;PPIL1;PPIE;ZMAT5;RBM19;RBM8A;U2AF1;DHX8;HNRNPU;PRPF4;SRSF10;SF3A3;HNRNPC;PSPC1;RBM6;SRRM1;SF3B2;SF3B1;ZCRB1;POLR2J;PPWD1;SYNCRIP;PDCD7;CWC22;PPIL3;SNRPB2;RBM15;SF1;RBM41;SF3A1;PUF60;FIP1L1;XAB2;WBP4
prerank,mitochondrial translational termination (GO:0070126),0.27169087743874915,0.7671718202761343,0.7881257275902211,1.0,1.0,28/88,22.04%,MRPL36;MRPS31;MRPL13;MRPL30;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;MRPL47;MRPL9;MRPL42;MRPL14;MRPL4;MRPS21;MRPL40;MRPL22;MRPL50;MRPS14;MRRF;OXA1L;MRPL24;MRPS12;MRPS10
prerank,immunoglobulin mediated immune response (GO:0016064),0.3860155661561636,0.766760514694296,0.7196078431372549,1.0,1.0,10/10,61.42%,CD27;ZP3;CD74;GAPT;CD19;FCER1G;CARD9;TLR8;CD81;FCGR2B
prerank,histone H3 deacetylation (GO:0070932),0.34974970327888993,0.7665389986765958,0.7091222030981067,1.0,1.0,6/15,19.59%,HDAC9;SFPQ;SIRT2;SIRT6;HDAC1;SMARCAD1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.31871502028155907,-0.7664225973579475,0.7777777777777778,0.951270652430485,1.0,6/11,35.72%,UQCRC1;UQCRC2;UQCR11;CYC1;UQCC3;CYCS
prerank,snRNA processing (GO:0016180),-0.2881608409475752,-0.766267902824742,0.7835051546391752,0.9506825005342114,1.0,6/16,28.48%,INTS6;INTS3;INTS2;INTS11;INTS14;TOE1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.3457383759335615,0.7659167999921574,0.7185929648241206,1.0,1.0,3/18,8.65%,MEF2C;ITGA4;ADAM17
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.36386494267277397,0.7646708008421272,0.7415329768270945,1.0,1.0,2/13,9.24%,CABP1;NUP153
prerank,DNA geometric change (GO:0032392),-0.2588956246733317,-0.7643853281265444,0.8038147138964578,0.9527030164828237,1.0,5/24,12.84%,HMGB1;MRE11;RAD50;BLM;NBN
prerank,protein-containing complex assembly (GO:0065003),0.24988111960836265,0.7636211193444533,0.8837448559670782,1.0,1.0,37/259,14.40%,DMD;TCAP;PDE4DIP;FERMT2;ANO6;SH3BGR;TBC1D20;SKAP2;CNIH2;AFG3L2;TERT;TP53;LAMC1;AREG;PPARGC1A;MDN1;YAP1;OPA1;SOX9;ADD2;KMT2D;AMER1;SEC13;MAGI1;TEAD1;DNM1L;KIFAP3;BOK;RUVBL1;NSF;SNX9;SEC24A;DMTN;KPNA3;SEC24C;EPRS1;LRRK2
prerank,regulation of complement activation (GO:0030449),-0.227578753433411,-0.7635791463922722,0.8383838383838383,0.9531077005761287,1.0,11/40,27.54%,VTN;PROS1;CD55;CD46;SERPING1;C1QB;CR1L;C1QC;C1QA;CFHR2;C2
prerank,DNA methylation (GO:0006306),-0.26089212757258523,-0.7633349013694432,0.80625,0.9526627668118665,1.0,13/23,45.31%,KMT2E;PPM1D;PICK1;TEX15;ZFP57;ATRX;BEND3;DNMT3B;EHMT2;EHMT1;ATF7IP;DMAP1;FOS
prerank,arachidonic acid metabolic process (GO:0019369),0.3007570728474324,0.7633335223939351,0.7330567081604425,1.0,1.0,8/35,16.23%,PTGIS;ALOX5;TBXAS1;CBR1;MGLL;PLA2G4A;PLA2G4C;EPHX1
prerank,positive regulation of neuron migration (GO:2001224),0.37329026263574083,0.7631634921692,0.7067137809187279,1.0,1.0,3/11,12.58%,ARHGEF2;DAB2IP;KIF20B
prerank,maturation of 5.8S rRNA (GO:0000460),-0.28179778705741576,-0.7629283070836497,0.794044665012407,0.9524581424849002,1.0,4/17,13.09%,NSA2;PRKDC;C1D;URB1
prerank,regulation of chromatin binding (GO:0035561),-0.3243286680116805,-0.7628400856812413,0.7927350427350427,0.9518218129629085,1.0,4/10,17.72%,BTAF1;MED25;DTX3L;KDM4D
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.3265410482572909,-0.7626831676944477,0.7777777777777778,0.9513070954935541,1.0,3/10,20.56%,HSPA5;HERPUD1;ATF4
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.3183304131226239,-0.7624092678319783,0.7811816192560175,0.9509428330078589,1.0,2/11,8.20%,NEDD4L;COMMD1
prerank,regulation of mitotic nuclear division (GO:0007088),0.28606039628391844,0.7623568751637203,0.7676240208877284,1.0,1.0,12/55,15.41%,PDGFB;NUP62;PIN1;CUL9;CHEK1;DAPK3;TOM1L2;PDGFRB;LRP5;KIF20B;FBXO5;CAV2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.32739805615297557,-0.7618796125529,0.7600896860986547,0.9509684074455016,1.0,2/10,5.68%,LGALS9;CD55
prerank,negative regulation of kinase activity (GO:0033673),-0.20466724519721052,-0.7616731578769685,0.8939393939393939,0.9504585744940888,1.0,16/62,20.37%,PRKAG2;NF1;DEPTOR;PDPK1;DTNBP1;PYDC1;WWTR1;PPM1F;TAB1;SNCA;AKT1;ITGB1BP1;TRIB1;PARK7;QARS1;CEACAM1
prerank,axonal transport (GO:0098930),0.3032072371453649,0.761605032759027,0.7690140845070422,1.0,1.0,10/36,17.37%,DST;KIF3B;KIF1A;MAPT;OPA1;HIF1A;FBXW11;AP3B2;BLOC1S5;DCTN1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.31003324638174284,0.7614916938322384,0.7359009628610729,1.0,1.0,7/36,10.48%,ITGB1;TAF1;FBXW7;AREG;ADAM17;HIF1A;HBEGF
prerank,tube closure (GO:0060606),0.3129439451020327,0.7614471456701823,0.7608695652173914,1.0,1.0,3/31,9.18%,DLC1;TGFB2;SKI
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3256326149557278,0.7612579697161076,0.7351598173515982,1.0,1.0,1/22,1.43%,ROCK1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3190479097990498,0.7611390475475911,0.75,1.0,1.0,3/31,6.42%,PMAIP1;BCL2;TP53
prerank,GPI anchor biosynthetic process (GO:0006506),0.31768198236867284,0.7608669751039313,0.7388724035608308,1.0,1.0,12/30,23.15%,PIGN;PIGA;PIGH;PIGB;PIGP;DPM2;PGAP4;PIGK;PIGZ;GPAA1;PIGS;PIGM
prerank,regulation of immune effector process (GO:0002697),-0.22636001763169408,-0.7605188060064593,0.8762886597938144,0.9514157781655277,1.0,18/41,40.50%,VTN;PROS1;CD55;CD46;SERPING1;C1QB;CR1L;C1QC;C1QA;CFHR2;C2;CR2;C3;C3AR1;C6;FCGR2B;C7;CD81
prerank,positive regulation of mRNA processing (GO:0050685),-0.271617748117637,-0.7603046770381124,0.8150134048257373,0.950947083167373,1.0,6/21,14.87%,TRA2B;CELF4;DAZAP1;SNW1;LEO1;NCBP2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.24649292680091167,-0.760242634299217,0.8171428571428572,0.950247932176748,1.0,10/26,32.16%,CUL3;CDC23;DUSP1;NEK6;ANAPC4;NSMCE2;ANAPC15;CDC16;CDC27;RIOK2
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.35533832238538493,0.7598736388640667,0.7116666666666667,1.0,1.0,2/15,11.57%,PLA2G3;ABCG1
prerank,protein targeting (GO:0006605),0.26175672410885326,0.7592677703215225,0.8052391799544419,1.0,1.0,37/118,22.34%,AKAP6;ZFAND2B;GOLGA7B;NACA;GABARAP;ZDHHC2;TRAK1;ZDHHC1;ZDHHC14;PEX19;LONP2;MFN2;ZFAND6;HPS4;AP1S3;TOMM5;AP4E1;ZDHHC4;BCAP31;MFF;TOMM7;ZDHHC3;RTP4;VPS37A;SPCS3;PARD3;SRP14;PEX1;MYO1C;LAMP2;TIMM9;CACNG3;TIMM22;SEC61G;GDAP1;PIKFYVE;TOMM22
prerank,sister chromatid segregation (GO:0000819),0.3097253574021914,0.7590461878313141,0.7453769559032717,1.0,1.0,9/31,17.20%,ZWINT;WRAP73;TOP2B;RB1;KIF18A;KNSTRN;INO80;DSN1;CENPK
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.31175661649869746,-0.759023733871187,0.7846153846153846,0.9503975239444727,1.0,3/11,16.60%,CCT8;CCT4;LARP7
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.31175661649869746,-0.759023733871187,0.7846153846153846,0.9503975239444727,1.0,3/11,16.60%,CCT8;CCT4;LARP7
prerank,mammary gland development (GO:0030879),0.3322022318376118,0.7586836659052335,0.7365079365079366,1.0,1.0,4/21,11.60%,TGFB3;CAV1;VEGFA;ARHGAP35
prerank,primary neural tube formation (GO:0014020),0.3154751095733002,0.7584466682749648,0.7694566813509545,1.0,1.0,3/30,9.18%,DLC1;TGFB2;SKI
prerank,purine-containing compound biosynthetic process (GO:0072522),0.32153022982827406,0.7584353584423038,0.7413793103448276,1.0,1.0,4/25,12.92%,AMPD1;AMPD2;PPAT;GMPR
prerank,lymphocyte chemotaxis (GO:0048247),0.29916048924239896,0.7584243982272751,0.7485955056179775,1.0,1.0,6/34,18.77%,CYP7B1;CCL5;CCL14;GAS6;CCL25;CCL19
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.2759026017773637,-0.7579588719377691,0.7979274611398963,0.9511066857148461,1.0,3/17,6.97%,PID1;NUPR1;HDAC4
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.26685796872738327,-0.7578147842233116,0.8138957816377171,0.9505408398229412,1.0,3/18,8.49%,PTPN11;CTR9;IL6R
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3433209143430295,0.75766105069707,0.7221324717285945,1.0,1.0,7/18,17.90%,RELA;ROCK2;ABCG1;CHRNA7;CLU;SP1;LRRTM3
prerank,sensory perception (GO:0007600),0.29285066361876444,0.757381945967169,0.7675033025099075,1.0,1.0,5/45,12.38%,ASIC3;TRPV2;NTSR2;KCNA2;CHRNA7
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.30181028441725083,0.7570522909666798,0.7545582047685835,1.0,1.0,5/38,6.82%,PDGFB;DOK7;CAV1;RAP2C;PTPN1
prerank,regulation of microtubule polymerization (GO:0031113),0.298746064471561,0.7570074985357564,0.7457627118644068,1.0,1.0,13/40,20.86%,PRUNE1;DYRK1A;MAPT;TOGARAM1;TBCD;CLIP3;CLASP1;STMN2;MAPRE3;DCTN1;ABL1;CAMSAP1;MAPRE1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.326931382955694,0.7568970097827736,0.7307692307692307,1.0,1.0,5/23,15.39%,SOCS5;SOCS4;CAV1;TSG101;CBLB
prerank,peroxisomal membrane transport (GO:0015919),-0.24932595156151996,-0.756306058189234,0.8383838383838383,0.951930892443161,1.0,9/27,21.53%,PEX14;SLC25A17;ALDH3A2;PEX5;ACBD5;ABCD3;FIS1;PXMP2;PEX13
prerank,response to growth factor (GO:0070848),0.29569492911018347,0.756235102820241,0.7479892761394102,1.0,1.0,13/41,20.78%,PDGFB;ACVR2A;BMPR1A;EPHA2;ACVR1B;BMPR1B;CPNE3;URI1;NOS1;HDAC6;SHC1;ACVR1;ERBB2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.25107279732127147,0.7561609831613885,0.8965163934426229,1.0,1.0,58/264,16.32%,LSM8;POLR2L;POLR2I;HNRNPR;CWC25;RAVER2;DDX23;WDR33;PCF11;SF3B5;POLR2G;U2AF2;TXNL4A;SFPQ;CLNS1A;SF3B3;SRSF4;PAPOLA;SNRPN;GPKOW;PRMT7;FUS;PPIL1;PPIE;ZMAT5;RBM19;RBM8A;U2AF1;DHX8;HNRNPU;PRPF4;SRSF10;DDX1;SF3A3;HNRNPC;PSPC1;RBM6;TGS1;SRRM1;SF3B2;SF3B1;ZCRB1;POLR2J;PPWD1;SYNCRIP;PDCD7;CWC22;PPIL3;SNRPB2;SRPK2;RBM15;SF1;RBM41;SF3A1;PUF60;FIP1L1;XAB2;WBP4
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.30296357776177757,0.7561279314723138,0.7610241820768137,1.0,1.0,6/33,8.65%,CCND2;ANXA1;FAM83D;PLCB1;CCND1;ADAM17
prerank,phospholipid metabolic process (GO:0006644),0.27632622749257774,0.7560723974645599,0.7946859903381642,1.0,1.0,11/71,15.00%,PLA2G3;PIP4K2A;LPL;PLPPR1;AGPAT3;PLCD1;PCYT2;PLB1;PNPLA3;PLA2G4A;PLA2G4C
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.284289412961865,0.7558651366035832,0.7878395860284605,1.0,1.0,6/56,7.82%,CD36;MYD88;CD14;MAPKAPK2;TRAF3;TIFA
prerank,regulation of mRNA catabolic process (GO:0061013),0.2605798895239367,0.7558561960871261,0.8288590604026845,1.0,1.0,23/121,16.90%,RBM24;VIM;SAMD4A;PARN;SET;UPF1;PSMC6;MAPKAPK2;YTHDF2;PSME4;PSMB1;PSMD5;PRKCD;DCP1A;CNOT7;PSMB2;ZFP36L1;PSMB7;PSMD3;PRKCA;PSMA2;XPO1;PSMD14
prerank,epidermal cell differentiation (GO:0009913),0.303122668696194,0.7556875802062053,0.7730978260869565,1.0,1.0,5/41,12.31%,ANXA1;JAG1;MED1;EPHA2;BCR
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.32516130788032,0.7556113004014834,0.7574404761904762,1.0,1.0,1/23,1.50%,PMAIP1
prerank,maintenance of protein localization in organelle (GO:0072595),0.3332421452478225,0.755322452250383,0.7187993680884676,1.0,1.0,4/19,10.29%,HK2;TAPT1;TAF8;HNRNPU
prerank,neuron projection development (GO:0031175),0.25622986509061096,0.7547944385881229,0.8572972972972973,1.0,1.0,30/168,15.42%,NTF3;ROCK1;FRY;PLXNB1;DOCK10;BTG2;MAPT;DAB2IP;GDNF;HDGFL3;NEDD4;ERCC6;DICER1;ATCAY;SAMD14;RB1;TNIK;PACSIN1;KIF20B;TAOK3;SGK1;MAP4;EPHB1;STMN2;LRRK2;ANKRD27;PPP1R9A;CNTNAP1;PTEN;DNM2
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.32063228041864167,0.7539987097964211,0.7481031866464339,1.0,1.0,6/27,12.55%,CPA4;NAT8;MSL3;KAT7;RUVBL1;MORF4L1
prerank,ceramide transport (GO:0035627),-0.30984660461121155,-0.753685612362537,0.7858672376873662,0.9549533830151822,1.0,6/12,22.22%,PLTP;SGPP1;CERT1;PLEKHA3;PSAP;ABCA2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.2698494824617376,-0.7534456041871371,0.8142857142857143,0.9545214149358512,1.0,5/18,22.22%,APOE;RDX;PTTG1IP;DACT1;ABCA2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.33606773825586145,0.7534054785116651,0.7369230769230769,1.0,1.0,2/22,6.73%,FZD5;IL12RB1
prerank,inositol lipid-mediated signaling (GO:0048017),0.28734989874678346,0.7533912061036557,0.7776298268974701,1.0,1.0,8/50,10.07%,PLCE1;PLCB4;PLCL1;KCNH1;IRS1;PLCB1;PLCD1;PDGFRB
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.373461429099992,0.7529528460271175,0.7176258992805755,1.0,1.0,3/11,13.20%,PAPOLA;AHCYL1;ZFP36L1
prerank,regulation of cellular response to stress (GO:0080135),0.26246329067039126,0.7528818916979644,0.8229398663697105,1.0,1.0,21/115,14.19%,CAMK2G;CAMK2D;NUP62;ALOX5;SLC38A2;MAPT;MAPKAPK2;NUAK1;SEC13;NUP153;BAG3;AMFR;NUP107;AAAS;ROCK2;ATF3;BAG2;NUP98;MAPK1;NUP37;MCL1
prerank,cellular response to amyloid-beta (GO:1904646),0.29802237132298015,0.7525136556723149,0.786628733997155,1.0,1.0,2/35,1.73%,CACNA2D1;CD36
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2639182033654846,-0.752347499121215,0.8082191780821918,0.9551935587473375,1.0,11/20,38.61%,GATM;PLOD2;PTDSS2;MTHFS;FPGS;GCLC;GCLM;PTDSS1;GAMT;PLSCR1;GGT1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3115998608028294,0.7522099187831929,0.7514285714285714,1.0,1.0,3/31,4.59%,CDK6;FHL1;JADE1
prerank,neuron differentiation (GO:0030182),0.2545396290714627,0.7519445514453554,0.8609625668449198,1.0,1.0,17/165,11.33%,MEF2C;FZD5;IRX5;FZD4;FZD8;ITM2C;VEGFA;PIN1;ERCC6;TGFB2;ADNP2;MAP2K1;NR4A2;BRSK1;HS6ST1;RUNX1;IL1RAPL1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.27599291833506,0.7517496363524107,0.8019925280199253,1.0,1.0,16/74,16.90%,LIMD1;CUL2;PSMC6;ELOC;VEGFA;HIF1A;PSME4;SIRT2;PSMB1;PSMD5;PSMB2;CITED2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,DNA replication initiation (GO:0006270),-0.22311176384181383,-0.7517272165937028,0.9010989010989011,0.9552778190102467,1.0,23/37,41.95%,ORC6;ORC5;POLE4;POLE2;CDC7;CDK2;ORC4;DBF4;POLA2;RPA3;ORC1;CDC34;PRIM1;MCM8;RPA2;CDC45;RPA1;POLE;MCM3;POLE3;POLA1;MCM5;MCM10
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.23113803630194646,-0.7515861226813885,0.8724137931034482,0.9547113406342798,1.0,14/33,28.62%,PABPN1;SLBP;SETX;MAZ;NCBP2;CPSF2;SCAF8;CSTF2T;SSU72;CPSF4;CSTF2;CPSF1;LSM11;CLP1
prerank,maintenance of protein location in nucleus (GO:0051457),0.3278710571616903,0.7509459964409283,0.7413793103448276,1.0,1.0,4/20,10.29%,SYNE1;TAF8;SUN2;HNRNPU
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.27159037531977076,-0.7508314238415277,0.8256130790190735,0.954999123542726,1.0,7/18,30.45%,PRKN;AKT1;PARK7;MAPK7;BAG5;HTRA2;PPIA
prerank,rRNA 3'-end processing (GO:0031125),-0.31801889184667065,-0.7503853900914367,0.7853982300884956,0.9548055083988306,1.0,6/10,25.12%,ERI3;EXOSC9;RPS21;EXOSC2;EXOSC7;EXOSC3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.30059684964397976,0.7492457812134362,0.7960618846694796,1.0,1.0,10/38,18.33%,FZD5;SAE1;FBXW7;SREBF2;HPS4;LRRK2;ATG13;LEPROT;USP36;TOMM7
prerank,histone deacetylation (GO:0016575),0.29688707299850214,0.7490863933174002,0.7771509167842031,1.0,1.0,15/43,19.59%,HDAC9;SFPQ;MSL3;MTA3;SIRT2;MIDEAS;BAZ2A;MORF4L1;MTA1;SIN3A;SIRT6;HDAC1;RBM14;HDAC6;SMARCAD1
prerank,protein stabilization (GO:0050821),0.25195669597195847,0.7488915587642064,0.8794788273615635,1.0,1.0,30/168,15.51%,FLNA;HIP1;CRTAP;TSPAN1;USP2;TESC;ATP1B1;TAF1;FBXW7;PIN1;PPARGC1A;CDK7;RPL5;BAG3;PARVA;STX12;PEX19;CCT3;PRKCD;USP13;TMEM88;CLU;PDCD10;HPS4;BAG2;MUL1;GNAQ;DVL1;PTEN;FLOT1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.31880588535636745,-0.748802965193133,0.7972027972027972,0.9563323835775509,1.0,1/10,4.15%,LPGAT1
prerank,oxoacid metabolic process (GO:0043436),-0.23961932070463846,-0.7485045067195246,0.8485804416403786,0.9559438363456684,1.0,5/27,12.79%,TPST1;BPNT2;PPA1;PPA2;ENPP1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3214403427189269,-0.7481732402555104,0.8036117381489842,0.9556744259897305,1.0,3/10,16.79%,MYO9A;OPHN1;CDC42
prerank,regulation of viral genome replication (GO:0045069),-0.2048201671042419,-0.7480181584405942,0.9174311926605505,0.9550951038289943,1.0,14/56,18.27%,DDX3X;STAU1;PARP10;PABPC1;DDB1;IFIT1;ADAR;BST2;PPIH;IFITM1;OAS2;SHFL;IFITM3;SRPK1
prerank,replicative senescence (GO:0090399),0.35868597787879103,0.7477921752121635,0.7508771929824561,1.0,1.0,3/12,7.52%,TERT;TP53;CHEK1
prerank,melanosome organization (GO:0032438),-0.24147035239097792,-0.7473789230303182,0.8426966292134831,0.9552094302771619,1.0,9/26,31.66%,SHROOM2;DTNBP1;AP1M1;RAB29;AP1G1;BLOC1S6;RAB32;BLOC1S2;TRAPPC6A
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.2766128396482332,-0.7472760040325064,0.8222222222222222,0.9545704069346016,1.0,5/17,19.06%,EMC2;SGTA;EMC3;EMC8;MMGT1
prerank,mRNA processing (GO:0006397),0.24736415308635581,0.7466868673178614,0.9152196118488254,1.0,1.0,62/287,16.32%,LSM8;POLR2L;POLR2I;HNRNPR;CWC25;RAVER2;GTF2H4;DDX23;WDR33;PCF11;SF3B5;POLR2G;U2AF2;TXNL4A;SFPQ;PPARGC1A;CELF1;SF3B3;SRSF4;PAPOLA;SNRPN;PRPF18;GPKOW;FUS;PPIL1;PPIE;ZC3H11A;ZMAT5;RBM19;CDK7;RBM8A;U2AF1;DHX8;HNRNPU;PRPF4;SRSF10;THOC7;SF3A3;HNRNPC;PSPC1;RBM6;SRRM1;SF3B2;SF3B1;ZCRB1;POLR2J;PPWD1;SON;SYNCRIP;PDCD7;CWC22;PRKACA;PPIL3;SNRPB2;RBM15;SF1;RBM41;SF3A1;PUF60;FIP1L1;XAB2;WBP4
prerank,signal peptide processing (GO:0006465),0.3579046705375879,0.7466839297443388,0.7454873646209387,1.0,1.0,1/11,2.22%,CLN5
prerank,positive regulation of phagocytosis (GO:0050766),0.28963016074545567,0.7466238568784355,0.7839262187088274,1.0,1.0,3/47,5.29%,MERTK;ANO6;MYO18A
prerank,cellular biogenic amine catabolic process (GO:0042402),0.3726027982931487,0.7463258434382877,0.7227191413237924,1.0,1.0,3/10,13.99%,SLC44A1;SARDH;COMT
prerank,negative regulation of myoblast differentiation (GO:0045662),0.35045386332408635,0.746067242956953,0.7389078498293515,1.0,1.0,2/13,7.68%,ANKRD2;SOX9
prerank,regulation of tau-protein kinase activity (GO:1902947),0.37523371860307514,0.7460344413879597,0.7193605683836589,1.0,1.0,3/10,18.45%,RB1;CLU;EGR1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3001581153046793,0.7460315101519105,0.7725381414701803,1.0,1.0,9/35,16.02%,CDK6;ACVR2A;MED1;ANKRD54;HIF1A;ACVR1B;ZFP36L1;STAT1;STAT3
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.3432704107513597,0.7455003905948991,0.7372742200328407,1.0,1.0,3/16,11.59%,ATP5MF;ATP5MC1;ATP5MG
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3541933861138221,0.7451944739597061,0.7452991452991453,1.0,1.0,6/13,19.61%,ALOX5;LPCAT3;CLU;EIF2AK3;NR1H3;WFS1
prerank,cilium organization (GO:0044782),0.24643693251331994,0.7445234748233354,0.881675392670157,1.0,1.0,20/209,11.49%,FLNA;DYNLL1;PLA2G3;KIF27;ARMC2;EHD2;CEP41;KIF3B;ACTR3;CEP290;IFT43;IFT81;PIBF1;BBIP1;IQCB1;PARVA;EXOC6;RAB11FIP3;FHDC1;KIFAP3
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.350886511438922,0.7443725358924677,0.7533783783783784,1.0,1.0,3/15,7.68%,VEGFA;GDNF;SOX9
prerank,mammary gland epithelium development (GO:0061180),-0.2904018133255356,-0.7440262592111664,0.8019323671497585,0.9581124335765646,1.0,1/14,1.10%,WNT4
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3111092412010771,-0.7433793018382586,0.8099762470308789,0.9582050068950124,1.0,5/11,29.16%,ARRB1;GRK2;GTF2H2;ADM;ADRB2
prerank,inorganic anion transport (GO:0015698),0.28000703638576396,0.7432924336792015,0.7878017789072427,1.0,1.0,6/53,9.10%,ANO1;ANO6;CLCN6;TTYH1;ANO10;XPR1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.2890246296631668,0.7431760131577602,0.7962466487935657,1.0,1.0,6/46,9.22%,CNN2;LCP1;IL12RB2;IL12RB1;PLCB1;PAK2
prerank,electron transport chain (GO:0022900),0.3446910737426625,0.7423535566766626,0.7392055267702936,1.0,1.0,5/15,16.06%,PPARGC1A;ETFA;SDHA;ENOX2;UQCRFS1
prerank,regulation of protein polymerization (GO:0032271),-0.2272934823251858,-0.7420882171748876,0.8983050847457628,0.9591809679057008,1.0,9/35,20.24%,ARHGAP28;RASA1;PFN2;PFN1;DBN1;TTBK1;TPPP3;ARL2;GBA2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.2329626643613418,-0.7418841852186233,0.8782894736842105,0.9586814458281014,1.0,10/30,26.21%,BCL2L1;CD44;MDM2;THOC5;PTTG1IP;KDM1A;TRIM32;SNAI1;YJU2;TWIST1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.3450726128757123,0.7416406424577805,0.7379310344827587,1.0,1.0,3/14,11.70%,MYD88;MAPKAPK2;HNRNPC
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.26244944987425556,0.7416199185494355,0.816374269005848,1.0,1.0,34/94,23.06%,DYNLL1;CEP41;HAUS8;CEP290;RPGRIP1L;IQCB1;CEP192;DYNC1I2;C2CD3;NEDD1;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PRKACA;PLK4;DCTN1;HAUS4;CEP135;CKAP5;ACTR1A;SFI1;MAPRE1;NPHP4;ODF2;PPP2R1A;NINL;TUBA4A;CEP63;YWHAG;NDE1
prerank,protein import into nucleus (GO:0006606),0.27119854611866645,0.7414236421143763,0.8251833740831296,1.0,1.0,24/66,20.76%,NUP62;KPNA4;RANBP17;SPRN;SEC13;NUP153;PPP1R10;NUP107;RANBP6;KPNA2;TNPO3;KPNA3;FAM53B;IPO4;IPO7;CBLB;FAM53C;STAT3;NUP54;NUP133;PHB2;IPO9;HIKESHI;TPR
prerank,peptidyl-methionine modification (GO:0018206),0.3597081336687331,0.7412335378143308,0.7451669595782073,1.0,1.0,2/12,8.20%,NAA25;NAA20
prerank,positive regulation of protein metabolic process (GO:0051247),0.25731049528323136,0.7408867875129622,0.8286674132138858,1.0,1.0,7/110,7.37%,AGTR1;NKD1;OAZ2;ATG7;DAB2IP;NEDD4;RASGRP1
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.2614452776657057,-0.7402870006938969,0.8142857142857143,0.9600191179847165,1.0,4/19,21.37%,DDX3X;CHUK;TLR3;HSPD1
prerank,positive regulation of cell aging (GO:0090343),0.36179362121669734,0.7402696967400154,0.7376146788990826,1.0,1.0,1/11,3.13%,CGAS
prerank,energy reserve metabolic process (GO:0006112),0.3408408775179687,0.7397841198593881,0.7640449438202247,1.0,1.0,2/19,4.84%,PYGM;GFPT1
prerank,regulation of protein targeting to membrane (GO:0090313),0.311883147575798,0.7396397373313597,0.7813411078717201,1.0,1.0,10/28,22.49%,KCNB1;MIEF2;MIEF1;DMTN;MTCL1;SLC51B;MFF;MYO1C;ERBB2;PDZK1
prerank,regulation of viral life cycle (GO:1903900),0.327878101299353,0.7393958096956984,0.7605633802816901,1.0,1.0,5/21,12.04%,TRIM68;AXL;NECTIN2;TSG101;KPNA2
prerank,negative regulation of programmed cell death (GO:0043069),0.24040942795721074,0.7392185829123489,0.9415322580645161,1.0,1.0,36/355,10.09%,FLNA;NAA38;ANGPT1;NR1H4;ANGPT4;MYD88;TCIM;CCND2;ANXA1;IL2;NUP62;ARHGAP10;ATAD3A;FXN;BCL2;MYO18A;MTDH;TP53;VEGFA;GDNF;PA2G4;MED1;BCL2L2;NAT8;OPA1;SOX9;RELA;API5;CBX4;VDAC1;TNFAIP8;GSTP1;PAK2;BAG3;AXL;FAIM2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.2796831495830072,0.738863124119562,0.8185328185328186,1.0,1.0,3/57,2.85%,MAP3K5;PMAIP1;ASPH
prerank,cytosolic transport (GO:0016482),0.257033586102934,0.7388059411804369,0.831672203765227,1.0,1.0,24/108,17.39%,MYO1D;CLN5;HOOK2;SORT1;RHOBTB3;VPS26A;EVI5;WASHC1;VPS26B;ANKFY1;HOOK1;AKTIP;PLEKHJ1;TMEM87A;PIK3C3;VPS50;RAB14;ANKRD27;SNX1;SPAG9;VPS35;CORO7;DCTN1;VPS51
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.23475823928640988,-0.7385554121573975,0.8626198083067093,0.9615054877553814,1.0,11/30,25.00%,LBR;GGPS1;CYP51A1;HMGCR;ACLY;ARV1;INSIG1;SQLE;PMVK;LSS;MVK
prerank,adrenergic receptor signaling pathway (GO:0071875),0.325068914268246,0.7384375613722296,0.7751937984496124,1.0,1.0,2/20,3.81%,ADRA1D;ADCY9
prerank,phagosome acidification (GO:0090383),0.3135092141140843,0.7383655527045098,0.7559523809523809,1.0,1.0,12/26,25.66%,ATP6V1H;ATP6V0A2;ATP6V1C1;ATP6V0D2;RAB38;ATP6V0C;ATP6V1F;ATP6V0E1;ATP6V1B2;ATP6V1G2;ATP6V0A1;RAB7A
prerank,ATP synthesis coupled proton transport (GO:0015986),0.3389214182711212,0.7373982834698566,0.7532679738562091,1.0,1.0,3/17,11.59%,ATP5MF;ATP5MC1;ATP5MG
prerank,negative regulation of secretion by cell (GO:1903531),0.2891442977685501,0.7371824139190728,0.797768479776848,1.0,1.0,5/38,11.33%,HTR1B;ANXA1;DPH3;HRH3;IL1RAPL1
prerank,negative regulation of DNA replication (GO:0008156),-0.2917004824038839,-0.737032618572406,0.8317757009345794,0.9626529241249787,1.0,2/13,5.09%,ATR;PDS5A
prerank,cytokine-mediated signaling pathway (GO:0019221),0.23784439479024944,0.7368901070870134,0.954864593781344,1.0,1.0,54/532,10.78%,CAMK2G;LIFR;ACTN4;CD36;LAMA5;LIMS1;MYD88;PDGFB;CNN2;RORA;VIM;CRLF1;ANXA1;GREM2;SOCS5;CAMK2D;IL2;TNFSF13B;LCP1;ITGB1;CCL5;IL12RB2;ALOX5;BCL2;SOCS6;IRS1;TNFRSF11A;PSMC6;TP53;VEGFA;IL10RA;IL12RB1;TRAF3;YAP1;IL22;RELA;PLCB1;TRIM68;CCND1;ADAM17;PAK2;SLA;INPPL1;HIF1A;PSME4;EDAR;TRAF5;PSMB1;IL13RA1;CCL14;PELI2;PSMD5;EIF5A;VAV1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3229594128717864,0.7368113640641923,0.7629032258064516,1.0,1.0,3/20,7.51%,CCL5;RPGRIP1L;PLEK
prerank,alpha-amino acid metabolic process (GO:1901605),0.28889089462382117,0.7362787533536069,0.8020434227330779,1.0,1.0,8/45,11.00%,RIMKLA;KMO;NAT8L;GOT1;GOT2;THAP4;GLS2;GLS
prerank,GPI anchor metabolic process (GO:0006505),0.31349836472420267,0.7355310324150802,0.7713414634146342,1.0,1.0,8/26,20.84%,PIGN;PIGA;PIGH;PIGB;PIGP;DPM2;PGAP4;PIGZ
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.3184938109772757,-0.7352830444488699,0.8067415730337079,0.9625557096118954,1.0,5/10,27.83%,BLM;NBN;SMARCAL1;ERCC1;DNA2
prerank,t-circle formation (GO:0090656),-0.3184938109772757,-0.7352830444488699,0.8067415730337079,0.9625557096118954,1.0,5/10,27.83%,BLM;NBN;SMARCAL1;ERCC1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.3184938109772757,-0.7352830444488699,0.8067415730337079,0.9625557096118954,1.0,5/10,27.83%,BLM;NBN;SMARCAL1;ERCC1;DNA2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.2862352014190442,0.7352005351469549,0.8143631436314364,1.0,1.0,8/45,15.91%,CAMK2G;CAMK2D;TRIM68;PRKCD;GBP2;OASL;STAT1;JAK2
prerank,response to insulin (GO:0032868),0.2670090028596488,0.7349511350198139,0.8112543962485346,1.0,1.0,8/80,7.78%,SLC2A4;SORT1;HDAC9;IRS1;SORBS1;CPEB1;PARP1;GOT1
prerank,indolalkylamine catabolic process (GO:0046218),0.3680227304652973,0.7345075971148849,0.7482758620689656,1.0,1.0,1/10,6.78%,KMO
prerank,negative regulation of potassium ion transport (GO:0043267),-0.29502403667817967,-0.7344685496285971,0.8266978922716628,0.9628557184541422,1.0,2/13,5.66%,NEDD4L;PTK2B
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.24929252604092395,0.7343567096666249,0.8686210640608035,1.0,1.0,21/161,10.85%,TMEM131L;NKD1;LIMD1;FZD4;RBMS3;JADE1;TBX18;SDHAF2;CAV1;PSMC6;DAB2IP;IGFBP4;SOX9;SNAI2;AMER1;PSME4;AMFR;PSMB1;SCYL2;PSMD5;LMBR1L
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.2855063018892555,-0.7340224999159072,0.8514150943396226,0.9626340485160179,1.0,6/14,17.31%,ADAM10;APH1A;NCSTN;CLN3;APH1B;PSEN2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.24118658074456112,-0.7338043077778215,0.861764705882353,0.962114606145534,1.0,16/26,42.50%,EPHA4;APH1A;LYN;NCSTN;APH1B;TTBK1;PSME3;PSENEN;PSME1;PSME2;PYCARD;GRIN1;AGER;AIM2;FYN;GRIN2B
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.29069769573946935,-0.7337834622763479,0.836104513064133,0.9613810629933945,1.0,2/13,9.33%,PID1;NOS3
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2665619073806388,0.7334339144329521,0.8137254901960784,1.0,1.0,19/78,17.98%,KLHL40;SOCS5;PABIR1;GABARAP;CAV1;TAF1;RNF180;SIRT2;CLU;BAG2;CSNK1E;LRRK2;DVL1;CSNK1A1;HSPBP1;SIRT6;BCAP31;RCHY1;PIAS1
prerank,positive regulation of cell death (GO:0010942),0.276537213026624,0.732010527851348,0.8191214470284238,1.0,1.0,5/59,7.56%,MAP3K5;CD36;MAPT;HEBP2;CELF1
prerank,lysosome localization (GO:0032418),0.28888299624756114,0.7319193789641523,0.7926136363636364,1.0,1.0,4/37,7.78%,MYH9;MILR1;RAB3A;KIF5B
prerank,canonical Wnt signaling pathway (GO:0060070),0.2731236715898237,0.7318157643755827,0.831055900621118,1.0,1.0,18/68,18.16%,FZD5;FZD4;FZD8;CAV1;FZD9;AMER1;PPP1CA;NR4A2;SCYL2;LRP5;CSNK1E;LRRK2;DVL1;CSNK1A1;PTEN;RYK;WNT5B;TCF7
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.28814172021820655,-0.7316811729398901,0.7888040712468194,0.9632229950186904,1.0,5/13,33.55%,PDE8A;PARK7;RACK1;HGF;GPR37
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.19585953072631898,-0.7316606788588574,0.9516129032258065,0.9624775032609473,1.0,29/70,32.65%,ITCH;PRKDC;PUS7;PSMD7;PSMD9;PSMD13;METTL3;PSMB3;PSMC5;PSMA5;PSMA1;PSMC2;N4BP2L2;SETD1A;LMO2;PSME3;PSMC4;TAL1;PSMB6;PSMB10;PSMA4;KMT2A;PSME1;PSMF1;PSMB9;LDB1;PSME2;TCF3;PSMA8
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.29518533368739025,0.7316296446010511,0.7859237536656891,1.0,1.0,8/31,17.16%,WDR1;LIN7C;RAP2A;MTCL1;PARD3B;ANK1;LIN7A;MARK2
prerank,negative regulation of response to stimulus (GO:0048585),0.2719636244167126,0.7314500980076534,0.816708229426434,1.0,1.0,17/60,19.68%,CDK6;SOCS5;ALOX5;KLF7;TERT;PTPN1;LPCAT3;TERF2;COL3A1;CLU;FBXO5;ADRA2A;NR1H3;HHIP;ACVR1;WFS1;VPS13C
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.18950441718407487,-0.7314245546195981,0.9585492227979274,0.9620143902998985,1.0,29/73,32.65%,ITCH;PRKDC;PUS7;PSMD7;PSMD9;PSMD13;METTL3;METTL14;PSMB3;PSMC5;PSMA5;PSMA1;PSMC2;SETD1A;LMO2;PSME3;PSMC4;TAL1;PSMB6;PSMB10;PSMA4;KMT2A;PSME1;PSMF1;PSMB9;LDB1;PSME2;TCF3;PSMA8
prerank,response to steroid hormone (GO:0048545),0.3066037916063509,0.731379724425354,0.7833333333333333,1.0,1.0,6/31,7.86%,TGFB3;CAV1;AR;MED1;YAP1;TGFB2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2620948223179143,0.7312064695898354,0.8136200716845878,1.0,1.0,22/84,15.98%,RBM24;KHDRBS3;U2AF2;CIRBP;CELF1;RBMXL1;SRSF4;MBNL2;RBM8A;MBNL1;HNRNPU;SRSF10;RBM3;ZBTB7A;RBM25;SON;NUP98;CWC22;SRPK2;RBM15;SF1;PUF60
prerank,peptidyl-glutamic acid modification (GO:0018200),0.31730606876214384,0.7305298052981771,0.7867078825347759,1.0,1.0,3/24,6.59%,TTLL7;CEP41;PARP1
prerank,prostaglandin metabolic process (GO:0006693),0.3037917168951384,0.7304770313545101,0.8085758039816233,1.0,1.0,6/26,17.14%,PTGIS;TBXAS1;GSTP1;PTGR1;PLA2G4A;MIF
prerank,cilium assembly (GO:0060271),0.2397208932143569,0.7302914552095582,0.9211873080859775,1.0,1.0,45/296,15.87%,FLNA;DYNLL1;PLA2G3;KIF27;EHD2;CEP41;HAUS8;DYNLRB1;RSPH1;KIF3B;ACTR3;TBC1D32;CEP290;RPGRIP1L;IFT43;IFT81;PIBF1;TOGARAM1;BBIP1;IQCB1;PARVA;CEP192;EXOC6;RAB11FIP3;DYNC1I2;FHDC1;KIFAP3;C2CD3;NEDD1;STK36;CLASP1;CEP72;SPATA6;CEP43;FOXJ1;CSNK1E;DCTN3;TTC39C;HAUS7;HAUS2;PRKACA;RAB8B;CCDC66;CFAP43;RFX3
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.27518377339756955,-0.7302428445070037,0.823076923076923,0.9627801747365862,1.0,1/15,1.06%,MOXD1
prerank,regulation of secretion (GO:0051046),-0.2857873842021621,-0.7296579153277453,0.7935034802784223,0.9627447712339786,1.0,4/13,18.59%,ACSL3;MYO6;OAS2;KCNQ1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.2780167195057325,-0.7295164076037982,0.8203883495145631,0.9621634035218181,1.0,11/15,38.16%,ZBTB8OS;ERN1;TSEN34;CPSF4;CSTF2;CPSF1;CLP1;TRPT1;TSEN54;TSEN15;RTRAF
prerank,positive regulation of catalytic activity (GO:0043085),-0.21771280040725088,-0.729434789207647,0.8928571428571429,0.9615173412572099,1.0,11/37,21.26%,MAPK14;XRCC5;STX4;IGF2;ABL2;APH1A;NCSTN;CHTOP;PSEN2;MSH6;FGFR4
prerank,glycoprotein catabolic process (GO:0006516),-0.2683307249815983,-0.7293042098239552,0.8209718670076727,0.9609097744176385,1.0,6/17,27.91%,NGLY1;CTSL;ADAMTS9;FBXO17;STT3B;FBXO44
prerank,positive regulation of translational initiation (GO:0045948),0.3275891256149107,0.7290008822668126,0.7657512116316639,1.0,1.0,3/18,6.97%,CCL5;POLR2G;YTHDF2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.35066322652046167,0.7280290734875011,0.7760942760942761,1.0,1.0,2/13,11.12%,CBFB;RUNX1
prerank,amino acid transmembrane transport (GO:0003333),0.28212945946161627,0.7278351513634239,0.8118421052631579,1.0,1.0,1/45,0.33%,SLC38A11
prerank,positive regulation of interleukin-4 production (GO:0032753),0.33088287888513357,0.7276209725607731,0.782258064516129,1.0,1.0,2/17,5.51%,HAVCR2;PRKCQ
prerank,positive regulation of macrophage migration (GO:1905523),0.32133369218325564,0.7270569688903702,0.750814332247557,1.0,1.0,2/19,5.41%,CCL5;RARRES2
prerank,cellular response to insulin stimulus (GO:0032869),0.25104585435219207,0.7263072166699325,0.8544857768052516,1.0,1.0,22/124,15.71%,SLC2A4;PDK4;BCAR3;HDAC9;RARRES2;ATP6V1H;IRS1;SORBS1;ATP6V0A2;CPEB1;PARP1;GOT1;ATP6V1C1;SLC39A14;ATP6V0D2;ZFP36L1;PDK2;EPRS1;IRS2;RAB8B;CAV2;NAMPT
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.26155861178945344,0.726305036729534,0.8499399759903962,1.0,1.0,27/87,21.64%,NDUFS1;NDUFA11;NDUFA2;SDHAF2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFAB1;NDUFAF5;SDHAF3;NDUFA1;LYRM7;NDUFAF2;UQCRFS1;NDUFAF1;SCO1;NDUFV3;UQCC2;NDUFS4;SLC25A33;COA5;OXA1L;NDUFA3;NDUFAF6
prerank,lymphocyte mediated immunity (GO:0002449),0.34805955860626264,0.7257328246317238,0.7581227436823105,1.0,1.0,1/12,3.14%,JAG1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.2878389898791345,-0.7256967027320922,0.8133971291866029,0.9646422027619022,1.0,6/13,26.50%,PRR5L;GTPBP1;PNPT1;ZC3H12A;ZC3HAV1;MOV10
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.3449817258242419,0.7254630213397679,0.7491638795986622,1.0,1.0,2/16,6.86%,FGF1;GDNF
prerank,clathrin coat assembly (GO:0048268),0.34031456330398924,0.7254105775961247,0.7597292724196277,1.0,1.0,1/15,1.87%,HIP1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.3365747977139151,0.7251928132762042,0.770940170940171,1.0,1.0,3/16,12.48%,NACC2;SNAI2;CLU
prerank,quinone biosynthetic process (GO:1901663),-0.2853505106203823,-0.7247811676464414,0.8117359413202934,0.9649860869052332,1.0,3/14,6.23%,COQ10B;COQ8B;COQ5
prerank,negative regulation of histone modification (GO:0031057),-0.284932491009402,-0.7247662398421579,0.8301435406698564,0.9642295694999001,1.0,10/14,39.21%,NOC2L;SNCA;TAF7;TWIST1;JARID2;PRMT6;BRCA1;AASS;THAP7;SPHK2
prerank,regulation of macrophage differentiation (GO:0045649),-0.2713390523257385,-0.7246577226479239,0.8417085427135679,0.9635956350170268,1.0,5/15,32.51%,CASP8;HSF1;PTPN2;C1QC;INHA
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.2658311853874148,-0.7240264538991679,0.8275,0.9636223191643268,1.0,3/17,18.92%,LPGAT1;PLAAT3;PLA2G12A
prerank,proton transmembrane transport (GO:1902600),0.2841420283822248,0.7238045448661452,0.7859116022099447,1.0,1.0,3/36,5.57%,ATP5MF;UCP3;ATP6V1H
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.26564784917791867,-0.7234866915265133,0.8214285714285714,0.9635165833701158,1.0,7/17,30.45%,UBQLN1;AKT1;P4HB;MAPK7;BAG5;HTRA2;PPIA
prerank,glycolipid biosynthetic process (GO:0009247),0.29074293863823997,0.7233987790371142,0.806993006993007,1.0,1.0,10/38,17.30%,LARGE1;PIGN;PIGA;ST8SIA5;A4GALT;ST3GAL2;PIGH;PIGB;PIGP;DPM2
prerank,membrane raft organization (GO:0031579),0.338937409717374,0.7233186618442167,0.7937956204379562,1.0,1.0,5/15,15.79%,FA2H;YJEFN3;NAXE;FLOT1;RFTN1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2569205565152471,-0.7231282602000765,0.8254364089775561,0.9631567154617633,1.0,5/19,19.27%,CAT;GPX1;ACOX1;PRDX4;PARK7
prerank,regulation of vesicle-mediated transport (GO:0060627),0.260914337864943,0.7228687478335037,0.868663594470046,1.0,1.0,18/91,16.59%,HIP1;PLA2G3;CDH13;PACSIN3;PACSIN2;PTPN1;RAB3A;DENND10;MAP2K1;MBTPS1;NSF;PACSIN1;MAPK1;LRRK2;SNX17;RAB8B;STON1;RAB8A
prerank,icosanoid secretion (GO:0032309),0.35574981578691395,0.7226709317657268,0.7522768670309654,1.0,1.0,1/12,2.79%,ANXA1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3092639477841347,-0.7224716260055036,0.8219780219780219,0.9631715833751283,1.0,3/10,17.43%,CCT8;CCT4;WRAP53
prerank,regulation of regulated secretory pathway (GO:1903305),0.2849763598288511,0.7223221771912178,0.7882689556509299,1.0,1.0,4/34,7.05%,UNC13D;RIMS3;SYT10;RAB3A
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.3518522691836099,0.7221063737951664,0.7562724014336918,1.0,1.0,5/12,20.63%,OPLAH;GGCT;CHAC2;CNDP2;HAGH
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2671936064498661,0.7220409490215344,0.8202653799758746,1.0,1.0,14/69,16.47%,POLR2L;POLR2I;ELL;POLR2G;TAF8;CCNT1;CDK7;INTS5;POLR2J;INTS12;INTS7;TAF11;SP1;INTS1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.30875927417145016,0.7209870447425698,0.7911764705882353,1.0,1.0,4/23,8.65%,ZEB2;TGFB1I1;SLC2A10;ADAM17
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.30875927417145016,0.7209870447425698,0.7911764705882353,1.0,1.0,4/23,8.65%,ZEB2;TGFB1I1;SLC2A10;ADAM17
prerank,bone morphogenesis (GO:0060349),0.33607056624201453,0.7203100200484269,0.7561779242174629,1.0,1.0,5/14,17.15%,OSR2;SKI;LRP5;BMPR1B;FGFR3
prerank,response to cytokine (GO:0034097),0.24244331997706864,0.7199052412153119,0.8758241758241758,1.0,1.0,13/141,8.40%,AKAP6;LIFR;ITIH4;MYD88;ANXA1;BCL2;PTPN18;MAP4K3;TNFRSF11A;MAPKAPK2;TIMP4;RELA;DDOST
prerank,regulation of lamellipodium organization (GO:1902743),-0.28459589648756684,-0.719739009352721,0.8200934579439252,0.9656537924418733,1.0,4/14,22.71%,PDPN;CD44;CDC42;CARMIL1
prerank,microtubule-based transport (GO:0099111),-0.2873175374340041,-0.7195327777221238,0.8096330275229358,0.9651258168644717,1.0,9/12,49.60%,DYNC1I1;SPEF2;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,amyloid-beta metabolic process (GO:0050435),0.3257541128978252,0.7191006158716343,0.7895622895622896,1.0,1.0,3/16,7.63%,DYRK1A;APEH;NAT8
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3015442161328319,-0.7190678676404625,0.8306264501160093,0.9649505987559851,1.0,1/11,3.97%,LDLR
prerank,negative regulation of cell aging (GO:0090344),0.332463389513287,0.71906784997299,0.765704584040747,1.0,1.0,5/16,17.14%,CDK6;TERT;TERF2;FBXO5;MIF
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2660384972189864,0.7185100292371871,0.8410757946210269,1.0,1.0,18/70,17.39%,SORT1;BCL2;GABARAP;DAB2IP;BCL2L2;TGFB2;BAG3;DEDD2;CASP8AP2;BOK;ACVR1B;DIABLO;DEDD;TNFRSF10B;MCL1;JAK2;FGFR3;TNFSF12
prerank,ubiquinone biosynthetic process (GO:0006744),-0.2774805376104008,-0.7182978307789933,0.836272040302267,0.9650549334744485,1.0,3/15,6.23%,COQ10B;COQ8B;COQ5
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3376557027131653,0.7180778974069054,0.7737704918032787,1.0,1.0,3/14,14.62%,DAB2IP;PTPN1;UFL1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.357224042210741,0.7175146277254159,0.7595628415300546,1.0,1.0,4/10,19.47%,PRMT7;PCGF5;PCGF3;DNMT3A
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.2599804506357513,-0.7174759853233982,0.856,0.9652694286568255,1.0,5/18,17.84%,SPTBN1;APPL1;CLN3;VAMP8;STX8
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.26053618908421594,0.7171948244771102,0.8292079207920792,1.0,1.0,12/67,13.33%,TBC1D1;ATP8B1;TBC1D20;CAV1;RABGAP1;EVI5;EPHA2;GAP43;MYO10;TRPM2;DMTN;CAPZB
prerank,regulation of protein localization to membrane (GO:1905475),0.3021648762316602,0.7169312791619088,0.8233532934131736,1.0,1.0,5/28,7.14%,SLC5A3;ACTB;GPC4;ZDHHC2;AR
prerank,cellular response to interleukin-1 (GO:0071347),0.24400521274564288,0.7153655097675159,0.8857758620689655,1.0,1.0,31/143,19.24%,MYD88;CCL5;PTGIS;UPF1;HAS2;PSMC6;DAB2IP;SOX9;RELA;PLCB1;NR1D1;HIF1A;PSME4;PSMB1;CCL14;PELI2;PSMD5;FBXW11;GBP2;PSMB2;HYAL1;PSMB7;PSMD3;PSMA2;PSMD14;IL1R1;CCL25;EGR1;CD47;CCL19;RPS27A
prerank,cellular response to interleukin-2 (GO:0071352),0.34918775886004194,0.7151423275836453,0.7793594306049823,1.0,1.0,1/11,3.19%,IL2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.34918775886004194,0.7151423275836453,0.7793594306049823,1.0,1.0,1/11,3.19%,IL2
prerank,negative regulation of cellular catabolic process (GO:0031330),0.26371512778721945,0.7149882795526522,0.8475,1.0,1.0,14/63,17.26%,ROCK1;BCL2;DAB2IP;IL10RA;TIMP4;WASHC1;SIRT2;HTR2B;MCL1;EIF4E;STAT3;MT3;WDR6;EIF4G2
prerank,protein localization to centrosome (GO:0071539),0.3237364552588299,0.7148896751803423,0.7934426229508197,1.0,1.0,4/17,11.87%,PIBF1;CEP192;C2CD3;NEDD1
prerank,regulation of exocytosis (GO:0017157),0.27261300959525053,0.7148379434992205,0.8201811125485123,1.0,1.0,9/46,16.59%,CLASP2;ANXA1;UNC13D;RAB3A;IL1RAPL1;NSF;CLASP1;RAB8B;RAB8A
prerank,response to sterol (GO:0036314),0.35034861039660753,0.7145036940759235,0.7845601436265709,1.0,1.0,1/11,2.57%,RORA
prerank,DNA strand elongation (GO:0022616),-0.2515577674535823,-0.7140749404611864,0.8519480519480519,0.9682626947796253,1.0,11/18,38.14%,MRE11;RAD50;NBN;GINS3;DCLRE1B;RFC3;GINS4;POLD3;GINS1;RFC4;MCM3
prerank,snRNA transcription (GO:0009301),0.2626543809454453,0.7132096319503735,0.8313397129186603,1.0,1.0,14/70,16.47%,POLR2L;POLR2I;ELL;POLR2G;TAF8;CCNT1;CDK7;INTS5;POLR2J;INTS12;INTS7;TAF11;SP1;INTS1
prerank,rRNA catabolic process (GO:0016075),-0.26532663128227624,-0.7130495514052774,0.8669833729216152,0.9686890796411163,1.0,7/16,27.20%,TRIR;DIS3;EXOSC9;EXOSC2;EXOSC7;EXOSC3;EXOSC5
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.2614676927988496,-0.7128235747757743,0.8371501272264631,0.9681945051073383,1.0,2/16,9.42%,PTPN22;AHR
prerank,regulation of cellular protein localization (GO:1903827),0.28124868581355944,0.712822891198746,0.8192612137203166,1.0,1.0,11/45,15.58%,LCP1;GPC4;MAPT;PARP1;PIN1;PTPN1;CEP72;CSNK1E;PRKAA2;DVL1;CCDC66
prerank,positive regulation of RNA splicing (GO:0033120),0.2982254439692013,0.7125678497917372,0.8071748878923767,1.0,1.0,7/29,14.03%,SLC38A2;DYRK1A;U2AF2;CIRBP;RBMXL1;RBM3;NUP98
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.272059882792244,-0.7118145236250434,0.853904282115869,0.9685888517340716,1.0,7/15,27.02%,RNF213;SFRP4;GPC3;DACT1;RSPO3;ZNRF3;TIAM1
prerank,RNA biosynthetic process (GO:0032774),-0.2240457939791507,-0.7117497856579513,0.9221183800623053,0.9678975104823371,1.0,11/31,30.67%,POLR2A;SETX;TTF1;TAF12;TAF13;SMN1;TAF7;TAF5;POLA2;NCOA6;PRIM1
prerank,hemidesmosome assembly (GO:0031581),0.3523687003981373,0.711438590745202,0.7832167832167832,1.0,1.0,2/11,6.91%,DST;LAMC1
prerank,regulation of response to oxidative stress (GO:1902882),0.3528700510944529,0.7104643882240582,0.7802197802197802,1.0,1.0,2/11,7.22%,ALOX5;HEBP2
prerank,regulation of histone deacetylation (GO:0031063),0.33578006575635877,0.7104320710048159,0.7653239929947461,1.0,1.0,1/13,3.16%,CAMK2D
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2889318380854109,0.7102629015454781,0.8180555555555555,1.0,1.0,6/35,11.83%,MUTYH;PARP1;MBD4;PARG;POLD1;POLG
prerank,myelin maintenance (GO:0043217),0.3539216088935182,0.7097889692102142,0.781651376146789,1.0,1.0,2/10,15.34%,CLU;PTEN
prerank,cristae formation (GO:0042407),0.29644556756031076,0.7095493905201912,0.8265460030165912,1.0,1.0,8/27,18.78%,ATP5MF;AFG3L2;DNAJC11;ATP5MC1;ATP5MG;IMMT;APOOL;ATP5F1D
prerank,regulation of ATP metabolic process (GO:1903578),0.27251880974405496,0.7088994569129229,0.8260325406758448,1.0,1.0,17/54,20.76%,NUP62;COX7A2L;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;UQCC2;SLC25A33;TPR
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.23354624925354273,0.7087068206091608,0.9439918533604889,1.0,1.0,43/306,13.20%,RPL3L;POLR2L;POLR2I;LARGE1;MLF1;EEFSEC;MRPL36;BRIP1;EXT2;MRPL13;PWP1;SET;HARS2;UPF1;MEF2A;POLR2G;TERT;TIPIN;RPL8;CHEK1;RAD9A;NFKBIB;MRPL43;TNIP1;NR4A2;MRPL51;KAT7;RPL5;MRPL23;RPS23;RHNO1;POLD1;GSPT1;PTMS;BAZ2A;MRPL9;TSFM;ORC2;RMI2;POLR2J;ST3GAL2;MRPL42;EEF2K
prerank,positive regulation of JNK cascade (GO:0046330),0.25896335258721564,0.7086524487025461,0.8647342995169082,1.0,1.0,9/70,10.27%,MAP3K5;MFHAS1;DAB2IP;TRAF3;RASGRP1;PLCB1;MAP3K10;EDAR;TRAF5
prerank,toll-like receptor signaling pathway (GO:0002224),0.2521986038239475,0.7085914429954046,0.8574793875147232,1.0,1.0,8/84,8.19%,NR1H4;CD36;MYD88;CD14;PIK3AP1;MAPKAPK2;TRAF3;TNIP1
prerank,regulation of cellular senescence (GO:2000772),0.30206804449630986,0.708570290548497,0.8291925465838509,1.0,1.0,5/28,11.53%,CDK6;CGAS;TERT;NUAK1;TERF2
prerank,cellular response to pH (GO:0071467),0.32253350061401126,0.7084755273928988,0.7790697674418605,1.0,1.0,3/17,14.35%,PKD1L3;IMPACT;HYAL1
prerank,cellular response to interleukin-12 (GO:0071349),0.27406313874573907,0.7083863123705698,0.8322237017310253,1.0,1.0,6/48,9.22%,CNN2;LCP1;IL12RB2;IL12RB1;PLCB1;PAK2
prerank,glycerol metabolic process (GO:0006071),-0.3062008161543389,-0.7081279449973703,0.8646080760095012,0.9711694963062653,1.0,6/10,32.72%,GK5;COQ3;PGP;GK;TPI1;ANGPTL3
prerank,"transcription, DNA-templated (GO:0006351)",0.23530652672862415,0.7077623027748104,0.912041884816754,1.0,1.0,27/207,13.03%,SOX5;POLR2L;POLR2I;MLF1;PWP1;GTF2H4;GTF3C4;ELL;CBFB;MEF2A;POLR2G;TAF1;ELOC;TP53;PARP1;ERCC6;NFKBIB;CCNT1;NR4A2;CDK7;NAT14;TFB2M;BAZ2A;NFX1;NELFB;SMARCA5;POLR2J
prerank,regulation of protein binding (GO:0043393),0.24476576642557263,0.7076564967916202,0.8849162011173184,1.0,1.0,22/114,15.51%,XIRP1;ROCK1;PDGFB;ACTB;CAV1;TAF1;TERT;PIN1;ADD2;PRMT7;PPP1CA;AMFR;PSME3IP1;PRKCD;AKTIP;BAG2;LDLRAP1;CSNK1E;LRRK2;DVL1;PRKACA;FLOT1
prerank,cholesterol biosynthetic process (GO:0006695),-0.22544813405791936,-0.7069760655774023,0.9243421052631579,0.9716703068543204,1.0,16/31,35.79%,LBR;GGPS1;CYP51A1;HMGCR;ACLY;ARV1;INSIG1;SQLE;PMVK;LSS;MVK;INSIG2;EBP;SC5D;TM7SF2;DHCR7
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.330933361616668,0.7068724161226951,0.8,1.0,1.0,4/15,17.46%,PPARGC1A;PPARA;MLXIPL;NR1H3
prerank,non-motile cilium assembly (GO:1905515),0.29302584181689995,0.7064836428080689,0.7997076023391813,1.0,1.0,5/30,7.53%,TBC1D32;CEP290;RPGRIP1L;PIBF1;TOGARAM1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.31896807704620517,0.7064266829539918,0.7980456026058632,1.0,1.0,5/18,13.00%,CLASP2;EMILIN1;RUNX1;RB1;CLASP1
prerank,positive regulation of cell cycle process (GO:0090068),0.2496306628040502,0.7063108086765308,0.866822429906542,1.0,1.0,11/91,12.58%,MAP3K20;PDGFB;NUP62;PKN2;SIRT2;PDGFRB;NSFL1C;RHNO1;LRP5;CEP120;KIF20B
prerank,carnitine metabolic process (GO:0009437),0.3436895538622555,0.7060676877440654,0.764406779661017,1.0,1.0,5/12,20.85%,CPT1B;CRAT;CPT1A;TMLHE;ACADM
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.2883791727714954,-0.7060529332798291,0.812933025404157,0.971940931087732,1.0,1/12,3.27%,IL18
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.33874431600843086,0.7059654339833343,0.778584392014519,1.0,1.0,4/11,20.82%,DCTD;NT5C3A;DCK;CTPS2
prerank,regulation of secretion by cell (GO:1903530),0.26819275830375544,0.7059106159108931,0.8430609597924773,1.0,1.0,2/54,2.79%,MEF2C;ANXA1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.32189465169627385,0.7058802239571504,0.8010033444816054,1.0,1.0,6/17,20.67%,COX7A2L;COX8A;COX7B;COX6C;COX5B;COX6A1
prerank,cellular response to hydroxyurea (GO:0072711),-0.2943458099064721,-0.7058200938024539,0.8262806236080178,0.9714212786603303,1.0,6/10,41.32%,BLM;FMR1;ATRX;TIMELESS;NSMCE3;DDX11
prerank,negative regulation by host of viral transcription (GO:0043922),0.3360208258960458,0.7058178512035364,0.773851590106007,1.0,1.0,1/12,3.64%,CCL5
prerank,polarized epithelial cell differentiation (GO:0030859),-0.2858917989569726,-0.7057690410890264,0.8653846153846154,0.9707037493042167,1.0,11/13,52.42%,MYO9A;OPHN1;CDC42;SCRIB;SH3BP1;CAMSAP3;MSN;EZR;RHOA;SYNE4;ZDHHC7
prerank,ubiquinone metabolic process (GO:0006743),-0.27287466486643136,-0.7056219229376912,0.8395061728395061,0.970115100377213,1.0,9/15,33.70%,COQ10B;COQ8B;COQ5;AIFM2;COQ3;FDXR;UBIAD1;COQ6;COQ7
prerank,negative regulation of signaling (GO:0023057),0.29684098147737975,0.7053704016298324,0.8048048048048048,1.0,1.0,2/25,6.82%,SOCS5;PTPN1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.2768384981915833,-0.7049689844784869,0.8540145985401459,0.9700168881292577,1.0,5/14,22.43%,PKD2;NFKBIA;G3BP2;MDFI;KEAP1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2906790717195666,0.7048050841524214,0.8342696629213483,1.0,1.0,4/32,8.24%,SLC44A5;STARD7;SLC44A1;LPCAT3
prerank,cellular response to cytokine stimulus (GO:0071345),0.2279180782805999,0.7047206434475355,0.9618090452261306,1.0,1.0,47/416,11.46%,AKAP6;LIFR;CD36;LAMA5;DOCK8;RORA;VIM;CRLF1;ANXA1;GREM2;SOCS5;IL2;ITGB1;CCL5;IL12RB2;PTGIS;ALOX5;BCL2;PTPN18;UPF1;SOCS6;ARHGEF2;HAS2;DAB2IP;TP53;VEGFA;IL10RA;IL12RB1;SOX9;IL22;RELA;DAPK3;CCND1;NR1D1;SLA;INPPL1;HIF1A;AXL;NPR2;HNRNPU;IL13RA1;CCL14;VAV1;GPER1;TNFRSF21;IL1RAPL1;ZFAND6
prerank,phosphatidylcholine metabolic process (GO:0046470),0.2594429640385093,0.7043076638296022,0.8511685116851169,1.0,1.0,16/70,20.64%,PLA2G3;SLC44A5;STARD7;ABCA3;SLC44A1;LPCAT3;PLB1;PLA2G4A;CHKB;PLA2G4C;NR1H3;SLC44A2;MBOAT7;CHPT1;LPCAT1;PLA2G15
prerank,negative regulation of cellular senescence (GO:2000773),0.3418060525092315,0.7039211053457607,0.779783393501805,1.0,1.0,4/13,15.12%,CDK6;TERT;TERF2;FBXO5
prerank,DNA modification (GO:0006304),0.30588464623845246,0.7038142593896919,0.7917304747320061,1.0,1.0,4/22,11.53%,MUTYH;PARP1;MBD4;TERF2
prerank,positive regulation of exosomal secretion (GO:1903543),-0.27043989509478306,-0.7035402182129127,0.8820638820638821,0.9707805540499008,1.0,4/15,15.59%,SDCBP;VPS4B;SDC4;HGS
prerank,regulation of cell aging (GO:0090342),-0.2991856851233019,-0.7032665858071725,0.8528784648187633,0.9703390221208601,1.0,4/11,19.70%,RSL1D1;NEK6;PNPT1;NEK4
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3319049168543979,0.7029498638868774,0.7858376511226253,1.0,1.0,4/13,15.71%,PTGIS;NAXE;NNMT;NAMPT
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.30036713642688995,0.7025377911858952,0.8078668683812406,1.0,1.0,7/25,16.02%,ACVR2A;MED1;ANKRD54;HIF1A;ACVR1B;STAT1;STAT3
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.25301147181969413,0.7022653841638214,0.8620689655172413,1.0,1.0,20/83,19.57%,CDK6;HINFP;EIF4EBP1;CUL2;CCND1;CDK7;CRLF3;CDK18;RB1;GSPT1;ACVR1B;CDK15;EIF4E;FBXO5;CDK14;BRD4;CUL5;MNAT1;CACUL1;ACVR1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.23963290961113318,0.7015675866245817,0.8962882096069869,1.0,1.0,31/145,17.51%,DYNLL1;FHL1;CEP41;HAUS8;CEP290;PSMC6;TPX2;CCND1;PSME4;CEP192;PSMB1;PSMD5;DYNC1I2;NEDD1;PSMB2;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PSMB7;PSMD3;PRKACA;FBXO5;PLK4;PSMA2;PSMD14;DCTN1;BRD4
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.24829635463396796,0.7015615102486721,0.8561484918793504,1.0,1.0,15/93,12.85%,MAP3K5;MFHAS1;DAB2IP;ARL6IP5;VEGFA;TRAF3;RASGRP1;TGFB2;PLCB1;MAP3K10;EDAR;TRAF5;EIF2AK2;PDCD10;TAOK3
prerank,copper ion transport (GO:0006825),-0.2959853641261413,-0.7013535644530474,0.8430913348946136,0.971657428753274,1.0,4/11,22.59%,STEAP3;ATOX1;STEAP2;SLC31A1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.2874912613102841,0.7012147569098138,0.8112391930835735,1.0,1.0,6/31,15.34%,PDLIM5;KIF1A;CUX2;LRRK2;LZTS3;PTEN
prerank,glycerophospholipid metabolic process (GO:0006650),0.2557609560094787,0.7009323878135174,0.8496420047732697,1.0,1.0,17/75,17.31%,PLA2G3;PIGN;PIGA;ABCA3;PLEK;PLCB1;PLCD1;PDGFRB;CPNE3;PNPLA3;PLA2G4A;PIGH;PLA2G4C;PIGB;PIGP;DPM2;PRDX6
prerank,regulation of exit from mitosis (GO:0007096),-0.21293891852313995,-0.7001763336515541,0.896875,0.9721790752222634,1.0,9/38,17.60%,CDC14B;ANAPC1;CDC23;UBC;RGCC;BUB3;CDC26;UBE2S;ANAPC4
prerank,negative regulation of biosynthetic process (GO:0009890),0.32512727821186405,0.6998925907977964,0.7764900662251656,1.0,1.0,4/16,10.84%,EMILIN1;PPARA;GSTP1;GPER1
prerank,cellular response to radiation (GO:0071478),0.27467400051456087,0.6996903159571995,0.8231197771587744,1.0,1.0,10/40,19.77%,NET1;RAD51AP1;TP53;RAD9A;RHNO1;CLOCK;INTS7;INO80;SWI5;RAD9B
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.27454198103090316,0.6996134924774834,0.8545994065281899,1.0,1.0,2/37,7.16%,ENTPD1;ENTPD7
prerank,regulation of macrophage chemotaxis (GO:0010758),0.30263739214537244,0.6993919359225244,0.8050314465408805,1.0,1.0,2/21,5.41%,CCL5;RARRES2
prerank,histone H4 acetylation (GO:0043967),0.26936756031211284,0.6992747416742847,0.8214285714285714,1.0,1.0,15/47,19.06%,MCRS1;JADE1;MSL3;KAT7;KANSL3;HAT1;RUVBL1;JADE3;MORF4L1;KANSL1;MSL1;ZZZ3;TADA3;ACTL6A;KAT8
prerank,nucleoside salvage (GO:0043174),-0.3028790540123488,-0.6989504507045313,0.8461538461538461,0.9727438239886514,1.0,2/10,11.75%,UPP2;HPRT1
prerank,regulation of double-strand break repair (GO:2000779),0.2772534591594602,0.6988272083527933,0.8375706214689266,1.0,1.0,5/39,8.53%,UBR5;RAD51AP1;ZCWPW1;CHEK1;SPIRE1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.2446019668374672,-0.6986774353131446,0.8823529411764706,0.9722546035857078,1.0,3/20,8.05%,AGO3;PUM1;TSNAX
prerank,positive regulation by host of viral transcription (GO:0043923),-0.265112889699455,-0.6984120480551301,0.8602941176470589,0.9717761900195447,1.0,6/15,25.15%,LEF1;SNW1;EP300;CHD1;NUCKS1;TFAP4
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.2827536636734821,-0.697905874870545,0.8489208633093526,0.9715531685345495,1.0,2/12,8.22%,BMP7;CD44
prerank,positive regulation of bone resorption (GO:0045780),-0.2881411751292947,-0.6978181555990505,0.8656387665198237,0.970890899733389,1.0,3/11,11.31%,SPP1;ATP6AP1;PLEKHM1
prerank,rRNA methylation (GO:0031167),-0.23627056847418043,-0.6978088914375514,0.8690807799442897,0.9701531058746776,1.0,11/22,35.67%,DIMT1;BUD23;NSUN3;METTL16;FTSJ3;EMG1;METTL15;FBL;MRM2;MRM3;TRMT112
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.27928231907870105,-0.697747878454805,0.8727272727272727,0.9694729108992355,1.0,4/13,20.58%,MPDU1;ALG14;ALG1;ALG12
prerank,nucleotide-excision repair (GO:0006289),0.2444539012583285,0.6974157466250146,0.8858447488584474,1.0,1.0,14/101,11.45%,POLR2L;POLR2I;BRIP1;GTF2H4;POLR2G;TP53;PARP1;ERCC6;HUS1B;SLX4;PPIE;CDK7;POLD1;COPS8
prerank,response to tumor necrosis factor (GO:0034612),0.24495585166905354,0.6962651234614781,0.881336405529954,1.0,1.0,16/91,14.35%,CCL5;ARHGEF2;HAS2;MAP4K3;TNFRSF11A;DAB2IP;RELA;NR1D1;CCL14;GPER1;TNFRSF21;ZFAND6;YTHDC2;GBP2;ZFP36L1;HYAL1
prerank,response to acidic pH (GO:0010447),0.3349806322148807,0.6954380132344072,0.7719298245614035,1.0,1.0,2/13,8.81%,PKD1L3;IMPACT
prerank,phospholipid homeostasis (GO:0055091),-0.2918601537245566,-0.6953589583550384,0.8445945945945946,0.9711122023117451,1.0,2/11,12.24%,ABCA1;RCN3
prerank,mitotic metaphase plate congression (GO:0007080),0.2622688124671836,0.6952081705626416,0.8586666666666667,1.0,1.0,8/51,14.11%,CHMP4C;NUP62;CHMP5;PIBF1;CENPE;CHMP2B;CHMP2A;KIF18A
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3132706250287176,0.6951355933835758,0.7788778877887789,1.0,1.0,4/19,11.70%,NAT10;HNRNPU;TERF2;HNRNPC
prerank,cellular biogenic amine metabolic process (GO:0006576),0.34150690862940203,0.6950484487054973,0.7985865724381626,1.0,1.0,2/12,10.81%,OAZ2;SMS
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.22427932131535147,-0.6950067267693142,0.9221556886227545,0.9707632664704074,1.0,11/28,36.26%,PRKDC;CYRIB;XRCC6;SIRPA;NCKAP1L;HSPD1;THY1;TYROBP;SH3KBP1;NOD2;PYCARD
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.28329565037049675,0.6938816294212944,0.8146551724137931,1.0,1.0,7/32,17.51%,HINFP;CDK18;RB1;CDK15;FBXO5;CDK14;BRD4
prerank,regulation of chromosome organization (GO:0033044),0.30354852412001404,0.6938470098908096,0.8109375,1.0,1.0,5/22,12.82%,UPF1;MAPT;RB1;TERF2;RMI2
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.2983663299938516,0.693717165133607,0.817629179331307,1.0,1.0,9/24,22.49%,KCNB1;MIEF2;MIEF1;MTCL1;SLC51B;MFF;MYO1C;ERBB2;PDZK1
prerank,peptide biosynthetic process (GO:0043043),0.23785246785664954,0.6935243718532045,0.9063509149623251,1.0,1.0,15/153,11.92%,DMD;RPL3L;CARNS1;MRPL36;MRPL13;HARS2;RPL8;MRPL43;TNIP1;MRPL51;RPL5;MRPL23;RPS23;GSPT1;MRPL9
prerank,translation (GO:0006412),0.2312189916555403,0.6933797138171645,0.9287958115183246,1.0,1.0,43/208,16.54%,RPL3L;EEFSEC;MRPL36;MRPL13;HARS2;LARS1;FTSJ1;APEH;GATB;RPL8;ABCE1;MRPL43;TNIP1;IARS2;MRPS28;MRPL51;RPL5;MRPL23;GFM2;RPS23;MRPL16;GSPT1;MRPL47;MRPL9;DRG2;AIMP1;TSFM;MRPL42;EEF2K;IARS1;N6AMT1;RPL15;SARS2;EPRS1;KARS1;LARS2;FASTKD2;RPL22;SARS1;FARS2;ETF1;RPL31;GTPBP2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.23105150711614514,-0.6933639557067586,0.8715846994535519,0.971731285183821,1.0,10/23,31.98%,ASAH2;PTGS2;EPHX2;ELOVL6;FADS1;GSTM2;ACOT7;HPGD;ALOX12;GPX4
prerank,cellular glucose homeostasis (GO:0001678),0.26474998519519044,0.6932276768917389,0.8335588633288228,1.0,1.0,10/41,14.87%,HK2;KCNB1;PPARGC1A;NR1D1;HIF1A;SLC39A14;GPER1;GAS6;PRKAA2;PRKACA
prerank,regulation of lysosomal lumen pH (GO:0035751),0.3342547910519163,0.6931721749632174,0.7908611599297012,1.0,1.0,1/12,2.22%,CLN5
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.29551233454729897,0.6919267694966577,0.8224582701062215,1.0,1.0,4/29,7.05%,SLC8A2;SHISA9;ZDHHC2;RAB3A
prerank,RNA interference (GO:0016246),0.3188866039804975,0.6918592256476963,0.8071895424836601,1.0,1.0,7/17,19.65%,TERT;CELF1;DICER1;DROSHA;DHX9;PRKRA;AGO1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.2533445534753294,0.6917583862404559,0.8806333739342266,1.0,1.0,10/71,12.63%,PMAIP1;CHMP4C;SOCS6;UBE2W;OTUD7A;LONP1;CAPN2;NR1D1;RSPRY1;DDI2
prerank,exit from mitosis (GO:0010458),-0.2791727539929252,-0.6917147963033132,0.8771929824561403,0.972646066636106,1.0,3/12,8.54%,EPS8;SPAST;SIRT7
prerank,protein kinase B signaling (GO:0043491),0.2990936275576831,0.6913134064463591,0.816793893129771,1.0,1.0,8/23,16.64%,CCL5;EPHA2;THEM4;SIRT2;ZFP36L1;GAS6;PTEN;MT3
prerank,mitotic recombination (GO:0006312),-0.26465325868693096,-0.6908118050974618,0.896640826873385,0.9728174308781624,1.0,5/15,24.53%,RAD50;SMC5;TPRKB;NSMCE2;ERCC1
prerank,neutral amino acid transport (GO:0015804),0.2924617461856963,0.6907235569452677,0.8600311041990669,1.0,1.0,6/28,14.11%,SLC6A17;SLC38A2;SLC1A5;SLC7A8;SLC6A15;SLC38A1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.33526451829299875,0.690086599630423,0.7766323024054983,1.0,1.0,1/11,4.47%,MFHAS1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.27830632099314373,0.6897052184782487,0.844207723035952,1.0,1.0,14/41,20.76%,NUP62;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.3265181849665425,0.6890824622448845,0.7921440261865794,1.0,1.0,5/15,16.48%,OSR2;CELF1;TGFB2;RICTOR;UBR3
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.2855442229138358,-0.6885314535430962,0.8609865470852018,0.9743218479657919,1.0,3/11,17.43%,CCT8;CCT4;WRAP53
prerank,positive regulation of hormone secretion (GO:0046887),0.3137518886246272,0.6881028818363458,0.8189368770764119,1.0,1.0,1/17,2.32%,PLA2G3
prerank,prostanoid biosynthetic process (GO:0046457),0.32076581040401997,0.6875582972236894,0.8168067226890756,1.0,1.0,2/15,4.83%,PTGIS;TBXAS1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.26974395840571536,-0.6874475700516529,0.8602409638554217,0.9746863859372129,1.0,1/14,3.27%,IL18
prerank,negative regulation of DNA binding (GO:0043392),0.2887124467036114,0.6873694251692852,0.8201754385964912,1.0,1.0,1/28,1.06%,HEY2
prerank,positive regulation of catabolic process (GO:0009896),0.2553084970248214,0.6872078416307424,0.8739495798319328,1.0,1.0,5/65,7.03%,NKD1;OAZ2;ATG7;DAB2IP;NEDD4
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3179373418488398,0.6870863547149956,0.8054607508532423,1.0,1.0,3/15,7.80%,TIPIN;RAD9A;HUS1B
prerank,response to amyloid-beta (GO:1904645),0.2637786159953762,0.6869381350099392,0.8463611859838275,1.0,1.0,2/44,1.73%,CACNA2D1;CD36
prerank,establishment of mitotic spindle orientation (GO:0000132),0.29490726817337154,0.6864124405413753,0.8188976377952756,1.0,1.0,6/23,17.51%,ITGB1;INSC;NSFL1C;FBXW11;DCTN1;UBXN2B
prerank,regulation of lamellipodium assembly (GO:0010591),0.27398324553285247,0.6863987556989525,0.845360824742268,1.0,1.0,6/34,13.33%,PLCE1;ACTR3;CYFIP1;EPHA2;DMTN;CAPZB
prerank,regulation of cholesterol transport (GO:0032374),0.30711026805862385,0.6862481136041308,0.8044515103338633,1.0,1.0,3/20,10.77%,ABCB4;YJEFN3;NAXE
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2608116367451202,0.6861862385232296,0.8592896174863388,1.0,1.0,2/42,3.64%,THPO;CCL5
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.28393452273458325,0.6860155936607186,0.8304597701149425,1.0,1.0,3/27,7.71%,PMAIP1;DYRK1A;SNAI2
prerank,receptor internalization (GO:0031623),0.2676979690132579,0.6859744416885355,0.8382352941176471,1.0,1.0,6/44,7.15%,CD36;ITGB1;SAG;CAV1;NEDD4;RAMP1
prerank,regulation of astrocyte differentiation (GO:0048710),0.32784693957957056,0.6857384149582193,0.8006814310051107,1.0,1.0,1/12,3.37%,SERPINE2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3198545141028411,0.6855873878455867,0.8181818181818182,1.0,1.0,3/15,11.28%,SIRT3;SAMD8;PRKCD
prerank,epidermis development (GO:0008544),-0.1972525251356729,-0.6854355594558456,0.9470899470899471,0.9759743768452934,1.0,14/56,26.36%,SVEP1;EMP1;ALDH3A2;LAMA3;FGFR2;CRABP2;SCEL;HDAC2;GATA6;PTHLH;FGF7;YBX1;EDA2R;LAMC2
prerank,regulation of urine volume (GO:0035809),0.33756699511507093,0.6851055113942228,0.8033088235294118,1.0,1.0,2/10,9.47%,HAS2;ADCY6
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.300445416382439,-0.6847419322768328,0.8489208633093526,0.9758713643955362,1.0,2/10,12.03%,CRY1;THOC5
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.29871328396558594,-0.6843942751328307,0.8859649122807017,0.9747114206048361,1.0,4/10,29.64%,AP2S1;AP2A2;CLTA;AP2M1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.29871328396558594,-0.6843942751328307,0.8859649122807017,0.9747114206048361,1.0,4/10,29.64%,AP2S1;AP2A2;CLTA;AP2M1
prerank,lysine metabolic process (GO:0006553),0.32728866607926477,0.6842411183322596,0.7916666666666666,1.0,1.0,2/12,7.08%,DLD;DLST
prerank,lysine catabolic process (GO:0006554),0.32728866607926477,0.6842411183322596,0.7916666666666666,1.0,1.0,2/12,7.08%,DLD;DLST
prerank,myeloid cell differentiation (GO:0030099),-0.1940430381361496,-0.6841976831822127,0.944206008583691,0.9741846604441624,1.0,12/47,26.07%,KMT2E;KIT;RPS19;TET2;LYN;HSPA9;SLC25A38;TIRAP;PTPN2;TAL1;UBA5;ZFPM1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.24874472164141476,0.684157441362184,0.8785276073619632,1.0,1.0,10/72,14.15%,FGF1;POLR2L;POLR2I;POLR2G;FLRT1;GALNT3;POLR2J;FGF10;MAPK1;RAB14
prerank,mRNA metabolic process (GO:0016071),0.24558584101522632,0.6818039361820565,0.8943661971830986,1.0,1.0,20/90,15.96%,HNRNPR;PCF11;U2AF2;TP53;SFPQ;YTHDF2;PPARGC1A;CELF1;SRSF4;DIS3L2;PRPF18;U2AF1;SF3A3;SF3B2;PCBP3;DXO;SON;PRKACA;LSM10;SF3A1
prerank,regulation of immune response (GO:0050776),0.2355573518731456,0.6814898426750051,0.9094922737306843,1.0,1.0,12/135,8.34%,FCGR3A;FCGR3B;ITGB1;LAG3;CD276;ELMOD2;CD200R1;CD200;TRAF3;TGFB2;ITGA4;CD300A
prerank,transcription preinitiation complex assembly (GO:0070897),0.32682122174284345,0.6810861576876174,0.8045774647887324,1.0,1.0,3/12,15.90%,TAF1;POLR1E;TAF11
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.2596886551417749,-0.6804745693469806,0.8578431372549019,0.9769935158220246,1.0,6/14,31.91%,RPL7L1;URB1;RPF2;FTSJ3;PES1;RPL35
prerank,RNA polyadenylation (GO:0043631),0.28123445463321994,0.6802962022187604,0.8253477588871716,1.0,1.0,4/26,9.42%,WDR33;PCF11;PAPOLA;AHCYL1
prerank,mRNA polyadenylation (GO:0006378),0.28123445463321994,0.6802962022187604,0.8253477588871716,1.0,1.0,4/26,9.42%,WDR33;PCF11;PAPOLA;AHCYL1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.24341338641659216,-0.6800292602970225,0.8839050131926122,0.9766558957689389,1.0,6/18,21.98%,ELOVL7;ACSL3;ACSL4;ELOVL6;HACD2;ELOVL1
prerank,chromosome organization (GO:0051276),0.23997000904599625,0.6800149933279243,0.905511811023622,1.0,1.0,23/99,21.52%,PADI3;PADI2;GEM;HMGN3;PARP1;TOP2B;COPS8;ZBTB7A;HMG20A;COPS4;CDAN1;CENPW;MSH2;HDAC1;COPS6;HMGN1;ABL1;RPS27A;NUP133;TCF7L1;H3-3A;CENPV;EZH2
prerank,response to amino acid (GO:0043200),0.27725379231557046,0.679875743521162,0.8680351906158358,1.0,1.0,6/31,12.51%,LARS1;CPEB1;CAPN2;RRAGB;SH3BP4;CPEB3
prerank,cellular response to interferon-gamma (GO:0071346),0.2391603646409075,0.6796005007878202,0.8952270081490105,1.0,1.0,18/88,18.77%,CAMK2G;CAMK2D;CCL5;IL12RB1;DAPK3;TRIM68;CCL14;PRKCD;GBP2;OASL;SYNCRIP;EPRS1;STAT1;JAK2;IRF3;CCL25;CD47;CCL19
prerank,positive regulation of proteolysis (GO:0045862),0.25970295293546974,0.6794056413535547,0.8704663212435233,1.0,1.0,9/55,13.17%,ANGPTL8;PACSIN3;ASPH;TNIP1;IST1;FBXW11;SNX9;PERP;BAG2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.25274344369937224,-0.6792621122524973,0.8900255754475703,0.9765609362980363,1.0,1/16,0.84%,APPL2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.33534584648713145,0.6792516558168975,0.7901234567901234,1.0,1.0,3/10,18.07%,SIRT3;PRKCD;SMPD2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.33534584648713145,0.6792516558168975,0.7901234567901234,1.0,1.0,3/10,18.07%,SIRT3;PRKCD;SMPD2
prerank,cellular iron ion homeostasis (GO:0006879),0.2600256630395336,0.6790394698326542,0.8769230769230769,1.0,1.0,4/55,6.32%,HJV;HMOX2;FXN;ATP6V0A2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.30598178307399027,0.6787344467763348,0.8330683624801272,1.0,1.0,4/20,14.19%,BCL2;BCL2L2;BOK;MCL1
prerank,lipid droplet formation (GO:0140042),-0.2913131705037075,-0.6783096250909746,0.8604118993135011,0.976706282319184,1.0,6/10,33.13%,ZFYVE1;CDS1;SQLE;BSCL2;CDS2;FITM2
prerank,response to estradiol (GO:0032355),0.2736655488072672,0.6780559264060811,0.8563134978229318,1.0,1.0,2/31,3.69%,ANXA1;STRN3
prerank,regulation of cellular metabolic process (GO:0031323),0.265829002200108,0.6778930945972639,0.8641160949868074,1.0,1.0,9/45,16.45%,ANGPTL8;PDK4;ACACB;PPARA;ABCG1;MKLN1;PDK2;FLOT1;VPS35
prerank,neuron projection fasciculation (GO:0106030),0.33957418049098403,0.6778630521195111,0.7787769784172662,1.0,1.0,2/10,11.60%,SEMA5A;ARHGAP35
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.31853978441483505,0.6775716205562604,0.8211678832116789,1.0,1.0,3/14,10.20%,HSD17B4;CRAT;SCP2
prerank,negative regulation of hydrolase activity (GO:0051346),-0.19429596574064684,-0.6774799512236935,0.9782608695652174,0.976720183017927,1.0,10/49,18.42%,CPEB2;WNK1;GMIP;GPSM1;RDX;RCC2;SH3RF2;ZCCHC9;LRCH1;ARL2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.29970778053833824,0.6762832087102627,0.8214285714285714,1.0,1.0,3/21,4.84%,NUDT7;NUDT4;NT5C2
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.2880309143173534,-0.6760340039429424,0.9049773755656109,0.9772432880296514,1.0,3/10,17.58%,CORO2B;PPM1F;SNX3
prerank,negative regulation of interferon-beta production (GO:0032688),-0.2819892593146482,-0.6759491140648546,0.8529411764705882,0.9765810006431246,1.0,3/10,15.76%,PPM1B;SIRPA;RELB
prerank,insulin receptor signaling pathway (GO:0008286),0.2449996718928261,0.6756448299922422,0.8859223300970874,1.0,1.0,14/69,15.71%,PDK4;BCAR3;RARRES2;ATP6V1H;IRS1;SORBS1;ATP6V0A2;ATP6V1C1;SLC39A14;ATP6V0D2;PDK2;IRS2;CAV2;NAMPT
prerank,protein autophosphorylation (GO:0046777),0.22652220766469383,0.6755902773710589,0.9292035398230089,1.0,1.0,25/157,14.40%,MYLK2;CAMK2D;MUSK;CAMKK2;PEAK1;DYRK1A;TAF1;MAPKAPK2;STK26;MAP3K10;WNK2;DAPK3;PAK2;STK33;STK24;PDGFRB;EIF2AK2;ACVR1B;CDK12;TNIK;TAOK3;EEF2K;STK10;EPHB1;LRRK2
prerank,regulation of phosphorylation (GO:0042325),0.23723810321473343,0.6752620646680662,0.9129955947136564,1.0,1.0,19/120,14.15%,DYNLL1;ROCK1;CCL5;NUP62;DSCAM;PIN1;CORO1C;AR;SEC13;NUP153;HIF1A;SIRT2;NUP107;AAAS;ZBTB7A;FNIP2;PLXNB2;NUP98;NUP37
prerank,negative regulation of B cell proliferation (GO:0030889),0.3312725584585363,0.6744226217084192,0.8254545454545454,1.0,1.0,2/11,10.86%,CD300A;TNFRSF21
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.2615419238779294,0.674124764432372,0.8877284595300261,1.0,1.0,9/51,11.70%,NAT10;PARN;PRKCQ;PKIB;NAF1;HNRNPU;CCT3;TERF2;HNRNPC
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.26300665982377236,0.6739222082930826,0.8923884514435696,1.0,1.0,12/47,14.04%,DAB2IP;ARL6IP5;RASGRP1;TGFB2;MAP2K1;GSTP1;RAP2A;EIF2AK2;PDCD10;TAOK3;EPHB1;MAPK1
prerank,ether lipid biosynthetic process (GO:0008611),0.33424456845593253,0.6724679808204072,0.8014981273408239,1.0,1.0,4/10,20.00%,PEDS1;PLA2G4A;PLA2G4C;CHPT1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.26619905165078095,-0.672350290970013,0.900709219858156,0.9791614261551671,1.0,7/14,26.26%,SRSF7;SRSF6;SFSWAP;RBMX;PCBP4;RNPS1;SRSF12
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.23761056352219495,0.6722206672330828,0.9141835518474374,1.0,1.0,11/80,12.24%,CDC42EP3;PLCE1;TGFB3;ACTR3;TAPT1;CYFIP1;WASHC1;ANLN;AGRN;ARHGAP35;CEP120
prerank,protein import into peroxisome matrix (GO:0016558),0.3244460031199087,0.6720806831124568,0.8121739130434783,1.0,1.0,5/12,20.10%,PEX2;PEX5L;PEX10;PEX26;PEX1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2202662018375729,0.6714926573258697,0.97165991902834,1.0,1.0,53/336,15.30%,CRIP1;RBM24;DYRK2;CGAS;HINFP;BTG2;MUTYH;GTF2H4;BCL2;UBR5;RAD51AP1;UPF1;TAF1;MAPKAPK2;TP53;PARP1;ZBTB38;MBD4;TDP1;CHEK1;BCL2L2;REXO4;YAP1;RAD9A;CCND1;SLX4;BRSK1;EPHA2;PSME4;STK33;RIF1;FBXO6;POLD1;BOK;AKTIP;NSMCE4A;MACROD1;RMI2;TAOK3;FNIP2;HPF1;BCL6;TRIM28;CSNK1E;SIRT4;ZRANB3;MCL1;ZBTB4;UFL1;UBA1;KMT5B;MAPK12;CHRNA4
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.29683865389753733,0.6712577581709727,0.8398744113029827,1.0,1.0,3/22,10.72%,PMAIP1;HEXIM1;EIF5A
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2513150004179685,0.6711654434879235,0.9014778325123153,1.0,1.0,12/60,13.54%,HEY2;CBFB;TP53;MED1;MED12;SOX9;RELA;CCND1;PAXIP1;MED14;MED8;TRIM28
prerank,negative regulation of T cell differentiation (GO:0045581),0.3345274689860441,0.6708991947463905,0.8261648745519713,1.0,1.0,2/10,13.52%,LAG3;FOXJ1
prerank,negative regulation of mRNA processing (GO:0050686),-0.2610830374361895,-0.6708503423940373,0.9097560975609756,0.9797083606268492,1.0,7/15,26.26%,SRSF7;SRSF6;SFSWAP;RBMX;PCBP4;RNPS1;SRSF12
prerank,nuclear pore organization (GO:0006999),0.31914426558826403,0.6703040822910356,0.8205128205128205,1.0,1.0,6/14,20.76%,NUP153;NUP107;NUP98;NUP54;NUP133;TPR
prerank,mRNA transport (GO:0051028),0.2373417967725107,0.6697431869179694,0.919774011299435,1.0,1.0,23/101,16.20%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;ZC3H11A;NUP153;MCM3AP;RBM8A;U2AF1;NUP107;AAAS;KIF5C;DDX25;THOC7;SRRM1;ZFP36L1;NUP98;NUP37;EIF4E;NUP210;FIP1L1
prerank,regulation of cytoplasmic transport (GO:1903649),0.33122755177215624,0.6694873368321248,0.8108108108108109,1.0,1.0,4/11,14.40%,DENND10;MAP2K1;MAPK1;LRRK2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2307127101023937,0.6690610528436399,0.9428263214670982,1.0,1.0,16/158,11.68%,FLNA;MYD88;ROR1;NUP62;MTDH;PPM1A;GOLT1B;TIFA;RELA;TRIM68;EDAR;TRAF5;PELI2;DDX1;ZDHHC17;HTR2B
prerank,tryptophan metabolic process (GO:0006568),0.3282770229960544,0.6690484223878028,0.8003442340791739,1.0,1.0,1/11,6.78%,KMO
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.23360337331315975,-0.6688630495979808,0.90625,0.9792602354006694,1.0,5/20,18.12%,IK;KLHL22;BUB3;MAD1L1;ATM
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.23360337331315975,-0.6688630495979808,0.90625,0.9792602354006694,1.0,5/20,18.12%,IK;KLHL22;BUB3;MAD1L1;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.23360337331315975,-0.6688630495979808,0.90625,0.9792602354006694,1.0,5/20,18.12%,IK;KLHL22;BUB3;MAD1L1;ATM
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.20592199372931852,-0.6675311671049221,0.9492063492063492,0.979699128138103,1.0,8/31,26.30%,LYN;CEBPB;SDC4;ATM;CD80;CD274;CD86;SOX11
prerank,keratan sulfate catabolic process (GO:0042340),-0.2775164969864711,-0.667203224291864,0.8655097613882863,0.9792500535439892,1.0,4/11,19.23%,HEXA;FMOD;GALNS;OMD
prerank,regulation of cellular pH (GO:0030641),0.27364471659804596,0.6671023287811036,0.8577524893314367,1.0,1.0,4/29,8.16%,SLC4A8;SLC4A3;SLC4A7;SLC9A8
prerank,regulation of RNA splicing (GO:0043484),0.2480033354457448,0.6670571322157154,0.9003645200486027,1.0,1.0,15/69,15.54%,KHDRBS3;RBM38;SLC38A2;DYRK1A;U2AF2;CELF1;MBNL2;FUS;PTBP2;MBNL1;SRSF10;SON;CWC22;SRPK2;SF1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.2952160471581584,0.6669456627471583,0.8500797448165869,1.0,1.0,5/20,16.35%,PLCB1;AGRN;CHRNA7;GNAQ;RGS10
prerank,cellular response to light stimulus (GO:0071482),0.2450531982890903,0.6661100172634938,0.87468671679198,1.0,1.0,15/66,20.99%,SAG;TAF1;TP53;PARP1;NEDD4;RHNO1;POLD1;PRKCD;INO80;EIF2AK4;USP28;N4BP1;EIF2S1;YY1;GNB1
prerank,positive regulation of telomere capping (GO:1904355),0.3104723057401592,0.6659698765844178,0.8224455611390284,1.0,1.0,3/17,14.04%,PRKCQ;PKIB;MAPK1
prerank,neuron cell-cell adhesion (GO:0007158),0.30966338861633697,0.665806947041005,0.837696335078534,1.0,1.0,2/14,8.14%,ASTN2;ASTN1
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.2741082294131805,-0.6650528636075149,0.9017467248908297,0.9802903765381663,1.0,3/12,12.82%,GART;HPRT1;PRPSAP2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.284586979279031,0.6649369387547697,0.85,1.0,1.0,6/27,16.20%,DCTD;AK7;NUDT13;AK2;CMPK1;GLRX
prerank,regulation of response to stress (GO:0080134),0.3278854762219983,0.6641952072061061,0.8046181172291297,1.0,1.0,1/10,5.19%,SLC38A2
prerank,granulocyte chemotaxis (GO:0071621),0.2443062396932813,0.6635743993936648,0.8878980891719745,1.0,1.0,9/55,18.77%,ANXA1;CCL5;TGFB2;CCL14;S100A8;S100A9;CCL25;SCG2;CCL19
prerank,protein modification by small protein conjugation (GO:0032446),0.2193520138244291,0.6635289415590664,0.9696663296258847,1.0,1.0,80/361,19.61%,TRIM54;UBA2;RNF152;TRIM55;TRIM63;DCUN1D2;NUP62;PDZRN3;LMO7;TNFAIP1;ASB2;ASB1;PIAS4;CUL2;RNF7;CNOT4;PEX2;ATG7;CBLL1;PCNP;SAE1;ELOC;FBXW7;UBE2W;NEDD4;UBE2F;CUL9;DCUN1D1;TRIM68;TRPM4;UBE2E1;NUP153;UHRF2;HIF1A;AMFR;TRIM7;NUP107;UBE2D1;AAAS;FBXO32;PIAS2;TRIM35;NFX1;FBXW11;UBA3;MUL1;TRIM28;NUP98;NUP37;TSPAN17;UFL1;UBA1;UBE2K;NUP210;GAN;UBR3;SMURF1;CCNF;RLIM;ANAPC16;PEX10;UBE2A;MIB2;CUL5;ISG15;RCHY1;PIAS1;BCL11A;RNF103;UBR1;ANAPC11;NUP54;RPS27A;SUMO1;TRIM23;UBE2I;NUP160;ATG10;MIB1;NUP133
prerank,T cell activation (GO:0042110),0.24575949021512394,0.6629176322746103,0.8866995073891626,1.0,1.0,10/69,13.44%,PPP3CA;IL2;LCP1;CD276;RASGRP1;DDOST;LMBR1L;RHOH;PPP3CB;NCK2
prerank,peroxisome organization (GO:0007031),0.277845868811984,0.6626102687219442,0.8508771929824561,1.0,1.0,9/25,20.34%,PEX2;ABCD4;DNM1L;PEX19;LONP2;PEX10;MFF;PEX1;PEX3
prerank,Golgi localization (GO:0051645),0.3208566500736324,0.6608466133331016,0.8229166666666666,1.0,1.0,2/11,12.63%,ARHGAP21;PDCD10
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.24334843937725575,0.6606332764788131,0.9004854368932039,1.0,1.0,6/69,7.37%,FZD5;LPL;HAVCR2;CD14;ARHGEF2;RASGRP1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.22454288607067244,0.6601705117600959,0.9391304347826087,1.0,1.0,28/148,17.54%,PRKAB2;DYRK2;PIP4K2A;BRIP1;PRDM1;USP2;TAF1;TP53;HEXIM1;PIN1;TPX2;CHEK1;RAD9A;NUAK1;RPL5;PRR5;RHNO1;RICTOR;RMI2;CHD4;SGK1;PRKAA2;PPP2R5C;TAF11;HIPK2;BOP1;BRD7;HDAC1
prerank,negative regulation of glycolytic process (GO:0045820),0.32924636870983404,0.6598693249494993,0.7933579335793358,1.0,1.0,2/10,8.61%,PFKFB1;PPARA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.32924636870983404,0.6598693249494993,0.7933579335793358,1.0,1.0,2/10,8.61%,PFKFB1;PPARA
prerank,androgen receptor signaling pathway (GO:0030521),0.3154203940000648,0.6598392093773727,0.8311926605504587,1.0,1.0,2/11,7.14%,ARID1A;AR
prerank,nuclear membrane reassembly (GO:0031468),0.2471667380032513,0.6595687708719541,0.9121447028423773,1.0,1.0,17/54,19.61%,CHMP4C;SEC13;IST1;SIRT2;NSFL1C;NUP107;CHMP2B;CHMP2A;NUP98;NUP37;UBXN2B;VPS4A;LMNA;SUMO1;UBE2I;NUP160;NUP133
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.2726753056710578,0.6594200497763497,0.8665730337078652,1.0,1.0,2/29,3.64%,ANO6;CCL5
prerank,regulation of cell projection organization (GO:0031344),-0.2641196749867862,-0.6593375082250108,0.8969555035128806,0.9843283701685457,1.0,6/13,28.19%,SEMA4D;MYO9A;SPRY2;MFSD2A;MOV10;NTNG1
prerank,regulation of adaptive immune response (GO:0002819),-0.24006663046474108,-0.6591785295397012,0.9272727272727272,0.9837173898150007,1.0,11/18,48.85%,ADCY7;AHR;SKAP1;PYCARD;IRF1;FCGR2B;IRF7;FADD;IL4I1;SASH3;IL6ST
prerank,histone modification (GO:0016570),0.23036190604067477,0.6587683504855879,0.931113662456946,1.0,1.0,28/109,19.73%,PADI3;CCNA2;PADI2;HDAC9;CPA4;MSL3;PRMT7;NSD3;MTA3;SIRT2;MIDEAS;PRKCD;BAZ2A;RUVBL1;MORF4L1;MTA1;UFL1;SIN3A;MT3;USP36;HDAC1;UBE2A;ATXN7L3;RBM14;HDAC6;KAT8;KDM4A;PRMT1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.3301478116786215,0.6586825731798028,0.8214936247723132,1.0,1.0,2/10,7.52%,SMARCB1;CHEK1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.24812159832360955,0.6585370161647992,0.8807588075880759,1.0,1.0,5/57,9.97%,MEF2C;SHISA9;CNIH2;GSG1L;ACTN2
prerank,lipid catabolic process (GO:0016042),0.28973769682825373,0.6583672901099766,0.8330683624801272,1.0,1.0,2/18,9.92%,LPL;SIRT2
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2501133465015534,0.658185706045088,0.8899082568807339,1.0,1.0,13/50,19.26%,KLHL40;U2AF2;CAV1;TAF1;BAG2;ADGRB1;UFL1;FBXO5;USP4;ISG15;N4BP1;ABL1;SENP2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.22806494475208722,0.6580549023746639,0.9228110599078341,1.0,1.0,14/108,13.74%,DLC1;MAP3K5;PMAIP1;HIP1;MAPT;ARL6IP5;RPS27L;ATP2A3;GPER1;CASP8AP2;BOK;DIABLO;MUL1;TNFRSF10B
prerank,tRNA modification (GO:0006400),0.24779781403069795,0.6575799747337431,0.9075949367088607,1.0,1.0,5/62,5.49%,WDR4;TRDMT1;CDKAL1;TYW5;FTSJ1
prerank,sulfur compound biosynthetic process (GO:0044272),0.23196188176462343,0.6574469713252398,0.9191343963553531,1.0,1.0,17/104,13.27%,ANGPT1;CSPG4;CHSY3;CSGALNACT1;BGN;CHST5;OGN;GSTT1;GSTP1;CHST3;OPLAH;GGCT;ESD;CHST1;GSTA4;ST3GAL2;MAT2A
prerank,regulation of cell death (GO:0010941),0.23550598590702063,0.6574326372420295,0.9304750869061413,1.0,1.0,20/94,17.66%,CD36;CCN1;FERMT2;CCL5;CELF1;ADNP2;IMPACT;HTR2B;CHRNA7;CLU;SARM1;CHMP2A;EPHB1;LRRK2;SNCG;DHCR24;VPS35;MT3;FAF1;SNCB
prerank,regulation of lipid kinase activity (GO:0043550),-0.2691246604588977,-0.6574296813689203,0.8806306306306306,0.9843390362012718,1.0,2/11,7.75%,PIK3R3;WDR91
prerank,regulation of cell killing (GO:0031341),0.30447582079721475,0.6573456974662019,0.8297161936560935,1.0,1.0,2/16,7.86%,CFH;TGFB2
prerank,regulation of T cell proliferation (GO:0042129),0.2448437134350836,0.6572563712254742,0.8985148514851485,1.0,1.0,3/61,4.17%,ANXA1;CCL5;CD276
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.2651491367399608,0.6570155294055307,0.876010781671159,1.0,1.0,11/38,18.18%,CENPP;CENPO;HAT1;RUVBL1;ITGB3BP;SMARCA5;CABIN1;IPO4;CENPW;CENPK;RSF1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.2910432735748929,0.6569739432815386,0.8487261146496815,1.0,1.0,1/18,3.83%,LAX1
prerank,synaptic vesicle localization (GO:0097479),0.3107307490559049,0.6567113558853901,0.8297101449275363,1.0,1.0,6/13,21.95%,KIF5B;KIF5C;KIF5A;DNM2;SNAPIN;SYNJ1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.2685027516380742,-0.6559841514915019,0.9019138755980861,0.9847445361581917,1.0,1/12,3.27%,IL18
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.26223036647455944,0.6557916198576633,0.8733509234828496,1.0,1.0,14/41,20.76%,NUP62;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,regulation of B cell apoptotic process (GO:0002902),0.31251990335549656,0.6551641108018834,0.8302828618968386,1.0,1.0,3/12,14.92%,IL2;BCL6;IRS2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.32510175635064265,0.6551111499249617,0.831304347826087,1.0,1.0,3/10,14.04%,MAP2K1;GSTP1;MAPK1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.2687737008465424,-0.6550352884344702,0.9136363636363637,0.9847655421172803,1.0,6/12,32.42%,AKAP8;AKAP8L;PRKD2;ZBTB7B;SAP30BP;APLNR
prerank,regulation of mononuclear cell migration (GO:0071675),0.28123621819693995,0.6550293381893296,0.8580152671755725,1.0,1.0,4/23,14.04%,CCL5;RARRES2;STK10;MAPK1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2666010583595596,0.6541310709755713,0.8681159420289855,1.0,1.0,4/31,7.96%,DCUN1D2;FBXW7;PIN1;DCUN1D1
prerank,regulation of cell cycle (GO:0051726),0.2153676160967541,0.653214317676791,0.9795291709314228,1.0,1.0,49/271,17.52%,MAP3K20;CDK6;FBXL22;TRNP1;MLF1;NR4A1;GMNN;MYBBP1A;JUND;DAB2IP;RPS6KA2;TP53;CHEK1;FZD9;SOX9;TGFB2;DAPK3;LIN37;WHAMM;CCND1;MAP2K1;UHRF2;CDK7;CRLF3;SIRT2;HNRNPU;BRINP1;GPER1;RB1;MFN2;LIN9;CITED2;KIF20B;FGF10;SON;PRKACA;MLXIPL;DHCR24;FBXO5;SRPK2;MAPK12;STAT3;HIPK2;TTC28;WDR6;MIF;EIF4G2;BOP1;MASTL
prerank,regulation of viral release from host cell (GO:1902186),-0.23155754536338508,-0.6527426048927143,0.926829268292683,0.9857845670381556,1.0,7/21,25.86%,PML;TRIM25;DDB1;TRIM5;MID2;TRIM21;TRIM32
prerank,extracellular transport (GO:0006858),-0.2627684054495664,-0.6526601426503019,0.8858447488584474,0.9850949365709926,1.0,9/12,49.60%,SPEF2;ARRDC1;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.2098652487539472,-0.652027909010262,0.9444444444444444,0.9848620612912299,1.0,6/28,19.28%,OCLN;SLAIN2;NAV3;GIT1;ARL2;MECP2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.2405844079033058,-0.6515568248211484,0.9025641025641026,0.9844674092562871,1.0,6/17,27.66%,PTPN22;PTPN2;CEACAM1;THY1;LAPTM5;PTPRJ
prerank,JNK cascade (GO:0007254),0.2573355325854796,0.6515064579107002,0.8863328822733424,1.0,1.0,3/40,8.12%,MAP3K5;MAP4K3;MAP3K10
prerank,sodium ion import across plasma membrane (GO:0098719),0.28904109472579176,0.6514219694238823,0.8573825503355704,1.0,1.0,3/17,12.67%,SLC8A1;TRPM4;HCN2
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.23711916899614727,-0.6512673827107692,0.9086161879895561,0.9839724293443181,1.0,4/18,18.40%,PRKDC;METTL3;XRCC6;NCKAP1L
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.28237929193579914,0.651166098608526,0.8472012102874432,1.0,1.0,7/22,17.90%,RELA;ROCK2;ABCG1;CHRNA7;CLU;SP1;LRRTM3
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3100490130562724,0.650984195966204,0.8362676056338029,1.0,1.0,3/13,14.40%,ENTPD7;OPA1;LRRK2
prerank,inner mitochondrial membrane organization (GO:0007007),0.24933827945121656,0.650855902917313,0.901749663526245,1.0,1.0,8/47,11.59%,ATP5MF;AFG3L2;OPA1;MTX1;DNAJC11;TIMM29;ATP5MC1;ATP5MG
prerank,protein localization to vacuole (GO:0072665),0.3104983996154469,0.6505538694110681,0.8286713286713286,1.0,1.0,2/13,10.83%,KPTN;SH3BP4
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.28392542016353195,0.6498444299455362,0.841692789968652,1.0,1.0,4/18,17.43%,KCNB1;IRS1;SIRT4;ADRA2A
prerank,negative regulation of protein processing (GO:0010955),0.3192224946262313,0.6497716123188192,0.8392226148409894,1.0,1.0,1/12,3.37%,SERPINE2
prerank,coenzyme A metabolic process (GO:0015936),-0.25264362687094677,-0.6493597661656784,0.9119804400977995,0.9847184161168173,1.0,7/14,27.04%,PPCDC;PANK1;ACLY;CROT;DCAKD;ACOT7;PPCS
prerank,RNA export from nucleus (GO:0006405),0.23127593141774094,0.6489549210887327,0.927683615819209,1.0,1.0,22/100,16.20%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;ZC3H11A;NUP153;MCM3AP;RBM8A;U2AF1;NUP107;AAAS;DDX25;THOC7;SRRM1;XPO5;NUP98;NUP37;EIF4E;NUP210;FIP1L1
prerank,regulation of actin nucleation (GO:0051125),-0.2701202685148545,-0.6482677940734884,0.9337899543378996,0.9847676175549761,1.0,10/12,48.42%,ARFIP2;PICK1;ARPIN;GSN;ARFIP1;WASHC5;CORO1B;CORO1A;SCIN;ARF1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3188233620985689,0.6479102375230366,0.8186528497409327,1.0,1.0,3/12,11.08%,LPCAT3;MBTPS1;SREBF2
prerank,regulation of mRNA processing (GO:0050684),0.2722734171199498,0.6476461727706286,0.8799435028248588,1.0,1.0,10/32,16.80%,KHDRBS3;PAPOLA;AHCYL1;SRSF10;ZFP36L1;SON;CWC22;SRPK2;SF1;DHX9
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.30110427287297287,0.6471437299252552,0.8436974789915966,1.0,1.0,3/15,11.97%,NAF1;CCT3;RUVBL1
prerank,dendritic spine morphogenesis (GO:0060997),0.29641999499516924,0.6469212532140071,0.8597662771285476,1.0,1.0,3/15,15.34%,DOCK10;EPHB1;PTEN
prerank,long-chain fatty acid metabolic process (GO:0001676),0.23674145178017525,0.6469089628369327,0.9072039072039072,1.0,1.0,14/64,18.67%,ALOX5;HSD17B4;ACSL5;FADS2;GSTP1;MGLL;SCP2;PNPLA3;CPT1A;PLA2G4A;PLA2G4C;EPHX1;ACSBG1;FAAH
prerank,regulation of mRNA metabolic process (GO:1903311),-0.26488975368298195,-0.6467703512328319,0.9054054054054054,0.985187723837031,1.0,2/11,18.27%,SAFB2;SRPK1
prerank,protein targeting to mitochondrion (GO:0006626),-0.179002299266325,-0.6464575943063159,0.97165991902834,0.984710457944417,1.0,17/52,30.43%,HSPA4;FBXO7;TIMM44;DNAJC19;FIS1;SAMM50;TOMM34;AIFM1;TIMM17B;HSPD1;IMMP2L;TOMM70;TIMM21;TIMM23;TIMM10B;TIMM8B;GRPEL1
prerank,positive regulation of cytokine production (GO:0001819),0.21414938351692214,0.6460570474199515,0.977482088024565,1.0,1.0,29/292,11.18%,NR1H4;POLR2L;MYD88;FZD5;RORA;ANXA1;CGAS;IL2;LPL;IL12RB2;CD276;HAVCR2;CD14;ARHGEF2;PRKCQ;IL12RB1;CD200;PIBF1;RASGRP1;MBP;RELA;PLCB1;ADAM17;LRRFIP1;HIF1A;EIF2AK2;ROCK2;RUNX1;PDE4D
prerank,tryptophan catabolic process (GO:0006569),0.31569614911498417,0.6456262533486582,0.8268251273344652,1.0,1.0,1/11,6.78%,KMO
prerank,positive regulation of exocytosis (GO:0045921),0.25944632134527407,0.645620632379162,0.8949579831932774,1.0,1.0,7/35,15.01%,CLASP2;UNC13D;RAB3A;TSG101;CLASP1;CHMP2A;STAM
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.3089096566381609,0.644014604998536,0.8447653429602888,1.0,1.0,1/11,4.25%,PARN
prerank,autophagosome assembly (GO:0000045),0.24454268617052052,0.6437121522278443,0.9124668435013262,1.0,1.0,12/52,17.51%,ATP2A2;ATG16L2;ATG7;GABARAP;NSFL1C;STX12;MFN2;WDR45;PIK3C3;ATG13;SMURF1;UBXN2B
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.23492655481810448,0.643283026506719,0.9227985524728589,1.0,1.0,6/73,7.37%,FZD5;LPL;HAVCR2;CD14;ARHGEF2;RASGRP1
prerank,vesicle organization (GO:0016050),0.2480758281184559,0.6429654639647054,0.8867667121418826,1.0,1.0,8/46,12.41%,HOOK2;SORT1;CAV1;HOOK1;CHMP2B;USP50;AKTIP;PLEKHJ1
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.25340255948371115,-0.642906370736712,0.9072681704260651,0.9865940300495692,1.0,5/14,24.62%,MYO9A;OPHN1;CDC42;FSCN1;SCRIB
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.27457149351179977,0.6426763516480151,0.8770614692653673,1.0,1.0,7/26,14.87%,EIF4EBP1;USP2;DUSP3;PKN2;PPP1R10;EIF4E;PRKCA
prerank,glycolipid metabolic process (GO:0006664),0.2503268236536102,0.6420391543132771,0.904891304347826,1.0,1.0,9/47,14.95%,ESYT2;NEU3;GLA;SUMF1;GM2A;ST3GAL2;GLTP;GLB1;CTSA
prerank,calcium-ion regulated exocytosis (GO:0017156),0.2628215985761724,0.640994590956123,0.8736842105263158,1.0,1.0,3/27,7.97%,RIMS3;SYT10;ARHGAP17
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.22025529455758974,-0.6409007532871799,0.9445983379501385,0.9873476008670476,1.0,7/23,24.55%,COPS2;DDB1;UBC;XPA;COPS7B;UBB;RAD23B
prerank,protein acylation (GO:0043543),0.25430693104307955,0.6408283398920573,0.8983050847457628,1.0,1.0,11/38,18.76%,NAT10;ZDHHC2;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;CLOCK;ZDHHC13;ZDHHC5;ZDHHC8;ZDHHC3
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3080475514675523,0.6407546495311383,0.8440677966101695,1.0,1.0,1/13,2.85%,ASPH
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3087433729436762,0.6407213689941976,0.8441780821917808,1.0,1.0,3/12,14.30%,LPCAT3;DGAT1;MTTP
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.21644666983293298,0.6404269062826007,0.9600431965442765,1.0,1.0,27/163,16.90%,MEF2C;CD79A;LAX1;CD276;BCL2;FYB2;PRKCQ;PSMC6;LCP2;RELA;PAK2;PSME4;PAG1;PSMB1;PSMD5;TNFRSF21;PDE4D;FBXW11;PSMB2;PLEKHA1;PSMB7;PSMD3;PRAM1;RFTN1;PSMA2;VAV3;PSMD14
prerank,positive regulation of synaptic transmission (GO:0050806),0.23549527466994752,0.6397407204545128,0.926829268292683,1.0,1.0,5/72,5.87%,CRHR2;SLC8A2;GRIN2C;RIMS3;ZDHHC2
prerank,iron ion homeostasis (GO:0055072),0.24326840698757157,0.6397163271039009,0.920253164556962,1.0,1.0,4/58,6.32%,HJV;HMOX2;FXN;ATP6V0A2
prerank,maturation of LSU-rRNA (GO:0000470),-0.2130614159855522,-0.6396349705613509,0.9413489736070382,0.9875100156590497,1.0,8/26,23.47%,NSA2;RSL1D1;RPL7L1;URB1;MRPL1;RPF2;FTSJ3;RPL10A
prerank,positive regulation of viral genome replication (GO:0045070),0.2683555253596959,0.6395672078321588,0.8871201157742402,1.0,1.0,6/29,11.80%,CCL5;PPARA;PPIE;PKN2;TOP2B;CNOT7
prerank,DNA repair (GO:0006281),0.21144593736502423,0.6386323841205713,0.9743326488706365,1.0,1.0,53/284,16.88%,HINFP;BRIP1;BTG2;MUTYH;RAD51AP2;GTF2H4;WDR33;RAD51AP1;UPF1;PIAS4;FAAP24;MLH3;TP53;PARP1;WRNIP1;MBD4;TDP1;CHEK1;REXO4;RAD9A;ERCC6;HUS1B;FTO;TENT4A;SLX4;USP1;FANCB;PSME4;FAAP100;FBXO6;RHNO1;DDX1;POLD1;KPNA2;FANCE;NSMCE4A;SMARCA5;RMI2;HPF1;TRIM28;CSNK1E;ZRANB3;MTA1;EXD2;KMT5B;CHRNA4;BABAM1;MAD2L2;RAD52;MGME1;RAD21;MSH2;INO80
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.22870994554032936,0.6384884659573405,0.9439359267734554,1.0,1.0,21/96,16.20%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;ZC3H11A;NUP153;MCM3AP;RBM8A;U2AF1;NUP107;AAAS;DDX25;THOC7;SRRM1;NUP98;NUP37;EIF4E;NUP210;FIP1L1
prerank,establishment of epithelial cell polarity (GO:0090162),-0.2272260556898394,-0.6378023941548667,0.937007874015748,0.9879872211549802,1.0,5/19,16.79%,GOLPH3;MYO9A;OPHN1;CYTH1;CDC42
prerank,response to leucine (GO:0043201),-0.2747944031767346,-0.6377252028885849,0.9,0.9865565467808141,1.0,5/10,29.70%,UBR2;KLHL22;RRAGD;SESN2;RPTOR
prerank,cellular response to leucine (GO:0071233),-0.2747944031767346,-0.6377252028885849,0.9,0.9865565467808141,1.0,5/10,29.70%,UBR2;KLHL22;RRAGD;SESN2;RPTOR
prerank,cellular response to superoxide (GO:0071451),-0.2754033008358587,-0.637278716174073,0.8733905579399142,0.9861351882757128,1.0,6/10,42.23%,NOS3;ADPRS;PRDX1;PRDX2;ATP7A;SOD1
prerank,cellular response to sterol (GO:0036315),0.2985281679615379,0.6365007680519306,0.8604651162790697,1.0,1.0,1/13,2.57%,RORA
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.31211573348677984,0.6360040308035806,0.8738404452690167,1.0,1.0,4/11,20.67%,CAV1;ACTN2;KCNH2;CAB39
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.27411261899685296,0.6358322115253416,0.8780487804878049,1.0,1.0,8/24,19.61%,ALOX5;OPA1;LPCAT3;CLU;LRRK2;NR1H3;CREB3;WFS1
prerank,integrated stress response signaling (GO:0140467),0.30118084551684954,0.6357975916770202,0.8433734939759037,1.0,1.0,6/14,22.56%,IMPACT;EIF2AK3;EIF2AK4;DDIT3;EIF2S1;QRICH1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.25955333811019526,-0.6355311593658352,0.9265402843601895,0.9866181373742731,1.0,6/12,34.93%,PLK2;CHFR;ZWILCH;WEE1;NABP1;BUB1B
prerank,piRNA metabolic process (GO:0034587),-0.22457964661110336,-0.6351284891874835,0.9021739130434783,0.9861333609885036,1.0,17/19,64.23%,TEX15;TDRKH;EXD1;TDRD9;DDX4;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2457933646519541,0.6351099834334673,0.8961038961038961,1.0,1.0,10/45,13.20%,BTG2;CHEK1;HECA;BTG1;TOM1L2;ZWINT;BRINP1;TRIM35;BCL6;ZFP36L1
prerank,mRNA methylation (GO:0080009),0.2878200058804986,0.6345352695432511,0.878839590443686,1.0,1.0,3/15,13.19%,TRMT10C;CBLL1;NSUN2
prerank,glycine metabolic process (GO:0006544),0.3041360132698535,0.6342804868134336,0.8558225508317929,1.0,1.0,1/12,6.00%,DLD
prerank,peptidyl-proline modification (GO:0018208),0.26864153938451796,0.6336974955948913,0.8831562974203339,1.0,1.0,7/25,17.34%,P3H2;PIN1;PPIL1;PPIE;PPWD1;PPIL3;FKBP4
prerank,RNA methylation (GO:0001510),0.24019802605596524,0.6334551789627059,0.931758530183727,1.0,1.0,11/60,15.34%,TRDMT1;FTSJ1;TRMT10C;CBLL1;TFB2M;ZCCHC4;TGS1;METTL6;NSUN2;TRMT44;RBM15
prerank,negative regulation of histone acetylation (GO:0035067),0.3101322370727523,0.6327856917172141,0.8542056074766355,1.0,1.0,1/11,4.30%,SET
prerank,serine family amino acid metabolic process (GO:0009069),0.2849370893211338,0.6327082178956465,0.8691275167785235,1.0,1.0,2/16,9.29%,SEPHS2;SEPSECS
prerank,regulation of tumor necrosis factor production (GO:0032680),0.22125680188593397,0.6319611172729376,0.9513023782559457,1.0,1.0,10/112,8.98%,NR1H4;FZD5;LPL;HAVCR2;CD14;ARHGEF2;MAPKAPK2;RASGRP1;DICER1;GSTP1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.2464560138900631,-0.6312802303897351,0.9205955334987593,0.9879997569668221,1.0,3/15,14.82%,TCF7L2;CAMK1;EMD
prerank,lipoprotein biosynthetic process (GO:0042158),0.30539815416236554,0.6312338586495374,0.8540925266903915,1.0,1.0,3/11,13.34%,ATG7;WDR45;PIK3C3
prerank,neuron apoptotic process (GO:0051402),0.28021274260839674,0.6311602347646802,0.8805237315875614,1.0,1.0,4/19,12.39%,BCL2;TRPC5;TNFRSF21;DIABLO
prerank,protein localization to lysosome (GO:0061462),-0.20781855367420854,-0.6311329474436641,0.9662921348314607,0.987374609900169,1.0,10/28,26.69%,SCARB2;GCC2;RTN4;AP3M1;HGS;LMBRD1;M6PR;GLMP;NCOA4;LAPTM5
prerank,inner dynein arm assembly (GO:0036159),-0.27816796184801573,-0.6308794215375492,0.888421052631579,0.9868194971039457,1.0,2/10,13.45%,DNAAF5;CCDC39
prerank,positive regulation of lipid localization (GO:1905954),0.3090928017614362,0.6308459104728936,0.857397504456328,1.0,1.0,1/11,3.34%,LPL
prerank,Golgi to lysosome transport (GO:0090160),0.31048734328152694,0.6306895400034109,0.8487544483985765,1.0,1.0,2/11,9.53%,SORT1;ANKFY1
prerank,regulation of chromosome segregation (GO:0051983),-0.23433075756695332,-0.6301894207595632,0.9425,0.9865274391786629,1.0,4/16,25.49%,PUM1;SMC5;CSNK2A2;CSNK2A1
prerank,protein catabolic process (GO:0030163),0.2369740545978807,0.6299433316261378,0.9193341869398207,1.0,1.0,6/59,10.11%,PMAIP1;CLN5;SOCS6;DAB2IP;NR1D1;FBXO6
prerank,pre-replicative complex assembly (GO:0036388),-0.1674500516569776,-0.6294563365102402,0.9952380952380953,0.986297829788074,1.0,24/64,32.65%,PSMD7;PSMD9;PSMD13;PSMB3;ORC6;UBC;ORC5;PSMC5;PSMA5;PSMA1;PSMC2;PSME3;UBB;PSMC4;PSMB6;ORC4;PSMB10;PSMA4;PSME1;ORC1;PSMF1;PSMB9;PSME2;PSMA8
prerank,base-excision repair (GO:0006284),0.24211194469633496,0.6292956261802106,0.914396887159533,1.0,1.0,7/48,11.83%,MUTYH;PARP1;MBD4;ERCC6;PARG;POLD1;POLG
prerank,tricarboxylic acid metabolic process (GO:0072350),0.30164557520050383,0.6291716464490171,0.8561020036429873,1.0,1.0,4/12,15.81%,ACO2;IDH3A;SIRT4;IREB2
prerank,lipid biosynthetic process (GO:0008610),0.23031954392198742,0.6290105987146506,0.9388004895960832,1.0,1.0,10/77,12.02%,LPL;ALOX5;ACSL5;PDSS2;AGPAT3;MVD;PCYT2;SCP2;NDUFAB1;PDSS1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.262762690598808,0.6274646808829127,0.8824362606232294,1.0,1.0,7/28,16.55%,PSMC6;DAB2IP;FBXW7;CLU;BAG2;PTEN;SMURF1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.25475360023134963,-0.6272009436229361,0.9202733485193622,0.9870251564513833,1.0,1/12,4.19%,RBP4
prerank,sensory perception of smell (GO:0007608),0.30636999322158903,0.6268408260116327,0.8432055749128919,1.0,1.0,1/11,4.63%,SYT10
prerank,phospholipid biosynthetic process (GO:0008654),0.24772805252716223,0.6262769521632238,0.9046283309957924,1.0,1.0,8/36,13.24%,IDI1;DHDDS;AGPAT3;MVD;PCYT2;SAMD8;SRD5A3;CPNE3
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.31136751257945966,0.6261028486072412,0.8648148148148148,1.0,1.0,2/10,10.07%,LIN7C;ARHGAP12
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.30176186599355315,0.6260183466028025,0.900974025974026,1.0,1.0,3/13,8.04%,SLC2A10;RAMP1;PLCB1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.3123660110462636,0.6259651394408043,0.8548672566371681,1.0,1.0,1/10,5.78%,MTHFD2L
prerank,nucleosome assembly (GO:0006334),0.2573160824524,0.625743064765066,0.9156118143459916,1.0,1.0,10/31,19.30%,CHAF1B;SOX9;HAT1;SMARCA5;CABIN1;IPO4;RSF1;NAP1L4;NAP1L2;BRD2
prerank,cell proliferation in forebrain (GO:0021846),0.30908629805267357,0.6254918095516325,0.8814814814814815,1.0,1.0,3/10,13.55%,AKNA;CEP120;NUMBL
prerank,lymphocyte migration (GO:0072676),0.2529987870303706,0.625414112365008,0.9150521609538003,1.0,1.0,5/32,19.67%,CCL5;CCL14;CCL25;CCL19;RET
prerank,negative regulation of mitochondrion organization (GO:0010823),0.2500176165972349,0.6250917244130754,0.9011461318051576,1.0,1.0,7/33,13.95%,FXN;MAPT;FZD9;OPA1;CLU;MUL1;ADCK1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3063427764178702,0.6238740748858044,0.8880994671403197,1.0,1.0,1/11,4.50%,BCL2
prerank,regulation of proteolysis (GO:0030162),0.23975785271710015,0.6236712899051383,0.9184210526315789,1.0,1.0,8/48,13.11%,ASPH;SERPINE2;CAV1;TRAF3;IST1;FBXW11;DNAJC1;PERP
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.31735768229369044,0.6235888821649408,0.8819320214669052,1.0,1.0,2/10,12.51%,CPEB1;CPEB3
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.2860633567302594,0.6230255248751357,0.8774509803921569,1.0,1.0,1/15,2.95%,FAM83D
prerank,I-kappaB phosphorylation (GO:0007252),-0.25952920235250254,-0.6229419462099425,0.9088729016786571,0.9889663240801077,1.0,4/10,26.16%,CHUK;TLR3;PRDX4;ERC1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.287597135029081,0.6228030288638878,0.8903654485049833,1.0,1.0,3/17,11.53%,MUTYH;MBD4;TERF2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.2396720275587906,0.6224522705266713,0.9211563731931669,1.0,1.0,10/50,16.90%,OAZ2;PSMC6;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,RNA transport (GO:0050658),0.22873133051811403,0.6221980485495178,0.9468599033816425,1.0,1.0,16/71,15.79%,NUP62;ATXN2;U2AF2;SRSF4;ZC3H11A;NUP153;RBM8A;U2AF1;KIF5C;THOC7;SRRM1;XPO5;ZFP36L1;EIF4E;FLOT1;RFTN1
prerank,phosphate ion transport (GO:0006817),0.2830882550294775,0.6212859236403756,0.8738170347003155,1.0,1.0,2/16,9.10%,SLC20A2;XPR1
prerank,TOR signaling (GO:0031929),-0.20151604879452345,-0.6206806440136191,0.9495268138801262,0.989607804976296,1.0,7/26,21.15%,SMG1;NPRL3;PRR5L;AKT1;RPS6KB2;MAPKAP1;SYAP1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.2278549222737956,-0.6199432168747635,0.9340659340659341,0.9893443743533685,1.0,8/17,41.90%,IK;BUB3;ZWILCH;BOD1;KNL1;TTK;SPDL1;CENPA
prerank,regulation of keratinocyte proliferation (GO:0010837),0.26979160519581,0.6196685064099422,0.8888888888888888,1.0,1.0,5/22,13.32%,AREG;MED1;SNAI2;ZFP36L1;FGF10
prerank,smoothened signaling pathway (GO:0007224),0.25830604141077457,0.6194631664590546,0.9066091954022989,1.0,1.0,6/32,17.80%,DYRK2;MAP3K10;DISP2;STK36;HIPK2;IFT27
prerank,nuclear migration (GO:0007097),0.29602937567727844,0.6193851729781921,0.8860294117647058,1.0,1.0,4/13,12.24%,SYNE2;SUN2;FBXW11;CEP120
prerank,phosphate ion transmembrane transport (GO:0035435),0.29670173743603695,0.6192712841379959,0.8514851485148515,1.0,1.0,2/12,9.10%,SLC20A2;XPR1
prerank,mismatch repair (GO:0006298),0.2631946335950214,0.6188453981073332,0.8953662182361734,1.0,1.0,6/27,19.08%,MUTYH;MLH3;POLD1;MSH5;MSH2;ABL1
prerank,protein acetylation (GO:0006473),0.2598539354076852,0.6187777025737271,0.9067055393586005,1.0,1.0,5/30,14.99%,NAT10;MAPT;HAT1;CLOCK;NAA35
prerank,ribonucleoprotein complex assembly (GO:0022618),0.21649094817772568,0.6185870917051456,0.9725877192982456,1.0,1.0,20/132,12.81%,RPL3L;DENR;DDX23;TXNL4A;RPS27L;NLE1;CLNS1A;MDN1;CELF1;DICER1;NAF1;EIF2D;PRPF18;PWP2;PRMT7;RPL5;SRSF10;DDX1;TGS1;SF3B1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.24202553140861605,-0.6168115712449822,0.9428571428571428,0.9905511446476417,1.0,10/14,38.16%,ZBTB8OS;TSEN34;CPSF4;CSTF2;CPSF1;CLP1;TRPT1;TSEN54;TSEN15;RTRAF
prerank,regulation of DNA metabolic process (GO:0051052),0.24238199530974944,0.6167583553093727,0.927694406548431,1.0,1.0,8/44,12.04%,UPF1;WRNIP1;USP1;KAT7;PDGFA;PARG;TERF2;KPNA2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.27364196338832913,0.6160029534616244,0.8847402597402597,1.0,1.0,1/19,2.09%,PDGFB
prerank,positive regulation of protein catabolic process (GO:0045732),0.2239203465833448,0.615870877974423,0.958041958041958,1.0,1.0,15/84,17.43%,NKD1;OAZ2;PACSIN3;ATG7;DAB2IP;NEDD4;AMER1;NSF;SNX9;VGLL4;VPS35;SMURF1;FAF1;TNFSF12;ADRA2A
prerank,regulation of oxidoreductase activity (GO:0051341),0.2938100371806093,0.6157848377630897,0.8964285714285715,1.0,1.0,5/13,21.24%,SIRT4;MT3;HDAC6;ABL1;OXA1L
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.3103670765681742,0.6151230587597337,0.8791208791208791,1.0,1.0,2/10,8.81%,CAV1;IMPACT
prerank,regulation of interferon-alpha production (GO:0032647),0.2616833652297049,0.6151106991374322,0.8971684053651267,1.0,1.0,9/23,25.10%,PTPRS;HAVCR2;STAT1;DHX9;IRF3;TLR7;TBK1;SETD2;IFIH1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2157544380112259,0.6145577976884081,0.9598163030998852,1.0,1.0,27/100,20.15%,KLHL40;SOCS5;PABIR1;GABARAP;TAF1;RNF180;GNA12;SIRT2;EIF3H;CLU;BAG2;CSNK1E;LRRK2;DVL1;UFL1;CSNK1A1;HSPBP1;XPO1;MAP1A;RCHY1;PIAS1;N4BP1;DESI1;UCHL5;SUMO1;FHIT;FOXF2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.22398372508604658,0.6143150146803588,0.9405469678953626,1.0,1.0,20/73,22.85%,POLR2L;ACTB;MYBBP1A;ERCC6;PRMT7;POLR1E;POLR1H;SMARCA5;SF3B1;MTA1;TFAP2C;TAF1A;HDAC6;DNMT3A;MYO1C;H3-3A;EZH2;CTCF;RBBP7;KAT2B
prerank,maturation of SSU-rRNA (GO:0030490),0.24866079640627492,0.6134932284075533,0.9173669467787114,1.0,1.0,4/34,8.69%,NAT10;NOB1;WDR46;PWP2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.2649909181409238,-0.6126294314079048,0.9258426966292135,0.9922639689896572,1.0,5/10,32.44%,GNB5;FMR1;DRD2;CALM3;CBARP
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.2243357536563655,0.6124670277320138,0.9614457831325302,1.0,1.0,9/72,11.45%,POLR2L;POLR2I;GTF2H4;POLR2G;ERCC6;PPIE;CDK7;POLD1;COPS8
prerank,interstrand cross-link repair (GO:0036297),0.23066637923484584,0.6120845990226952,0.9331619537275064,1.0,1.0,8/53,12.17%,RAD51AP2;RAD51AP1;FAAP24;SLX4;USP1;FANCB;FAAP100;FANCE
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2044788892631228,0.6117712190561229,0.9840595111583422,1.0,1.0,57/184,23.06%,DYNLL1;CEP41;HAUS8;CEP290;ANAPC10;PSMC6;TPX2;UBE2E1;ANLN;PSME4;CEP192;SIRT2;CENPE;PSMB1;PSMD5;UBE2D1;DYNC1I2;NEDD1;PSMB2;CLASP1;CEP72;ZFP36L1;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PSMB7;PSMD3;PRKACA;FBXO5;PLK4;PSMA2;INO80;PSMD14;ANAPC16;DCTN1;ANAPC5;HAUS4;ANAPC11;CEP135;RPS27A;CKAP5;ACTR1A;SFI1;MAPRE1;ODF2;ZFP36L2;PPP2R1A;ZW10;NINL;TUBA4A;CEP63;YWHAG;PSMA7;CDC14A;NDE1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.1882742920562909,-0.6116784969265677,0.9963636363636363,0.9920938759536501,1.0,21/36,44.96%,WNT5A;PRKN;IRGM;PARP14;NLRC5;CASP4;AGPAT1;LAPTM5;AGPAT2;EDN1;TRIM6;HSPA1A;ZBP1;TXK;CASP1;IL7;CXCR4;CD300LF;PARP9;FADD;C1QTNF4
prerank,positive regulation of lipid storage (GO:0010884),0.2708947333282083,0.6113841544049936,0.9,1.0,1.0,3/21,13.42%,LPL;SREBF2;OSBPL11
prerank,endosome organization (GO:0007032),0.2382685468827156,0.6109933986643664,0.9192886456908345,1.0,1.0,7/41,12.41%,HOOK2;CORO1C;HOOK1;CHMP2B;USP50;AKTIP;PLEKHJ1
prerank,dopaminergic neuron differentiation (GO:0071542),0.2731076259426002,0.6106418191036858,0.905144694533762,1.0,1.0,2/19,9.10%,VEGFA;NR4A2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.23117949570909294,0.6106376720101506,0.9316455696202531,1.0,1.0,6/54,9.57%,RPL3L;RRP15;RPF1;NLE1;MDN1;RPL5
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.2638994015215749,-0.6104883093410668,0.9131455399061033,0.992011732153296,1.0,2/10,13.83%,IL33;KDR
prerank,RNA 3'-end processing (GO:0031123),0.22184282612262146,0.6103230651262633,0.958179581795818,1.0,1.0,11/69,12.22%,WDR33;PCF11;U2AF2;SRSF4;PAPOLA;TENT4A;ZC3H11A;RBM8A;U2AF1;THOC7;SRRM1
prerank,response to ionizing radiation (GO:0010212),0.223462114746291,0.6091450972515252,0.9432799013563502,1.0,1.0,18/70,19.77%,ANXA1;NET1;RAD51AP1;TP53;RAD9A;BRSK1;PAXIP1;RHNO1;CLOCK;MTA1;INTS7;BABAM1;MSH2;INO80;USP28;MEN1;SWI5;RAD9B
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.23205112218890778,-0.6089875363235921,0.9205955334987593,0.9920763440840658,1.0,9/14,36.79%,ENPP3;ENPP1;ITPA;AK4;SMPDL3A;AK1;NME2;AK3;AK5
prerank,microglial cell activation (GO:0001774),-0.20888044312116316,-0.6084656227605466,0.9619565217391305,0.9916631318398126,1.0,4/21,16.89%,APP;CX3CL1;SNCA;GRN
prerank,retinol metabolic process (GO:0042572),-0.2400883681221312,-0.6071694310369486,0.9344262295081968,0.9916352021261876,1.0,2/14,8.42%,RBP4;CYP1B1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.29331763795245763,0.6066645153313716,0.8908145580589255,1.0,1.0,1/12,4.50%,BCL2
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.1738237032879402,-0.6063835696853788,0.9927007299270073,0.991338066237606,1.0,22/46,40.55%,FBXO7;TIMM44;DNAJC19;FIS1;AKT1;TOMM34;AIFM1;TIMM17B;HSPD1;TOMM70;TIMM21;TIMM23;TIMM10B;TIMM8B;GRPEL1;DNLZ;TOMM40L;TOMM40;RALA;TIMM50;GRPEL2;TIMM10
prerank,cellular response to chemokine (GO:1990869),0.22917539993418323,0.6063704559706375,0.9418282548476454,1.0,1.0,2/46,3.64%,DOCK8;CCL5
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.28203039966030236,0.6049915273048257,0.8961937716262975,1.0,1.0,5/16,17.31%,CIRBP;RBMXL1;RBM3;NUP98;PRDX6
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.2627611935346917,-0.6048916586813216,0.9280575539568345,0.9913891414808634,1.0,5/10,36.81%,KDM1A;ATRX;JARID2;BRCA1;DNMT3B
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.26318373440431597,-0.6044513408271445,0.920704845814978,0.990906760345905,1.0,4/10,35.64%,DNAJB2;DNAJA4;DNAJB1;HSPA1A
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.24618042085977795,0.6043404233620497,0.911504424778761,1.0,1.0,5/33,13.67%,DUSP3;RELA;CD300A;NECTIN2;DGKZ
prerank,glutamine family amino acid metabolic process (GO:0009064),0.24996765650892414,0.6042351707609813,0.9220055710306406,1.0,1.0,7/33,13.71%,RIMKLA;ART4;GOT1;GOT2;GLS2;GLS;SIRT4
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.2674170283787447,0.6041869200399625,0.8988580750407831,1.0,1.0,1/21,3.22%,HK2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.23884120044435916,0.6041750951454185,0.9401114206128134,1.0,1.0,4/37,9.57%,MYD88;ALOX5;PPARA;HIF1A
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.2560473631117318,0.6027786382552311,0.9141193595342066,1.0,1.0,8/29,18.18%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,CENP-A containing chromatin organization (GO:0061641),0.2560473631117318,0.6027786382552311,0.9141193595342066,1.0,1.0,8/29,18.18%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,mRNA export from nucleus (GO:0006406),0.21498289263346793,0.6027095463787004,0.9771689497716894,1.0,1.0,21/102,16.20%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;ZC3H11A;NUP153;MCM3AP;RBM8A;U2AF1;NUP107;AAAS;DDX25;THOC7;SRRM1;NUP98;NUP37;EIF4E;NUP210;FIP1L1
prerank,determination of bilateral symmetry (GO:0009855),0.2569336760889513,0.6023623817000306,0.8928,1.0,1.0,5/24,17.66%,KIF3B;DNAH11;CITED2;FOXJ1;GALNT11
prerank,regulation of intracellular pH (GO:0051453),0.243196565738363,0.6022710526248133,0.9269340974212035,1.0,1.0,4/34,8.16%,SLC4A8;SLC4A3;SLC4A7;SLC9A8
prerank,nuclear pore complex assembly (GO:0051292),0.2986537145118267,0.6019007795582719,0.8780487804878049,1.0,1.0,3/10,14.03%,NUP153;NUP107;NUP98
prerank,innate immune response in mucosa (GO:0002227),-0.25386882215494727,-0.601848497710932,0.9113636363636364,0.991591272715942,1.0,1/10,9.13%,DEFA6
prerank,transferrin transport (GO:0033572),0.24627881234441612,0.6014144523515763,0.9157303370786517,1.0,1.0,8/33,19.28%,ATP6V1H;ATP6V0A2;ARHGAP1;ATP6V1C1;ATP6V0D2;DNM2;ATP6V0C;CLTC
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.23883481091259975,0.6013316945754035,0.9177304964539007,1.0,1.0,5/34,11.24%,PDGFB;NUP62;PDGFRB;RB1;LRP5
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.20886468268600492,-0.6009231432870765,0.9429347826086957,0.991360644202708,1.0,5/21,18.12%,IK;KLHL22;BUB3;MAD1L1;ATM
prerank,spliceosomal snRNP assembly (GO:0000387),-0.1798160024307498,-0.6002282661455003,0.9723320158102767,0.9909983795483668,1.0,14/38,30.46%,GEMIN8;SART3;SNRPD1;GEMIN7;SMN1;PRPF19;LSM2;AAR2;PRPF31;PRPF8;SRSF12;PRPF3;SART1;DDX20
prerank,defense response to bacterium (GO:0042742),0.2095709284633051,0.5991915970006094,0.9738636363636364,1.0,1.0,18/105,17.91%,MYD88;DMBT1;RARRES2;LYST;MBL2;ADAM17;LPO;PRKCD;GBP2;DROSHA;CFP;ADGRB1;RNASE3;MR1;MPEG1;S100A8;S100A9;ISG15
prerank,autophagosome organization (GO:1905037),0.22920328784576266,0.5987590976405593,0.9610738255033557,1.0,1.0,8/50,13.34%,ATP2A2;ATG16L2;ATG7;GABARAP;NSFL1C;STX12;WDR45;PIK3C3
prerank,regulation of protein transport (GO:0051223),0.25000971375330894,0.598581087677029,0.9122023809523809,1.0,1.0,3/27,12.06%,LCP1;PTPN1;DNAJC1
prerank,receptor metabolic process (GO:0043112),0.22598276896653097,0.5982992368038124,0.950507614213198,1.0,1.0,5/53,7.15%,CD36;ITGB1;CAV1;NEDD4;RAMP1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2560813009944784,0.5982209292685345,0.925764192139738,1.0,1.0,3/27,7.81%,PARN;PCF11;DICER1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.22531235965660257,0.5976226107291852,0.9391979301423027,1.0,1.0,15/51,19.61%,CHMP4C;SEC13;IST1;SIRT2;NUP107;CHMP2B;CHMP2A;NUP98;NUP37;VPS4A;LMNA;SUMO1;UBE2I;NUP160;NUP133
prerank,mitotic nuclear membrane organization (GO:0101024),0.22531235965660257,0.5976226107291852,0.9391979301423027,1.0,1.0,15/51,19.61%,CHMP4C;SEC13;IST1;SIRT2;NUP107;CHMP2B;CHMP2A;NUP98;NUP37;VPS4A;LMNA;SUMO1;UBE2I;NUP160;NUP133
prerank,negative regulation of B cell activation (GO:0050869),0.26185822706059536,0.5975351171225336,0.9040650406504065,1.0,1.0,4/21,13.52%,CD300A;SAMSN1;TNFRSF21;FOXJ1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.24394196695672982,0.5969425573670721,0.9161931818181818,1.0,1.0,5/31,16.16%,IL2;PAXIP1;RIF1;KMT5B;MAD2L2
prerank,positive regulation of chromatin organization (GO:1905269),-0.24819370846943303,-0.5967844899081077,0.9443155452436195,0.992001102780899,1.0,6/12,33.67%,TERF2IP;MIER1;TAL1;TINF2;ATRX;ACD
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.21528715540467905,0.5965654492291442,0.9574468085106383,1.0,1.0,18/87,17.48%,CDK6;FHL1;JADE1;PSMC6;PSME4;PSMB1;PSMD5;RB1;PSMB2;ZFP36L1;PSMB7;PSMD3;FBXO5;PTEN;PSMA2;CDK2AP2;PSMD14;BRD7
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.23052440383825207,-0.5961473263005678,0.9465648854961832,0.9916061697119459,1.0,2/15,8.95%,LDLR;SIK1
prerank,negative regulation of cell death (GO:0060548),0.2157210959275937,0.5961468866245443,0.9681227863046045,1.0,1.0,9/88,8.81%,CCN1;FERMT2;NUP62;INPP5A;CD200R1;CD200;PPARGC1A;ADNP2;IMPACT
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.239654984606076,0.5957747005174051,0.9302649930264993,1.0,1.0,10/38,18.00%,PHLDA3;PPARA;EPHA2;THEM4;GPER1;MUL1;PLEKHA1;PTEN;PPP2R5C;DDIT3
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.22559970568871918,0.5949563741317182,0.9432258064516129,1.0,1.0,10/53,16.90%,OAZ2;PSMC6;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,chromatin remodeling (GO:0006338),0.2117593682148353,0.5949086175759991,0.9672316384180791,1.0,1.0,16/100,13.22%,SMARCD3;CHRAC1;ARID1A;ACTB;SUV39H2;SMARCB1;INO80C;ERCC6;SOX9;RB1;BAZ2A;ZBTB7A;HNRNPC;RUVBL1;SMARCA5;CHD4
prerank,T cell differentiation (GO:0030217),0.23415300042042111,0.594884260288132,0.9196185286103542,1.0,1.0,6/40,13.20%,ANXA1;IL2;ADAM17;LMBR1L;RHOH;ZFP36L1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.24859008729990034,-0.594748299979474,0.9312796208530806,0.9915948183801214,1.0,2/10,11.67%,LGALS9;LYN
prerank,DNA catabolic process (GO:0006308),0.29400493019653917,0.5946080743776129,0.9065743944636678,1.0,1.0,2/11,13.68%,REXO4;DNASE1L1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.19649714309722927,-0.5938172633119813,0.9843260188087775,0.9913048257351149,1.0,6/28,20.24%,ARHGAP28;RASA1;PFN2;PFN1;DBN1;GBA2
prerank,chromatin assembly (GO:0031497),0.2358016773865123,0.5932994816151236,0.9153439153439153,1.0,1.0,10/38,19.30%,H1-0;CHAF1B;TP53;SOX9;SMARCA5;CDAN1;RSF1;NAP1L4;NAP1L2;BRD2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.2855785706485493,0.5923595657513837,0.8935779816513761,1.0,1.0,2/12,8.98%,AR;GSTP1
prerank,regulation of cell division (GO:0051302),0.21637295436199097,0.5919055989446282,0.951278928136419,1.0,1.0,10/72,13.34%,FGF1;EFHC1;PIN1;CALM1;INSC;SIRT2;RAB11FIP3;RAB11FIP4;HTR2B;PIK3C3
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.2482615993699724,0.5915985408721417,0.9224137931034483,1.0,1.0,1/30,1.15%,KLHL40
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.22888386624944052,-0.5914726838530396,0.9341176470588235,0.9916959229844001,1.0,6/13,31.93%,HSPA5;NCK1;DNAJB9;RACK1;PPP1R15B;ATF6B
prerank,positive regulation of histone acetylation (GO:0035066),0.25815494674202927,0.5905958610290345,0.9090909090909091,1.0,1.0,4/23,9.41%,SMARCB1;PPARGC1A;KAT7;PAXIP1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.2602388799500134,0.590462238252604,0.8964968152866242,1.0,1.0,4/21,10.58%,MED1;MED12;PAXIP1;MED14
prerank,response to UV (GO:0009411),0.20591095679096783,0.5895379190059405,0.9692671394799054,1.0,1.0,23/95,18.98%,MAP4K3;TAF1;TP53;PARP1;CIRBP;NEDD4;ERCC6;RELA;CCND1;BRSK1;USP1;RHNO1;POLD1;PRKCD;ZRANB3;MSH2;INO80;SPRTN;EIF2AK4;UBE2A;USP28;MEN1;N4BP1
prerank,rRNA modification (GO:0000154),0.2575435195167451,0.5894846686211711,0.8915470494417863,1.0,1.0,3/21,11.54%,NAT10;TFB2M;ZCCHC4
prerank,nuclear body organization (GO:0030575),0.2816470887546383,0.5890044295996438,0.901213171577123,1.0,1.0,7/12,23.05%,USP50;SRPK2;HIPK2;HABP4;SERBP1;ETS1;ZPR1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2320486050780045,0.5889017891238493,0.9387186629526463,1.0,1.0,9/40,15.12%,MAPT;WRNIP1;USP1;PARG;PRKCD;NSMCE4A;MCL1;FEM1B;FBXO5
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.22277365077125214,0.5881447890113531,0.9593908629441624,1.0,1.0,10/56,13.93%,ROCK1;EFHC1;SPIRE1;ANLN;IST1;SNX18;ROCK2;SNX9;SON;DCTN3
prerank,positive regulation of transport (GO:0051050),0.21098772712767366,0.5877100402193202,0.9789473684210527,1.0,1.0,5/85,5.85%,MERTK;KCTD7;ANXA1;ACTB;CBLL1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.2635922041584794,0.5874822316216056,0.9274447949526814,1.0,1.0,6/20,16.69%,BBS12;LONP1;CLU;HOPX;PTGES3L;NDUFAF1
prerank,regulation of isotype switching (GO:0045191),0.2782568595251738,0.5865180895090726,0.9083333333333333,1.0,1.0,4/14,16.16%,PAXIP1;RIF1;KMT5B;MAD2L2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.24957801836550153,-0.5854386565040518,0.922077922077922,0.9938607317387331,1.0,3/11,19.66%,NF2;HGS;BCL3
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.2163123977743781,-0.5852933771565935,0.9383886255924171,0.9932144373433607,1.0,1/17,1.61%,CADM1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.2570477392843392,0.5852818486999318,0.9131147540983606,1.0,1.0,4/19,15.30%,RAPSN;CHRNA7;CHRFAM7A;CHRNA4
prerank,apoptotic nuclear changes (GO:0030262),0.24837974041198363,0.5849907069728215,0.9201807228915663,1.0,1.0,4/24,10.84%,H1-0;DICER1;DEDD2;GPER1
prerank,intracellular protein transmembrane transport (GO:0065002),0.22788558504854575,0.5839786343930942,0.9477303988995873,1.0,1.0,3/42,5.39%,ZFAND2B;RTN2;PEX2
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.24694318622167633,-0.5839054460431554,0.9321266968325792,0.9931393548745174,1.0,4/10,24.69%,MTMR4;DNAJC19;MFSD2A;MTMR2
prerank,chromatin remodeling at centromere (GO:0031055),0.24352923900681,0.5835774011090222,0.9193776520509194,1.0,1.0,8/31,18.18%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,cellular response to oxygen levels (GO:0071453),-0.24774608397666692,-0.5833045372156701,0.9434389140271493,0.9926684821212267,1.0,5/10,27.12%,ATP6AP1;ATP6V1G1;PICK1;ATP6V0D1;TMEM199
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.2410651098993649,-0.5830431986210642,0.9425287356321839,0.9920869749789144,1.0,5/12,32.49%,UPP2;DHODH;UMPS;CDA;CAD
prerank,positive regulation of protein deacetylation (GO:0090312),-0.2262665307453114,-0.5821336623936725,0.9602803738317757,0.9917826976760464,1.0,8/14,38.79%,AKAP8;AKAP8L;ZBTB7B;SAP30BP;APLNR;BRMS1;ING2;FNTA
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.2534000035828132,-0.5815196763905551,0.9463087248322147,0.9913215315429628,1.0,1/10,2.80%,PRKCH
prerank,positive regulation of isotype switching (GO:0045830),0.2677934227790245,0.5810240670122374,0.9131886477462438,1.0,1.0,4/15,16.16%,PAXIP1;RIF1;KMT5B;MAD2L2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.2002654925814064,-0.5806086475440737,0.9805013927576601,0.9909721116817785,1.0,3/20,12.08%,ARRB1;TADA2A;SOX4
prerank,response to light stimulus (GO:0009416),0.2212441443778388,0.5805673906186191,0.9584415584415584,1.0,1.0,12/55,18.63%,MAP4K3;CIRBP;CPT1B;ERCC6;BRSK1;USP1;POLD1;ZRANB3;CLOCK;SPRTN;UBE2A;MEN1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.27232324144243414,0.5801963046231745,0.909688013136289,1.0,1.0,4/15,15.51%,EHD2;CD53;ADGRB1;FLOT1
prerank,intracellular pH reduction (GO:0051452),0.23826537280741858,0.5797271972512313,0.9376811594202898,1.0,1.0,13/33,25.66%,ATP6V1H;ATP6V0A2;ATP6V1C1;ATP6V0D2;RAB38;ATP6V0C;DMXL1;ATP6V1F;ATP6V0E1;ATP6V1B2;ATP6V1G2;ATP6V0A1;RAB7A
prerank,protein alkylation (GO:0008213),0.2555358962591134,0.579573163003466,0.9292452830188679,1.0,1.0,9/22,19.73%,METTL22;GSPT1;VCPKMT;EEF1AKMT2;ETF1;FAM98B;PCMT1;SNRPD3;PRMT1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.21984335913279307,-0.578058959577594,0.9514563106796117,0.9913455289873913,1.0,1/16,1.61%,CADM1
prerank,innate immune response (GO:0045087),0.19190925582184934,0.5780557144908327,0.9906639004149378,1.0,1.0,14/217,10.10%,NCF2;MYD88;FRK;ATAD3A;MFHAS1;DMBT1;RARRES2;MBL2;TIFA;RELA;TRIM68;SLA;MASP2;ZDHHC1
prerank,synaptonemal complex organization (GO:0070193),0.27324668801406427,0.576013120266505,0.9269949066213922,1.0,1.0,15/15,72.70%,SYCP2;RAD21;SYCE3;SYCE1;SYCP1;HORMAD1;RAD21L1;STAG3;TEX12;SYCE2;TRIP13;REC8;BAG6;TEX11;P3H4
prerank,synaptonemal complex assembly (GO:0007130),0.27324668801406427,0.576013120266505,0.9269949066213922,1.0,1.0,15/15,72.70%,SYCP2;RAD21;SYCE3;SYCE1;SYCP1;HORMAD1;RAD21L1;STAG3;TEX12;SYCE2;TRIP13;REC8;BAG6;TEX11;P3H4
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.28896827993068963,0.5760061746105383,0.9110320284697508,1.0,1.0,3/10,18.78%,ATP5MC1;ATP5MG;ATP5F1D
prerank,modulation by host of symbiont process (GO:0051851),-0.1887939175197825,-0.5750839584916815,0.9806451612903225,0.9919240262418875,1.0,6/31,15.29%,LEF1;NAPEPLD;SNW1;TARDBP;EP300;CHD1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.2117972702906492,-0.5750283832064857,0.9601990049751243,0.9912287809091278,1.0,14/16,59.16%,CD274;TYROBP;TRIB2;JAK3;FCGR2B;DLL1;AGER;LILRB1;VSIR;PDCD1LG2;IL23A;FOXP3;IL23R;IL12B
prerank,positive regulation of nervous system process (GO:0031646),0.2558031134675536,0.5748615020540042,0.9319286871961102,1.0,1.0,3/18,11.92%,TPPP;DICER1;ATPSCKMT
prerank,serine family amino acid catabolic process (GO:0009071),0.28272665010431214,0.5748606425989282,0.9077490774907749,1.0,1.0,1/10,6.00%,DLD
prerank,regulation of mitochondrial depolarization (GO:0051900),0.2861419465295069,0.5746314553558026,0.9159049360146252,1.0,1.0,3/10,14.40%,BCL2;FZD9;LRRK2
prerank,glutamate metabolic process (GO:0006536),0.25891756751535067,0.5744528989531063,0.9275590551181102,1.0,1.0,4/19,11.00%,GOT1;GOT2;GLS2;GLS
prerank,macromolecule catabolic process (GO:0009057),0.24087221093451502,0.5740459320584043,0.9394387001477105,1.0,1.0,2/26,7.03%,CLN5;NEDD4
prerank,regulation of phosphatase activity (GO:0010921),0.24525225055648947,0.5738168963991989,0.9293078055964654,1.0,1.0,1/24,2.47%,PPP1R26
prerank,rRNA metabolic process (GO:0016072),0.19472502856358012,0.5732940712125398,0.990405117270789,1.0,1.0,36/160,20.30%,NOL6;UTP14A;NOB1;MAPT;WDR46;RPL8;RPF1;WDR36;MDN1;HELQ;PWP2;RPL5;DEDD2;DIS3L;NOP58;TEX10;RPL15;IMP4;LAS1L;PELP1;RPL22;RPL31;DDX49;RPS6;BOP1;RCL1;PDCD11;RPS17;MPHOSPH6;EXOSC10;NIFK;RPS14;EXOSC8;DDX10;WDR43;DHX37
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.23346672632469612,-0.573051689864641,0.9463087248322147,0.9912476364181839,1.0,6/12,35.54%,ESR1;TGFB1;ZC3H12A;ZC3H10;NCOR1;BCDIN3D
prerank,microtubule depolymerization (GO:0007019),0.26447046507213046,0.572127309916656,0.912396694214876,1.0,1.0,5/17,20.56%,KIF2A;KIF18A;STMN2;CKAP5;STMN3
prerank,protein modification by small protein removal (GO:0070646),0.18934681177270557,0.5720003391700821,0.9948132780082988,1.0,1.0,61/252,19.33%,CCNA2;ADRM1;MCRS1;USP2;ACTB;ASXL1;MBD5;PSMC6;TP53;AR;TRAF3;INO80C;OTUD6B;TNIP1;OTUD7A;USP1;HIF1A;PSME4;PSMB1;PSMD5;UBE2D1;STAM2;NFRKB;OTUD4;COPS8;USP13;RUVBL1;USP50;PSMB2;WDR20;SENP6;USP35;USP20;JOSD1;USP30;PSMB7;PSMD3;USP42;COPS4;STAM;USP4;PTEN;BABAM1;ABRAXAS2;RHOT1;PSMA2;INO80;PSMD14;USP36;MBD6;TADA3;USP28;COPS6;INO80D;ACTL6A;DESI2;DESI1;UCHL5;RPS27A;SENP2;SMAD1
prerank,regulation of cell cycle process (GO:0010564),0.19818521274667253,0.5718888201155441,0.9873125720876585,1.0,1.0,20/104,16.69%,TIPIN;PIN1;YTHDF2;CALM1;CUL9;CHEK1;SOX9;DAPK3;RAB11FIP3;RAB11FIP4;GPER1;CEP85;KIF20B;RMI2;PIK3C3;KNSTRN;FBXO5;CAV2;PLK4;MAP9
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.24693117149121765,0.5717104865900875,0.9291101055806938,1.0,1.0,6/25,14.55%,KANK1;YAP1;PRKCD;TCHP;CAPZB;ARHGAP24
prerank,regulation of aerobic respiration (GO:1903715),0.26486595780975153,0.5703097310571994,0.899488926746167,1.0,1.0,1/15,4.78%,COX7A2L
prerank,centromere complex assembly (GO:0034508),0.23356928976834607,0.5698616999848132,0.9354395604395604,1.0,1.0,9/36,18.18%,CENPP;CENPO;CENPE;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,regulation of immunoglobulin production (GO:0002637),0.2412383098839797,0.569706469095487,0.931782945736434,1.0,1.0,1/23,3.19%,IL2
prerank,regulation of synapse maturation (GO:0090128),-0.24407939398261502,-0.5692525789233894,0.952808988764045,0.9920369354729867,1.0,4/10,27.91%,NRXN1;ARHGEF15;YWHAZ;RELN
prerank,ncRNA catabolic process (GO:0034661),0.2364053087731714,0.5690457394278381,0.9490538573508006,1.0,1.0,4/28,10.66%,PARN;DIS3L2;DEDD2;DIS3L
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.24409992678144568,0.5685118023416392,0.9476117103235747,1.0,1.0,2/23,7.02%,SAG;CALM1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.27298850341251685,0.5679989214684485,0.90625,1.0,1.0,4/12,22.00%,RB1;RAD21;WAPL;CTCF
prerank,cilium-dependent cell motility (GO:0060285),0.24581347286134037,0.5679314324299642,0.9307086614173228,1.0,1.0,2/22,6.37%,DNAH17;EFHC1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.20284576019453127,0.5674891431471853,0.9786729857819905,1.0,1.0,17/88,17.82%,FBXL22;CUL2;PSMC6;FBXW7;FBXL18;PSME4;FBXO6;PSMB1;PSMD5;FBXW11;PSMB2;PSMB7;PSMD3;PSMA2;CCNF;PSMD14;CUL5
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.22897983825530147,0.5674098314382484,0.9471488178025035,1.0,1.0,4/36,11.91%,KLHL40;F8A1;PSME3IP1;EIF3H
prerank,regulation of mitotic cell cycle (GO:0007346),0.1926057340653541,0.5648498326240617,0.9935483870967742,1.0,1.0,35/171,17.95%,BTG2;EIF4EBP1;USP2;ANAPC10;PSMC6;DUSP3;PIN1;CUL9;HECA;BTG1;DAPK3;UBE2E1;PKN2;PSME4;HNRNPU;PSMB1;PSMD5;BRINP1;UBE2D1;RB1;TRIM35;PSMB2;KIF20B;PSMB7;PSMD3;EIF4E;PRKCA;FBXO5;CAV2;PSMA2;TTC28;PSMD14;ANAPC16;ANAPC5;BRINP2
prerank,DNA duplex unwinding (GO:0032508),0.2151415572496222,0.5647205112735513,0.966078697421981,1.0,1.0,5/50,11.06%,ANXA1;GTF2H4;PARP1;MCMDC2;DDX1
prerank,ceramide catabolic process (GO:0046514),0.2637429879043759,0.5644035086343085,0.9331046312178388,1.0,1.0,3/14,12.90%,NEU3;GLA;GM2A
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.25714687173942974,0.564157861847053,0.9235772357723577,1.0,1.0,3/16,14.99%,NAA25;NAA20;NAA35
prerank,response to nitric oxide (GO:0071731),0.26937420043407206,0.5639895812972612,0.921146953405018,1.0,1.0,1/13,3.85%,GUCY1B1
prerank,glial cell development (GO:0021782),0.23484998884607253,0.5633205227569928,0.94679186228482,1.0,1.0,6/25,17.14%,CDK6;TPPP;NRROS;SOX10;MT3;S100A9
prerank,lipoxygenase pathway (GO:0019372),0.27135338097320894,0.5626293558986186,0.9242685025817556,1.0,1.0,1/14,4.29%,ALOX5
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.2349390941992336,0.5623437190191972,0.9384164222873901,1.0,1.0,3/26,13.15%,LARGE1;TNIP1;ST3GAL2
prerank,negative regulation of protein kinase activity (GO:0006469),0.19812380739447324,0.5595143072887193,0.9836829836829837,1.0,1.0,15/88,14.51%,SLC8A1;PPM1E;CAV1;DAB2IP;DUSP3;PTPN1;CORO1C;GSTP1;PAK2;RB1;LRP5;CEP85;CEP43;GNAQ;DVL1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.2595578909433298,0.5591401209536967,0.946875,1.0,1.0,5/18,17.25%,DAB2IP;AMER1;VGLL4;VPS35;FAF1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.27399616217510736,0.5570712906042713,0.9023090586145648,1.0,1.0,2/10,14.40%,STK26;LRRK2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.245583986874169,0.5570366343267528,0.9462025316455697,1.0,1.0,7/21,19.21%,TTC23;STK36;TUBD1;RAB34;KIF7;DLG5;UCHL5
prerank,response to organophosphorus (GO:0046683),-0.21026856396374555,-0.557002089559746,0.9672544080604534,0.9957967071849254,1.0,5/16,32.28%,DGKQ;TRIM16;TYMS;RFC3;VGF
prerank,negative regulation of viral process (GO:0048525),0.20870011139010322,0.5558535580273457,0.9720101781170484,1.0,1.0,13/57,19.46%,CCL5;HEXIM1;MBL2;TNIP1;EIF2AK2;TRIM35;OASL;TRIM28;SRPK2;STAT1;ISG15;N4BP1;ILF3
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.22739110038439747,0.5557508316724948,0.9402560455192034,1.0,1.0,3/31,10.20%,ALOX5;MOCS1;SCP2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.2323278857690596,-0.555154053561549,0.9681093394077449,0.9957374131869526,1.0,4/11,20.56%,HSPA5;CEBPB;CREB3L1;ATF4
prerank,response to axon injury (GO:0048678),-0.20462485821129645,-0.5547755078889152,0.9626666666666667,0.9951438653390013,1.0,11/18,42.80%,APOD;MAPK8IP3;DPYSL3;FLRT3;MORN4;MTR;TYROBP;P2RY12;SOD1;TREM2;DHFR
prerank,motile cilium assembly (GO:0044458),-0.22809132816166083,-0.5539565936082874,0.9495614035087719,0.9946912408311771,1.0,2/12,18.73%,CCDC39;E2F4
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.2059727538805552,-0.5535855419591885,0.9828009828009828,0.9940967571195342,1.0,7/17,32.02%,WASF2;ARFIP2;PICK1;ABI2;CTNNA2;ARFIP1;GMFB
prerank,microtubule bundle formation (GO:0001578),0.21824982121869232,0.55357630299987,0.9631147540983607,1.0,1.0,8/42,15.58%,RSPH1;TPPP;TOGARAM1;AAAS;CLASP1;FOXJ1;MTCL1;CCDC66
prerank,histone H2A monoubiquitination (GO:0035518),0.25854963275220205,0.5531297848222073,0.9198036006546645,1.0,1.0,5/17,19.55%,PCGF6;PCGF5;PCGF3;KDM2B;PCGF2
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.27749248366624846,0.5524089760353909,0.9343065693430657,1.0,1.0,3/10,19.53%,NAF1;RUVBL1;ZNHIT6
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.2761747990592617,0.5508334868515915,0.918625678119349,1.0,1.0,2/10,10.21%,GNE;ST6GAL1
prerank,DNA metabolic process (GO:0006259),0.18281823904946545,0.5507758393276034,0.9979550102249489,1.0,1.0,41/270,15.30%,HINFP;GMNN;BTG2;MUTYH;GTF2H4;DDX23;RAD51AP1;UPF1;SMARCB1;TERT;PARP1;PRIM2;MBD4;TDP1;CHEK1;REXO4;RAD9A;HUS1B;SLX4;LONP1;UHRF2;PSME4;RIF1;FBXO6;TOP2B;PARG;POLD1;TERF2;POLG;KPNA2;ORC2;NSMCE4A;RMI2;TRIM28;CSNK1E;DNASE1L1;ZRANB3;EXD2;KMT5B;SRPK2;CHRNA4
prerank,regulation of B cell differentiation (GO:0045577),-0.20494639892872435,-0.5496833794372536,0.9846153846153847,0.9946881740573892,1.0,10/17,48.06%,NCKAP1L;PPP2R3C;MMP14;SYK;INHA;BTK;XBP1;SFRP1;IL4I1;IKZF3
prerank,DNA replication (GO:0006260),0.19059003636127017,0.5490937538271602,0.989841986455982,1.0,1.0,15/105,13.93%,BRIP1;SET;UPF1;TIPIN;WRNIP1;CHEK1;RAD9A;KAT7;RHNO1;POLD1;PTMS;POLG;ORC2;RMI2;NT5M
prerank,mitochondrial transport (GO:0006839),0.20703576529322262,0.5487311012575607,0.9721854304635762,1.0,1.0,14/53,22.50%,PMAIP1;BCL2;MFN2;TOMM5;BCAP31;MFF;TOMM7;SLC25A16;TIMM9;TIMM22;OXA1L;GDAP1;TOMM22;STARD3
prerank,positive regulation of cell communication (GO:0010647),-0.1761558359983019,-0.5480613143763671,0.9796610169491525,0.9945019845520184,1.0,7/28,26.31%,SYT1;WLS;RIMS2;CD80;NMU;SOX11;EDN3
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.2274410123456057,-0.5474093823408042,0.9572446555819477,0.9939740958871348,1.0,3/11,20.12%,RBBP4;ASF1A;HIRA
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.2580974106018775,0.5471674438438868,0.9344827586206896,1.0,1.0,5/15,19.08%,RPL5;BAG2;FBXO5;MAD2L2;ABL1
prerank,peptidyl-lysine acetylation (GO:0018394),0.2677839133453032,0.5465283257493664,0.9238754325259516,1.0,1.0,3/10,22.85%,KAT7;ESCO1;KAT2B
prerank,prostanoid metabolic process (GO:0006692),0.25302425186220107,0.5445999760821705,0.9424460431654677,1.0,1.0,2/13,10.96%,GSTP1;PTGR1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.23567218234649082,0.5442423314390811,0.9552,1.0,1.0,5/20,14.38%,RELA;ADAM17;MBTPS1;HM13;SPPL2B
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.22606030180865821,0.5439992706135635,0.9505247376311844,1.0,1.0,5/26,17.37%,MAPT;TOGARAM1;CLASP1;STMN2;DCTN1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.2472456823752756,0.5434360852681078,0.9378151260504202,1.0,1.0,2/17,7.86%,CCL5;TGFB2
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.2310133176161973,-0.5428641872124406,0.9686800894854586,0.9947055823786651,1.0,3/11,16.93%,CAT;GPX1;PRDX4
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.26190644206246305,0.5423490838452545,0.9472759226713533,1.0,1.0,2/12,9.70%,HUS1B;STK33
prerank,protein targeting to peroxisome (GO:0006625),0.22324086196083115,0.5422234145792351,0.9560906515580736,1.0,1.0,11/29,21.72%,PEX2;ATAD1;PEX19;LONP2;ZFAND6;RAB8B;PEX10;PEX26;PEX1;PEX3;GDAP1
prerank,GTP metabolic process (GO:0046039),0.2538202238444312,0.5420975419935221,0.9416809605488851,1.0,1.0,3/15,14.40%,ENTPD7;OPA1;LRRK2
prerank,male meiosis I (GO:0007141),0.24696050896974067,0.5415672546213528,0.9308072487644151,1.0,1.0,1/16,5.67%,FOXJ3
prerank,mRNA modification (GO:0016556),0.231167592219336,0.5398399535624804,0.957613814756672,1.0,1.0,6/22,19.04%,TRMT10C;CBLL1;NSUN2;TRUB1;TRUB2;TRMT6
prerank,pseudouridine synthesis (GO:0001522),-0.21529593404201858,-0.5388196672956675,0.9741176470588235,0.9951663879259748,1.0,6/13,37.59%,PUS7;PUS3;GAR1;NOP10;PUS1;NHP2
prerank,positive regulation of cellular protein localization (GO:1903829),0.20118898964593798,0.5382150709322333,0.9854368932038835,1.0,1.0,7/69,11.09%,FERMT2;SLC5A3;NUP62;MAPT;YAP1;KAT7;GPD1L
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.19874995318815725,0.5365787953958708,0.9876390605686032,1.0,1.0,11/62,15.29%,BCL2;ARHGEF2;BCL2L2;OPA1;SNAI2;NDUFS3;RTKN2;CLU;MCL1;LRRK2;URI1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.24381625349256342,0.5362794448363662,0.9472049689440993,1.0,1.0,2/19,8.66%,MTHFD2L;ALDH1L2
prerank,"phototransduction, visible light (GO:0007603)",0.2491382839777175,0.5353561742489142,0.9341216216216216,1.0,1.0,2/14,13.94%,SAG;GNAQ
prerank,mitotic cytokinesis (GO:0000281),0.20735169719012125,0.5342540826060107,0.977027027027027,1.0,1.0,7/47,13.64%,ROCK1;EFHC1;ANLN;SNX18;ROCK2;SNX9;SON
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.24835661010229396,0.5342192721150623,0.9434571890145396,1.0,1.0,4/15,15.59%,CNOT7;CPEB3;ZFP36L1;NANOS1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.24835661010229396,0.5342192721150623,0.9434571890145396,1.0,1.0,4/15,15.59%,CNOT7;CPEB3;ZFP36L1;NANOS1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.206392769924726,0.5341128559109884,0.9646596858638743,1.0,1.0,5/44,11.78%,HSD17B10;CYP7B1;HSD17B4;SCP2;OSBPL2
prerank,steroid catabolic process (GO:0006706),-0.22923770462534754,-0.533884410661193,0.9562363238512035,0.9957718088788047,1.0,3/10,34.39%,SPP1;HSD17B11;HSD11B1
prerank,protein deneddylation (GO:0000338),-0.2297365313213559,-0.53368261354143,0.9726651480637813,0.9951179197748892,1.0,4/10,30.05%,COPS2;COPS7B;TOR1A;GPS1
prerank,regulation of TOR signaling (GO:0032006),0.1943237118008057,0.5336636478517719,0.9839108910891089,1.0,1.0,12/67,15.37%,FAM83D;LARS1;GNA12;SEC13;RRAGB;EPM2A;NPRL2;SH3BP4;RICTOR;GAS6;PRKAA2;ITFG2
prerank,regulation of phosphate metabolic process (GO:0019220),-0.1956703927667115,-0.5315136642073366,0.9835294117647059,0.9949516213515682,1.0,7/16,40.26%,IGBP1;SMG6;SRPX2;CD24;PSEN1;TIGAR;IKBKB
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.21334843623185618,-0.5312997194413913,0.9698375870069605,0.9942866132293684,1.0,5/13,32.47%,IL18;LAMP1;ZBTB1;AP1G1;TYROBP
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.23638636947452246,0.5306742837917727,0.959731543624161,1.0,1.0,8/19,22.49%,FOXJ1;MTCL1;PARD3B;CLIC4;MARK2;PARD3;PATJ;ERBIN
prerank,central nervous system neuron differentiation (GO:0021953),0.21707196692227002,0.5306602616522549,0.9675141242937854,1.0,1.0,8/33,19.41%,MAPT;NR4A2;FAIM2;SIN3A;RYK;NPY;MDGA1;AGTPBP1
prerank,ribosome biogenesis (GO:0042254),0.179402622080413,0.530075763143973,0.9989484752891693,1.0,1.0,42/187,20.44%,NOL6;MRPL36;UTP14A;NOB1;WDR46;RPL8;RPF1;ABCE1;WDR36;MDN1;NAF1;HELQ;PWP2;RPL5;NOP58;LSG1;TEX10;RPL15;IMP4;LAS1L;PELP1;RPL22;RPL31;GTF3A;XPO1;DDX49;RPS6;BOP1;RCL1;PDCD11;RPS17;DHX29;MPHOSPH6;MRPL22;EXOSC10;RPS14;MALSU1;EXOSC8;DDX10;WDR43;DHX37;EIF2A
prerank,negative regulation of interleukin-12 production (GO:0032695),0.24836015966170308,0.5293630229387923,0.9358108108108109,1.0,1.0,1/14,7.27%,PIBF1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.22468667751411286,0.5281809303468848,0.9494799405646359,1.0,1.0,3/24,12.48%,BCL2;SNAI2;CLU
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.21590741977683015,0.5270447098782999,0.9649859943977591,1.0,1.0,4/35,9.78%,CCL5;CAV1;IL10RA;CRLF3
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.2501849346152036,0.5268399544151037,0.9474576271186441,1.0,1.0,1/15,4.94%,LNPK
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.19760680559476768,0.5259383835818308,0.9844961240310077,1.0,1.0,14/53,20.15%,PSMC6;DAB2IP;FBXW7;F8A1;GNA12;PSME3IP1;BAG2;UFL1;PRKACA;XPO1;PSMD14;DESI1;UCHL5;FOXF2
prerank,regulation of centriole replication (GO:0046599),0.23968122164460542,0.5248808653684209,0.9517133956386293,1.0,1.0,4/17,18.49%,NUP62;PLK4;RBM14;CEP295
prerank,neuron projection organization (GO:0106027),0.24012198942356755,0.5240944967578487,0.9486301369863014,1.0,1.0,5/15,17.50%,CHRNA7;ATP1A3;PLS1;DCTN1;MAP1A
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.22823615591529733,0.5239160910872624,0.9732441471571907,1.0,1.0,2/19,7.14%,ELL;AR
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.2505494131518438,0.5233717848664599,0.9305555555555556,1.0,1.0,3/13,15.91%,GSTP1;NAMPT;JAK2
prerank,protein localization to phagophore assembly site (GO:0034497),0.25675705978978625,0.5232049869917423,0.9344262295081968,1.0,1.0,3/11,15.65%,MFN2;WDR45;ATG13
prerank,recombinational repair (GO:0000725),0.18998835836702588,0.5231773244642428,0.991715976331361,1.0,1.0,15/77,17.43%,RAD51AP2;RAD51AP1;PARP1;SFPQ;HUS1B;SLX4;HELQ;SFR1;RHNO1;MORF4L1;EXD2;RAD52;INO80;PSMD14;REV3L
prerank,nuclear envelope organization (GO:0006998),-0.18411764372598682,-0.523176051493301,0.9873737373737373,0.9955916535566739,1.0,8/20,31.67%,TOR1AIP1;EMD;LEMD2;TMEM43;TOR1A;REEP3;NUP155;NEMP1
prerank,regulation of rRNA processing (GO:2000232),-0.2010287447006055,-0.5217823517462034,0.9768041237113402,0.9952099203679062,1.0,7/16,35.67%,SIRT7;DIMT1;BUD23;HEATR1;RIOK2;NUDT16;TRMT112
prerank,homocysteine metabolic process (GO:0050667),0.25434372418228984,0.518226915337856,0.9451114922813036,1.0,1.0,1/11,5.94%,BLMH
prerank,response to nutrient levels (GO:0031667),0.2350552226540472,0.5176402424130775,0.9548494983277592,1.0,1.0,3/17,18.87%,KCNB1;PRKAA2;ULK1
prerank,aromatic amino acid family metabolic process (GO:0009072),0.2574208358165701,0.5167932081498493,0.9475465313028765,1.0,1.0,2/10,14.06%,THAP4;QDPR
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.23122669255259923,0.5165845745999922,0.9441786283891547,1.0,1.0,3/18,13.52%,FZD9;BOK;MUL1
prerank,folic acid metabolic process (GO:0046655),0.236865694768205,0.5153675201270275,0.9537480063795853,1.0,1.0,2/18,8.66%,MTHFD2L;ALDH1L2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.19000852383032216,0.5152258740860546,0.991442542787286,1.0,1.0,7/68,9.19%,MCCC2;MTHFD2L;SLC23A2;SLC23A1;ALDH1L2;ABCD4;AASDHPPT
prerank,cellular response to UV-A (GO:0071492),-0.2143060262921761,-0.5140411050267966,0.9750566893424036,0.9961768733955019,1.0,6/11,45.26%,MMP2;MMP1;MME;OPN3;TIMP1;MMP3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.22540480237571658,0.5123246796666698,0.9483568075117371,1.0,1.0,5/22,16.29%,PSME4;PSMB1;PSMB2;PSMB7;PSMA2
prerank,protein K63-linked deubiquitination (GO:0070536),0.21109948561660263,0.5122705810245441,0.9756446991404012,1.0,1.0,8/31,16.90%,OTUD7A;OTUD4;USP13;USP50;USP20;BABAM1;ABRAXAS2;PSMD14
prerank,central nervous system neuron development (GO:0021954),0.23200291588426142,0.5074195378006994,0.9395509499136442,1.0,1.0,4/15,18.54%,MAPT;ARHGAP35;PTEN;NPY
prerank,tRNA metabolic process (GO:0006399),0.2274778427807069,0.5063689164873783,0.9585987261146497,1.0,1.0,4/17,16.15%,DTD1;KARS1;SARS1;FARS2
prerank,antibacterial humoral response (GO:0019731),0.23358377184807233,0.5062434946665304,0.9641638225255973,1.0,1.0,1/16,5.11%,DMBT1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.19826304466537983,0.504794669737548,0.9811827956989247,1.0,1.0,12/45,21.34%,GCNT2;ATXN2;CYFIP1;DDX25;RBM3;EIF4E;NANOS1;METAP1;YTHDC1;EIF2A;LARP1;RPL10
prerank,neutrophil migration (GO:1990266),-0.13780099494194537,-0.5037689220565087,1.0,0.9975920658591202,1.0,4/58,8.21%,PECAM1;CXADR;GBF1;BSG
prerank,regulation of cytokine production (GO:0001817),0.17357301626230953,0.5034279466253807,0.9988801791713325,1.0,1.0,9/126,7.87%,ANXA1;HDAC9;CD276;ALOX5;ASB1;MAPKAPK2;TRAF3;SNAI2;ATP2B1
prerank,homologous chromosome segregation (GO:0045143),-0.17832673047354652,-0.5026586988812667,0.9887323943661972,0.997061915864646,1.0,2/20,8.54%,CENPC;SIRT7
prerank,modulation by host of viral genome replication (GO:0044827),0.23851392611340205,0.5014795716368017,0.9599303135888502,1.0,1.0,3/13,17.63%,TBC1D20;YTHDC2;EIF2AK4
prerank,double-strand break repair via homologous recombination (GO:0000724),0.17887275705522332,0.5013750283911621,0.9942922374429224,1.0,1.0,22/95,20.91%,RAD51AP2;RAD51AP1;PARP1;SFPQ;HUS1B;SLX4;HELQ;FANCB;SFR1;MCMDC2;MORF4L1;EXD2;RAD52;RAD21;INO80;PSMD14;REV3L;RAD54B;SWI5;YY1;MCM4;RAD51D
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.24430355909861304,0.4999578973905438,0.974025974025974,1.0,1.0,11/11,75.59%,TIMM29;TIMM9;TIMM22;ROMO1;TIMM13;AGK;TIMM10;NDUFA13;TIMM8B;TIMM10B;TOMM70
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.23125860764758954,0.4993120352175762,0.9646643109540636,1.0,1.0,2/14,11.86%,RELA;NECTIN2
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.2488241868793679,0.4984038145647877,0.9584837545126353,1.0,1.0,2/10,11.53%,RIF1;TERF2
prerank,histone exchange (GO:0043486),0.19849092054603146,0.49742095066285574,0.9835390946502057,1.0,1.0,9/37,18.57%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1;VPS72
prerank,regulation of lipid catabolic process (GO:0050994),0.22318719005536958,0.4959808949053905,0.9726027397260274,1.0,1.0,2/19,10.90%,RARRES2;LONP2
prerank,positive regulation of immune response (GO:0050778),0.18389812326074859,0.4947547735704494,0.9900373599003736,1.0,1.0,4/64,7.86%,IL2;CCL5;IL12RB1;TGFB2
prerank,negative regulation of phosphatase activity (GO:0010923),0.20842175638890392,0.49439781347808165,0.969521044992743,1.0,1.0,2/25,7.86%,PPP1R26;TGFB2
prerank,renal absorption (GO:0070293),0.24772638473298758,0.49428902956501497,0.9522968197879859,1.0,1.0,3/10,18.12%,HAS2;SGK1;SLC15A2
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.21455723491466228,0.49371518998819014,0.9669811320754716,1.0,1.0,3/21,12.78%,MFHAS1;ENSA;ARPP19
prerank,regulation of transferase activity (GO:0051338),0.2241674823246663,0.4935426625991878,0.9693053311793215,1.0,1.0,5/17,21.43%,FEM1A;FEM1B;PPP1R3F;HMBOX1;EMP2
prerank,axoneme assembly (GO:0035082),0.20642766270567456,0.4928163254235676,0.9800918836140888,1.0,1.0,4/30,16.16%,RSPH1;TOGARAM1;FOXJ1;DNAI4
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.21416101808129723,0.4925830658952234,0.9844961240310077,1.0,1.0,3/23,7.68%,VEGFA;GDNF;SOX9
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.21388955064469312,0.49090897212055024,0.9843505477308294,1.0,1.0,2/24,4.89%,FXN;SUCLA2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.21264024049669222,-0.4902235294112193,0.9841986455981941,0.9985273305353719,1.0,2/10,15.44%,OS9;INSIG1
prerank,histone H2A acetylation (GO:0043968),0.22584111461573841,0.4889131064781708,0.967266775777414,1.0,1.0,3/16,12.55%,MSL3;RUVBL1;MORF4L1
prerank,cellular response to inorganic substance (GO:0071241),-0.17150407900861053,-0.4884791261586593,1.0,0.9980760994180033,1.0,8/21,32.10%,FOXO1;KCNC2;BLM;FMR1;CDK2;ATRX;TIMELESS;MTR
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.2398178904902195,0.4869119527524189,0.9582608695652174,1.0,1.0,1/11,5.82%,ATP1B1
prerank,mitotic DNA replication (GO:1902969),-0.20905629455563476,-0.4866666480447469,0.9885321100917431,0.9976523272059927,1.0,6/10,41.61%,GINS3;LIG1;CDC45;GINS1;MCM3;POLA1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.23358443188951655,0.48574935040870154,0.9525483304042179,1.0,1.0,12/12,76.66%,MCMDC2;MCM4;MCM7;MCM2;MCM6;GINS2;MCM5;MCM3;CDC45;GINS4;MUS81;CDC7
prerank,sensory perception of pain (GO:0019233),-0.16650382489166216,-0.48537656885804836,0.9917808219178083,0.9971236426017254,1.0,12/21,48.72%,RETREG1;SCN9A;MME;PTGES;TRPA1;CCR2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3;PROK2
prerank,regulation of neuron projection arborization (GO:0150011),0.22462895718174136,0.48455821316940634,0.9624183006535948,1.0,1.0,1/15,3.34%,FZD4
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.211529140833618,0.4840651862040469,0.9766355140186916,1.0,1.0,3/22,13.67%,DUSP3;CD300A;DGKZ
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.21884015548959612,0.48316953230863985,0.9788273615635179,1.0,1.0,3/17,12.98%,CALM1;SIRT2;DMTN
prerank,glial cell differentiation (GO:0010001),0.2027044878133056,0.47938438808332257,0.9867256637168141,1.0,1.0,7/28,18.80%,TPPP;SOX9;CDH2;FGF10;STAT3;SOX10;METRN
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.2252613865026747,0.4791688944979262,0.978441127694859,1.0,1.0,4/13,21.01%,AXL;GAS6;DHX9;TRIM44
prerank,positive regulation of response to stimulus (GO:0048584),0.19349654389516038,0.47847460609175974,0.9929178470254958,1.0,1.0,5/40,12.70%,CGAS;TGFB2;PRKCD;HOMER1;NSMCE4A
prerank,cell junction maintenance (GO:0034331),-0.18141469245604183,-0.47304725604512504,0.9878934624697336,0.998089445736133,1.0,7/14,42.02%,NLGN2;CLDN1;CHCHD10;CSF1R;F2R;CBLN1;PRTN3
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.17941671550066787,0.4679667246067075,0.9921875,1.0,1.0,10/55,16.90%,FHL1;PSMC6;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.1854783513717836,-0.46663640441427395,0.9878345498783455,0.9981139514546912,1.0,6/13,33.03%,UPP2;SMUG1;DUT;OGG1;TDG;NEIL1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.20415517209420633,0.4663292184812159,0.9817629179331308,1.0,1.0,7/22,19.69%,NEDD4;TSG101;VPS36;STAM;VPS4A;TOM1L1;VPS37A
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.18543937257048956,0.4639474234786699,0.9928977272727273,1.0,1.0,5/33,16.99%,TESC;RUNX1;ZFP36L1;PRKCA;ACIN1
prerank,negative regulation of cholesterol transport (GO:0032375),0.2263210784984687,0.4617992778236776,0.9664310954063604,1.0,1.0,1/10,11.08%,SREBF2
prerank,regulation of B cell activation (GO:0050864),0.19570266952594834,0.4617258454685444,0.9799691833590138,1.0,1.0,3/25,13.52%,SAMSN1;ZFP36L1;FOXJ1
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.19458262344445024,-0.459419909051574,0.9890829694323144,0.9982027666063161,1.0,7/10,59.16%,NCKAP1L;TLR4;VSIR;IL12A;PRNP;FOXP3;IL12B
prerank,regulation of oxidative phosphorylation (GO:0002082),0.21330092352707014,0.45917815014229435,0.9774305555555556,1.0,1.0,4/16,20.51%,COX7A2L;MLXIPL;UQCC2;SLC25A33
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.19439026700535122,0.45817804037805854,0.9871977240398293,1.0,1.0,4/29,19.07%,ZCWPW1;SYCP2;RAD21;TERB1
prerank,mitochondrial transcription (GO:0006390),0.22450879458757145,0.4580455760441258,0.9768683274021353,1.0,1.0,4/10,22.80%,TFB2M;TEFM;SLC25A33;TFAM
prerank,pigment granule transport (GO:0051904),0.204172141111133,0.45620058752399945,0.9793977812995246,1.0,1.0,6/18,24.21%,MREG;BLOC1S5;MLPH;BBS5;MYO5A;BBS7
prerank,melanosome transport (GO:0032402),0.204172141111133,0.45620058752399945,0.9793977812995246,1.0,1.0,6/18,24.21%,MREG;BLOC1S5;MLPH;BBS5;MYO5A;BBS7
prerank,cilium movement (GO:0003341),-0.1300388512962944,-0.45512149982834454,1.0,0.9979081694180711,1.0,31/47,50.92%,DNAAF5;ODAD1;CCDC39;DNHD1;SPEF2;GAS8;CFAP61;DNAH5;CFAP70;CFAP251;CFAP53;ROPN1L;ODAD2;CAMSAP3;ADCY10;SPAG17;ODAD3;SPA17;DNAH9;DNAAF2;ODAD4;TEKT2;CFAP100;CFAP206;RSPH9;CCDC40;DNAAF4;CCDC63;TTC29;CFAP91;TEKT5
prerank,pinocytosis (GO:0006907),0.2249331314891263,0.45486091251379224,0.9765765765765766,1.0,1.0,2/10,14.68%,MAPKAPK2;RAB34
prerank,negative regulation of centrosome duplication (GO:0010826),0.22366890789354404,0.45270566761377123,0.9822064056939501,1.0,1.0,5/11,24.76%,CCNF;RBM14;CENATAC;KAT2B;TRIM37
prerank,response to hydroxyurea (GO:0072710),0.22324253205215178,0.4512836206616185,0.9876106194690265,1.0,1.0,2/11,12.63%,KAT7;DDI2
prerank,outer dynein arm assembly (GO:0036158),0.2060283731147577,0.44671315228014036,0.9728813559322034,1.0,1.0,1/14,5.18%,DNAH17
prerank,cell differentiation in hindbrain (GO:0021533),-0.18335564344661687,-0.44645269749279043,0.9927360774818402,0.997966129696448,1.0,7/11,46.95%,OPHN1;GRID2;ATP7A;LHX1;CBLN1;CEND1;NOG
prerank,regulation of response to interferon-gamma (GO:0060330),0.20755615843259445,0.4461931500879641,0.9761092150170648,1.0,1.0,4/14,19.25%,STAT1;JAK2;PIAS1;SUMO1
prerank,DNA-dependent DNA replication (GO:0006261),0.15370094334460796,0.44494463092671127,1.0,1.0,1.0,20/128,17.43%,GMNN;DDX23;PSMC6;WRNIP1;PRIM2;PSME4;PSMB1;MCMDC2;PSMD5;POLD1;POLG;PSMB2;ORC2;PSMB7;PSMD3;SRPK2;PSMA2;MGME1;PSMD14;REV3L
prerank,mesoderm development (GO:0007498),0.20144751860487817,0.4446122734117821,0.9825396825396825,1.0,1.0,4/18,17.54%,VEGFA;IKZF1;JAK2;GDF11
prerank,response to hexose (GO:0009746),0.18766423268689095,0.43832182562173133,0.9924012158054711,1.0,1.0,1/25,3.34%,LPL
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.18186987000727012,0.4339963039484255,0.9954545454545455,1.0,1.0,4/29,15.26%,IL12RB1;RASGRP1;NECTIN2;STX7
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.20768302603568364,0.42759492817029804,0.9825783972125436,1.0,1.0,1/12,7.27%,PIBF1
prerank,phagosome-lysosome fusion (GO:0090385),-0.1820377418102932,-0.42732936677347577,0.9912854030501089,0.9985059811270655,1.0,3/10,29.86%,CLN3;SYT7;RAB39A
prerank,determination of left/right symmetry (GO:0007368),0.1696613334435562,0.42492674008485426,0.9971428571428571,1.0,1.0,7/36,17.66%,KIF3B;DNAH11;CITED2;FOXJ1;RFX3;DAND5;GALNT11
prerank,regulation of cilium movement (GO:0003352),0.21531341327677847,0.4244126429838166,0.9922928709055877,1.0,1.0,2/10,15.78%,DNAH11;CFAP43
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.19861789462799523,0.4204125454522564,0.9788273615635179,1.0,1.0,2/16,15.26%,IL12RB1;STX7
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.20153954038555033,0.4197916281768672,0.9982758620689656,1.0,1.0,4/13,21.99%,EDEM2;SLC51B;BCAP31;SEC16A
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.18869138767505078,0.418859359815007,0.9896907216494846,1.0,1.0,3/17,16.02%,IRS1;IRS2;STAT3
prerank,cellular response to interleukin-7 (GO:0098761),0.18869138767505078,0.418859359815007,0.9896907216494846,1.0,1.0,3/17,16.02%,IRS1;IRS2;STAT3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.17200643504851706,-0.4165322831727237,0.9929742388758782,0.998411780489065,1.0,6/11,52.32%,HDAC2;TAF7;CIITA;XBP1;PF4;IL4
prerank,B cell activation involved in immune response (GO:0002312),0.19925921275660724,0.41572040717321673,0.9947089947089947,1.0,1.0,13/13,80.09%,CD180;MSH2;RNF168;CD40LG;GPR183;GAPT;CD19;RNF8;FCGR2B;LIG4;BATF;EXOSC3;MSH6
prerank,axonemal dynein complex assembly (GO:0070286),0.1725755606151789,0.4139454983954775,0.9939024390243902,1.0,1.0,2/27,8.54%,DNAH17;CFAP73
prerank,phagolysosome assembly (GO:0001845),0.19787480915668468,0.41082513555312933,0.9872029250457038,1.0,1.0,6/12,25.66%,RAB14;RAB34;PIKFYVE;ARL8B;RAB7B;RAB7A
prerank,lipid droplet organization (GO:0034389),0.1761250144403614,0.40686440984037653,0.9954337899543378,1.0,1.0,3/22,15.00%,AUP1;PNPLA3;PLA2G4C
prerank,neutrophil chemotaxis (GO:0030593),0.15136098980160678,0.40627354356091755,1.0,1.0,1.0,10/53,22.41%,CCL5;TGFB2;CCL14;S100A8;S100A9;CCL25;CCL19;PIKFYVE;PPIB;CCL13
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.19717478235587677,0.3867311370453021,0.9962049335863378,1.0,1.0,2/10,14.82%,SIRT2;KNSTRN
prerank,receptor recycling (GO:0001881),0.19162691438614102,0.38333691472778036,0.9887429643527205,1.0,1.0,10/10,80.85%,PLEKHJ1;ARFGEF2;NSG1;RAB11B;LMTK2;SORL1;PHETA2;REP15;PHETA1;EHD3
prerank,nuclear transport (GO:0051169),0.17325234073983795,0.37569690199614975,0.9932885906040269,1.0,1.0,5/16,23.13%,AAAS;NUP98;XPO1;ANP32A;RBM15B
prerank,nucleocytoplasmic transport (GO:0006913),0.14726636035709442,0.3655511966170514,0.9986541049798116,1.0,1.0,9/40,21.68%,ATXN1;AAAS;LSG1;NUP98;XPO1;SNRPD3;GEMIN6;SNUPN;ANP32A
prerank,tRNA wobble uridine modification (GO:0002098),0.16930647859666803,0.3592998099318577,0.9983050847457627,1.0,1.0,2/14,15.85%,DPH3;ELP3
prerank,tetrapyrrole metabolic process (GO:0033013),0.16183119819140918,0.3582523427403037,0.9984591679506933,1.0,1.0,18/18,83.84%,ABCD4;MMAB;MMAA;ABCC1;MMACHC;CBLIF;CTRC;AMN;TCN1;MTRR;TCN2;ABCB6;MMADHC;CD320;MTR;MMUT;CUBN;LMBRD1
prerank,cobalamin metabolic process (GO:0009235),0.16182103610675042,0.3568241087252449,0.9968553459119497,1.0,1.0,17/17,83.84%,ABCD4;MMAB;MMAA;ABCC1;MMACHC;CBLIF;CTRC;AMN;TCN1;MTRR;TCN2;MMADHC;CD320;MTR;MMUT;CUBN;LMBRD1
prerank,dendritic cell differentiation (GO:0097028),0.15793960832443976,0.35179732125660046,1.0,1.0,1.0,3/22,13.57%,AXL;TRPM2;GAS6
prerank,tRNA wobble base modification (GO:0002097),0.16429843999799618,0.3493219039635486,0.9982847341337907,0.9999372180406542,1.0,2/14,15.85%,DPH3;ELP3
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.15825406675006165,0.3463169003413575,0.9966101694915255,0.9995959404245497,1.0,15/16,65.44%,MCMDC2;MCM4;MCM7;MCM2;PURA;SSBP1;RECQL;MCM6;RECQL5;RECQL4;HMGA1;WRN;TWNK;RPA1;RAD51
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.12618816845125408,0.3097654594924717,1.0,0.9998340436266114,1.0,7/32,23.16%,FAM3A;RNASE3;S100A9;RPL30;ROMO1;CCL13;GAPDH
